Citrus Sinensis ID: 012739

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------
Protein Sequence
METSNSTAIAPDAKSSHAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPSH
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHccccccccEEcccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEEccccEEEEEEEcccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHcHcHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHHHEEccccccccHcHccHHEEcccccccEEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
metsnstaiapdaksshahhkhylhnnsvsdqshvhrhAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKsssedshgssfkdnksgssRFIAHMTinstcspdvkgwcfngghvrsnnvlpaapttaynyvrdkGVVQVFTYKELETatenfsegnvigngGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLliseympngtlqqhlhrhnnryrpldwRTRLIIALDCAMALEFlhehatppvihrdfkcsnvlldqnfraKVTDFGLAKMvsdkingqistrvlgttgylapeyastgklttksdvYSYGVVLLELLtgrvpvdpnrppgehvlvswalprltsreeavemvdpslqgqypkkdLIQIAAIAAVCvqpeaayrplMTDVVQSLIPvvknnaagaisfgssrfqhqtpspsh
Flexible Loop (DISEMBL)
metsnstaiapdakssHAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKsssedshgssfkdnksgsSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETatenfsegnvigNGGFGVVYKGVLSDGTVAAIKKlhrdgkqreRAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAkmvsdkingqistrvlgttgYLAPEyastgklttksdVYSYGVVLLELLTGrvpvdpnrppgehVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFgssrfqhqtpspsh
Low Complexity Region (SEG)
METSNSTAIAPDAKSSHAHHKHYLHNNSVSDQSHVHRHAilsfhsiiiiivsvisvivlvallllvlmlrrlksssEDSHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEgnvignggfgvvYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLiqiaaiaaVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPSH
Disordered region (IsUnstruct)
*********************************HVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRR**********************FIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN**PGEHVLVSWALPRLTS*******V***LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAIS***************
Disordered Region (DISOPRED)
**********************************************IIIIVSVISVIVLVALLLLVLM*************************************************************************QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP**PPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI***************************
Disordered Region (DISEMBL)
*******************HKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLK****************GSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGS************
Disordered Region (DISPRO)
*****************************************SFHSIIIIIVSVISVIVLVALLLLVLMLRRL******************************************************************GVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METSNSTAIAPDAKSSHAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPSH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	457	2.2.26 [Sep-21-2011]
Q9SFT7	414	Serine/threonine-protein	no	no	0.673	0.743	0.512	2e-83
Q9FE20	456	Serine/threonine-protein	no	no	0.628	0.629	0.520	6e-83
Q8RWW0	744	Receptor-like serine/thre	no	no	0.619	0.380	0.536	2e-81
Q9LQQ8	423	Probable serine/threonine	no	no	0.632	0.683	0.5	6e-79
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.619	0.415	0.501	1e-77
P43293	389	Probable serine/threonine	no	no	0.663	0.778	0.448	3e-77
Q9LFP7	493	Probable receptor-like pr	no	no	0.673	0.624	0.431	2e-76
Q9C660	762	Proline-rich receptor-lik	no	no	0.665	0.398	0.470	6e-76
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.794	0.511	0.416	6e-76
Q9SGY7	718	Putative proline-rich rec	no	no	0.619	0.394	0.498	7e-76

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  309 bits (792), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 165/322 (51%), Positives = 210/322 (65%), Gaps = 14/322 (4%)

Query: 120 SNNVLPAAPTTA----YNYVRDKGVV-----QVFTYKELETATENFSEGNVIGNGGFGVV 170
           +N   P  P T      N   DK V      Q F+++EL TAT+NF +  +IG GGFG V
Sbjct: 34  NNKTHPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRV 93

Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           YKG L   G + A+K+L R+G Q  + F +EV +LS LH   LV L+GYCAD + RLL+ 
Sbjct: 94  YKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVY 153

Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EYM  G+L+ HL        PLDW TR+ IAL  AM LE+LH+ A PPVI+RD K +N+L
Sbjct: 154 EYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANIL 213

Query: 290 LDQNFRAKVTDFGLAKM--VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGV 347
           LD  F AK++DFGLAK+  V DK    +S+RV+GT GY APEY  TG+LTTKSDVYS+GV
Sbjct: 214 LDGEFNAKLSDFGLAKLGPVGDK--QHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGV 271

Query: 348 VLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAI 407
           VLLEL+TGR  +D  RP  E  LV+WA P         E+ DPSL+G +P+K L Q  A+
Sbjct: 272 VLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAV 331

Query: 408 AAVCVQPEAAYRPLMTDVVQSL 429
           AA+C+Q EA  RPLM+DVV +L
Sbjct: 332 AAMCLQEEATVRPLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  308 bits (789), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 150/288 (52%), Positives = 194/288 (67%), Gaps = 1/288 (0%)

Query: 143 VFTYKELETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEV 201
            F ++EL  AT NF     +G GGFG VYKG L S G V A+K+L R+G Q  R F +EV
Sbjct: 73  TFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEV 132

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
            +LS LH P LV L+GYCAD + RLL+ E+MP G+L+ HLH        LDW  R+ IA 
Sbjct: 133 LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAA 192

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
             A  LEFLH+ A PPVI+RDFK SN+LLD+ F  K++DFGLAK+        +STRV+G
Sbjct: 193 GAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMG 252

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR 381
           T GY APEYA TG+LT KSDVYS+GVV LEL+TGR  +D   P GE  LV+WA P    R
Sbjct: 253 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDR 312

Query: 382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
            + +++ DP L+G++P + L Q  A+A++C+Q +AA RPL+ DVV +L
Sbjct: 313 RKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  303 bits (776), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 155/289 (53%), Positives = 199/289 (68%), Gaps = 6/289 (2%)

Query: 141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRME 200
           V+ FT  ELE AT+ FS   V+G GGFG VY+G + DGT  A+K L RD + R+R F  E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
           V++LSRLH   LV+L+G C +   R LI E + NG+++ HLH        LDW  RL IA
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT-----LDWDARLKIA 448

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
           L  A  L +LHE + P VIHRDFK SNVLL+ +F  KV+DFGLA+  ++  +  ISTRV+
Sbjct: 449 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVM 507

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
           GT GY+APEYA TG L  KSDVYSYGVVLLELLTGR PVD ++P GE  LV+WA P L +
Sbjct: 508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLAN 567

Query: 381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           RE   ++VDP+L G Y   D+ ++AAIA++CV  E ++RP M +VVQ+L
Sbjct: 568 REGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  295 bits (754), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 145/290 (50%), Positives = 194/290 (66%), Gaps = 1/290 (0%)

Query: 141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRM 199
            Q FT++EL  AT NF     +G GGFG V+KG +     V AIK+L R+G Q  R F +
Sbjct: 88  AQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVV 147

Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV  LS    P LV+L+G+CA+ + RLL+ EYMP G+L+ HLH   +  +PLDW TR+ I
Sbjct: 148 EVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKI 207

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A   A  LE+LH+  TPPVI+RD KCSN+LL ++++ K++DFGLAK+        +STRV
Sbjct: 208 AAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRV 267

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT 379
           +GT GY AP+YA TG+LT KSD+YS+GVVLLEL+TGR  +D  +   +  LV WA P   
Sbjct: 268 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFK 327

Query: 380 SREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
            R    +MVDP LQGQYP + L Q  AI+A+CVQ +   RP+++DVV +L
Sbjct: 328 DRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLAL 377

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  290 bits (743), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 146/291 (50%), Positives = 194/291 (66%), Gaps = 8/291 (2%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
           F+Y EL   T  FSE N++G GGFG VYKGVLSDG   A+K+L   G Q ER F+ EV++
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP-LDWRTRLIIALD 262
           +SR+H   LV L+GYC  + HRLL+ +Y+PN TL  HLH      RP + W TR+ +A  
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPG---RPVMTWETRVRVAAG 443

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-KINGQISTRVLG 321
            A  + +LHE   P +IHRD K SN+LLD +F A V DFGLAK+  +  +N  +STRV+G
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL--- 378
           T GY+APEYA++GKL+ K+DVYSYGV+LLEL+TGR PVD ++P G+  LV WA P L   
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query: 379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              EE  E+VDP L   +   ++ ++   AA CV+  AA RP M+ VV++L
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  289 bits (740), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 144/321 (44%), Positives = 210/321 (65%), Gaps = 18/321 (5%)

Query: 126 AAPTTAYNYV-RDKGVV------QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSD- 177
            + T +++Y+ R +G +      + F+  EL++AT NF   +V+G GGFG V+KG + + 
Sbjct: 31  GSSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDES 90

Query: 178 ---------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
                    G V A+K+L+++G Q  R +  E++ L +L  P LV+L+GYC ++ HRLL+
Sbjct: 91  SLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLV 150

Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
            E+M  G+L+ HL R    Y+PL W TR+ +AL  A  L FLH +A P VI+RDFK SN+
Sbjct: 151 YEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNI 209

Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           LLD N+ AK++DFGLA+      N  +STRV+GT GY APEY +TG L+ KSDVYS+GVV
Sbjct: 210 LLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVV 269

Query: 349 LLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIA 408
           LLELL+GR  +D N+P GEH LV WA P LT++   + ++DP LQGQY     ++IA +A
Sbjct: 270 LLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLA 329

Query: 409 AVCVQPEAAYRPLMTDVVQSL 429
             C+  +A  RP M ++V+++
Sbjct: 330 LDCISIDAKSRPTMNEIVKTM 350

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  286 bits (733), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 147/341 (43%), Positives = 204/341 (59%), Gaps = 33/341 (9%)

Query: 141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSD----------GTVAAIKKLHRDG 190
           ++ FT+ +L+ +T NF   +++G GGFG V+KG + +          G   A+K L+ DG
Sbjct: 127 LRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG 186

Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
            Q  + +  E++ L  L  P LV+L+GYC + + RLL+ E+MP G+L+ HL R   R  P
Sbjct: 187 LQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLP 243

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           L W  R+ IAL  A  L FLHE A  PVI+RDFK SN+LLD ++ AK++DFGLAK   D+
Sbjct: 244 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDE 303

Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
               +STRV+GT GY APEY  TG LT+KSDVYS+GVVLLE+LTGR  +D NRP GEH L
Sbjct: 304 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 363

Query: 371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI 430
           V WA P L  +     ++DP L+G +  K   ++  +AA C+  +   RP M+DVV++L 
Sbjct: 364 VEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALK 423

Query: 431 PV--------------------VKNNAAGAISFGSSRFQHQ 451
           P+                    +KN +  +  FGS   QHQ
Sbjct: 424 PLPHLKDMASSSYYFQTMQAERLKNGSGRSQGFGSRNGQHQ 464

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  285 bits (729), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 146/310 (47%), Positives = 197/310 (63%), Gaps = 6/310 (1%)

Query: 142 QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
           ++F+Y+EL  AT  FS+ N++G GGFG VYKGVL D  V A+K+L   G Q +R F+ EV
Sbjct: 416 ELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEV 475

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
           D +SR+H   L+ ++GYC  +N RLLI +Y+PN  L  HLH        LDW TR+ IA 
Sbjct: 476 DTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWATRVKIAA 533

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
             A  L +LHE   P +IHRD K SN+LL+ NF A V+DFGLAK+  D  N  I+TRV+G
Sbjct: 534 GAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALD-CNTHITTRVMG 592

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL--- 378
           T GY+APEYAS+GKLT KSDV+S+GVVLLEL+TGR PVD ++P G+  LV WA P L   
Sbjct: 593 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNA 652

Query: 379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA 438
           T  EE   + DP L   Y   ++ ++   AA C++  A  RP M+ +V++   + + +  
Sbjct: 653 TETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLT 712

Query: 439 GAISFGSSRF 448
             +  G S  
Sbjct: 713 NGMRLGESEI 722

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  285 bits (728), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 167/401 (41%), Positives = 230/401 (57%), Gaps = 38/401 (9%)

Query: 53  VISVIVLVALLLLVLMLRRLKSSSEDSH--------------------GSSFKDNKSGSS 92
            I+   ++AL+ +V ++RR K  + D++                    G +     SG  
Sbjct: 240 AIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPG 299

Query: 93  RFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETA 152
            + +    NS  S         GG+ RS     +AP +A   V   G    FTY+EL   
Sbjct: 300 GYNSQQQSNSGNS--FGSQRGGGGYTRSG----SAPDSA---VMGSGQTH-FTYEELTDI 349

Query: 153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
           TE FS+ N++G GGFG VYKG L+DG + A+K+L     Q +R F+ EV+++SR+H   L
Sbjct: 350 TEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHL 409

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP-LDWRTRLIIALDCAMALEFLH 271
           V L+GYC   + RLLI EY+PN TL+ HLH    + RP L+W  R+ IA+  A  L +LH
Sbjct: 410 VSLVGYCIADSERLLIYEYVPNQTLEHHLH---GKGRPVLEWARRVRIAIGSAKGLAYLH 466

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
           E   P +IHRD K +N+LLD  F A+V DFGLAK+ +D     +STRV+GT GYLAPEYA
Sbjct: 467 EDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKL-NDSTQTHVSTRVMGTFGYLAPEYA 525

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA---VEMV 388
            +GKLT +SDV+S+GVVLLEL+TGR PVD  +P GE  LV WA P L    E     E+V
Sbjct: 526 QSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELV 585

Query: 389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           D  L+  Y + ++ ++   AA CV+     RP M  VV++L
Sbjct: 586 DRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  285 bits (728), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 144/289 (49%), Positives = 190/289 (65%), Gaps = 6/289 (2%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
           FTY+EL   TE F +  V+G GGFG VYKG+L +G   AIK+L     +  R F+ EV++
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           +SR+H   LV L+GYC  + HR LI E++PN TL  HLH  N     L+W  R+ IA+  
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKN--LPVLEWSRRVRIAIGA 475

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  L +LHE   P +IHRD K SN+LLD  F A+V DFGLA++ +D     ISTRV+GT 
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARL-NDTAQSHISTRVMGTF 534

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL---TS 380
           GYLAPEYAS+GKLT +SDV+S+GVVLLEL+TGR PVD ++P GE  LV WA PRL     
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594

Query: 381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           + +  E+VDP L+  Y + ++ ++   AA CV+  A  RP M  VV++L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
225451019	438	PREDICTED: receptor-like serine/threonin	0.894	0.933	0.687	1e-155
351727421	441	protein kinase [Glycine max] gi|22345240	0.949	0.984	0.627	1e-151
224123230	434	predicted protein [Populus trichocarpa]	0.879	0.926	0.678	1e-150
356535105	441	PREDICTED: receptor-like serine/threonin	0.945	0.979	0.624	1e-149
357441597	446	Protein kinase 2B [Medicago truncatula]	0.945	0.968	0.618	1e-148
449436012	432	PREDICTED: receptor-like serine/threonin	0.919	0.972	0.666	1e-145
297848062	460	predicted protein [Arabidopsis lyrata su	0.816	0.810	0.635	1e-131
242087857	473	hypothetical protein SORBIDRAFT_09g01962	0.846	0.818	0.594	1e-128
115463747	491	Os05g0398800 [Oryza sativa Japonica Grou	0.763	0.710	0.611	1e-128
218196756	491	hypothetical protein OsI_19878 [Oryza sa	0.763	0.710	0.611	1e-128

>gi|225451019|ref|XP_002281041.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2 [Vitis vinifera] gi|296088299|emb|CBI36744.3| unnamed protein product [Vitis vinifera]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 291/423 (68%), Positives = 333/423 (78%), Gaps = 14/423 (3%)

Query: 32  QSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKSGS 91
           Q   H H IL   S+++II+  IS+++LVA++++V+MLRRLKS+    +  S   +    
Sbjct: 27  QPDTHHHGILPSDSMLVIIIPTISILLLVAIIVIVIMLRRLKSAKNRGNSKSNSSSSGNQ 86

Query: 92  SR-FIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELE 150
           +  FIAH  IN   SPDVK  C  GG +      PA+        R KGV QVFTYKELE
Sbjct: 87  NCNFIAHTAINFNSSPDVKSGCLYGGSLIRT---PAS--------RFKGV-QVFTYKELE 134

Query: 151 TATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP 210
            AT+ FSE NVIGNGGFGVVY+GVLSDGTVAAIK L RDGKQ ERAFRMEVDLL+RLHS 
Sbjct: 135 MATDKFSEANVIGNGGFGVVYRGVLSDGTVAAIKVLRRDGKQGERAFRMEVDLLTRLHSL 194

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            LVELLGYCADQ++RLLI EYMPNGTLQ  LH  +N+ R LDW TRL +ALDCA ALEFL
Sbjct: 195 YLVELLGYCADQHYRLLIFEYMPNGTLQSQLHPSHNQQRVLDWGTRLRVALDCARALEFL 254

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           HEHA P +IHRDFK SN+LLDQNFRAKV+DFGLAK  SDKIN QI TRV+GTTGYLAPEY
Sbjct: 255 HEHAVPSIIHRDFKPSNILLDQNFRAKVSDFGLAKTSSDKINSQIPTRVIGTTGYLAPEY 314

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
           AS+GKLTTKSDVYSYGVVLLELLTGRVP+D  RPPGE VLVSWALPRLT+R++ VEMVDP
Sbjct: 315 ASSGKLTTKSDVYSYGVVLLELLTGRVPLDTKRPPGEDVLVSWALPRLTNRQKLVEMVDP 374

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQH 450
           +LQG+Y KKDLIQIAAIAAVCVQ EA YRPLMTDVVQSLIP+VKN+++   S  SSRFQ 
Sbjct: 375 ALQGRYSKKDLIQIAAIAAVCVQHEADYRPLMTDVVQSLIPLVKNHSS-VSSSCSSRFQM 433

Query: 451 QTP 453
            +P
Sbjct: 434 LSP 436

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727421|ref|NP_001237672.1| protein kinase [Glycine max] gi|223452406|gb|ACM89530.1| protein kinase [Glycine max]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 291/464 (62%), Positives = 346/464 (74%), Gaps = 30/464 (6%)

Query: 1   METSNSTAI-APDAKSSHAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVL 59
           ME + +T + A     +H++  H+LH+     + H H H      +I+III  V  V VL
Sbjct: 1   MEVNTTTTVPAGPPTRNHSYTPHHLHS-----ERHSHSHGHFPSKTILIIIALVTLVTVL 55

Query: 60  VALLLLVLMLRRLKSSSEDSHGSSFKDNKS---GSSRFIAHMTINSTCSPDVKGWCFNGG 116
             + +++ ++RR KS S++  G+  +D++     SSR I   T+NS  SPDVK  C NGG
Sbjct: 56  FIIFVVLFLIRRQKSFSKN--GTCEEDSRELHDTSSRLITSTTLNS--SPDVKSGCLNGG 111

Query: 117 HVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGN---GGFGVVYKG 173
           +      L   P   +     +GV QVFTY+ELE AT+ FSE NVIG+   GG G++Y+G
Sbjct: 112 N------LSRTPAPKF-----RGV-QVFTYRELEIATDGFSEANVIGSNGIGGHGLMYRG 159

Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           VLSDGT+AAIK LH +GKQ ERAFR+ VDLLSRLHSP  VELLGYCADQ+HRLLI EYMP
Sbjct: 160 VLSDGTMAAIKLLHTEGKQGERAFRIAVDLLSRLHSPHSVELLGYCADQHHRLLIFEYMP 219

Query: 234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
           NGTL  HLH  N++ RPLDW  R+ IALDCA ALEFLHEHA  PVIHRDFK +NVLLDQN
Sbjct: 220 NGTLHYHLHTLNDQTRPLDWWARMRIALDCARALEFLHEHAVSPVIHRDFKSNNVLLDQN 279

Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            RAKV+DFGL KM SDK NGQ+STR+LGTTGYLAPEYA  GKLTTKSDVYSYGVVLLELL
Sbjct: 280 LRAKVSDFGLPKMGSDKRNGQVSTRMLGTTGYLAPEYA-MGKLTTKSDVYSYGVVLLELL 338

Query: 354 TGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQ 413
           TGRVPVD  R PGEHVLVSWALPRLT+RE+ +EMVDP+L+GQY KKDLIQIAAIAA+C+Q
Sbjct: 339 TGRVPVDIKRAPGEHVLVSWALPRLTNREKVIEMVDPALRGQYSKKDLIQIAAIAAMCIQ 398

Query: 414 PEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPSH 457
           PEA YRPLMTDVVQSLIP+V+N ++   S  S RFQ QTPSPSH
Sbjct: 399 PEADYRPLMTDVVQSLIPLVRNQSS-LSSSSSLRFQKQTPSPSH 441

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224123230|ref|XP_002319027.1| predicted protein [Populus trichocarpa] gi|222857403|gb|EEE94950.1| predicted protein [Populus trichocarpa]

 Score =  536 bits (1381), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 285/420 (67%), Positives = 333/420 (79%), Gaps = 18/420 (4%)

Query: 16  SHAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSS 75
           SH +H +  H  S+  Q H H H ILS  SI+III+S ISV++++ + L++ MLRRLKSS
Sbjct: 12  SHGNHTNKHH--SLHSQLHDHHHGILSSTSILIIIISAISVVLVLTIFLIIAMLRRLKSS 69

Query: 76  SEDSHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYV 135
              + GS    +   +S+F+AH  I+ T SPDV G C  G     +N+    P+      
Sbjct: 70  K--NRGSCRDLSSCNTSKFVAHTNISFTSSPDVNGGCLYG-----SNLGHKPPS------ 116

Query: 136 RDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER 195
           + KGV QVFTYKELE AT  FS  NVIGNGG+GVVY+G LSDGTVAAIK LHR+GKQ ER
Sbjct: 117 KHKGV-QVFTYKELEIATNKFSASNVIGNGGYGVVYRGTLSDGTVAAIKMLHREGKQGER 175

Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
           AFR+E +LLSRLHSP LVELLGYCADQNHRLLI E+M NG+LQ HLH  + +YRPL+W T
Sbjct: 176 AFRVEANLLSRLHSPYLVELLGYCADQNHRLLIFEFMHNGSLQHHLH--HKQYRPLEWGT 233

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
           RL IAL CA ALEFLHEH  P VIHRD KCSN+LLDQ+FRAKV+DFGLAKM SD+INGQ 
Sbjct: 234 RLRIALGCARALEFLHEHTIPAVIHRDLKCSNILLDQDFRAKVSDFGLAKMGSDRINGQN 293

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL 375
           STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLL++LTGR+P+D  RP GEHVLVSWAL
Sbjct: 294 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLQILTGRIPIDTKRPSGEHVLVSWAL 353

Query: 376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN 435
           PRLT+R++ +EMVDP+LQGQY  KDLIQ+AAIAAVCVQPEA YRPLMTDVVQSL+P+VKN
Sbjct: 354 PRLTNRDKVMEMVDPALQGQYLMKDLIQVAAIAAVCVQPEADYRPLMTDVVQSLVPLVKN 413

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535105|ref|XP_003536089.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max]

 Score =  536 bits (1380), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 291/466 (62%), Positives = 346/466 (74%), Gaps = 34/466 (7%)

Query: 1   METSNSTAIAPDAKSS--HAHHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIV 58
           ME + +T   P    +  H++ +H LH+      SH H H      +I+III  V  V V
Sbjct: 1   MEVNTTTTTVPSGPPTRNHSYTQHRLHSER---HSHNHSHGHFPSKTILIIIAFVTLVTV 57

Query: 59  LVALLLLVLMLRRLKSSSEDSHGSSFKDNKS---GSSRFIAHMTINSTCSPDVKGWCFNG 115
           L  + +++ ++RR KSSS++  G+  +D++     SSR I   T+NS  SPDVK  C +G
Sbjct: 58  LFIIFVVLFLIRRQKSSSKN--GTCEEDSRELHDTSSRLITSTTLNS--SPDVKSGCLHG 113

Query: 116 GHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGN----GGFGVVY 171
           G+      L   P   +     +GV QVFTY+ELE AT+ FSE NVIG+    GG G++Y
Sbjct: 114 GN------LSRTPAPKF-----RGV-QVFTYRELEIATDGFSEANVIGSNGIIGGHGLIY 161

Query: 172 KGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY 231
           +GVLSDGT+AAIK L  +GKQ ERAFR+EVDLLSRLHSP LVELLGYCADQ+HRLLI EY
Sbjct: 162 RGVLSDGTLAAIKLLRTEGKQGERAFRIEVDLLSRLHSPHLVELLGYCADQHHRLLIFEY 221

Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           MPNGTL  HLH  N++Y+ LDW  R+ IALDCA ALEFLHEHA  PVIHRDFK +NVLLD
Sbjct: 222 MPNGTLHYHLHTPNDQYQLLDWWARMRIALDCARALEFLHEHAVSPVIHRDFKSNNVLLD 281

Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
           QNFRAKV+DFGLAKM S+K NG    RVLGTTGYLAPEYA TGKLTTKSDVYSYGVVLLE
Sbjct: 282 QNFRAKVSDFGLAKMGSEKRNG----RVLGTTGYLAPEYA-TGKLTTKSDVYSYGVVLLE 336

Query: 352 LLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVC 411
           LLTGRVPVD  R PGEHVLVSWALPRLT+RE+ +EMVDP+L+GQY KKDLIQIAAIAA+C
Sbjct: 337 LLTGRVPVDIKRAPGEHVLVSWALPRLTNREKVIEMVDPALRGQYSKKDLIQIAAIAAMC 396

Query: 412 VQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPSH 457
           +QPEA YRPLMTDVVQSLIP+V+N ++   S  S RFQ QTPSP+H
Sbjct: 397 IQPEADYRPLMTDVVQSLIPLVRNQSS-LSSSSSLRFQKQTPSPTH 441

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357441597|ref|XP_003591076.1| Protein kinase 2B [Medicago truncatula] gi|355480124|gb|AES61327.1| Protein kinase 2B [Medicago truncatula]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 289/467 (61%), Positives = 339/467 (72%), Gaps = 35/467 (7%)

Query: 1   METSNSTAI--APDAKSSH----AHHKHYLHNNSVSDQSHVHRH-AILSFHSIIIIIVSV 53
           ME ++ST +   P   S+      HH H+LH+     +   H H     F +IIIII  V
Sbjct: 1   MEVNSSTTVPAGPPTISTKNHTFIHHYHHLHS-----EKDYHNHVGHFPFKTIIIIITMV 55

Query: 54  ISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKS-----GSSRFIAHMTINSTCSPDV 108
             +++L  + L+V ++RR KSSS++  G    D +S      S R IA   ++   SPDV
Sbjct: 56  ALIMLLFTIFLVVCLIRRQKSSSKN--GVCKDDCESRVLHDTSRRHIAPTILSFDSSPDV 113

Query: 109 KGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGF- 167
           KG C  GG     N+    PT  +     +GV QVFTY+ELE AT  F+E N IGNGG  
Sbjct: 114 KGGCLYGG-----NLSRTPPTPKF-----RGV-QVFTYRELEVATNGFNEANEIGNGGIN 162

Query: 168 GVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL 227
           G++YKGVLSDGT+AAIK L  +GKQ ERAFR+EVDLLS+L SP LVELLGYCADQ+HRLL
Sbjct: 163 GLMYKGVLSDGTLAAIKLLQSEGKQGERAFRIEVDLLSQLRSPYLVELLGYCADQHHRLL 222

Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           I EYMPNGTLQ HLH  N++ +PLDW +R+ IALDCA ALEFLHEHA  PVIHRDFK  N
Sbjct: 223 IFEYMPNGTLQHHLHSLNDKTQPLDWWSRMRIALDCARALEFLHEHAVSPVIHRDFKTYN 282

Query: 288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGV 347
           VLLDQNFRAKV DFGLA M S+K NGQ+STRVLGTTGYLAPEYASTGKLTTKSDVYSYGV
Sbjct: 283 VLLDQNFRAKVADFGLANMGSEKRNGQVSTRVLGTTGYLAPEYASTGKLTTKSDVYSYGV 342

Query: 348 VLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAI 407
           VLLELLTGRVPVD  RP GEHVLVSWALPRLT+RE+ VEMVDP L GQY KK L+Q+AAI
Sbjct: 343 VLLELLTGRVPVDIKRPTGEHVLVSWALPRLTNREKVVEMVDPVLHGQYSKKALVQVAAI 402

Query: 408 AAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPS 454
           AA+C+QPEA YRPLMTDVVQSLIP+V+ ++  +    S RFQ Q PS
Sbjct: 403 AAMCIQPEADYRPLMTDVVQSLIPLVRAHSLSS----SLRFQKQIPS 445

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436012|ref|XP_004135788.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] gi|449518769|ref|XP_004166408.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus]

 Score =  520 bits (1339), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 292/438 (66%), Positives = 339/438 (77%), Gaps = 18/438 (4%)

Query: 1   METSNSTAIAPDAKSSHAHHKHYLHNNSVSDQSHVHRH-AILSFHSIIIIIVSVISVIVL 59
           ME +N++   P       H  +  HNNS   Q H H H AILS +SI+III S+IS+ +L
Sbjct: 1   MEVNNNSRTLPPPPPPRTHFHN--HNNSKPHQ-HFHTHNAILSSNSILIIIASIISITIL 57

Query: 60  VALLLLVLMLRRLKSSSEDSHGSSFKDNKSGSSRFI-AHMTINSTCSPDVKGW-CFNGGH 117
           +A+ LL+ ML RLKS+   +  +S     + S+ FI  H TIN   SP+VKG  C  GG 
Sbjct: 58  LAIFLLIFMLLRLKSARNTATATSASSATTQSTTFIIPHTTINFDSSPEVKGGGCLYGG- 116

Query: 118 VRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSD 177
             ++  +P          R +GV QVFTYKELE AT+NFSE NVIGNG  G VY+GVL+D
Sbjct: 117 --NSGRIPQ--------YRIRGV-QVFTYKELELATDNFSEANVIGNGRLGFVYRGVLAD 165

Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G V AIK LHRDGKQRER+FRMEVDLLSRLHSP LVELLGYCADQ+HRLLI E+M NGTL
Sbjct: 166 GAVVAIKMLHRDGKQRERSFRMEVDLLSRLHSPCLVELLGYCADQHHRLLIFEFMHNGTL 225

Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
             HLH  N+  +PLDW TRL IALDCA ALEFLHEHA P VIHR+FKC+NVLLDQ+ RAK
Sbjct: 226 HHHLHNPNSESQPLDWNTRLRIALDCAKALEFLHEHAVPSVIHRNFKCTNVLLDQDLRAK 285

Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           V+DFG AKM SDKINGQIST+VLGTTGYLAPEYASTGKLTTKSDVYS+GVVLLELLTGRV
Sbjct: 286 VSDFGSAKMGSDKINGQISTQVLGTTGYLAPEYASTGKLTTKSDVYSFGVVLLELLTGRV 345

Query: 358 PVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAA 417
           PVD  RP GEHVLVSWALPRLT+RE+  +M+DP++QG+Y KKDLIQ+AAIAA+CVQPEA 
Sbjct: 346 PVDIKRPQGEHVLVSWALPRLTNREKVEKMIDPAIQGKYSKKDLIQVAAIAAMCVQPEAD 405

Query: 418 YRPLMTDVVQSLIPVVKN 435
           YRPLMTDVVQSL+P+VKN
Sbjct: 406 YRPLMTDVVQSLVPLVKN 423

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297848062|ref|XP_002891912.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297337754|gb|EFH68171.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 248/390 (63%), Positives = 293/390 (75%), Gaps = 17/390 (4%)

Query: 71  RLKSSSEDSHGSSFKDNKSGSSRFIAHMTINSTCSPD-VKGWCFNGGHVRSNNVLPAAPT 129
           RLKS+ + +   S K++ +  +        + T SPD +K  C    +  S   LP   T
Sbjct: 62  RLKSARDKAQELSCKESFNNMNNGGTSTNYSYTSSPDDIKRDCLYSRNPTSFRQLPQQ-T 120

Query: 130 TAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLH-- 187
            +    R +GV +V+TYKELE AT NFSEG  IG+GG+G VYKGVL DGTVAAIKKLH  
Sbjct: 121 KSCRRSRAEGV-EVYTYKELEIATNNFSEGKKIGSGGYGDVYKGVLRDGTVAAIKKLHML 179

Query: 188 ----RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR 243
                + K  ER+FR+EVDLLSRL  P LVELLGYCADQ HR+LI EYMPNGTL+ HLH 
Sbjct: 180 NDNASNQKHEERSFRLEVDLLSRLQCPYLVELLGYCADQTHRILIFEYMPNGTLEHHLHD 239

Query: 244 HN-----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
           H+     ++ +PLDW TRL IALDCA ALEFLHE+    VIHR+FKC+N+LLDQN RAKV
Sbjct: 240 HSCKNLKDQSQPLDWGTRLRIALDCARALEFLHENTVSTVIHRNFKCTNILLDQNNRAKV 299

Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +DFGLAK  SDK+NG+ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG+VLL+LLTGR P
Sbjct: 300 SDFGLAKTGSDKLNGEISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGIVLLQLLTGRTP 359

Query: 359 VDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAY 418
           +D  RP G+ VLVSWALPRLT+RE+  EMVDP+++GQY +KDLIQ+AAIAAVCVQPEA+Y
Sbjct: 360 IDSRRPRGQDVLVSWALPRLTNREKISEMVDPTMKGQYSQKDLIQVAAIAAVCVQPEASY 419

Query: 419 RPLMTDVVQSLIPVVKNNAAGAISFGSSRF 448
           RPLMTDVV SLIP+VK   A   S  SSRF
Sbjct: 420 RPLMTDVVHSLIPLVK---AFNKSTESSRF 446

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242087857|ref|XP_002439761.1| hypothetical protein SORBIDRAFT_09g019620 [Sorghum bicolor] gi|241945046|gb|EES18191.1| hypothetical protein SORBIDRAFT_09g019620 [Sorghum bicolor]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 240/404 (59%), Positives = 297/404 (73%), Gaps = 17/404 (4%)

Query: 43  FHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKSGS--SRFIAHMTI 100
             +I+ +    I +++LVA+ +++ + RR +    D+ GS   D K G+  S   +H   
Sbjct: 58  LFTILPVSALAIGLVLLVAVAVILAVTRRARPRQADASGSCSGDGKPGAPPSSCGSH--- 114

Query: 101 NSTCSPDVKG-WCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEG 159
           N+ C     G  C   G +   +   A P       R +G  QVFTY+ELE AT+ FSE 
Sbjct: 115 NTRCGYAAAGTGCIYAGRLVGFSA--AQP-------RSRGA-QVFTYRELERATDGFSEC 164

Query: 160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGY 218
           NV+G G  G V++G L+DGT AAIK+L  D  +Q ER FR+EVDLLSR+ SP LV LLGY
Sbjct: 165 NVVGRGASGAVFRGRLADGTTAAIKRLRLDHRRQGEREFRIEVDLLSRMDSPYLVGLLGY 224

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
           CADQ+HRLL+ EYMPNG+L+ HLH       PLDW+TRL IALDCA ALEFLHEH++P V
Sbjct: 225 CADQSHRLLVFEYMPNGSLKSHLHPPRPPPPPLDWQTRLGIALDCARALEFLHEHSSPAV 284

Query: 279 IHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT 338
           IHRDF CSNVLLD N+RA+V+DFG+AK+ S+K +GQ+ TRVLGTTGYLAPEYASTGKLTT
Sbjct: 285 IHRDFNCSNVLLDHNYRARVSDFGMAKVGSNKADGQVVTRVLGTTGYLAPEYASTGKLTT 344

Query: 339 KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK 398
           KSDVYSYGVVLLELLTGRVPVD  RPPGEHVLVSWALPRLT+R++ V+MVDP+L+GQ+  
Sbjct: 345 KSDVYSYGVVLLELLTGRVPVDTQRPPGEHVLVSWALPRLTNRQKLVQMVDPALKGQFAL 404

Query: 399 KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAIS 442
           KDLIQ+AAIAA+C+Q +A YRPLMTDVVQSLIP+ K   A + S
Sbjct: 405 KDLIQVAAIAAMCIQTKAEYRPLMTDVVQSLIPIAKTTPAMSCS 448

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115463747|ref|NP_001055473.1| Os05g0398800 [Oryza sativa Japonica Group] gi|51854422|gb|AAU10801.1| putative protein kinase [Oryza sativa Japonica Group] gi|113579024|dbj|BAF17387.1| Os05g0398800 [Oryza sativa Japonica Group]

 Score =  463 bits (1192), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 236/386 (61%), Positives = 291/386 (75%), Gaps = 37/386 (9%)

Query: 68  MLRRLKSSSED-SHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGW------------CFN 114
           M RR K  + D + G+S   +K G +         S+C   V+G+            C  
Sbjct: 81  MTRRWKPGTVDGAGGASCNGDKPGGA-------PASSCGSSVRGYNNSRYYAAAAAGCIY 133

Query: 115 GGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV 174
           GG +   +V P          R++G  QVFTY+ELE+AT+ FSE NV+G G +GVV++G 
Sbjct: 134 GGRL-GFSVQP----------RNRGA-QVFTYRELESATDGFSECNVVGRGAYGVVFRGR 181

Query: 175 LSDGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           L DGT AAIK+L  DG++  ER FR+EVDLLSR+HSP LV LLGYCADQ+HRLL+ E+MP
Sbjct: 182 LGDGTTAAIKRLKMDGRREGEREFRIEVDLLSRMHSPYLVGLLGYCADQSHRLLVFEFMP 241

Query: 234 NGTLQQHLHRHN----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           NG+L+ HLHR       +  PLDW+TRL IALDCA ALEFLHEH++P VIHRDFKCSN+L
Sbjct: 242 NGSLKSHLHRRALAPAEQPPPLDWQTRLGIALDCARALEFLHEHSSPAVIHRDFKCSNIL 301

Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           LD N+RA+V+DFG+AK+ S+K NGQ++TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL
Sbjct: 302 LDHNYRARVSDFGMAKLGSNKANGQVTTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 361

Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAA 409
           LELLTGRVPVD  RPPG+HVLVSWALPRLT+RE+ V+MVDP+L GQ+  KDL+Q+AAI A
Sbjct: 362 LELLTGRVPVDTKRPPGQHVLVSWALPRLTNREKLVQMVDPALIGQFSLKDLVQVAAITA 421

Query: 410 VCVQPEAAYRPLMTDVVQSLIPVVKN 435
           +C+Q +A YRPLMTDVVQSLIP+VK+
Sbjct: 422 MCIQTKADYRPLMTDVVQSLIPIVKS 447

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218196756|gb|EEC79183.1| hypothetical protein OsI_19878 [Oryza sativa Indica Group]

 Score =  463 bits (1192), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 236/386 (61%), Positives = 291/386 (75%), Gaps = 37/386 (9%)

Query: 68  MLRRLKSSSED-SHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGW------------CFN 114
           M RR K  + D + G+S   +K G +         S+C   V+G+            C  
Sbjct: 81  MTRRWKPGAVDGAGGASCNGDKPGGA-------PASSCGSSVRGYNNSRYYAAAAAGCIY 133

Query: 115 GGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV 174
           GG +   +V P          R++G  QVFTY+ELE+AT+ FSE NV+G G +GVV++G 
Sbjct: 134 GGRL-GFSVQP----------RNRGA-QVFTYRELESATDGFSECNVVGRGAYGVVFRGR 181

Query: 175 LSDGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           L DGT AAIK+L  DG++  ER FR+EVDLLSR+HSP LV LLGYCADQ+HRLL+ E+MP
Sbjct: 182 LGDGTTAAIKRLKMDGRREGEREFRIEVDLLSRMHSPYLVGLLGYCADQSHRLLVFEFMP 241

Query: 234 NGTLQQHLHRHN----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           NG+L+ HLHR       +  PLDW+TRL IALDCA ALEFLHEH++P VIHRDFKCSN+L
Sbjct: 242 NGSLKSHLHRRALAPAEQPPPLDWQTRLGIALDCARALEFLHEHSSPAVIHRDFKCSNIL 301

Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           LD N+RA+V+DFG+AK+ S+K NGQ++TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL
Sbjct: 302 LDHNYRARVSDFGMAKLGSNKANGQVTTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 361

Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAA 409
           LELLTGRVPVD  RPPG+HVLVSWALPRLT+RE+ V+MVDP+L GQ+  KDL+Q+AAI A
Sbjct: 362 LELLTGRVPVDTKRPPGQHVLVSWALPRLTNREKLVQMVDPALIGQFSLKDLVQVAAITA 421

Query: 410 VCVQPEAAYRPLMTDVVQSLIPVVKN 435
           +C+Q +A YRPLMTDVVQSLIP+VK+
Sbjct: 422 MCIQTKADYRPLMTDVVQSLIPIVKS 447

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
TAIR|locus:2010965	458	AT1G54820 [Arabidopsis thalian	0.778	0.777	0.609	1.9e-110
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.684	0.782	0.575	1.7e-91
TAIR|locus:2132168	725	AT4G02010 [Arabidopsis thalian	0.623	0.393	0.512	2.5e-72
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.636	0.769	0.510	3.2e-72
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.663	0.272	0.485	3.9e-72
TAIR|locus:2183018	513	AT5G18610 [Arabidopsis thalian	0.625	0.557	0.512	6.7e-72
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.634	0.389	0.491	2.9e-70
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.625	0.627	0.491	3.8e-69
TAIR|locus:2098580	414	AT3G07070 [Arabidopsis thalian	0.625	0.690	0.501	4.9e-69
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.649	0.769	0.478	1e-68

TAIR|locus:2010965 AT1G54820 [Arabidopsis thaliana (taxid:3702)]

 Score = 1073 (382.8 bits), Expect = 1.9e-110, Sum P(2) = 1.9e-110
 Identities = 231/379 (60%), Positives = 270/379 (71%)

Query:    83 SFKDNKSGSSRFIAHMTINSTCSPD-VKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVV 141
             SF +  +G     A    + T SPD +K  C    +  S   LP   T +    R +GV 
Sbjct:    79 SFNNMNNGG----ASTNYSYTSSPDDIKRDCLYSRNPTSFRQLPPQ-TKSCRRSRAEGV- 132

Query:   142 QVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLH--RDG----KQRER 195
             +V+TYKELE AT NFSE            YKGVLSDGTVAAIKKLH   D     K  ER
Sbjct:   133 EVYTYKELEIATNNFSEEKKIGNGDV---YKGVLSDGTVAAIKKLHMFNDNASNQKHEER 189

Query:   196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHN-----NRYRP 250
             +FR+EVDLLSRL  P LVELLGYCADQNHR+LI E+MPNGT++ HLH HN     +R +P
Sbjct:   190 SFRLEVDLLSRLQCPYLVELLGYCADQNHRILIYEFMPNGTVEHHLHDHNFKNLKDRPQP 249

Query:   251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
             LDW  RL IALDCA ALEFLHE+    VIHR+FKC+N+LLDQN RAKV+DFGLAK  SDK
Sbjct:   250 LDWGARLRIALDCARALEFLHENTISTVIHRNFKCTNILLDQNNRAKVSDFGLAKTGSDK 309

Query:   311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
             +NG+ISTRV+GTTGYLAPEYASTGKLTTKSDVYSYG+VLL+LLTGR P+D  RP G+ VL
Sbjct:   310 LNGEISTRVIGTTGYLAPEYASTGKLTTKSDVYSYGIVLLQLLTGRTPIDSRRPRGQDVL 369

Query:   371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLI 430
             VSWALPRLT+RE+  EMVDP+++GQY +KDL        VCVQPEA+YRPLMTDVV SLI
Sbjct:   370 VSWALPRLTNREKISEMVDPTMKGQYSQKDLIQVAAIAAVCVQPEASYRPLMTDVVHSLI 429

Query:   431 PVVK--NNAAGAISFGSSR 447
             P+VK  N +  +  F S R
Sbjct:   430 PLVKAFNKSTDSSRFPSRR 448

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
 Identities = 183/318 (57%), Positives = 230/318 (72%)

Query:   135 VRDKGVVQVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRE 194
             V + G+ Q+FT+K+L +AT  FS+            Y+GVL+DG   AIK +   GKQ E
Sbjct:    67 VTENGL-QIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAGKQGE 125

Query:   195 RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR--YRP-L 251
               F+MEV+LLSRL SP L+ LLGYC+D +H+LL+ E+M NG LQ+HL+  N      P L
Sbjct:   126 EEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRL 185

Query:   252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
             DW TR+ IA++ A  LE+LHE  +PPVIHRDFK SN+LLD+NF AKV+DFGLAK+ SDK 
Sbjct:   186 DWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKA 245

Query:   312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV 371
              G +STRVLGT GY+APEYA TG LTTKSDVYSYGVVLLELLTGRVPVD  R  GE VLV
Sbjct:   246 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLV 305

Query:   372 SWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIP 431
             SWALP+L  R++ V+++DP+L+GQY  K++        +CVQ EA YRPLM DVVQSL+P
Sbjct:   306 SWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQSLVP 365

Query:   432 VVKNN-AAGAISFGSSRF 448
             +V+N  +A  +S  SS F
Sbjct:   366 LVRNRRSASKLSGCSSSF 383

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)]

 Score = 731 (262.4 bits), Expect = 2.5e-72, P = 2.5e-72
 Identities = 147/287 (51%), Positives = 187/287 (65%)

Query:   145 TYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLL 204
             +Y+EL+ AT NF              Y+G+L+DGT  AIKKL   G Q ++ F++E+D+L
Sbjct:   369 SYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDML 428

Query:   205 SRLHSPQLVELLGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
             SRLH   LV+L+GY +  D +  LL  E +PNG+L+  LH       PLDW TR+ IALD
Sbjct:   429 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIALD 488

Query:   263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
              A  L +LHE + P VIHRDFK SN+LL+ NF AKV DFGLAK   +     +STRV+GT
Sbjct:   489 AARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMGT 548

Query:   323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
              GY+APEYA TG L  KSDVYSYGVVLLELLTGR PVD ++P G+  LV+W  P L  ++
Sbjct:   549 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKD 608

Query:   383 EAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
                E+VD  L+G+YPK+D          CV PEA+ RP M +VVQSL
Sbjct:   609 RLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSL 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
 Identities = 151/296 (51%), Positives = 190/296 (64%)

Query:   137 DKGVVQVFTYKELETATENFSEXXXXXXXXXXXXYKGVL-SDGTVAAIKKLHRDGKQRER 195
             D  V Q FT+ EL TAT NF +            YKG L S    AAIK+L  +G Q  R
Sbjct:    54 DHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNR 113

Query:   196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
              F +EV +LS LH P LV L+GYCAD + RLL+ EYMP G+L+ HLH  +   +PLDW T
Sbjct:   114 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNT 173

Query:   256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM--VSDKING 313
             R+ IA   A  LE+LH+   PPVI+RD KCSN+LLD ++  K++DFGLAK+  V DK   
Sbjct:   174 RMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDK--S 231

Query:   314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW 373
              +STRV+GT GY APEYA TG+LT KSDVYS+GVVLLE++TGR  +D +R  GE  LV+W
Sbjct:   232 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAW 291

Query:   374 ALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
             A P    R +  +M DP LQGQYP + L        +CVQ +   RPL+ DVV +L
Sbjct:   292 ARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTAL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 711 (255.3 bits), Expect = 3.9e-72, Sum P(2) = 3.9e-72
 Identities = 148/305 (48%), Positives = 189/305 (61%)

Query:   142 QVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
             + FT  E+  AT NF E            Y+GV  DGT  A+K L RD +Q  R F  EV
Sbjct:   709 KTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFLAEV 768

Query:   202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
             ++LSRLH   LV L+G C +  +R L+ E +PNG+++ HLH  +    PLDW  RL IAL
Sbjct:   769 EMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLKIAL 828

Query:   262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVL 320
               A  L +LHE ++P VIHRDFK SN+LL+ +F  KV+DFGLA+  + D+ N  ISTRV+
Sbjct:   829 GAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHISTRVM 888

Query:   321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
             GT GY+APEYA TG L  KSDVYSYGVVLLELLTGR PVD ++PPG+  LVSW  P LTS
Sbjct:   889 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPFLTS 948

Query:   381 REEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA 440
              E    ++D SL  +     +        +CVQPE ++RP M +VVQ+L  +V N    A
Sbjct:   949 AEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQAL-KLVSNECDEA 1007

Query:   441 ISFGS 445
                 S
Sbjct:  1008 KELNS 1012

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 149/291 (51%), Positives = 190/291 (65%)

Query:   142 QVFTYKELETATENFSEXXXXXXXXXXXXYKGVL-SDGTVAAIKKLHRDGKQRERAFRME 200
             Q FT++EL  AT+NF              YKG L + G + A+K+L R+G Q  R F +E
Sbjct:    69 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGNREFLVE 128

Query:   201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
             V +LS LH P LV L+GYCAD + RLL+ EYMP G+L+ HLH       PLDW TR+ IA
Sbjct:   129 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIA 188

Query:   261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM--VSDKINGQISTR 318
                A  LE+LH+ A PPVI+RD K SN+LL   +  K++DFGLAK+  V DK +  +STR
Sbjct:   189 AGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTH--VSTR 246

Query:   319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL 378
             V+GT GY APEYA TG+LT KSDVYS+GVV LEL+TGR  +D  R PGEH LV+WA P  
Sbjct:   247 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLF 306

Query:   379 TSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
               R +  +M DPSLQG+YP + L        +C+Q +AA RPL+ DVV +L
Sbjct:   307 KDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 2.9e-70, Sum P(2) = 2.9e-70
 Identities = 146/297 (49%), Positives = 189/297 (63%)

Query:   141 VQVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRERAFRME 200
             V+ FT  ELE AT+ FS             Y+G + DGT  A+K L RD + R+R F  E
Sbjct:   334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393

Query:   201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
             V++LSRLH   LV+L+G C +   R LI E + NG+++ HLH        LDW  RL IA
Sbjct:   394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT-----LDWDARLKIA 448

Query:   261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
             L  A  L +LHE + P VIHRDFK SNVLL+ +F  KV+DFGLA+  ++  +  ISTRV+
Sbjct:   449 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVM 507

Query:   321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
             GT GY+APEYA TG L  KSDVYSYGVVLLELLTGR PVD ++P GE  LV+WA P L +
Sbjct:   508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLAN 567

Query:   381 REEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
             RE   ++VDP+L G Y   D+        +CV  E ++RP M +VVQ+L  ++ N+A
Sbjct:   568 REGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL-KLIYNDA 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
 Identities = 141/287 (49%), Positives = 182/287 (63%)

Query:   144 FTYKELETATENFSEXXXXXXXXXXXXYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVD 202
             F ++EL  AT NF              YKG L S G V A+K+L R+G Q  R F +EV 
Sbjct:    74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133

Query:   203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
             +LS LH P LV L+GYCAD + RLL+ E+MP G+L+ HLH        LDW  R+ IA  
Sbjct:   134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193

Query:   263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
              A  LEFLH+ A PPVI+RDFK SN+LLD+ F  K++DFGLAK+        +STRV+GT
Sbjct:   194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253

Query:   323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
              GY APEYA TG+LT KSDVYS+GVV LEL+TGR  +D   P GE  LV+WA P    R 
Sbjct:   254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313

Query:   383 EAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
             + +++ DP L+G++P + L        +C+Q +AA RPL+ DVV +L
Sbjct:   314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)]

 Score = 700 (251.5 bits), Expect = 4.9e-69, P = 4.9e-69
 Identities = 146/291 (50%), Positives = 189/291 (64%)

Query:   142 QVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSD-GTVAAIKKLHRDGKQRERAFRME 200
             Q F+++EL TAT+NF +            YKG L   G + A+K+L R+G Q  + F +E
Sbjct:    65 QTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVE 124

Query:   201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
             V +LS LH   LV L+GYCAD + RLL+ EYM  G+L+ HL        PLDW TR+ IA
Sbjct:   125 VLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIA 184

Query:   261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM--VSDKINGQISTR 318
             L  AM LE+LH+ A PPVI+RD K +N+LLD  F AK++DFGLAK+  V DK +  +S+R
Sbjct:   185 LGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH--VSSR 242

Query:   319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL 378
             V+GT GY APEY  TG+LTTKSDVYS+GVVLLEL+TGR  +D  RP  E  LV+WA P  
Sbjct:   243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302

Query:   379 TSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
                    E+ DPSL+G +P+K L        +C+Q EA  RPLM+DVV +L
Sbjct:   303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
 Identities = 144/301 (47%), Positives = 191/301 (63%)

Query:   143 VFTYKELETATENFSEXXXXXXXXXXXXYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEV 201
             +FT++EL  AT+NF+             YKG + +   V A+K+L R+G Q  R F +EV
Sbjct:    69 IFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEV 128

Query:   202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL-HRHNNRYRPLDWRTRLIIA 260
              +LS LH   LV L+GYCAD + R+L+ EYM NG+L+ HL     N+ +PLDW TR+ +A
Sbjct:   129 MMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVA 188

Query:   261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
                A  LE+LHE A PPVI+RDFK SN+LLD+ F  K++DFGLAK+        +STRV+
Sbjct:   189 AGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVM 248

Query:   321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
             GT GY APEYA TG+LT KSDVYS+GVV LE++TGR  +D  +P  E  LV+WA P    
Sbjct:   249 GTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKD 308

Query:   381 REEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL--IPVVKNNAA 438
             R +   M DP L+G+YP K L        +C+Q EAA RP+M+DVV +L  + V K    
Sbjct:   309 RRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTKTEED 368

Query:   439 G 439
             G
Sbjct:   369 G 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	457
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-46
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-27
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-22
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-16
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-15
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-06
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (462), Expect = 7e-55
 Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 12/195 (6%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYC 219
           +G GGFG VY       G   AIK + ++           E+++L +L+ P +V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
            D+NH  L+ EY   G+L+  L  +      L     L I L     LE+LH +    +I
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 280 HRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLT 337
           HRD K  N+LLD  N + K+ DFGL+K+++   +  +   ++GT  Y+APE     G  +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 338 TKSDVYSYGVVLLEL 352
            KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  171 bits (437), Expect = 1e-50
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 159 GNVIGNGGFGVVYKGVLSDG-----TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQL 212
           G  +G G FG VYKG L           A+K L  D  +++   F  E  ++ +L  P +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V+LLG C ++   +++ EYMP G L  +L ++  R + L     L  AL  A  +E+L  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLES 121

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYA 331
                 IHRD    N L+ +N   K++DFGL++ +  D        ++     ++APE  
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176

Query: 332 STGKLTTKSDVYSYGVVLLELLT-GRVP 358
             GK T+KSDV+S+GV+L E+ T G  P
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (435), Expect = 2e-50
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 16/208 (7%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVA-----AIKKLHRDGKQRERA-FRMEVDLLSRLHSPQL 212
           G  +G G FG VYKG L           A+K L  D  +++   F  E  ++ +L  P +
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V+LLG C ++    ++ EYM  G L  +L ++  +   L     L  AL  A  +E+L  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLES 120

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYA 331
                 IHRD    N L+ +N   K++DFGL++ +  D    +   ++     ++APE  
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESL 175

Query: 332 STGKLTTKSDVYSYGVVLLELLT-GRVP 358
             GK T+KSDV+S+GV+L E+ T G  P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  169 bits (431), Expect = 1e-49
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 159 GNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQL 212
           G  +G G FG VYKG L        T  A+K L     + ER  F  E  ++ +L  P +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V LLG C       +++EYMP G L   L +H      L  +  L +AL  A  +E+L  
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLES 120

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL-----A 327
                 +HRD    N L+ +N   K++DFGL++ + +              G L     A
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWMA 172

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           PE    GK T+KSDV+S+GV+L E+ T G  P
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  167 bits (425), Expect = 9e-49
 Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 26/216 (12%)

Query: 160 NVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVE 214
             +G G FG VYKG L       T  A+K L  D  + ER  F  E  ++ +L  P +V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYR-----PLDWRTRLIIALDCAMALEF 269
           LLG C ++    L+ EYM  G L  +L +    +       L  +  L  A+  A  +E+
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD------KINGQISTRVLGTT 323
           L        +HRD    N L+ ++   K++DFGL++ V D      K  G++  R     
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            ++APE    G  T+KSDV+S+GV+L E+ T G  P
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (424), Expect = 9e-49
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 14/206 (6%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQL 212
           +     +G G FG VY       G + AIK + +    K RER  R E+ +L +L  P +
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR-EIKILKKLKHPNI 59

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V L     D++   L+ EY   G L   L +        D   R  +      ALE+LH 
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDE-ARFYLR-QILSALEYLHS 115

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                ++HRD K  N+LLD++   K+ DFGLA+ +      +++T V GT  Y+APE   
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLL 169

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVP 358
                   D++S GV+L ELLTG+ P
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 6e-48
 Identities = 76/220 (34%), Positives = 109/220 (49%), Gaps = 13/220 (5%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQL 212
           +     +G+G FG VYK      G + A+K L +     ++++  R E+ +L RL  P +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V L+    D++H  L+ EY   G L  +L R      PL       IAL     LE+LH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHS 116

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
           +    +IHRD K  N+LLD+N   K+ DFGLAK +    +    T  +GT  Y+APE   
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPWYMAPEVLL 171

Query: 333 TGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV 371
            G     K DV+S GV+L ELLTG+ P        +  L+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  160 bits (407), Expect = 3e-46
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKK--LHRDGKQRERAFRMEVDLLSRLHSPQ 211
            ++ G ++G G FG VY  +  D G + A+K   L  D ++   A   E+ +LS L  P 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 212 LVELLGYC--ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR-----TRLIIALDCA 264
           +V   G     ++N   +  EY+  G+L   L +    +  L        TR I+     
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILE---- 112

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             L +LH +    ++HRD K +N+L+D +   K+ DFG AK + D   G+ +  V GT  
Sbjct: 113 -GLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE     +    +D++S G  ++E+ TG+ P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 7e-38
 Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 21/205 (10%)

Query: 162 IGNGGFGVVYKGV--LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G G FG V   V     G + A+K L        K+ E     E ++LSR++ P +V+L
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKL 58

Query: 216 LGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
             + A   +    L+ EY P G L  HL +     R  + R R   A +  +ALE+LH  
Sbjct: 59  --HYAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAA-EIVLALEYLHSL 112

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               +I+RD K  N+LLD +   K+TDFGLAK +S +   + +T   GT  YLAPE    
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC-GTPEYLAPEVLLG 167

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +S GV+L E+LTG+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (348), Expect = 9e-38
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)

Query: 156 FSEGNVIGNGGFGVVYKG-VLSDGTVAAIKKL-HRDGKQRERAFRMEVDLLSRLHSPQLV 213
           F     IG GGFG VYK      G   AIK +     +++E+    E+ +L +   P +V
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60

Query: 214 ELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           +  G    +   L ++ E+   G+L+  L    +  + L       +  +    LE+LH 
Sbjct: 61  KYYG-SYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
           +    +IHRD K +N+LL  +   K+ DFGL+  +SD    +    ++GT  ++APE  +
Sbjct: 117 NG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD---TKARNTMVGTPYWMAPEVIN 170

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVP 358
                 K+D++S G+  +EL  G+ P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 8e-37
 Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 26/214 (12%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKK--LHRDGKQRERAFRMEVDLLSRLHSPQ 211
           N+  G++IG G FGVVYKG+ L  G   AIK+  L +  ++  ++   E+DLL  L  P 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM------ 265
           +V+ +G     +   +I EY  NG+L+Q + +       L            A+      
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-----------VAVYVYQVL 109

Query: 266 -ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             L +LHE     VIHRD K +N+L  ++   K+ DFG+A  ++D    +    V+GT  
Sbjct: 110 QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPY 164

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE       +T SD++S G  ++ELLTG  P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (339), Expect = 3e-36
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
             IG G FG VY     SDG +  +K++   +   K+RE A   EV +L +L+ P +++ 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKY 64

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP------LDWRTRLIIALDCAMALEF 269
                ++    ++ EY   G L Q + +     +P      LDW  +L       +AL++
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH      ++HRD K  N+ L  N   K+ DFG++K++S      ++  V+GT  YL+PE
Sbjct: 119 LHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPE 173

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                    KSD++S G VL EL T + P
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (327), Expect = 8e-35
 Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 17/203 (8%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY 218
           G  IG G FG V  G      VA +K L  D    + AF  E  +++ L  P LV+LLG 
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKVA-VKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGV 68

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRP-LDWRTRLIIALDCAMALEFLHEHATPP 277
               N   +++EYM  G+L  +L    +R R  +    +L  ALD    +E+L E     
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLR---SRGRAVITLAQQLGFALDVCEGMEYLEEKN--- 122

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN-GQISTRVLGTTGYLAPEYASTGKL 336
            +HRD    NVL+ ++  AKV+DFGLAK  S   + G++  +      + APE     K 
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTAPEALREKKF 176

Query: 337 TTKSDVYSYGVVLLELLT-GRVP 358
           +TKSDV+S+G++L E+ + GRVP
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (307), Expect = 1e-31
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 31/277 (11%)

Query: 160 NVIGNGGFGVVYKG---VLSDGT--VAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLV 213
             +G G FG V       L D T    A+K L+  G+++ R+ F  E+++L  L    +V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 214 ELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +  G C     R   LI EY+P+G+L+ +L RH ++   ++ +  L+ +      +++L 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTG 324
                  IHRD    N+L++     K++DFGLAK++ +       K  G+          
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------ 177

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR-PPGEHVLVSWALPRLTSREE 383
           + APE   T K ++ SDV+S+GV L EL T     DP++ PP E + +            
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIAQGQMIVTR 234

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
            +E++    +   P     ++  +  +C + E   RP
Sbjct: 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 7e-31
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 12/200 (6%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+ G  +  T  A+K L + G     AF  E  ++ +L   +LV+L   C++
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           +    +++EYM  G+L   L     +   L    +L+ +A   A  + +L        IH
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRL---PQLVDMAAQIAEGMAYLESRN---YIH 126

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-NGQISTRVLGTTGYLAPEYASTGKLTTK 339
           RD    N+L+ +N   K+ DFGLA+++ D     +   +      + APE A+ G+ T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184

Query: 340 SDVYSYGVVLLELLT-GRVP 358
           SDV+S+G++L E++T GRVP
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 6e-30
 Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 18/218 (8%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERA---FRMEVDLLSRL-HSP 210
           ++     +G G FG VY     D  + A+K L +  + + +    F  E+ +L+ L H P
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            +V+L  +  D+    L+ EY+  G+L+  L +   R  PL     L I      ALE+L
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL-KKIGRKGPLSESEALFILAQILSALEYL 117

Query: 271 HEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDK----INGQISTRVLGTTGY 325
           H      +IHRD K  N+LLD++    K+ DFGLAK++ D         + +  +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 326 LAPEYA---STGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           +APE     S    ++ SD++S G+ L ELLTG  P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (291), Expect = 1e-29
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 8/210 (3%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E   E F+    +G+G FG V++G+  +    AIK L  D   +++ F+ EV  L RL  
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             L+ L   C+      +I+E M  G+L   L   +   + L   + + +A   A  + +
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           L E      IHRD    N+L+ ++   KV DFGLA+++ + +      ++     + APE
Sbjct: 120 LEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPE 174

Query: 330 YASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            AS G  +TKSDV+S+G++L E+ T G+VP
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  116 bits (291), Expect = 1e-29
 Identities = 73/209 (34%), Positives = 105/209 (50%), Gaps = 16/209 (7%)

Query: 160 NVIGNGGFGVVYKGVL-SDGTVAAIKKLH---RDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           N IG G FGVV+K V  +D  V A+K++     + ++RE A   E  +L++L S  ++  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSYIIRY 64

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD--WRTRLIIALDCAMALEFLHEH 273
                D+    ++ EY  NG L + L     R  P D  WR  + I L     L  LH  
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLHSK 120

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               ++HRD K  N+ LD     K+ D G+AK++SD  N   +  ++GT  YL+PE    
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCED 175

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
                KSDV++ GVVL E  TG+ P D N
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 9e-29
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 39/277 (14%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA 220
           IG G FG VYKGVL   T  A+K          +  F  E ++L +   P +V+L+G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
            +    ++ E +P G+L   L +  NR   L  +  L ++LD A  +E+L        IH
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAK-------MVSDKINGQISTRVLGTTGYLAPEYAST 333
           RD    N L+ +N   K++DFG+++        VSD +  QI  +      + APE  + 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL-KQIPIK------WTAPEALNY 169

Query: 334 GKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL 392
           G+ T++SDV+SYG++L E  + G  P      PG             S ++  E ++   
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPY-----PG------------MSNQQTRERIESGY 212

Query: 393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           +   P+    +I  +   C   +   RP  +++   L
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 1e-28
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 12/200 (6%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V++G+ ++ T  A+K L + G    + F  E  ++ +L  P+L++L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           +    +++E M  G+L ++L     R   L    +LI +A   A  + +L        IH
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKL---PQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-NGQISTRVLGTTGYLAPEYASTGKLTTK 339
           RD    NVL+ +N   KV DFGLA+++ + I   +   +      + APE A   + + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 340 SDVYSYGVVLLELLT-GRVP 358
           SDV+S+G++L E++T GR+P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 12/210 (5%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           IG+G FG+V+ G   +    AIK + R+G   E  F  E  ++ +L  P+LV+L G C +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           ++   L+ E+M +G L  +L     ++      T L + LD    + +L       VIHR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           D    N L+ +N   KV+DFG+ + V  D+      T+      + +PE  S  K ++KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKS 182

Query: 341 DVYSYGVVLLELLT-GRVPVDPNRPPGEHV 369
           DV+S+GV++ E+ + G+ P + NR   E V
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYE-NRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (285), Expect = 2e-28
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 42/234 (17%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIK-----KLHRDGKQ----RERAFRMEVDL 203
           ++F  G +IG G F  V            AIK     +L ++ K      E+      ++
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK------EV 54

Query: 204 LSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           L+RL   P +++L     D+ +   + EY PNG L Q++ ++ +        TR   A +
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC---TRFYAA-E 110

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD------------- 309
             +ALE+LH      +IHRD K  N+LLD++   K+TDFG AK++               
Sbjct: 111 ILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 310 -KINGQISTR----VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                + + R     +GT  Y++PE  +       SD+++ G ++ ++LTG+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 3e-28
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 17/222 (7%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G+G FGVV+ G        AIK +  +G   E  F  E  ++ +L  P LV+L G C  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           Q    +++EYM NG L  +L     +         L +  D   A+E+L  +     IHR
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTT 338
           D    N L+ ++   KV+DFGLA+ V D       T   GT     +  PE     + ++
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 339 KSDVYSYGVVLLELLT-GRVPVD--PNRPPGEHVLVSWALPR 377
           KSDV+S+GV++ E+ + G++P +   N    E V   + L R
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  111 bits (280), Expect = 5e-28
 Identities = 69/238 (28%), Positives = 115/238 (48%), Gaps = 17/238 (7%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLG 217
             +G G  GVV K +    G + A+K +  +  +  +     E+D+L + +SP +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
              +     +  EYM  G+L + L     R  P     ++ +A+     L +LHE     
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV--LKGLTYLHE--KHK 121

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           +IHRD K SN+L++   + K+ DFG    VS ++   ++   +GT+ Y+APE       +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTFVGTSSYMAPERIQGNDYS 177

Query: 338 TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL------VSWALPRLTSREEAVEMVD 389
            KSD++S G+ L+EL TGR P  P   P + +       V+   PRL S + + +  D
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 7e-27
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 16/206 (7%)

Query: 162 IGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVE 214
           +G G FG+VY+G+          T  AIK ++ +   RER  F  E  ++   +   +V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALE 268
           LLG  +     L++ E M  G L+ +L        +N    P   +  + +A + A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +L        +HRD    N ++ ++   K+ DFG+ + + +    +   + L    ++AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT 354
           E    G  TTKSDV+S+GVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  108 bits (271), Expect = 7e-27
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHSP 210
           +F    VIG G FG V      D   + A+K +++     K   R    E  +L  L+ P
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            LV L     D+ +  L+ + +  G L+ HL +   + +  + + +  I  +  +ALE+L
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWIC-EIVLALEYL 116

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H      +IHRD K  N+LLD+     +TDF +A  V+      ++T   GT GY+APE 
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAPEV 170

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 +   D +S GV   E L G+ P
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  108 bits (271), Expect = 8e-27
 Identities = 72/212 (33%), Positives = 107/212 (50%), Gaps = 27/212 (12%)

Query: 162 IGNGGFGVVY---KGVLSDGTVAAIKKLHRDGKQRERAFR---MEVDLLSRLHSPQLVEL 215
           I  G +G V+   K   S G + AIK + +    R+        E D+LS+  SP +V+L
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 216 LGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
             Y +   + +  L+ EY+P G L   L          D   R+ IA +  +ALE+LH +
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDV-ARIYIA-EIVLALEYLHSN 112

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK--MVSDKINGQIST----RVLGTTGYLA 327
               +IHRD K  N+L+D N   K+TDFGL+K  +V  +IN         R++GT  Y+A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 328 PEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           PE    G+  +K+ D +S G +L E L G  P
Sbjct: 170 PEVI-LGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 1e-26
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVA----AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQL 212
             V+G+G FG VYKGV + +G       AIK L  +   +  +    E  +++ +  P +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEF 269
           V LLG C       LI++ MP G L  ++  H +       L+W  ++      A  + +
Sbjct: 72  VRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           L E     ++HRD    NVL+      K+TDFGLAK++        +        ++A E
Sbjct: 125 LEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 330 YASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
                  T KSDV+SYGV + EL+T G  P +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  108 bits (271), Expect = 1e-26
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 36/295 (12%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLS--DGTVA----AIKKLHRDGK-QRERAFRMEVD 202
           E   ++ +    +G+G FG VY+G+    DG       A+K L      Q E  F ME  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHN----NRYRPLDWRTRLI 258
           ++S+ +   +V L+G   ++  R ++ E M  G L+  L R N     R   L  +  L 
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLF 120

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGLAKMVSDKINGQI 315
            A D A   ++L E+     IHRD    N LL        AK+ DFG+A+ +      + 
Sbjct: 121 CARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA 374
             R +    ++ PE    G  T+K+DV+S+GV+L E+ + G +P  P R           
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-PGRT---------- 226

Query: 375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                  +E +E V    +   PK     +  I   C Q     RP    +++ +
Sbjct: 227 ------NQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            E +     IG G  G VYK    + G   AIKK+    + +E     E+ ++     P 
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPN 76

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA---LDCAMALE 268
           +V+        +   ++ EYM  G+L   + ++  R           IA    +    LE
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRM------NEPQIAYVCREVLQGLE 130

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR------VLGT 322
           +LH      VIHRD K  N+LL ++   K+ DFG A         Q++        V+GT
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA--------AQLTKEKSKRNSVVGT 179

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             ++APE         K D++S G++ +E+  G  P
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  104 bits (261), Expect = 1e-25
 Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 28/270 (10%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FGVV  G        AIK + ++G   E  F  E  ++ +L   +LV+L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           Q    +++EYM NG L  +L  H  R++P      L +  D    + +L        IHR
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIHR 124

Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           D    N L+D     KV+DFGL++ V  D+    + ++      +  PE     K ++KS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKS 182

Query: 341 DVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKK 399
           DV+++GV++ E+ + G++P +                R  +  E VE V   L+   P  
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE----------------RFNN-SETVEKVSQGLRLYRPHL 225

Query: 400 DLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              ++ AI   C   +A  RP    ++ S+
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 2e-25
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 162 IGNGGFGVVYKGVL------SDGTVAAIKKLHR--DGKQRERAFRMEVDLLSRLHSPQLV 213
           +G G FG VYKG L         T  AIK L    + K ++  FR E +L+S L  P +V
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPNIV 71

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIAL 261
            LLG C  +    ++ EY+ +G L + L R++                 LD    L IA+
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVL 320
             A  +E+L  H     +HRD    N L+ +    K++DFGL++ + S       S  +L
Sbjct: 132 QIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
               ++ PE    GK TT+SD++S+GVVL E+
Sbjct: 189 PVR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 160 NVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVE 214
            VIG G FG V +G L          AIK L      ++R  F  E  ++ +   P ++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEH 273
           L G        ++I+EYM NG+L + L  ++ ++       +L+  L   A  +++L E 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTV----GQLVGMLRGIASGMKYLSEM 125

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------INGQISTRVLGTTGYLA 327
                +HRD    N+L++ N   KV+DFGL++ + D         G+I  R      + A
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTA 176

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLT 354
           PE  +  K T+ SDV+S+G+V+ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 162 IGNGGFGVVYK-GVLSDGTVAAIKKLHR----DGKQRERAFRMEVDLLSRLHSPQLVELL 216
           +G GGFG V    V S     A+K + +    +  Q+E  F  E ++L   + P +V+L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD-WRTRLIIALDCAM-ALEFLHEHA 274
               D+ +  ++ EY   G L   L          D +  R  IA  C + A E+LH   
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIA--CVVLAFEYLHNRG 113

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              +I+RD K  N+LLD N   K+ DFG AK +    +GQ +    GT  Y+APE     
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPEIILNK 167

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +S G++L ELLTGR P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (261), Expect = 3e-25
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 162 IGNGGFGVVYK---GVLSDGT--VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           +G G FG V       L D T  V A+KKL     +  R F  E+++L  L    +V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 217 GYC--ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           G C  A + +  L+ EY+P G+L+ +L +H  R   LD R  L+ A      +E+L    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYAST 333
           +   +HRD    N+L++   R K+ DFGL K++  DK   ++         + APE  + 
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185

Query: 334 GKLTTKSDVYSYGVVLLELLT 354
            K +  SDV+S+GVVL EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  104 bits (260), Expect = 4e-25
 Identities = 87/288 (30%), Positives = 138/288 (47%), Gaps = 33/288 (11%)

Query: 161 VIGNGGFGVV----YKGVLSDGT--VAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLV 213
           V+G G FG V    Y    +DGT  + A+K L R+ G+Q    ++ E+++L  L+   +V
Sbjct: 11  VLGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 214 ELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +  G C++Q  +   LI EY+P G+L+ +L +H      L+    L+ A      + +LH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLH 124

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLA 327
                  IHRD    NVLLD +   K+ DFGLAK V +   G    RV         + A
Sbjct: 125 SQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYA 178

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR-PPGEHVLVSWALPRLTSREEAVE 386
            E     K +  SDV+S+GV L ELLT     D  + PP +   +        +    +E
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTH---CDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235

Query: 387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK 434
           +++  ++   PK    ++  +   C + EA +RP      +SLIP++K
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP----TFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (258), Expect = 5e-25
 Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIK--KLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           GN IG G FG VY  V L  G + A+K  ++  +  +  +    E+ +L  L  P LV+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 216 LGYCADQNHR---LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
            G    + HR    +  EY   GTL++ L       R LD     +  L     L +LH 
Sbjct: 65  YGV---EVHREKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHS 117

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAP 328
           H    ++HRD K +N+ LD N   K+ DFG A  + +  N       +    GT  Y+AP
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN--NTTTMGEEVQSLAGTPAYMAP 172

Query: 329 EYASTGKLTTK---SDVYSYGVVLLELLTGRVP 358
           E  + GK       +D++S G V+LE+ TG+ P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (256), Expect = 8e-25
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 53/283 (18%)

Query: 162 IGNGGFGVVYK-GVLSDGTVAAIKKLH-RDGKQRERAFRM-EVDLLSRLHSPQLVELLGY 218
           +G G +G VYK   LSD    A+K++      Q+ER   + E+ +L+ ++ P ++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD----WRTRLIIALDCAMALEFLHEHA 274
             D N   ++ EY P G L + + +   + + +     WR    I +     L+ LHE  
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQALHEQK 123

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              ++HRD K +N+LL  N   K+ D G++K++       ++   +GT  Y+APE     
Sbjct: 124 ---ILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKGR 176

Query: 335 KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ- 393
             + KSD++S G +L E+ T   P                        EA  M D   + 
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF-----------------------EARSMQDLRYKV 213

Query: 394 --GQYPK------KDLIQIAAIAAVCVQPEAAYRPLMTDVVQS 428
             G+YP       +DL          +Q +   RP    ++ S
Sbjct: 214 QRGKYPPIPPIYSQDLQN---FIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (257), Expect = 8e-25
 Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 54/295 (18%)

Query: 161 VIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRE--RAFRMEVDLLSRLHSPQL 212
            +G G FG V+ G         D  + A+K L ++    +  + F  E +LL+      +
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENI 70

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRH----------NNRYRPLDWRTRLIIALD 262
           V+  G C + +  +++ EYM +G L + L  H          ++    L     L IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST---RV 319
            A  + +L   A+   +HRD    N L+  +   K+ DFG+++ V        +T   RV
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-------YTTDYYRV 180

Query: 320 LGTT----GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA 374
            G T     ++ PE     K TT+SDV+S+GVVL E+ T G+      +P          
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK------QPWYGL------ 228

Query: 375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                S EE +E +      Q P+    ++  I   C + +   R  + D+ + L
Sbjct: 229 -----SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  102 bits (256), Expect = 1e-24
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 33/227 (14%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG-KQRER-AFRMEVD 202
           Y+ LET          IG G FG V K    SDG +   K++      ++E+     EV+
Sbjct: 2   YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51

Query: 203 LLSRLHSPQLVELLGYCAD-QNHRL-LISEYMPNGTLQQHLHR--HNNRYRPLD--WR-- 254
           +L  L  P +V       D  N  L ++ EY   G L Q + +     +Y   +  WR  
Sbjct: 52  ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111

Query: 255 TRLIIALD-CAMALEFLH--EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           T+L++AL  C       H        V+HRD K +N+ LD N   K+ DFGLAK++    
Sbjct: 112 TQLLLALYEC-------HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-- 162

Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +   +   +GT  Y++PE  +      KSD++S G ++ EL     P
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 27/219 (12%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAF-RMEVDLLSRLHSPQLV 213
           F+    IG G FG VYK +      V AIK +  +  + E    + E+  LS+  SP + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           +  G     +   +I EY   G+    L     +   LD      I  +  + LE+LHE 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL------GTTGYLA 327
                IHRD K +N+LL +    K+ DFG++        GQ+++ +       GT  ++A
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGTPFWMA 166

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNR 363
           PE         K+D++S G+  +EL  G  P   + P R
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (250), Expect = 5e-24
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 160 NVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY 218
           + +G G +G VY+GV        A+K L  D  + E  F  E  ++  +  P LV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 70

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
           C  +    +I+E+M  G L  +L R  NR + ++    L +A   + A+E+L +      
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 279 IHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT---GYLAPEYASTGK 335
           IHRD    N L+ +N   KV DFGL+++++    G   T   G      + APE  +  K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 336 LTTKSDVYSYGVVLLELLT 354
            + KSDV+++GV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 5e-24
 Identities = 69/208 (33%), Positives = 114/208 (54%), Gaps = 19/208 (9%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIK--KLHRDGKQRERAFRM---EVDLLSRLHSPQL 212
           G ++G+G FG VY+G+ L DG   A+K   L  DG+  + A +    E+ LLS+L  P +
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLIIALDCAMALEFLH 271
           V+ LG   ++++  +  E +P G+L + L ++ +   P+    TR I+       LE+LH
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY- 330
           +  T   +HRD K +N+L+D N   K+ DFG+AK V +       +   G+  ++APE  
Sbjct: 120 DRNT---VHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKS-FKGSPYWMAPEVI 173

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  G     +D++S G  +LE+ TG+ P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.9 bits (249), Expect = 8e-24
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 20/214 (9%)

Query: 160 NVIGNGGFGVVYKGVLSDG----TVAAIKKLHR--DGKQRERAFRMEVDLLSRLHSPQLV 213
            VIG G FG VY G L D        A+K L+R  D ++ E  F  E  ++     P ++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 214 ELLGYCADQNHR-LLISEYMPNGTLQQHLH--RHNNRYRPLDWRTRLIIALDCAMALEFL 270
            LLG C       L++  YM +G L+  +    HN   + L     +   L  A  +E+L
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK--INGQISTRVLGTTGYLAP 328
              A+   +HRD    N +LD++F  KV DFGLA+ + DK   +    T       ++A 
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
           E   T K TTKSDV+S+GV+L EL+T   P  P+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 8e-24
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 39/277 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQ 211
            +     V+G G  GVVYK      G + A+KK+H DG +  R     E+  L    SP 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM---ALE 268
           +V+  G    +    ++ EYM  G+L   L +      P       ++A         L+
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP-------VLAYIARQILKGLD 113

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH      +IHRD K SN+L++     K+ DFG++K++ + +  Q +T V GT  Y++P
Sbjct: 114 YLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFV-GTVTYMSP 169

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG-----EHVLVSWALPRLTSREE 383
           E       +  +D++S G+ LLE   G+ P  P   P      + +      P L + E 
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEF 228

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
           + E            +D I      + C+Q +   RP
Sbjct: 229 SPEF-----------RDFI------SACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 99.7 bits (248), Expect = 8e-24
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E   E+      +GNG FG V+ G  +  T  A+K L + G     +F  E  ++ +L  
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LE 268
            +LV+L    +++    +++EYM  G+L   L     R   L     +   +   MA +E
Sbjct: 61  DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYL 326
            ++       IHRD + +N+L+      K+ DFGLA+++ D    + + R        + 
Sbjct: 120 RMN------YIHRDLRSANILVGDGLVCKIADFGLARLIEDN---EYTARQGAKFPIKWT 170

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV 385
           APE A  G+ T KSDV+S+G++L EL+T GRVP                 P + +R E +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP----------------YPGMNNR-EVL 213

Query: 386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
           E V+   +   P+   I +  +   C + +   RP
Sbjct: 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 42/282 (14%)

Query: 161 VIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVE 214
           VIG G FG V++G+L      +  VA IK L     +++R  F  E  ++ +     ++ 
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD-CAMALEFLHEH 273
           L G        ++I+EYM NG L ++L  H+  +       +L+  L   A  +++L + 
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYLSDM 126

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG-----YLAP 328
                +HRD    N+L++ N   KV+DFGL++++ D   G  +T    + G     + AP
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAP 179

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
           E  +  K T+ SDV+S+G+V+ E+++ G  P              W +    S  E ++ 
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPY-------------WDM----SNHEVMKA 222

Query: 388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           ++   +   P      +  +   C Q + A RP   D+V  L
Sbjct: 223 INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 99.2 bits (247), Expect = 1e-23
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 38/276 (13%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G+G FGVV+ G        AIK +  +G   E  F  E  ++ +L  P+LV+L G C  
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           Q    +++E+M NG L  +L +   +         L +  D    +E+L  ++    IHR
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG------YLAPEYASTGK 335
           D    N L+      KV+DFG+ + V D            ++G      +  PE  +  K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 336 LTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG 394
            ++KSDV+S+GV++ E+ T G++P +                   S  E VEM+    + 
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEK-----------------KSNYEVVEMISRGFRL 220

Query: 395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI 430
             PK   + +  +   C   +   RP   ++++++ 
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 19/214 (8%)

Query: 156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKL-----HRDGKQRE-RAFRMEVDLLSRLHS 209
           +++G V+G G +G VY G+ + G + A+K++     +    ++E    + EVDLL  L  
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCAMALE 268
             +V+ LG C D N   +  E++P G++   L+R      P+  + T+ I+       + 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVA 116

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS----DKINGQISTRVLGTTG 324
           +LH +    V+HRD K +NV+L  N   K+ DFG A+ ++       +  +   + GT  
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE  +      KSD++S G  + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (256), Expect = 3e-23
 Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 25/276 (9%)

Query: 158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           E NVI  G  G  YKG      +  + K   +          E+  + +L  P +V+L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVK---EINDVNSIPSSEIADMGKLQHPNIVKLIG 750

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
            C  +    LI EY+    L + L       R L W  R  IA+  A AL FLH   +P 
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           V+  +     +++D      +    L  ++         T+   ++ Y+APE   T  +T
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDIT 856

Query: 338 TKSDVYSYGVVLLELLTGRVPVDPNRPPGEH-VLVSWALPRLTSREEAVEM-VDPSLQGQ 395
            KSD+Y +G++L+ELLTG+ P D     G H  +V WA  R    +  ++M +DPS++G 
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWA--RYCYSDCHLDMWIDPSIRGD 912

Query: 396 YP--KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
               + +++++  +A  C   +   RP   DV+++L
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 11/211 (5%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRL 207
             NF     IG G F VVYK + L DG V A+KK+      D K R+   + E+DLL +L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
             P +++ L    + N   ++ E    G L + +     + R +  RT     +    AL
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           E +H      ++HRD K +NV +      K+ D GL +  S K     S  ++GT  Y++
Sbjct: 120 EHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE         KSD++S G +L E+   + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 26/271 (9%)

Query: 161 VIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYC 219
           ++G G FG V+KG L D T  A+K    D  Q  +  F  E  +L +   P +V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
             +    ++ E +P G     L +  +    L  +  +  ALD A  + +L    +   I
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD    N L+ +N   K++DFG+++   D I      + +    + APE  + G+ +++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174

Query: 340 SDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK 398
           SDV+SYG++L E  + G  P      PG             + ++A E V+   +   P+
Sbjct: 175 SDVWSYGILLWETFSLGVCPY-----PG------------MTNQQAREQVEKGYRMSCPQ 217

Query: 399 KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           K    +  +   C   +   RP  +++ + L
Sbjct: 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.3 bits (239), Expect = 1e-22
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+ G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIH 280
           +    +++EYM  G+L   L     +Y  L     +   +   MA +E ++       +H
Sbjct: 73  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVH 125

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTT 338
           RD + +N+L+ +N   KV DFGLA+++ D    + + R        + APE A  G+ T 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 339 KSDVYSYGVVLLELLT-GRVP 358
           KSDV+S+G++L EL T GRVP
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 70/200 (35%), Positives = 103/200 (51%), Gaps = 15/200 (7%)

Query: 161 VIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
            IG G FG V  G    G   A+K +  D   +  AF  E  ++++L    LV+LLG   
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 221 DQNHRLLI-SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
           ++   L I +EYM  G+L  +L R   R   L     L  +LD   A+E+L  +     +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL-RSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD    NVL+ ++  AKV+DFGL K  S     Q + ++     + APE     K +TK
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKL--PVKWTAPEALREKKFSTK 179

Query: 340 SDVYSYGVVLLELLT-GRVP 358
           SDV+S+G++L E+ + GRVP
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)

Query: 158 EGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH-----RDGKQRER----AFRMEVDLLSRL 207
           +G +IG+G FG VY G+  S G + A+K++         K R+R    A   E+ LL  L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCAMA 266
               +V+ LG   D +H  +  EY+P G++   L+ +      L     R I+       
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK-----G 118

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI----NGQISTRVLGT 322
           L +LH      +IHRD K +N+L+D     K++DFG++K +               + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             ++APE       T K+D++S G +++E+LTG+ P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+ G  +  T  AIK L + G     AF  E +L+ +L  P+LV L      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVT 71

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           Q    +I+EYM NG+L   L         ++   +LI +A   A  + F+        IH
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTIN---KLIDMAAQIAEGMAFIERKNY---IH 125

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG------YLAPEYASTG 334
           RD + +N+L+ +    K+ DFGLA+++ D              G      + APE  + G
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIED-------NEYTAREGAKFPIKWTAPEAINYG 178

Query: 335 KLTTKSDVYSYGVVLLELLT-GRVP 358
             T KSDV+S+G++L E++T GR+P
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER------AFRMEVDLLSRLHSPQLVE 214
           IG G +G VYK      G + A+KK+  +    E+      A R E+ LL +L  P +V 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIR-EIKLLQKLRHPNIVR 62

Query: 215 LLGYC--ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----AL 267
           L        +    ++ EYM +  L   L     ++            + C M      L
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE--------SQIKCYMKQLLEGL 113

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           ++LH +    ++HRD K SN+L++ +   K+ DFGLA+  + + +   + RV+ T  Y  
Sbjct: 114 QYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 328 PE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
           PE    +T +   + D++S G +L EL  G+
Sbjct: 170 PELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 160 NVIGNGGFGVVYKG----VLSDGT---VAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
           N +G+G FG VY+G    +L  G+     A+K L +    +E+  F  E  L+S  + P 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLH--RHNNRYRPLDWRTRLI-IALDCAMALE 268
           +V+LLG C     + +I E M  G L  +L   R      PL     L+ I LD A    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 269 FLHE-HATPPVIHRDFKCSNVLL-----DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
           +L + H     IHRD    N L+     D +   K+ DFGLA+ +      +     L  
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             ++APE    GK TT+SDV+S+GV++ E+LT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 12/204 (5%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQ 211
            + +  V+G G FG+V+           I K     +  K    A + E  +L  L  P 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           ++E      +    +++ EY P GTL +++ +  N    LD  T L   +   +AL  +H
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL--LDEDTILHFFVQILLALHHVH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
                 ++HRD K  N+LLD++    K+ DFG++K++S K     +  V+GT  Y++PE 
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SKAYTVVGTPCYISPEL 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLT 354
                   KSD+++ G VL EL +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.0 bits (233), Expect = 8e-22
 Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 17/221 (7%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+ G  +  T  AIK L + G     AF  E  ++ +L   +LV L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           +    +++E+M  G+L   L   + +Y  L    +L+ +A   A  + ++        IH
Sbjct: 73  EP-IYIVTEFMGKGSLLDFLKEGDGKYLKL---PQLVDMAAQIADGMAYIERMN---YIH 125

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTT 338
           RD + +N+L+  N   K+ DFGLA+++ D    + + R        + APE A  G+ T 
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 339 KSDVYSYGVVLLELLT-GRVPVDP--NRPPGEHVLVSWALP 376
           KSDV+S+G++L EL+T GRVP     NR   E V   + +P
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 72/239 (30%), Positives = 104/239 (43%), Gaps = 44/239 (18%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSR 206
           ++F    VIG G FG V+   L      G V A+K L +     + +    R E D+L+ 
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
             SP +V+L     D+ H  L+ EYMP G L   L R  + +   +   R  IA +  +A
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPE-ET-ARFYIA-ELVLA 113

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK----------MVSDKINGQIS 316
           L+ +H+      IHRD K  N+L+D +   K+ DFGL K           ++D  N    
Sbjct: 114 LDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 317 TRVL-----------------GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             VL                 GT  Y+APE         + D +S GV+L E+L G  P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 30/219 (13%)

Query: 162 IGNGGFGVVYK----GVLS--DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVE 214
           IG G FG V++    G+L     T+ A+K L  +     +  F+ E  L++    P +V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNN-------------------RYRPLDWRT 255
           LLG CA      L+ EYM  G L + L RH +                      PL    
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
           +L IA   A  + +L E      +HRD    N L+ +N   K+ DFGL++ +      + 
Sbjct: 132 QLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           S        ++ PE     + TT+SDV++YGVVL E+ +
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 41/279 (14%)

Query: 163 GNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCA 220
           GNGG  V     +  GTV A K +H   K   R++  R E+ ++    SP +V   G   
Sbjct: 16  GNGG-SVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQIMHECRSPYIVSFYGAFL 73

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH-EHATPPVI 279
           ++N+  +  E+M  G     L R   +  P+       IA+     L +L+  H    ++
Sbjct: 74  NENNICMCMEFMDCG----SLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IM 126

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD K SN+L++   + K+ DFG    VS ++   I+   +GT+ Y++PE    GK T K
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFG----VSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 340 SDVYSYGVVLLELLTGRVPVD--PNRPPGE----------HVLVSWALPRLTSR---EEA 384
           SDV+S G+ ++EL  G+ P         G+            +V    PRL S    E+ 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 385 VEMVD----------PSLQGQYPKKDLIQIAAIAAVCVQ 413
            + VD          P+ Q        IQ    + V +Q
Sbjct: 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQ 281

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 162 IGNGGFGVVY----------------KGVLSDGTV-AAIKKLHRDGKQRERA-FRMEVDL 203
           +G G FG V+                +   +D  V  A+K L  D     R  F  EV +
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH-------NNRYRPLDWRTR 256
           LSRL  P +  LLG C       +I EYM NG L Q L +H           + L + T 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           L +A   A  + +L        +HRD    N L+ +N+  K+ DFG+++ +      ++ 
Sbjct: 133 LYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            R      ++A E    GK TTKSDV+++GV L E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)

Query: 161 VIGNGGFG--VVYKGVLSDGTVAAIKK--LHR-DGKQRERAFRMEVDLLSRLHSPQLVEL 215
           V+G G FG   +Y+    D ++   K+  L R   K+R  A   E+ +LS L  P ++  
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAY 64

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
             +  D N  L+  EY   GTL   + R   +    +    L        A+ ++H+   
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKAG- 121

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             ++HRD K  N+ L +    K+ DFG++K++  + +   +  V+GT  Y++PE     K
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177

Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
              KSD+++ G VL ELLT +   D   P                      +V   +QG 
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPL--------------------NLVVKIVQGN 217

Query: 396 Y-PKKDLIQIAAIAAV--CVQPEAAYRPLMTDVVQSLIP 431
           Y P   +     I+ V   +Q +   RP   +V+   + 
Sbjct: 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 12/184 (6%)

Query: 180 VAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           + A+K L  D  +  R  F  E+ ++SRL +P ++ LLG C   +   +I+EYM NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 239 QHLHR--------HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           Q L +        H N    +     L +A+  A  +++L   A+   +HRD    N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             ++  K+ DFG+++ +      +I  R +    ++A E    GK TT SDV+++GV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 351 ELLT 354
           E+ T
Sbjct: 223 EMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 77/264 (29%), Positives = 128/264 (48%), Gaps = 34/264 (12%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY 218
           G +IG G FG V +G  + G   A+K +  D     +AF  E  ++++LH   LV LLG 
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPP 277
               N   ++ E M  G L   L     R R L    +L+  +LD A  +E+L    +  
Sbjct: 68  IL-HNGLYIVMELMSKGNLVNFLR---TRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           ++HRD    N+L+ ++  AKV+DFGLA++ S  ++   ++++     + APE     K +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALKHKKFS 175

Query: 338 TKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQY 396
           +KSDV+SYGV+L E+ + GR P                 P+++ + E  E V+   + + 
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP----------------YPKMSLK-EVKECVEKGYRMEP 218

Query: 397 PKKDLIQIAAIAAVCVQPEAAYRP 420
           P+     +  +   C + E   RP
Sbjct: 219 PEGCPADVYVLMTSCWETEPKKRP 242

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 92.7 bits (230), Expect = 5e-21
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 11/181 (6%)

Query: 182 AIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
           A+K L  D  +  R  F  E+ ++SRL  P ++ LL  C   +   +I+EYM NG L Q 
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 241 LHRHNNRYRPLDWRTRLI-------IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
           L RH  +          I       +A   A  +++L   ++   +HRD    N L+ +N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKN 166

Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           +  K+ DFG+++ +      +I  R +    +++ E    GK TT SDV+++GV L E+L
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 354 T 354
           T
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 92.3 bits (229), Expect = 7e-21
 Identities = 61/190 (32%), Positives = 95/190 (50%), Gaps = 19/190 (10%)

Query: 180 VAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           + A+K L  D  +  R  F  EV +LSRL  P ++ LLG C D++   +I+EYM NG L 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 239 QHLHRH--------NNRYRPLD-------WRTRLIIALDCAMALEFLHEHATPPVIHRDF 283
           Q L  H         N   P         + + L +AL  A  +++L   ++   +HRD 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 284 KCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVY 343
              N L+ +N   K+ DFG+++ +      +I  R +    ++A E    GK TT SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 344 SYGVVLLELL 353
           ++GV L E+L
Sbjct: 225 AFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 92.4 bits (229), Expect = 7e-21
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 29/221 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLS-DGT--VAAIKKLHRDGKQRE-RAFRMEVDLLSRL-H 208
           E+    +VIG G FG V + ++  DG    AAIK L     + + R F  E+++L +L H
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH------------RHNNRYRPLDWRTR 256
            P ++ LLG C ++ +  +  EY P G L   L             + +     L  +  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK---MVSDKING 313
           L  A D A  +++L E      IHRD    NVL+ +N  +K+ DFGL++   +   K  G
Sbjct: 122 LQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           ++  R      ++A E  +    TTKSDV+S+GV+L E+++
Sbjct: 179 RLPVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 161 VIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVEL 215
           VIG G FG V +G L          AIK L     +++R  F  E  ++ +   P ++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHA 274
            G        ++I+E+M NG L   L +++ ++  +    +L+  L   A  +++L E  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYLSEMN 126

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG---TTGYLAPEYA 331
               +HRD    N+L++ N   KV+DFGL++ + D  +    T  LG      + APE  
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 332 STGKLTTKSDVYSYGVVLLELLT 354
           +  K T+ SDV+SYG+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 160 NVIGNGGFGVVYKGVLS-DGTV--AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVE 214
           +VIG G FG V K  +  DG    AAIK++     + + R F  E+++L +L H P ++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLH------------RHNNRYRPLDWRTRLIIALD 262
           LLG C  + +  L  EY P+G L   L               N+    L  +  L  A D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRV 319
            A  +++L +      IHRD    N+L+ +N+ AK+ DFGL++   +   K  G++  R 
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 176

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                ++A E  +    TT SDV+SYGV+L E+++
Sbjct: 177 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKK-----LHRDGKQRERAFRMEVDLLSRLH 208
           N+  G ++G G FG VY     D G   A+K+        + K+   A   E+ LL  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH----NNRYRPLDWRTRLIIALDCA 264
             ++V+  G   D     +  EYMP G+++  L  +        R     TR I+     
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY---TRQILE---- 115

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTT 323
             +E+LH +    ++HRD K +N+L D     K+ DFG +K +    +     + V GT 
Sbjct: 116 -GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +++PE  S      K+DV+S G  ++E+LT + P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 57/218 (26%), Positives = 109/218 (50%), Gaps = 22/218 (10%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL--------HRDGKQRE--RAFRMEVDL 203
            + +G +IG G +G VY  + ++ G + A+K++          D +Q++  +A R E++ 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLIIALD 262
           L  L    +V+ LG+   + +  +  EY+P G++   L  +      L  + T  ++   
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-- 119

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
               L +LH      ++HRD K  N+L+D +   K++DFG++K   D  +   +  + G+
Sbjct: 120 ---GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 323 TGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVP 358
             ++APE   +     + K D++S G V+LE+  GR P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 26/218 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKL-HRDGKQRERAFRMEVDLLSR 206
            N  E   +G G FG V+             T+  +K L     +  +  FR E+D+  +
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL-----HRHNNRYRPLDWRTRLIIAL 261
           L    +V LLG C +     +I EY   G L+Q L          +  PL  + ++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK-----INGQIS 316
             A+ ++ L   +    +HRD    N L+      KV+   L+K V +       N  I 
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            R      +LAPE       +TKSDV+S+GV++ E+ T
Sbjct: 182 LR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 29/215 (13%)

Query: 160 NVIGNGGFGVVYKG-VLSDGTV--AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVE 214
           +VIG G FG V K  +  DG    AAIK++     + + R F  E+++L +L H P ++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NNRYRPLDWRTRLIIALD 262
           LLG C  + +  L  EY P+G L   L +             N+    L  +  L  A D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRV 319
            A  +++L +      IHRD    N+L+ +N+ AK+ DFGL++   +   K  G++  R 
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                ++A E  +    TT SDV+SYGV+L E+++
Sbjct: 189 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC 219
            +G G +G VYK +    G V AIK +  +   +E     E+ +L +  SP +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVKYYGSY 67

Query: 220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
                  ++ EY   G++   +       + L       I       LE+LH +     I
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHSNKK---I 121

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD K  N+LL++  +AK+ DFG++  ++D    + +T V+GT  ++APE         K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDT-MAKRNT-VIGTPFWMAPEVIQEIGYNNK 179

Query: 340 SDVYSYGVVLLELLTGRVP-----------VDPNRPP 365
           +D++S G+  +E+  G+ P           + PN+PP
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP 216

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           IG G +GVVYK      G + AIKK+          + A R E+ LL  L+ P +++LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
               +    L+ E+M     +  L +   R  P       +  L     L F H H    
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKSYLYQLLQG--LAFCHSHG--- 118

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKINGQISTRVLGTTGYLAPE--YAS 332
           ++HRD K  N+L++     K+ DFGLA+            + TR      Y APE     
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGD 173

Query: 333 TGKLTTKSDVYSYGVVLLELLTGR 356
            G  +T  D++S G +  ELL+ R
Sbjct: 174 KG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 14/202 (6%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQLVELLG 217
           +G GGFG V    +   G + A KKL +   ++ +  +M   E  +L ++ S  +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII-ALDCAMALEFLHEHATP 276
               ++   L+   M  G L+ H++       P     R I  A      LE LH+    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR-- 115

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            +++RD K  NVLLD +   +++D GLA  +     G+      GT GY+APE       
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 337 TTKSDVYSYGVVLLELLTGRVP 358
               D ++ G  L E++ GR P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 76/279 (27%), Positives = 128/279 (45%), Gaps = 35/279 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQ 211
           E F++   IG G FG V+KG+ +    V AIK +  +  + E    + E+ +LS+  SP 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           + +  G         +I EY+  G+    L        PLD      I  +    L++LH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS-TRVLGTTGYLAPEY 330
                  IHRD K +NVLL ++   K+ DFG+A  ++D    QI     +GT  ++APE 
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
                  +K+D++S G+  +EL  G  P     P    + V + +P+            P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLIPKNNP---------P 219

Query: 391 SLQGQY--PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           +L+G Y  P K+ ++       C+  E ++RP   ++++
Sbjct: 220 TLEGNYSKPLKEFVE------ACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 67/213 (31%), Positives = 94/213 (44%), Gaps = 13/213 (6%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGV---LSDGTVA---AIKKLHRDGKQRER-AFRMEVD 202
           E    N S G  +G G FG V +     LS        A+K L       ER A   E+ 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 203 LLSRLHSPQ-LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
           ++S L + + +V LLG C      L+I+EY   G L   L R   R   L     L  + 
Sbjct: 91  IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSY 148

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
             A  + FL   A+   IHRD    NVLL      K+ DFGLA+ + +  N  +      
Sbjct: 149 QVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
              ++APE       T +SDV+SYG++L E+ +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 25/215 (11%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL-------HRDGKQRERAFRMEVDLLSR 206
            + +G  +G G + VVYK      G + AIKK+        +DG     A R E+ LL  
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQE 58

Query: 207 LHSPQLVELLG-YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           L  P ++ LL  +    N  L+  E+M    L++ +   +    P D ++ +++ L    
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVF-EFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---R 113

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            LE+LH +    ++HRD K +N+L+  +   K+ DFGLA+      N +++ +V+ T  Y
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV-TRWY 168

Query: 326 LAPE--YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            APE  + +        D++S G +  ELL  RVP
Sbjct: 169 RAPELLFGAR-HYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL----HRDGKQRE--RAFRMEVDLLSRL 207
            + +G  +G G F   Y+   +  GT+ A+K++    +   +Q E   A R E+ L++RL
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           + P ++ +LG   + +H  L  E+M  G++   L     +Y        +         L
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKIN--GQISTRVLGTTG 324
            +LHE+    +IHRD K +N+L+D    R ++ DFG A  ++ K    G+   ++LGT  
Sbjct: 117 SYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE     +     DV+S G V++E+ T + P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 35/279 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGT-VAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQ 211
           E F++   IG G FG VYKG+ +    V AIK +  +  + E    + E+ +LS+  SP 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +    G         +I EY+  G+    L     +  PL+      I  +    L++LH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV-LGTTGYLAPEY 330
                  IHRD K +NVLL +    K+ DFG+A  ++D    QI     +GT  ++APE 
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
                   K+D++S G+  +EL  G  P     P    + V + +P+ +          P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIPKNSP---------P 219

Query: 391 SLQGQY--PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           +L+GQY  P K+ ++       C+  +  +RP   ++++
Sbjct: 220 TLEGQYSKPFKEFVE------ACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 162 IGNGGFGVVY--KGVLSDGTVAAIKKLHR---DGKQRERAFRME-VDLLSRLHSPQLVEL 215
           I  G FG VY  K   + G   AIK L +     K +    + E   ++ +  SP + +L
Sbjct: 4   ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 216 LGYCADQNHRLLISEYMPNG---TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
                 +++  L+ EY+  G   +L + L        P DW  + I  +   + +E LH+
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLG-----GLPEDWAKQYIAEV--VLGVEDLHQ 115

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                +IHRD K  N+L+DQ    K+TDFGL++       G  + + +GT  YLAPE   
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETIL 166

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
                  SD +S G V+ E L G  P     P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 20/223 (8%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTV----AAIKKLH-RDGKQRERAFRMEVDLLSR 206
                +  ++G+G FG V+KG+ + +G       AIK +  R G+Q  +     +  +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDC 263
           L    +V LLG C   + +L +++  P G+L  H+ +H +   P   L+W  ++      
Sbjct: 66  LDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------ 118

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  + +L EH    ++HR+    N+LL  +   ++ DFG+A ++         +      
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
            ++A E    G+ T +SDV+SYGV + E+++ G  P    RP 
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.5 bits (223), Expect = 6e-20
 Identities = 73/215 (33%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 154 ENFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDG----KQRERAFRMEVDLLS 205
           ++F     +G G FG V    +KG    G   A+K L +      KQ E     E  +L 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLN-EKRILQ 56

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            +  P LV L G   D ++  L+ EY+P G L  HL R + R+ P     R   A    +
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRF-PEPV-ARFYAA-QVVL 112

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTG 324
           ALE+LH      +++RD K  N+LLD +   K+TDFG AK V  +      T  L GT  
Sbjct: 113 ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPE 163

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           YLAPE     K   K+ D ++ G+++ E+L G  P
Sbjct: 164 YLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.5 bits (219), Expect = 7e-20
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+ G  ++ T  A+K L + G    +AF  E +L+  L   +LV L      
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           +    +I+EYM  G+L   L         L    +LI  +   A  + ++        IH
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLL---PKLIDFSAQIAEGMAYIERKN---YIH 126

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTT 338
           RD + +NVL+ ++   K+ DFGLA+++ D    + + R        + APE  + G  T 
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTI 183

Query: 339 KSDVYSYGVVLLELLT-GRVP 358
           KSDV+S+G++L E++T G++P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.6 bits (219), Expect = 9e-20
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 150 ETATENFSEGNVIGNGGFGVVY----KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVD 202
           E A E  +    +G G FG+VY    KGV+ D   T  AIK ++     RER  F  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH------RHNNRYRPLDWRTR 256
           ++   +   +V LLG  +     L+I E M  G L+ +L        +N    P   +  
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           + +A + A  + +L+ +     +HRD    N ++ ++F  K+ DFG+ + + +    +  
Sbjct: 122 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            + L    +++PE    G  TT SDV+S+GVVL E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           +G G +GVVYK      G + A+KK+      +G     A R E+ LL  L  P +V+LL
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST-ALR-EISLLKELKHPNIVKLL 64

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
                +    L+ EY     L+++L +      PL       I       L + H H   
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR-- 118

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE------- 329
            ++HRD K  N+L++++   K+ DFGLA+     +    +  V+ T  Y APE       
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYRAPEILLGSKH 175

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGR 356
           Y      +T  D++S G +  E++TG+
Sbjct: 176 Y------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 27/234 (11%)

Query: 134 YVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKG-VLSDGTVAAIKKLHRDGKQ 192
           Y+   G        +LE   E       IG+G  G VYK      G V A+K++ R G +
Sbjct: 2   YLTIDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK 54

Query: 193 RE-RAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
            E +   M++D++ + H  P +V+  GY    +   +  E M   T    L +      P
Sbjct: 55  EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIP 112

Query: 251 LDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA-KMVS 308
            D   ++ +A+    AL +L E H    VIHRD K SN+LLD +   K+ DFG++ ++V 
Sbjct: 113 EDILGKMTVAI--VKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167

Query: 309 DKINGQISTRVLGTTGYLAPEY----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            K      TR  G   Y+APE         K   ++DV+S G+ L+EL TG+ P
Sbjct: 168 SKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 38/282 (13%)

Query: 162 IGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G G FG V+           D  + A+K L    +   + F+ E +LL+ L    +V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYR-----------PLDWRTRLIIALDCA 264
            G C +    L++ EYM +G L + L  H    +            L     L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             + +L   A+   +HRD    N L+ Q    K+ DFG+++ +      ++  R +    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREE 383
           ++ PE     K TT+SD++S+GVVL E+ T G+ P              W      S  E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP--------------W---YQLSNTE 232

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDV 425
           A+E +    + + P+    ++ AI   C Q E   R ++ D+
Sbjct: 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 31/229 (13%)

Query: 149 LETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           L   T  F    VIG G +G VYK      G + AIK +     + E   + E ++L + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEI-KEEYNILRKY 59

Query: 208 -HSPQLVELLGYCADQNHRL------LISEYMPNGT---LQQHLHRHNNRYRPLDWRTRL 257
            + P +    G    +N         L+ E    G+   L + L +   R +  +W    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW---- 114

Query: 258 IIALDC---AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            IA         L +LHE+    VIHRD K  N+LL +N   K+ DFG++  + D   G+
Sbjct: 115 -IAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGR 169

Query: 315 ISTRVLGTTGYLAPE-----YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +T + GT  ++APE              +SDV+S G+  +EL  G+ P
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 34/221 (15%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVA----AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVE 214
           V+G+G FG VYKG+ + +G       AIK L+   G +    F  E  +++ +  P LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEFLH 271
           LLG C     +L +++ MP+G L  ++H H +       L+W  ++      A  + +L 
Sbjct: 74  LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS------DKINGQISTRVLGTTGY 325
           E     ++HRD    NVL+      K+TDFGLA+++       +   G++  +      +
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------W 177

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD--PNR 363
           +A E     K T +SDV+SYGV + EL+T G  P D  P R
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 21/238 (8%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGY 218
           +IG G +G VY+G  +  G V A+K ++ D    + +  + EV LLS+L   Q   +  Y
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 219 --CADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
                +  RL +I EY   G++     R   +  P+  +   +I  +  +AL+++H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVLVALKYIHKV-- 120

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             VIHRD K +N+L+      K+ DFG+A +++   N    +  +GT  ++APE  + GK
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLN--QNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 336 L-TTKSDVYSYGVVLLELLTGRVP---VDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
              TK+D++S G+ + E+ TG  P   VD  R     ++     PRL     +  + +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFR--AMMLIPKSKPPRLEDNGYSKLLRE 233

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 77/287 (26%), Positives = 130/287 (45%), Gaps = 36/287 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQ 211
           E F++   IG G FG V+KG+ +    V AIK +  +  + E    + E+ +LS+  SP 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           + +  G         +I EY+  G+    L     R  P D      +  +    L++LH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV-LGTTGYLAPEY 330
                  IHRD K +NVLL +    K+ DFG+A  ++D    QI     +GT  ++APE 
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
                  +K+D++S G+  +EL  G  P     P    + V + +P+            P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNNP---------P 219

Query: 391 SLQGQYPK--KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN 435
           +L G++ K  K+ I        C+  + ++RP   ++++    +VKN
Sbjct: 220 TLTGEFSKPFKEFID------ACLNKDPSFRPTAKELLKHKF-IVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 48/285 (16%)

Query: 161 VIGNGGFGVVYKGVLS----DGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLV 213
           VIG G FG V  G L          AIK L   + + KQR R F  E  ++ +   P ++
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQR-RDFLSEASIMGQFDHPNII 68

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHE 272
            L G        ++++EYM NG+L   L +H+ ++  +    +L+  L   A  +++L +
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI----QLVGMLRGIASGMKYLSD 124

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTGY 325
                 +HRD    N+L++ N   KV+DFGL++++ D          G+I  R      +
Sbjct: 125 MG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR------W 175

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
            APE  +  K T+ SDV+SYG+V+ E+++ G  P              W +    S ++ 
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WEM----SNQDV 218

Query: 385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           ++ ++   +   P      +  +   C Q +   RP    +V  L
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 161 VIGNGGFGVV----YKGVLSDGTVAAIKKLHRDG-KQRERAFRMEVDL---------LSR 206
           V+G G FG V     KG      + A+K L +D   Q +     +V+          L+ 
Sbjct: 2   VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDD-----DVECTMTEKRVLALAG 53

Query: 207 LHSPQLVELLGYCADQ--NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            H P L +L  +   Q  +    + EY+  G L  H+ R        D       A +  
Sbjct: 54  KH-PFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIV 106

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           + L+FLHE     +I+RD K  NVLLD     K+ DFG+ K     + G  ++   GT  
Sbjct: 107 LGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPD 161

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           Y+APE  S        D ++ GV+L E+L G+ P +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 155 NFSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLH---RDGKQRERAFRMEVDLLSRLHSP 210
            +     IG G  G+V+K      G   A+KK+     +G    +A R E+  L     P
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM---AL 267
            +V+LL      +  +L+ EYMP   L + L    +  RPL       +     M    +
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLR---DEERPL---PEAQVKSYMRMLLKGV 112

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            ++H +    ++HRD K +N+L+  +   K+ DFGLA++ S++     S +V  T  Y A
Sbjct: 113 AYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRA 168

Query: 328 PE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
           PE  Y +  K     D+++ G +  ELL G 
Sbjct: 169 PELLYGAR-KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAF-RMEVDLLSRLHSPQLVELLG 217
            VIG G   VVY  + L +    AIK++  +  Q      R EV  +S+ + P +V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
                +   L+  Y+  G+L   + + +     LD      +  +    LE+LH +    
Sbjct: 67  SFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYAST 333
            IHRD K  N+LL ++   K+ DFG++  ++D   G  + +V     GT  ++APE    
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLAD--GGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 334 GK-LTTKSDVYSYGVVLLELLTGRVP 358
                 K+D++S+G+  +EL TG  P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 65/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)

Query: 155 NFSEGNVIGNGGFGVVYKGV------LSDGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRL 207
           N   G  +G G FG V K         +  T  A+K L  +    E R    E +LL ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH--------------RHNNRY----- 248
           + P +++L G C+     LLI EY   G+L+  L                 N+ Y     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 249 -RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV 307
            R L     +  A   +  +++L E     ++HRD    NVL+ +  + K++DFGL++ V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
            ++ +    ++      ++A E       TT+SDV+S+GV+L E++T G  P  P   P
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIAP 235

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 27/277 (9%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHS 209
           NF     IG G F  VY+   L DG   A+KK+      D K R    + E+DLL +L+ 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNH 61

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P +++      + N   ++ E    G L + +     + R +  +T     +    ALE 
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H      V+HRD K +NV +      K+ D GL +  S K     S  ++GT  Y++PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
                    KSD++S G +L E+   + P   ++              L S  + +E  D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLYSLCKKIEQCD 224

Query: 390 -PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDV 425
            P L   +  ++L Q+  +   C+ P+   RP +T V
Sbjct: 225 YPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 161 VIGNGGFGVVY--KGVLSDGTVAAIKK--LHRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
            IG G FG +Y  K   SD     IK+  L +   + + A + EV LL+++  P +V   
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
               +     ++ EY   G L + +    NR R + +    I++    ++L   H H   
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRI----NRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 277 PVIHRDFKCSNVLLDQNFR-AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
            ++HRD K  N+ L +N   AK+ DFG+A+ ++D +  +++   +GT  YL+PE      
Sbjct: 122 -ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRP 178

Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPN 362
              K+D++S G VL EL T + P + N
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 73/226 (32%), Positives = 107/226 (47%), Gaps = 29/226 (12%)

Query: 147 KELETATENFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDG--KQRERAFRME 200
            +L    E+F    VIG G FG V    +K   S   V A+K L +    K+ + AF  E
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 201 V-DLLSRLHSPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
             D+++  +S  +V+L  + A Q+ + L  + EYMP G L   +   +N   P  W  R 
Sbjct: 93  ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKW-ARF 146

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI-S 316
             A +  +AL+ +H       IHRD K  N+LLD++   K+ DFG   M  D  NG +  
Sbjct: 147 YTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDA-NGMVRC 200

Query: 317 TRVLGTTGYLAPEY----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              +GT  Y++PE        G    + D +S GV L E+L G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
           E++     IG+G +G VYK   ++ G + AIK +  +        + E+ +L     P +
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 213 VELLG-YCADQNHRLLIS-EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL--- 267
           V   G Y   +  +L I  EY   G+LQ           PL   + L IA  C   L   
Sbjct: 63  VAYFGSYL--RRDKLWIVMEYCGGGSLQDIYQVTR---GPL---SELQIAYVCRETLKGL 114

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGY 325
            +LHE      IHRD K +N+LL ++   K+ DFG    VS ++   I+ R   +GT  +
Sbjct: 115 AYLHETG---KIHRDIKGANILLTEDGDVKLADFG----VSAQLTATIAKRKSFIGTPYW 167

Query: 326 LAPEYA---STGKLTTKSDVYSYGVVLLELLTGRVP---VDPNR 363
           +APE A     G    K D+++ G+  +EL   + P   + P R
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 67/222 (30%), Positives = 96/222 (43%), Gaps = 23/222 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRL 207
           E   E + +G G  G V K  L + G + A+K +  D      KQ  R    E+++    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSC 56

Query: 208 HSPQLVELLGYCADQNHRLLIS---EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            SP +V+  G   D      I    EY   G+L     +   R   +  +    IA    
Sbjct: 57  KSPYIVKYYGAFLD-ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTT 323
             L +LH      +IHRD K SN+LL +  + K+ DFG    VS + +N    T   GT+
Sbjct: 116 KGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFT-GTS 167

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
            Y+APE       +  SDV+S G+ LLE+   R P  P   P
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 162 IGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLG 217
           +G GGFG V    V + G + A KKL +     K  E+   +E ++L +++SP +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
               + H  L+   M  G L+ H++    R   ++     +I     +    LH H+   
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME----RVIHYSAQITCGILHLHSMD- 115

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           +++RD K  NVLLD     +++D GLA  + D   G+  T+  GT GY+APE       +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYS 172

Query: 338 TKSDVYSYGVVLLELLTGRVP 358
              D ++ G  + E++ GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 30/207 (14%)

Query: 162 IGNGGFGVVYKGV--LSDGTV--AAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELL 216
           +G+G FG V KGV  +  G     A+K L ++     ++ F  E  ++++L  P +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 217 GYC-ADQNHRLLISEYMPNGTLQQHL--HRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           G C  +    +L+ E  P G L ++L   R        +       A   AM + +L   
Sbjct: 63  GVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG------YLA 327
                +HRD    NVLL    +AK++DFG+++ +     G  S     TT       + A
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYA 166

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLT 354
           PE  + GK ++KSDV+SYGV L E  +
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 23/218 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD---GTVAAIKKLHRDGKQRERA---FRMEVDLLSRL 207
           ++F   +++G G FG V   V+ +   G + A+K + +     +     F  E D+LS  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +SP + +L     D+++  L+ EY P G L   L+R+ +     D         +  +A+
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAI 115

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG-LAKMVSDKINGQISTRVLGTTGYL 326
             +H+      +HRD K  NVL+D+    K+ DFG  A++ ++K+    S   +GT  Y+
Sbjct: 116 HSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTPDYI 170

Query: 327 APEYASTGKLTTKS------DVYSYGVVLLELLTGRVP 358
           APE  +T     K       D +S GV+  E++ GR P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 19/207 (9%)

Query: 162 IGNGGFGVVYKG--VLSDGTV--AAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELL 216
           +G+G FGVV +G    S G V   A+K L  D        F  E  ++  L    L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHAT 275
           G        ++++E  P G+L   L +    +  +   + L   A+  A  + +L     
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI---STLCDYAVQIANGMRYLESKR- 117

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ--ISTRVLGTT-GYLAPEYAS 332
              IHRD    N+LL  + + K+ DFGL  M +   N    +    L     + APE   
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGL--MRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 333 TGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T   +  SDV+ +GV L E+ T G  P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRER------AFRMEVDLLSRL 207
            F + N IG G +G+VY+   +  G + A+KK+  D    ER      + R E+ LL  L
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIPISSLR-EITLLLNL 63

Query: 208 HSPQLVELLGYCADQ--NHRLLISEYMPNGTLQQHLHRH-NNRYRPLDWRTRLIIALDCA 264
             P +VEL      +  +   L+ EY      +Q L    +N   P        + L   
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             L++LHE+    +IHRD K SN+LL      K+ DFGLA+         ++ +V+ T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVV-TLW 173

Query: 325 YLAPE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
           Y APE     T   TT  D+++ G +L ELL  +
Sbjct: 174 YRAPELLLGCT-TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 162 IGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G G FG V+           D  + A+K L        + F  E +LL+ L    +V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRH---------NNRYRPLDWRTRLIIALDCAMA 266
            G C + +  +++ EYM +G L + L  H          NR   L     L IA   A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           + +L   A+   +HRD    N L+ +N   K+ DFG+++ V      ++    +    ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            PE     K TT+SDV+S GVVL E+ T G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 170 VYKGVLSDG--TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL- 226
           +YKG+ ++    +   KK H+  K        E+  L R+ S  ++++ G+  D    L 
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 227 ---LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF 283
              LI EY   G L++ L    ++ + L ++T+L +A+DC   L  L+++   P  +++ 
Sbjct: 96  RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 284 KCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST--GKLTTKSD 341
              + L+ +N++ K+   GL K++S      ++  V     Y + +  +    + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204

Query: 342 VYSYGVVLLELLTGRVPVD 360
           +YS GVVL E+ TG++P +
Sbjct: 205 IYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)

Query: 162 IGNGGFGVVYKGVL-----SDGTVAAIKKLHR-DGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G   FG +YKG L         + AIK L   +  Q+   F+ E  L++ LH P +V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHL-------------HRHNNRYRPLDWRTRLIIALD 262
           LG    +    ++ EY+  G L + L                      LD    L IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
            A  +E+L  H     +H+D    N+L+ +    K++D GL++ +      ++  + L  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             ++ PE    GK ++ SD++S+GVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 28/223 (12%)

Query: 156 FSEGNVIGNGGFGVVYKGVLS--DGTV--AAIKKLHRDG-KQRE-RAFRMEVDLLSRLHS 209
              G ++G G FG V +G LS  DG+    A+K +  D     E   F  E   +     
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 210 PQLVELLGYCADQNHR------LLISEYMPNGTLQQHLHRH----NNRYRPLDWRTRLII 259
           P +++L+G C + +        ++I  +M +G L   L            PL  +T L  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI---NGQIS 316
            +D A+ +E+L   +    IHRD    N +L ++    V DFGL+K +        G+I+
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                   ++A E  +    T+KSDV+++GV + E+ T G+ P
Sbjct: 176 KM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 45/218 (20%)

Query: 162 IGNGGFGVVYKGVLSD---GTVAAIKKLH---RDGKQRERAFRMEVDLLSRL-HSPQLVE 214
           +G G +G+V+K +  D     V A+KK+    R+    +R FR E+  L  L   P +V+
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 215 LLG-YCADQNHRL-LISEYMPNGTLQQHLH---RHN------NRYRPLDWRTRLIIALDC 263
           LL    A+ +  + L+ EYM     +  LH   R N       RY          I    
Sbjct: 72  LLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY----------IMYQL 116

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS---DKINGQISTRVL 320
             AL+++H   +  VIHRD K SN+LL+ + R K+ DFGLA+ +S   +     + T  +
Sbjct: 117 LKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 321 GTTGYLAPE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
            T  Y APE    ST + T   D++S G +L E+L G+
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)

Query: 162 IGNGGFGVVYKGVLS-DGTVAAIK--KLHRDGKQRERAFR---MEVDLLSRLHSPQLVEL 215
           +G G +G VYK +    G   A+K  +L  D    E  F    ME+D+L +  SP +V+ 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKFNQIIMELDILHKAVSPYIVDF 64

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
            G    +    +  EYM  G+L + L+        +       I       L+FL E   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +IHRD K +NVL++ N + K+ DFG    VS  +   ++   +G   Y+APE   +G 
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 336 L------TTKSDVYSYGVVLLELLTGRVPVDP 361
                  T +SDV+S G+ +LE+  GR P  P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)

Query: 161 VIGNGGFGVVYKG-VLSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           V+G G +GVV K    + G + AIKK      D   ++ A R EV +L +L    +V L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLK 66

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
                +    L+ EY+   TL + L        P     R  I      A+ + H H   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD--AVRSYI-WQLLQAIAYCHSHN-- 120

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE----YAS 332
            +IHRD K  N+L+ ++   K+ DFG A+ +  +      T  + T  Y APE      +
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLVGDTN 178

Query: 333 TGKLTTKSDVYSYGVVLLELLTGR 356
            GK     DV++ G ++ ELL G 
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 27/279 (9%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHS 209
           NF     IG G F  VY+   L D    A+KK+      D K R+   + E+DLL +L+ 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNH 61

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P +++ L    + N   ++ E    G L Q +     + R +  RT     +    A+E 
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H      V+HRD K +NV +      K+ D GL +  S K     S  ++GT  Y++PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
                    KSD++S G +L E+   + P   ++              L S  + +E  D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLFSLCQKIEQCD 224

Query: 390 -PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
            P L  ++  + L ++ ++   C+ P+   RP +  V Q
Sbjct: 225 YPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 15/210 (7%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIK--KLHRDGKQRERAFRMEVDL 203
           E   E+ + G  IG G FG VY+GV     ++    A+K  K       RE+ F  E  +
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYI 60

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           + +   P +V+L+G   + N   ++ E  P G L+ +L  +      LD  + ++ +   
Sbjct: 61  MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQL 116

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           + AL +L    +   +HRD    NVL+      K+ DFGL++ + D+   + S   L   
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PI 172

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            ++APE  +  + T+ SDV+ +GV + E+L
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)

Query: 162 IGNGGFGVVYKG------VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G G FG V+           D  + A+K L        + F+ E +LL+ L    +V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIALDC 263
            G C D +  +++ EYM +G L + L  H                  L     L IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  + +L   A+   +HRD    N L+  N   K+ DFG+++ V      ++    +   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            ++ PE     K TT+SDV+S+GV+L E+ T G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 29/213 (13%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM-EVDLLSRLHS-PQL 212
           +     +G+G FG VY       G + AIKK+ +     E    + EV  L +L+  P +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V+L     + +    + EYM  G L Q +     +        R II       L  +H+
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES-VIRSII-YQILQGLAHIHK 117

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK--INGQISTRVLGTTGYLAPE- 329
           H      HRD K  N+L+      K+ DFGLA+ +  +      +STR      Y APE 
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI 169

Query: 330 ------YASTGKLTTKSDVYSYGVVLLELLTGR 356
                 Y+S        D+++ G ++ EL T R
Sbjct: 170 LLRSTSYSS------PVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 14/205 (6%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRDGKQRE---RAFRMEVDLLSRLHSPQLVELL 216
           V+G G FG V+   +   G + A+K L +D   ++        E  +LS   +   +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 217 GYCADQNHRLL-ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
             C     RL  + E++  G L  H+ +     R  D       A +   AL FLH+   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKG- 116

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +I+RD K  NVLLD     K+ DFG+ K      NG+ ++   GT  Y+APE      
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 336 LTTKSDVYSYGVVLLELLTGRVPVD 360
                D ++ GV+L E+L G  P +
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)

Query: 162 IGNGGFGVVYKGVL-SDGTVAAIKK----LHRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           IG G FG V+ G L +D T  A+K     L  D K +   F  E  +L +   P +V L+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK---FLQEARILKQYSHPNIVRLI 59

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
           G C  +    ++ E +  G     L     R   L  +  + +  + A  +E+L    + 
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLE---SK 113

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    N L+ +    K++DFG+++   D +             + APE  + G+ 
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 337 TTKSDVYSYGVVLLELLT-GRVP 358
           +++SDV+S+G++L E  + G VP
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 18/218 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR----DGKQRERAFRMEVDLLSRLH 208
           ++      +G G FG V+           A+K +        KQ +     E  +L  + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVS 59

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P ++ L     DQ    ++ EY+P G L  +L R++ R+      T L  A +   ALE
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSN---STGLFYASEIVCALE 115

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH      +++RD K  N+LLD+    K+TDFG AK + D+     +  + GT  YLAP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAP 167

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG 366
           E   +       D ++ G+++ E+L G  P   + P G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 24/224 (10%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR--DGKQRERAFRME 200
           FT ++L+   E       IG G FG V K +    GT+ A+K++    D K+++R   M+
Sbjct: 1   FTAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMD 52

Query: 201 VDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNG--TLQQHLHRHNNRYRPLDWRTRL 257
           +D++ R    P +V+  G    +    +  E M        ++++       P +   + 
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK- 111

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            IA+    AL +L E     +IHRD K SN+LLD+N   K+ DFG++  + D I     T
Sbjct: 112 -IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKT 165

Query: 318 RVLGTTGYLAPEYASTG---KLTTKSDVYSYGVVLLELLTGRVP 358
           R  G   Y+APE            +SDV+S G+ L E+ TG+ P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)

Query: 162 IGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVE 214
           +G G FG+VY+G   D       T  A+K ++     RER  F  E  ++       +V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLH-----RHNNRYRPLDWRTRLI-IALDCAMALE 268
           LLG  +     L++ E M +G L+ +L        NN  RP      +I +A + A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +L+       +HRD    N ++  +F  K+ DFG+ + + +    +   + L    ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT 354
           E    G  TT SD++S+GVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 33/213 (15%)

Query: 161 VIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLL----------SR 206
           V+G G FG V    YK     G + AIK L    K+ +   R EV+ L          + 
Sbjct: 6   VLGRGHFGKVLLAEYK---KTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANS 58

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY-RPLDWRTRLIIALDCAM 265
              P LV L      ++H   + EY   G L  H+H   + +  P   R     A    +
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEP---RAVFYAACVV-L 112

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L++LHE+    +++RD K  N+LLD     K+ DFGL K       G  ++   GT  +
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEF 167

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           LAPE  +    T   D +  GV++ E+L G  P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 23/213 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM----EVDLLSRLH 208
           + + + N I  G +GVVY+      G + A+KKL  + K++E  F +    E+++L +L 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME-KEKE-GFPITSLREINILLKLQ 62

Query: 209 SPQLVEL----LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            P +V +    +G  ++ +   ++ EY+ +  L+  +      +   + +  L++ L   
Sbjct: 63  HPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSG 118

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           +A   LH++    ++HRD K SN+LL+     K+ DFGLA+     +  +  T+++ T  
Sbjct: 119 VA--HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLW 171

Query: 325 YLAPE-YASTGKLTTKSDVYSYGVVLLELLTGR 356
           Y APE      + +T  D++S G +  ELLT +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 71/219 (32%), Positives = 99/219 (45%), Gaps = 38/219 (17%)

Query: 155 NFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRM--------EVD 202
           +F  G  +G G FG V    +KG    G   AIK L    K+RE   +M        E  
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCL----KKRE-ILKMKQVQHVAQEKS 70

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           +L  L  P +V ++    D+N    + E++  G L  HL R   R+ P D     +    
Sbjct: 71  ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRF-PND-----VAKFY 123

Query: 263 CA---MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
            A   +A E+LH      +I+RD K  N+LLD     KVTDFG AK V D+     +  +
Sbjct: 124 HAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTL 175

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            GT  YLAPE   +       D ++ GV+L E + G  P
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 12/213 (5%)

Query: 154 ENFSEGNVIGNGGFGVVYKG-VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
                   IG G  G+V      S G   A+KK+    +QR      EV ++     P +
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           VE+       +   ++ E++  G L   +         ++      + L    AL FLH 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHA 133

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                VIHRD K  ++LL  + R K++DFG    VS ++  + S  ++GT  ++APE  S
Sbjct: 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
                T+ D++S G++++E++ G  P   N PP
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYF-NEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDG--KQRERAFRM-EVDLLSR---LHSPQLVE 214
           IG G FG VY+    D   + A+K L +     ++E A  + E ++L R     SP +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L       +   L+++YM  G L  HL +   R+   + R +  IA +  +ALE LH++ 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFS--EDRAKFYIA-ELVLALEHLHKY- 115

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              +++RD K  N+LLD      + DFGL+K  ++  + + +    GTT YLAPE     
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 335 KLTTKS-DVYSYGVVLLELLTGRVP 358
           K  TK  D +S GV++ E+  G  P
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 53/248 (21%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR-DGKQRERA--FRMEVDLLSRLHS 209
           ++F    VIG G FG V      D G + A+KKL + +  ++E+    R E D+L+   +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 210 PQLVELLGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           P +V+L  Y +  D+N+  LI EY+P G +   L + +         TR  IA +  +A+
Sbjct: 61  PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE---ETRFYIA-ETILAI 114

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-------------MVSDKINGQ 314
           + +H+      IHRD K  N+LLD     K++DFGL               +     +  
Sbjct: 115 DSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 315 IST------------------RVL-----GTTGYLAPE-YASTGKLTTKSDVYSYGVVLL 350
           +                    R L     GT  Y+APE +  TG    + D +S GV++ 
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY 230

Query: 351 ELLTGRVP 358
           E+L G  P
Sbjct: 231 EMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 57/224 (25%), Positives = 110/224 (49%), Gaps = 12/224 (5%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G V+  + ++ G   AIK+++   + ++     E+ ++  L +P +V  L    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
             +   ++ EY+  G+L   +         +D      +  +C  ALEFLH +    VIH
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIH 138

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD K  NVLL  +   K+TDFG    ++ + + +  + ++GT  ++APE  +      K 
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196

Query: 341 DVYSYGVVLLELLTGRVP-VDPNRPPGEHVLVSWALPRLTSREE 383
           D++S G++ +E++ G  P ++ N     +++ +   P L + E+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 17/205 (8%)

Query: 161 VIGNGGFGVVY---KGVLSD-GTVAAIKKLHRDG-KQRERA-FRMEVDLLSRLHSPQLVE 214
           V+G G FG V+   K    D G + A+K L +   K R+R   +ME D+L+ ++ P +V+
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 215 LLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           L  Y      +L LI +++  G L   L +    +   D +  L    + A+AL+ LH  
Sbjct: 63  L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLA---ELALALDHLH-- 115

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
            +  +I+RD K  N+LLD+    K+TDFGL+K   D      S    GT  Y+APE  + 
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 172

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
              T  +D +S+GV++ E+LTG +P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD 221
           +G G FG V+    +  T  A+K + + G     AF  E +++  L   +LV+L      
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIH 280
           +    +I+E+M  G+L   L       +PL    +LI  +   A  + F+ +      IH
Sbjct: 73  EP-IYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTT 338
           RD + +N+L+  +   K+ DFGLA+++ D    + + R        + APE  + G  T 
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 339 KSDVYSYGVVLLELLT-GRVP 358
           KSDV+S+G++L+E++T GR+P
Sbjct: 183 KSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 23/232 (9%)

Query: 135 VRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR 193
           ++D  + ++F  ++ E     F++   IG+G FG VY    +    V AIKK+   GKQ 
Sbjct: 9   LKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS 65

Query: 194 ERAFR---MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
              ++    EV  L R+  P  +E  G    ++   L+ EY   G+    L  H    +P
Sbjct: 66  NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK---KP 121

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           L       I       L +LH H    +IHRD K  N+LL +  + K+ DFG A + S  
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177

Query: 311 INGQISTRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPV 359
                +   +GT  ++APE       G+   K DV+S G+  +EL   + P+
Sbjct: 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQ 211
           NF +   +G G +  VYKG   + G + A+K++H D ++     A R E+ L+  L    
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V L      +N  +L+ EYM +  L++++  H  R   LD  T           + F H
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKGIAFCH 117

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
           E+    V+HRD K  N+L+++    K+ DFGLA+     +N   S  V+ T  Y AP+  
Sbjct: 118 ENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV-TLWYRAPDVL 172

Query: 332 STGKL-TTKSDVYSYGVVLLELLTGR 356
              +  +T  D++S G ++ E++TGR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 52/181 (28%), Positives = 91/181 (50%), Gaps = 10/181 (5%)

Query: 178 GTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPN 234
           G   A+K L    G       + E+++L  L+   +V+  G C +       LI E++P+
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+++L R+ N+   ++ + +L  A+     +++L    +   +HRD    NVL++   
Sbjct: 93  GSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146

Query: 295 RAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           + K+ DFGL K + +DK    +   +     + APE     K    SDV+S+GV L ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 354 T 354
           T
Sbjct: 207 T 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 28/257 (10%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRD-GKQRERAFRMEVDLLSR-LHSPQLVELLGY 218
           +G G +GVV K   +  GT+ A+K++      Q ++   M++D+  R +  P  V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 219 CADQNHRLLISEYMPNG--TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
              +    +  E M        + ++       P D   +  IA+    ALE+LH   + 
Sbjct: 69  LFREGDVWICMEVMDTSLDKFYKKVYDKGLTI-PEDILGK--IAVSIVKALEYLHSKLS- 124

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY----AS 332
            VIHRD K SNVL+++N + K+ DFG++  + D +     T   G   Y+APE      +
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELN 180

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV--LVSWALPRLTSREEAVEMVD- 389
                 KSDV+S G+ ++EL TGR P D  + P + +  +V    P+L + + + E  D 
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDF 240

Query: 390 --------PSLQGQYPK 398
                      +  YP+
Sbjct: 241 VNKCLKKNYKERPNYPE 257

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)

Query: 161 VIGNGGFGVVYKGV-LSDG----TVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVE 214
           V+G+G FG VYKG+ + DG       AIK L  +   +  +    E  +++ + SP +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           LLG C     +L +++ MP G L  ++  + +R   +  +  L   +  A  + +L E  
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR---IGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKIN-----GQISTRVLGTTGYLAP 328
              ++HRD    NVL+      K+TDFGLA+++  D+       G++  +      ++A 
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WMAL 180

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
           E     + T +SDV+SYGV + EL+T G  P D
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 18/215 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRE-----RAFRMEVDLLSRL 207
            N+  G ++G G FG VY    +D G   A+K++  D   +E      A   E+ LL  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 208 HSPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCA 264
              ++V+  G   D   + L    EYMP G+++  L  +      +  R TR I+     
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----- 116

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTT 323
             + +LH +    ++HRD K +N+L D     K+ DFG +K +    ++G     V GT 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +++PE  S      K+DV+S    ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHSPQL 212
             IG+G +GVV   V    G   AIKK+        D K   R  R E+ LL  L    +
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK---RILR-EIKLLRHLRHENI 61

Query: 213 VELL-----GYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLIIALDCAM 265
           + LL         D N   +++E M     +  LH+   + +    D     +  +    
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRG- 115

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTG 324
            L++LH  A   VIHRD K SN+L++ N   K+ DFGLA+ +  D+      T  + T  
Sbjct: 116 -LKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRV 357
           Y APE   +    TK+ D++S G +  ELLT + 
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRDGKQRE---RAFRMEVDLLSRLHSPQLVELL 216
           V+G G FG V+         + AIK L +D   ++       +E  +L+    P  +  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 217 GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
             C     RL  + EY+  G L  H+ +      P      +  A + ++ L FLH    
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRRG- 121

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +I+RD K  NV+LD     K+ DFG+ K     ++G  +    GT  Y+APE  +   
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 336 LTTKSDVYSYGVVLLELLTGRVPVD 360
                D ++YGV+L E+L G+ P D
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL-GYC 219
           +G+G FG VYK      G  AA K +  + ++    F +E+D+LS    P +V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
            +    +LI E+   G L   +       R L       +      AL FLH H    VI
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VI 125

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLT 337
           HRD K  N+LL  +   K+ DFG    VS K    +  R   +GT  ++APE  +     
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFG----VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 338 T-----KSDVYSYGVVLLELLTGRVP 358
                 K+D++S G+ L+EL     P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 45/238 (18%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRERAFRMEV 201
           E E   +  + G  +G G FG V K            +  A+K L  D  +++ +     
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS----- 60

Query: 202 DLLSRLH-------SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH---NNRYRPL 251
           DL+S +           ++ LLG C  +    ++ EY  +G L+  L           P 
Sbjct: 61  DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 252 DWRTR---------LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG 302
           D R           +  A   A  +EFL   A+   IHRD    NVL+ ++   K+ DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 303 LAKMVSD------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           LA+ +          NG++  +      ++APE       T +SDV+S+GV+L E+ T
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 14/213 (6%)

Query: 162 IGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFR---MEVDLLSRLHSPQLVELLG 217
           +G GGFG V    + + G + A KKL++   ++ + +    +E  +L+++HS  +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
               +    L+   M  G L+ H++  +                     LE LH+     
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKL 336
           +I+RD K  NVLLD +   +++D GLA  + D   GQ  T+   GT G++APE     + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKD---GQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 337 TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
               D ++ GV L E++  R P    R  GE V
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF---RARGEKV 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 16/197 (8%)

Query: 162 IGNGGFGVVYKGVL----SDGTVAA--IKKLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
           +G+G FG V KG+     S+ TVA   +K  + D   ++   R E +++ +L +P +V +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
           +G C  ++  +L+ E    G L + L +  N++      T L+  +  +M +++L E   
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQK--NKHVTEKNITELVHQV--SMGMKYLEETN- 115

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTG 334
              +HRD    NVLL     AK++DFGL+K + +D+   +  T       + APE  +  
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 335 KLTTKSDVYSYGVVLLE 351
           K ++KSDV+S+GV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 15/203 (7%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELL 216
           ++G G FG V+     + G   A+K L ++    K        E  +L     P L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60

Query: 217 GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
            Y    + RL  + EY   G L  HL R          R R   A +   AL +LH    
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGA-EIVSALGYLHSCD- 115

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE      
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 336 LTTKSDVYSYGVVLLELLTGRVP 358
                D +  GVV+ E++ GR+P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 25/230 (10%)

Query: 137 DKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRER 195
           D  + ++F+  + E    +  E   IG+G FG VY         V AIKK+   GKQ   
Sbjct: 1   DPEIAELFSKDDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 57

Query: 196 AFR---MEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPL 251
            ++    EV  L +L  P  +E  G C  + H   L+ EY   G+    L  H    +PL
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHK---KPL 112

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
                  I       L +LH H     IHRD K  N+LL +    K+ DFG A +VS   
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167

Query: 312 NGQISTRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               +   +GT  ++APE       G+   K DV+S G+  +EL   + P
Sbjct: 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 14/217 (6%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR 206
           E E   +   E  V+G G +G+VY    LS     AIK++     +  +    E+ L S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM- 265
           L    +V+ LG  ++     +  E +P G+L   L    +++ PL    + II     + 
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR---SKWGPLKDNEQTIIFYTKQIL 118

Query: 266 -ALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
             L++LH++    ++HRD K  NVL++  +   K++DFG +K ++  IN    T   GT 
Sbjct: 119 EGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTET-FTGTL 173

Query: 324 GYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVP 358
            Y+APE    G       +D++S G  ++E+ TG+ P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 156 FSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQ 211
           F    V+G GGFG V    V + G + A KKL +   ++ +   M   E  +L +++S  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 212 LVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           +V L  Y  +    L L+   M  G L+ H++   N     D    +  A +    LE L
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFDEERAVFYAAEITCGLEDL 118

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H      +++RD K  N+LLD     +++D GLA  + +     I  RV GT GY+APE 
Sbjct: 119 HRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGYMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               + T   D +  G ++ E++ G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 161 VIGNGGFG--VVYKGVLSDGTVAAIK-KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           V+G G FG  ++ + V SD   A  + +L +     E + R E  LL+++  P +V    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKE 65

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP----LDWRTRLIIALDCAMALEFLHEH 273
                 H  ++ EY   G L Q +     +  P    L W  ++       + ++ +HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM------CLGVQHIHEK 119

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               V+HRD K  N+ L QN + K+ DFG A++++    G  +   +GT  Y+ PE    
Sbjct: 120 R---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWEN 174

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
                KSD++S G +L EL T + P   N
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRE-----RAFRMEVDLLSRLH 208
           N+  G ++G G FG VY    +D G   A+K++  D +  E      A   E+ LL  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 209 SPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCAM 265
             ++V+  G   D   R L    E+MP G+++  L  +      +  + TR I+      
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE----- 117

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK-INGQISTRVLGTTG 324
            + +LH +    ++HRD K +N+L D     K+ DFG +K +    ++G     V GT  
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +++PE  S      K+D++S G  ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.5 bits (190), Expect = 8e-16
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 12/224 (5%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G VY  + ++ G   AI++++   + ++     E+ ++    +P +V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
             +   ++ EY+  G+L   +         +D      +  +C  ALEFLH +    VIH
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIH 139

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD K  N+LL  +   K+TDFG    ++ + + +  + ++GT  ++APE  +      K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197

Query: 341 DVYSYGVVLLELLTGRVP-VDPNRPPGEHVLVSWALPRLTSREE 383
           D++S G++ +E++ G  P ++ N     +++ +   P L + E+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 8e-16
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 160 NVIGNGGFGVVYKG-VLSDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLG 217
            ++G+G  G VYK   L    + A+K +  D   + ++    E+++L +  SP ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
               +N   + +E+M  G+L        + YR +       IA+     L +L    +  
Sbjct: 67  AFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLW---SLK 115

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           ++HRD K SN+L++   + K+ DFG    VS ++   I+   +GT  Y+APE  S  +  
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 338 TKSDVYSYGVVLLELLTGRVP 358
             SDV+S G+  +EL  GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.9 bits (197), Expect = 9e-16
 Identities = 62/192 (32%), Positives = 91/192 (47%), Gaps = 23/192 (11%)

Query: 182 AIKKLHRDGKQRERA---FRMEVDLLSRLHSPQLVELL--GYCADQNHRLL-ISEYMPNG 235
           AIK L  D  + E     FR E  L +RL+ P +V LL  G        L  + EY+P  
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPGR 64

Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQ 292
           TL++ L    +   P     RL++ +  A+A      H    ++HRD K  N+++     
Sbjct: 65  TLREVLA--ADGALPAGETGRLMLQVLDALA----CAHNQG-IVHRDLKPQNIMVSQTGV 117

Query: 293 NFRAKVTDFGLAKMVSD--KINGQISTR---VLGTTGYLAPEYASTGKLTTKSDVYSYGV 347
              AKV DFG+  ++      +    TR   VLGT  Y APE      +T  SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 348 VLLELLTGRVPV 359
           + LE LTG+  V
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 18/214 (8%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRE-----RAFRMEVDLLSRLH 208
           N+  G ++G G FG VY     D G   A K++  D +  E      A   E+ LL  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 209 SPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCAM 265
             ++V+  G   D+  + L    EYMP G+++  L  +      +  + TR I+      
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK-INGQISTRVLGTTG 324
            + +LH +    ++HRD K +N+L D     K+ DFG +K +    ++G     V GT  
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +++PE  S      K+DV+S G  ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 17/220 (7%)

Query: 147 KELETATENFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD 202
           ++L+   E++    VIG G FG V    +K       +  + K     +     F  E D
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           +++  +SP +V+L     D  +  ++ EYMP G L   ++  +N   P  W        +
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKWAK--FYTAE 150

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
             +AL+ +H      +IHRD K  N+LLD++   K+ DFG   M  D+         +GT
Sbjct: 151 VVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGT 206

Query: 323 TGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVP 358
             Y++PE   +    G    + D +S GV L E+L G  P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 156 FSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQ 211
           F +  V+G GGFG V    V + G + A K+L +   ++ +   M   E  +L +++S Q
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-Q 60

Query: 212 LVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRP-LDWRTRLIIALDCAMALEF 269
            V  L Y  +    L L+   M  G L+ H++   N   P  +    L  A +    LE 
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLED 117

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV--SDKINGQISTRVLGTTGYLA 327
           LH   T   ++RD K  N+LLD     +++D GLA  +   + I G++     GT GY+A
Sbjct: 118 LHRENT---VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMA 169

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE  +  + T   D +  G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLH-RDGKQRER-AFRMEVDLLSRLHSPQLVELLG 217
           V+G G +G V      +DG    IKKL+ R+  +RER A   E  LLS+L  P +V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 218 YCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRP----LDWRTRLIIALDCAMALEFLHE 272
               ++  L ++  +   G L   L     +  P    ++W  ++      AMAL++LHE
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                ++HRD K  NV L +    KV D G+A+++ ++ +  +++ ++GT  Y++PE  S
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFS 175

Query: 333 TGKLTTKSDVYSYGVVLLELLT 354
                 KSDV++ G  + E+ T
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 161 VIGNGGFGVVYKGVLSDGT-VAAIKKLHRD---------GKQRERAFRMEVDLLSRLHSP 210
           V+G G FG V    L       AIK L +D             ER     V  L+  H P
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER----RVLALAWEH-P 56

Query: 211 QLVELLGYCADQ--NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            L  L  +C  Q   H   + EY+  G L  H+    +  R  + R R   A +    L+
Sbjct: 57  FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFY-AAEIICGLQ 110

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLA 327
           FLH+     +I+RD K  NVLLD++   K+ DFG+ K   + +NG+       GT  Y+A
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTPDYIA 164

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE     K     D +S+GV+L E+L G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 46/221 (20%)

Query: 161 VIGNGGFGVVYKGVLSD--GT--VAAIKKLHRD------------GKQRERAFRMEVDLL 204
           V+G G FG V   +L++  GT  + AIK L +D             ++R  A   +   L
Sbjct: 7   VLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 205 SRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           ++LHS         C     RL  + EY+  G L  H+ +      P      +  A + 
Sbjct: 64  TQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEI 110

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GT 322
           A+ L FLH      +I+RD K  NV+LD     K+ DFG+ K   + I G  +TR   GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGT 164

Query: 323 TGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
             Y+APE   Y   GK     D +++GV+L E+L G+ P D
Sbjct: 165 PDYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 11/198 (5%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G VY  + ++ G   AIK+++   + ++     E+ ++     P +V  L    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
             +   ++ EY+  G+L   +         +D      +  +C  ALEFLH +    VIH
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIH 138

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD K  N+LL  +   K+TDFG    ++ + + +  + ++GT  ++APE  +      K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196

Query: 341 DVYSYGVVLLELLTGRVP 358
           D++S G++ +E++ G  P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 66/213 (30%), Positives = 92/213 (43%), Gaps = 34/213 (15%)

Query: 161 VIGNGGFGVVYKGVLSDGT--VAAIKKLHRDG------------KQRERAFRMEVDLLSR 206
           V+G G FG V    L  GT  V AIK L +D             ++R  A   +   L+ 
Sbjct: 2   VLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 207 LHSPQLVELLGYCADQNHRLL-ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           LH          C     RL  + EY+  G L   + R     R  D       A +  +
Sbjct: 61  LHC---------CFQTKDRLFFVMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTL 107

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
           AL FLH H    VI+RD K  N+LLD     K+ DFG+ K     +NG  +T   GT  Y
Sbjct: 108 ALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDY 162

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +APE     +     D ++ GV++ E++ G+ P
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 14/208 (6%)

Query: 156 FSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQ 211
           F +  V+G GGFG V    V + G + A KKL +   ++ +   M   E  +L +++S +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-R 60

Query: 212 LVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            V  L Y  +    L L+   M  G L+ H++         +    +  A +    LE L
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA--GFEEGRAVFYAAEICCGLEDL 118

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H+     +++RD K  N+LLD +   +++D GLA  V +   GQ     +GT GY+APE 
Sbjct: 119 HQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               + T   D ++ G +L E++ G+ P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 35/215 (16%)

Query: 161 VIGNGGFGVVYKGVLSDGT----VAAIKKLHRDG---KQRERAF-RMEVDLLSRLHSPQL 212
           V+G GG+G V++     G     + A+K L +      Q++ A  + E ++L  +  P +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 213 VELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA------- 264
           V+L+ Y      +L LI EY+  G L  HL R              I   D A       
Sbjct: 63  VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREG------------IFMEDTACFYLSEI 109

Query: 265 -MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
            +ALE LH+     +I+RD K  N+LLD     K+TDFGL K       G ++    GT 
Sbjct: 110 SLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTI 164

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            Y+APE           D +S G ++ ++LTG  P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 54/225 (24%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRM------EVDLL 204
           + E   IG G +G VYK   L+ G   A+KK+      +G        +      E+ LL
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--------IPLSTLREIALL 52

Query: 205 SRLHS---PQLVELLGYCAD-QNHR----LLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            +L S   P +V LL  C   +  R     L+ E++      Q L  + ++         
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPE 107

Query: 257 LIIALDCAM--ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            I  L   +   ++FLH H    ++HRD K  N+L+  + + K+ DFGLA++ S     +
Sbjct: 108 TIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF----E 160

Query: 315 IS-TRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLEL 352
           ++ T V+ T  Y APE      YA+        D++S G +  EL
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)

Query: 162 IGNGGFGVVYKGVL----SDGTVAAIKKLH---RDGKQRERAFRMEVDLLSRLHSPQLVE 214
           IG G FG   K +L     DG    IK+++      K+RE + R EV +LS +  P +V+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP----LDWRTRLIIALDCAMALEFL 270
                 +  +  ++ +Y   G L + ++       P    LDW  ++       +AL+ +
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI------CLALKHV 117

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H+     ++HRD K  N+ L ++   K+ DFG+A++++  +  +++   +GT  YL+PE 
Sbjct: 118 HDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEI 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLT 354
                   KSD+++ G VL E+ T
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFR---MEVDLLSRLHSPQ 211
           FS+   IG+G FG VY    + +  V AIKK+   GKQ    ++    EV  L +L  P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
            ++  G    ++   L+ EY   G+    L  H    +PL       +       L +LH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY- 330
            H    +IHRD K  N+LL +    K+ DFG A +++       +   +GT  ++APE  
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVI 183

Query: 331 --ASTGKLTTKSDVYSYGVVLLELLTGRVPV 359
                G+   K DV+S G+  +EL   + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 12/223 (5%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G VY  + ++ G   AIK+++   + ++     E+ ++    +P +V  L    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
             +   ++ EY+  G+L   +         +D      +  +C  AL+FLH +    VIH
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIH 138

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD K  N+LL  +   K+TDFG    ++ + + +  + ++GT  ++APE  +      K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196

Query: 341 DVYSYGVVLLELLTGRVP-VDPNRPPGEHVLVSWALPRLTSRE 382
           D++S G++ +E++ G  P ++ N     +++ +   P L + E
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 23/232 (9%)

Query: 135 VRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQR 193
           V+D  +  +F YK+     E F   + IG+G FG VY    S    V A+KK+   GKQ 
Sbjct: 5   VKDPEIADLF-YKD--DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT 61

Query: 194 ERAFR---MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
              ++    EV  L +L  P  +E  G    ++   L+ EY   G+    L  H    +P
Sbjct: 62  NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK---KP 117

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           L       I       L +LH H    +IHRD K  N+LL +  + K+ DFG A   S  
Sbjct: 118 LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173

Query: 311 INGQISTRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPV 359
                +   +GT  ++APE       G+   K DV+S G+  +EL   + P+
Sbjct: 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 16/212 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSP 210
           ++F +   +G G  GVV K +    G + A K +H + K   R +  R E+ +L   +SP
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR-ELKVLHECNSP 59

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            +V   G         +  E+M  G+L Q L +      P +   ++ IA+     L +L
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAV--LRGLTYL 115

Query: 271 HE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            E H    ++HRD K SN+L++     K+ DFG    VS ++   ++   +GT  Y++PE
Sbjct: 116 REKHK---IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPE 168

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
                  T +SD++S G+ L+E+  GR P+ P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 68/248 (27%), Positives = 102/248 (41%), Gaps = 24/248 (9%)

Query: 162 IGNGGFGVVYKGVLSDGTVAA---IKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLG 217
           IGNG FG V  G    G   A   +K+L       E+  F  EV     L+ P +++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
            C +    LL+ E+ P G L+ +L R N        +  ++  + C +A   L  H    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-D 120

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLA--KMVSDKINGQISTRVLGTTGYLAPEYAS--- 332
            IH D    N  L  +   K+ D+GLA  +   D    +    V     +LAPE      
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELVEIRG 178

Query: 333 ----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV 388
                   T KS+++S GV + EL T      P+    E VL      +   RE+ +++ 
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVL------KQVVREQDIKLP 231

Query: 389 DPSLQGQY 396
            P L  +Y
Sbjct: 232 KPQLDLKY 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 20/237 (8%)

Query: 162 IGNGGFGVV-YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G+V    V S G + A+KK+    +QR      EV ++       +VE+     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 221 DQNHRLLISEYMPNGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
             +   ++ E++  G L   + H   N  +         IA  C   L+ L       VI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQ---------IAAVCLAVLKALSVLHAQGVI 138

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD K  ++LL  + R K++DFG    VS ++  + S  ++GT  ++APE  S      +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPE 196

Query: 340 SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
            D++S G++++E++ G  P   N PP    L +  + R  L  + + +  V PSL+G
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYF-NEPP----LKAMKMIRDNLPPKLKNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 11/153 (7%)

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           +P LV L       +   L+ EY+  G L  H+ R     R L        A +  +AL 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALN 110

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN-GQISTRVLGTTGYLA 327
           FLHE     +I+RD K  NVLLD +   K+TD+G+ K   + +  G  ++   GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIA 164

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           PE     +     D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 32/221 (14%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDG----TVAAIKKLHRDGKQRERAFRM-EVDLLSRLHS 209
           F +  V+G+G FG VYKG+ + +G       AIK+L      +     + E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMA 266
           P +  LLG C     +L I++ MP G L  ++  H +       L+W  ++      A  
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS------DKINGQISTRVL 320
           + +L E     ++HRD    NVL+      K+TDFGLAK++           G++  + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
                L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 ALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 18/209 (8%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSP 210
           NF +   IG G +GVVYK      G V A+KK+  D +       A R E+ LL  L+ P
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA--LDCAMALE 268
            +V+LL     +N   L+ E+     L Q L +  +          LI +        L 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           F H H    V+HRD K  N+L++     K+ DFGLA+     +  +  T  + T  Y AP
Sbjct: 115 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAP 169

Query: 329 EYASTGKL-TTKSDVYSYGVVLLELLTGR 356
           E     K  +T  D++S G +  E++T R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 67/256 (26%), Positives = 106/256 (41%), Gaps = 60/256 (23%)

Query: 154 ENFSEGNVIGNGGFG---VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRL 207
           E+F    VIG G FG   +V K     G + A+K L +     K +    + E D+L+  
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            SP +V L     D  +  LI E++P G L   L +++     +   TR  +A +C +A+
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMA-ECVLAI 114

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA----------------------- 304
           E +H+      IHRD K  N+L+D+    K++DFGL+                       
Sbjct: 115 EAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 305 ------KMVSDKINGQISTR----------------VLGTTGYLAPEYASTGKLTTKSDV 342
                  +  D IN  +S++                 +GT  Y+APE         + D 
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231

Query: 343 YSYGVVLLELLTGRVP 358
           +S G ++ E L G  P
Sbjct: 232 WSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)

Query: 156 FSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQ 211
           F    V+G GGFG V    V + G + A KKL +   ++ +   M   E  +L +++S +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-R 60

Query: 212 LVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            V  L Y  +    L L+   M  G L+ H++   N     D +  +  A +    LE L
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDL 118

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
                  +++RD K  N+LLD     +++D GLA  + +   G+     +GT GY+APE 
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEV 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +  K T   D +  G ++ E++ G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 9e-15
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLV- 213
           V+G+G  G V+    +SDG   A+K +  +G     K R +A   EV  L       +V 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQA---EVCCLLNCDFFSIVK 95

Query: 214 --ELLGYCADQNHRL-----LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
             E       +N        L+ +Y   G L+Q +       R        ++ +   +A
Sbjct: 96  CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           +  +H   +  +IHRD K +N+LL  N   K+ DFG +KM +  ++  +     GT  Y+
Sbjct: 156 VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           APE       + K+D++S GV+L ELLT + P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 155 NFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHR-----DGKQRERAFRMEVDLLS 205
           NF    V+G G +G V+     G    G + A+K L +       K  E   R E  +L 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59

Query: 206 RLH-SPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
            +   P LV L  Y    + +L LI +Y+  G L  HL+     +   +   R+ IA + 
Sbjct: 60  AVRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT--ESEVRVYIA-EI 114

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
            +AL+ LH+     +I+RD K  N+LLD      +TDFGL+K    +   + +    GT 
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTI 170

Query: 324 GYLAPEYASTGKLTTKS--DVYSYGVVLLELLTGRVP 358
            Y+APE    G        D +S GV+  ELLTG  P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 40/216 (18%)

Query: 161 VIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG------------KQRERAFRMEVDLLSRL 207
           V+G G FG V    L   G   A+K L +D             ++R  A   E   L+ L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 208 HSPQLVELLGYCADQ--NHRLLISEYMPNGTLQQHLHRHN--NRYRPLDWRTRLIIALDC 263
                     YC  Q   H   + E++  G L  H+      + YR   +   ++    C
Sbjct: 62  ----------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIV----C 107

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ-ISTRVLGT 322
              L+FLH      +I+RD K  NV+LD++   K+ DFG+ K   + + G   ++   GT
Sbjct: 108 G--LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGT 159

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             Y+APE     K T   D +S+GV+L E+L G+ P
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 162 IGNGGFGVVYKGVL---SDGTVAAIKKLHRDGKQRERAFRM-EVDLLSRLHSPQLVELLG 217
           +G+G FG V KGV          AIK L  + ++  R   M E +++ +L +P +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL--DCAMALEFLHEHAT 275
            C  +   +L+ E    G L + L    +           ++ L    +M +++L     
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKKDEIT-----VSNVVELMHQVSMGMKYLEGKN- 115

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYAST 333
              +HRD    NVLL     AK++DFGL+K +    +     R  G     + APE  + 
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINF 172

Query: 334 GKLTTKSDVYSYGVVLLELLT-GRVP 358
            K +++SDV+SYG+ + E  + G+ P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLG 217
           +G GG+G V+     D G + A+K++ +         R    E D+L+   S  LV+LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
              D  +  L  EY+P G  +  L   NN     +   R  +A +   A++ LHE     
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALHELG--- 121

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
            IHRD K  N L+D +   K+TDFGL+K +    N      V+G+  Y+APE        
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYD 176

Query: 338 TKSDVYSYGVVLLELLTGRVPVDPNRP 364
              D +S G +L E L G  P   + P
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 22/236 (9%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGY 218
           ++GNG +G VYKG  +  G +AAIK +   G + E   + E+++L +  H   +    G 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHRNIATYYGA 71

Query: 219 CADQN------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
              +N         L+ E+   G++   +          +W     I  +    L  LH+
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQ 129

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
           H    VIHRD K  NVLL +N   K+ DFG++  + D+  G+ +T  +GT  ++APE  +
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNT-FIGTPYWMAPEVIA 184

Query: 333 T-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW-ALPRLTSRE 382
                      KSD++S G+  +E+  G  P+    P     L+     PRL S++
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 26/227 (11%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGVLSDGT------VAAIKKLHR--DGKQRERAFRM 199
           E+  +T  F E   +G   FG VYKG L            AIK L    +G  RE  F+ 
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKH 57

Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL---HRHNNRYRPLDWRTR 256
           E  + SRL  P +V LLG    +    +I  Y  +  L + L     H++     D +T 
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 257 ---------LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV 307
                    + I    A  +EFL  H    V+H+D    NVL+      K++D GL + V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174

Query: 308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 ++    L    +++PE    GK +  SD++SYGVVL E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 17/220 (7%)

Query: 147 KELETATENFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD 202
           ++L    E++    VIG G FG V    +K       +  + K     +     F  E D
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           +++  +SP +V+L     D  +  ++ EYMP G L   ++  +N   P  W  R   A +
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYTA-E 150

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
             +AL+ +H       IHRD K  N+LLD++   K+ DFG    ++ +   +  T V GT
Sbjct: 151 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206

Query: 323 TGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVP 358
             Y++PE   +    G    + D +S GV L E+L G  P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 161 VIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE---RAFRMEVDLLS-RLHSPQLVEL 215
           ++G G FG V+   L       AIK L +D    +       +E  +LS     P L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 216 LGYCADQN--HRLLISEYMPNGTLQQHL---HRHNNRYRPLDWRTRLIIALDCAMALEFL 270
             YC  Q   +   + EY+  G L  H+   H+        D       A +    L+FL
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-------FDLPRATFYAAEIICGLQFL 112

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPE 329
           H      +++RD K  N+LLD +   K+ DFG+ K   + + G   T    GT  Y+APE
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPE 166

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                K  T  D +S+GV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 16/212 (7%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM--EVDLLSRLHSPQLVELLG 217
           VIG G +GVV   +    G   AIKK++   +    A R+  E+ LL  L  P +VE+  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLH---RHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
                + R     Y+    ++  LH   + N+   P   +  L   L    AL+++H   
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---RALKYIH--- 120

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS-TRVLGTTGYLAPEYAST 333
           T  V HRD K  N+L + + + K+ DFGLA++  +     I  T  + T  Y APE   +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 334 --GKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
              K T   D++S G +  E+LTG+ P+ P +
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK 211

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           IG G +GVV+K    + G + AIKK      D   ++ A R E+ +L +L  P LV L+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLI- 66

Query: 218 YCADQNHRL-LISEYMPNGTLQQHLHRHNN-----RYRPLDWRTRLIIALDCAMALEFLH 271
               +  +L L+ EY  + T+   L ++         + + W+T          A+ F H
Sbjct: 67  EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCH 117

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY- 330
           +H     IHRD K  N+L+ +  + K+ DFG A++++    G   T  + T  Y APE  
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDYTDYVATRWYRAPELL 172

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
               +     DV++ G V  ELLTG  P+ P +
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG 217
           IG G +GVVYKG     G + A+KK+  + ++      A R E+ LL  L  P +V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHA 274
               ++   LI E+     L   L ++ +       +D              + F H   
Sbjct: 67  VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YAST 333
              V+HRD K  N+L+D     K+ DFGLA+     I  ++ T  + T  Y APE    +
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG--IPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 334 GKLTTKSDVYSYGVVLLELLTGR 356
            + +T  D++S G +  E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 34/227 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVA--AIKKLHRDG----KQRERAFRMEVDLLSRL 207
           E+F    +I NG +G VY  V    T    A+KK+++       Q ++ F +E D+L+  
Sbjct: 1   EDFETIKLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFA 58

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNG---TLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            +P +V +      + H  ++ EY+  G   TL +++        P+D   R+  A +  
Sbjct: 59  ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA-----LPVD-MARMYFA-ETV 111

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-----MVSDKINGQIS--T 317
           +ALE+LH +    ++HRD K  N+L+      K+TDFGL+K     + ++   G I   T
Sbjct: 112 LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168

Query: 318 R------VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           R      V GT  Y+APE           D ++ G++L E L G VP
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 14/215 (6%)

Query: 150 ETATENFSEGNVIGNGGFGVVYK-GVLSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSR 206
           E   ++F   + +G G  GVV K      G + A K +H + K   R +  R E+ +L  
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHE 59

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            +SP +V   G         +  E+M  G+L Q L     +  P +   ++ IA+     
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAV--LRG 115

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L +L E     ++HRD K SN+L++     K+ DFG    VS ++   ++   +GT  Y+
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYM 169

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
           +PE       + +SD++S G+ L+EL  GR P+ P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV L      ++    + EY+  G L  H+ R     R L        + + ++AL +
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNY 111

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVD-------PNRPPGEHVLV-----SWALPR 377
                      D ++ GV++ E++ GR P D       P++   +++          +PR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226

Query: 378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ--SLIPVVKN 435
             S + A   V  S   + PK+ L          +Q    +R +  D+++   ++P  K 
Sbjct: 227 SLSVKAA--SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKP 284

Query: 436 NAAGAISFGSSRFQHQ 451
           N +G   FG   F  Q
Sbjct: 285 NISG--EFGLDNFDAQ 298

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 32/221 (14%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGVLSDGT-VAAIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           +  +++  GN+IGNG FGVVY+ +  D +   AIKK+ +D + + R    E+ ++  L+ 
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNH 118

Query: 210 PQLVELLGY----CADQNHRLL----ISEYMPNGTLQQHL--HRHNNRYRPLDWRTRLII 259
             ++ L  Y    C  +N + +    + E++P  T+ +++  +  NN   PL      ++
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL-----FLV 172

Query: 260 AL---DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQI 315
            L       AL ++H      + HRD K  N+L+D N    K+ DFG AK   + + GQ 
Sbjct: 173 KLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQR 226

Query: 316 STRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTG 355
           S   + +  Y APE        TT  D++S G ++ E++ G
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 19/226 (8%)

Query: 145 TYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTV--AAIKKLHR----DGKQRERAFR 198
             ++ +   E+F+    +G G FG V      +      AIK+  +      KQ +  F 
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
            E  +L+ ++ P  V L G   D+++  L+ E++  G     L R N R+ P D      
Sbjct: 81  -ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRF-PND--VGCF 135

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
            A    +  E+L    +  +++RD K  N+LLD++   K+TDFG AK+V  +     +  
Sbjct: 136 YAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYT 187

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
           + GT  Y+APE          +D ++ G+ + E+L G  P   N P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 210 PQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           P LV L   C     RL  + E++  G L  H+ R     R L        + + ++AL 
Sbjct: 56  PFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALN 110

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           FLHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+AP
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAP 165

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           E           D ++ GV++ E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 18/199 (9%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           +G+G FG VYK    + G +AA K +    ++    + +E+++L+  + P +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
                 ++ E+ P G +   +   +   R L   T   I + C   LE L    +  +IH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELD---RGL---TEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYA--STGKL 336
           RD K  NVLL  +   K+ DFG    VS K    +  R   +GT  ++APE     T K 
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 337 TT---KSDVYSYGVVLLEL 352
           T    K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 153 TENFSEGNVIGNGGFGVV--YKGVLSDGTVAAIKKLHRDGKQRERAFRM--EVDLLSRLH 208
           T  + +   +G G FG+V   +  L+   VA IKK+ +       A R   E+ LL  L 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVA-IKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 209 SPQLVELLGYCADQNHRLLISE----YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
              ++ L          + IS     Y     L   LHR     RPL+ +          
Sbjct: 68  HENIISL--------SDIFISPLEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQIL 118

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             L+++H   +  V+HRD K SN+L+++N   K+ DFGLA++   ++ G +STR      
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170

Query: 325 YLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
           Y APE   T  K   + D++S G +  E+L G+ P+ P +  
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 14/215 (6%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSR 206
           E   ++F + + +G G  GVV+K      G + A K +H + K   R +  R E+ +L  
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHE 59

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            +SP +V   G         +  E+M  G+L Q L +      P     ++ IA+     
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV--IKG 115

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L +L E     ++HRD K SN+L++     K+ DFG    VS ++   ++   +GT  Y+
Sbjct: 116 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYM 169

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
           +PE       + +SD++S G+ L+E+  GR P+ P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 40/292 (13%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           ++G G +G+V K    + G + AIKK      D   ++ A R E+ +L +L    LV L+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
                +    L+ E++ + T+   L ++ N    LD              +EF H H   
Sbjct: 67  EVFRRKKRLYLVFEFVDH-TVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN-- 120

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY----AS 332
            +IHRD K  N+L+ Q+   K+ DFG A+ ++    G++ T  + T  Y APE       
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELLVGDTK 177

Query: 333 TGKLTTKSDVYSYGVVLLELLTGR--VPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
            G+     D+++ G ++ E+LTG    P D +     H++    L  L  R + +   +P
Sbjct: 178 YGRAV---DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK--CLGNLIPRHQEIFQKNP 232

Query: 391 SLQG--------------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS 428
              G              ++PK   + +  +A  C++ +   RP  + ++  
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRPSSSQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           +G+G FG VYK    + G +AA K +    ++    + +E+D+L+    P +V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
            +N+  ++ E+   G +   +       RPL      ++      AL +LHE+    +IH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIH 126

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYA--STGK- 335
           RD K  N+L   +   K+ DFG    VS K    I  R   +GT  ++APE     T K 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 336 --LTTKSDVYSYGVVLLEL 352
                K+DV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 23/206 (11%)

Query: 162 IGNGGFGVVYKGVLSDGT----VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           IG G FG V +    D      +  I+K H   +        E  +L++++ P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHN--NRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
                    L+  ++  G L  HL R    +  R   +   L+ AL+       LH+   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALEN------LHKFN- 113

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM---VSDKINGQISTRVLGTTGYLAPEYAS 332
             VI+RD K  N+LLD      + DFGL K+     DK N        GT  YLAPE   
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN-----TFCGTPEYLAPELLL 166

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVP 358
               T   D ++ GV+L E+LTG  P
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 45/266 (16%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGY 218
           V+GNG +G VYKG  +  G +AAIK +    +  E   ++E+++L +  H   +    G 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 219 C-----ADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
                    + +L L+ E+   G++   +          DW     I  +    L  LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHA 139

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
           H    VIHRD K  NVLL +N   K+ DFG++  + D+  G+ +T  +GT  ++APE  +
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNT-FIGTPYWMAPEVIA 194

Query: 333 T-----GKLTTKSDVYSYGVVLLELLTGRVP-----------VDPNRPPGEHVLVSWALP 376
                      +SD++S G+  +E+  G  P           + P  PP          P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP----------P 244

Query: 377 RLTSR---EEAVEMVDPSLQGQYPKK 399
           +L S+   ++ ++ ++  L   Y  +
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSR 270

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 19/216 (8%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHSPQLV 213
           +IG GGFG VY    +D G + A+K L +       G+      R+ + L+S    P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            +       +    I + M  G L  HL +H   +   + R     A +  + LE +H  
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMR---FYATEIILGLEHMHNR 116

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               V++RD K +N+LLD++   +++D GLA   S K         +GT GY+APE    
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK 169

Query: 334 GK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH 368
           G    + +D +S G +L +LL G  P   ++   +H
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)

Query: 162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G+V        G   A+KK+    +QR      EV ++   H   +V++     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
             +   ++ E++  G L   +      +  ++      + L    AL +LH      VIH
Sbjct: 90  VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD K  ++LL  + R K++DFG    VS ++  + S  ++GT  ++APE  S     T+ 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199

Query: 341 DVYSYGVVLLELLTGRVPVDPNRPP 365
           D++S G++++E++ G  P   N PP
Sbjct: 200 DIWSLGIMVIEMIDGEPPYF-NEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 49/264 (18%)

Query: 161 VIGNGGFGVVYKGVLSD--GT--VAAIKKLHRDG------------KQRERAFRMEVDLL 204
           V+G G FG V   +L++  GT  + AIK L +D             ++R  A   +   L
Sbjct: 7   VLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63

Query: 205 SRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           ++LHS         C     RL  + EY+  G L   + +      P      +  A + 
Sbjct: 64  TQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEI 110

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A+ L FLH      +I+RD K  NV+LD     K+ DFG+ K   +  +G  +    GT 
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN------RPPGEHVLVSWALPR 377
            Y+APE  +        D +++GV+L E+L G+ P +        +   EH +   A P+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPK 222

Query: 378 LTSREEAVEMVDPSLQGQYPKKDL 401
             S+ EAV +    L  ++P K L
Sbjct: 223 SMSK-EAVAICKG-LMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 160 NVIGNGGFGVVYKGVLSD-GTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHSPQL 212
           + +G+G +G V     +  G   AIKKL R        K   R +R E+ LL  +    +
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK---RTYR-ELRLLKHMDHENV 76

Query: 213 VELLG-YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           + LL  +    +       Y+    +   L+      +  D   + ++       L+++H
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV-YQILRGLKYIH 135

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-- 329
              +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y APE  
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 187

Query: 330 -----YASTGKLTTKSDVYSYGVVLLELLTGRV 357
                Y  T       D++S G ++ ELLTG+ 
Sbjct: 188 LNWMHYNQT------VDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 21/217 (9%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAF---RMEVDLLSRLHSPQLV 213
           +IG GGFG VY    +D G + A+K L +     KQ E      R+ + L+S    P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 ELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
             + Y      +L  I + M  G L  HL +H   +   + R     A +  + LE +H 
Sbjct: 61  -CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEAEMR---FYAAEIILGLEHMHN 115

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                V++RD K +N+LLD++   +++D GLA   S K         +GT GY+APE   
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQ 168

Query: 333 TG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH 368
            G    + +D +S G +L +LL G  P   ++   +H
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 159 GNVIGNGGFGVVYKGVLS-DGTV--AAIK--KLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           G  +G G FG V +G L+ D ++   A+K  K+    +     F  E   +     P ++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 214 ELLGYCADQNHR------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL--DCAM 265
            L+G C            ++I  +M +G L   L        P    T++++    D A 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK---INGQISTRVLGT 322
            +E+L   ++   IHRD    N +L++N    V DFGL+K + +      G+I+      
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---P 177

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
             ++A E  +    TTKSDV+S+GV + E+ T G+ P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR--ERAFRMEVDLLSRLHSP 210
             +   + IG G +G+V        G   AIKK+     Q   +R  R E+ +L R    
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63

Query: 211 QLVELL------GYCADQNHRLLISEYMPNG----TLQQHL---HRHNNRYRPLDWRTRL 257
            ++ +L       + +  N   ++ E M          QHL   H     Y+ L      
Sbjct: 64  NIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL------ 116

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQIS 316
                    L+++H   +  V+HRD K SN+LL+ N   K+ DFGLA++   +  +    
Sbjct: 117 -------RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 317 TRVLGTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNR 363
           T  + T  Y APE     K  TK+ D++S G +L E+L+ R P+ P +
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGK 213

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
           E+F     IG+G +G VYK   ++ G +AAIK +  +  +     + E+ ++       +
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V   G    ++   +  E+   G+LQ   H       PL   +   IA      L+ L+ 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PL---SESQIAYVSRETLQGLYY 121

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEY 330
             +   +HRD K +N+LL  N   K+ DFG    VS +I   I+ R   +GT  ++APE 
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFG----VSAQITATIAKRKSFIGTPYWMAPEV 177

Query: 331 AST---GKLTTKSDVYSYGVVLLEL 352
           A+    G      D+++ G+  +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 38/232 (16%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL--H--RDGKQRERAFRMEVDLLS 205
           +   ++     +G G FG VYK   +  G V A+KK+  H  +DG     A R E+ +L 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT-ALR-EIKILK 62

Query: 206 RLHSP---QLVELLGYCADQNHRLLISEYM--P------NGTLQQHLHRHNNRYRPLDWR 254
           +L  P    L+++     D++ R   S YM  P      +G L       N   +  + +
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL------ENPSVKLTESQ 116

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI--- 311
            +  + L     + +LHE+    ++HRD K +N+L+D     K+ DFGLA+         
Sbjct: 117 IKCYM-LQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 312 ------NGQISTRVLGTTGYLAPEY-ASTGKLTTKSDVYSYGVVLLELLTGR 356
                   +  T ++ T  Y  PE      + TT  D++  G V  E+ T R
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 3/133 (2%)

Query: 226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
           LLI EY   G L + + +    + P       ++     +AL+ +H      ++HRD K 
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197

Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
           +N+ L      K+ DFG +K  SD ++  +++   GT  YLAPE     + + K+D++S 
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257

Query: 346 GVVLLELLTGRVP 358
           GV+L ELLT   P
Sbjct: 258 GVILYELLTLHRP 270

Length = 478

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 70/204 (34%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVD--LLSRLHSPQLVEL 215
           VIG G FG V+     SDG+  A+K L +    K++E+   M     LL  L  P LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
             Y      +L  + +Y+  G L  HL R      P   R R   A + A A+ +LH   
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAA-EVASAIGYLH--- 113

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
           +  +I+RD K  N+LLD      +TDFGL K   +      ST   GT  YLAPE     
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST-FCGTPEYLAPEVLRKE 171

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 47/238 (19%)

Query: 150 ETATENFSEGNVIGNGGFGVVY--------KGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
           E + +  + G  +G G FG V         K    +    A+K L  D  +++ +     
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS----- 65

Query: 202 DLLSRLH-------SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHN--------- 245
           DL+S +           ++ LLG C       +I EY   G L+++L             
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 246 -NRY--RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG 302
             R     + ++  +      A  +E+L   A+   IHRD    NVL+ +N   K+ DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 303 LAKMVSD------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           LA+ V++        NG++  +      ++APE       T +SDV+S+GV++ E+ T
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELL 216
           ++G G FG V+     + G   A+K L ++    K        E  +L     P L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
                ++    + EY+  G L  HL R   R    D RTR   A +   AL++LH   + 
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSED-RTRFYGA-EIVSALDYLH---SG 114

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYASTGK 335
            +++RD K  N++LD++   K+TDFGL K   + I    + +   GT  YLAPE      
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 336 LTTKSDVYSYGVVLLELLTGRVP 358
                D +  GVV+ E++ GR+P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 23/217 (10%)

Query: 155 NFSEGNVIGNGGFGVVY---KGVLSD-GTVAAIKKLHR-----DGKQRERAFRMEVDLLS 205
           NF    V+G G +G V+   K    D G + A+K L +       K  E   R E  +L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59

Query: 206 RLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            +     +  L Y    + +L LI +Y+  G L  HL   + R R  +   ++    +  
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSG-EIV 115

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTT 323
           +ALE LH+     +I+RD K  N+LLD N    +TDFGL+K    D++    S    GT 
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTI 170

Query: 324 GYLAPEYASTGKL--TTKSDVYSYGVVLLELLTGRVP 358
            Y+AP+    G        D +S GV++ ELLTG  P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG-TVAAIKKLHRDG--KQRERA-FRMEVDLLSRLHS 209
           E+F    VIG G FG V    L +   V A+K L++    K+ E A FR E D+L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD----WRTRLIIALDCAM 265
             +  L     D+N+  L+ +Y   G L   L +  +R  P D    +   ++IA+D   
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDSVH 119

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG-LAKMVSDKINGQISTRV-LGTT 323
            L +         +HRD K  N+L+D N   ++ DFG   K++ D   G + + V +GT 
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED---GTVQSSVAVGTP 167

Query: 324 GYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVP 358
            Y++PE         GK   + D +S GV + E+L G  P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 154 ENFSEGNVIGNGGFG-VVYKGVLSDGTVAAIKKLHRDG--KQRERA-FRMEVDLLSRLHS 209
           ++F    VIG G FG V    +     + A+K L++    K+ E A FR E ++L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59

Query: 210 PQLVELLGYC-ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            Q +  L Y   D+N+  L+ +Y   G L   L +  +R  P D   R  IA +  +A+ 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PED-MARFYIA-EMVLAIH 116

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG-LAKMVSDKINGQISTRV-LGTTGYL 326
            +H+      +HRD K  NVLLD N   ++ DFG   KM  D   G + + V +GT  Y+
Sbjct: 117 SIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD---GTVQSSVAVGTPDYI 170

Query: 327 APEYAST-----GKLTTKSDVYSYGVVLLELLTGRVP 358
           +PE         GK   + D +S GV + E+L G  P
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 14/203 (6%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRDG---KQRERAFRMEVD-LLSRLHSPQLVEL 215
           VIG G FG V+     ++    A+K L +     K+ E+    E + LL  +  P LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
                  +    + +Y+  G L  HL R      P   R R   A + A AL +LH   +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAA-EIASALGYLH---S 114

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +++RD K  N+LLD      +TDFGL K   +  NG  ST   GT  YLAPE      
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST-FCGTPEYLAPEVLHKQP 172

Query: 336 LTTKSDVYSYGVVLLELLTGRVP 358
                D +  G VL E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 14/200 (7%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG 217
           IG G +GVVYK      G + A+KK+  + +       A R E+ LL  L+ P +V LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
               +N   L+ E++ +  L++++                +  L     + + H H    
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL-LQ-GIAYCHSHR--- 119

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL- 336
           V+HRD K  N+L+D+    K+ DFGLA+     +  +  T  + T  Y APE     +  
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGSRQY 177

Query: 337 TTKSDVYSYGVVLLELLTGR 356
           +T  D++S G +  E++  R
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELL 216
           ++G G FG V+     + G   A+K L ++    K        E  +L     P L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60

Query: 217 GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
            Y    + RL  + EY   G L  HL R   R    + R R   A +   ALE+LH    
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEE-RARFYGA-EIVSALEYLHSRD- 115

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYASTG 334
             V++RD K  N++LD++   K+TDFGL K   + I+   + +   GT  YLAPE     
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 45/317 (14%)

Query: 152 ATENFSE---GNVIGNGGFGVVYKGV-LSDGTVAAIKKL---HRDGKQRERAFRMEVDLL 204
           A ++ SE    N IG+G  G VYK +    G + A+K +   H D  +R+     E+++L
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQIC--REIEIL 126

Query: 205 SRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
             ++ P +V+      D N  + ++ E+M  G+L+     H    + L    R I++   
Sbjct: 127 RDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQILS--- 179

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
              + +LH      ++HRD K SN+L++     K+ DFG++++++  ++   S+  +GT 
Sbjct: 180 --GIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTI 232

Query: 324 GYLAPEYAST----GKLTTKS-DVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL 378
            Y++PE  +T    G     + D++S GV +LE   GR P    R  G+     WA    
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGD-----WA---- 282

Query: 379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA 438
            S   A+ M  P    + P     +     + C+Q E A R     ++Q   P +     
Sbjct: 283 -SLMCAICMSQPP---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH--PFILRAQP 336

Query: 439 GAISFGSSRFQHQTPSP 455
           G    G +  Q   P  
Sbjct: 337 GQGQGGPNLHQLLPPPR 353

Length = 353

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 20/216 (9%)

Query: 154 ENFSEGNVIGNGGFG-VVYKGVLSDGTVAAIKKLHRDG--KQRERA-FRMEVDLLSRLHS 209
           ++F    VIG G FG V    + + G V A+K L++    K+ E A FR E D+L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +  L     D+N+  L+ +Y   G L   L +  +R  P D   R  +A +  +A++ 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDM-ARFYLA-EMVLAIDS 117

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG-LAKMVSDKINGQISTRV-LGTTGYLA 327
           +H+      +HRD K  NVLLD+N   ++ DFG   ++++D   G + + V +GT  Y++
Sbjct: 118 VHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAVGTPDYIS 171

Query: 328 PEY-----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE         G+   + D +S GV + E+L G  P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 45/280 (16%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLH-------RDGKQRERA-FRMEVDLLSRLHSPQLV 213
           +G G FG VY  ++ D    A ++L         +    E      E  LLS+L  P +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLH--RHNNRYRP----LDWRTRLIIALDCAMAL 267
           +      +++   +I+EY     L   L   +H  +        +W  +L++ +      
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            ++H+     ++HRD K  N+ L  N   K+ DFG+++++    +  ++T   GT  Y++
Sbjct: 121 -YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMS 173

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
           PE        +KSD++S G +L E+               H         +  R   VE 
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCC-----------LAHAFEGQNFLSVVLR--IVEG 220

Query: 388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
             PSL   Y +    Q+ +I    +  + + RP   ++++
Sbjct: 221 PTPSLPETYSR----QLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 44/248 (17%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR-DGKQRERA--FRMEVDLLSRLHS 209
           E+F    VIG G FG V      D G V A+K L + D  ++E+    R E D+L    S
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +V++     D+ +  LI E++P G +   L + +      +  T+  IA +  +A++ 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIA-ETVLAIDS 116

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA-----------------KMVSD--- 309
           +H+      IHRD K  N+LLD     K++DFGL                   + SD   
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 310 -KING------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
             +N             Q++   +GT  Y+APE           D +S GV++ E+L G 
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 357 VPVDPNRP 364
            P     P
Sbjct: 234 PPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 53/241 (21%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDG-----------TVAAIKKLHRDGKQRERAFR 198
           E   +    G  +G G FG V   V+++            T  A+K L  D  +++ +  
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-- 68

Query: 199 MEVDLLSRLH-------SPQLVELLGYCADQNHRLLISEYMPNGTLQQHL---------H 242
              DL+S +           ++ LLG C       +I EY   G L+++L         +
Sbjct: 69  ---DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125

Query: 243 RHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
            +N    P   L ++  +  A   A  +E+L   A+   IHRD    NVL+ ++   K+ 
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 182

Query: 300 DFGLAKMV------SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           DFGLA+ +          NG++  +      ++APE       T +SDV+S+GV+L E+ 
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Query: 354 T 354
           T
Sbjct: 237 T 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 69/290 (23%), Positives = 130/290 (44%), Gaps = 47/290 (16%)

Query: 162 IGNGGFGVVYKGVLSDG--TVAAIKKLH-------RDGKQRERAFRMEVDLLS----RLH 208
           +G+G FG VYK    +    + A+K+++       +D ++R+++    V  ++    +L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 209 SPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            P +V        +N RL ++ + +    L +H +    + +         I +   +AL
Sbjct: 68  HPNIVRYYKTFL-ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            +LH+     ++HRD   +N++L ++ +  +TDFGLAK    K      T V+GT  Y  
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
           PE         K+DV+++G +L ++ T + P                   L+   + VE 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------------MLSLATKIVEA 228

Query: 388 V-DPSLQGQYPKK--DLIQIAAIAAVCVQPEAAYRPLMTDVVQ--SLIPV 432
           V +P  +G Y +   D+I        C+ P+A  RP   D++Q  ++I  
Sbjct: 229 VYEPLPEGMYSEDVTDVIT------SCLTPDAEARP---DIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 68/204 (33%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG--KQRERAFRMEVD--LLSRLHSPQLVEL 215
           VIG G FG V      +DG   A+K L +    K++E+   M     LL  +  P LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
                  +    + +Y+  G L  HL R   R  P + R R   A + A AL +LH    
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFP-EPRARFYAA-EIASALGYLHSLN- 116

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYASTG 334
             +I+RD K  N+LLD      +TDFGL K   + I    +T    GT  YLAPE     
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 65/204 (31%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELL 216
           ++G G FG V+     + G   A+K L ++    K        E  +L     P L  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60

Query: 217 GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
            Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH  + 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGA-EIVSALDYLH--SE 114

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYASTG 334
             V++RD K  N++LD++   K+TDFGL K  + D   G       GT  YLAPE     
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMKTFCGTPEYLAPEVLEDN 171

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/207 (31%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 161 VIGNGGFG-VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVD-LLSRLHSPQLVEL 215
           VIG G FG V+      DG   A+K L +     ++ ++    E + LL  +  P LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
             Y      +L  + +++  G L  HL R  +   P   R R   A + A AL +LH   
Sbjct: 62  -HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA-EIASALGYLH--- 113

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRVLGTTGYLAPEYA 331
           +  +++RD K  N+LLD      +TDFGL K     SD      +T   GT  YLAPE  
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-----TTTFCGTPEYLAPEVI 168

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVP 358
                    D +  G VL E+L G  P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 161 VIGNGGFGVVYKGVLS----DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLV 213
           ++G G FG + +G L          AI  L R G   KQR R F  E   L +     +V
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIV 69

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            L G     N  ++++EYM NG L   L +H  +   L     + +    A  +++L E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSEM 126

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL--APEYA 331
                +H+      VL++ +   K++ F   ++  DK    I T + G +  L  APE  
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEA-IYTTMSGKSPVLWAAPEAI 180

Query: 332 STGKLTTKSDVYSYGVVLLELLT 354
                ++ SDV+S+G+V+ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL--DWRTRLIIALDCAMAL 267
           P +V L  Y   ++   L+ ++   G L  H+ +  N        W   +++ALD     
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
             LH      ++ RD   +N+LLD     ++T F     V D  +G+    +     Y A
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCA 150

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
           PE     + T   D +S G +L ELLTG+  V+ + P G +   +  +P   S E  
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECH-PSGINTHTTLNIPEWVSEEAR 206

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHS 209
           + + +   +G+G +G V   +    G   AIKKL+R  +     +RA+R E+ LL  +  
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKH 73

Query: 210 PQLVELLG-YCADQN-----HRLLISEYMPN--GTLQQHLHRHNNRYRPLDWRTRLIIAL 261
             ++ LL  +  D +        L+  +M    G L +H     +R + L ++       
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM------ 127

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
                L+++H      +IHRD K  N+ ++++   K+ DFGLA+    ++ G + TR   
Sbjct: 128 --LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--- 179

Query: 322 TTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGR 356
              Y APE   +    T   D++S G ++ E+LTG+
Sbjct: 180 --WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 26/218 (11%)

Query: 155 NFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG-KQRERAF---RMEVDLLSR 206
           NF    V+G G +G V+          G + A+K L +    Q+ +     R E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 207 L-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +  SP LV L      +    LI +Y+  G +  HL++ +N +   + R     + +  +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN-FSEDEVR---FYSGEIIL 116

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTG 324
           ALE LH+     +++RD K  N+LLD      +TDFGL+K  +S++     S    GT  
Sbjct: 117 ALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIE 171

Query: 325 YLAPEY----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           Y+APE        GK     D +S G+++ ELLTG  P
Sbjct: 172 YMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)

Query: 162 IGNGGFGVVYKGVL---SDGTVAAIKKLHRDGKQRE----RAFRMEVDLLSRLHSPQLVE 214
           IG G +G VYK       DG   AIKK   D +Q       A R E+ LL  L    +V 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVS 66

Query: 215 LLGYCADQNHRL--LISEYMPNGTLQQ-HLHRHNNRYRPLDWRT--RLIIALDCAMALEF 269
           L+    +   +   L+ +Y  +   Q    HR   R   +       L+  +   +   +
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQILNGVH--Y 123

Query: 270 LHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQIS-TRVLGTTG 324
           LH +    V+HRD K +N+L+     +    K+ D GLA++ +  +        V+ T  
Sbjct: 124 LHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           Y APE     +  TK+ D+++ G +  ELLT    
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 32/242 (13%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRE----RAFRMEVDLL 204
           +   + F     IG G +G VYK    D G + A+KK+  D  ++E     A R E+ +L
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKEGFPITAIR-EIKIL 60

Query: 205 SRLHSPQLVELLGYCADQNHRL----------LISEYMPN---GTLQQHLHRHNNRYRPL 251
            +L+   +V L     D+   L          L+ EYM +   G L+  L   +  +   
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI-- 118

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
             ++ +   L+    L + H+      +HRD KCSN+LL+   + K+ DFGLA++ + + 
Sbjct: 119 --KSFMKQLLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +   + +V+ T  Y  PE     +    + DV+S G +L EL T +     N+   +  L
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229

Query: 371 VS 372
           +S
Sbjct: 230 IS 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 55/242 (22%)

Query: 150 ETATENFSEGNVIGNGGFGVVY--------KGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
           E +    + G  +G G FG V         K   +     A+K L  D   ++ +     
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS----- 62

Query: 202 DLLSRLH-------SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---- 250
           DL+S +           ++ LLG C       ++ EY   G L+++L       RP    
Sbjct: 63  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR----RPPGMD 118

Query: 251 ------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
                       L ++  +  A   A  +E+L   A+   IHRD    NVL+ ++   K+
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKI 175

Query: 299 TDFGLAKMVSD------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
            DFGLA+ V +        NG++  +      ++APE       T +SDV+S+GV+L E+
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Query: 353 LT 354
            T
Sbjct: 230 FT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 53/258 (20%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLHR-DGKQRERA--FRMEVDLLSRLHSPQLVELLG 217
           IG G FG V      D   + A+K L + D   R +A   + E D+L+   +  +V+L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
              D+++   + +Y+P G +   L R       L    R  IA +   A+E +H+     
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG--- 121

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLA--------------------------KMVSDKI 311
            IHRD K  N+L+D++   K+TDFGL                           +  S+  
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 312 NGQIST----------RVL-----GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
             ++            R L     GT  Y+APE       T   D +S GV+L E+L G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 357 VPVDPNRPPG-EHVLVSW 373
            P   + P   +  +++W
Sbjct: 242 PPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 40/98 (40%), Positives = 57/98 (58%), Gaps = 7/98 (7%)

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L+++H   +  V+HRD K SN+LL+ N   K+ DFGLA+  S+K  G   T  + T  Y 
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK--GDFMTEYVVTRWYR 175

Query: 327 APE-YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
           APE   +  + TT  DV+S G +  ELL GR P+ P +
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGK 212

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)

Query: 150 ETATENFSEGNVIGNGGFGVVYK----GVLSD----GTVAAIKKLHRDGKQRERA---FR 198
           E   +    G  +G G FG V +    G+           A+K L  +   ++ A     
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67

Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NN 246
           ME+  L   H   ++ LLG C  +    +I EY   G L++ L                 
Sbjct: 68  MELMKLIGKHK-NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 247 RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
               L ++  +  A   A  +E+L    +   IHRD    NVL+ ++   K+ DFGLA+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 307 VSD------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           V D        NG++  +      ++APE       T +SDV+S+G+++ E+ T
Sbjct: 184 VHDIDYYKKTSNGRLPVK------WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 17/197 (8%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           +G+G +G VYK   L  G +AA+K +  +        + E+ ++       +V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
            +    +  EY   G+LQ   H       PL   + L IA  C   L+ L    +   +H
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTG----PL---SELQIAYVCRETLQGLAYLHSKGKMH 129

Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYAS---TGK 335
           RD K +N+LL  N   K+ DFG+A     KI   I+ R   +GT  ++APE A+    G 
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAA----KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 336 LTTKSDVYSYGVVLLEL 352
                D+++ G+  +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 23/210 (10%)

Query: 162 IGNGGFGVV-YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           IG G  G+V        G   A+K +    +QR      EV ++       +VE+     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI---IALDCA---MALEFLHEHA 274
                 ++ E++  G L   + +           TRL    IA  C     AL +LH   
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQG 137

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              VIHRD K  ++LL  + R K++DFG    +S  +  + S  ++GT  ++APE  S  
Sbjct: 138 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRT 192

Query: 335 KLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
              T+ D++S G++++E++ G  P   + P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM--EVDLLSRLHS---PQLVEL 215
           IG G +G VYK      G   A+K +     +         EV LL RL +   P +V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 216 LGYCA----DQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           +  CA    D+  ++ L+ E++ +  L+ +L +      P +    L+        L+FL
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG--LDFL 124

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H +    ++HRD K  N+L+    + K+ DFGLA++ S ++     T V+ T  Y APE 
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEV 178

Query: 331 ASTGKLTTKSDVYSYGVVLLELL 353
                  T  D++S G +  E+ 
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 20/219 (9%)

Query: 156 FSEGNVIGNGGFGVVYKGVL--SDGTV--AAIKKLHRD--GKQRERAFRMEVDLLSRLHS 209
           F+ G ++G G FG V +  L   DG+    A+K L  D         F  E   +     
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 210 PQLVELLGYCADQNHR------LLISEYMPNGTLQQHL--HRHNNRYRPLDWRTRLIIAL 261
           P +++L+G       +      ++I  +M +G L   L   R       L  +T +   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVL 320
           D A  +E+L   ++   IHRD    N +L++N    V DFGL+K + S     Q     L
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
               +LA E  +    TT SDV+++GV + E++T G+ P
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 66/245 (26%), Positives = 107/245 (43%), Gaps = 24/245 (9%)

Query: 162 IGNGGFGVVYKGVLSDGTVAA---IKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLG 217
           IGNG FG V  G ++ G   A   +K+L      Q +  F  E      L    L++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 218 YCADQNHRLLISEYMPNGTLQQHLH--RHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
            C +    LL+ E+ P G L+ +L   R      P D  T   +A + A+ L  LH++  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHKNN- 120

Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-- 333
              IH D    N LL  +   K+ D+GL+     +       ++     ++APE      
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 334 GKL-----TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV 388
           G L     T +S+V+S GV + EL    +   P R   +  ++++     T RE+ +++ 
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLTY-----TVREQQLKLP 231

Query: 389 DPSLQ 393
            P L+
Sbjct: 232 KPRLK 236

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 44/248 (17%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR-DGKQRERA--FRMEVDLLSRLHS 209
           ++F    VIG G FG V      D G + A+K L + D  ++E+    R E D+L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +V++     D+ +  LI E++P G +   L + +         T+  IA +  +A++ 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE---ATQFYIA-ETVLAIDA 116

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-----------------SD--- 309
           +H+      IHRD K  N+LLD     K++DFGL   +                 SD   
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 310 -------------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
                        K   Q++   +GT  Y+APE           D +S GV++ E+L G 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 357 VPVDPNRP 364
            P     P
Sbjct: 234 PPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 17/206 (8%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG 217
           IG G +G V+K        + A+K++  D         A R E+ LL  L    +V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYR-PLDWRTRLIIALDCAMALEFLHEHATP 276
                    L+ EY       Q L ++ +     +D              L F H H   
Sbjct: 67  VLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN-- 119

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            V+HRD K  N+L+++N   K+ DFGLA+     +    S  V+ T  Y  P+     KL
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVV-TLWYRPPDVLFGAKL 176

Query: 337 -TTKSDVYSYGVVLLELLTGRVPVDP 361
            +T  D++S G +  EL     P+ P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)

Query: 162 IGNGGFGVVYKG-VLSDGTVAAIKKLHRDGKQRERAFRM-EVDLLSRL-HSPQLVELLGY 218
           IG G F  V K      G   AIK + +  K  E+   + E+  L RL   P ++ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 219 CADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
             D+   RL L+ E M +  L + +     R RPL  +           +L+ +H +   
Sbjct: 67  LFDRKTGRLALVFELM-DMNLYELI---KGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK--INGQISTRVLGTTGYLAPE-YAST 333
            + HRD K  N+L+  +   K+ DFG  + +  K      ISTR      Y APE   + 
Sbjct: 121 -IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLLTD 173

Query: 334 GKLTTKSDVYSYGVVLLELLT 354
           G    K D+++ G V  E+L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 11/157 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGT----VAAIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E F     I  G FG VY G   + +    V  +KK     K      + E D L+   S
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P +V L       N+  L+ EY+  G ++  LH     Y   D    +    + A+AL++
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDY 119

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
           LH H    +IHRD K  N+L+      K+TDFGL+K+
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 34/231 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTV----AAIKKLHRDGKQRERAFRM--EVDLLSRL 207
           +  +  +++  G FG ++ G+L D           K  +D     +   +  E  LL  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 208 HSPQLVELLGYCA-DQNHRLLISEYMPNGTLQQHLH--RHNNRYRPLDWRTRLII--ALD 262
               ++ +L  C  D     ++  YM  G L+  L   R      P    T+ ++  A+ 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV--------SDKINGQ 314
            A  + +LH+     VIH+D    N ++D+  + K+TD  L++ +         D  N  
Sbjct: 126 IACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP---VDP 361
           +         ++A E     + ++ SDV+S+GV+L EL+T G+ P   +DP
Sbjct: 183 VK--------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 52/237 (21%)

Query: 161 VIGNGGFGVVY----KG--------VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH 208
           ++G G  G V+    KG        VL    +    K+ R           E ++L+ L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--------VLTEQEILATLD 59

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P L  L      + +  L+ +Y P G L + L R   +    +   R   A +  +ALE
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLLALE 117

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---------------SDKING 313
           +LH      +++RD K  N+LL ++    ++DF L+K                       
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 314 QISTRVL------------GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            I +               GT  Y+APE  S     +  D ++ G++L E+L G  P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)

Query: 249 RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS 308
            PLD    L  +   A  ++FL   A+   IHRD    NVLL     AK+ DFGLA+ + 
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263

Query: 309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
           +  N  +         ++APE       T +SDV+SYG++L E+ + G+ P         
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--------- 314

Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
                   P +    +  +MV    Q   P     +I +I  +C   E   RP  + + Q
Sbjct: 315 -------YPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 162 IGNGGFGVVYKG--VLSDGTVAAIKKLHRDGKQRERAFRM--EVDLLSRLHS---PQLVE 214
           IG G +G V+K   + + G   A+K++     +         EV +L  L +   P +V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 215 LLGYCA----DQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           L   C     D+  +L L+ E++ +  L  +L +      P +    ++  L     L+F
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDF 125

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH H    V+HRD K  N+L+  + + K+ DFGLA++ S ++     T V+ T  Y APE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 179

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGR 356
                   T  D++S G +  E+   +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG 217
           +G+G +G V   +    G   AIKKL R  +     +RA+R E+ LL  +    ++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 218 -YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
            + +  +       Y+    +Q  L +        D    L+  + C   L+++H     
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG--LKYIHSAG-- 137

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            +IHRD K  N+ ++++   K+ DFGLA+    ++ G + TR      Y APE       
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWMH 191

Query: 337 TTKS-DVYSYGVVLLELLTGR 356
             ++ D++S G ++ E+LTG+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 54/289 (18%)

Query: 162 IGNGGFGVVYKGVL---SDGTVAA--------IKKLHRDGKQRERAFRMEVDLLSRLHSP 210
           +G G F  +YKGVL   SD  +          +K L  D +    AF     L+S+L   
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            LV+L G C    + +++ EY+  G L   LHR  N    L W  +L +A   A AL +L
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNV-SLHW--KLDVAKQLASALHYL 117

Query: 271 HEHATPPVIHRDFKCSNVLLDQN--------FRAKVTDFGLAKMVSDKINGQISTRVLGT 322
            +     ++H +    N+L+ +         F  K++D G+   V          RV   
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPF-IKLSDPGIPITV-----LSREERVERI 168

Query: 323 TGYLAPEYASTG--KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
             ++APE    G   LT  +D +S+G  LLE+ +           GE  L + +      
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLSTLSSSEKER 217

Query: 381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
             +         Q + P  D  ++A +   C   +   RP    +++ L
Sbjct: 218 FYQD--------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 18/205 (8%)

Query: 162 IGNGGFGVVYKGVLSDGTVAA---IKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLG 217
           IGNG FG V    +   T  A   +K+L  +   +E+  F  + D    L  P +++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
            C +    LL+ EY   G L+ +L +     R         +A + A  +  +H+H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGL--AKMVSDKINGQISTRVLGTTGYLAPEYAS--- 332
            +H D    N  L  +   KV D+G+  ++   D I  +          +LAPE      
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI--ETEDDKCVPLRWLAPELVGEFH 177

Query: 333 ----TGKLTTKSDVYSYGVVLLELL 353
               T + T  S+V++ GV L EL 
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 8/126 (6%)

Query: 246 NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK 305
            R RPL     LII       L +LH      +IHRD K  N+ ++   +  + D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Query: 306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRVPVDPNR 363
                +       + GT    APE  +  K  +K+D++S G+VL E+L     +  DP  
Sbjct: 206 F---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262

Query: 364 PPGEHV 369
            P E+V
Sbjct: 263 TPEEYV 268

Length = 357

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 24/233 (10%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH--RDGKQRERAFRMEVDL 203
           + L   T+ +     IG G +G VYK     DG++AA+K L    D  +   A   E ++
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNI 71

Query: 204 LSRL-HSPQLVELLG--YCADQ---NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           L  L + P +V+  G  Y AD+       L+ E    G++ + +       + LD     
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL-AKMVSDKINGQIS 316
            I     + L+ LH +    +IHRD K +N+LL      K+ DFG+ A++ S ++    S
Sbjct: 132 YILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 317 TRVLGTTGYLAPEYASTGK-----LTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
              +GT  ++APE  +  +        + DV+S G+  +EL  G  P+    P
Sbjct: 189 ---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 38/197 (19%)

Query: 253 WRTRLII------ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
           W++ L +      +   A  +EFL   A+   IHRD    N+LL +N   K+ DFGLA+ 
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223

Query: 307 VSD------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPV 359
           +        K + ++  +      ++APE       TT+SDV+S+GV+L E+ + G  P 
Sbjct: 224 IYKDPDYVRKGSARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Query: 360 DPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYR 419
                PG  +            EE  + +    + + P+    +I  I   C Q +   R
Sbjct: 278 -----PGVQI-----------NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321

Query: 420 PLMTDVVQSLIPVVKNN 436
           P  + +V+ L  +++ N
Sbjct: 322 PTFSALVEILGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 9/116 (7%)

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           LD    L  +   A  + FL   A+   IHRD    N+LL      K+ DFGLA+ + + 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------GRVPVD 360
            N  +         ++APE       T +SDV+SYG++L E+ +        +PVD
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQLVELL 216
           V+G G +GVV K    +   + AIKK  +D ++ E        E+ +L  L    +VEL 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
                +    L+ EY+    L+  L    N   P   R+ +   +    A+ + H++   
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIK---AIHWCHKND-- 120

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            ++HRD K  N+L+  N   K+ DFG A+ +S+  N    T  + T  Y +PE       
Sbjct: 121 -IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPY 178

Query: 337 TTKSDVYSYGVVLLELLTGRVPVDP 361
               D++S G +L EL  G+ P+ P
Sbjct: 179 GKAVDMWSVGCILGELSDGQ-PLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 52/234 (22%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLH-RDGKQRERAFRMEVD-------------L 203
           G  +G G +G V K      G + AIKK+   +        R  V              +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA-LD 262
           ++ +    ++ L+    + +   L+ + M            ++  + +D + RL  + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVVDRKIRLTESQVK 122

Query: 263 CAM-----ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-----MVSDKIN 312
           C +      L  LH+      +HRD   +N+ ++     K+ DFGLA+       SD ++
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 313 GQIST--------RVLGTTGYLAPE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
              +         +V+ T  Y APE    +  K     D++S G +  ELLTG+
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 11/99 (11%)

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKI-NGQI 315
           +   A  +EFL   A+   IHRD    N+LL +N   K+ DFGLA+ +    D +  G  
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-- 233

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             R+     ++APE       TT+SDV+S+GV+L E+ +
Sbjct: 234 DARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)

Query: 162 IGNGGFGVVYKGVLSD---GTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVEL 215
           IG GG G VY     D       A+KK+  D       ++ F  E  + + L  P +V +
Sbjct: 10  IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLH---RHNNRYRPLDWRTRL-----IIALDCAMAL 267
              C+D +       Y+   TL+  L    +  +  + L  +T +     I    CA  +
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA-TI 126

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST---------- 317
           E++H      V+HRD K  N+LL       + D+G A     +    +            
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 318 ------RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 +++GT  Y+APE       +  +D+Y+ GV+L ++LT   P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD--KINGQISTRVLGTT 323
            L+++H   +  V+HRD K  N+L++ +   K+ DFGLA+  S+    N    T  + T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 324 GYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPV 359
            Y APE   + +  TK+ DV+S G +L ELL GR PV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 10/208 (4%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           IG G FGVV+      DG   A+KK+    ++    +R FR E+ +L       ++  L 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
                +       Y+    +Q  LH+     +PL      +        L++LH   +  
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAG 123

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-L 336
           ++HRD K  N+L++ N   K+ DFGLA+ V +    +  T+ + T  Y APE     +  
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILMGSRHY 182

Query: 337 TTKSDVYSYGVVLLELLTGRVPVDPNRP 364
           T+  D++S G +  ELL  R+      P
Sbjct: 183 TSAVDIWSVGCIFAELLGRRILFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 33/113 (29%), Positives = 49/113 (43%), Gaps = 3/113 (2%)

Query: 246 NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK 305
           +R  PL     + I      AL +LH      +IHRD K  N+ LD+   A + DFG A 
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233

Query: 306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +    +        GT    +PE  +      K+D++S G+VL E+    V 
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 51/172 (29%), Positives = 74/172 (43%), Gaps = 23/172 (13%)

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  +EFL   A+   +HRD    NVLL Q    K+ DFGLA+ +    N           
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSRE 382
            ++APE       TT SDV+SYG++L E+ + G  P      PG  V  ++        +
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY-----PGMIVDSTF----YNKIK 354

Query: 383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL---MTDVVQSLIP 431
               M  P    Q       ++  I   C   E   RP    ++D+V+SL+P
Sbjct: 355 SGYRMAKPDHATQ-------EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKG--VLSDGTVA--AIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E + + + +G G +  VYKG   L+D  VA   I+  H +G     A R EV LL  L  
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT-AIR-EVSLLKDLKH 63

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHL-------HRHNNRYRPLDWRTRLIIALD 262
             +V L      +    L+ EY+ +  L+Q+L       + HN +          +    
Sbjct: 64  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK----------LFLFQ 112

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
               L + H      V+HRD K  N+L+++    K+ DFGLA+  S  I  +  +  + T
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYSNEVVT 167

Query: 323 TGYLAPE-YASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
             Y  P+    +   +T+ D++  G +  E+ TGR P+ P
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 162 IGNGGFGVVYKGV--LSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           IG G +GVVYK    +++ T+A +KK+     D      A R E+ LL  +    +V L 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIA-LKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQ 67

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM--ALEFLHEHA 274
                +    L+ EY     L   L +H +         RLI      +   + + H H 
Sbjct: 68  DVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122

Query: 275 TPPVIHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
              V+HRD K  N+L+D+   A K+ DFGLA+     I  +  T  + T  Y APE    
Sbjct: 123 ---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWYRAPEILLG 177

Query: 334 GK-LTTKSDVYSYGVVLLELLTGRVPVDP 361
            +  +T  D++S G +  E++  + P+ P
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK-PLFP 205

Length = 294

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)

Query: 151 TATENFSEGNVIGNGGFGVV---YKGVLSDGTVAAIKKLHR---DGKQRERAFRMEVDLL 204
           T  + + +   IG+G  G+V   +  VL  G   A+KKL R   +    +RA+R E+ LL
Sbjct: 18  TVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLL 74

Query: 205 SRLHSPQLVELLGYCADQ------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
             ++   ++ LL     Q          L+ E M +  L Q +H   +  R     + L+
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHER----MSYLL 129

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
             + C +     H H+   +IHRD K SN+++  +   K+ DFGLA+         + T 
Sbjct: 130 YQMLCGIK----HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTP 181

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
            + T  Y APE           D++S G ++ EL+ G V
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 35/232 (15%)

Query: 145 TYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL------HRDGKQRERAF 197
            YK +E           IG+G +GVV   +    G   AIKK+          K   R  
Sbjct: 6   RYKPIEN----------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK---RTL 52

Query: 198 RMEVDLLSRLHSPQLVELLG-YCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWR 254
           R E+ +L       ++ +                Y+    ++  LH   H+++    +  
Sbjct: 53  R-ELKILRHFKHDNIIAIRDILRPPGAD--FKDVYVVMDLMESDLHHIIHSDQPLTEEHI 109

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK--MVSDKIN 312
              +  L     L+++H   +  VIHRD K SN+L++++   ++ DFG+A+    S   +
Sbjct: 110 RYFLYQLLRG--LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164

Query: 313 GQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
               T  + T  Y APE   S  + TT  D++S G +  E+L GR  + P +
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGK 215

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 9/92 (9%)

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L+++H   +  +IHRD K SNV ++++   ++ DFGLA+   D++ G ++TR      Y 
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYR 182

Query: 327 APEYASTGKLTTKS-DVYSYGVVLLELLTGRV 357
           APE         ++ D++S G ++ ELL G+ 
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 20/182 (10%)

Query: 249 RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS 308
           + L     +  +   A  +EFL   A+   IHRD    N+LL +N   K+ DFGLA+ + 
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
              +            ++APE       T +SDV+S+GV+L E+ + G  P      PG 
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGV 285

Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
            +   +   RL   +E   M  P     Y   ++ Q       C   E + RP  +++V+
Sbjct: 286 KIDEEFCR-RL---KEGTRMRAP----DYTTPEMYQTMLD---CWHGEPSQRPTFSELVE 334

Query: 428 SL 429
            L
Sbjct: 335 HL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 56/258 (21%)

Query: 156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQ 211
           F +   +G G FG V      D   + A+K L +     + +    + E D+L+   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V L     D+++   + +Y+P G +   L R      P D     I  L CA  +E +H
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCA--VESVH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL--------------------------AK 305
           +      IHRD K  N+L+D++   K+TDFGL                          + 
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 306 MVSDKINGQISTR-------------------VLGTTGYLAPEYASTGKLTTKSDVYSYG 346
              D  N +   R                   ++GT  Y+APE       T   D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 347 VVLLELLTGRVPVDPNRP 364
           V+L E+L G+ P     P
Sbjct: 236 VILYEMLVGQPPFLAQTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 162 IGNGGFGVVYKGVLS--DGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHS-PQLVEL 215
           IG G +G V+K VL+  +G+ AA+K L   H   ++ E     E ++L  L   P +V+ 
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIE----AEYNILKALSDHPNVVKF 80

Query: 216 LG--YCADQ---NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            G  Y  D    +   L+ E    G++   +     R   ++      I  +  M L+ L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL-AKMVSDKINGQISTRVLGTTGYLAPE 329
           H + T   IHRD K +N+LL      K+ DFG+ A++ S ++    S   +GT  ++APE
Sbjct: 141 HVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPE 194

Query: 330 Y-ASTGKLTT----KSDVYSYGVVLLELLTGRVPVDPNRP 364
             A   +L +    + DV+S G+  +EL  G  P+    P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 56/252 (22%)

Query: 156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR-DGKQRERA--FRMEVDLLSRLHSPQ 211
           F +   +G G FG V      D   + A+K L + D   R +    + E D+L+   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+L     D+++   + +Y+P G +   L R       L    R  IA +  +A+E +H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIESVH 118

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL--------------------------AK 305
           +      IHRD K  N+L+D +   K+TDFGL                          + 
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 306 MVSDKINGQISTR-------------------VLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           +  D  N +   R                   ++GT  Y+APE       T   D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 347 VVLLELLTGRVP 358
           V+L E+L G+ P
Sbjct: 236 VILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 18/214 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRL-H 208
           + + +   IG G +G VYK    + G + A+KK   +  +      A R E+ LL  L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY-----RPLDWRTRLIIALDC 263
           S  +V LL     +      S Y+    L   L +  +       RPL  +T        
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
              +   H+H    V+HRD K  N+L+D Q    K+ D GL +  S  +     T  + T
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174

Query: 323 TGYLAPE-YASTGKLTTKSDVYSYGVVLLELLTG 355
             Y APE    +   +T  D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 5/105 (4%)

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  +EFL   A+   +HRD    NVL+ +    K+ DFGLA+ +    N           
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
            ++APE       TT SDV+S+G++L E+ T G  P  P  P  E
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY-PELPMNE 349

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 4e-07
 Identities = 45/149 (30%), Positives = 63/149 (42%), Gaps = 30/149 (20%)

Query: 223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR-TRLIIALDCAMALEFLHEHATPPVIHR 281
              +LI +Y+ +G L   L +       L     + II      AL  LH+H    +IH 
Sbjct: 82  KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVE-ALNDLHKHN---IIHN 133

Query: 282 DFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           D K  NVL D+   R  + D+GL K++     G  S    GT  Y +PE     K+  K 
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYD-GTLDYFSPE-----KI--KG 180

Query: 341 DVYSY-------GVVLLELLTGRVPVDPN 362
             Y         GV+  ELLTG+ P   +
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 37/268 (13%)

Query: 162 IGNGGFGVVYKGVLSD-GTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYC 219
           +G G  G+V+  V SD     A+KK+   D +  + A R E+ ++ RL    +V++    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 220 ADQNHRL---------LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
                 L         L S Y+    ++  L     +    +   RL         L+++
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF-MYQLLRGLKYI 130

Query: 271 HEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKIN--GQISTRVLGTTGYLA 327
           H   +  V+HRD K +NV ++  +   K+ DFGLA++V    +  G +S  ++ T  Y +
Sbjct: 131 H---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRS 186

Query: 328 PEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRPPGEH-------VLVSWALPRLT 379
           P    +    TK+ D+++ G +  E+LTG+         G H       +L S  + R  
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF-----AGAHELEQMQLILESVPVVREE 241

Query: 380 SREEAVEMVDPSL---QGQYPKKDLIQI 404
            R E +  V PS     G  P++ L  +
Sbjct: 242 DRNELLN-VIPSFVRNDGGEPRRPLRDL 268

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 35/243 (14%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDGKQRERA-FRME 200
           Y + E+    +     IGNG FG V+    K         AI   +R  K+RE++   +E
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS--YRGLKEREKSQLVIE 62

Query: 201 VDLLSRLHSPQLVELLG-YCADQNHRLLI-SEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           V+++  L    +V  +  +    N +L I  E+   G L +++ +    +  ++    + 
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 259 IALDCAMALEFLHEHATPP----VIHRDFKCSNVLLDQNFR-----------------AK 297
           I      AL + H     P    V+HRD K  N+ L    R                 AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA--STGKLTTKSDVYSYGVVLLELLTG 355
           + DFGL+K +  +    ++   +GT  Y +PE     T     KSD+++ G ++ EL +G
Sbjct: 183 IGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 356 RVP 358
           + P
Sbjct: 240 KTP 242

Length = 1021

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 25/214 (11%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRM--EVDLLSRLHSPQLVELL 216
           G    +     + K      T+ A+KK++ D   +E    +  E+    +L  P ++  +
Sbjct: 7   GKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL---DCAMALEFLHEH 273
                 +   ++S  M  G+ +  L  H     P      L IA    D   AL+++H  
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSK 120

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY-------L 326
                IHR  K S++LL  + +  ++  GL   VS   +G+    V             L
Sbjct: 121 G---FIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 327 APE--YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +PE    +      KSD+YS G+   EL  G VP
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 17/213 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKG--VLSDGTVA--AIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E + + + +G G +  V+KG   L++  VA   I+  H +G     A R EV LL  L  
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIR-EVSLLKNLKH 62

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +V L      +    L+ EY+ +  L+Q+L    N    +      I        L +
Sbjct: 63  ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNL---MSMHNVKIFMFQLLRGLSY 118

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H+     ++HRD K  N+L+++    K+ DFGLA+  S  +  +  +  + T  Y  P+
Sbjct: 119 CHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS--VPTKTYSNEVVTLWYRPPD 173

Query: 330 -YASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
               + + +T  D++  G +L E+ TGR P+ P
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 15/204 (7%)

Query: 162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE--RAFRMEVDLLSRLHSPQLVELLGY 218
           +G G +  VYKG+   +G + A+K +    ++     A R E  LL  L    +V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
              +     + EYM +  L Q++ +H     P + R  +   L     L ++H      +
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHGQH---I 124

Query: 279 IHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLT 337
           +HRD K  N+L+      K+ DFGLA+  +  I  Q  +  + T  Y  P+        +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 338 TKSDVYSYGVVLLELLTGRVPVDP 361
           +  D++  G + +E+L G+ P  P
Sbjct: 183 SALDIWGAGCIFIEMLQGQ-PAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 26/184 (14%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM----EVDLLSRLHSPQLVELL 216
           IG G FG V+K        + A+KK+  +    +  F +    E+ +L  L    +V L+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 217 GYC-----ADQNHR---LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
             C         ++    L+ E+  +  L   L   N ++   + +  + + L+    L 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN---GLY 133

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ---ISTRVLGTTGY 325
           ++H      ++HRD K +N+L+ ++   K+ DFGLA+  S   N +    + RV+ T  Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189

Query: 326 LAPE 329
             PE
Sbjct: 190 RPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 17/205 (8%)

Query: 162 IGNGGFGVVYKGV---LSDG-----TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           +G G F  ++KG+   + D      T   +K L +  +    +F     ++S+L    LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
              G C   +  +++ EY+  G+L  +L ++ N    + W  +L +A   A AL FL + 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISW--KLEVAKQLAWALHFLEDK 119

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYA 331
               + H +    NVLL +    K  +    K+    I+  +  +  +L    ++ PE  
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176

Query: 332 STGK-LTTKSDVYSYGVVLLELLTG 355
              + L+  +D +S+G  L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKG--VLSDGTVA--AIKKLHRDGKQRERAFRMEVDLLSRLHS 209
           E + +   +G G +  V+KG   L++  VA   I+  H +G     A R EV LL  L  
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIR-EVSLLKDLKH 63

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +V L           L+ EY+ +  L+Q++    N    +      I        L +
Sbjct: 64  ANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN---IMSMHNVKIFLYQILRGLAY 119

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H      V+HRD K  N+L+++    K+ DFGLA+  S  +  +  +  + T  Y  P+
Sbjct: 120 CHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS--VPTKTYSNEVVTLWYRPPD 174

Query: 330 -YASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
               + + +T+ D++  G +  E+ +GR P+ P
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 14/198 (7%)

Query: 162 IGNGGFGVVYKGVLS-DGTVAAIK--KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY 218
           +G G +  VYKG    +G + A+K  +L  +      A R E  LL  L    +V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
              +    L+ EY+ +  L Q++ +H     P + +  L   L     L ++H+     +
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---I 124

Query: 279 IHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLT 337
           +HRD K  N+L+      K+ DFGLA+  S  +     +  + T  Y  P+    + + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKS--VPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 338 TKSDVYSYGVVLLELLTG 355
           T  D++  G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 161 VIGNGGFGVV---YKGVLSDGTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHSPQLVE 214
            IG+G  G+V   Y  V   G   AIKKL R   +    +RA+R E+ L+  ++   ++ 
Sbjct: 23  PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79

Query: 215 LLGYCADQ------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           LL     Q          L+ E M +  L Q +    +  R     + L+  + C +   
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHER----MSYLLYQMLCGIK-- 132

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
             H H+   +IHRD K SN+++  +   K+ DFGLA+         + T  + T  Y AP
Sbjct: 133 --HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAP 186

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           E           D++S G ++ E++ G V
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 27/116 (23%), Positives = 36/116 (31%), Gaps = 12/116 (10%)

Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
            +R         LL+RLHS                 L         L + L     R   
Sbjct: 89  AERGALLEALARLLARLHS----------VPPEALPLARRLRRRLKLLRQLAAALRRLVA 138

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPV-IHRDFKCSNVLLDQNFR-AKVTDFGLA 304
            +   RL    +  +A       A P V +H D    N+L+D   R   V DF  A
Sbjct: 139 AELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDA 194

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 162 IGNGGFGVV---YKGVLSDGTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHSPQLVEL 215
           IG+G  G+V   Y  VL      AIKKL R   +    +RA+R E+ L+  ++   ++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 216 LGYCADQ------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           L     Q          L+ E M +  L Q +    +  R     + L+  + C +    
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHER----MSYLLYQMLCGIK--- 133

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H H+   +IHRD K SN+++  +   K+ DFGLA+         + T  + T  Y APE
Sbjct: 134 -HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW 373
                      D++S G ++ E++  ++       PG   +  W
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILF-----PGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 158 EGNVIGNGGFGVVYKGVLSDGTVA---AIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE 214
           EG  +G G +G VYK    DG      A+K++   G     A R E+ LL  L  P ++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-ACR-EIALLRELKHPNVIA 62

Query: 215 LLGYCADQNHR--LLISEYMPNG---TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           L       + R   L+ +Y  +     ++ H     N+ +P+     ++ +L     L+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK-KPMQLPRSMVKSL-LYQILDG 120

Query: 270 LHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTG 324
           +H      V+HRD K +N+L+     +  R K+ D G A++ +  +        V+ T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLT 354
           Y APE     +  TK+ D+++ G +  ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 26/207 (12%)

Query: 162 IGNGGFGVV---YKGVLSDGTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHSPQLVEL 215
           IG+G  G+V   Y  +L      AIKKL R   +    +RA+R E+ L+  ++   ++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 216 LGYCADQN-----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           L     Q        + I   + +  L Q +    +  R     + L+  + C +     
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER----MSYLLYQMLCGIK---- 140

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H H+   +IHRD K SN+++  +   K+ DFGLA+         + T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEV 196

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRV 357
                     D++S G ++ E++ G V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA-LDCAMALEFLHEHATP 276
           Y   Q +   +  +M +            + RPL  +TR I+  L CA  +E++H+    
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDW-------KDRPLLKQTRAIMKQLLCA--VEYIHDKK-- 287

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            +IHRD K  N+ L+ + +  + DFG A M  +K         +GT    +PE  +    
Sbjct: 288 -LIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGY 345

Query: 337 TTKSDVYSYGVVLLELLTGR-VPVDPN-RPPGEHVL 370
              +D++S G++LL++L+    P+      PG+ +L
Sbjct: 346 CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381

Length = 501

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 45/231 (19%)

Query: 145 TYKELETATENFSEGNVIGNGGFGVVYKGV--LSDGTVA--AIKKLHRDGKQRERAFRME 200
           TYK+L+           +G G +  VYKG   L+   VA   I+  H +G     A R E
Sbjct: 6   TYKKLD----------KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT-AIR-E 53

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
             LL  L    +V L      +    L+ EY+ +  L+Q++          + R  L   
Sbjct: 54  ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL 112

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV- 319
           L     L + H+     V+HRD K  N+L+ +    K+ DFGLA+  S       +  V 
Sbjct: 113 L---RGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT 166

Query: 320 ---------LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
                    LG+T Y           +T  D++  G +  E+ TGR P+ P
Sbjct: 167 LWYRPPDVLLGSTEY-----------STSLDMWGVGCIFYEMATGR-PLFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
           A+++LHE+    +IHRD K  N+ ++      + DFG A    D IN        GT   
Sbjct: 194 AIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD-INANKYYGWAGTIAT 249

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
            APE  +        D++S G+VL E+ T  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 158 EGNVIGNGGFGVVYKGVLSDGTVA---AIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE 214
           EG  +G G +G VYK    DG      A+K++   G     A R E+ LL  L  P ++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-ACR-EIALLRELKHPNVIS 62

Query: 215 L----LGYCADQNHRLLI--SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           L    L + AD+   LL   +E+     ++ H     N+ +P+     ++ +L     L+
Sbjct: 63  LQKVFLSH-ADRKVWLLFDYAEHDLWHIIKFHRASKANK-KPVQLPRGMVKSL-LYQILD 119

Query: 269 FLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTT 323
            +H      V+HRD K +N+L+     +  R K+ D G A++ +  +        V+ T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 324 GYLAPEYASTGKLTTKS-DVYSYGVVLLELLT 354
            Y APE     +  TK+ D+++ G +  ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 40/243 (16%)

Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
           AF     L+S++    L  + G C   +  +++ E++ +G L   L +   R  P+ W  
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAW-- 118

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA-------KVTDFGLAKMVS 308
           ++ +A   A AL +L +     ++H +    N+LL +   A       K++D G++    
Sbjct: 119 KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175

Query: 309 DKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSYGVVLLEL-LTGRVPVDPNRPPG 366
            +       RV     ++APE       L+T +D +S+G  LLE+   G VP+    P  
Sbjct: 176 SR-----EERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Query: 367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVV 426
           +         R   ++  +   +PS +         ++A + + C+  E   RP    ++
Sbjct: 230 KE--------RFYEKKHRLP--EPSCK---------ELATLISQCLTYEPTQRPSFRTIL 270

Query: 427 QSL 429
           + L
Sbjct: 271 RDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 46/146 (31%), Positives = 64/146 (43%), Gaps = 26/146 (17%)

Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--IALDCAMALEFLHEHATPPVIHRDFK 284
           +IS +M  G+    L      Y P      LI  I       L +LH++     IHR+ K
Sbjct: 76  VISPFMAYGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIK 128

Query: 285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQ----------ISTRVLGTTGYLAPEY--AS 332
            S++L+  +    V+  GL+ + S   NGQ           ST VL    +L+PE     
Sbjct: 129 ASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQD 183

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVP 358
                 KSD+YS G+   EL TGRVP
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 3/105 (2%)

Query: 247 RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
           R RPL       +A     A++++H      +IHRD K  NVL++      + DFG A  
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF 309

Query: 307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
                +      + GT    APE  +    T   D++S G+V+ E
Sbjct: 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 16/147 (10%)

Query: 162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLV-ELLGYC 219
           +  G    VY   L       + K++    ++      EV +L  L      V ++L   
Sbjct: 6   LKGGLTNRVYL--LGTKDEDYVLKINPSR-EKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
                  L+ E++   TL +           +    +  IA   A  L  LH+     + 
Sbjct: 63  ESDGWSYLLMEWIEGETLDE-----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKM 306
           H D    N+L+D      + D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 40/226 (17%)

Query: 161 VIGNGGFGVVYK------GVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE 214
           +IG GGFG VY+        +++  VA I+ L  +         ME  + + ++    + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE------TIVMETLVYNNIYDIDKIA 72

Query: 215 LLGYCADQNHRLLISEYMPNGT-----------LQQHLHRHNNRY--RPLDWRTRLI--I 259
           L     + +H L I +Y   G+           L + L  +      R      +LI  I
Sbjct: 73  LWKNIHNIDH-LGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA-------KMVSDKIN 312
             D    LE++HEH    + H D K  N+++D N R  + D+G+A       K +     
Sbjct: 132 MKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +   R  GT  Y   +  +   +T + D+ S G  +L+    ++P
Sbjct: 189 QKDLHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	457
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
smart00090	237	RIO RIO-like kinase.	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.1
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
PRK09902	216	hypothetical protein; Provisional	98.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.24
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
PLN02876	822	acyl-CoA dehydrogenase	98.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
PRK10593	297	hypothetical protein; Provisional	97.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.94
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.9
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.88
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.77
PRK05231	319	homoserine kinase; Provisional	97.58
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.57
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.38
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.31
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.02
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.0
PLN02236	344	choline kinase	96.97
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.57
KOG2270	520	consensus Serine/threonine protein kinase involved	96.55
PLN02756	418	S-methyl-5-thioribose kinase	96.44
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	96.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.31
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.23
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.21
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.1
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.0
COG2334	331	Putative homoserine kinase type II (protein kinase	95.93
PRK12396	409	5-methylribose kinase; Reviewed	95.9
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.89
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.87
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.78
PRK11768	325	serine/threonine protein kinase; Provisional	95.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-56  Score=434.90  Aligned_cols=291  Identities=56%  Similarity=0.951  Sum_probs=256.1

Q ss_pred             ceeeechHHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012739          140 VVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC  219 (457)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~  219 (457)
                      ....|+|+++..++++|...+.||+|+||.||+|...++..||||++........++|..|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46679999999999999999999999999999999999999999988766433145599999999999999999999999


Q ss_pred             EcCC-eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          220 ADQN-HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       220 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      .+.+ +.+||||||++|+|.++|+.....  +++|..+++|+.++|+||+|||....++||||||||+|||+|+++.+||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999886543  7999999999999999999999998889999999999999999999999


Q ss_pred             eeccCccccccccCCcccccc-ccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          299 TDFGLAKMVSDKINGQISTRV-LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      +|||+++.....  ....... .||.+|+|||++..+..+.|+||||||++|+||+||+.+.+...+.+...+..|..+.
T Consensus       219 sDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  219 SDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999655431  1111122 7999999999999999999999999999999999999999877655666688888666


Q ss_pred             cCchhHHhhhcCCcCC-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          378 LTSREEAVEMVDPSLQ-GQYPK-KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +... .+.+++|+.+. ..++. .....+..++..|++.+|..||+|.||++.|+.+.+.
T Consensus       297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            6654 78899999987 67765 6888999999999999999999999999999766654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4e-51  Score=416.43  Aligned_cols=268  Identities=27%  Similarity=0.460  Sum_probs=235.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      ..+....+.||+|.||+||+|...      +...||||.++..... ..++|++|++++..|+|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            445566788999999999999853      4568999999887655 556799999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNR----------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      +||+|||..|||.+||......          ..+|+..+.+.|+.|||.||.||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            9999999999999999875431          224889999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  374 (457)
                      |||+||||++.....++.+......-..+||+||.|..++||.+||||||||+|||+++ |+.||.+...          
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----------  711 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----------  711 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------
Confidence            99999999999887777776666677889999999999999999999999999999999 8889875322          


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                             +++++.+...-.-+.|++++.+++.|+..||+.+|.+||+++||-..|+.+.+..+..+
T Consensus       712 -------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  712 -------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             -------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence                   45666665554478899999999999999999999999999999999998887766543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=376.76  Aligned_cols=262  Identities=28%  Similarity=0.450  Sum_probs=218.3

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-eEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-HRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~  231 (457)
                      +++.++.||+|..|+|||++++ +++.+|+|++..+ .....+++.+|+++++..+||+||.++|.|...+ ...|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999976 5888999999555 4455578999999999999999999999999988 59999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++|+|.+++...+    .+++...-+|+.++++||.|||+ ++   ||||||||+|||++..|++||||||.++.+.+.
T Consensus       160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999987653    49999999999999999999996 66   999999999999999999999999999987654


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                          ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.||.+.......    |+       +-+..+++ 
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~----~~-------~Ll~~Iv~-  296 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD----IF-------ELLCAIVD-  296 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC----HH-------HHHHHHhc-
Confidence                457788999999999999999999999999999999999999999865221111    10       11112222 


Q ss_pred             cCCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCcc
Q 012739          391 SLQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAI  441 (457)
Q Consensus       391 ~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~  441 (457)
                      ......|.+ ++.+++.++..||++||.+||+++|+++|  .++++.+.+-.
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H--pfi~~~~~~~v  346 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH--PFIKKFEDPNV  346 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC--HHHhhcccccc
Confidence            112233443 67799999999999999999999999999  88887655433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7e-50  Score=390.11  Aligned_cols=261  Identities=36%  Similarity=0.588  Sum_probs=218.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-eEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQN-HRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~  231 (457)
                      .+...+.||.|+||+||+|.+.+...||+|++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3444566999999999999996666699999976532  22568999999999999999999999999887 79999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~~~  310 (457)
                      +++|+|.++++..  ....+++..++.++.|||+||.|||+++.  ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999885  23469999999999999999999999874  89999999999999998 9999999999876543


Q ss_pred             cCCccccccccCCCcccccccc--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          311 INGQISTRVLGTTGYLAPEYAS--TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .  ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||......                .....+.
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----------------~~~~~v~  259 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----------------QVASAVV  259 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHH
Confidence            2  2234478999999999999  569999999999999999999999999864331                1112222


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ....+...+..+...+..|+..||+.||..||++.+++..|+.+...-.
T Consensus       260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            3334445555577799999999999999999999999999999888633

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=394.55  Aligned_cols=265  Identities=29%  Similarity=0.471  Sum_probs=230.0

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++...+.++..+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            33334445667889999999999999988889999999765 34456788999999999999999999999998899999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||||+.|+|.+||+...  ...+...+.+.++.|||+||+||++++   +|||||..+||||++++.+||+||||++...
T Consensus       280 tE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999833  245888999999999999999999999   9999999999999999999999999999544


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      +. .........-...|.|||.+..+.++.||||||||++||||+| |+.||....                 ..++.+.
T Consensus       355 d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~  416 (468)
T KOG0197|consen  355 DD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLEL  416 (468)
T ss_pred             CC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHH
Confidence            33 2222333345678999999999999999999999999999999 788877543                 3677888


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ++...+...|..|+..+.+++..||+.+|++|||+..+...|+++.....
T Consensus       417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            89999989999999999999999999999999999999999998876543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-49  Score=390.42  Aligned_cols=253  Identities=25%  Similarity=0.471  Sum_probs=216.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+|...++||+|+|+.||.++. ..|..||+|++.+.   .....+.+.+||++.+.|+|||||+++++|++.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999997 78999999999763   2223345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |+|.+++|..++..+    +++++.+++.++.||+.||.|||+++   |+|||||..|+|++++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999998743    36999999999999999999999999   99999999999999999999999999998864


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  +....+.||||.|.|||++.....+..+||||+|||||.||+|++||+......                ....+..
T Consensus       171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------------ty~~Ik~  232 (592)
T KOG0575|consen  171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------------TYNKIKL  232 (592)
T ss_pred             c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------------HHHHHHh
Confidence            3  345677999999999999999999999999999999999999999998543211                1111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...  ..|.....+..+||.++|+.||.+|||+++|+.+  +++++
T Consensus       233 ~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~  274 (592)
T KOG0575|consen  233 NEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKS  274 (592)
T ss_pred             cCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhC
Confidence            111  2244556689999999999999999999999998  88854

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=366.89  Aligned_cols=201  Identities=34%  Similarity=0.572  Sum_probs=182.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .+|...+.||+|+||+||+|++. ++..||||.+...  .....+.+..|+.+|+.++|||||++++++..++..|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56777888999999999999975 5899999999766  45555668899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC------CcEEEeeccCc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN------FRAKVTDFGLA  304 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgl~  304 (457)
                      ||.||+|.+||+.++.    +++..+..++.|++.||++||+++   ||||||||.|||++..      -.+||+|||++
T Consensus        90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999998764    999999999999999999999999   9999999999999764      56899999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      +.+..   +....+.+|++-|||||++....|+.|+|+||+|+|+|++++|+.||+....
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            98874   3556789999999999999999999999999999999999999999986543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-49  Score=395.30  Aligned_cols=279  Identities=25%  Similarity=0.423  Sum_probs=242.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ....+.++||.|.||.|++|+++    ....||||.++..-.++ ...|+.|..+|.+++||||++|.|+........||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            45577899999999999999975    24579999998764443 45699999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +|||++|+|+.||+.+.++   +.+.++.-++.+|+.||.||-+++   +|||||..+|||++.+..+|++||||++.+.
T Consensus       709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999997753   888899999999999999999999   9999999999999999999999999999886


Q ss_pred             cccCCcccccc--ccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          309 DKINGQISTRV--LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       309 ~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      +... ...+..  .-..+|.|||.+...+++.+|||||||++|||.++ |..||..+.                 +.+++
T Consensus       783 dd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdVI  844 (996)
T KOG0196|consen  783 DDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVI  844 (996)
T ss_pred             cCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHHHH
Confidence            5432 222222  23568999999999999999999999999999888 899986432                 36777


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC-CccccCCCCcccCCCCCC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA-GAISFGSSRFQHQTPSPS  456 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~-~~~~~~~~~~~~~~~~~~  456 (457)
                      ..++..++...|.+|+..|.+|++.||++|..+||.+.+|+..|++++++... ......+++++++.++++
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~  916 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRS  916 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCC
Confidence            88888888888999999999999999999999999999999999999999555 555666678888877754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-49  Score=368.31  Aligned_cols=262  Identities=23%  Similarity=0.396  Sum_probs=214.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK-------QRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||.+.....       .......+|+++|++|+|||||++.++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999985 5799999999976421       12233578999999999999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEEEee
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVTD  300 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D  300 (457)
                      ..||||||++||+|.+++..+..    +.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999987654    777778889999999999999999   9999999999999766   7899999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCC---CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK---LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      ||+++..+.   ...+.+.|||+.|.|||++....   +..++|+||+||+||-+++|.+||........  +..     
T Consensus       323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e-----  392 (475)
T KOG0615|consen  323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE-----  392 (475)
T ss_pred             cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH-----
Confidence            999998763   45678899999999999997643   33488999999999999999999985432210  000     


Q ss_pred             cCchhHHhhhcCCc--CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          378 LTSREEAVEMVDPS--LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       378 ~~~~~~~~~~~d~~--l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                              .+..-.  +.+.......++..+||.+||..||++|||+.|++++  ++++...+.+
T Consensus       393 --------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h--pW~~~~~~~s  447 (475)
T KOG0615|consen  393 --------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH--PWFKDAPCLS  447 (475)
T ss_pred             --------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC--hhhhcccccc
Confidence                    011111  1112344667799999999999999999999999999  8888766644

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-49  Score=356.49  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=210.6

Q ss_pred             cCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEE-EEEcCCe-EEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLG-YCADQNH-RLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~-~~~~~~~-~~lv  228 (457)
                      .+|+++++||+|.||+||++. ..+|..+|.|.+...  +....+.+..|+.+|++|+|||||++++ .|.++++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            456778899999999999998 468999999999755  3334456889999999999999999999 5555555 8999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||..|+|.+.|.......+-+++..+|+++.|++.||..+|++- +..++||||||.||+++.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999987777778999999999999999999999821 123999999999999999999999999999988


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...  .......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+...                 ..+.+.
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------------~~L~~K  239 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------------LSLCKK  239 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----------------HHHHHH
Confidence            653  2345678999999999999999999999999999999999999999986421                 111111


Q ss_pred             cCCcCCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          388 VDPSLQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       388 ~d~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      +...--...| .-.+.++..||..|+..||+.||+.-.+++.+
T Consensus       240 I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            1111111233 45678999999999999999999864444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=346.94  Aligned_cols=266  Identities=25%  Similarity=0.344  Sum_probs=214.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +.|+.+.++|+|+||.||+++++ +|+.||||++..... .. .+-..+|+++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35677789999999999999976 499999999976533 22 3446789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||+..-|. -|.....   .++...+.+++.|++.|+.|+|+++   +|||||||+|||++.+|.+||||||+++.+.. 
T Consensus        82 ~~dhTvL~-eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHTVLH-ELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchHHHH-HHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            99764444 4444332   4899999999999999999999999   99999999999999999999999999998875 


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                       .+...+..+.|.+|+|||++.+ .+|...+||||+||++.||++|.+-|.+...-++...+...+..+..+..-.-.-.
T Consensus       154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             2345677788999999999877 79999999999999999999999999887766666666665555544332211111


Q ss_pred             CcCCC----------CCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQG----------QYP---KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~----------~~~---~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +.+.+          ...   .....-+.+++..||+.||++|++.++++.+
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            21211          111   1234578899999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=351.73  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|+++++||+|+||+||.++.. +++.+|+|++++..   ..+.+....|..+|..++||.||++.-.|++.+++|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467899999999999999999954 58899999997653   33445678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||+.||.|..+|++.+.    +++..+..++.+|+.||.|||+++   ||||||||+|||+|.+|.++|+||||++..-
T Consensus       104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999987654    899999999999999999999999   9999999999999999999999999998543


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .  .+....+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+..                 ...+.+
T Consensus       177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----------------~~~~~I  237 (357)
T KOG0598|consen  177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----------------KMYDKI  237 (357)
T ss_pred             c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----------------HHHHHH
Confidence            2  223456689999999999999999999999999999999999999999864321                 111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP----LMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP----s~~evl~~  428 (457)
                      ...-....+.-...+..+++..+++.||++|.    .+.+|-++
T Consensus       238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             hcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            11111122322445789999999999999995    45555443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=365.10  Aligned_cols=267  Identities=27%  Similarity=0.489  Sum_probs=220.7

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      ++++...+.+.+...||+|.||+||+|++.+  .||||+++.+  ..+..+.|+.|+..+++-+|.||+-+.|||.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            5666677778889999999999999999854  4999999766  34566789999999999999999999999998877


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                       .||+.+|+|.+|+.+|+....   .|+..+.+.|+.||++||.|||.++   |||||||..|||+.++++|||+||||+
T Consensus       463 -AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence             999999999999999998764   4999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ..-.............|...|||||++.   ..+|+..+||||||+++|||+||..||..... +.   +-|..   .. 
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq---IifmV---Gr-  607 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ---IIFMV---GR-  607 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh---eEEEe---cc-
Confidence            7665544444455567888999999985   46899999999999999999999999983222 11   11111   00 


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +    ...+.+. ....++..++.+|+..||..++++||.+.+|+..|+.+++.
T Consensus       608 G----~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  608 G----YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             c----ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            0    0011110 12235667999999999999999999999999999999985

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-45  Score=363.48  Aligned_cols=265  Identities=26%  Similarity=0.412  Sum_probs=209.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC-
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ-  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~-  222 (457)
                      ..++|++.++||+|+||.||+|.+      .++..||+|++.... ....+.+..|+.+++.+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            356789999999999999999974      235689999987543 23345688999999999 899999999988764 


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCC-------------------------------------------------------
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNR-------------------------------------------------------  247 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  247 (457)
                      +..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4688999999999999999753210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCC
Q 012739          248 ---YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG  324 (457)
Q Consensus       248 ---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  324 (457)
                         ..++++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               135888899999999999999999999   99999999999999999999999999986543222222233456788


Q ss_pred             ccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHH
Q 012739          325 YLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQ  403 (457)
Q Consensus       325 y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  403 (457)
                      |+|||++.+..++.++||||||+++|||++ |..||........                ....+........+...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----------------FCQRLKDGTRMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----------------HHHHHhcCCCCCCCCCCCHH
Confidence            999999999999999999999999999997 9999975332110                00000000111122334557


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          404 IAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       404 l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +.+++.+||+.+|.+|||+.++++.|++++++
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=358.38  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=223.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHH-HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..+.+.+.++||+|-||.|.++....+..||+|+++.+..... +.|..|+++|.+++||||++++|+|..++..++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4566788899999999999999998889999999988765555 779999999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||++|+|.+|+..+...  .+.-...+.|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+...
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999987432  2455667789999999999999999   999999999999999999999999999988777


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .+.....+.+-..+|||+|.+.-++++.+||||+||+++||+++  ...||........          .   +...+++
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----------v---en~~~~~  757 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----------V---ENAGEFF  757 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----------H---Hhhhhhc
Confidence            77777777888899999999999999999999999999999865  6788864322100          0   1122233


Q ss_pred             CCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          389 DPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       389 d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +..-.   ...|.-++..+.+++..||+.+-++||+++++...|.+..
T Consensus       758 ~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  758 RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            32222   2345667889999999999999999999999999987643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=357.85  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=213.5

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNH  224 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~  224 (457)
                      .....+|..++.||+|+|++|++|+.. .++.+|||++.+.-   ..+.+-...|-..|..| .||.|++|+-.|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445678999999999999999999954 68999999986542   22234466788899999 89999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      +|+|+||+++|+|.++|.+.+.    |++...+.++.||+.||+|||++|   ||||||||+|||+|.|+.+||+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999998765    999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC---------ccc--cccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh
Q 012739          305 KMVSDKING---------QIS--TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       305 ~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~  373 (457)
                      +.+.+....         ...  ..++||..|.+||++.++..+..+|+|+||||||+|+.|++||....+.    ++  
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li--  295 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI--  295 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH--
Confidence            987543222         111  4589999999999999999999999999999999999999999864331    11  


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                                ...+++-.+  .++...+....+|+.+.|..||.+|+|..+|.+|.
T Consensus       296 ----------FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 ----------FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ----------HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                      111111111  33444556899999999999999999999999884

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=346.82  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=211.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--eEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN--HRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~lv~e  230 (457)
                      .++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456667899999999999999754 8999999887664444667899999999999999999999854444  6899999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~  309 (457)
                      |+++|+|.+++...+.   .+++..+..++.|+++||.|||+++   ||||||||+|||++. ++.+||+|||++.....
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999988664   4999999999999999999999999   999999999999999 79999999999987653


Q ss_pred             -ccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          310 -KINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       310 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                       ...........||+.|||||++..+ ....++|||||||++.||+||+.||.....  .             ......+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~-------------~~~~~~i  235 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--E-------------AEALLLI  235 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--h-------------HHHHHHH
Confidence             1122234457899999999999864 334599999999999999999999975300  0             0111122


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ......+.+|...+.+..+++..|++.+|+.|||+.+++++  .++++...
T Consensus       236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h--pf~~~~~~  284 (313)
T KOG0198|consen  236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH--PFLKQNSI  284 (313)
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC--hhhhcccc
Confidence            22222235566677789999999999999999999999999  45554433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=356.47  Aligned_cols=271  Identities=23%  Similarity=0.310  Sum_probs=218.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHH-HHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC-eEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLH-SPQLVELLGYCADQN-HRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~-~~~lv  228 (457)
                      -++|...++||.|+||.||+|+. .++..||||++++.-... +-.-.+|++.|++|+ ||||++|.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            46788889999999999999995 468999999987653222 222467999999998 999999999998877 99999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||| ..+|++++..++   +.+++.++..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+||||||.+.
T Consensus        89 fE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            9999 579999998763   57999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCCccccccccCCCccccccc-cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh-----
Q 012739          309 DKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE-----  382 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  382 (457)
                      ..   ...+..+.|.+|+|||++ ..+-|+.+.|+||+|||++|+.+-++-|.+..+.++...+-.++.......     
T Consensus       162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            43   335667889999999987 467899999999999999999999999988776665555544443332221     


Q ss_pred             HHhhhcCCcC---CC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          383 EAVEMVDPSL---QG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 ~~~~~~d~~l---~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+...+.-.+   .+    ..-.....+..+|+.+|+++||++|||+.|++++  .+.+.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~--pffq~  296 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH--PFFQV  296 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC--ccccc
Confidence            1112221111   11    1112366789999999999999999999999998  66665

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-45  Score=350.08  Aligned_cols=270  Identities=23%  Similarity=0.276  Sum_probs=210.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lv  228 (457)
                      +.|+.+++||+|+||.||+|+. .+|+.||+|++..+..  .......+||.+|++|+||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4566778899999999999994 5799999999987752  2234467899999999999999999998776  789999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +|||+. +|.-++....-   .|++.++..++.|++.||+|||+++   |+|||||.+|||||.+|.+||+||||++.+.
T Consensus       197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            999965 88888876543   4899999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH-hh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA-VE  386 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  386 (457)
                      .... ...+..+.|.+|+|||++.+ ..|+.++|+||.||||.||++|++.|.+...-.+...+.....-..+.... ..
T Consensus       270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5432 33566778999999999876 589999999999999999999999998866543333332221111110000 00


Q ss_pred             hcC-CcCCC--CCC-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          387 MVD-PSLQG--QYP-------KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       387 ~~d-~~l~~--~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +.. ..++.  .|.       ...+....+|+..+|..||.+|.|+.++++.  +++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF  403 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYF  403 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--ccc
Confidence            000 00010  111       1234578899999999999999999999987  666

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=351.47  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=212.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC----ch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD----GK-QRERAFRMEVDLLSRLH-SPQLVELLGYCADQNH  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~  224 (457)
                      ...+|.+.+.||+|+||+|++|.. .++..||+|.+.+.    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456889999999999999999985 46899999976553    11 23345778999999999 9999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccC
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGL  303 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl  303 (457)
                      .++||||+.+|+|.+++....    .+.+.++..++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999998833    4888999999999999999999999   9999999999999999 9999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCC-CC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +....  .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+........             
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------------  232 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------------  232 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            98774  1234567889999999999999877 86 7899999999999999999999863221100             


Q ss_pred             hHHhhhcCCcCCCCCCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKD-LIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                         ..+....+  .+|... ..++..|+.+|+..||.+|+++.+|+++  .+++.
T Consensus       233 ---~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~~  280 (370)
T KOG0583|consen  233 ---RKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQK  280 (370)
T ss_pred             ---HHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhcc
Confidence               00111111  223333 6689999999999999999999999944  88886

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=380.86  Aligned_cols=263  Identities=30%  Similarity=0.482  Sum_probs=222.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC--Cc----EEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD--GT----VAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      ..+....+.||+|.||.||.|...+  +.    .||+|.+.+. ..++..+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3455667899999999999999654  33    4999999876 455567799999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          226 LLISEYMPNGTLQQHLHRHNN---RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      +|++|||.+|+|..||++.+.   ....+...+.+.++.|||+|+.||++++   +|||||..+|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998632   2346899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCch
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++.+....+........-...|||||.+.++.++.|+|||||||+|||++| |..||...+.                 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------  910 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------  910 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------
Confidence            9997666555444444445679999999999999999999999999999999 7888875433                 


Q ss_pred             hHHhh-hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          382 EEAVE-MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       382 ~~~~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .++.. .+... +.+.|..|+..+.+|+.+||+.+|++||++..|++++.+++...
T Consensus       911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            12222 22222 44677778889999999999999999999999999999988863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=339.64  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=212.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .+.|++.++||.|..++||+|+. ..+..||||++..+.... .+.+++|+..|+.++||||++++..|..+..+|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46788899999999999999995 468999999998775443 4779999999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||.+|++.+.+......  .+++..+..|+.++++||.|||.+|   .||||||+.||||+.+|.+||+|||.+..+...
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999886542  4999999999999999999999999   999999999999999999999999998877553


Q ss_pred             cCCcc--ccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          311 INGQI--STRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       311 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .....  .....||++|||||++..  ..|+.|+||||||++..||.+|..||....+.....+      .+...  ...
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------tLqn~--pp~  251 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------TLQND--PPT  251 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------HhcCC--CCC
Confidence            32211  156789999999999643  5799999999999999999999999986544211110      00000  000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+..+........+.+++..||+.||.+|||+.+++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            000011111122344589999999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=355.20  Aligned_cols=253  Identities=24%  Similarity=0.418  Sum_probs=217.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ..|....+||+|..|.||.+.. .+++.||||++........+.+.+|+.+|+..+|+|||++++.|..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4688888999999999999984 568899999998877777777899999999999999999999999889999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      +||+|.+.+....     +++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       353 ~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999887643     899999999999999999999999   99999999999999999999999999988765432


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        .....+||+.|||||++....|..|+||||||++++||+-|.+||-...+-....+             +...-.+.+
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------------Ia~ng~P~l  489 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------IATNGTPKL  489 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------------HhhcCCCCc
Confidence              34667899999999999999999999999999999999999999975443211111             111111222


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                        .-+...+..|.+|+.+||+.|+++|+++.|+|++  .++
T Consensus       490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H--pFl  526 (550)
T KOG0578|consen  490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH--PFL  526 (550)
T ss_pred             --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC--hhh
Confidence              3345567799999999999999999999999998  666

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.3e-44  Score=318.50  Aligned_cols=271  Identities=24%  Similarity=0.309  Sum_probs=213.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .+|...++||+|.||.||+|+. .+|+.||||+++.....  -.....+|++.|+.++|+||+.++++|...+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577788999999999999995 56999999999765322  12456789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||+ .+|...|....   ..+...++..++.++++||+|||.+.   |+||||||+|+|++.+|.+||+|||+++.+...
T Consensus        82 fm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            995 69999987654   46999999999999999999999999   999999999999999999999999999988765


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC--------ch
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT--------SR  381 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~  381 (457)
                      ...  .+..+.|.+|+|||++.+ ..|+..+|+||.|||+.||+-|.+-|.+...-++...+..++....        ..
T Consensus       155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            332  333478999999998866 6799999999999999999999887776544333333322222221        11


Q ss_pred             hHHhhhc---CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          382 EEAVEMV---DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       382 ~~~~~~~---d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+..++.   .+.+.. .=..+..+..+|+..|+..||.+|+++.|++++  +.++..
T Consensus       233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~  287 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSL  287 (318)
T ss_pred             ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcC
Confidence            1111111   111111 112344567999999999999999999999998  788763

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-43  Score=353.44  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=208.3

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      ...++|++.+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+.+++.+ +||||++++++|...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3355788899999999999999973      235689999987543 33345688899999999 899999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCC--------------------------------------------------------
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNN--------------------------------------------------------  246 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  246 (457)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999975321                                                        


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          247 ---------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       247 ---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                                     ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                           0125788999999999999999999999   9999999999999999999999999998664432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |..||.......                .....+..
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----------------~~~~~~~~  332 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----------------KFYKMIKE  332 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----------------HHHHHHHh
Confidence            2222223345678999999999999999999999999999998 888886432211                01111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ......+...+.++.+|+.+||+.||++||++.+|++.|++.+
T Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence            1111122223457999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.3e-43  Score=338.01  Aligned_cols=246  Identities=22%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEEEEEe
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHRLLISEY  231 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~  231 (457)
                      ...||+|++|.||+|.+ +|+.||+|++.......   .+.+.+|+.+|++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 78899999987653222   3567899999999999999999999876    3568899999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      +++|+|.+++....    .+++...+.++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+++.+...
T Consensus       104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            99999999997643    488999999999999999999984 6   889999999999999999999999998865432


Q ss_pred             cCCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          311 INGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                           .....++..|+|||.+.+  ..++.++|||||||++|||++|+.||.......                ....+.
T Consensus       177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----------------~~~~i~  235 (283)
T PHA02988        177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----------------IYDLII  235 (283)
T ss_pred             -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHH
Confidence                 123457889999999976  689999999999999999999999997542210                000111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ........+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111112233345668999999999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-45  Score=352.01  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=210.5

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++...+.+..++-||.|+.|.||+|++ .++.||||+++.-.       +.+|+.|++|+||||+.+.|+|.....+|||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            444445556678899999999999999 56789999885432       3478999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||||..|.|...|....    ++.......|..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++...
T Consensus       191 MEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh
Confidence            99999999999998754    4888899999999999999999999   9999999999999999999999999998775


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      +.   ...-.++||..|||||++...+.++|+|||||||||||||||..||..-+..    .+-|            .+-
T Consensus       264 ~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw------------GVG  324 (904)
T KOG4721|consen  264 DK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW------------GVG  324 (904)
T ss_pred             hh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE------------ecc
Confidence            53   2234578999999999999999999999999999999999999999753221    1111            111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ...+....|..++..+.-|+++||+-.|..||++++++.+|+
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            223444567778889999999999999999999999999996

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-43  Score=352.20  Aligned_cols=266  Identities=29%  Similarity=0.421  Sum_probs=209.7

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      ....++|++.+.||+|+||.||+|...      ++..||+|++.... ......+.+|+.+++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344567889999999999999998842      24579999997553 33345688899999999 89999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCC-------------------------------------------------------
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNN-------------------------------------------------------  246 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  246 (457)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999865321                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          247 -----------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       247 -----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                                 ...++++.+++.++.|++.||.|||+++   ++||||||+|||+++++.+||+|||+++..........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       1124788999999999999999999999   99999999999999999999999999986543322222


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||........                ...........
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~~  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQM  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccCc
Confidence            223345678999999998999999999999999999997 9999975322110                01111111111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ..+...+.++.+++.+||+.+|.+||++.+|++.|++++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~~  374 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQLG  374 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHhC
Confidence            1122234589999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.5e-44  Score=348.99  Aligned_cols=252  Identities=31%  Similarity=0.460  Sum_probs=214.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.+  ..+.+.+++|+++++.++|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777888999999999999965 58899999987654  3345668999999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+.| +|..+|.....    ++++.+..++.+++.||.|||+.+   |.|||+||.|||++.+|.+|+||||+++.+.. 
T Consensus        82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9965 99999988765    999999999999999999999999   99999999999999999999999999998765 


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                       +....+...|||.|||||++.+.+|+..+|.||+|||+||+++|++||......   .++             ..+.-.
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv-------------~~I~~d  215 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLV-------------KSILKD  215 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHH-------------HHHhcC
Confidence             334567788999999999999999999999999999999999999999742110   001             011111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..  .+|......+..++...|.+||..|.|..+++.+  .+++.
T Consensus       216 ~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H--pF~k~  256 (808)
T KOG0597|consen  216 PV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH--PFWKG  256 (808)
T ss_pred             CC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC--hHHhh
Confidence            11  2344667789999999999999999999999988  66654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=353.25  Aligned_cols=266  Identities=27%  Similarity=0.448  Sum_probs=221.2

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcC--C--cE-EEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSD--G--TV-AAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGY  218 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~  218 (457)
                      +.|+...++....++||+|+||.||+|++..  +  .. ||+|..+..   ......++..|.++|+.++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445555667778999999999999999653  2  23 899988752   45666789999999999999999999999


Q ss_pred             EEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      +......++|||+|.||+|.++|.....   .++..+++.++.+.|.||+|||+++   ++||||..+|+|++.++.+||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999998654   4899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccccccCCcccc-ccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcc
Q 012739          299 TDFGLAKMVSDKINGQIST-RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      +||||++.-..   ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....           
T Consensus       304 SDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----------  369 (474)
T KOG0194|consen  304 SDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----------  369 (474)
T ss_pred             CccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----------
Confidence            99999875431   11111 1234678999999999999999999999999999999 88898864331           


Q ss_pred             ccCchhHHhhhc-CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          377 RLTSREEAVEMV-DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       377 ~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                            ++...+ ....+...+...+..+..++.+||..+|++||+|.++.+.|+.+.+....
T Consensus       370 ------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  370 ------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                  222222 34444555556677899999999999999999999999999999988665

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.3e-43  Score=341.49  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=208.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56888999999999999999864 333    38999986543 34456688999999999999999999999765 5679


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ++||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999986442   4888999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......                 ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~~~  222 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISS  222 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHH
Confidence            54322222223345678999999999999999999999999999998 99998743211                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+........+..+...+.+++.+||+.+|.+||++.+++..|.++.++...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence            1111111112223445789999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-43  Score=338.44  Aligned_cols=265  Identities=28%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-----------------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeee
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-----------------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVE  214 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~  214 (457)
                      ..+|.+.++||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578888999999999999998532                 3369999887653 333456889999999999999999


Q ss_pred             EEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012739          215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNN---------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVI  279 (457)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  279 (457)
                      +++++.+.+..++||||+++|+|.+++.....               ....+++..++.++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999999999999999999999999865321               1134788899999999999999999999   99


Q ss_pred             eccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc--CCC
Q 012739          280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRV  357 (457)
Q Consensus       280 H~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt--g~~  357 (457)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||.+....++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986644332222334456788999999988899999999999999999987  556


Q ss_pred             CCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          358 PVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       358 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ||.......   ......       ..............+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ---VIENAG-------EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH---HHHHHH-------HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            766432211   110000       000000000111122234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.6e-43  Score=334.74  Aligned_cols=259  Identities=31%  Similarity=0.512  Sum_probs=211.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      .+|++.+.||+|+||.||+|....      ...+++|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998643      25799998865532 33456889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC
Q 012739          227 LISEYMPNGTLQQHLHRHNNR------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                      ++|||+++++|.+++......            ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            999999999999999764221            135888999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~  373 (457)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....         
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---------  232 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---------  232 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            999999999986644333333344567889999999988899999999999999999998 9999875322         


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                              .+....+........+..++.++.+|+.+||+.+|.+||++.+|+++|+.+
T Consensus       233 --------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 --------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                    111122222222233455667899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=318.72  Aligned_cols=236  Identities=28%  Similarity=0.429  Sum_probs=204.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHH---HHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRER---AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~---~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|+..+.||.|+||+|.+++.+ +|..+|+|++.+..-.+.+   ...+|..+|+.+.||.++++.+.|.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56778899999999999999965 5889999999877544443   3567999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||++||.|.+++++.+.    +++..++.++.||+.||+|||+++   |++|||||+|||+|.+|.+||+|||+++.+..
T Consensus       124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999988654    999999999999999999999999   99999999999999999999999999998754


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     ..+.||||.|+|||.+....|..++|.||||+++|||+.|.+||....+.                .....++.
T Consensus       197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI~~  255 (355)
T KOG0616|consen  197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKILE  255 (355)
T ss_pred             c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHHHh
Confidence            3     56789999999999999999999999999999999999999999865441                11112222


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYR  419 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~R  419 (457)
                      -.+  .+|.-...++.+|+...|+.|-.+|
T Consensus       256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            222  3455556689999999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=343.59  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=213.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..|+..+.||+|.||.||+|.+. .++.||+|++..+. ....+.+.+|+.++.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34666688999999999999964 58899999997763 44456788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      |.||++.+.+....    .+++.++..++.+++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus        93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999987644    3578888889999999999999999   9999999999999999999999999998876543


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      .  ...++.||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+..-                 .-++-+.
T Consensus       166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----------------lflIpk~  226 (467)
T KOG0201|consen  166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----------------LFLIPKS  226 (467)
T ss_pred             h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------------EEeccCC
Confidence            2  23678999999999999988999999999999999999999999986554211                 1111112


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+.+...+...+++++..||++||+.||++.+++++  +++++
T Consensus       227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh--~FIk~  268 (467)
T KOG0201|consen  227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH--KFIKR  268 (467)
T ss_pred             CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh--HHHHh
Confidence            2222333455589999999999999999999999987  66654

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-42  Score=330.63  Aligned_cols=257  Identities=21%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|++.+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+..++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888899999999999999853    356899999876532 334568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....   ..+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999997643   25899999999999999999999999   999999999999999999999999987654


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......                 +...
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~  219 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----------------DVIK  219 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHH
Confidence            22111 11112335678999999999999999999999999999875 99999754321                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .+........+..++..+.+++.+||+.+|++||++.+|++.|.+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            11111111223445568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=315.92  Aligned_cols=267  Identities=23%  Similarity=0.341  Sum_probs=217.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHR  225 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~  225 (457)
                      ..++|++.+.||+|||+.||+++ ..++..+|+|++.....+..+...+|++..++++||||++++++...+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999999 567899999999888777777889999999999999999999876433     458


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ||+++|+..|+|.+.+.....++..+++.+++.|+.++++||.+||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999999988777778999999999999999999999986 579999999999999999999999999987


Q ss_pred             ccccccCCc-------cccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc
Q 012739          306 MVSDKINGQ-------ISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       306 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ...-...+.       .......|..|+|||++.   +...++++|||||||+||+|+.|..||+..-..+.-.      
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------  251 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------  251 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE------
Confidence            653221111       122345788999999885   4567899999999999999999999998432211110      


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                              ...+....+...-....+..+.+++.+|++.||.+||+..+++..++.++
T Consensus       252 --------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 --------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    01111222211111225668999999999999999999999999998875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=349.51  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=213.5

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      -|++++.||.|+-|.|-+|++ .+|+.+|||.+.+..   ......+.+|+-+|+.+.||||++++++|.+..++|+|+|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            467789999999999999995 579999999987652   2223458899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|.|.+++..++.    +.+.++.+++.||+.|+.|+|..+   |+||||||+|+|+|..+.+||+|||+|..-.. 
T Consensus        93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999988764    999999999999999999999999   99999999999999999999999999976433 


Q ss_pred             cCCccccccccCCCccccccccCCCCC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                        +....+.||.+.|.|||++.+.+|+ .++||||.|||||.||||+.||++...                 +.+...+.
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----------------r~LLlKV~  225 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----------------RVLLLKVQ  225 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----------------HHHHHHHH
Confidence              3556778999999999999999985 689999999999999999999984221                 11111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ... -+.|...+.+.++|+.+|+..||.+|.|++||++|  .++..
T Consensus       226 ~G~-f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH--P~l~g  268 (786)
T KOG0588|consen  226 RGV-FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH--PFLSG  268 (786)
T ss_pred             cCc-ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC--chhhc
Confidence            111 03445566789999999999999999999999999  66664

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.5e-43  Score=339.06  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=208.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..++|..+++||+|+||.||+|+-+ +|..+|+|++++...   ...+..+.|-.+|...++|.||+|+-.|++...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999954 699999999987743   334457889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||++||++..+|....    .|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|.+||+||||+..+
T Consensus       219 iMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999998765    4999999999999999999999999   999999999999999999999999998532


Q ss_pred             cc---------------cc-------CC-----------------------ccccccccCCCccccccccCCCCCcccch
Q 012739          308 SD---------------KI-------NG-----------------------QISTRVLGTTGYLAPEYASTGKLTTKSDV  342 (457)
Q Consensus       308 ~~---------------~~-------~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV  342 (457)
                      ..               ..       ..                       ......+|||.|||||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11               00       00                       00122469999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 012739          343 YSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL  421 (457)
Q Consensus       343 ~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  421 (457)
                      ||||||+||||.|.+||....+..... ...|        ..       .+...-......+..+||.+|+. ||++|..
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw--------r~-------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNW--------RE-------TLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--------hh-------hccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999766532211 1111        11       11111122334689999999999 9999974


Q ss_pred             ---HHHHHHHHHHhhh
Q 012739          422 ---MTDVVQSLIPVVK  434 (457)
Q Consensus       422 ---~~evl~~L~~~~~  434 (457)
                         +.||.++  .+++
T Consensus       436 ~~G~~EIK~H--PfF~  449 (550)
T KOG0605|consen  436 SKGAEEIKKH--PFFK  449 (550)
T ss_pred             cccHHHHhcC--Cccc
Confidence               7777666  5554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.4e-42  Score=331.78  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=211.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ..+|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888899999999999999842      34568999887665555667899999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          227 LISEYMPNGTLQQHLHRHNN---------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                      +||||+++++|.+++.....         +...+++.+++.++.|++.||+|||+.+   ++||||||+|||+++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            99999999999999975431         2235899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......          
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----------  230 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----------  230 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------
Confidence            999999986543322222233445778999999998899999999999999999998 899986432210          


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                             ..+.+........+...+.++.+++.+||+.+|.+|||+.++++.|+++.+.
T Consensus       231 -------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         231 -------VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -------HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                   0000000000111222345799999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=356.74  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             CCCCceeccCCcEEEEEEEEc-C-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-D-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      |.+.+.||+|+||.||+|... + +..||+|++..........++.|+.+++.++||||+++++++...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            778899999999999999853 3 57788888766655555668889999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++........++++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999998765444457899999999999999999999999   999999999999999999999999999876543332


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .             .......... 
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~-------------~~~~~~~~~~-  288 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---E-------------IMQQVLYGKY-  288 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---H-------------HHHHHHhCCC-
Confidence            3345567999999999999999999999999999999999999999743210   0             0001111000 


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...+...+..+.+++..||+.+|++||++.+++++
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            11223344579999999999999999999998754

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.2e-42  Score=331.42  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999853      23578888886553 3344668899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCc
Q 012739          228 ISEYMPNGTLQQHLHRHNN--------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN  287 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  287 (457)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999999875321                    1235889999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCC
Q 012739          288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPG  366 (457)
Q Consensus       288 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~  366 (457)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |..||....+. 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222233445678999999988889999999999999999999 99998643221 


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                      .+.+.+........+......+.+++.+||+.+|++||++.++++.|++++.+
T Consensus       237 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         237 ----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             ----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence                            11112222222223334456899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-42  Score=347.11  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCchH-HHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLH-SPQLVELLGYCA  220 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-hpniv~l~~~~~  220 (457)
                      +.....+|.+.++||+|+||.||+|.+..      +..||+|++...... ..+.+.+|+++++.+. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34446788999999999999999998532      346999999755333 3356889999999996 999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCC------------------------------------------------------
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNN------------------------------------------------------  246 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  246 (457)
                      +.+..+|||||+++|+|.++|.....                                                      
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            99999999999999999999875321                                                      


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          247 --------------------------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       247 --------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                                                            ....+++.+++.++.|++.||.|||+.+   ++||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                  0124788889999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE  367 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~  367 (457)
                      |++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999999986643322222233456788999999998999999999999999999997 999987432110 


Q ss_pred             chhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                                     .....+........+...+..+.+++.+||+.+|++||++.+|.+.|+++++
T Consensus       348 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 ---------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                           0001111111112233445689999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-42  Score=332.32  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=205.8

Q ss_pred             CCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      |+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999996 468999999886542   12234577899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.+++.....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++...... 
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            999999988865332  35899999999999999999999999   999999999999999999999999999765332 


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......||..|+|||++.+..++.++|||||||++|||++|+.||.........             ......+ ..
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-------------~~~~~~~-~~  219 (285)
T cd05631         156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEVDRRV-KE  219 (285)
T ss_pred             --CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHHh-hc
Confidence              1223457899999999999999999999999999999999999999854321110             0011101 01


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~~  435 (457)
                      ....++......+.+|+.+||+.||++||+     +.+++++  +++++
T Consensus       220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h--~~~~~  266 (285)
T cd05631         220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH--PIFKN  266 (285)
T ss_pred             ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC--HhhcC
Confidence            111233445568999999999999999997     8888876  55554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=324.65  Aligned_cols=274  Identities=25%  Similarity=0.403  Sum_probs=205.9

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC----eEEEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR--LHSPQLVELLGYCADQN----HRLLIS  229 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~----~~~lv~  229 (457)
                      .+..++||+|.||.||||.+ +++.||||++...   ..+.|..|-++.+.  ++|+||++++++-....    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            34557799999999999999 5599999999643   34457777666655  58999999999865444    889999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH------ATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ||.+.|+|.+||..+     .++|.+..+|+..+++||+|||+.      .+++|+|||||++||||.+|++..|+||||
T Consensus       288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999875     489999999999999999999974      356899999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      +..+.........-..+||.+|||||++.+.      ..-.+.||||+|.|||||++.-.-+++...+.-..-....+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9988765444444458899999999999653      1234789999999999999976665431111100000001111


Q ss_pred             cCchhHHhh-hcCCcCCCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          378 LTSREEAVE-MVDPSLQGQYPK-----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       378 ~~~~~~~~~-~~d~~l~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      -...++..+ ++.+..++.++.     ..+.-+++.+..||..|++.|.|+.=|-+++.++.+-++.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            111112211 122222222221     4467899999999999999999999999999988887665

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=326.06  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.+.||+|+||.||+|.+..    ...|++|.+.... ......+..|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998742    4579999886543 33345688899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.++|+|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999976443   5899999999999999999999998   9999999999999999999999999998775


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||......                 .....
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~  220 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----------------DVIKA  220 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----------------HHHHH
Confidence            2222112222345678999999998999999999999999999998 99998643211                 11111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +........+..++..+.+++.+||+.+|++||++.+|+++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1111111223344568999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=340.73  Aligned_cols=265  Identities=26%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc-C
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD-Q  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-~  222 (457)
                      ..++|++.++||+|+||.||+|...      .++.||+|++.... ....+.+..|+.+++++ +|+||++++++|.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3467899999999999999999742      24789999987543 33345677899999999 89999999998864 4


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCC-------------------------------------------------------
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNR-------------------------------------------------------  247 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  247 (457)
                      ...++++||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5788999999999999998653211                                                       


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCc
Q 012739          248 --YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY  325 (457)
Q Consensus       248 --~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  325 (457)
                        ..++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              126889999999999999999999999   999999999999999999999999999876433222222334566789


Q ss_pred             cccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHH
Q 012739          326 LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQI  404 (457)
Q Consensus       326 ~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  404 (457)
                      +|||++.+..++.++|||||||++|||++ |..||.......                .....+........+.....++
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~  305 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATPEI  305 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCHHH
Confidence            99999999999999999999999999998 999986432211                0001111111112223345579


Q ss_pred             HHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          405 AAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       405 ~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+++.+||+.+|++||++.||+++|+++++.
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=330.47  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=216.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++++.   .++.-.+++||++|..|+||||+.++.+|...+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46788889999999999999985 679999999998764   34445588999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||..+|.|++|+...+.    |++.++..++.||..|+.|+|.++   ++|||||.+|||+|+++++||+||||+..+.
T Consensus       132 MEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999998765    999999999999999999999999   9999999999999999999999999998876


Q ss_pred             cccCCccccccccCCCccccccccCCCCC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      +.   ....++||++-|.+||.+.+.+|. +.+|-||||++||.|+.|..||++.+-   ..++.               
T Consensus       205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---------------  263 (668)
T KOG0611|consen  205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---------------  263 (668)
T ss_pred             cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---------------
Confidence            53   557789999999999999999885 689999999999999999999986432   11111               


Q ss_pred             cCCcCCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          388 VDPSLQGQY-PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       388 ~d~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                        ..-++.| ....+....-||.+||..||++|-|+.+|..+   ++-||.-..
T Consensus       264 --QIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH---WWvNwgy~~  312 (668)
T KOG0611|consen  264 --QISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH---WWVNWGYNM  312 (668)
T ss_pred             --HhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh---heeeccccc
Confidence              1111222 12234467789999999999999999999876   666665543

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-42  Score=329.16  Aligned_cols=257  Identities=30%  Similarity=0.487  Sum_probs=213.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ...+|++.++||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45668888999999999999999888999999999877655566788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999976432  45899999999999999999999999   9999999999999999999999999997664321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  ......++..|+|||.+....++.++||||||+++|+|++ |+.||......                 .....+..
T Consensus       159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~  219 (261)
T cd05148         159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----------------EVYDQITA  219 (261)
T ss_pred             c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHHh
Confidence            1  1123345678999999988899999999999999999998 89999643211                 11111112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ......+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            222223344556899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-42  Score=330.48  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=208.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      .+|.+.+.||+|+||.||+|...+      +..+|+|.+...... ..+.+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999998643      478999998765444 4467899999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          227 LISEYMPNGTLQQHLHRHNN----------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      +||||+++++|.+++.....          ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999976532          2235789999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      +|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......          
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----------  231 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----------  231 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----------
Confidence            9999999876533222222233446788999999999999999999999999999998 99998643221          


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                             ...+.+........+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 -------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                   111111111111223344568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=336.04  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=205.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999975 58899999986532   223355788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999997643    4889999999999999999999999   99999999999999999999999999886543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......   .             ...+..
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~-------------~~~i~~  212 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---I-------------YEKILA  212 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHHh
Confidence            2     233568999999999999899999999999999999999999997543210   0             001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVK  434 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~  434 (457)
                      ..  ..++......+.+|+.+||+.||.+||+     +.+++++  .+++
T Consensus       213 ~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h--~~~~  258 (291)
T cd05612         213 GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH--RWFK  258 (291)
T ss_pred             CC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC--cccc
Confidence            11  1223333557899999999999999995     8898887  4454

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.2e-42  Score=336.22  Aligned_cols=274  Identities=22%  Similarity=0.333  Sum_probs=210.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367889999999999999999975 57889999886553 2334568899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.+.  |+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999997643    48899999999999999999998532  999999999999999999999999998765432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc------------ccc
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL------------PRL  378 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~------------~~~  378 (457)
                          ......|++.|+|||.+.+..++.++|||||||++|||++|+.||................            +..
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                1234568999999999999999999999999999999999999997533211000000000            000


Q ss_pred             -----------------CchhHHhhhcCCcCCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          379 -----------------TSREEAVEMVDPSLQGQ-YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       379 -----------------~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                                       .......+.+....... .......++.+|+.+||+.||++|||+++++++  .+++..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h--~~~~~~~~  309 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH--TFIKRSEV  309 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC--hHHhhccc
Confidence                             00000000000000011 111345689999999999999999999999998  67776544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4e-42  Score=341.03  Aligned_cols=273  Identities=23%  Similarity=0.384  Sum_probs=209.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .+|+..++||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566788999999999999965 589999999865432 3345688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+..        ...+..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986432        2567788899999999999999999   9999999999999999999999999998764321


Q ss_pred             CCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                        .......||..|+|||.+..     ...+.++|||||||++|||++|+.||..........              ...
T Consensus       223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--------------~~~  286 (353)
T PLN00034        223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS--------------LMC  286 (353)
T ss_pred             --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH--------------HHH
Confidence              11234578999999998743     234568999999999999999999997332211100              000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCccccCCCCcccCCCCCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPSPS  456 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (457)
                      ..........+.....++.+|+.+||+.+|++||++.|++++  .++.+....... ...+.++..++||
T Consensus       287 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h--p~~~~~~~~~~~-~~~~~~~~~~~~~  353 (353)
T PLN00034        287 AICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH--PFILRAQPGQGQ-GGPNLHQLLPPPR  353 (353)
T ss_pred             HHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC--cccccCCccccc-CCCCccCCCCCCC
Confidence            000001112233445589999999999999999999999998  788876555333 3445556666654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=343.83  Aligned_cols=268  Identities=24%  Similarity=0.414  Sum_probs=232.6

Q ss_pred             hHHHHHHhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          146 YKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       146 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      +++|+-...++....+||-|.||.||.|.|+. .-.||||.++.+.. ..++|..|..+|+.++|||+|+|+|+|..+-.
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            46777777888888999999999999999875 56799999987754 45678999999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      +|||+|||.+|+|.+||+....  ..++....++++.||+.||+||..++   +|||||..+|+|+.++..+|++||||+
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence            9999999999999999988553  34677788999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      +.+....+ .......-...|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+-                 +...
T Consensus       413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----------------dlSq  474 (1157)
T KOG4278|consen  413 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------------DLSQ  474 (1157)
T ss_pred             hhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----------------cHHH
Confidence            99865422 11222334568999999999999999999999999999999 77777642                 1245


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      +.++++..++.+.|+.|+..+++|++.||+++|.+||++.|+.+.++.++..++
T Consensus       475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            667788888888899999999999999999999999999999999999887543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.6e-42  Score=329.82  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=212.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++.++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777889999999999999842      345688999877665556678999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          228 ISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999976432            1234889999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  374 (457)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......         
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------  232 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---------  232 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence            99999999976544322222334456788999999999999999999999999999999 99998653221         


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                              ...+.+........+...+..+.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         233 --------EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --------HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                    01111111111112223455799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.4e-42  Score=329.75  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=205.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      ..++|++.+.||+|+||.||+|...      .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999998753      25679999886543 2334568889999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNR------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      .++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999999764321      234678899999999999999999998   999999999999999999999


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccc
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......            
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------------  228 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------------  228 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence            99999876543322222223345778999999998899999999999999999999 78888643221            


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                           ...+.+........+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 -----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 111110000011222334557999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-42  Score=325.85  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346688899999999999999998788889999986543 2345688899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999997644  235899999999999999999999999   9999999999999999999999999998765321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .. .......+..|+|||.+.+..++.++||||||+++|||+| |+.||......                 .....++.
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~  219 (261)
T cd05068         158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----------------EVLQQVDQ  219 (261)
T ss_pred             cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHc
Confidence            11 1111223457999999998899999999999999999999 99998753221                 11111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            111122334456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.4e-42  Score=331.61  Aligned_cols=266  Identities=24%  Similarity=0.400  Sum_probs=212.6

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCA  220 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~  220 (457)
                      +....++|++.+.||+|+||.||++...+      ...+|+|.+.... ......+.+|+++++.+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34455678889999999999999998642      3678999887542 33345688899999999 8999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                      .++..+++|||+++|+|.+++....            .....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            9999999999999999999997532            22346899999999999999999999998   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE  367 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~  367 (457)
                      |++.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......  
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  241 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  241 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence            999999999999999987654322222223345678999999988899999999999999999998 89988643221  


Q ss_pred             chhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                                     .....+........+..+...+.+|+.+||+.+|++|||+.++++.|+.+++
T Consensus       242 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         242 ---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence                           1111111111122333445689999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-42  Score=331.44  Aligned_cols=267  Identities=21%  Similarity=0.254  Sum_probs=202.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|+||.||+++.. +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999975 57889999886542  2233557889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++++.+..+....    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99887766544322    24889999999999999999999999   999999999999999999999999999876432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH-------
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE-------  383 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  383 (457)
                      .. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+...........+.....       
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            21 1223456899999999999889999999999999999999999999764332211111111111100000       


Q ss_pred             -HhhhcCCcCC------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 -AVEMVDPSLQ------GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 -~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ......+...      ..+....+..+.+|+.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000      01111245579999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=329.84  Aligned_cols=250  Identities=34%  Similarity=0.571  Sum_probs=197.0

Q ss_pred             CCceeccCCcEEEEEEEEc-----CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          158 EGNVIGNGGFGVVYKGVLS-----DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +.+.||.|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3478999999999999986     26689999996543 33467789999999999999999999999988889999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.++|....  ...+++.+++.|+.|++.||.|||+.+   ++|+||+++|||++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999862  235899999999999999999999998   9999999999999999999999999998763322


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .............|+|||.+.+..++.++||||||+++|||++ |+.||.....                 ....+.+..
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----------------~~~~~~~~~  220 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----------------EEIIEKLKQ  220 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----------------HHHHHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccccc
Confidence            2223334456778999999998889999999999999999999 6788764321                 111111122


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ......+..++..+.+++..||..+|++||++.++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            222223334566899999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-42  Score=339.92  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56788899999999999999975 58899999986542   123345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999997643    4888999999999999999999999   99999999999999999999999999986643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......                ....+..
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~  229 (329)
T PTZ00263        171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEKILA  229 (329)
T ss_pred             C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhc
Confidence            2     224578999999999999999999999999999999999999997432210                0011111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                      ..+  .++......+.+|+.+||+.||.+||+     +.+++++
T Consensus       230 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 GRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111  122223457899999999999999996     6888876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.3e-42  Score=323.97  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=207.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            357888899999999999999988888999999865432 3456889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999976432  35788899999999999999999998   99999999999999999999999999987643211


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       .......++..|+|||.+....++.++||||||+++|+|+| |+.||.......   ....              +...
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~--------------~~~~  220 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA--------------LQRG  220 (261)
T ss_pred             -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH--------------HHcC
Confidence             11222345678999999988889999999999999999998 999986432210   1100              0101


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      .........+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11111123445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=347.40  Aligned_cols=241  Identities=28%  Similarity=0.435  Sum_probs=206.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~  226 (457)
                      ..++|.++++||+|.||+|+++..+ +++.+|||.++++.   ..+.+....|.+++... +||.+++++.+|...+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4468999999999999999999975 57899999998873   44556677788888877 5999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+.||++..+.+.     ..+++..+..++..|+.||.|||+++   ||+||||.+|||+|.+|.+||+||||++.
T Consensus       446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            99999999995444332     24999999999999999999999999   99999999999999999999999999985


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .-.  .+...++.+|||.|||||++.+..|+..+|.|||||+|||||.|..||.+.+..                    +
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------------------e  575 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------------------E  575 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------H
Confidence            432  345678899999999999999999999999999999999999999999865431                    2


Q ss_pred             hcCCcCC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 012739          387 MVDPSLQ--GQYPKKDLIQIAAIAAVCVQPEAAYRPLM  422 (457)
Q Consensus       387 ~~d~~l~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~  422 (457)
                      ++|..+.  ..||.-.+.+...++.++|.++|++|..+
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2222222  24677778899999999999999999865

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.7e-42  Score=327.94  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|++.+.||+|+||.||+|..     .++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999984     246789999987543 3444678899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC
Q 012739          228 ISEYMPNGTLQQHLHRHNN-------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                      ||||+++++|.+++.....             ....+++.+++.++.|++.||.|||+++   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999864321             1235788999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~  373 (457)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....         
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---------  232 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---------  232 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            999999999987644322222333446778999999988889999999999999999998 9989864321         


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                              ....+.++.......+..++..+.+++.+||+.+|.+||++.+|+++|..
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 --------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                    11111111111112233445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3e-42  Score=337.76  Aligned_cols=242  Identities=25%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.||+|+||.||++... +++.+|+|++....   ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999986542   223345778999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      +|.+++....    .+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  151 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence            9999987643    4899999999999999999999999   999999999999999999999999998753221  122


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ  395 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  395 (457)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....             .+....  ..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~-------------~~~~~~--~~  213 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE-------------LILMEE--IR  213 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH-------------HHHcCC--CC
Confidence            34467999999999999999999999999999999999999999743211   0000             000000  12


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          396 YPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       396 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ++.....++.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            2334455789999999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=339.37  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 48899999986542   223355788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999997643    4889999999999999999999999   99999999999999999999999999976543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                           ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.          .....+.
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----------~~~~~~~  218 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----------YWKETLQ  218 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----------hcccccc
Confidence                 2345679999999999999999999999999999999999999997543211100000          0000011


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .............++.+++.+||+.+|.+||++.+++++
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000011335578999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=353.10  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=214.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCC-cEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEE-EEc------C
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDG-TVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGY-CAD------Q  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~-~~~------~  222 (457)
                      ...++++.++|.+|||+.||+|....+ ..+|+|++...++...+.+.+||++|+.|. |+|||.+++. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            445678889999999999999998766 999999998888888899999999999996 9999999993 211      2


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      -+++|.||||.||.|-+++..+...  .|++.++++|+.++++|+.+||... +||||||||-+||||+.++..||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence            3678999999999999999876553  3999999999999999999999985 789999999999999999999999999


Q ss_pred             CccccccccC-Ccc------ccccccCCCccccccc---cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh
Q 012739          303 LAKMVSDKIN-GQI------STRVLGTTGYLAPEYA---STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       303 l~~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~  372 (457)
                      .+........ ...      .-...-|+.|+|||++   .+..+++|+|||||||+||-||....||+....        
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------  263 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------  263 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence            9864322211 100      0112468899999987   577899999999999999999999999985422        


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                  ..+++-.+.-.-...+...|.+||..||+.||++||++-+|+..+.++...
T Consensus       264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                        122333332222246788999999999999999999999999999887653

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-41  Score=323.04  Aligned_cols=256  Identities=26%  Similarity=0.448  Sum_probs=208.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .+|.+.+.||+|+||.||+|... .++.+++|.+..+. .....+.+|+++++.++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45777889999999999999965 48889999886543 33456888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999976432  35899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |..||......                 +....+...
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~  221 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKG  221 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCC
Confidence            1 1112234568999999999999999999999999999998 89998643221                 111111112


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .....+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            222333445568999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-42  Score=353.95  Aligned_cols=259  Identities=23%  Similarity=0.338  Sum_probs=209.5

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC---
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN---  223 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~---  223 (457)
                      ....++|.+.+.||+|+||+||+|+. .+++.||+|++...  .......+.+|+..+..++|+||+++.+.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999985 46899999998654  2344456788999999999999999988765332   


Q ss_pred             -----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          224 -----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       224 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                           ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 367999999999999999876554567999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..        
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~--------  253 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EV--------  253 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HH--------
Confidence            9999998765443333345567999999999999999999999999999999999999999743210   00        


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                           ....... .....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       254 -----~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 -----MHKTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -----HHHHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                 0001110 0112233445689999999999999999999999875

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-41  Score=325.09  Aligned_cols=259  Identities=24%  Similarity=0.431  Sum_probs=205.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|++.+.||+|+||.||+|.+. ++.    .+++|++.... ......+..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999964 343    47788875442 2334567788889999999999999998864 45788


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ++||+++|+|.+++....   ..+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            999999999999997643   25899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......                 ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~  222 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----------------EVPD  222 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHH
Confidence            44322222334557788999999998899999999999999999998 99999754321                 0111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+........+..+...+.+++.+||..+|.+|||+.|+++.|..+.++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            11111111112223457888999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-41  Score=321.90  Aligned_cols=251  Identities=26%  Similarity=0.453  Sum_probs=202.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.+++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577788999999999999999888899999886543 234567889999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++.....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          83 NGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            9999999875432   4889999999999999999999999   99999999999999999999999999876533211 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....             + ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~-------------i-~~~~  218 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEM-------------I-SRGF  218 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-------------H-HCCC
Confidence            11122335568999999988899999999999999999999 899987533211   0000             0 0000


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1111222345789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=322.19  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             CCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-----
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH-----  224 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-----  224 (457)
                      |.+.+.||+|+||.||+|....    +..+|+|+++...  ......+..|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998642    3679999987542  3344578899999999999999999998866544     


Q ss_pred             -EEEEEEeCCCCcHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          225 -RLLISEYMPNGTLQQHLHRHNN--RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       225 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                       .++++||+++|+|..++.....  ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             7999999999999999865432  2235899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||......               
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------------  222 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------------  222 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------------
Confidence            99987654332222222345678999999988899999999999999999999 88888643211               


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                        +..+.+........+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         223 --EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             --HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence              111111111111233345668999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.1e-41  Score=373.89  Aligned_cols=266  Identities=27%  Similarity=0.524  Sum_probs=211.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ...+...++||+|+||.||+|.. .++..||+|++......    ...|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577888999999999999997 57899999998654322    23468899999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.+++..       ++|.++..++.|++.||+|||....++++||||||+||+++.++..++. ||.......  
T Consensus       765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            999999999953       8899999999999999999996544459999999999999999888875 665543321  


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                          .....+++.|+|||++.+..++.++|||||||++|||+||+.||+..... ......|....... ......+|+.
T Consensus       835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~  908 (968)
T PLN00113        835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD-CHLDMWIDPS  908 (968)
T ss_pred             ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc-cchhheeCcc
Confidence                12235789999999999999999999999999999999999999643222 22233343222211 2234455666


Q ss_pred             CCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          392 LQG--QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       392 l~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      +..  ..+.++..++.+++.+||+.+|++||+|.||++.|+++.+..+.
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence            543  33456777899999999999999999999999999999886543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-41  Score=325.58  Aligned_cols=263  Identities=22%  Similarity=0.356  Sum_probs=211.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~  225 (457)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     6889999887553 3344568889999999999999999998765 5678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNR----YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      ++++||+++++|.+++......    ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999764322    146899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+..   ...        
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--------  230 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA--------  230 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH--------
Confidence            99986644322222233456778999999988889999999999999999999 999997532210   111        


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                            .+........+..++..+.+++.+||+.+|++|||+.++++.|+++.++
T Consensus       231 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         231 ------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                  1111111111223445789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-42  Score=328.49  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      +|.+.+.||+|+||.||+|...+      +..||+|++....... ...+..|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35667889999999999998632      4789999997654332 3558889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          228 ISEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      ++||+++++|.+++....            .....+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999986421            11235888999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  374 (457)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.....          
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------  232 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----------  232 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence            99999999887644332222334456789999999988889999999999999999998 7888764321          


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                             .+..+.+.......++.+++..+.+++.+||+.+|.+||++++|++.|+.+
T Consensus       233 -------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  283 (283)
T cd05091         233 -------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW  283 (283)
T ss_pred             -------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence                   111111111111223445566899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-42  Score=336.98  Aligned_cols=251  Identities=25%  Similarity=0.421  Sum_probs=215.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-EEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH-RLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-~~lv~  229 (457)
                      ++|...+++|+|+||.+++++.+ ++..+++|++....  ....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46778899999999999998864 57789999886553  2223357789999999999999999999998888 99999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      +||+||+|.+.|....  ..-++++.++.++.|++.|+.|||+++   |+|||||+.|||++.++.+||+|||+++.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998765  345899999999999999999999888   99999999999999999999999999998876


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..                 .+...+.
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----------------~Li~ki~  219 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----------------ELILKIN  219 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----------------HHHHHHh
Confidence            43  2567789999999999999999999999999999999999999999865432                 2222222


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +......+..+..++..++..|++.+|..||++.+++.+
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            222335566677799999999999999999999999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=322.18  Aligned_cols=277  Identities=23%  Similarity=0.288  Sum_probs=220.5

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcc--cCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLH--RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-----  221 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~--~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-----  221 (457)
                      ......|...+.||+|+||.|+.+... +|..||||++.  .......+...+|+++|+.++|+||+.+++.+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344556666789999999999999964 68999999997  3455556777889999999999999999998854     


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      -+..|+|+|+| +.+|.+.|....    .++...+..++.|+++||.|+|+.+   ++||||||.|+|++.+..+||+||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence            45789999999 679999987754    3999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ||++...........+..+.|.+|+|||++. ...|+...||||+||||.||++|++-|.+.+.-.+..++....+....
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            9999886543334457788999999999874 578999999999999999999999999987765555555444443321


Q ss_pred             hhHHhhhc--------C---CcCCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 REEAVEMV--------D---PSLQG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 ~~~~~~~~--------d---~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                       +....+-        .   ..-..    -++ .......+|+.+||..||.+|+|++|.+++  ..+.....
T Consensus       250 -e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h--PYl~~~hd  318 (359)
T KOG0660|consen  250 -EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH--PYLAPYHD  318 (359)
T ss_pred             -HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC--hhhhhhcC
Confidence             1111111        0   00000    111 334578899999999999999999999998  66665443

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-41  Score=329.10  Aligned_cols=264  Identities=24%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      .++|.+.+.||+|+||.||++...        +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            457889999999999999999852        23569999987542 33345678899999999 799999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNR------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      +..++||||+++|+|.+++......            ...+++.+++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            9999999999999999999864321            135889999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcch
Q 012739          291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHV  369 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~  369 (457)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999876543221111222234568999999988889999999999999999998 8888864321     


Q ss_pred             hhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                                  .+....+........+.....++.+++.+||+.+|++||++.+|++.|+++++..
T Consensus       249 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 ------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                        1111111111122233345568999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=337.80  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=223.4

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcC---C--cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSD---G--TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~---~--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      +...+.....+.||+|.||.||+|.+.+   |  -.||||..+.+ .....+.|..|..+|+.++||||++++|+|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3444556667899999999999999643   2  35899999886 445566799999999999999999999999865 


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..|||||.++.|.|..||+.+..   .++......++.||+.||.|||+.+   +|||||..+|||+....-+||+||||
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence            68999999999999999998765   4888999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ++.+.+..+.... ...-...|||||.+...+++.+||||-||+.+||++. |..||..-..                 .
T Consensus       538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------s  599 (974)
T KOG4257|consen  538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------S  599 (974)
T ss_pred             hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------c
Confidence            9999876654433 4455678999999999999999999999999999887 9999985332                 2


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +++..++..-+...|+.|+..|..|+.+||..+|.+||++.|+...|++++++
T Consensus       600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            33344444455578888999999999999999999999999999999999884

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-41  Score=340.31  Aligned_cols=266  Identities=26%  Similarity=0.398  Sum_probs=211.2

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLH-SPQLVELLGYCA  220 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~  220 (457)
                      +....++|.+.++||+|+||.||+|++.      .+..||+|++..... ...+.+..|++++..+. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4455567888999999999999999863      246799999976532 22346888999999997 999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCC------------------------------------------------------
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNN------------------------------------------------------  246 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  246 (457)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999975421                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccC
Q 012739          247 ----------------------------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS  286 (457)
Q Consensus       247 ----------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~  286 (457)
                                                              ....+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124678888999999999999999998   999999999


Q ss_pred             ceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCC
Q 012739          287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP  365 (457)
Q Consensus       287 NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~  365 (457)
                      |||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533221112223456788999999998889999999999999999998 88898643211


Q ss_pred             CcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          366 GEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                                      +.....+........+......+.+++.+||+.+|.+||++++|++.|++++
T Consensus       349 ----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 ----------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                            1111111112222233344568999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-41  Score=319.21  Aligned_cols=248  Identities=24%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999974 68899999876543 33445688999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++.............
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99997543   24889999999999999999999999   9999999999999999999999999987654321111111


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQY  396 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  396 (457)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||......                 .....+........
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVRLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCCC
Confidence            1223457999999998899999999999999999998 88888643211                 11111111222233


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          397 PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       397 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3445568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.3e-41  Score=320.94  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=200.6

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCc---EEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------Ce
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGT---VAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------NH  224 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~  224 (457)
                      |.+.+.||+|+||.||+|.+.+..   .+|+|.++..  .....+.+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            346788999999999999975432   5899988654  234456688899999999999999999987432      24


Q ss_pred             EEEEEEeCCCCcHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          225 RLLISEYMPNGTLQQHLHRHN--NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      .+++|||+++|+|.+++....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885432  22345899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCch
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   ...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----------  224 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----------  224 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----------
Confidence            9987654322112223346678999999999999999999999999999999 78888643211   000          


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                          +.+...-....+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         225 ----DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                000000001122234557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-42  Score=337.54  Aligned_cols=246  Identities=24%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC--CcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD--GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|.+.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568888999999999999998643  3689999886432   2233457889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999997643    4899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..             ...+
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~-------------~~~i  240 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LI-------------YQKI  240 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HH-------------HHHH
Confidence            322     23457999999999999888999999999999999999999999753221   00             0011


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      .....  .++......+.+++.+||+.+|++|+     ++++++++
T Consensus       241 ~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        241 LEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             hcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11111  12333345788999999999999995     89999887

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.5e-41  Score=331.54  Aligned_cols=272  Identities=23%  Similarity=0.360  Sum_probs=208.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467899999999999999999975 57888999876542 3334568899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+. +   ++|+||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999997643    488899999999999999999974 5   99999999999999999999999999876533


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh------hh----ccccC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS------WA----LPRLT  379 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~------~~----~~~~~  379 (457)
                      .    ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.............      ..    .+...
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            2    1233568999999999998899999999999999999999999997533211100000      00    00000


Q ss_pred             c-----------------hhHHhhhcCCcCCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          380 S-----------------REEAVEMVDPSLQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       380 ~-----------------~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .                 .......+........+ .....++.+|+.+||+.||++|||+.|++++  .++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~~~~  306 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIKRSE  306 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHhcCc
Confidence            0                 00000000000000011 1134578999999999999999999999987  7887654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-43  Score=306.49  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=212.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++++.||+|-||.||.|+.+ ++..||+|++.+..   .....++++|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467889999999999999999964 57899999987653   22346789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||.++|.|...|.....  ..+++.....++.|+|.||.|+|.++   ++||||||+|+|++.++.+||+|||.+....
T Consensus       101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999999986443  35888899999999999999999999   9999999999999999999999999986543


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                          .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||......                +...++.
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~  235 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR  235 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH
Confidence                22346689999999999999999999999999999999999999999864311                1111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .-.+  .+|........++|.+|+..+|.+|.+..|++.+  .++..
T Consensus       236 k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h--pwI~a  278 (281)
T KOG0580|consen  236 KVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH--PWIVA  278 (281)
T ss_pred             Hccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh--HHHHh
Confidence            1111  2234445588999999999999999999999987  55543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=328.60  Aligned_cols=257  Identities=25%  Similarity=0.361  Sum_probs=203.9

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--------------HHHHHHHHHHHHHhcCCCCee
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--------------RERAFRMEVDLLSRLHSPQLV  213 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------------~~~~~~~Ei~~l~~l~hpniv  213 (457)
                      -....++|++.+.||+|.||.|-+|... +++.||||++.+....              ..+...+||.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3445578999999999999999999954 6899999998654211              124678999999999999999


Q ss_pred             eEEEEEEc--CCeEEEEEEeCCCCcHHHHHhhhCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          214 ELLGYCAD--QNHRLLISEYMPNGTLQQHLHRHNNRYRP-LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       214 ~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      +|+.+..+  .+.+|||+|||..|.+...-..     ++ +++.++++++.+++.||+|||.++   ||||||||+|+||
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            99999865  5689999999998877543211     23 899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccc---cCCccccccccCCCccccccccCCC----CCcccchHHHHHHHHHHHcCCCCCCCCC
Q 012739          291 DQNFRAKVTDFGLAKMVSDK---INGQISTRVLGTTGYLAPEYASTGK----LTTKSDVYSYGVVLLELLTGRVPVDPNR  363 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlG~il~elltg~~p~~~~~  363 (457)
                      +++|.+||+|||.+......   ..........|||.|+|||++.++.    .+.+.||||+||+||.|+.|+.||....
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            99999999999998766322   1122334478999999999987632    3467899999999999999999998532


Q ss_pred             CCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          364 PPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ..                +....++...+.-...++....+.+||.+||++||+.|.+..+|..+.
T Consensus       324 ~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 EL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            21                112233333333222234567899999999999999999999999883

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-41  Score=323.47  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=205.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|.+.+.||+|+||.||+|.+.+      +..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4668888999999999999999753      5678999886543 33345688899999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC---cEEEe
Q 012739          226 LLISEYMPNGTLQQHLHRHNN---RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF---RAKVT  299 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  299 (457)
                      ++||||+++++|.+++.....   ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999977532   1235899999999999999999999999   99999999999998654   59999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......             
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------------  228 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------------  228 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence            9999987633221111222334568999999998999999999999999999997 99998753321             


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                          .....+........+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                111111111122333444568999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.6e-41  Score=327.15  Aligned_cols=265  Identities=23%  Similarity=0.378  Sum_probs=211.0

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCA  220 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~  220 (457)
                      ....+|.+.+.||+|+||.||++...        ++..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567888899999999999999741        24578999886542 33446688999999999 8999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                      .....++||||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+.+   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            99999999999999999999986432            1235788899999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE  367 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~  367 (457)
                      +++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence            999999999999999987644322222233446678999999988889999999999999999998 78887643211  


Q ss_pred             chhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                     +..+.+........+..++..+.+++.+||+.+|.+||++.++++.|++++.-
T Consensus       247 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ---------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                           11111111111122334556899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-41  Score=333.21  Aligned_cols=242  Identities=26%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.||+|+||.||++... ++..||+|++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999986542   233345678999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      +|..++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~  151 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence            9998887643    4899999999999999999999999   999999999999999999999999998753221  112


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ  395 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  395 (457)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   .             .........  .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~-------------~~~~~~~~~--~  213 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L-------------FELILMEEI--R  213 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHhcCCC--C
Confidence            234578999999999999999999999999999999999999997532210   0             001111111  2


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          396 YPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       396 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ++......+.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            2333455789999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.1e-41  Score=324.22  Aligned_cols=265  Identities=23%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999753      245799998865532 23345788999999999999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNN------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                      ..++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+++   ++||||||+|||+++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999976432      1234677888999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......           
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----------  228 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----------  228 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence            999999886543222222223345678999999998899999999999999999998 78888643211           


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                            +....+........+...+..+.+++.+||+.+|++|||+.++++.|++.+..
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         229 ------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence                  11111100001112223346899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.8e-41  Score=317.58  Aligned_cols=259  Identities=24%  Similarity=0.356  Sum_probs=210.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...   .......+..|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999964 6889999987542   2333456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++.....+...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999998764444456889999999999999999999999   99999999999999999999999999886643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......+++.|+|||.+.+..++.++|+||||+++|||++|+.||........               .....+.
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------------~~~~~~~  221 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---------------SLCQKIE  221 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---------------HHHHHHh
Confidence            21  112335688899999999888899999999999999999999999864322100               1111111


Q ss_pred             C-cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          390 P-SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       390 ~-~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      . .............+.+++.+||+.+|++||++.+|++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1 111112234556899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-41  Score=326.80  Aligned_cols=266  Identities=22%  Similarity=0.293  Sum_probs=201.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|.+.++||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999865 588999998865422 2234567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++....   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            96 58999887543   24788999999999999999999999   9999999999999999999999999987643221


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh--------ccccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA--------LPRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  382 (457)
                        .......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...............        ++......
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              12234567899999998865 56899999999999999999999999754332111111100        01111111


Q ss_pred             HHhhhcCCcCCCCC----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQGQY----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+......    ......++.+|+.+||+.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11111111111100    11224578899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=317.86  Aligned_cols=372  Identities=21%  Similarity=0.275  Sum_probs=271.7

Q ss_pred             cCCCCCCcccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCccCcC--CCCCCCCCC-----CCccceecc
Q 012739           26 NNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSEDSH--GSSFKDNKS-----GSSRFIAHM   98 (457)
Q Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~li~~~~~~~~~rr~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~   98 (457)
                      +.+.+..++.+.-+..+...++++++++++++++++++++++..+.+|+......  .+.+....+     .++.+....
T Consensus       167 ~~~~~~~~~~v~~p~s~~~~f~V~v~va~a~v~lva~il~c~~~~s~Kr~~~~~~i~tSs~~~l~~~qps~~st~y~~P~  246 (563)
T KOG1024|consen  167 DDFDPMLRENVVPPASGLVTFIVGVIVALALVSLVALILYCAKGPSKKRSNGVHLIKTSSFQRLPTIQPSAHSTIYVTPS  246 (563)
T ss_pred             ccccccccccccCCCcccEEEeeeHHHHHHHHHHHHHHHHHHhcccchhhccCcccchhhhhcCCcCCccccCCcccCCC
Confidence            3356777788888888888888888888888877777777776665554221111  111111100     001111000


Q ss_pred             cccCCCCCCCCCcccCCCccccCCCCCCCCcccccccccCCceeeechHHHHHHhcCCCCCceeccCCcEEEEEEEEc--
Q 012739           99 TINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLS--  176 (457)
Q Consensus        99 ~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--  176 (457)
                      ++...++...       .....+...+..|..           -.-..+++.....+++...++-+|.||.||+|.+.  
T Consensus       247 t~tpi~sap~-------~r~~~ns~~~~~p~e-----------~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE  308 (563)
T KOG1024|consen  247 TITPIYSAPL-------TRSSPNSEYEHEPEE-----------FNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE  308 (563)
T ss_pred             ccccccCCCc-------ccCCCCccccCChHH-----------HhhhHHhhhhhhhheechhhhhcCchhheeeeeeccc
Confidence            0000000000       000000000111100           01123456666778888999999999999999654  


Q ss_pred             ----CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEEEeCCCCcHHHHHhhhC----C
Q 012739          177 ----DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHRLLISEYMPNGTLQQHLHRHN----N  246 (457)
Q Consensus       177 ----~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~----~  246 (457)
                          +.+.|.+|.++....+ ....+..|.-++..+.|||+..+.+++.+ ....+++++++.-|+|..||...+    .
T Consensus       309 dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~  388 (563)
T KOG1024|consen  309 DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPS  388 (563)
T ss_pred             CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCc
Confidence                3456778888766433 34568889999999999999999998855 456788999999999999998422    2


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCcc
Q 012739          247 RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL  326 (457)
Q Consensus       247 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~  326 (457)
                      ..+.+...+...++.|++.|++|||+.+   +||.||..+|++|++...+||+|-.+++.+.+.++.....+......||
T Consensus       389 ~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWM  465 (563)
T KOG1024|consen  389 YAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWM  465 (563)
T ss_pred             cccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCccccc
Confidence            3456888899999999999999999999   9999999999999999999999999999999988888888888899999


Q ss_pred             ccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHH
Q 012739          327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIA  405 (457)
Q Consensus       327 aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  405 (457)
                      +||.+....|+.++||||||++||||+| |+.|+..-++.                 +....+.+..+-..|.+|++++.
T Consensus       466 slEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-----------------Em~~ylkdGyRlaQP~NCPDeLf  528 (563)
T KOG1024|consen  466 SLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-----------------EMEHYLKDGYRLAQPFNCPDELF  528 (563)
T ss_pred             CHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-----------------HHHHHHhccceecCCCCCcHHHH
Confidence            9999999999999999999999999999 89999865542                 33334444555566778899999


Q ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          406 AIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       406 ~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .++.-||...|++||++.|++.-|.++--+
T Consensus       529 ~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  529 TVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             HHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            999999999999999999999999876543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.9e-41  Score=327.24  Aligned_cols=267  Identities=23%  Similarity=0.384  Sum_probs=211.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      ...+|.+.+.||+|+||.||++...        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467888999999999999999742        24568999887543 33445688899999999 69999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      .+..+++|||+++|+|.+++.....            ....+++.++..++.|++.||.|||+.+   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            9999999999999999999976431            1235889999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 012739          290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEH  368 (457)
Q Consensus       290 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~  368 (457)
                      ++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......   
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---  243 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---  243 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999986643222221222334567999999988899999999999999999999 88888643221   


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                                    +..+.+........+..++.++.+++.+||+.+|++||++.++++.|.++......
T Consensus       244 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         244 --------------ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             --------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence                          11111111111122334455889999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-42  Score=314.46  Aligned_cols=271  Identities=22%  Similarity=0.277  Sum_probs=213.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHH--HHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE--RAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lv  228 (457)
                      +.|+.++.|++|+||.||+|+++ +++.||+|+++.+....-  -.-.+||.+|.+.+|||||.+..+...  -+..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777889999999999999964 688999999976632111  224679999999999999999988743  4579999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||||+. +|...+....   +++...++..++.|+++|++|||+..   |+|||||++|+|++..|.+||+||||++.++
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            999964 8999998866   46899999999999999999999999   9999999999999999999999999999987


Q ss_pred             cccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch------
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR------  381 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  381 (457)
                      ...  ...+..+.|.+|+|||++.+ ..|+...|+||+|||+.||+++++-|.+....++...+...+....+.      
T Consensus       229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            653  33567788999999998876 579999999999999999999999999877655554443332222111      


Q ss_pred             --hHHh-----hhcCCcCCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 --EEAV-----EMVDPSLQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 --~~~~-----~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        ..+.     ...-..++..++.. ....-.+|+..+|..||.+|.|+.|.+++  .++++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e  366 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRE  366 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--ccccc
Confidence              0000     00000111112111 34577899999999999999999999998  88877

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=330.88  Aligned_cols=240  Identities=25%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||+|+||.||++... ++..||+|++...   .......+..|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 5788999998643   223345577899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            99997643    4899999999999999999999999   9999999999999999999999999987543221  2234


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......                ..........  .++
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------------~~~~~~~~~~--~~~  213 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------------MYRKILQEPL--RFP  213 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------------HHHHHHcCCC--CCC
Confidence            4679999999999999999999999999999999999999997532110                0011111111  233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPL---MTDVVQS  428 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~  428 (457)
                      ......+.+++.+||+.||.+||+   +.+++++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            344567899999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-42  Score=323.83  Aligned_cols=268  Identities=25%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----eEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~lv  228 (457)
                      .|...+++|.|+||.||+|... +++.||||++..+.+..    .+|+++|+.++|||||+++-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999965 47999999997775433    35999999999999999998885422     34589


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCcccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMV  307 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~~~~  307 (457)
                      ||||+ .+|.++++......+.++...+..+.+||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99996 5999999875444456888888999999999999999999   9999999999999976 99999999999988


Q ss_pred             ccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh-
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV-  385 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  385 (457)
                      ...   ........|..|+|||++.+ ..|+.+.||||.||++.||+-|++-|.+....++...+..++...... ++. 
T Consensus       177 ~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e-~I~~  252 (364)
T KOG0658|consen  177 VKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE-DIKS  252 (364)
T ss_pred             ccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH-HHhh
Confidence            653   22355667889999999876 689999999999999999999999998866555544444444333321 111 


Q ss_pred             ------hhcCCcCCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          386 ------EMVDPSLQGQ-----YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       386 ------~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                            +...+.+...     .......+..+|+.++++.+|.+|.++.|++.+  ++..+.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdel  312 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDEL  312 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHh
Confidence                  1111222221     233456789999999999999999999999987  555543

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.4e-41  Score=319.21  Aligned_cols=252  Identities=28%  Similarity=0.432  Sum_probs=203.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577888999999999999998777789999887543 234568889999999999999999999999889999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++.....   .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            9999999976432   5899999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......                 ....+....
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~  218 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----------------TVEKVSQGL  218 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHhcCC
Confidence            11122335678999999988889999999999999999999 999986432210                 000000111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11112223568999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-41  Score=322.88  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|.+.+.||+|+||.||+|...+      +..+++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578888999999999999998643      4689999986553 23345688899999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEe
Q 012739          226 LLISEYMPNGTLQQHLHRHNNR------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT  299 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  299 (457)
                      ++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999999764321      224788999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++|||+| |+.||.......            
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------------  229 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------------  229 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------------
Confidence            9999886654332222334456789999999988889999999999999999998 899986432211            


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                           ....+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 -----VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                 11111111111223334568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.7e-41  Score=323.83  Aligned_cols=262  Identities=29%  Similarity=0.443  Sum_probs=207.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-C--cEEEEEEcccC-chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-G--TVAAIKKLHRD-GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.++||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568889999999999999998754 3  24788887643 233445688899999999 799999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          229 SEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      +||+++++|.+++.....            ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999976431            1135889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||++.......   .......+..|+|||.+....++.++|||||||++|||++ |..||......          
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----------  225 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----------  225 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence            999999986432111   1111223457999999988899999999999999999998 99999753221          


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                             .....+........+...+..+.+|+.+||+.+|.+||++.++++.|+++++....
T Consensus       226 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         226 -------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                   11111111122223334456899999999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-41  Score=331.67  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=197.7

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.||+|+||.||++... ++..+|+|++....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 58899999986542   233456778999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      +|..++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  151 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT  151 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence            9999886543    4899999999999999999999999   999999999999999999999999998754221  112


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ  395 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  395 (457)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   ....           ....+.    .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~-----------~~~~~~----~  213 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL-----------ILMEDI----K  213 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHH-----------hccCCc----c
Confidence            334679999999999999999999999999999999999999997432210   0000           000011    2


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          396 YPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       396 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ++.....++.+++.+||+.||.+||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2333455789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.6e-41  Score=320.73  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=206.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ..+|++.++||+|+||.||+|.+. ++.    .||+|.+.... ....+.+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356788899999999999999853 343    48999886543 33445688899999999999999999999764 468


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +++||+++|+|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence            9999999999999997643   24899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      +.............++..|+|||.+.+..++.++|||||||++|||++ |..||......                 ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~  221 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----------------EIP  221 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence            643222111222345678999999988899999999999999999998 89998643211                 111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..+........+...+..+.+++.+||+.||+.||++.++++.|+++.++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            111111111222334557899999999999999999999999998887665

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.6e-41  Score=321.95  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=206.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|...++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56778899999999999999742      356789998876666666779999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          228 ISEYMPNGTLQQHLHRHNNR-----------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      +|||+++++|.+++......           ...+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            99999999999999764321           124889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......         
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------  232 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---------  232 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---------
Confidence            9999999876543222122233345678999999999999999999999999999998 899986432211         


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                              ....+........+..++..+.+++.+||+.+|.+||++++|++.|+
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 --------AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --------HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                    01111111111122234457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-41  Score=332.06  Aligned_cols=265  Identities=25%  Similarity=0.389  Sum_probs=206.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc-C
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD-Q  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-~  222 (457)
                      ..++|++.+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++..+ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346789999999999999999973      346789999997643 33345688899999999 68999999998865 4


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCC-------------------------------------------------------
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNR-------------------------------------------------------  247 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  247 (457)
                      ...+++|||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5678999999999999998753210                                                       


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccccc
Q 012739          248 --------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV  319 (457)
Q Consensus       248 --------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  319 (457)
                              ...+++.++..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    124688889999999999999999999   999999999999999999999999998865432221122233


Q ss_pred             ccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCH
Q 012739          320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK  398 (457)
Q Consensus       320 ~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  398 (457)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||........                ....+........+.
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~  305 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRMRAPD  305 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----------------HHHHHhccCCCCCCC
Confidence            45678999999988899999999999999999997 8999864322100                000111111111111


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          399 KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       399 ~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....++.+++..||+.+|++||++.+|+++|+++++.
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            2334789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-41  Score=332.93  Aligned_cols=274  Identities=23%  Similarity=0.321  Sum_probs=202.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHRL  226 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~~  226 (457)
                      +|++.++||+|+||.||+|... ++..||+|++...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999964 6899999998643  223344678899999999999999999988543     3579


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+ +++|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence            999999 478998886543    4899999999999999999999999   99999999999999999999999999986


Q ss_pred             cccccCC-ccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc------
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR------  377 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------  377 (457)
                      ....... .......||+.|+|||++.+  ..++.++|||||||++|||+||+.||..................      
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            5332211 12234578999999999865  67899999999999999999999999754321110000000000      


Q ss_pred             --cCc--hhHHhhhcCCcCCCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          378 --LTS--REEAVEMVDPSLQGQYP---KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       378 --~~~--~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        +..  .......+.+.......   ......+.+++.+||+.+|++|||+.|++++  +++++...
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h--p~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD--PYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC--chhhhcCc
Confidence              000  00001111111100000   1123468899999999999999999999997  77765433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9e-41  Score=317.37  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=205.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ..+|++.++||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356889999999999999999987777899999875432 23568889999999999999999998754 5679999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.......
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999976432  35789999999999999999999999   99999999999999999999999999976643321


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       .......++..|+|||...+..++.++||||||+++|||+| |..||......                 .........
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----------------~~~~~~~~~  219 (262)
T cd05071         158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERG  219 (262)
T ss_pred             -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----------------HHHHHHhcC
Confidence             11223345678999999988899999999999999999999 88888643221                 000111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .....+.+.+..+.+++.+|++.+|++||++.++++.|++++
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            111223345568999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.9e-41  Score=318.05  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=205.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457888999999999999999988888999999875433 2356889999999999999999999885 45679999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          83 SKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999976432  35889999999999999999999999   99999999999999999999999999976543221


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |..||......                 +..+.+...
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~  219 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----------------EVLEQVERG  219 (260)
T ss_pred             c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcC
Confidence            1 1122335668999999988899999999999999999999 88998643211                 111111112


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      .....+...+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            22233444556899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-41  Score=330.12  Aligned_cols=242  Identities=26%  Similarity=0.405  Sum_probs=196.8

Q ss_pred             ceeccCCcEEEEEEEE----cCCcEEEEEEcccCc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +.||+|+||.||+++.    .+++.||+|.+....    ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    357899999986532    12234567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....    .+.+..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            99999999987643    4788889999999999999999999   999999999999999999999999998754321 


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       ........||+.|+|||++.+..++.++||||||+++|||++|+.||......                .....+....
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~~~~~  216 (323)
T cd05584         154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKILKGK  216 (323)
T ss_pred             -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence             12233457999999999999888999999999999999999999999753221                0111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      .  ..+......+.+++.+||+.+|++||     ++.+++++
T Consensus       217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1  22333445789999999999999999     88888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-40  Score=319.26  Aligned_cols=268  Identities=28%  Similarity=0.425  Sum_probs=206.4

Q ss_pred             CCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLL  227 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l  227 (457)
                      |+..+.||+|+||+||++..     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     3577899999876532 3345688899999999999999999988653  46889


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      +|||+++++|.+++...     .+++.+++.++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999999653     3899999999999999999999999   999999999999999999999999999866


Q ss_pred             ccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+||..||......-. .......... ......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~  235 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIE  235 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhhh
Confidence            4322111 11223456679999999888999999999999999999999999864322110 0111110000 0111222


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ..+.......+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22222322334455678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.6e-41  Score=337.59  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=197.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .|...+.||+|+||+||+|+.. +++.+|+|++....   ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 57899999986542   2334568889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999987643    4888999999999999999999999   999999999999999999999999997643210


Q ss_pred             cC---------------------------------------------CccccccccCCCccccccccCCCCCcccchHHH
Q 012739          311 IN---------------------------------------------GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY  345 (457)
Q Consensus       311 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~Sl  345 (457)
                      ..                                             ........||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             001123579999999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC--CcCCCCCCHHHHHHHHHHHHh--hcCCCCCCCCC
Q 012739          346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD--PSLQGQYPKKDLIQIAAIAAV--CVQPEAAYRPL  421 (457)
Q Consensus       346 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~--cl~~~p~~RPs  421 (457)
                      ||++|||+||+.||........                ...+.+  ..+..........++.+|+.+  |+..++..||+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~  298 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTET----------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG  298 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHH----------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence            9999999999999975432111                001111  011111111234467788877  45566667999


Q ss_pred             HHHHHHH
Q 012739          422 MTDVVQS  428 (457)
Q Consensus       422 ~~evl~~  428 (457)
                      +.+++++
T Consensus       299 ~~~~l~h  305 (381)
T cd05626         299 ADDIKAH  305 (381)
T ss_pred             HHHHhcC
Confidence            9999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.8e-41  Score=325.50  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=196.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc--CCcEEEEEEcccCch--HHHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----c
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS--DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRL---HSPQLVELLGYCA-----D  221 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~-----~  221 (457)
                      ++|++.+.||+|+||.||+|...  ++..||+|++.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  467899998865421  1223455677776665   6999999999885     3


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      ....++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999995 699999876432  35889999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |+++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+....... ..
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-~~  230 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GE  230 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Ch
Confidence            999765432   22345568999999999988899999999999999999999999998654321111110000000 00


Q ss_pred             hHH---hhhcCCcCCC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEA---VEMVDPSLQG-------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~---~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...   .......+..       ....+....+.+|+.+||+.+|++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000   0000000000       0111234578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-41  Score=316.84  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=202.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999987778899998865432 23457789999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999999976432   5899999999999999999999999   999999999999999999999999998765432111


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......                 ....+....
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~  218 (256)
T cd05059         157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----------------VVESVSAGY  218 (256)
T ss_pred             -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence             1111223457999999998999999999999999999999 899987432211                 001111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1122333456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.5e-40  Score=313.45  Aligned_cols=260  Identities=26%  Similarity=0.405  Sum_probs=211.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|... +++.+++|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 7899999988542   2233456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++.........+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999999765444456899999999999999999999999   99999999999999999999999999876543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......    .           ....+.+.
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~-----------~~~~~~~~  221 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-----------YSLCKKIE  221 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----H-----------HHHHhhhh
Confidence            21  1123346888999999998888999999999999999999999998643211    0           01111111


Q ss_pred             CcCCCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          390 PSLQGQYPK-KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       390 ~~l~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .......+. .....+.+++.+||..+|++||++.+|++.|+++-
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111112222 45568999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-41  Score=330.90  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=199.9

Q ss_pred             CCCCCceeccCCcEEEEEEEE----cCCcEEEEEEcccCc----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~  225 (457)
                      +|++.+.||+|+||.||+++.    .++..+|+|++....    ....+.+..|+.+++.+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999885    357899999986432    12234577899999999 589999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999997643    4899999999999999999999999   9999999999999999999999999988


Q ss_pred             ccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ....... .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||............          ...
T Consensus       154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----------~~~  222 (332)
T cd05614         154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----------SRR  222 (332)
T ss_pred             cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH----------HHH
Confidence            6533221 122345799999999998765 4789999999999999999999999743321111000          000


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ....++.    .+......+.+++.+||+.||++||     ++.+++++
T Consensus       223 ~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         223 ILKCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HhcCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0111222    2233445789999999999999999     77788876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-40  Score=315.46  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=198.5

Q ss_pred             eeccCCcEEEEEEEE---cCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          161 VIGNGGFGVVYKGVL---SDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      .||+|+||.||+|.+   .++..+|+|++....  ....+.+..|+.+++.++||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975   357889999886543  2334568899999999999999999998864 4678999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      +|.+++....    .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.+||+|||+++.+........
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999997543    4889999999999999999999999   99999999999999999999999999987644322111


Q ss_pred             -ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          316 -STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       316 -~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.||......                 .....++....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i~~~~~  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMIESGER  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHCCCC
Confidence             122234578999999988889999999999999999998 99999753221                 11112222222


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ...+...+.++.+++.+||+.||++||++.+|.+.|+++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            233444556899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=323.34  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=208.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      ..++|.+.+.||+|+||.||++...      .+..+|+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467888999999999999999742      34579999887553 33345688999999999 7999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||+++|+|.+++.....  ..+++.++..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999976432  23899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......                
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----------------  251 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----------------  251 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----------------
Confidence            986543322112223345778999999999999999999999999999998 999987432211                


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .....+........+...+.++.+++.+||+.+|++||++.++++.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            111111111111122233457999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.3e-41  Score=324.91  Aligned_cols=272  Identities=19%  Similarity=0.276  Sum_probs=202.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|.+.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999975 688999999865432 223356789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++ ++|.+++....   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            994 68888886543   24888999999999999999999999   999999999999999999999999998754322


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhccccCchh--H--H
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTSRE--E--A  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~--~--~  384 (457)
                      .  .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .............  .  .
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            1  12234568899999998865 468899999999999999999999997543211100 0000000000000  0  0


Q ss_pred             hhhcCCc-CCCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPS-LQGQYPK---------KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~-l~~~~~~---------~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+++. +....+.         .....+.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h--~~f~~  293 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH--EYFSD  293 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC--ccccc
Confidence            0000000 0000000         123468899999999999999999999987  66654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.9e-41  Score=320.65  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=202.4

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||+|+||+||++... +++.+|+|++.....   ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 688999999865422   2234567899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      ..++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            9888654444456899999999999999999999999   9999999999999999999999999987654321  1223


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||..........            ..........  ..++
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~~--~~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILNDS--VTYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhcccC--CCCc
Confidence            4578999999999999999999999999999999999999997543211100            0001111111  1233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhh
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKN  435 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~  435 (457)
                      ...+..+.+++.+||+.+|++||     ++.+++++  +++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h--~~~~~  262 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH--PLFRD  262 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC--hhhhc
Confidence            44556899999999999999999     77888876  55554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-40  Score=316.18  Aligned_cols=257  Identities=26%  Similarity=0.467  Sum_probs=205.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-C---cEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-G---TVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .+|+..+.||+|+||.||+|.... +   ..+++|++.... ....+.+..|+++++.++||||+++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467778999999999999999742 3   379999986553 33345688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....   ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999997643   24899999999999999999999999   9999999999999999999999999987664


Q ss_pred             cccCCccc-cccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKINGQIS-TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ........ .....+..|+|||.+....++.++||||||+++|||++ |+.||......                 +...
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----------------~~~~  221 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----------------EVMK  221 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----------------HHHH
Confidence            32211111 11223457999999988889999999999999999998 99998643211                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .+........+.+.+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       222 ~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11111111223344568999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-40  Score=323.66  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=207.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc--EEEEEEcccC-chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT--VAAIKKLHRD-GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.+.||+|+||.||+|.+. ++.  .+++|.+... .......+.+|++++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56788899999999999999964 343  4677776543 233445688899999999 899999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          229 SEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      |||+++++|.+++.....            ....+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999976432            1235889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||+| |..||......          
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------  230 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------  230 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----------
Confidence            999999986432110   1111234567999999988889999999999999999998 99998643221          


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                             +..+.+........+...+..+.+|+.+||+.+|++||++.++++.|++++.+...
T Consensus       231 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         231 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             -------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence                   01111111111122223445789999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=336.59  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999975 68999999986542   233456888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999998752    4899999999999999999999999   99999999999999999999999999986644


Q ss_pred             cc---------------------------CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 012739          310 KI---------------------------NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN  362 (457)
Q Consensus       310 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~  362 (457)
                      ..                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                           001223456899999999999999999999999999999999999999754


Q ss_pred             CCCCcchhhhhhccccCchhHHhhhcC--CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 012739          363 RPPGEHVLVSWALPRLTSREEAVEMVD--PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-MTDVVQS  428 (457)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~  428 (457)
                      ....                ....+..  ..+........+..+.+++.+|++ +|.+||+ +.+++++
T Consensus       234 ~~~~----------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQE----------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHH----------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            3210                0001111  111111111135578999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-40  Score=327.42  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcC--------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYC  219 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~  219 (457)
                      +....+|++.+.||+|+||.||++....        ...+|+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3444578999999999999999997421        2368999887543 33446788999999999 899999999999


Q ss_pred             EcCCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCc
Q 012739          220 ADQNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN  287 (457)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  287 (457)
                      ...+..++++||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+.+   ++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence            999999999999999999999976431            2235888999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCC
Q 012739          288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPG  366 (457)
Q Consensus       288 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~  366 (457)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  243 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-  243 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986643222112222334567999999999999999999999999999998 88888643211 


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                                      +....+........+......+.+++.+||+.+|++||++.++++.|++++...
T Consensus       244 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ----------------ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                            111111111111223344558999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=336.31  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999975 58899999986542   223345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999997643    4899999999999999999999999   99999999999999999999999999875432


Q ss_pred             ccCCc------------------------------------cccccccCCCccccccccCCCCCcccchHHHHHHHHHHH
Q 012739          310 KINGQ------------------------------------ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL  353 (457)
Q Consensus       310 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ell  353 (457)
                      .....                                    .....+||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    011246999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 012739          354 TGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL---MTDVVQS  428 (457)
Q Consensus       354 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~  428 (457)
                      +|..||........   ..          ..... ...+...........+.+++.+|+. +|.+|++   +.+++++
T Consensus       234 ~G~~Pf~~~~~~~~---~~----------~i~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQET---YR----------KIINW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHHH---HH----------HHHcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999975432110   00          00000 0011100111234578899999996 8999997   9998886

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-40  Score=316.36  Aligned_cols=256  Identities=28%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|++.++||+|+||.||+|...+++.+|+|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467888999999999999999988899999999875533 3456888999999999999999999874 4568999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999876432  35889999999999999999999998   9999999999999999999999999987664221


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . .......++..|+|||.+....++.++||||||+++|||++ |+.||......                 +....+..
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~  218 (260)
T cd05067         157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----------------EVIQNLER  218 (260)
T ss_pred             c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----------------HHHHHHHc
Confidence            1 11223345678999999988889999999999999999999 99999743321                 11111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ......+...+.++.+++.+||+.+|++||+++++++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            111122233455899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-40  Score=317.12  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=204.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-C---cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-G---TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .+|++.+.||+|+||.||+|.... +   ..|++|.+... .......|..|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            346778999999999999999653 3   36999998764 333456789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999987643   24889999999999999999999999   9999999999999999999999999987654


Q ss_pred             cccCCccccc-cc--cCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          309 DKINGQISTR-VL--GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       309 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......... ..  .+..|+|||.+.+..++.++||||||+++|||++ |..||......                 ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----------------~~  220 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------DV  220 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----------------HH
Confidence            3221111111 11  2357999999999999999999999999999887 99998743221                 01


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ...+........+.+++..+.+++.+||+.+|.+||++.+|++.|++++
T Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            1111111111222344557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-40  Score=318.18  Aligned_cols=272  Identities=25%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-----CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-----DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~  226 (457)
                      .+|++.+.||+|+||.||++...     ++..|++|++........+.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999742     578999999977766666778999999999999999999998753  34688


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +|+||+++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999997543   24899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCcc-ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQI-STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......-....... ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHHHH
Confidence            643221111 1112234569999999888999999999999999999999877643211000000000 00000001111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      +.+........+...+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            22222111122334456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-41  Score=314.89  Aligned_cols=278  Identities=23%  Similarity=0.285  Sum_probs=210.0

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCC------e
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQ-LVELLGYCADQN------H  224 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~------~  224 (457)
                      .|...++||+|+||+||+|+. .+|+.||+|++......  ......+|+.+++.++|+| |+++.+++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            344556799999999999995 46889999999766432  2234578999999999999 999999998877      8


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++|+||+ .-+|..++.......+.++...+..++.|++.||+|||+++   |+||||||.||||+++|.+||+|||++
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence            89999999 56999999876533245777889999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh-
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE-  382 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  382 (457)
                      +...-.  ....+..++|..|+|||++.+. .|+...||||+|||++||++++.-|.+....++...+...+....... 
T Consensus       168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            965422  2235667899999999998876 799999999999999999999999987654333222222221111100 


Q ss_pred             -HHhhhc--CCcCCCCC-CH-------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          383 -EAVEMV--DPSLQGQY-PK-------KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       383 -~~~~~~--d~~l~~~~-~~-------~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                       .+....  +..+.... +.       .......+++.+|++.+|.+|.|++.++++  ..+.+....+
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h--~yf~~~~~~~  312 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH--PYFSELPEKS  312 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC--hhhcccccch
Confidence             001000  10111000 11       112478899999999999999999999998  5555554433

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-40  Score=320.67  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=205.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||++...      ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999863      46789999987653 33345688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCc
Q 012739          226 LLISEYMPNGTLQQHLHRHNN------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN  287 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  287 (457)
                      +++|||+++|+|.+++.....                  ....+++.+++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999975321                  1134788899999999999999999998   9999999999


Q ss_pred             eEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCC
Q 012739          288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPG  366 (457)
Q Consensus       288 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~  366 (457)
                      |+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322122223345667999999988899999999999999999998 88888643211 


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                                      +....+........+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----------------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                            1111111111111233345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-41  Score=336.41  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..++|++.+.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467899999999999999999975 58899999986432   2233457789999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999998653     3788889999999999999999999   999999999999999999999999999765


Q ss_pred             ccccCCccccccccCCCccccccccCC----CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTG----KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......                .
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~  255 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------T  255 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----------------H
Confidence            43211 122345799999999998643    47899999999999999999999997543210                1


Q ss_pred             HhhhcCCcCCCCCCH--HHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHHHhhh
Q 012739          384 AVEMVDPSLQGQYPK--KDLIQIAAIAAVCVQPEAAY--RPLMTDVVQSLIPVVK  434 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~--~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~~~~~  434 (457)
                      ...+.+......++.  ..+..+.+|+.+||+.+|.+  |+++.+++++  ++++
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h--~~~~  308 (370)
T cd05596         256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH--PFFK  308 (370)
T ss_pred             HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC--cccC
Confidence            111111110111111  24568899999999999988  9999999987  4444

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.1e-40  Score=312.88  Aligned_cols=248  Identities=24%  Similarity=0.421  Sum_probs=198.1

Q ss_pred             eeccCCcEEEEEEEEc---CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          161 VIGNGGFGVVYKGVLS---DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .||+|+||.||+|.+.   ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999864   355799998876533 334568899999999999999999998864 57899999999999


Q ss_pred             HHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc-c
Q 012739          237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ-I  315 (457)
Q Consensus       237 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~  315 (457)
                      |.+++....   ..+++..++.++.|++.||.|||+++   ++|+||||+|||++.++.+||+|||++.......... .
T Consensus        81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999987543   35899999999999999999999999   9999999999999999999999999997654322111 1


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      .....++..|+|||.+....++.++||||||+++|||++ |..||......                 +....+......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------EVMSFIEQGKRL  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHCCCCC
Confidence            112233578999999988889999999999999999996 99998743221                 111122222222


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            33444566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.7e-41  Score=332.66  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=196.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||+||++... +++.+|+|++....   ......+..|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999865 58899999986532   222345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999997643    4899999999999999999999999   99999999999999999999999999875432


Q ss_pred             ccC---------------------------------CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCC
Q 012739          310 KIN---------------------------------GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR  356 (457)
Q Consensus       310 ~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~  356 (457)
                      ...                                 .......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                 00112357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcchhhhhhccccCchhHHhhhcC-CcCCCCCCHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHH
Q 012739          357 VPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD-PSLQGQYPKKDLIQIAAIAAVCVQ--PEAAYRPLMTDVVQS  428 (457)
Q Consensus       357 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~li~~cl~--~~p~~RPs~~evl~~  428 (457)
                      .||..........             .+..... ..+...  .....++.+++.+++.  .++..||++.||+++
T Consensus       234 ~Pf~~~~~~~~~~-------------~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQETYK-------------KVMNWKETLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHHHH-------------HHHcCcCcccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9997543211000             0000000 001111  1123467777777543  334456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=315.63  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=205.9

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC----e
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR--LHSPQLVELLGYCADQN----H  224 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~----~  224 (457)
                      ....+..+.+.||+|.||.||+|++ -|+.||||++...+   ++.+.+|.++.+.  |+|+||+.+++.-..++    +
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            3456678889999999999999999 68899999996543   4556777777766  49999999998765443    6


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeccCccCceEeCCCCcEEEe
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-----HATPPVIHRDFKCSNVLLDQNFRAKVT  299 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~  299 (457)
                      +|||++|.+.|+|.+||...     +++....++++..+|.||++||.     +|+|.|.|||||++|||+..++.+.|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            89999999999999999873     48999999999999999999995     678899999999999999999999999


Q ss_pred             eccCccccccccCC--ccccccccCCCccccccccCC----CC--CcccchHHHHHHHHHHHcC----------CCCCCC
Q 012739          300 DFGLAKMVSDKING--QISTRVLGTTGYLAPEYASTG----KL--TTKSDVYSYGVVLLELLTG----------RVPVDP  361 (457)
Q Consensus       300 Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~--s~~sDV~SlG~il~elltg----------~~p~~~  361 (457)
                      |+||+.......+.  ...+..+||.+|||||++...    .+  -..+||||||.|+||+...          +.||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999876543211  123457899999999998642    12  2478999999999999762          456654


Q ss_pred             CCCCCcchhhhhhccccCchhHH-----hhhcCCcCCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          362 NRPPGEHVLVSWALPRLTSREEA-----VEMVDPSLQGQ-YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .-+.+.            ..++.     .+.+.|.+... .+.+.+..+.++++.||..||..|.|+-.|.+.|.++.+
T Consensus       439 ~Vp~DP------------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDP------------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCC------------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            322111            11111     12223333222 234678899999999999999999999999999998875

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=315.48  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=208.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|.+.+.||+|+||.||+|..+++..+++|.+..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4567889999999999999999988888999999875432 345688899999999999999999999998899999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999976432  35899999999999999999999999   9999999999999999999999999987664321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . ........+..|+|||.+.+..++.++||||||+++|||++ |+.||......                 ........
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~  219 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----------------EVLEQVER  219 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHc
Confidence            1 11122334568999999998889999999999999999999 99998643211                 01111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ......+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         220 GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            111122223355799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=312.59  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|.+.+.||+|++|.||++... ++..+++|.+....     ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 58899999876432     1223468889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |+||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999987643    4888999999999999999999999   999999999999999999999999998765


Q ss_pred             ccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......                .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~  218 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFK  218 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----------------HHHHH
Confidence            4321111 113356788999999999988999999999999999999999999743211                01111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..........+......+.+++.+||..+|++|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            111112223344455689999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=314.55  Aligned_cols=252  Identities=30%  Similarity=0.464  Sum_probs=198.9

Q ss_pred             ceeccCCcEEEEEEEEcC-Cc--EEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD-GT--VAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|...+ +.  .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999999754 33  46888886532 33445688899999999 899999999999999999999999999


Q ss_pred             CcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          235 GTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       235 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      |+|.+++.....            ....+++.+++.++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999976431            1234789999999999999999999998   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCch
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ++.......   .......+..|+|||.+....++.++||||||+++|||++ |..||......                
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----------------  218 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------------  218 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----------------
Confidence            986332110   1111233567999999988899999999999999999997 99998643211                


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                       .....+........+.....++.+++.+||+.+|.+|||+.++++.|++++.
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         219 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence             1111111111112223344578999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-40  Score=314.73  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.+.... ....+.+..|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999863    23479999886543 33345688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999997643   24889999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCCcc-ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKINGQI-STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....... .....++..|+|||.+.+..++.++||||||+++||+++ |..||.......   ....          ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~----------~~~  224 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA----------IEE  224 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH----------HhC
Confidence            4321111 112233567999999998899999999999999999887 999987543211   0000          000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                          ......+...+..+.+++.+|++.+|.+||++.++++.|++++
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         225 ----GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence                0111122234557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=320.29  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=203.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +|+..++||+|+||.||++... +++.||+|++.....   .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999964 688999999865421   223446789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988865332  35899999999999999999999999   999999999999999999999999998765322


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                         .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........             ......+..
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~~  219 (285)
T cd05605         156 ---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVKE  219 (285)
T ss_pred             ---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhhh
Confidence               1223456899999999999889999999999999999999999999753321100             011111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                       ....++...+..+.+|+..||+.||.+||     ++.+++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             11123344556889999999999999999     88898877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.6e-41  Score=335.87  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +|...++||+|+||.||+|+.. +++.+|+|++....   ......+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999964 58899999986542   2233567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999987643    4888999999999999999999999   999999999999999999999999997533110


Q ss_pred             cC---------------------------------------------CccccccccCCCccccccccCCCCCcccchHHH
Q 012739          311 IN---------------------------------------------GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY  345 (457)
Q Consensus       311 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~Sl  345 (457)
                      ..                                             ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             001123568999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc--CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC--
Q 012739          346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV--DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL--  421 (457)
Q Consensus       346 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs--  421 (457)
                      ||++|||++|+.||....+...                ...+.  ...+..........++.+++.+|+ .+|.+|++  
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~  297 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET----------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN  297 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH----------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence            9999999999999975432110                01111  111111111123446778887776 49999987  


Q ss_pred             -HHHHHHH
Q 012739          422 -MTDVVQS  428 (457)
Q Consensus       422 -~~evl~~  428 (457)
                       +.+++++
T Consensus       298 ~~~ei~~h  305 (382)
T cd05625         298 GADEIKAH  305 (382)
T ss_pred             CHHHHhcC
Confidence             8888776

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=321.26  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=203.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC---------------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD---------------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELL  216 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~  216 (457)
                      ..+|++.+.||+|+||.||++...+               ...||+|++.... ......+.+|+++++.++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578889999999999999987532               2358999987653 33345688999999999999999999


Q ss_pred             EEEEcCCeEEEEEEeCCCCcHHHHHhhhCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          217 GYCADQNHRLLISEYMPNGTLQQHLHRHNN--------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                      +++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999965321        1124788999999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCCCC
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRVPVDPNRPPG  366 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt--g~~p~~~~~~~~  366 (457)
                      +++.++.+||+|||++................++..|+|||.+....++.++||||||+++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976543322222233445778999999988899999999999999999998  566776432211


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                         .....       ...............+...+..+.+|+.+||+.+|++||++.+|++.|++
T Consensus       241 ---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 ---VIENT-------GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ---HHHHH-------HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence               00000       00000000001111122234589999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=335.90  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999864 68899999886532   223356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999997643    4889999999999999999999999   99999999999999999999999999864321


Q ss_pred             ccCC---------------------------------------------ccccccccCCCccccccccCCCCCcccchHH
Q 012739          310 KING---------------------------------------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYS  344 (457)
Q Consensus       310 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S  344 (457)
                      ....                                             .......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                             0001246999999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCC---CC
Q 012739          345 YGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYR---PL  421 (457)
Q Consensus       345 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps  421 (457)
                      |||++|||++|..||..........             ..... ...+.-.-......++.+|+.+|++ +|.+|   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~-------------~i~~~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYR-------------KIINW-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHH-------------HHHcc-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999997543211000             00000 0001000011234578899999997 66655   69


Q ss_pred             HHHHHHH
Q 012739          422 MTDVVQS  428 (457)
Q Consensus       422 ~~evl~~  428 (457)
                      +.+++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-40  Score=314.45  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=209.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+|++.+.||+|+||.||++.. .++..+++|.+...   .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577788999999999999995 47899999987643   2233356888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998764444456899999999999999999999999   99999999999999999999999999876543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..          ........
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~----------~~~~~~~~  225 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LC----------KKIEQCDY  225 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hh----------hhhhcCCC
Confidence            21  1123456888999999998888999999999999999999999998643221000 00          00001001


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +   ...+......+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1   1112234568999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-40  Score=320.55  Aligned_cols=265  Identities=27%  Similarity=0.395  Sum_probs=206.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-----------------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeee
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-----------------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVE  214 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~  214 (457)
                      .++|++.+.||+|+||.||++...+                 +..+|+|++.... ....+.+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999988643                 2458999987653 334456889999999999999999


Q ss_pred             EEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCc
Q 012739          215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNN-------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN  287 (457)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  287 (457)
                      +++++..++..++++||+++++|.+++.....       ....+++..++.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999976542       1225899999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCCC
Q 012739          288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRVPVDPNRPP  365 (457)
Q Consensus       288 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt--g~~p~~~~~~~  365 (457)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999886544332223344556788999999988889999999999999999998  67777643211


Q ss_pred             CcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          366 GEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      .   ......       ..............+...+.++.+++.+||+.+|++|||+.+|++.|+
T Consensus       241 ~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAG-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHH-------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            0   010000       000000011111122233458999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=312.41  Aligned_cols=251  Identities=30%  Similarity=0.491  Sum_probs=206.3

Q ss_pred             ceeccCCcEEEEEEEEcC----CcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|....    +..+++|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999754    7889999997664333 56788999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          235 GTLQQHLHRHNNR-----YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       235 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ++|.+++......     ...+++.+++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875221     246899999999999999999999999   99999999999999999999999999987754


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..||......                 ...+.+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~  220 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----------------EVLEYL  220 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHH
Confidence            432223344567889999999988899999999999999999999 69998754211                 111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ........+...+.++.+++.+||+.+|++||++.+++++|+
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111122334444668999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-40  Score=320.38  Aligned_cols=266  Identities=26%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-----------------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeee
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-----------------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVE  214 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~  214 (457)
                      .++|++.+.||+|+||.||++...                 +...+|+|++.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998632                 23468999987653 333456889999999999999999


Q ss_pred             EEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCc
Q 012739          215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR-------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN  287 (457)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  287 (457)
                      +++++...+..++||||+++++|.+++......       ...+++.+++.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            999999999999999999999999999764321       124788899999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCCC
Q 012739          288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT--GRVPVDPNRPP  365 (457)
Q Consensus       288 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt--g~~p~~~~~~~  365 (457)
                      ||++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999886543322222233445678999999888889999999999999999998  77888643221


Q ss_pred             CcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          366 GEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                      ..   ...       ................+..++..+.+|+.+||+.||++||++.+|++.|++
T Consensus       241 ~~---~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QV---IEN-------TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH---HHH-------HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10   000       000000000000011122344689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=311.84  Aligned_cols=251  Identities=31%  Similarity=0.491  Sum_probs=207.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||.|+||.||+|.. .++.|++|.+..... ..+.+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35678889999999999999987 478899999976644 4567888999999999999999999999899999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...... 
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            99999999976542  25899999999999999999999999   9999999999999999999999999998763321 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                          .....+..|+|||.+....++.++||||||+++|||++ |..||......                 +....+...
T Consensus       157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~  215 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPHVEKG  215 (256)
T ss_pred             ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhcC
Confidence                12334567999999988889999999999999999997 99998643211                 111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11222333456899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.2e-41  Score=329.94  Aligned_cols=242  Identities=25%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.||+|+||.||++... ++..+|+|.+....   ......+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999986532   223345678999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      +|..++....    .+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~  151 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA  151 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence            9999886543    48999999999999999999997 67   999999999999999999999999998753221  11


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......   ..             ..+....  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~-------------~~i~~~~--~  213 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF-------------ELILMEE--I  213 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HH-------------HHHhcCC--C
Confidence            2234579999999999999999999999999999999999999997432210   00             0000000  1


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      .++.....++.+++.+||+.||++|+     ++.+++++
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12333445789999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.6e-40  Score=309.86  Aligned_cols=247  Identities=28%  Similarity=0.474  Sum_probs=199.9

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      ++||+|+||.||+|...++..+|+|++...... ....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999999888999999998765432 3345888999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccc
Q 012739          239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR  318 (457)
Q Consensus       239 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  318 (457)
                      +++....   ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......... ....
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~  153 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL  153 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence            9987543   24889999999999999999999999   999999999999999999999999998754332111 1112


Q ss_pred             cccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       319 ~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ..++..|+|||++....++.++||||||+++|++++ |..||.......                 ....+........+
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~  216 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEKGYRMSCP  216 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCC
Confidence            234567999999988899999999999999999998 999987432210                 00111111112223


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            334568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4e-40  Score=311.14  Aligned_cols=250  Identities=29%  Similarity=0.462  Sum_probs=205.2

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|.+.+.||+|++|.||++... ++..+++|.+...  .......+..|+++++.++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677789999999999999965 5889999988643  234456688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999998752  246899999999999999999999998   9999999999999999999999999988665432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......   ...             .... ..
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~-------------~~~~-~~  216 (256)
T cd08529         156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI-------------LKII-RG  216 (256)
T ss_pred             --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHH-cC
Confidence              1223456889999999999989999999999999999999999999754310   000             0011 11


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+......+.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1112223445689999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.7e-41  Score=333.86  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=204.3

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ...++|++.+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            33568999999999999999999975 5788999988542   1223345788999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999998653     3788999999999999999999999   99999999999999999999999999986


Q ss_pred             cccccCCccccccccCCCccccccccCC----CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTG----KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ...... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......                .
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----------------~  254 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----------------G  254 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----------------H
Confidence            643211 122356799999999998653    3789999999999999999999999754221                0


Q ss_pred             HHhhhcCCcCCCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHHHhhhh
Q 012739          383 EAVEMVDPSLQGQYP--KKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~~~~~~  435 (457)
                      ....+.+......++  ......+.+++..|++.++.+  |+++.|++++  +++++
T Consensus       255 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h--p~~~~  309 (370)
T cd05621         255 TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH--PFFKN  309 (370)
T ss_pred             HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC--cccCC
Confidence            111111111111122  233557889999999866654  8999999998  66654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.9e-41  Score=327.45  Aligned_cols=245  Identities=26%  Similarity=0.401  Sum_probs=195.5

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHH---HhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLL---SRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      |++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999865 58899999986542   22234466666554   566899999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|..++..     ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988754     24899999999999999999999999   9999999999999999999999999987532


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.......   .             ...+.
T Consensus       153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~-------------~~~i~  214 (324)
T cd05589         153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---V-------------FDSIV  214 (324)
T ss_pred             CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHH
Confidence            21  122345679999999999999999999999999999999999999997532210   0             00111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ...  ..++...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       215 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         215 NDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             hCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            111  122333455789999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-40  Score=315.27  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=208.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-Cc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|++.+.||+|+||.||+|.+.+ +.    .+++|.+.... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999998643 32    58999886654 3344668899999999999999999999987 78899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |+||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999976443   4899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............++..|+|||.+....++.++||||||+++|||++ |+.||......                 +...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~  222 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----------------EIPD  222 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHH
Confidence            53322211222234568999999988899999999999999999999 99998753221                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .+........+..+...+.+++.+||..+|..||++.++++.|+++.++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            111111112222344578999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.6e-41  Score=326.64  Aligned_cols=242  Identities=26%  Similarity=0.402  Sum_probs=194.8

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 58899999986532   22334566788888776 699999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~  151 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK  151 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence            99999887643    4899999999999999999999999   999999999999999999999999998754221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...             ..+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~-------------~~i~~~~~--  213 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF-------------EAILNDEV--  213 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH-------------HHHhcCCC--
Confidence            234467999999999999999999999999999999999999999753321   000             01111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLM------TDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  428 (457)
                      ..+.....++.+++.+||+.||.+||++      ++++++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1222344578999999999999999998      666665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-40  Score=324.31  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=191.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSR-LHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|... +++.||+|.+....   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 47889999986542   2223344556666664 4899999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            99999987643    4899999999999999999999999   9999999999999999999999999987543221  2


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...             ..+..  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~-------------~~i~~--~~~  213 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF-------------DSILN--DRP  213 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHc--CCC
Confidence            234567999999999999999999999999999999999999999753221   000             00000  011


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMT-DVVQ  427 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  427 (457)
                      .++.....++.+++.+||+.+|++||++. ++++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            22333455788999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.8e-40  Score=319.95  Aligned_cols=273  Identities=23%  Similarity=0.358  Sum_probs=209.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 57788888886543 33345688899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      +++++|.+++....    .+++..+..++.|++.||.|||+ .+   ++|+||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999997643    48899999999999999999997 47   999999999999999999999999998765332


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc----------
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS----------  380 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  380 (457)
                          ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....................          
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence                123456889999999998888999999999999999999999999654321111111000000000          


Q ss_pred             ---------hhHHhhhcCCcCCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          381 ---------REEAVEMVDPSLQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       381 ---------~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                               ..+..+..-.......+ .....++.+++.+||+.+|++||++.+|+++  +++++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--~~~~~~~~~  296 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH--PFIKRAELE  296 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC--hhhhhcccc
Confidence                     00000000000001111 1234579999999999999999999999998  777776554

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.7e-40  Score=311.95  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      .+|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999998777789999886543 23356788999999999999999999875 456889999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          84 KGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            9999999976432  35789999999999999999999999   99999999999999999999999999976543211 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......   ..              ..+....
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~--------------~~~~~~~  220 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL--------------EQVERGY  220 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHHcCC
Confidence            11122345678999999988899999999999999999999 899987432210   00              0011111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                      ....+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112233455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-40  Score=333.28  Aligned_cols=266  Identities=20%  Similarity=0.239  Sum_probs=202.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+|++.+.||+|+||.||++... +++.||+|+...      ..+.+|+++++.++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999964 588999997532      2357899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      + .++|..++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       165 ~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 Y-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             C-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            9 578988886643    4889999999999999999999999   9999999999999999999999999987543221


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcc----hhhhhhccc-------c--
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH----VLVSWALPR-------L--  378 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~----~~~~~~~~~-------~--  378 (457)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........    .........       .  
T Consensus       237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             11233467999999999999999999999999999999999999887643221110    000000000       0  


Q ss_pred             CchhHHhhhc---------CCcCCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          379 TSREEAVEMV---------DPSLQGQY--PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       379 ~~~~~~~~~~---------d~~l~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..........         .+......  ....+.++.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h--p~f~~  381 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF--AAFQD  381 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC--hhhcc
Confidence            0000000000         00000000  01235578999999999999999999999987  67655

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-40  Score=314.67  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999996 46889999998765444556688899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....    ++++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999999986543    4899999999999999999999998   9999999999999999999999999998664321


Q ss_pred             CCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .  ......++..|+|||.+.   ...++.++||||||+++|||++|+.||....+.......  .     .    ....
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~-----~----~~~~  227 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S-----K----SNFQ  227 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e-----c----CCCC
Confidence            1  123346888999999874   455788999999999999999999998643321110000  0     0    0000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .+...  .....+..+.+++.+||+.+|++||++++++++|
T Consensus       228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            01110  1112345899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.9e-41  Score=327.81  Aligned_cols=249  Identities=23%  Similarity=0.380  Sum_probs=197.2

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||++... +++.||+|.++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 58899999987542   22334577899999988 799999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  151 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD  151 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence            99999886543    4999999999999999999999999   999999999999999999999999998743211  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCC--cchhhhhhccccCchhHHhhhcCCcC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG--EHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.         ...+.....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQVILEKQI  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HHHHHcCCC
Confidence            2345679999999999999999999999999999999999999997432211  00000010         001111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPL------MTDVVQS  428 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~~  428 (457)
                        ..+......+.+++.+||+.||.+||+      +.+++++
T Consensus       223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              223334557899999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-40  Score=325.43  Aligned_cols=247  Identities=26%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCC-CeeeEEEEEEcCCeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSP-QLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hp-niv~l~~~~~~~~~~~lv~  229 (457)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..++|+ +|+++.+++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999965 47789999986542   22334577899999999764 6888999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999987643    3889999999999999999999999   99999999999999999999999999875322


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  ........||+.|+|||++.+..++.++|||||||++|||+||+.||......   ...             ..+..
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~-------------~~i~~  215 (324)
T cd05587         154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF-------------QSIME  215 (324)
T ss_pred             C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHc
Confidence            1  12233467899999999999999999999999999999999999999753221   000             01111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  428 (457)
                      .  ...++......+.+++.+||+.+|.+|++.     .+++++
T Consensus       216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         216 H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1  112233345578999999999999999976     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-40  Score=320.33  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=205.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45777889999999999999864 343    478888865532 3334688899999999999999999998764 4679


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ++||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999876432   4889999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......                 ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----------------~~~~  222 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----------------EIPD  222 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence            43322212223445778999999998999999999999999999997 89998643211                 0111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+........+..+...+.+++..||..+|++||++.++++.|.++.++...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (303)
T cd05110         223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR  274 (303)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence            1111111111222345789999999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-40  Score=311.63  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=201.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~  232 (457)
                      .+|.+.+.||+|+||.||++.. .+..+++|.+....  ..+.+.+|+.+++.++|+|++++++++. .++..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4678889999999999999987 47789999886543  2356888999999999999999999764 556789999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....  
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  155 (256)
T cd05082          83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  155 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc--
Confidence            99999999976432  34889999999999999999999999   999999999999999999999999998754332  


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....                 ......+...
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~  215 (256)
T cd05082         156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKG  215 (256)
T ss_pred             ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcC
Confidence               122334568999999988899999999999999999998 9999864321                 1111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      .....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            12222334456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-40  Score=325.40  Aligned_cols=250  Identities=23%  Similarity=0.386  Sum_probs=196.4

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||++... +++.+|+|.+...   .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 5789999998754   223334577888888776 899999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~  151 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD  151 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence            99998886543    4899999999999999999999999   999999999999999999999999998753221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh-hcCCcCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE-MVDPSLQ  393 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~  393 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........        ......... +....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~~~~~~~~~~i~~~~--  221 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQVILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--------cccHHHHHHHHhcCC--
Confidence            2334678999999999999999999999999999999999999996422211100        000000111 11111  


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPL------MTDVVQS  428 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~~  428 (457)
                      ...+......+.+++.+||+.||++||+      +.+++++
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1234445567899999999999999998      4677766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-40  Score=325.78  Aligned_cols=242  Identities=27%  Similarity=0.396  Sum_probs=195.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999975 47899999986542   22334466788888866 799999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ..
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~  151 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV  151 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence            99999887643    4889999999999999999999999   999999999999999999999999998754322  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..             ..+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~-------------~~i~~~~~--  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF-------------ESILHDDV--  213 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH-------------HHHHcCCC--
Confidence            2344678999999999999999999999999999999999999997543210   00             01111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRP-------LMTDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RP-------s~~evl~~  428 (457)
                      .++.....++.+++.+||+.+|++||       ++.+++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            12222345789999999999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.3e-41  Score=330.54  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.+.||+|+||.||++... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888899999999999999965 68899999987542   223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999987532   4899999999999999999999999   99999999999999999999999999987643


Q ss_pred             ccCCccccccccCCCcccccccc------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          310 KINGQISTRVLGTTGYLAPEYAS------TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ... .......||+.|+|||++.      ...++.++|||||||++|||++|+.||.........             ..
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------------~~  220 (330)
T cd05601         155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-------------NN  220 (330)
T ss_pred             CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-------------HH
Confidence            221 1223457899999999986      456789999999999999999999999753321100             00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +... ...+.-......+..+.+|+..|++ +|.+||++.+++++
T Consensus       221 i~~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         221 IMNF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHcC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0000 0001001111245578999999998 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.5e-41  Score=335.24  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+++.. +++.+|+|.+....   ......+.+|+++++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999964 58899999986432   122345778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999997643    4888899999999999999999999   99999999999999999999999999753210


Q ss_pred             ccC-----------------------------------------CccccccccCCCccccccccCCCCCcccchHHHHHH
Q 012739          310 KIN-----------------------------------------GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV  348 (457)
Q Consensus       310 ~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~i  348 (457)
                      ...                                         ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                         001123579999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHH
Q 012739          349 LLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP---LMTDV  425 (457)
Q Consensus       349 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~ev  425 (457)
                      +|||++|+.||...........             . ......+...........+.+++.+|+ .+|.+|+   ++.++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~-------------i-~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLK-------------V-INWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHH-------------H-hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999999975432111000             0 000011111111123446778888876 5999999   89999


Q ss_pred             HHH
Q 012739          426 VQS  428 (457)
Q Consensus       426 l~~  428 (457)
                      +++
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-40  Score=324.90  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=197.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +|.+.+.||+|+||.||+|... ++..+|+|.+....   ....+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999975 47799999987542   22233456677888777 5799999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999987643    4889999999999999999999999   99999999999999999999999999875432


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  ........||+.|+|||++.+..++.++|||||||++|||+||+.||......   ...             ..+..
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~-------------~~i~~  215 (323)
T cd05616         154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF-------------QSIME  215 (323)
T ss_pred             C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHh
Confidence            1  12234567899999999999999999999999999999999999999753221   000             01111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  428 (457)
                      ..  ..++.....++.+++.+||+.+|.+|++.     .+++++
T Consensus       216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            11  12333445688999999999999999984     566544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-40  Score=339.62  Aligned_cols=268  Identities=24%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--------~  223 (457)
                      ..+|.+.++||+|+||.||+|... +++.||+|++.....    ...+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999974 588999998865422    235699999999999999999886432        2


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeecc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFG  302 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  302 (457)
                      ..++||||++ ++|.+++.........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            4679999996 5787777654434456899999999999999999999999   99999999999998664 79999999


Q ss_pred             CccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +++.+...   .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+......... 
T Consensus       217 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~-  292 (440)
T PTZ00036        217 SAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE-  292 (440)
T ss_pred             cchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-
Confidence            99866432   12234568999999998865 46899999999999999999999999764432211111111100000 


Q ss_pred             hHHhhhcCC-------------cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EEAVEMVDP-------------SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~~~~~~d~-------------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +.. ....+             .+...++...+.++.+|+.+||+.+|.+|||+.|++++  +++++
T Consensus       293 ~~~-~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h--p~f~~  356 (440)
T PTZ00036        293 DQL-KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD--PFFDD  356 (440)
T ss_pred             HHH-HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC--hhHHh
Confidence            000 00000             01111222345689999999999999999999999988  66654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=325.15  Aligned_cols=258  Identities=26%  Similarity=0.351  Sum_probs=218.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCch---HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK---QRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRL  226 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~  226 (457)
                      ....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+...   .....+.+|+.+|+.+. |||||.+.++|.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678888999999999999999765 99999999976533   23357889999999998 999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC----CCcEEEeecc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ----NFRAKVTDFG  302 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg  302 (457)
                      +|||++.||.|.+.|...    . +++.++..++.|++.++.|||+.|   ++||||||+|+|+..    ++.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999876    1 899999999999999999999999   999999999999953    3579999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........            
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~------------  249 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA------------  249 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH------------
Confidence            9988765   3456778999999999999999999999999999999999999999986543222110            


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                        ....+..+..++.......+.+++..|+..||..|+|+.+++++  .+++..
T Consensus       250 --i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H--pWi~~~  299 (382)
T KOG0032|consen  250 --ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH--PWIKSI  299 (382)
T ss_pred             --HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC--ccccCC
Confidence              11112233334445667789999999999999999999999998  777764

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=308.03  Aligned_cols=248  Identities=28%  Similarity=0.472  Sum_probs=201.1

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      ++||+|+||.||++...+++.|++|++...... ....+..|+++++.++||||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            368999999999999877999999988765433 4457889999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccc
Q 012739          239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR  318 (457)
Q Consensus       239 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  318 (457)
                      +++.....   .+++..++.++.+++.||.|||+++   ++||||||+|||++.++.++|+|||++..............
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            99976432   4789999999999999999999999   99999999999999999999999999876543221111122


Q ss_pred             cccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       319 ~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...+..|+|||.+.+..++.++||||||+++|||+| |..||.......                 ....+........+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIESGYRMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhcCCCCCCC
Confidence            234567999999988899999999999999999999 888886433211                 11111111111223


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            344568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-40  Score=323.72  Aligned_cols=242  Identities=27%  Similarity=0.422  Sum_probs=192.6

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|... ++..||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 57899999986542   12234456677777654 899999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||+++.....  ..
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  151 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN  151 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence            99999987643    4889999999999999999999999   999999999999999999999999998743221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...           .......+    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~-----------~~~~~~~~----  213 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF-----------ESIRVDTP----  213 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH-----------HHHHhCCC----
Confidence            234567999999999999999999999999999999999999999743221   000           00001111    


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMT-DVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~~  428 (457)
                      .++.....++.+++.+||+.||++||++. +++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            22223445789999999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.5e-40  Score=310.96  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|++.+.||+|+||.||++...++..+++|.+.... .....+.+|+.+++.++|+||+++.+++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            346788899999999999999998788889999887543 334568889999999999999999999887 778999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999976432  35788899999999999999999998   9999999999999999999999999987654321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . .......++..|+|||.+....++.++|+||||+++|+++| |+.||.......                 ....+..
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----------------~~~~~~~  218 (260)
T cd05073         157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----------------VIRALER  218 (260)
T ss_pred             c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHhC
Confidence            1 11122345677999999988889999999999999999999 899987432210                 0111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ......+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            111122233455799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-40  Score=309.27  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             ceeccCCcEEEEEEEEcC----CcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|.+..    +..+|+|.+..... ...+.+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999876543 34456889999999999999999999876 4567999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997654    4899999999999999999999999   9999999999999999999999999998764432211


Q ss_pred             c-ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          315 I-STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       315 ~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   ...              ..+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~--------------~~~~~~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVI--------------AMLESGE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHH--------------HHHHcCC
Confidence            1 111223567999999998899999999999999999998 99999754321   111              1111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122334456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-41  Score=327.62  Aligned_cols=238  Identities=26%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             ceeccCCcEEEEEEEE----cCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          160 NVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +.||+|+||.||+++.    .+++.+|+|++.....  .....+..|+++++.++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3578999999875421  223446779999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999999986543    4899999999999999999999999   9999999999999999999999999987654321  


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......   .             ....+..... 
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~-------------~~~~i~~~~~-  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---E-------------TMTMILKAKL-  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---H-------------HHHHHHcCCC-
Confidence            2233467899999999999888999999999999999999999999753221   0             0001111111 


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD  424 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  424 (457)
                       ..+......+.+|+.+||+.||++||++.+
T Consensus       216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             223334457899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.9e-40  Score=314.57  Aligned_cols=272  Identities=21%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~  225 (457)
                      ..|++.+.||+|+||.||+++.     .++..||+|.+.... ......+.+|+.+++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999984     357889999987553 33445688999999999999999999998775  568


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            99999999999999986543   24899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+|++.|+......-.... ....... .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI-GPTHGQM-TVTRL  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc-ccccccc-cHHHH
Confidence            76433221 112234567789999999888899999999999999999998876542111000000 0000000 00011


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ...+........+..++..+.+|+.+||+.+|++||++.++++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            1111111111223345668999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.6e-40  Score=311.49  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|.+.+.||+|+||.||+|...+    ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3557888999999999999998643    3468999887654 4445678899999999999999999998875 45789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            999999999999997643   24899999999999999999999999   999999999999999999999999998766


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......++..|+|||.+....++.++||||||+++|||++ |..||........   ..+             
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~-------------  220 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR-------------  220 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-------------
Confidence            44311 11222334568999999988889999999999999999986 9999975432110   000             


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       +........+..++..+.+++.+|+..+|++|||+.++++.|+++..+
T Consensus       221 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         221 -IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             000001112234456899999999999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.2e-40  Score=310.00  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=194.8

Q ss_pred             ceeccCCcEEEEEEEEcC----CcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCeEEEEEEeCC
Q 012739          160 NVIGNGGFGVVYKGVLSD----GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMP  233 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~  233 (457)
                      +.||+|+||.||+|.+.+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998532    457999988543 3344567888999999999999999999775 4556889999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....   .+.+..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+......
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999976432   3677888999999999999999998   999999999999999999999999999765432111


Q ss_pred             --ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          314 --QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG-RVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       314 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                        .......++..|+|||.+....++.++||||||+++|||++| ..||......   ...              ..+..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~--------------~~~~~  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT--------------VYLLQ  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--------------HHHhc
Confidence              111233456789999999888999999999999999999996 4555432110   000              00000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ......+...+..+.+++.+||+.+|++||++.+|++.|++++.
T Consensus       218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            00111122234579999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-40  Score=322.12  Aligned_cols=242  Identities=28%  Similarity=0.421  Sum_probs=192.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSR-LHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 47899999986542   1223345567777775 4999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  151 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DA  151 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CC
Confidence            99999987643    4889999999999999999999999   999999999999999999999999998753221  11


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...           .......+    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~-----------~~i~~~~~----  213 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF-----------QSIRMDNP----  213 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH-----------HHHHhCCC----
Confidence            233457899999999999999999999999999999999999999753221   000           00011111    


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMT-DVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~~  428 (457)
                      .++......+.+++.+||+.+|++||++. +++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            12223345789999999999999999997 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=305.12  Aligned_cols=259  Identities=21%  Similarity=0.311  Sum_probs=209.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+.|++.++||+|.|+.||++.. .+|+.+|+|.+...  .....+.+.+|+.+.+.|+||||+++.+.+.+.+..|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35677778899999999999885 46888888876433  2335677899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeeccCccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKM  306 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl~~~  306 (457)
                      |+|.|++|..-|..+.    .+++..+-..+.||++||.|+|.++   |||||+||+|+|+.   ..--+||+|||++..
T Consensus        90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999988777653    3788899999999999999999999   99999999999994   345699999999998


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      +.   .+.......|||+|||||++...+|+..+|||+.|+|||-|+.|.+||.+.+..   .+....           .
T Consensus       163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I-----------~  225 (355)
T KOG0033|consen  163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI-----------K  225 (355)
T ss_pred             eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH-----------h
Confidence            87   344566788999999999999999999999999999999999999999853221   111000           0


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .-+-.+.+.+......+..+|+.+||..||.+|.|+.|.+++  +++++.+
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H--pWi~~r~  274 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH--PWICNRE  274 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC--chhcchH
Confidence            001111222233445688999999999999999999999987  6666543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.9e-40  Score=313.97  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=194.6

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||+|+||.||++... +++.+|+|++....   ......+..|+++++.++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 58999999986432   12233456799999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++.....  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......   ....
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~  152 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT  152 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence            988865432  35889999999999999999999999   999999999999999999999999998765432   1223


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||..........            ............. ..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~~-~~  219 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------------ELKRRTLEDEVKF-EH  219 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH------------HHHHHhhcccccc-cc
Confidence            4568999999999998889999999999999999999999997432211100            0001111111110 01


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .....++.+|+..||+.||++||+++|+++.+
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            12345789999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-40  Score=322.46  Aligned_cols=242  Identities=27%  Similarity=0.413  Sum_probs=195.9

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||++... ++..+|+|.+....   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 47899999987542   22334567788888888 799999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~  151 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV  151 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence            99999887643    4899999999999999999999999   999999999999999999999999998753221  11


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ...             ..+.....  
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~-------------~~i~~~~~--  213 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF-------------QSILEDEV--  213 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH-------------HHHHcCCC--
Confidence            233456899999999999999999999999999999999999999743211   000             01111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  428 (457)
                      .++......+.+++.+||+.||.+||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            2233345578999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-40  Score=310.80  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=213.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..|++++.||.|.-|+||++.+.+ +..+|+|++.+..   ..+......|-++|+.++||.++.|++.|..+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456778899999999999999865 5899999997663   334455677999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |||+||+|..+++.+..  +.+++..+..++.+++-||+|||..|   ||.|||||+||||-++|.+-|+||.|+....-
T Consensus       157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999887655  56999999999999999999999999   99999999999999999999999999743210


Q ss_pred             ---------------------------------ccC---------------------CccccccccCCCccccccccCCC
Q 012739          310 ---------------------------------KIN---------------------GQISTRVLGTTGYLAPEYASTGK  335 (457)
Q Consensus       310 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~  335 (457)
                                                       ...                     +......+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             000                     01123367999999999999999


Q ss_pred             CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCC
Q 012739          336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPE  415 (457)
Q Consensus       336 ~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~  415 (457)
                      .+.++|.|+||+++|||+.|..||.+....                ++...++-..+.-.-....+..+.+||.+.|.+|
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            999999999999999999999999865432                3444454444432222256778999999999999


Q ss_pred             CCCCCC----HHHHHHHHHHhhh
Q 012739          416 AAYRPL----MTDVVQSLIPVVK  434 (457)
Q Consensus       416 p~~RPs----~~evl~~L~~~~~  434 (457)
                      |.+|..    +.||.++  .+++
T Consensus       376 P~kRlg~~rGA~eIK~H--pFF~  396 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRH--PFFE  396 (459)
T ss_pred             hhhhhccccchHHhhcC--cccc
Confidence            999998    8888877  4444

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-39  Score=312.50  Aligned_cols=258  Identities=22%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.++||+|+||.||+|.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 46889999988654 3334456889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|..+.        .+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999996542        3678888999999999999999999   999999999999999999999999998765432  


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||............         ........+...
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~~~~  217 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVDEDP  217 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhccCC
Confidence              223457899999999999999999999999999999999999999753321111000         000001111110


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..........++.+++.+||+.+|++||++.+++++  +++++...
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~--~~~~~~~~  261 (279)
T cd06619         218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH--PFIVQYND  261 (279)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC--cccccccC
Confidence            000111234478999999999999999999999987  66665443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.6e-40  Score=309.03  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=203.2

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.+.||+|+||.||++... ++..+++|.+.... ....+.+..|+.+++.++||||+++++.+.+++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 58899999886432 334456788999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            99999998875332  35789999999999999999999999   9999999999999999999999999987664321 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.......                ....... ..
T Consensus       155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~  216 (255)
T cd08219         155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------------LILKVCQ-GS  216 (255)
T ss_pred             -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----------------HHHHHhc-CC
Confidence             12234568889999999998889999999999999999999999997532210                0000000 11


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....+......+.+++.+||+.+|++||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111223344578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.1e-40  Score=312.47  Aligned_cols=251  Identities=30%  Similarity=0.455  Sum_probs=199.4

Q ss_pred             ceeccCCcEEEEEEEEcC-------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSD-------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +.||+|+||.||+|...+       +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998643       2578999876543 23445688899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-----cEEEeeccC
Q 012739          232 MPNGTLQQHLHRHNNR---YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-----RAKVTDFGL  303 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl  303 (457)
                      +++++|.+++......   ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999764321   234789999999999999999999998   99999999999999877     899999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ++...............++..|+|||.+.+..++.++||||||+++|||+| |+.||......                 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----------------  220 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----------------  220 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----------------
Confidence            976643322222223345778999999999999999999999999999998 99998643211                 


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      +....+........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            011111111111223344568899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-39  Score=315.53  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=207.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .+|++.+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788889999999999999985 468899999987665555567889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++...     .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus       100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-  170 (296)
T cd06654         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (296)
T ss_pred             CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence            999999998642     3789999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ...             ......
T Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~-------------~~~~~~  234 (296)
T cd06654         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI-------------ATNGTP  234 (296)
T ss_pred             -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH-------------hcCCCC
Confidence             1123346888999999998888999999999999999999999999754321110  000             000000


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ....+......+.+++.+||..+|++||++.+++++  ++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~--~~~~  274 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLK  274 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC--hhhh
Confidence            111223345578999999999999999999999986  4444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-39  Score=310.09  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=193.7

Q ss_pred             ceeccCCcEEEEEEEEcC---CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD---GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.||+|+||.||+|...+   +..+++|++.... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   4578999887653 233456888999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          236 TLQQHLHRHNN-RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       236 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      +|.+++..... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 2234677888899999999999999999   9999999999999999999999999987543322222


Q ss_pred             cccccccCCCccccccccCC-------CCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          315 ISTRVLGTTGYLAPEYASTG-------KLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||........   .....     ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~-----~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV-----REQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh-----hcccCC
Confidence            22345678889999988542       35789999999999999996 9999975332111   00000     000011


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ..++.+.    ......+.+++..|+ .+|++|||+++|++.|+
T Consensus       230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1112221    123346888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=312.90  Aligned_cols=271  Identities=24%  Similarity=0.399  Sum_probs=209.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-----CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-----DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~  225 (457)
                      ..|++.+.||+|+||.||++.+.     ++..+|+|.+...... ..+.+..|+++++.+.||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677789999999999999854     3678999999766443 45678999999999999999999999877  5678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      +++|||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999999976442   4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ......... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.............  ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~  235 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRL  235 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHH
Confidence            765322111 1112344567999999988899999999999999999999999986432211000000  0000011122


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      .+.+........+..++.++.+++.+||+.+|++||++.||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            222222222222334456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-39  Score=308.42  Aligned_cols=251  Identities=28%  Similarity=0.474  Sum_probs=202.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      .+|++.+.||+|+||.||++.+.++..+++|.+..... ....+.+|+++++.++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            45777889999999999999987788999998865432 23468889999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            9999999876432   4789999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......                 ...+.+....
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~  218 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----------------EVVETINAGF  218 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHhCCC
Confidence            11122334678999999998899999999999999999998 99998743211                 1111111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ....+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1111222346899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-39  Score=308.28  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             ceeccCCcEEEEEEEEcC--C--cEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD--G--TVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|++|.||+|.+.+  +  ..+|+|.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998643  3  3689999977655 455678999999999999999999999988 889999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.......
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999987542  45899999999999999999999999   9999999999999999999999999998765422211


Q ss_pred             -cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          315 -ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       315 -~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....          ...   ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----------~~~---~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKK----------IDK---EGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----------HHh---cCC
Confidence             1223456788999999998899999999999999999999 999986432210   0000          000   001


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122334568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-40  Score=323.25  Aligned_cols=237  Identities=27%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEV-DLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||+||+|... +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68899999986532   12223344444 456889999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~  151 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK  151 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence            99999987643    4889999999999999999999999   999999999999999999999999998754221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                ....+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~~~--  213 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNILNKPL--  213 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcCCC--
Confidence            2345679999999999999999999999999999999999999997532110                0001111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMT  423 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~  423 (457)
                      ..+......+.+++.+||+.+|.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11222355789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.7e-40  Score=328.76  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      .++....++|++.+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999975 57889999885422   22334577899999999999999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      +..++||||+++|+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999998653     3788889999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCC----CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTG----KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      +++...... ........||+.|+|||++...    .++.++|||||||++|||++|+.||.......            
T Consensus       188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------------  254 (371)
T cd05622         188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------  254 (371)
T ss_pred             ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------------
Confidence            998664321 1122356799999999998653    37899999999999999999999997532210            


Q ss_pred             CchhHHhhhcCC--cCCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHH
Q 012739          379 TSREEAVEMVDP--SLQGQYPKKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQSL  429 (457)
Q Consensus       379 ~~~~~~~~~~d~--~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L  429 (457)
                          ....+...  .+........+..+.+++..|+..++.+  |+++.+++++.
T Consensus       255 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         255 ----TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                01111110  0111111234557899999999855543  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-39  Score=313.62  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      |+..+.||+|+||.||++... +++.+|+|.+....   ......+..|+.+++.++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999965 58899999886542   22234567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998865432  35889999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........             .......+ .
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-------------~~~~~~~~-~  219 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLVK-E  219 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------HHHHhhhh-h
Confidence               123346899999999999999999999999999999999999999753221100             00101110 1


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~~  435 (457)
                      ....++......+.+|+.+||+.+|++|||     +.|++++  +++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h--~~~~~  266 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH--PLFKQ  266 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC--hhhhc
Confidence            111223334557899999999999999999     8899987  56654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.7e-40  Score=322.75  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=196.2

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||++... +++.+|+|++....   ....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57889999997542   22334577899999888 699999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~  151 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD  151 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence            99999886543    4899999999999999999999999   999999999999999999999999998753221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+..         ........  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~--  220 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---------QVILEKPI--  220 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---------HHHHhCCC--
Confidence            2345679999999999999999999999999999999999999997432211111111100         01111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLM------TDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  428 (457)
                      ..+...+..+.+++.+||+.||.+|+++      .+++++
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            2333344578999999999999999984      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-39  Score=308.94  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---------QRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      +|.+.+.||+|+||.||+|... ++..+++|.+.....         ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 578999998864321         112457889999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999997643    4888999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          305 KMVSDKING----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       305 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      +........    .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......               
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------  218 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---------------  218 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------------
Confidence            876532111    1112345788999999999888999999999999999999999999743211               


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ........ ......+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       219 -~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         219 -QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             01111101 11122333455689999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3e-40  Score=328.48  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+..|+.++..++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5788899999999999999965 58899999986432   2233557889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          82 FLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             CCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999997643    4899999999999999999999999   999999999999999999999999998754321


Q ss_pred             cCC---------------------------------ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCC
Q 012739          311 ING---------------------------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV  357 (457)
Q Consensus       311 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~  357 (457)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 01123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCH--HHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 012739          358 PVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK--KDLIQIAAIAAVCVQPEAAYRPL---MTDVVQS  428 (457)
Q Consensus       358 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~l~~li~~cl~~~p~~RPs---~~evl~~  428 (457)
                      ||.........                ..+........++.  ....++.+++.+|+. +|.+|++   +.+++++
T Consensus       235 Pf~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETY----------------RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHH----------------HHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            99754331110                00110000001111  134478888888774 9999985   6777776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.8e-40  Score=323.11  Aligned_cols=240  Identities=27%  Similarity=0.342  Sum_probs=189.4

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHH-HHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E-i~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|+.. +++.+|+|.+....   ......+..| ..+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999975 57789999986532   1222233334 4457889999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+.+..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~  151 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG  151 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence            99999987643    3788888999999999999999999   999999999999999999999999998754321  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..             ..+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~-------------~~i~~~~~--  213 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MY-------------DNILNKPL--  213 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HH-------------HHHHhCCc--
Confidence            2345679999999999999999999999999999999999999997532210   00             01111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVV  426 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  426 (457)
                      ..+......+.+++.+||+.+|.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            12223445789999999999999999877433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-39  Score=307.99  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=202.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +|+..+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12234588899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||+++++|.+++....    ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999997643    4789999999999999999999999   9999999999999999999999999987653


Q ss_pred             ccc----CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          309 DKI----NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       309 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ...    .........++..|+|||.+.+..++.++||||||+++|+|++|+.||............           ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-----------~~  222 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-----------GA  222 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-----------hh
Confidence            211    111223456889999999999888999999999999999999999999743221100000           00


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+    ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       223 ~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 HRGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ccCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000111    2223345578999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.5e-40  Score=311.63  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=199.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC------C
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ------N  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~------~  223 (457)
                      +...|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888889999999999999865 57889999886543 2334678899999998 799999999998653      4


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..+++|||+++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            68999999999999999876432  35889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||..........         
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~---------  226 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------  226 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---------
Confidence            87654321  1234467899999999985     3468889999999999999999999996432211000         


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                             ...........+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus       227 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         227 -------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                   0000011111122334578999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-39  Score=308.46  Aligned_cols=239  Identities=20%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             ceeccCCcEEEEEEEEcC-------------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          160 NVIGNGGFGVVYKGVLSD-------------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      +.||+|+||.||+|...+             ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             2358888876655555567888999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc-------EEEe
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR-------AKVT  299 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~  299 (457)
                      +||||+++++|..++....   ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999999886543   35899999999999999999999999   999999999999987664       8999


Q ss_pred             eccCccccccccCCccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHH-cCCCCCCCCCCCCcchhhhhhccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELL-TGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      |||++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|..||.......           
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----------  217 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----------  217 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----------
Confidence            99998654321      2245778899999886 567899999999999999997 5888876432110           


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                            ..........  ........+.+|+.+||+.+|++||++.+|++.|
T Consensus       218 ------~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 ------KERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ------HHHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                  0001111111  1111235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-40  Score=329.45  Aligned_cols=268  Identities=18%  Similarity=0.252  Sum_probs=205.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc---CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..+|.+.+.||+|+||.||++...   .+..|++|.+...     ....+|+++++.++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3567899987543     23457999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |++. ++|.+++...    ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++.....
T Consensus       166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9994 7888888433    35899999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC-------c--
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT-------S--  380 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~--  380 (457)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.       .  
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            4333333456799999999999999999999999999999999999999976543321111100000000       0  


Q ss_pred             -hh--HHhhhcCCcCCCCCC-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 -RE--EAVEMVDPSLQGQYP-------KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 -~~--~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ..  .....+....+..+.       .....++.+++.+||+.+|++|||+.|++.+  +++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~--p~f~~  380 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL--PLFTK  380 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC--chhhc
Confidence             00  000001111111111       1123578899999999999999999999998  66654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-40  Score=328.40  Aligned_cols=270  Identities=21%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----eEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRL  226 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~  226 (457)
                      +|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999996 46899999998653  2334456888999999999999999999998776     789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +|+||+. ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999995 67888775432    4899999999999999999999999   99999999999999999999999999986


Q ss_pred             cccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch----
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR----  381 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  381 (457)
                      ..... ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+..........    
T Consensus       153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            54321 1223344678999999998764 57999999999999999999999998654322211111111000000    


Q ss_pred             --hHHhh-hcCCcCCC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 --EEAVE-MVDPSLQG-------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 --~~~~~-~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        ..... +.......       ........++.+|+.+||+.||++|||+.|++++  .++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h--p~~~~  293 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH--PYLDE  293 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC--HhhCC
Confidence              00000 00000000       1112234578899999999999999999999987  56655

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-39  Score=323.14  Aligned_cols=272  Identities=22%  Similarity=0.290  Sum_probs=202.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-----  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----  223 (457)
                      ..++|++.+.||+|+||.||++... ++..+|+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999864 5889999998653  2334456778999999999999999999986443     


Q ss_pred             -eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          224 -HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       224 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                       ..++||||++ ++|.+.+..      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence             5799999996 466666542      3788899999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc--
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS--  380 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  380 (457)
                      +++.....   .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.................  
T Consensus       169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            98754322   1223456899999999999999999999999999999999999999854321100000000000000  


Q ss_pred             ----hhHHhhhc--CCcCC----------------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 ----REEAVEMV--DPSLQ----------------GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 ----~~~~~~~~--d~~l~----------------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                          ........  .+...                ...+......+.+|+.+||+.||++|||+.|++++  .+++.+-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h--p~~~~~~~  323 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH--PYITVWYD  323 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC--chhhhhcC
Confidence                00000000  00000                00111224578999999999999999999999998  66665433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-39  Score=331.16  Aligned_cols=273  Identities=20%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC------CCeeeEEEEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS------PQLVELLGYC  219 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h------pniv~l~~~~  219 (457)
                      +++.....+|++.++||+|+||+||+|... .++.||||++.... .....+..|+.+++.++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            444556788999999999999999999864 57889999986432 223345567777776654      4588999988


Q ss_pred             EcC-CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCC---
Q 012739          220 ADQ-NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNF---  294 (457)
Q Consensus       220 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~---  294 (457)
                      ... ...++|||++ +++|.+++....    .+++.++..++.|++.||.|||+ .+   ||||||||+|||++.++   
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence            754 5788999988 788998887643    48999999999999999999998 48   99999999999998765   


Q ss_pred             -------------cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          295 -------------RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       295 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                                   .+||+|||++.....     ......||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         499999998754321     23456799999999999999999999999999999999999999976


Q ss_pred             CCCCCcchhhhhhccccCc-------hhHHhhhcCCc--CCCCC---------------CHHHHHHHHHHHHhhcCCCCC
Q 012739          362 NRPPGEHVLVSWALPRLTS-------REEAVEMVDPS--LQGQY---------------PKKDLIQIAAIAAVCVQPEAA  417 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~li~~cl~~~p~  417 (457)
                      .........+......+..       ..+...+++..  +....               .......+.+|+.+||+.||+
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            4432111111111111000       00000010000  00000               001134678999999999999


Q ss_pred             CCCCHHHHHHHHHHhhhh
Q 012739          418 YRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       418 ~RPs~~evl~~L~~~~~~  435 (457)
                      +|||+.|++++  .++++
T Consensus       428 ~R~ta~e~L~H--p~~~~  443 (467)
T PTZ00284        428 KRLNARQMTTH--PYVLK  443 (467)
T ss_pred             hCCCHHHHhcC--ccccc
Confidence            99999999998  77765

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-39  Score=305.66  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lv~e  230 (457)
                      +|++.+.||+|++|.||++... +++.+++|++....  ....+.+.+|+++++.++|+|++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999965 47889999986542  3344568889999999999999999998764 456789999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++.....  ..+++.+++.++.|++.|+.+||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999976432  45899999999999999999999999   999999999999999999999999999866432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......      .          ...... 
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~----------~~~~~~-  216 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------L----------VYRIIE-  216 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------H----------HHHHHh-
Confidence            1  22334568899999999999999999999999999999999999987432110      0          000000 


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ......+......+.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11112333455689999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-39  Score=344.52  Aligned_cols=264  Identities=23%  Similarity=0.315  Sum_probs=207.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.++||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999965 58899999986542   223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          230 EYMPNGTLQQHLHRHNN-------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      ||+++|+|.+++.....       ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999875321       1134667888999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccC----------------CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 012739          303 LAKMVSDKIN----------------GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG  366 (457)
Q Consensus       303 l~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~  366 (457)
                      +++.......                ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621100                011123569999999999999999999999999999999999999997532210


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHhhhh
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-LMTDVVQSLIPVVKN  435 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~  435 (457)
                      ..    .       .   ....++... ....+.+..+.+++.+|++.||++|| +++++++.|+++++.
T Consensus       239 i~----~-------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS----Y-------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh----h-------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00    0       0   000011000 00123345788999999999999995 788888999988775

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.7e-39  Score=308.05  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=205.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..|+..+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999975 58899999886543 34456788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++...     ++++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999998642     4888999999999999999999998   9999999999999999999999999997664322


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......++..|+|||.+.+..++.++||||||+++|||+||+.||....+..                 ........
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~~~~  216 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----------------VLFLIPKN  216 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----------------HhhhhhcC
Confidence              11233467889999999988889999999999999999999999997543211                 01111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1223445567789999999999999999999999888

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.6e-40  Score=319.98  Aligned_cols=241  Identities=26%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +|+..+.||+|+||.||+|... +++.||+|++....   ....+.+..|..+++.+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999965 58899999986542   223345677888888886 577888999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999987643    4899999999999999999999999   99999999999999999999999999875432


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..             ...+..
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~-------------~~~i~~  215 (323)
T cd05615         154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL-------------FQSIME  215 (323)
T ss_pred             C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH-------------HHHHHh
Confidence            1  11233456899999999999999999999999999999999999999754221   00             011111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM  422 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  422 (457)
                      ..  ..++......+.+++.+||+.+|.+|++.
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11  12333445578999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4e-40  Score=323.02  Aligned_cols=239  Identities=26%  Similarity=0.347  Sum_probs=189.3

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHH-HHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVD-LLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|+.. +++.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999964 68899999986531   222334444544 57789999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|..++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  151 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD  151 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence            99998887543    4899999999999999999999999   999999999999999999999999998753221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .             ........+  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~-------------~~~~~~~~~--  213 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M-------------YDNILHKPL--  213 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H-------------HHHHHcCCc--
Confidence            2345679999999999999999999999999999999999999997532210   0             001111111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDV  425 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  425 (457)
                      ..+......+.+++.+|++.+|.+||++++.
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            1112234578899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.2e-40  Score=320.61  Aligned_cols=237  Identities=27%  Similarity=0.356  Sum_probs=188.5

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEV-DLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||.||+|+.. ++..+|+|.+....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999986532   12223344444 467889999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|..++....    .+.+.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~  151 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE  151 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence            99998886533    4888899999999999999999999   999999999999999999999999998753221  12


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......   ..             ...+....  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~-------------~~~i~~~~--~  213 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QM-------------YDNILHKP--L  213 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HH-------------HHHHhcCC--C
Confidence            234467899999999999989999999999999999999999999753211   00             00111111  1


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMT  423 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~  423 (457)
                      ..+......+.+++.+||+.+|.+||+..
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23334455789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-40  Score=310.43  Aligned_cols=253  Identities=30%  Similarity=0.508  Sum_probs=201.0

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHH--HHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRER--AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      |++.+.||+|+||+||+++... ++.+|+|.+.........  ...+|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5667899999999999999765 568999999877544332  3456999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....    .+++.+++.++.|+++||.+||+.+   ++|+||||+||+++.++.++|+|||.+.....  .
T Consensus        81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~  151 (260)
T PF00069_consen   81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N  151 (260)
T ss_dssp             TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred             ccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--c
Confidence            9999999998433    4899999999999999999999999   99999999999999999999999999875411  1


Q ss_pred             CccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      ........++..|+|||.+. +..++.++||||||+++|+|++|..||......+........         ........
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---------~~~~~~~~  222 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---------LKRPLPSS  222 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---------HHTHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---------cccccccc
Confidence            23345567899999999998 888999999999999999999999999854111111100000         00000000


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .  .........+.+++.+||+.+|++||++.+++++
T Consensus       223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  0001112689999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=309.44  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.+.||.|+||.||+|... +++.+++|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5778889999999999999965 58899999886553 334456888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++...     ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++...... 
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999998753     5899999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       .......++..|+|||.+.+..++.++||||||+++|+|+||+.||....+...                 ...+....
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----------------~~~~~~~~  214 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----------------LFLIPKNN  214 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----------------HHHhhhcC
Confidence             122345688899999999988899999999999999999999999975432100                 00000011


Q ss_pred             CCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          393 QGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....+.. .+..+.+++.+||..+|++|||+++++++  +++++
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~--~~~~~  256 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH--KFIKK  256 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC--hhhcC
Confidence            1111111 44578999999999999999999999886  66654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.1e-39  Score=310.22  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=203.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .+.|++.+.||.|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3668889999999999999999754 889999998776666667788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|..++....   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...... 
T Consensus        91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-  163 (292)
T cd06644          91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-  163 (292)
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence            99999998876543   24899999999999999999999998   999999999999999999999999998754322 


Q ss_pred             CCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          312 NGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                       ........++..|+|||.+.     ...++.++|||||||++|||++|+.||.......                ....
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------------~~~~  226 (292)
T cd06644         164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----------------VLLK  226 (292)
T ss_pred             -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH----------------HHHH
Confidence             11123456788999999884     3457889999999999999999999987532210                0011


Q ss_pred             hcCCcC-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSL-QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...... ....+.....++.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         227 IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            110000 001122344578999999999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-39  Score=308.79  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|.+.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46677788999999999999864 58899999987665555566788999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999987543    4899999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          313 GQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                       .......|+..|+|||.+.   ...++.++|||||||++|+|++|+.||....+.......  .         ......
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~---------~~~~~~  228 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--T---------KSNFQP  228 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--h---------ccCCCC
Confidence             1123456899999999874   456889999999999999999999998643321110000  0         000000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +....  ....+..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            11110  01223468899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.9e-39  Score=306.24  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +.+++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344556666678999999999999954 5778999998776666667789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCcc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPL--DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~  305 (457)
                      +||+++++|.+++.....   ++  ++..+..++.|++.||.|||+.+   ++||||||+||+++. ++.++|+|||++.
T Consensus        84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          84 MEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            999999999999986432   24  78888899999999999999999   999999999999976 6799999999987


Q ss_pred             ccccccCCccccccccCCCccccccccCC--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ......  .......++..|+|||.+...  .++.++||||||+++|+|++|+.||.........   .+.         
T Consensus       158 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~---------  223 (268)
T cd06624         158 RLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK---------  223 (268)
T ss_pred             ecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh---------
Confidence            653221  112234578899999998654  3789999999999999999999998643221110   000         


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                         ..........+.....++.+++.+||+.+|.+|||+.+++++
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         224 ---VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               000001112333455679999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-39  Score=311.37  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=200.1

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ......+.+|+++++.++|+||+++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999964 58899999886542   12234567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++...... 
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            999999998875432  35999999999999999999999999   999999999999999999999999998765322 


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..........             .....+...
T Consensus       156 --~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~-------------~~~~~~~~~  220 (285)
T cd05632         156 --ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE-------------EVDRRVLET  220 (285)
T ss_pred             --CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHHhhhcc
Confidence              11234568999999999998899999999999999999999999997532211000             000000000


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                       ...++......+.+|+..||+.+|++||+     +.+++++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             01122334457899999999999999999     6677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-39  Score=307.61  Aligned_cols=253  Identities=26%  Similarity=0.341  Sum_probs=190.3

Q ss_pred             eeccCCcEEEEEEEEcC---CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          161 VIGNGGFGVVYKGVLSD---GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3568888776443 3334567889999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcc
Q 012739          237 LQQHLHRHNNR-YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       237 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      |.+++...... ....++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999875432 233567888899999999999999999   99999999999999999999999999875433211111


Q ss_pred             ccccccCCCcccccccc-------CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          316 STRVLGTTGYLAPEYAS-------TGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      .....++..|+|||++.       ...++.++|||||||++|||++ |..||.......  ... ....     ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~-~~~~-----~~~~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK-QVVR-----EQDIKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH-HHhh-----ccCccC
Confidence            23334567899999864       3457889999999999999999 788886432210  000 0000     000011


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .++    ..+......+.+++..|| .+|++||++++|++.|
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111    222334457788888898 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-39  Score=303.91  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=205.0

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|+..+.||.|+||.||.++. .++..+++|++...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999885 45888999987644  234445688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....  ...+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999997643  235889999999999999999999999   9999999999999999999999999988664432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      .  ......+++.|+|||.+.+..++.++||||||+++|||++|..||......                ..........
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~  217 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----------------NLVVKIVQGN  217 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCC
Confidence            1  233456899999999998888999999999999999999999999753221                0111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .. ..+...+..+.+++.+||+.+|++||++.++++++
T Consensus       218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11 11233455799999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.9e-39  Score=312.85  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999996 46899999998766555556788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++...     .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999998652     3788999999999999999999999   9999999999999999999999999987654321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... .+      .      ...+.
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~------~------~~~~~  234 (297)
T cd06656         170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA------T------NGTPE  234 (297)
T ss_pred             --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ec------c------CCCCC
Confidence              112345688899999999988899999999999999999999999975432111000 00      0      00000


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        ...+......+.+++.+||+.+|++||++.+++++  ++++.
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~~  274 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH--PFLKL  274 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--chhcc
Confidence              11223344578899999999999999999999997  66654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.6e-39  Score=308.83  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      |++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5667889999999999999764 778899988766555566788899999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|..++....   .++++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            99998876532   35899999999999999999999999   9999999999999999999999999987653321  1


Q ss_pred             cccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          315 ISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||........  ...           ......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~-----------~~~~~~  225 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK-----------IAKSEP  225 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH-----------HhhcCC
Confidence            223456889999999873     45678899999999999999999999874322100  000           000000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      +..  ..+......+.+++.+||+.+|.+||++.+++++  ++++..
T Consensus       226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~--~~~~~~  268 (282)
T cd06643         226 PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH--PFVTVN  268 (282)
T ss_pred             CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--CCEecc
Confidence            111  1222344589999999999999999999999877  555543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-39  Score=304.38  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|+..+.||.|+||.||+|...+ +..+++|.+.....  .+.+.+|+++++.++||||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568888999999999999999765 78999999865532  567899999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999987543   35899999999999999999999999   99999999999999999999999999887654321


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........             ......+. 
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~~-  218 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKPPPT-  218 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCCCCC-
Confidence              22334578899999999988999999999999999999999999975432111000             00000000 


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ...+......+.+++.+||+.+|++|||+.+|+++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             11223345579999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-39  Score=318.89  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ...+|.+.+.||+|+||.||+|... ++..||+|.....      ....|+.+++.++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999975 4678899875432      13458999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ++ .++|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       138 ~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             cc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99 568888886533   35899999999999999999999999   999999999999999999999999998753221


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh-------hhhcccc-----
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV-------SWALPRL-----  378 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~-----  378 (457)
                         .......||..|+|||++.+..++.++|||||||++|||+++..|+....+.......       ......+     
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence               1223456899999999999999999999999999999999976655332221111000       0000000     


Q ss_pred             -----CchhHHhhhcCCc--CCCCC-------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          379 -----TSREEAVEMVDPS--LQGQY-------PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       379 -----~~~~~~~~~~d~~--l~~~~-------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                           .........++..  .+..+       .......+.+|+.+||+.||.+|||+.|++++  .+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h--p~f~  355 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY--PMFA  355 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC--chhc
Confidence                 0000000000000  00000       01223456779999999999999999999987  5544

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.4e-39  Score=305.06  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=204.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lv~  229 (457)
                      +|++.+.||.|+||.||++... ++..+++|.+...  .....+.+..|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6788999988654  23344568889999999999999999998754  45679999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      ||+++++|.+++........++++..++.++.|++.||.|||     +.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999875444457999999999999999999999     666   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....   .              ..
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~--------------~~  218 (265)
T cd08217         158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---L--------------QL  218 (265)
T ss_pred             ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---H--------------HH
Confidence            8765432  112345689999999999988899999999999999999999999975431   0              11


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+.+........+...+..+.+++.+|++.+|++||++.+|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         219 ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            11111111123344455689999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-40  Score=327.36  Aligned_cols=269  Identities=27%  Similarity=0.353  Sum_probs=210.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-S-----PQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h-----pniv~l~~~~~~~~~~  225 (457)
                      ..+|.+.++||+|+||.|.+|.+. +++.||||++++. .....+...|+.+|..|+ |     -|+|+++++|...++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            347899999999999999999954 5999999999765 344456677999999997 4     4899999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC--CcEEEeeccC
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--FRAKVTDFGL  303 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgl  303 (457)
                      |||+|.+ .-+|.++|..+.  ..+++...+..|+.||+.||..||..+   |||+||||+||||.+-  ..+||+|||+
T Consensus       264 ciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999 679999998754  467999999999999999999999999   9999999999999653  3799999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc-----
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL-----  378 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  378 (457)
                      +........     ....+..|+|||++.+.+|+.+.|+||||||++||++|.+.|.+..+.++...+...+...     
T Consensus       338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            987655432     5567778999999999999999999999999999999988887665433322221111100     


Q ss_pred             --------------------Cchh--------HH--------hhhcCC-c---CCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 012739          379 --------------------TSRE--------EA--------VEMVDP-S---LQGQYPKKDLIQIAAIAAVCVQPEAAY  418 (457)
Q Consensus       379 --------------------~~~~--------~~--------~~~~d~-~---l~~~~~~~~~~~l~~li~~cl~~~p~~  418 (457)
                                          ....        ..        .+...| .   +....+......+.+++++||.+||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                                0000        00        000001 0   011122244567899999999999999


Q ss_pred             CCCHHHHHHHHHHhhhh
Q 012739          419 RPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       419 RPs~~evl~~L~~~~~~  435 (457)
                      |+|..+++++  .++..
T Consensus       493 R~tp~qal~H--pfl~~  507 (586)
T KOG0667|consen  493 RITPAQALNH--PFLTG  507 (586)
T ss_pred             cCCHHHHhcC--ccccc
Confidence            9999999998  77773

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-39  Score=309.72  Aligned_cols=239  Identities=22%  Similarity=0.398  Sum_probs=188.1

Q ss_pred             eeccCCcEEEEEEEEcC-------------------------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeE
Q 012739          161 VIGNGGFGVVYKGVLSD-------------------------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVEL  215 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l  215 (457)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13588888866544445668889999999999999999


Q ss_pred             EEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-
Q 012739          216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-  294 (457)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-  294 (457)
                      ++++.+....++||||+++|+|..++....   ..+++..++.++.|++.||.|||+++   ++||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            999999999999999999999999987533   24889999999999999999999998   99999999999997643 


Q ss_pred             ------cEEEeeccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHH-cCCCCCCCCCCCC
Q 012739          295 ------RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELL-TGRVPVDPNRPPG  366 (457)
Q Consensus       295 ------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~ell-tg~~p~~~~~~~~  366 (457)
                            .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  4899999987644221      22346788999998865 56899999999999999984 7999987543211


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ..                 ..+....  ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus       230 ~~-----------------~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KE-----------------RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-----------------HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10                 0011000  111112346899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-39  Score=316.36  Aligned_cols=273  Identities=20%  Similarity=0.276  Sum_probs=204.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|.+.+.||+|+||.||+|... ++..+|+|++..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999865 578899998865432 2233567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++....   ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            96 58888876543   24788999999999999999999999   9999999999999999999999999987543221


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--------ccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--------RLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  382 (457)
                        .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||......+..........        .+....
T Consensus       159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              11233467899999998865 5689999999999999999999999976543222111111100        000000


Q ss_pred             HHhhhcCCcCCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          383 EAVEMVDPSLQG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       383 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .....-.+....    ........++.+|+.+||+.||.+|||+.|++++  .+++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~~~~~~  293 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH--AYFRSLG  293 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC--hhhhhcc
Confidence            000000011000    0011234578899999999999999999999987  6776543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=318.39  Aligned_cols=254  Identities=24%  Similarity=0.311  Sum_probs=196.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888999999999999999965 5889999998642   1223345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999997643   24889999999999999999999999   99999999999999999999999999876543


Q ss_pred             ccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.........             ...
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------------~~i  220 (331)
T cd05597         155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------------GKI  220 (331)
T ss_pred             CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-------------HHH
Confidence            211 11223468999999999863     45788999999999999999999999753221000             000


Q ss_pred             hhhcCCcCC-CCCCHHHHHHHHHHHHhhcCCCCC--CCCCHHHHHHH
Q 012739          385 VEMVDPSLQ-GQYPKKDLIQIAAIAAVCVQPEAA--YRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~p~--~RPs~~evl~~  428 (457)
                      ... ...+. .......+..+.+++.+|+..+++  .||++.+++++
T Consensus       221 ~~~-~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         221 MNH-KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HcC-CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000 00000 001112345788888887755443  47899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.8e-39  Score=305.42  Aligned_cols=246  Identities=29%  Similarity=0.466  Sum_probs=199.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.+.||+|+||.||++.. ++..+|+|.+....  ....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578889999999999999975 67789999886543  234688899999999999999999998765 4799999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            9999999976432  35789999999999999999999998   999999999999999999999999998764322   


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.......                 ....+....
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~  214 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVEKGY  214 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhCCC
Confidence              122334567999999988899999999999999999998 999987543211                 111111112


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ....+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            22223344568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.7e-39  Score=306.61  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             eeccCCcEEEEEEEEcCC---cEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          161 VIGNGGFGVVYKGVLSDG---TVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999985443   346677665443 3345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccc
Q 012739          237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS  316 (457)
Q Consensus       237 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  316 (457)
                      |.+++.........+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999875443445777788899999999999999998   999999999999999999999999997643221111122


Q ss_pred             cccccCCCccccccccC-------CCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          317 TRVLGTTGYLAPEYAST-------GKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       317 ~~~~gt~~y~aPE~~~~-------~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||.......   ......     .+......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~-----~~~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVI-----KDQQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-----hhcccccC
Confidence            34567889999998743       345789999999999999997 566775432110   000000     01111223


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3333322    3347888999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-39  Score=312.37  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=208.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999985 468899999887655445567888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++...     .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999988642     3899999999999999999999999   99999999999999999999999999876543221


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........             ......+. 
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-------------~~~~~~~~-  234 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------IATNGTPE-  234 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhcCCcc-
Confidence              12335688899999999988899999999999999999999999975432111000             00000001 


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ...+......+.+++.+||..+|++||++.+++++  ++++.
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~--~~~~~  274 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH--PFLKL  274 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhhh
Confidence             11233345578999999999999999999999987  77764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=345.19  Aligned_cols=264  Identities=22%  Similarity=0.356  Sum_probs=203.5

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCe
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNH  224 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~  224 (457)
                      .....+|.+.+.||+|+||.||++... ++..+|+|.+...  .......+..|+.+++.|+||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445578999999999999999999965 4678889987643  23344568889999999999999999998854  457


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeccCccCceEeCC--------
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT----PPVIHRDFKCSNVLLDQ--------  292 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dlkp~NIll~~--------  292 (457)
                      +||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999998754434569999999999999999999998542    23999999999999964        


Q ss_pred             ---------CCcEEEeeccCccccccccCCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          293 ---------NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       293 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                               .+.+||+|||++..+...   .......||+.|+|||++.+  ..++.++||||||||||||+||+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     335899999999865432   12234578999999999854  4589999999999999999999999974


Q ss_pred             CCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ......  +.          ..+...  +.+.   ....+.++.+||..||+.+|.+||++.|++++  +++++
T Consensus       246 ~~~~~q--li----------~~lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h--~~ik~  300 (1021)
T PTZ00266        246 ANNFSQ--LI----------SELKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY--QIIKN  300 (1021)
T ss_pred             CCcHHH--HH----------HHHhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc--HHHhh
Confidence            322100  00          000000  1110   01224579999999999999999999999965  55553

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.8e-39  Score=306.39  Aligned_cols=254  Identities=22%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC--CcEEEEEEcccC----------chHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEc
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD--GTVAAIKKLHRD----------GKQRERAFRMEVDLLSR-LHSPQLVELLGYCAD  221 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~  221 (457)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999765  688999987532          12223446678887765 799999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                      ++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999987644444568999999999999999999996 66   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ||++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......              
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------------  220 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------------  220 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------------
Confidence            99998654432   2344568889999999998889999999999999999999999987432210              


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                        ......+..............+.+++.+||+.||++||++.|+..+|+
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         221 --LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              000111111111111123457999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-39  Score=310.21  Aligned_cols=264  Identities=23%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE--
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCA--  220 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~--  220 (457)
                      .++.+..+.++|++.+.||+|+||.||++... +++.+++|++.... .....+..|+.+++.+ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34556667889999999999999999999864 57889999875432 2234577899999999 7999999999874  


Q ss_pred             ---cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          221 ---DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       221 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                         .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence               345789999999999999988754433456889999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~  372 (457)
                      |+|||++.......  .......|+..|+|||.+..     ..++.++|||||||++|||++|+.||.........  ..
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~  240 (286)
T cd06638         165 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK  240 (286)
T ss_pred             EccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence            99999987664321  12233468999999998753     45789999999999999999999999754321100  00


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                           .      .....+.+  ..+......+.+++.+||+.+|++||++.|+++++
T Consensus       241 -----~------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         241 -----I------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -----c------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                 0      00000000  01112234799999999999999999999999873

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.7e-39  Score=303.95  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=198.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~  225 (457)
                      .+|...+.||+|+||.||+|... ++..+++|++....     ......+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888899999999999999864 58899999875431     2233458889999999999999999998865  3678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++++||+++++|.+++....    .+++...+.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999999997643    3889999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||......                ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------------~~~  218 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------------AAI  218 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----------------HHH
Confidence            65432111 1122345788999999999888999999999999999999999999743211                111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ............+......+.+++ +||..+|++||+++||+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            111111112233344445677777 6888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=331.30  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=221.8

Q ss_pred             CCCceeccCCcEEEEEEEEc-CC----cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLS-DG----TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~-~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +..++||.|+||+||+|.+- +|    -+||+|++... ..+...++.+|+-+|..++|||+++|+|+|.... .-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            44688999999999999963 33    46899988665 4455678999999999999999999999998776 789999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++.|+|.+|++.++.   .+..+..+.|..|||+||.|||.++   +|||||..+|||+..-..+||.|||+++.+...
T Consensus       778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999998665   5888999999999999999999999   999999999999999999999999999988765


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..........-.+.|||-|.+....|+.++|||||||++|||+| |..|++....                 +++.+++.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHh
Confidence            54444444445678999999999999999999999999999999 8899875432                 45555566


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ...+-..|+.+..++..++.+||..|+..||+++++...+.++.++..
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            555567788889999999999999999999999999999999988744

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-39  Score=318.21  Aligned_cols=252  Identities=24%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.++||+|+||.||+++... ++.+|+|.+....   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            368888999999999999999754 7789999885432   222344788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999976432   4889999999999999999999999   99999999999999999999999999875532


Q ss_pred             ccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          310 KINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .. ........||+.|+|||++.     ...++.++|||||||++|||++|+.||........                .
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~----------------~  217 (332)
T cd05623         155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------------Y  217 (332)
T ss_pred             CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH----------------H
Confidence            21 11223457999999999985     34688999999999999999999999975322110                0


Q ss_pred             hhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 012739          385 VEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  428 (457)
                      ..+........+   .......+.+|+.+|+..++.+  |+++.+++++
T Consensus       218 ~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            011111100011   1233557888999988655544  6899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-39  Score=329.23  Aligned_cols=263  Identities=19%  Similarity=0.240  Sum_probs=197.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+|.+.+.||+|+||.||++... .++.||+|....      ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347899999999999999999975 478899996432      2356799999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      + .++|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 Y-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9 578988886543   25999999999999999999999999   9999999999999999999999999998664432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-CCCcc----hh---hhhhc---cccC-
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR-PPGEH----VL---VSWAL---PRLT-  379 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~-~~~~~----~~---~~~~~---~~~~-  379 (457)
                      .........||..|+|||++.+..++.++|||||||+||||++|..|+.... .....    ..   +.+..   ..+. 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            2222334679999999999999999999999999999999999887654321 11100    00   00000   0000 


Q ss_pred             --chhHHhhh-------cCCcCCC-CCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          380 --SREEAVEM-------VDPSLQG-QYP--KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       380 --~~~~~~~~-------~d~~l~~-~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ........       ..+.... .+.  ......+.+|+.+||+.||.+|||+.|++++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence              00000000       0000000 000  0123468899999999999999999999987

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-39  Score=310.57  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=203.3

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      |+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            455577999999999999864 57889999886543 3344568899999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            9999998854     24889999999999999999999998   9999999999999999999999999987664321  


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.||....+...                 ...+.....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~~~~~~~~  218 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----------------LFLIPKNSP  218 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----------------HhhhhcCCC
Confidence            112234678899999999988999999999999999999999999874322110                 001111111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+...+..+.+++.+||+.+|++||++.+++++  .++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~--~~~~~  258 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH--KFITR  258 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh--HHHHH
Confidence            12233445679999999999999999999999986  44444

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-39  Score=312.86  Aligned_cols=264  Identities=23%  Similarity=0.264  Sum_probs=194.0

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEc-----CC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRL---HSPQLVELLGYCAD-----QN  223 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~-----~~  223 (457)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999965 588999998865321  1123345566666655   79999999998864     34


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..+++|||++ ++|.+++.....  ..+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence            5799999996 589888876432  34899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+............ ....
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~  230 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP-PEDD  230 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC-Chhh
Confidence            98664321   1234567899999999998899999999999999999999999997543221111000000000 0000


Q ss_pred             Hh-------hhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AV-------EMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..       ..+.+...   ..........+.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00       00000000   01112334578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=308.72  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=208.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||.|+||.||++... ++..+|+|.+........+.+..|+++++.++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356788889999999999999974 5889999998776666667788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999987643   35899999999999999999999999   9999999999999999999999999987553321


Q ss_pred             CCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          312 NGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                        .......+++.|+|||.+.     ...++.++||||||+++|||++|+.||.......  ....           ...
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~-----------~~~  222 (280)
T cd06611         158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK-----------ILK  222 (280)
T ss_pred             --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH-----------Hhc
Confidence              1223456889999999874     3457889999999999999999999997542211  0000           000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+.+  ..+......+.+++..||+.+|.+||++.+++++  +++++.
T Consensus       223 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~~~  268 (280)
T cd06611         223 SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH--PFVSDQ  268 (280)
T ss_pred             CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC--hhhccc
Confidence            000111  1222344578999999999999999999999987  666554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=302.98  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=206.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999964 57889999987765556677899999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....   ..+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            9999999987653   24889999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CccccccccCCCccccccccCC---CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTG---KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                       .......++..|+|||.+...   .++.++||||||+++|||+||+.||...........            .....+.
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------------~~~~~~~  222 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------------ISKSNFP  222 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhccCC
Confidence             122345678899999999776   889999999999999999999999975332111000            0000001


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +. ........+.++.+++.+||+.+|.+|||+.+|+.+
T Consensus       223 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         223 PP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             Cc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10 111233456689999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.7e-39  Score=302.00  Aligned_cols=251  Identities=30%  Similarity=0.528  Sum_probs=202.0

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-----CcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-----GTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +++.+.||.|+||.||++...+     +..+|+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999754     478999999766433 4567889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++.....  ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999976432  12899999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......                 .....+
T Consensus       156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~~~  217 (258)
T smart00219      156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----------------EVLEYL  217 (258)
T ss_pred             ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence            32211 112336789999999988889999999999999999998 78887642210                 111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ........+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11111122223556899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.6e-39  Score=302.99  Aligned_cols=248  Identities=25%  Similarity=0.461  Sum_probs=202.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +|+..+.||+|+||.||+|... ++..|++|.+....     ....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999876532     23456788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999997643    4889999999999999999999999   9999999999999999999999999987654


Q ss_pred             cccCCccccccccCCCccccccccCCC-CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...   ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.......                .....
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~  214 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----------------AVFKI  214 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----------------HHHHH
Confidence            322   233456888999999987766 8999999999999999999999997532110                00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .........+......+.+++.+||+.+|.+||++.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            00001112233345678999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.4e-39  Score=305.64  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=199.8

Q ss_pred             CCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN------  223 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------  223 (457)
                      |.+.+.||+|+||.||+|.+.    .+..+|+|.+...  .....+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566788999999999999853    3678999988654  2344566888999999999999999999885432      


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNN--RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      ..++++||+.+|+|.+++.....  +...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            24788999999999998764322  2235788999999999999999999998   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |+.||......   ....+.      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~------  228 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL------  228 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH------
Confidence            99986643322222233345678999999998889999999999999999999 88888643221   000000      


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                          .....  +  ..+......+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ----~~~~~--~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 ----IKGNR--L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----HcCCc--C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00000  0  11223445899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-39  Score=321.64  Aligned_cols=269  Identities=22%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------  222 (457)
                      ..++|.+.+.||+|+||.||++... .++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999864 5888999998654  233345677899999999999999999987543      


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      ...++||||++ ++|.+++..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence            35799999995 577777643      3788899999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc------
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP------  376 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------  376 (457)
                      +++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...........+.....      
T Consensus       172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99865432   122345689999999999999999999999999999999999999975432111110000000      


Q ss_pred             --ccCch-hHH------------hhhcCCcC---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          377 --RLTSR-EEA------------VEMVDPSL---QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       377 --~~~~~-~~~------------~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        .+... ...            ...+....   ...........+.+|+.+||+.||.+|||+.+++++  .++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h--p~~~~  323 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH--PYINV  323 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC--ccccc
Confidence              00000 000            00000000   001111223578999999999999999999999998  55554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.7e-39  Score=306.41  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ++|++.+.||+|+||.||+|+..      +...+++|.+...... ....+.+|+++++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999964      3467899988654333 3456889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          227 LISEYMPNGTLQQHLHRHNNR-----YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      +||||+++|+|.+++......     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999765422     125899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..         
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~---------  228 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL---------  228 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH---------
Confidence            99875432211 11223346778999999988889999999999999999999 788886432110   00         


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                          .......+....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         229 ----NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ----HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                0011111111122234458999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.6e-39  Score=302.64  Aligned_cols=250  Identities=20%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|+||.||++... +++.+++|++...  .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999864 6889999988643  233445688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999999876332  34789999999999999999999999   9999999999999999999999999997654321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......                ..........
T Consensus       156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~  217 (256)
T cd08218         156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKIIRGS  217 (256)
T ss_pred             --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHhcCC
Confidence              1122345788999999998889999999999999999999999998743211                0011111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ....+.....++.+++.+||+.+|++||++.+|+++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             112233445689999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-39  Score=321.03  Aligned_cols=269  Identities=22%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----  222 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----  222 (457)
                      ...++|++.+.||+|+||.||++... .++.+|+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999864 5889999998654  233345677899999999999999999988543     


Q ss_pred             -CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          223 -NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       223 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                       ...++||||++ ++|.+.+..      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence             35799999996 467666643      3788899999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC--
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT--  379 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  379 (457)
                      |+++.....   .......||..|+|||++.+..++.++|||||||++|||++|+.||....................  
T Consensus       164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865432   122345789999999999999999999999999999999999999975432111000000000000  


Q ss_pred             ---c-hhHHhhhcC---------------CcC---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          380 ---S-REEAVEMVD---------------PSL---QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       380 ---~-~~~~~~~~d---------------~~l---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                         . .......++               ..+   ....+......+.+|+.+||+.||++|||+.|++++  .++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h--p~~~  315 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH--PYIN  315 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC--cchh
Confidence               0 000000000               000   001112234578999999999999999999999998  4554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=324.43  Aligned_cols=245  Identities=29%  Similarity=0.428  Sum_probs=205.1

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .|..++.||.|+||.||.|++ .+..+||||+....+++   +...+..|+..|++++|||++.+.|+|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            356677899999999999995 46889999999876544   34567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      || -|+-.+++....   +++.+.++..|..+.+.||+|||+.+   .||||||..|||+++.|.|||+|||.+..+.+ 
T Consensus       107 YC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            99 678888887654   47999999999999999999999999   99999999999999999999999999987654 


Q ss_pred             cCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          311 INGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                           ...++|||.|||||++.   .+.|+-++||||||++..||.-.++|+..+..-...             ..+..-
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------------YHIAQN  240 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YHIAQN  240 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------------HHHHhc
Confidence                 45678999999999985   578999999999999999999999998754331111             111111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      -.|.+.   ..+....++.++..||++-|.+|||..+++++
T Consensus       241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            122232   34556789999999999999999999998875

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-39  Score=317.60  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.+....   ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 57889999886532   223345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999976432   4889999999999999999999999   99999999999999999999999999976643


Q ss_pred             ccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ... .......||+.|+|||++.+     ..++.++||||||+++|||++|+.||.......                ..
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~  217 (331)
T cd05624         155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TY  217 (331)
T ss_pred             CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----------------HH
Confidence            221 11233569999999999865     568899999999999999999999997532210                00


Q ss_pred             hhhcCCcCCCCCC---HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYP---KKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  428 (457)
                      ..+........++   .+.+.++.+++.+|+...+.+  |+++++++++
T Consensus       218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0111110000111   123457889999999876554  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.2e-39  Score=306.64  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=201.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDL-LSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|+||.||++... ++..||+|++.... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999975 58999999886542 2233445556554 677799999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |++ |+|.+++.........+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 789888876544445799999999999999999999987 7   99999999999999999999999999876543


Q ss_pred             ccCCccccccccCCCccccccccC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      .   .......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.......               +...
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~  218 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---------------QQLK  218 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---------------HHHH
Confidence            2   11233467889999998864    457899999999999999999999996422110               0111


Q ss_pred             hhcCCcCCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          386 EMVDPSLQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       386 ~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..... .....+ ...+.++.+++.+||..+|++||++.+++++  +++++...
T Consensus       219 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~--~~~~~~~~  269 (283)
T cd06617         219 QVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH--PFFELHLS  269 (283)
T ss_pred             HHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--chhhhccc
Confidence            11111 001111 1234579999999999999999999999987  66666543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-39  Score=319.63  Aligned_cols=269  Identities=22%  Similarity=0.313  Sum_probs=201.7

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC----
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ----  222 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----  222 (457)
                      ....++|.+.+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.+++.++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999864 67899999986542  22334577899999999999999999987533    


Q ss_pred             --CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          223 --NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       223 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                        ...++++|++ +++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence              4578999998 7899887753     24899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc----
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL----  375 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~----  375 (457)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................    
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     234568999999999876 578999999999999999999999997543211100000000    


Q ss_pred             ----cccCchhHHhhhcCCcCCCCCC--------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          376 ----PRLTSREEAVEMVDPSLQGQYP--------KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       376 ----~~~~~~~~~~~~~d~~l~~~~~--------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                          ..+.. ........ .+. ..+        ......+.+|+.+||+.||.+|||+.|++++  .++.+..
T Consensus       237 ~~~~~~~~~-~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h--p~~~~~~  305 (343)
T cd07878         237 PEVLKKISS-EHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH--PYFSQYH  305 (343)
T ss_pred             HHHHHhcch-hhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cchhccC
Confidence                00000 00000000 000 000        0122357899999999999999999999988  6666543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-39  Score=309.95  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|++|.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999975 68899999886442  22335678899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++..... ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            96 689888865332 245899999999999999999999999   9999999999999999999999999987653321


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh--------ccccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA--------LPRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  382 (457)
                        .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...............        ++......
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              12233457889999998865 45789999999999999999999999754321110000000        00000000


Q ss_pred             HHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+......   ........++.+++.+||+.||.+|||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            111111110000   0111234578899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2e-38  Score=301.47  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~  225 (457)
                      .+|++.+.||+|+||.||++... ++..|++|.+....     ....+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999964 58899999875321     22345688899999999999999999998763  567


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      +++|||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999987543    3788899999999999999999999   9999999999999999999999999988


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||......                ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~  218 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------------AAI  218 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------------HHH
Confidence            65432111 1123356888999999998888999999999999999999999999743211                011


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ............+......+.+++.+|+. +|.+||++++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            11111111223445556688899999995 89999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-38  Score=311.55  Aligned_cols=198  Identities=25%  Similarity=0.356  Sum_probs=161.8

Q ss_pred             CceeccCCcEEEEEEEEc---CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEEEEeCC
Q 012739          159 GNVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLISEYMP  233 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~  233 (457)
                      .++||+|+||.||+|+..   ++..+|+|.+.....  ...+.+|+.+++.++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999864   467899999865432  2346789999999999999999998854  456889999994


Q ss_pred             CCcHHHHHhhhCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe----CCCCcEEEeeccCc
Q 012739          234 NGTLQQHLHRHNN-----RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLA  304 (457)
Q Consensus       234 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgl~  304 (457)
                       ++|.+++.....     +...+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             688888764321     2235889999999999999999999999   9999999999999    45678999999999


Q ss_pred             cccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 012739          305 KMVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPN  362 (457)
Q Consensus       305 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~  362 (457)
                      +........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433211 12234678999999999876 46899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=306.04  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=210.6

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      |.++++||+|+||.||++.++ .|.++|||++..+.  +.+++..|+.+|++.+.|+||+++|.+.....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            556788999999999999965 59999999987653  456778899999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |++.+.++.++   ++|.+.++..++...+.||+|||...   -+|||||..|||++.+|.+||+|||.+..+.+...  
T Consensus       113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            99999998755   47999999999999999999999998   89999999999999999999999999988766432  


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ...++.||+-|||||++..-.|+.++||||||++..||..|++||..-.+-....++.             ....|.+  
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~PPPTF--  249 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TKPPPTF--  249 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CCCCCCC--
Confidence            2456789999999999999999999999999999999999999997543311111100             0001111  


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .-|+..+.++.+++.+||-++|++|-|+.+++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            2355667899999999999999999999999987

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.9e-39  Score=308.28  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             echHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      +++.++..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.+ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566667889999999999999999999974 68899999886542 2234577899999999 89999999999865


Q ss_pred             C-----CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          222 Q-----NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       222 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      .     +..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     3589999999999999998764444456899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCC-----CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-----KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV  371 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~  371 (457)
                      ||+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||.........  .
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--F  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--H
Confidence            9999999876543211  12234678899999987543     3689999999999999999999999753221100  0


Q ss_pred             hhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          372 SWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       372 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                                 .......+.+  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       244 -----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 -----------KIPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -----------HHhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                       0000000111  1122344579999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-38  Score=304.58  Aligned_cols=255  Identities=23%  Similarity=0.433  Sum_probs=200.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch----------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK----------QRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      +|...+.||.|+||.||+|... +++.+|+|.+.....          ...+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999864 688999998753211          11235778999999999999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence            9999999999999999997653    4889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ++...............++..|+|||.+....  ++.++|+||||+++|||++|..||.......  ....     ... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~-----~~~-  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK-----LGN-  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH-----hhc-
Confidence            97654322222233456888999999987654  8999999999999999999999986322110  0000     000 


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                          ......+........+..+.+++.+||+.+|++||++.+|+++
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 ----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                0001111111222345689999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-39  Score=307.83  Aligned_cols=240  Identities=23%  Similarity=0.437  Sum_probs=190.6

Q ss_pred             ceeccCCcEEEEEEEEcC--------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642        234788887655545556788899999999999999999999998899999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc--------EEEeeccC
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR--------AKVTDFGL  303 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgl  303 (457)
                      +++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999999976442   4889999999999999999999999   999999999999987765        69999998


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCC-CCCCCCCCCCcchhhhhhccccCch
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGR-VPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +.....      .....++..|+|||.+.+ ..++.++||||||+++|||++|. .||.......               
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------------  213 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------------  213 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------------
Confidence            865432      223457889999999976 45799999999999999999995 5554322110               


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                        .......  ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       214 --~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         214 --KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0001111  11222233457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.9e-39  Score=314.08  Aligned_cols=271  Identities=18%  Similarity=0.261  Sum_probs=198.9

Q ss_pred             CCceeccC--CcEEEEEEEE-cCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          158 EGNVIGNG--GFGVVYKGVL-SDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       158 ~~~~LG~G--~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +.++||+|  +|++||++.. .+++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  7899999986 468999999986542  333456788999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999976432  24889999999999999999999999   99999999999999999999999987544322110


Q ss_pred             C-----ccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhccccCch---
Q 012739          313 G-----QISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTSR---  381 (457)
Q Consensus       313 ~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~---  381 (457)
                      .     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......... ......+.....   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0     11122356778999999875  468999999999999999999999997432211000 000000000000   


Q ss_pred             --hHH-------------hh--h-------cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 --EEA-------------VE--M-------VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 --~~~-------------~~--~-------~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        ++.             .+  .       ................+.+|+.+||+.||++|||+.|++++  .++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~--p~f~~  312 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH--SFFKQ  312 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC--hhhhh
Confidence              000             00  0       00000011222345689999999999999999999999987  45544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=324.57  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=210.8

Q ss_pred             ceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          160 NVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      -+||+|.||+||.|++.+ ...+|||.+........+-+.+||.+.+.|+|.|||+++|.+.+++.+-|.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999654 5678999998776666677899999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCccccccccCCcc
Q 012739          239 QHLHRHNNRYRPL--DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       239 ~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      ++|+..=+   |+  .+...-.+..||++||.|||++.   |||||||-+|||++. .|.+||+|||-++.+..-  ...
T Consensus       661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~  732 (1226)
T KOG4279|consen  661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPC  732 (1226)
T ss_pred             HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccc
Confidence            99987533   45  67778889999999999999999   999999999999964 789999999999887542  123


Q ss_pred             ccccccCCCccccccccCC--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          316 STRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      ..++.||..|||||++..+  .|..++|||||||++.||.||++||-..+.+.........               -...
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm---------------yKvH  797 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM---------------YKVH  797 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc---------------eecC
Confidence            4567899999999999764  6899999999999999999999999866554332211111               1123


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      +..|.+...+...+|.+|+.++|.+||+++++++.  ++++.+
T Consensus       798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D--pFlq~~  838 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD--PFLQHN  838 (1226)
T ss_pred             CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC--cccccC
Confidence            46788888899999999999999999999999976  666543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-39  Score=307.08  Aligned_cols=260  Identities=26%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999975 6899999988654 3334466889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++++|..++..... ...+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++..+... 
T Consensus        82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          82 DAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             CCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999998876321 2358999999999999999999997 47   999999999999999999999999998765332 


Q ss_pred             CCccccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          312 NGQISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                         ......++..|+|||.+.+.      .++.++|||||||++|+|++|+.||.........             ....
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~~~  220 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQLS  220 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HHHH
Confidence               12334578899999998543      3588999999999999999999999753221100             0011


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ...+. .....+.+...++.+++.+||+.+|++||++.+++.+  +++.+...
T Consensus       221 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~--~~~~~~~~  270 (286)
T cd06622         221 AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH--PWLVKYKN  270 (286)
T ss_pred             HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC--hhhhhccC
Confidence            11111 1112334456689999999999999999999999986  66666544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-38  Score=300.25  Aligned_cols=249  Identities=25%  Similarity=0.443  Sum_probs=202.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|+..+.||+|+||.||++... ++..+++|++...  .....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6888999988654  233456688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~~~~~~~  310 (457)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++++ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999976432  35889999999999999999999999   9999999999999855 46899999999876432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........                .......
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----------------~~~~~~~  216 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----------------VLKIMSG  216 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----------------HHHHHhc
Confidence            1   12335688899999999988899999999999999999999999975432110                0011111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      . ....+......+.+++.+||+.+|++|||+.|++++
T Consensus       217 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 T-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             C-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0 111222345579999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.9e-39  Score=311.20  Aligned_cols=259  Identities=23%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      |.....||+|+||.||++... ++..+|+|++........+.+.+|+..++.++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344467999999999999864 5889999998766555566788999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|.+++...     .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .
T Consensus       104 ~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~  173 (292)
T cd06658         104 GALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P  173 (292)
T ss_pred             CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence            9999988542     3889999999999999999999999   9999999999999999999999999987653321  1


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||........  .           ......+.+.+..
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-----------~~~~~~~~~~~~~  240 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M-----------RRIRDNLPPRVKD  240 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----------HHHHhcCCCcccc
Confidence            12335688999999999888899999999999999999999999974322100  0           0111111111111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCcc
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAI  441 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~  441 (457)
                        .......+.+++.+||..+|.+|||+.+++++  ++++....++.
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~--~~~~~~~~~~~  283 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH--PFLKLAGPPSC  283 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhhccCCccc
Confidence              11234578899999999999999999999987  77776665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.7e-39  Score=303.35  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=208.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|+..+.||+|+||.||++... +++.+++|++.... ......+.+|+++++.++||||+++++++...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677788999999999999976 58899999887653 344566888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++++|.+++....   ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999997653   358899999999999999999999 88   9999999999999999999999999987664321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      .    ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... .          ..........
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~----------~~~~~~~~~~  220 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-F----------ELLQYIVNEP  220 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-H----------HHHHHHhcCC
Confidence            1    12668889999999999999999999999999999999999997543211110 0          0011111111


Q ss_pred             CCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          392 LQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       392 l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                       ....+.. ....+.+++.+||..+|++|||+.+++++  +++++.+
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~--~~~~~~~  264 (265)
T cd06605         221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH--PFIKKYE  264 (265)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC--chhhccc
Confidence             1112222 55679999999999999999999999987  6666543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-38  Score=301.41  Aligned_cols=254  Identities=24%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....      ....+.+..|+++++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 568899999886432      1234568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKM  306 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~  306 (457)
                      |+||+++++|.+++....    ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999997643    4889999999999999999999999   99999999999998776 699999999877


Q ss_pred             cccccCC--ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          307 VSDKING--QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........             ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~  220 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-------------LI  220 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-------------HH
Confidence            6543211  11223567889999999988889999999999999999999999996432211111             01


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ............+.....++.+++.+||+.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            11111111223444556789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.4e-39  Score=307.09  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|+||+||++... ++..+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777889999999999999965 58889999876543 33346688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      +++++|.+++....    ++++..+..++.+++.||.|||+ .+   ++|+||||+||++++++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999999887643    48999999999999999999997 46   999999999999999999999999998654322


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                          ......|+..|+|||++.+..++.++|||||||++|+|+||+.||...............   +  ..........
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~--~~~~~~~~~~  228 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG---I--LDLLQQIVQE  228 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH---H--HHHHHHHhhc
Confidence                122456899999999998889999999999999999999999999854332110000000   0  0001111111


Q ss_pred             cCCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          391 SLQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       391 ~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .. ...+ ...+..+.+|+.+||+.+|++|||+.|++++.
T Consensus       229 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 PP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             cC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11 1111 12456799999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-38  Score=306.26  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=201.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|+..+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788899999999999999976 58899999886442  2223457889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++++.|..++....    .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999988887765432    4899999999999999999999999   999999999999999999999999999876443


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch-hHH----
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR-EEA----  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----  384 (457)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+............... ...    
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            21  1223457889999999865 567899999999999999999999997544322111111000000000 000    


Q ss_pred             ---hhhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 ---VEMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ---~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                         .....+......+     ......+.+|+.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence               0000000000000     1234578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-38  Score=299.28  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.+.||+|++|.||++...+ ++.+++|++..... .....+..|+..+..++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            57788999999999999999764 89999999876643 44567889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++++|.+++...    .++++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999765    358999999999999999999999 98   9999999999999999999999999988764332


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|+||+.||............             ..+. ..
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------------~~~~-~~  218 (264)
T cd06623         155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM-------------QAIC-DG  218 (264)
T ss_pred             C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH-------------HHHh-cC
Confidence            1  122456788999999999889999999999999999999999999754321111111             1111 11


Q ss_pred             CCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          392 LQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .....+.. .+..+.+++.+||..+|++||++.+++++  +++++
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~--~~~~~  261 (264)
T cd06623         219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH--PFIKK  261 (264)
T ss_pred             CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC--HHHHh
Confidence            11122223 45689999999999999999999999987  66543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=318.54  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=186.5

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRL---HSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ||+|+||+||+|+.. +++.||+|++.....   ........|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 588999999864321   1222344566666655   699999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~  151 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NK  151 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CC
Confidence            99999887643    4899999999999999999999999   999999999999999999999999998754221  12


Q ss_pred             cccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          315 ISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......   ...          . ....+..+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~----------~-i~~~~~~~~  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYR----------N-IAFGKVRFP  217 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHH----------H-HHcCCCCCC
Confidence            23456799999999998654 58999999999999999999999997532210   000          0 000001111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHHH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRP----LMTDVVQS  428 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RP----s~~evl~~  428 (457)
                         .......+.+++.+||+.+|.+||    ++.+++++
T Consensus       218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               012345788999999999999998    56666664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=307.99  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|+||.||+|... +++.|++|++....  ....+.+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6788899999999999999975 57899999886532  22335688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++++.+..++...    ..+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9887776655432    24899999999999999999999999   9999999999999999999999999988765432


Q ss_pred             CCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...........+..........++
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2 122345678899999999887 88999999999999999999999997543221111111100000000000000000


Q ss_pred             cC--------------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SL--------------QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l--------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..              ...++...+.++.+|+.+||..+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00              001222335689999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-38  Score=302.94  Aligned_cols=262  Identities=27%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lv~e  230 (457)
                      +|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|+++++.++||||++++++|.+  .+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777889999999999999974 57889999887543 2345668889999999999999999998865  346899999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            99999999988764444456889999999999999999999999   999999999999999999999999998765432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC--CcchhhhhhccccCchhHHhhhc
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP--GEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  .......+..          ...
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~  224 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----------NMP  224 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----------cCC
Confidence            1    12345788999999999899999999999999999999999999854321  1111111110          000


Q ss_pred             CCcCCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYP--KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+.+.....  ...+..+.+++.+||+.+|.+|||+.|++++  +++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~--~~~~~  271 (287)
T cd06621         225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH--PWIKA  271 (287)
T ss_pred             chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC--ccccc
Confidence            111111111  2345689999999999999999999999997  56644

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9e-39  Score=309.90  Aligned_cols=271  Identities=22%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999865 578999998865422 2233567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            96 68988887643   24889999999999999999999999   9999999999999999999999999987543221


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc--------cccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL--------PRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  382 (457)
                        .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||................        +......
T Consensus       159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              11233457889999998865 457889999999999999999999997543211110000000        0000000


Q ss_pred             HHhhhcCCcCCCC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          383 EAVEMVDPSLQGQ----YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 ~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .....-.+.....    ........+.+|+.+||+.||.+|||+.|++++  ++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h--~~f~~  291 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH--PYFHC  291 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC--ccccc
Confidence            0000000111100    111234578899999999999999999999986  44443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.9e-40  Score=292.92  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=206.1

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----h---HHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----K---QRERAFRMEVDLLSRL-HSPQLVELLGYCA  220 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~---~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~  220 (457)
                      ....+|...+.||+|..+.|-++..+ ++...|+|++....     .   .-.++-.+|+.+|+++ .||+|+.+.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34466777889999999999998854 57888888875321     1   1123456799999998 7999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                      .+...++|+|.|+.|.|.++|...-.    +++.+...|+.|+.+|+.|||.++   ||||||||+|||++++.++||+|
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999987654    999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccC------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYAST------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      ||++..+...   ......||||+|+|||.+..      ..|+..+|.||+|+|||.|+.|.+||.....   .    ..
T Consensus       167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---m----lM  236 (411)
T KOG0599|consen  167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---M----LM  236 (411)
T ss_pred             cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---H----HH
Confidence            9999988653   44677899999999998853      4688999999999999999999999963210   0    00


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +..++.+       .-.+...-..+......+||.+||+.||++|.|++|++++
T Consensus       237 LR~ImeG-------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  237 LRMIMEG-------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHhc-------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            0001100       0112222334667789999999999999999999999987

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=309.08  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=214.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .-|.+.+.||+|.|..|-+|++ -.|..||||++.+....  ....+.+|++.|+.++|||||+++.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466678899999999999984 47999999999765322  23457789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~~~~  309 (457)
                      +-++|+|.+||-++..   .+.+.-+.+++.||+.|+.|+|...   +|||||||+||.+. .-|-+||.|||++..+.+
T Consensus        98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999988764   5999999999999999999999999   99999999998875 568999999999987755


Q ss_pred             ccCCccccccccCCCccccccccCCCCC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   +..++.||...|-|||.+.+..|+ +++||||||||||-|++|+.||+.....                +.+--++
T Consensus       172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmIm  232 (864)
T KOG4717|consen  172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIM  232 (864)
T ss_pred             c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhh
Confidence            3   456788999999999999999997 4789999999999999999999854321                2233333


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      |-.+  ..|.-...++.+||..||..||.+|-+.+||...  .|++.
T Consensus       233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~--~Wlq~  275 (864)
T KOG4717|consen  233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST--SWLQA  275 (864)
T ss_pred             cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc--ccccC
Confidence            4333  3455667799999999999999999999999987  66665

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-38  Score=300.48  Aligned_cols=238  Identities=27%  Similarity=0.468  Sum_probs=190.0

Q ss_pred             ceeccCCcEEEEEEEEcCCc-----------EEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          160 NVIGNGGFGVVYKGVLSDGT-----------VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36899999999999976433           4777877554333 5678899999999999999999999988 778999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-------cEEEeec
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-------RAKVTDF  301 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df  301 (457)
                      |||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999999987542   5889999999999999999999999   99999999999999887       7999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCC--CCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcccc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |++.....      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||.........   .+.    
T Consensus       153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~----  219 (259)
T cd05037         153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY----  219 (259)
T ss_pred             Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH----
Confidence            99876543      1223466789999998776  78999999999999999999 57777644321100   000    


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                             .  ...   ..+......+.+++.+||..+|++||++.++++.|+
T Consensus       220 -------~--~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 -------Q--DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------h--cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   0  000   011111258899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=308.44  Aligned_cols=259  Identities=22%  Similarity=0.324  Sum_probs=205.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|+..+.||+|+||.||+|...+ +..+|+|.+.....   ...+.+..|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367888999999999999999754 89999999876532   23456888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+.+++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999987542  245899999999999999999999999   99999999999999999999999999875432


Q ss_pred             ccCC---------------------------ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 012739          310 KING---------------------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN  362 (457)
Q Consensus       310 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~  362 (457)
                      ....                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1100                           0112346788999999999889999999999999999999999999754


Q ss_pred             CCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHHHHHHhhhh
Q 012739          363 RPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL----MTDVVQSLIPVVKN  435 (457)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~evl~~L~~~~~~  435 (457)
                      ....                ......+...........+..+.+++.+||+.+|++||+    +.+++++  +++++
T Consensus       236 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~--~~~~~  294 (316)
T cd05574         236 NRDE----------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH--PFFRG  294 (316)
T ss_pred             chHH----------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC--chhhc
Confidence            3210                111111111111111124568999999999999999999    7777765  45544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=304.00  Aligned_cols=259  Identities=25%  Similarity=0.432  Sum_probs=207.0

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC-chHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .|+..+.||+|+||.||+|.. .++..+++|.+... .......+.+|+.+++.++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467778899999999999996 46889999988654 2334456888999999996   999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999988652     4899999999999999999999999   99999999999999999999999999887654


Q ss_pred             ccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........   .          .....
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~----------~~~~~  218 (277)
T cd06917         154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L----------IPKSK  218 (277)
T ss_pred             Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c----------cccCC
Confidence            32  11233468889999998865 457899999999999999999999997533211000   0          00000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCcc
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAI  441 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~  441 (457)
                      .+.+...   ..+.++.+++.+||+.+|++||++.+++++  +++++....+.
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~--~~~~~~~~~~~  266 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS--KWIKAHSKTPV  266 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC--hHhhccccCch
Confidence            1111111   144579999999999999999999999986  88877665433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-39  Score=314.95  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=208.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ...|+++++||+||.+.||++...+.+.+|+|++...  +.....-|..|+.+|.+| .|.+||+|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3568889999999999999999988899999987654  344456699999999999 5899999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||- ..+|..+|.+....  ..+| .+..+..|++.|+.++|..|   |||.||||.|+|+- .|.+||+|||.+..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            986 67999999876542  2334 67778899999999999999   99999999999994 57999999999998877


Q ss_pred             ccCCccccccccCCCccccccccCCC-----------CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGK-----------LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      ....-.....+||+.||+||.+....           .+.++||||||||||+|+-|+.||.....       .      
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~------  578 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------Q------  578 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------H------
Confidence            66666677789999999999986533           46799999999999999999999974211       1      


Q ss_pred             CchhHHhhhcCCcCCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ......+.||.-.-+|+.- ...++.+++..||+.||++||+..|+|++
T Consensus       579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              1234456666544344321 12249999999999999999999999987

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.7e-38  Score=298.70  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=206.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888999999999999999964 57889999986543 23456788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++..... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976432 135899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCc--cccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQ--ISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  ......++..|+|||.+... .++.++|+||||+++|+|++|+.||........  ....           ....
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~-----------~~~~  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT-----------LQND  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH-----------hcCC
Confidence            221  22345688999999998776 789999999999999999999999975433211  0000           0001


Q ss_pred             CCcCCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          389 DPSLQGQY-PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+.+.... ....+..+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11111111 12345688999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-38  Score=304.20  Aligned_cols=260  Identities=24%  Similarity=0.390  Sum_probs=203.3

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc-
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD-  221 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-  221 (457)
                      ++.++......|++.+.||.|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34455566788999999999999999999974 57889999886543 2334578899999998 79999999999853 


Q ss_pred             -----CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          222 -----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       222 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                           ....+++|||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence                 4678999999999999999876432  35788889999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV  371 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~  371 (457)
                      +|+|||++.......  .......|+..|+|||.+.     ...++.++||||||+++|||++|+.||.........   
T Consensus       161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---  235 (282)
T cd06636         161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---  235 (282)
T ss_pred             EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence            999999987653221  1123456889999999875     356888999999999999999999999743221110   


Q ss_pred             hhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          372 SWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       372 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                                   ................+..+.+++.+||+.+|.+||++.|++++
T Consensus       236 -------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 -------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                         00001101111112344589999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.7e-38  Score=304.90  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=202.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||++... +++.+|+|.+....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999965 58899999886542   223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999997653    4899999999999999999999999   99999999999999999999999999887643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......                ........
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~  212 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------------QIYEKILE  212 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhc
Confidence            3     23456889999999998888999999999999999999999999754310                00001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ..  ...+......+.+++.+||+.+|.+|+     ++++++++
T Consensus       213 ~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         213 GK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            11  122333355889999999999999999     78888766

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.8e-38  Score=300.48  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=201.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      -|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999864 68899999876443 333456889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++...     .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            999999998642     4889999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......                 ....+....
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~  217 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----------------VLFLIPKNN  217 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----------------HHHHHhcCC
Confidence             11233467889999999988889999999999999999999999987432210                 000011111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            112223345578999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-38  Score=306.68  Aligned_cols=198  Identities=25%  Similarity=0.360  Sum_probs=161.1

Q ss_pred             CceeccCCcEEEEEEEEc---CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeEEEEEEeCC
Q 012739          159 GNVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA--DQNHRLLISEYMP  233 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~  233 (457)
                      ..+||+|+||.||+|...   ++..+|+|.+.....  ...+.+|+.+++.++||||+++++++.  .+...++|+||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            367999999999999965   357899998865432  234678999999999999999999884  3567899999985


Q ss_pred             CCcHHHHHhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe----CCCCcEEEeeccCc
Q 012739          234 NGTLQQHLHRHN-----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLA  304 (457)
Q Consensus       234 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgl~  304 (457)
                       ++|.+++....     .....+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57888775422     12235889999999999999999999999   9999999999999    56679999999999


Q ss_pred             cccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 012739          305 KMVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPN  362 (457)
Q Consensus       305 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~  362 (457)
                      +........ .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221 12234568999999999876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=300.44  Aligned_cols=256  Identities=25%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC------
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN------  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~------  223 (457)
                      .+++|++.+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++.+ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999975 578899998866543 345688999999999 7999999999996644      


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999998765433356899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      +.......  .......++..|+|||.+..     ..++.++||||||+++|+|++|+.||........  ..       
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~-------  228 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF-------  228 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH-------
Confidence            87654321  12234568889999998753     3477899999999999999999999974322100  00       


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                          .......+.  ...+......+.+++.+||..||++|||+.+++++
T Consensus       229 ----~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 ----KIPRNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ----HhhccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                000000111  11223355689999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.3e-38  Score=297.96  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=202.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|+..+.||+|+||.||+|... ++..+++|.+.....  ...+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 688999999876543  3556789999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999987643    3788999999999999999999999   9999999999999999999999999988765432


Q ss_pred             CCcc--ccccccCCCccccccccCCC---CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          312 NGQI--STRVLGTTGYLAPEYASTGK---LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       312 ~~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....  .....++..|+|||.+.+..   ++.++||||||+++|||++|+.||........   ..+.         ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~---------~~~  221 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFH---------VGA  221 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHH---------Hhc
Confidence            2111  12356788999999998766   89999999999999999999999975321110   0000         000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...+.+.  ........+.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 GHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0011111  111235578899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=320.59  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=214.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC--C--cEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD--G--TVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++....++||+|.||.|++|.|..  |  -.||||.++.+... ....|.+|+.+|.+|+|||+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            445566889999999999999853  3  35899999876443 55679999999999999999999999988 678899


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +|+++.|+|.+.|++  .....|-......++.|||.||.||..++   +|||||..+|+|+..-..+||+||||.+-+.
T Consensus       189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999988  23345778888899999999999999999   9999999999999999999999999999887


Q ss_pred             cccCCcccc-ccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKINGQIST-RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .......+. ...-...|.|||.+....++.++|||+|||++|||+| |..||-+...                 ..+.+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~  326 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILK  326 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHH
Confidence            655444333 3344668999999999999999999999999999999 6788764322                 35556


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .+|..-+...++.|++++++++..||..+|.+|||+..|.+.+
T Consensus       327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            6676666677888999999999999999999999999998554

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.9e-39  Score=307.98  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|+..+.||+|+||.||+|... +++.+|+|++.....  ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999975 588999998765422  234567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|..+.....    .+++.+++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999998888765432    3899999999999999999999998   999999999999999999999999998765432


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh-HH----
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE-EA----  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----  384 (457)
                      .  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..................+.... ..    
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  12233457889999998865 4578899999999999999999999875432111111111101110000 00    


Q ss_pred             ---hhhcCCcCCC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 ---VEMVDPSLQG-----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ---~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                         .....+....     ......+..+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               0000000000     0011335679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.7e-38  Score=302.57  Aligned_cols=256  Identities=24%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +|...+.||+|++|.||++.. .++..+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567899999999999986 4688999998876555555668899999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++...     .+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            99999998762     3889999999999999999999999   99999999999999999999999998875533211 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........   .          ........+...
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~----------~~~~~~~~~~~~  236 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---M----------KRIRDNLPPKLK  236 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---H----------HHHHhcCCCCCc
Confidence             12334688999999999888899999999999999999999999875332100   0          000011111111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                        .+......+.+++.+||+.+|++||++.+++++  +++++..
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~--~~~~~~~  276 (285)
T cd06648         237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH--PFLAKAG  276 (285)
T ss_pred             --ccccCCHHHHHHHHHHcccChhhCcCHHHHccC--cccccCC
Confidence              111234579999999999999999999999986  6666543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-38  Score=304.44  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=201.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|+||.||+|... ++..+++|++....  ......+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999964 68899999986553  23345688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      + +++|.+++....   .++++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999987644   45899999999999999999999999   9999999999999999999999999988764432


Q ss_pred             CCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh--------ccccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA--------LPRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  382 (457)
                      . .......++..|+|||.+.+. .++.++||||||+++|||+||..||...............        .+......
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            1 123345688999999988654 4689999999999999999998887643321110000000        00000000


Q ss_pred             HHhhhcCCcCC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQ----GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+...    .+...+....+.+++.+||+.+|.+||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000    00111234689999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.3e-38  Score=304.61  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +|.+.+.||+|+||.||++... .++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6788899999999999999975 478899998865532   233467789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.....
T Consensus        82 ~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          82 YVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999997643    4889999999999999999999998   999999999999999999999999998642111


Q ss_pred             cCC-------------ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          311 ING-------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       311 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      ...             .......++..|+|||.+.+..++.++||||||+++|||++|..||......  .....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~-----  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQ-----  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-----
Confidence            000             0112245788999999998888999999999999999999999999743221  00000     


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                          ........+..    +...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       228 ----~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 ----VISDDIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----HHhcccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                00000011111    11234578999999999999999996655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-38  Score=304.93  Aligned_cols=275  Identities=22%  Similarity=0.261  Sum_probs=207.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH-----HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ-----RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +|...+.||+|+||.||+|... +++.|++|++......     ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999965 5889999998765322     234567899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+ +++|.+++....   ..+++..++.++.|+++||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999997643   25899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh--H--
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE--E--  383 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~--  383 (457)
                      ...  .......++..|+|||.+.+ ..++.++|||||||++|||++|..||.......................  .  
T Consensus       154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            421  11233356788999998854 5678999999999999999999887764332111100000000000000  0  


Q ss_pred             -HhhhcCCcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          384 -AVEMVDPSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       384 -~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                       .............     .......+.+++.+||+.+|++|||+.|++++  .+++++....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~~~~~~~  292 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFSNDPAPT  292 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--ccccCCCCCC
Confidence             0000000000011     12235678999999999999999999999997  8888877644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.7e-38  Score=303.76  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=207.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888899999999999999854 67889999986554444566888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++...     .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998653     3788999999999999999999999   99999999999999999999999999876543221


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                        ......+++.|+|||.+....++.++||||||+++|+|++|+.||............ +              .....
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-~--------------~~~~~  233 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-A--------------TNGTP  233 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-h--------------cCCCC
Confidence              123346888999999998888999999999999999999999999754331110000 0              00000


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....+......+.+++.+||+.+|++||++.+++.+  +++++
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h--~~~~~  274 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH--PFLKI  274 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--HHHhc
Confidence            011122344578999999999999999999999988  55553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-38  Score=305.91  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=197.0

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|+..+.||+|+||.||+|... +|..+++|++.....  .....+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 588999998865421  2224567899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++....   ..+++..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            96 58888776533   24899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             CCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhccccCch--hHHhhh
Q 012739          312 NGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTSR--EEAVEM  387 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~  387 (457)
                        .......++..|+|||.+.+. .++.++|||||||++|||+||+.|+.......... ............  ......
T Consensus       154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence              112334578899999988664 47899999999999999999999975432211100 000000000000  000000


Q ss_pred             cCCc----CCC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPS----LQG-----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~----l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+..    ...     +.......++.+++.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000    000     1112234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-37  Score=293.20  Aligned_cols=252  Identities=25%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLIS  229 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lv~  229 (457)
                      +|...+.||+|++|.||+|... +++.+++|++.....  ...+.+.+|++.+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 688999998866542  4456788999999999999999999999988  8999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999997654    5899999999999999999999998   99999999999999999999999999887655


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++|..||......   .            ........
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~------------~~~~~~~~  218 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---M------------AALYKIGS  218 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H------------HHHHhccc
Confidence            43211233456888999999998888999999999999999999999999754310   0            01111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+......+.+++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            112223444456789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=303.76  Aligned_cols=266  Identities=20%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999975 6889999998654322 223466799999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++.....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++......
T Consensus        85 ~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            97 599998876432   5889999999999999999999999   9999999999999999999999999987543211


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh---
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM---  387 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  387 (457)
                        .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............+..............   
T Consensus       158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence              11223346788999998865 568999999999999999999999996543111111000000000000000000   


Q ss_pred             ---cC--------CcCCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 ---VD--------PSLQGQY-PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ---~d--------~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                         ..        ..+.... .......+.+++.+||+.+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               00        0000000 00112577899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-37  Score=292.22  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=204.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +|...+.||+|++|.||++... ++..+++|++..........+.+|++.++.++|||++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677789999999999999975 688999999977655456678899999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987753   35899999999999999999999998   99999999999999999999999999877654321 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ..          .....-+.+ 
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~----------~~~~~~~~~-  217 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FK----------IATNGPPGL-  217 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---HH----------HHhcCCCCc-
Confidence              23456888999999998888999999999999999999999999753221000   00          000000001 


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ..+......+.+++.+||+.+|++|||+.+++++
T Consensus       218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             0111124579999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.3e-38  Score=297.08  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|+||.||+++.. ++..+++|++....  ......+.+|+++++.++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999854 67899999886542  23345577899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999999775444456899999999999999999999999   999999999999999999999999999876543 


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.||......                 .....+...
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRG  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcC
Confidence               222345788999999999989999999999999999999999999754321                 111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+.....++.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1122334556689999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-38  Score=306.28  Aligned_cols=246  Identities=22%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             CCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          158 EGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      ....||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999864 688999999865544445668889999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccc
Q 012739          237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS  316 (457)
Q Consensus       237 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  316 (457)
                      |.+++..     ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  ...
T Consensus       105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            9998754     23889999999999999999999999   9999999999999999999999999987554321  112


Q ss_pred             cccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCC
Q 012739          317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQY  396 (457)
Q Consensus       317 ~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  396 (457)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||........   ...          ......+..  ..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~----------~~~~~~~~~--~~  239 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR----------LRDSPPPKL--KN  239 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----------HhccCCCCc--cc
Confidence            345688999999999988999999999999999999999999974332110   000          000000001  11


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          397 PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       397 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11234478999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-37  Score=302.68  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=197.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +.|...+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999965 58899999886432   233456888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||++ |+|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 67777775433   25899999999999999999999999   99999999999999999999999999875532


Q ss_pred             ccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||+||+.||.........                ..
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~----------------~~  225 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YH  225 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH----------------HH
Confidence            2      2345788999999874   466889999999999999999999998743221100                00


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..........+......+.+++.+||+.+|++||++.+|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000001122345679999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-37  Score=294.30  Aligned_cols=252  Identities=26%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|.+.+.||.|+||.||++... ++..+++|++.....  .....+.+|+++++.++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777899999999999999975 588999999876532  4456688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.........+++.++..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999876433456999999999999999999999998   9999999999999999999999999987664432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   .             ...... .
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~-------------~~~~~~-~  218 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L-------------ALKILK-G  218 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H-------------HHHHhc-C
Confidence              22334568889999999988889999999999999999999999997543210   0             000111 1


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+......+.+++.+||..+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1112233445689999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-37  Score=299.72  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..+.|+..+.||+|++|.||++... ++..+++|++..... ....+..|+++++.++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4466788889999999999999976 688999999876544 45668889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999998754   35999999999999999999999998   999999999999999999999999998765432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  .......++..|++||.+.+..++.++||||||+++|+|++|+.||....+...                .......
T Consensus       170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----------------~~~~~~~  231 (286)
T cd06614         170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----------------LFLITTK  231 (286)
T ss_pred             h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhc
Confidence            1  112334578899999999888899999999999999999999999874322100                0000000


Q ss_pred             cCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ... ...+...+..+.+++.+||+.+|.+||++.+++++  +++++
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~--~~~~~  275 (286)
T cd06614         232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH--PFLKK  275 (286)
T ss_pred             CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC--hHhhc
Confidence            010 01112245579999999999999999999999986  66665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=306.06  Aligned_cols=270  Identities=22%  Similarity=0.261  Sum_probs=199.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEc---CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRL  226 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~  226 (457)
                      +|.+.+.||+|+||.||+|...   ++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999975   47899999987632   22335577899999999999999999999888  8899


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC----CCcEEEeec
Q 012739          227 LISEYMPNGTLQQHLHRHNNRY-RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ----NFRAKVTDF  301 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  301 (457)
                      +||||++ ++|.+++....... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 57777776543322 36899999999999999999999999   999999999999999    999999999


Q ss_pred             cCccccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch------hhhh
Q 012739          302 GLAKMVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV------LVSW  373 (457)
Q Consensus       302 gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~------~~~~  373 (457)
                      |++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........      ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876443221 11234567889999998765 468999999999999999999999998654322000      0000


Q ss_pred             hccccC-----------chhHHhhhcCCcCCCCCC---------H--HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          374 ALPRLT-----------SREEAVEMVDPSLQGQYP---------K--KDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       374 ~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....+.           ...+.....+......++         .  ....++.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000           000000000000000111         0  234578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.2e-38  Score=302.37  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=198.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|...+.||+|+||.||++... +++.+|+|++.... ......+..|+.++.++. ||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3455678999999999999965 58899999986543 334456888999999996 99999999999999999999999


Q ss_pred             CCCCcHHHHHhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRH-NNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      +. ++|.++.... ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||+++....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            85 4665543321 11124589999999999999999999975 7   99999999999999999999999999876543


Q ss_pred             ccCCccccccccCCCccccccccCC---CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTG---KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..   ......|+..|+|||.+.+.   .++.++||||||+++|||++|+.||......     ....       .....
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~-------~~~~~  225 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQL-------TQVVK  225 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHH-------hhhcC
Confidence            21   12334578899999998765   6899999999999999999999999743210     0000       00000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+.+....+...+..+.+|+.+||+.+|++|||+.+|+++  +++++
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~--~~~~~  272 (288)
T cd06616         226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH--PFIKD  272 (288)
T ss_pred             CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC--hhhhc
Confidence            111222222223456689999999999999999999999988  66654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=318.11  Aligned_cols=248  Identities=23%  Similarity=0.399  Sum_probs=204.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCC-cEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDG-TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      .|.++..||.|+||.||+|+.++. -..|.|++........+.+.-||++|...+||+||+|++.|...+.+||..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            355667899999999999997764 4566788877677777889999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      ||-++..+....   .+|.+.++..++.|++.||.|||+++   |||||||..|||++-+|.++|+|||.+.....  .-
T Consensus       113 GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  113 GGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            999998887654   46999999999999999999999999   99999999999999999999999999864432  12


Q ss_pred             ccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh-
Q 012739          314 QISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM-  387 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  387 (457)
                      .....+.|||+|||||+..     +.+|+.++||||||++|.||..+.+|-..-.+-                ..+..+ 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVllKia  248 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLKIA  248 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHHHHh
Confidence            3345689999999999864     578999999999999999999999997543221                111111 


Q ss_pred             -cC-CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 -VD-PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 -~d-~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       -+ |.+  -.|......+.+++..||.+||..||++.+++++
T Consensus       249 KSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  249 KSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence             11 111  1234456689999999999999999999999876

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.7e-38  Score=295.65  Aligned_cols=250  Identities=23%  Similarity=0.418  Sum_probs=201.2

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|.+.+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999975 47889999886542  22345678899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~~~  310 (457)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999876432  35789999999999999999999999   99999999999998886 4699999998766432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  .......|++.|+|||.+....++.++||||||+++|||++|..||.......                ........
T Consensus       156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~  217 (257)
T cd08225         156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----------------LVLKICQG  217 (257)
T ss_pred             c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHhcc
Confidence            1  12233458889999999988889999999999999999999999987432110                11111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .. ...+......+.+++.+||+.+|++|||+.+++++
T Consensus       218 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11 11122334579999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.2e-38  Score=298.04  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=203.6

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +|++.+.||.|+||.||++... ++..+++|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999975 58899999886542   2345678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+.+++|.+++...    .++++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999765    25899999999999999999999999   999999999999999999999999998766432


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .   ......++..|+|||.+....++.++|+||||+++|+|++|+.||.........              ........
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD--------------QIRAKQET  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH--------------HHHHHhcc
Confidence            1   223456788999999998888999999999999999999999999854432111              11111110


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM--TDVVQ  427 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~evl~  427 (457)
                       .....+...+..+.+++.+||+.+|.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             1123333445789999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-37  Score=308.76  Aligned_cols=270  Identities=23%  Similarity=0.284  Sum_probs=202.5

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----  222 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----  222 (457)
                      ...++|+..+.||+|+||.||+|... +++.+|+|.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999964 6889999998643  233345577899999999999999999988543     


Q ss_pred             -CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          223 -NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       223 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                       ...++||||+. ++|.+.+..      .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence             35799999995 588887753      2788899999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc-
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS-  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  380 (457)
                      |+++......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......... 
T Consensus       163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9998654321   123346788999999999999999999999999999999999999754321110000000000000 


Q ss_pred             --------------------hhHHhhhcCCcC----CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 --------------------REEAVEMVDPSL----QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 --------------------~~~~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                          .....+.+....    ....+......+.+++.+||+.||.+|||+.|++++  .+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~--~~~~~  316 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH--PYINV  316 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC--hhHhh
Confidence                                000000000000    001122345678999999999999999999999987  66654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-37  Score=297.38  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=193.2

Q ss_pred             eeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHH---HhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          161 VIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLL---SRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..++   ...+||||+.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 58899999886432   12222334444433   34479999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++......   
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---  150 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence            999999987643    4899999999999999999999999   999999999999999999999999998755332   


Q ss_pred             ccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......|+..|+|||.+. +..++.++|||||||++|||++|..||..........              .... ....
T Consensus       151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~~-~~~~  214 (279)
T cd05633         151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRM-TLTV  214 (279)
T ss_pred             -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------HHHH-hhcC
Confidence             122346899999999886 4568999999999999999999999997543221110              0000 0111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhhcC
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~~~  437 (457)
                      ....+.....++.+++.+||+.||.+||     ++++++++  .+++...
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h--~~~~~~~  262 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH--VFFKGID  262 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC--ccccCCC
Confidence            1223444556899999999999999999     69999888  5665533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.3e-37  Score=300.45  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=198.0

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      |...+.||+|+||.||+++.. ++..+|+|++....   ......+..|+++++.++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667788999999999999964 68899999886432   23345688899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ |+|.+++....   .++++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            96 57877775533   35899999999999999999999999   99999999999999999999999999875432  


Q ss_pred             CCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                          .....++..|+|||.+.   .+.++.++||||||+++|||++|+.||.......                ......
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----------------~~~~~~  237 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIA  237 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH
Confidence                22346888999999873   4678999999999999999999999987432110                000111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ...............+.+++.+||+.+|.+||++.++++++..+.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         238 QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            111111112234457899999999999999999999999865433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.5e-38  Score=301.48  Aligned_cols=266  Identities=24%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|+..+.||.|++|.||+|+.. ++..+++|++....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999865 58899999886542  22234678899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +. ++|.+++.....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            95 689988876432  35899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             CCccccccccCCCccccccccCCC-CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh-hhhhc-------cccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL-VSWAL-------PRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~-~~~~~-------~~~~~~~  382 (457)
                        .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........... .....       +......
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence              1123345688999999886644 68899999999999999999999975432111100 00000       0000000


Q ss_pred             HHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+......   .........+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000000000000   0011233568899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.3e-38  Score=301.49  Aligned_cols=266  Identities=22%  Similarity=0.298  Sum_probs=199.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lv  228 (457)
                      ++|++.+.||.|+||.||+|... +++.+++|.+......  ....+.+|+.+++.++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999976 5889999998654322  223467899999999999999999998777  889999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||++ ++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99996 599988876432   5899999999999999999999999   9999999999999999999999999988765


Q ss_pred             cccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc--------cC
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR--------LT  379 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~  379 (457)
                      ...  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..................        ..
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            432  112334578899999988654 4689999999999999999999999754321111100000000        00


Q ss_pred             chh-----HHhhhcCCcCCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          380 SRE-----EAVEMVDPSLQGQYPKK-DLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       380 ~~~-----~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...     .........+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000     00000000111112222 35678999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-37  Score=294.17  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||.|+||.||+++.. +++.+++|.+....   ....+.+..|+.+++.++||||+++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 48899999886542   23345688999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            99997643    3889999999999999999999998   9999999999999999999999999998765431   123


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...++..|++||.+.+..++.++|+||||+++|+|++|..||........              .......+......++
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM--------------EIYNDILKGNGKLEFP  216 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH--------------HHHHHHhccCCCCCCC
Confidence            34678899999999888899999999999999999999999975432100              1111111111122334


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhhh
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVKN  435 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~~  435 (457)
                      ......+.+++.+||+.+|++||+     ++|++++  .++++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~--~~~~~  257 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH--KWFNG  257 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC--hhhhC
Confidence            344668999999999999999999     7787775  45543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-37  Score=299.98  Aligned_cols=267  Identities=20%  Similarity=0.270  Sum_probs=197.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|.+.+.||+|+||.||+|... ++..+++|.+....... ...+.+|+.+++.++|+||+++.+++..++..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467888999999999999999864 68899999986543222 2356789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+. ++|.+++....   ..+.+.++..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            995 77877775432   24778889999999999999999999   999999999999999999999999998754332


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH---H--
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE---A--  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--  384 (457)
                      .  .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.............|..........   .  
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            1  11233457889999999865 45789999999999999999999999754322111111110000000000   0  


Q ss_pred             -----hhhcCCcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 -----VEMVDPSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 -----~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                           ............     .......+.+++.+|++.||.+|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                 000000000000     00124578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=291.59  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=201.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-----GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~  225 (457)
                      .+|.+.+.||+|+||.||+|... ++..+++|.+...     .......+.+|+++++.++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999964 5889999987532     123345688999999999999999999998664  468


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++++||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999987543    3788999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccC-CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKIN-GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ....... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||......                ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~  218 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAI  218 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHH
Confidence            6543211 11123456889999999998888999999999999999999999999743211                111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ............+......+.+++.+||+ +|.+||+..+++.+
T Consensus       219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11111112223455556789999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-38  Score=279.88  Aligned_cols=278  Identities=25%  Similarity=0.387  Sum_probs=211.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +++.+..||.|+.|.|+++... .|...|||...+. +.++.+.+...++++..-+ .|.||+.+|||..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3455677999999999999965 5889999998776 4555567777887776664 89999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      | ...+..++....   +++++..+-++...++.||.||.++..  |+|||+||+|||+|+.|.+||||||.+..+.+. 
T Consensus       173 M-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  173 M-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             H-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc-
Confidence            9 556777666543   368999899999999999999987654  999999999999999999999999999877653 


Q ss_pred             CCccccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                        ...+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||......  ....          -.+..-.
T Consensus       246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~l----------tkvln~e  311 (391)
T KOG0983|consen  246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVL----------TKVLNEE  311 (391)
T ss_pred             --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHH----------HHHHhcC
Confidence              34566789999999999853   47899999999999999999999999864321  0000          0111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH------------HHHhhhhcCC-CccccCCCCcccCCCCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS------------LIPVVKNNAA-GAISFGSSRFQHQTPSP  455 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~------------L~~~~~~~~~-~~~~~~~~~~~~~~~~~  455 (457)
                      .|.+.  .....+..+++++..||++|+.+||...+++++            ...++++-.. .++.+.+...++|..+.
T Consensus       312 PP~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~~~~~~~~~~~s~~~~p~  389 (391)
T KOG0983|consen  312 PPLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMAKTESPRTSGVLSQPHLPF  389 (391)
T ss_pred             CCCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHhcccccccCCcccCCCCcc
Confidence            12222  122256689999999999999999999999986            1233333222 33445555566665554

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-37  Score=296.29  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +|++.+.||.|++|.||+|... ++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 5889999998765322 2345678999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      + ++|.+++..... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-  154 (284)
T cd07836          81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-  154 (284)
T ss_pred             C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence            7 589888876442 245899999999999999999999999   9999999999999999999999999997654321 


Q ss_pred             CccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC-C
Q 012739          313 GQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD-P  390 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~  390 (457)
                       .......++..|++||.+.+ ..++.++||||||+++|+|++|+.||................... .........+ +
T Consensus       155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (284)
T cd07836         155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP-TESTWPGISQLP  232 (284)
T ss_pred             -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC-ChhhHHHHhcCc
Confidence             11233457889999998865 457899999999999999999999997543321111000000000 0000000000 0


Q ss_pred             cCCC-----------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SLQG-----------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l~~-----------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+..           ......+..+.+++.+|++.+|.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000           1112234578899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=326.96  Aligned_cols=269  Identities=28%  Similarity=0.445  Sum_probs=221.0

Q ss_pred             HHHHHhcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012739          148 ELETATENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLG  217 (457)
Q Consensus       148 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~  217 (457)
                      .++...++..+.+.||+|.||.|++|...        ....||||.++... ..+.+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555566677779999999999999843        14579999997663 34456789999999999 6999999999


Q ss_pred             EEEcCCeEEEEEEeCCCCcHHHHHhhhC---C---C----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCcc
Q 012739          218 YCADQNHRLLISEYMPNGTLQQHLHRHN---N---R----Y--RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC  285 (457)
Q Consensus       218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~---~----~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp  285 (457)
                      +|.+++..++|+||+..|+|.++|+..+   .   .    .  ..+...+.+.++.|||.||+||++..   +|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999999876   1   0    0  23889999999999999999999998   99999999


Q ss_pred             CceEeCCCCcEEEeeccCccccccccCCcccccc-ccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 012739          286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV-LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNR  363 (457)
Q Consensus       286 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~  363 (457)
                      +|||++++..+||+|||+++.............. .-...|||||.+....|+.++||||||++|||++| |..||....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976554333211111 13456999999999999999999999999999999 788876421


Q ss_pred             CCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          364 PPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .                ..++.+.+.+..+...|..+..++.++++.||+.+|++||++.++++.++..+.+
T Consensus       527 ~----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  527 P----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             c----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            1                1233445566666677777888999999999999999999999999999998764

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.4e-37  Score=295.16  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=198.2

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||+|+||+||++... +++.+++|.+....   ......+..|+++++.++||||+++.+++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 58899999886432   22234567899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++.....  ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......   ....
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~  152 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK  152 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence            999976542  35899999999999999999999999   999999999999999999999999998765431   1123


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.........             ........ ......+
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~-~~~~~~~  218 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------EELKRRTL-EMAVEYP  218 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------------HHHHhccc-cccccCC
Confidence            345788999999998888999999999999999999999999754321110             01111000 0111233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhh
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKN  435 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~  435 (457)
                      ......+.+++.+||+.+|.+||     ++.+++++  +++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h--~~~~~  259 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH--PLFKD  259 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC--hhhhc
Confidence            34456899999999999999999     66667765  55654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-37  Score=304.84  Aligned_cols=280  Identities=23%  Similarity=0.311  Sum_probs=205.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC--CeE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ--NHR  225 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~--~~~  225 (457)
                      ..++|.+.+.||+|+||.||+|... ++..+|+|++...  .......+..|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888899999999999999975 5789999988543  223334567899999999 999999999998643  468


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||++ ++|.+++...     .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999996 6998888653     4889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC---ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          306 MVSDKING---QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       306 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ........   .......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            76443221   22334568899999998754 567899999999999999999999997543221111111110000000


Q ss_pred             -------hHHhhhcCC---cCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCccc
Q 012739          382 -------EEAVEMVDP---SLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAIS  442 (457)
Q Consensus       382 -------~~~~~~~d~---~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~  442 (457)
                             .....+++.   .-.   ..........+.+++.+||+.+|.+|||+.+++++  +++++...++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~--~~~~~~~~~~~~  307 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH--PYVAQFHNPSDE  307 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC--hhhhhhccCCCC
Confidence                   000001110   000   01111245689999999999999999999999987  666665443333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-37  Score=298.45  Aligned_cols=254  Identities=22%  Similarity=0.382  Sum_probs=203.8

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      .+||+|+||.||++... ++..+|+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999874 68899999986555555566889999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccc
Q 012739          239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR  318 (457)
Q Consensus       239 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  318 (457)
                      +++...     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            987542     3789999999999999999999999   9999999999999999999999999987654321  11233


Q ss_pred             cccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCH
Q 012739          319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK  398 (457)
Q Consensus       319 ~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  398 (457)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||........   .          ........+.+..  ..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~----------~~~~~~~~~~~~~--~~  240 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M----------KMIRDNLPPKLKN--LH  240 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----------HHHHhhCCcccCC--cc
Confidence            5688999999999888899999999999999999999999874322100   0          0000111111111  11


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          399 KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       399 ~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                      .....+.+++.+||+.+|.+||++.+++++  +++.+.-.++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~~~~  280 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAGPPS  280 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccCCCc
Confidence            234468899999999999999999999996  7777655433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=314.39  Aligned_cols=249  Identities=24%  Similarity=0.460  Sum_probs=198.1

Q ss_pred             CceeccCCcEEEEEEEEc-CCcEEEEEEcccC----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe--EEEEEEe
Q 012739          159 GNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH--RLLISEY  231 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~  231 (457)
                      ..+||+|+|-+||+|.+. +|..||--.++..    .....+.|..|+.+|+.|+||||++++.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            457999999999999974 3666664333221    23344678999999999999999999999977655  7799999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~  310 (457)
                      +..|+|..|+.+.+.    ++...+..|+.||++||.|||++ .|||+|||||-+||||+. .|.|||+|+|||......
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999988764    88999999999999999999998 588999999999999975 589999999999987543


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                          ......|||.|||||+.. ..|++.+||||||+.++||+|+..||..-..+.+                +...+-.
T Consensus       200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ----------------IYKKV~S  258 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ----------------IYKKVTS  258 (632)
T ss_pred             ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH----------------HHHHHHc
Confidence                234478999999999986 7899999999999999999999999975333211                1111111


Q ss_pred             cCCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          391 SLQGQ-YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       391 ~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+. +..-...++.++|.+|+.. ..+|||+.|+|+.  .++..+
T Consensus       259 GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d--~Ff~~d  302 (632)
T KOG0584|consen  259 GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD--PFFDED  302 (632)
T ss_pred             CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC--hhhccc
Confidence            11110 1111134789999999999 9999999999987  777664

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=298.16  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=197.7

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      |++.+.||.|++|.||+|... ++..|++|++....  ......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999864 68999999886542  222345778999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                       +++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-  153 (283)
T cd07835          81 -DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-  153 (283)
T ss_pred             -CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence             4689999876442  35899999999999999999999998   9999999999999999999999999987653221 


Q ss_pred             CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--------ccCchhH
Q 012739          313 GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--------RLTSREE  383 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~  383 (457)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.................        ......+
T Consensus       154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             112233568899999987654 578999999999999999999999975432111000000000        0000000


Q ss_pred             HhhhcCC---cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AVEMVDP---SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....+..   .............+.+++.+||+.+|.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000   00001112234578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.9e-37  Score=294.38  Aligned_cols=260  Identities=21%  Similarity=0.232  Sum_probs=193.5

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcC--CeEEEEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLH-SPQLVELLGYCADQ--NHRLLISE  230 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e  230 (457)
                      |++.+.||+|+||.||+|... ++..+|+|++.... .........|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999964 68899999886542 222223456888888885 99999999999887  88999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++ ++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 58888876533   35899999999999999999999999   999999999999999 99999999999866432


Q ss_pred             cCCccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   ......++..|+|||.+. +..++.++|||||||++|||++|+.||......+.............  ......+.
T Consensus       153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  227 (282)
T cd07831         153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD--AEVLKKFR  227 (282)
T ss_pred             C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC--HHHHHhhc
Confidence            1   123345788999999764 45678999999999999999999999975433211110000000000  00000000


Q ss_pred             CcC--CCC-----------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSL--QGQ-----------YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l--~~~-----------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..-  ...           .....+..+.+++.+||+.+|++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000  000           012345789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=288.35  Aligned_cols=248  Identities=30%  Similarity=0.513  Sum_probs=203.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|++.+.||+|++|.||++... +++.+++|.+.....  .....+.+|+++++.++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 578999999876643  3446788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999987653    4899999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      .  ......++..|+|||...+..++.++||||||+++|+|++|+.||......    ...+            ... ..
T Consensus       154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~------------~~~-~~  214 (254)
T cd06627         154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALF------------RIV-QD  214 (254)
T ss_pred             c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHH------------HHh-cc
Confidence            2  123456788999999998888899999999999999999999998743210    0000            000 00


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .....+...+..+.+++.+||..+|++||++.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            1112233345689999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.9e-37  Score=298.15  Aligned_cols=269  Identities=22%  Similarity=0.247  Sum_probs=196.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCe-----
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLH-SPQLVELLGYCADQNH-----  224 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~-----  224 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999965 588999998765422  22345778999999995 6999999999877655     


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeecc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNR-YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFG  302 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  302 (457)
                      .++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898888764332 346899999999999999999999999   999999999999998 8999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +++.......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......................
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9876533211  1122356788999998765 467999999999999999999999997543211110000000000000


Q ss_pred             --hHHhhhc----CCcCCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 --EEAVEMV----DPSLQG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 --~~~~~~~----d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        .......    -+....    .........+.+++.+||+.+|.+||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              0000000    000000    0011245578999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.9e-37  Score=300.42  Aligned_cols=268  Identities=19%  Similarity=0.269  Sum_probs=197.2

Q ss_pred             eeccC--CcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          161 VIGNG--GFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       161 ~LG~G--~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      .||+|  +||+||++... +++.||+|.+...  .....+.+.+|+.+++.++||||++++++|...+..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999964 6899999998654  2334467889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc-
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ-  314 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-  314 (457)
                      +|.+++.....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999887533  35889999999999999999999998   9999999999999999999999998654332211100 


Q ss_pred             ----cccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh-h------hhccccCch
Q 012739          315 ----ISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV-S------WALPRLTSR  381 (457)
Q Consensus       315 ----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~-~------~~~~~~~~~  381 (457)
                          ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .      +........
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                0111234567999999876  35789999999999999999999999754321110000 0      000000000


Q ss_pred             hH----------------------HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EE----------------------AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~----------------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..                      .....+..+....+..+...+.+|+.+||+.||++|||+.|++++  +++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~--~~~~~  313 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH--AFFKQ  313 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC--HHHHH
Confidence            00                      000111112222234566789999999999999999999999987  55554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-37  Score=317.65  Aligned_cols=272  Identities=16%  Similarity=0.204  Sum_probs=190.6

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEcC--CcEEEEE------------------EcccCchHHHHHHHHHHHHHHhcCCC
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLSD--GTVAAIK------------------KLHRDGKQRERAFRMEVDLLSRLHSP  210 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~hp  210 (457)
                      ....+|++.+.||+|+||+||++....  +...++|                  ++. ........+.+|+.+++.++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987532  2222221                  111 1122334578899999999999


Q ss_pred             CeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR-YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       211 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      ||+++++++...+..|+|+|++ .++|.+++...... .......++..++.|++.||.|||+++   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            9999999999999999999999 56787777553221 112345677889999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCC-CCCCCCcc
Q 012739          290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD-PNRPPGEH  368 (457)
Q Consensus       290 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~-~~~~~~~~  368 (457)
                      ++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++. ........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987643211 12234679999999999999999999999999999999999886543 22211111


Q ss_pred             hhhhhhc--c----ccCc-hhHHhhhcCCcCC----CCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          369 VLVSWAL--P----RLTS-REEAVEMVDPSLQ----GQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       369 ~~~~~~~--~----~~~~-~~~~~~~~d~~l~----~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+.....  .    .+.. .....+.++....    ...+     ......+.+++.+||+.||.+|||+.|++++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1110000  0    0000 0001111110000    0000     0123467788999999999999999999986

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.9e-37  Score=298.83  Aligned_cols=276  Identities=24%  Similarity=0.291  Sum_probs=203.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l  227 (457)
                      .++|++.+.||+|+||.||+|... ++..||+|++.....  .....+.+|+.+++.++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367888999999999999999975 589999998864422  1123456799999999999999999998754  56899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+. ++|.+++....   ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999995 58888887543   35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--------cc
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--------RL  378 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~  378 (457)
                      ....  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.................        ..
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            5322  11222345788999998865 5689999999999999999999999975433211111100000        00


Q ss_pred             CchhH--HhhhcCCcCCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          379 TSREE--AVEMVDPSLQG--QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       379 ~~~~~--~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                      .....  ...........  .........+.+++.+||+.||++|||+.+++++  +++++.+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~~~~~~  299 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFKEKPLP  299 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhccCCCC
Confidence            00000  00000000000  0001124578899999999999999999999987  888876664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.4e-37  Score=296.30  Aligned_cols=271  Identities=21%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|++|.||+|... +++.+++|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999975 688999998865422  223557889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~  309 (457)
                      |++ ++|.+++.....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            995 588887755332  24678888899999999999999998   999999999999985 56799999999975532


Q ss_pred             ccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--------ccCc
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--------RLTS  380 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~  380 (457)
                      ..  .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+..........        ....
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            21  11233457889999998865 4678999999999999999999999975433211110000000        0000


Q ss_pred             hhHHhhhcCCcCCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 REEAVEMVDPSLQG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 ~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ........ +....    .........+.+++.+|++.+|++||++.+++++  +++++
T Consensus       234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~--~~~~~  289 (294)
T PLN00009        234 LPDYKSAF-PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH--EYFKD  289 (294)
T ss_pred             chhhhhhc-ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC--chHhH
Confidence            00000000 00000    0111234578999999999999999999999986  55554

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.1e-37  Score=290.92  Aligned_cols=243  Identities=27%  Similarity=0.436  Sum_probs=195.0

Q ss_pred             eccCCcEEEEEEEEcC-CcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||.|+||.||++...+ ++.+++|.+.....   ...+.+.+|+++++.++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 89999999865532   3445688899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC-----
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN-----  312 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-----  312 (457)
                      .+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99997644    4899999999999999999999999   99999999999999999999999999875433211     


Q ss_pred             -CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 -GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 -~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       ........++..|+|||......++.++||||||+++|+|++|+.||.......   .             ........
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~-------------~~~~~~~~  217 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---I-------------FQNILNGK  217 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHhcCC
Confidence             012234567889999999988889999999999999999999999997543210   0             00010000


Q ss_pred             CCCCCCHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          392 LQGQYPKK--DLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       392 l~~~~~~~--~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .  ..+..  .+..+.+++.+||+.+|++|||+..+.+.|
T Consensus       218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            1  11111  256889999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-36  Score=289.25  Aligned_cols=249  Identities=23%  Similarity=0.303  Sum_probs=192.7

Q ss_pred             HHHHHhcCCCCCcee--ccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          148 ELETATENFSEGNVI--GNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       148 ~~~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      +.....++|.+.+.+  |+|+||.||++... ++..+|+|.+.......     .|+.....+ +||||+++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445667776666  99999999999964 57889999875432111     122222222 7999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeecc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFG  302 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  302 (457)
                      ..++||||+++++|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999997643    5899999999999999999999999   99999999999999988 99999999


Q ss_pred             CccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ++......      ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...           .
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~-----------~  217 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDL-----------E  217 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhH-----------H
Confidence            98765432      23458889999999999899999999999999999999999997432211 000           0


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-MTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~  428 (457)
                      ..........  .........+.+++.+||+.+|.+||+ +++++++
T Consensus       218 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        218 SLLKRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHHhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            1111111111  122245568999999999999999996 6999876

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-37  Score=303.63  Aligned_cols=266  Identities=22%  Similarity=0.270  Sum_probs=198.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~  224 (457)
                      ..+|.+.+.||+|+||.||++... ++..||+|++...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999964 5889999988653  222344567899999999999999999987643     35


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++|+||+. ++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 78988886533    4899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc-------
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP-------  376 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  376 (457)
                      .......  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.................       
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            8664321  22334567889999998764 5689999999999999999999999975422110000000000       


Q ss_pred             -ccCc--hhHHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          377 -RLTS--REEAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       377 -~~~~--~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ....  ..............   ....+.+.++.+++.+||+.+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence             0000  00000000000000   1112345678999999999999999999999999

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=294.13  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLISE  230 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lv~e  230 (457)
                      |++.+.||.|+||.||+|+.. +++.+++|++....  ......+.+|+++++.++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999975 48899999997653  33345678899999999999999999999887  89999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++ ++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            996 58888886542   35899999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch--hHH---
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR--EEA---  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---  384 (457)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......................  ...   
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            21 12233456788999997764 467899999999999999999999997654321111110000000000  000   


Q ss_pred             --hhhcCC------cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 --VEMVDP------SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 --~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        .....+      .+...+...+...+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              000000      00000111125688999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-37  Score=297.60  Aligned_cols=269  Identities=20%  Similarity=0.257  Sum_probs=195.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN------  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------  223 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357888999999999999999965 58899999886442  122234567999999999999999999986543      


Q ss_pred             --eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          224 --HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       224 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                        ..++||||+. ++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence              4599999995 58888876543   24899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCC--ccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          302 GLAKMVSDKING--QISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       302 gl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...................
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866432221  112334578889999988654 47889999999999999999999997544321111111110000


Q ss_pred             Cch----hHHhhhcCCc-CCCCC---------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSR----EEAVEMVDPS-LQGQY---------PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~----~~~~~~~d~~-l~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...    .......+.. +....         +......+.+++.+||+.||.+|||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000    0000000000 00000         00123467899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=304.39  Aligned_cols=272  Identities=21%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~  225 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467899999999999999999864 68899999986432 23345577899999999999999999987543     357


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++|+||+. ++|.+++..     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            99999995 588877754     24899999999999999999999999   9999999999999999999999999988


Q ss_pred             ccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||................... ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~  233 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQED  233 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHH
Confidence            65432211 11233568899999998654 568999999999999999999999997543211100000000000 0000


Q ss_pred             HhhhcCCc---------CCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          384 AVEMVDPS---------LQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       384 ~~~~~d~~---------l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+.+..         .....+     .....++.+++.+||+.+|++|||+.+++++  +++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h--p~~~~~  298 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH--PYLEQY  298 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC--cccccc
Confidence            00000000         000000     1224578999999999999999999999998  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=288.09  Aligned_cols=248  Identities=24%  Similarity=0.294  Sum_probs=189.9

Q ss_pred             ceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDL-LSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|... +++.+|+|.+.....   .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999864 588999999865422   122233445444 4455899999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      ++|.+++....    ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++....     
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999997643    4889999999999999999999998   99999999999999999999999999875432     


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG  394 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  394 (457)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......   ....           ..........
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-----------~~~~~~~~~~  214 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDN-----------ILSRRINWPE  214 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-----------HHhcccCCCC
Confidence             233457889999999988889999999999999999999999997532210   0000           0000001111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH-Hhhh
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI-PVVK  434 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~-~~~~  434 (457)
                      .....++..+.+++.+||+.+|++||++.++.+.|. ++++
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~  255 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK  255 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence            112234568999999999999999997654443332 4444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=293.69  Aligned_cols=259  Identities=17%  Similarity=0.201  Sum_probs=185.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCchHH--H---------HHHHHHHHHHHhcCCCCeeeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGKQR--E---------RAFRMEVDLLSRLHSPQLVELLG  217 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~--~---------~~~~~Ei~~l~~l~hpniv~l~~  217 (457)
                      .++|++.++||+|+||.||+|...+    +..+++|.........  .         .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4678999999999999999999754    3456666543222111  0         01122344556678999999999


Q ss_pred             EEEcCC----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC
Q 012739          218 YCADQN----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN  293 (457)
Q Consensus       218 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  293 (457)
                      ++....    ..++++|++ ..++.+.+....    ..++..+..++.|++.||.|||+.+   ++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            765443    446788877 346666665432    2567888999999999999999998   9999999999999999


Q ss_pred             CcEEEeeccCccccccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 012739          294 FRAKVTDFGLAKMVSDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH  368 (457)
Q Consensus       294 ~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~  368 (457)
                      +.++|+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999866432111     1122346999999999999999999999999999999999999999754322111


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .....       .+....+....+.   ....+..+.+++..|++.+|++||++.++++.|
T Consensus       243 ~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAK-------CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhH-------HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            10000       0000111111110   112345799999999999999999999999876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-37  Score=300.54  Aligned_cols=274  Identities=22%  Similarity=0.277  Sum_probs=206.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----eEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRL  226 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~  226 (457)
                      +|++.+.||.|+||.||+|... ++..+++|++....  ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999975 48899999987643  334466888999999999999999999987765     789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ++|||++ ++|.+++....    ++++..++.++.|++.||.|||+.+   ++|+||||.|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999996 58888886533    5999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCC-ccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC-----
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT-----  379 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  379 (457)
                      ....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            6543210 112345678899999999877 889999999999999999999999976543111100000000000     


Q ss_pred             -----chhHHhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          380 -----SREEAVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       380 -----~~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                           ..............   ..........+.+++.+||+.+|++||++.+++++  +++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--~~~~~~~~  297 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH--PYLAQLHD  297 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC--ccHHhhcc
Confidence                 00000000000000   01112245678999999999999999999999987  45554333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-36  Score=293.81  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=199.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|.+.+.||+|+||.||+|...+ ++.+|+|.+.... ......+..|+.++... .||||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999999865 8899999986543 23334566677766666 4999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||+. ++|.+++.....   .+++..+..++.|++.||.|||+ .+   ++||||+|+||++++++.+||+|||++..+.
T Consensus        94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9984 577777655332   68999999999999999999997 47   9999999999999999999999999987654


Q ss_pred             cccCCccccccccCCCccccccccCCC----CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGK----LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ...   ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... ..              ..
T Consensus       167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~--------------~~  228 (296)
T cd06618         167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FE--------------VL  228 (296)
T ss_pred             CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HH--------------HH
Confidence            321   122345778999999987543    789999999999999999999999642211 00              01


Q ss_pred             hhhcCCcCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          385 VEMVDPSLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       385 ~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ...++.... .........++.+++.+||+.+|.+||++.+++++  +++++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~--~~~~~~~~  281 (296)
T cd06618         229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH--PFIRRYET  281 (296)
T ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC--hhhhccch
Confidence            111111100 01111234579999999999999999999999988  66665444

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.1e-36  Score=293.04  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=194.2

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      |...+.||+|+||.||+|+.. ++..+++|++....   ......+..|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566778999999999999964 58899999886432   23335678899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +. ++|.+++....   .++++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            95 67877776533   35899999999999999999999999   99999999999999999999999999864322  


Q ss_pred             CCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                          .....|+..|+|||.+.   ...++.++||||||+++|||++|..||..........                ...
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~----------------~~~  233 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------------HIA  233 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH----------------HHH
Confidence                23456888999999984   4668899999999999999999999987543211100                000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...............+.+++.+||+.+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000001112233468999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.4e-37  Score=302.56  Aligned_cols=276  Identities=20%  Similarity=0.277  Sum_probs=205.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~  225 (457)
                      ..+|++.+.||+|+||.||+|... ++..|++|++....  ......+.+|+.+++.++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888899999999999999964 58999999986542  2234557789999999999999999988753    3568


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+. ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 68988886532    4899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccccC--CccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC---
Q 012739          306 MVSDKIN--GQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT---  379 (457)
Q Consensus       306 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  379 (457)
                      .......  ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....................   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6543221  112234578899999998865 5689999999999999999999999976433211111000000000   


Q ss_pred             ----chhHHhhhcCCc-CCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          380 ----SREEAVEMVDPS-LQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       380 ----~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                          ......+..+.. .....     ....+..+.+++.+||+.+|++||++.+++.+  +++++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~--~~~~~~~~  302 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH--PFLAQYHD  302 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC--hhhhhccC
Confidence                000111111100 00011     12235689999999999999999999999987  77766544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-36  Score=291.61  Aligned_cols=252  Identities=27%  Similarity=0.374  Sum_probs=198.0

Q ss_pred             CCCCCceeccCCcEEEEEEEE----cCCcEEEEEEcccCch----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDGK----QRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~  225 (457)
                      +|++.+.||.|+||.||++..    .+|..||+|++.....    ...+.+..|+.+++.+ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999986    3688999999865321    2235578899999999 589999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999997643    4888999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccccCCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ....... .......|+..|+|||.+..  ..++.++||||||+++|+|++|+.||.........             ..
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------~~  219 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-------------AE  219 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH-------------HH
Confidence            6543211 11233568889999999865  34788999999999999999999999643221110             01


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ....+.. ....++......+.+++.+||+.+|++||     ++.+++++
T Consensus       220 ~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         220 ISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            1111000 01123334456889999999999999997     67777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7e-37  Score=289.98  Aligned_cols=251  Identities=20%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC-CcEEEEEEccc---C--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR---D--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~---~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      +|.+.+.||+|+||.||++.... +..+++|.++.   .  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998643 33444444432   1  122334566799999999999999999999988899999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      +||+++++|.+++.........+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999999765444457999999999999999999999999   999999999999975 569999999987664


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......                .......
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~~~~~~  218 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------------SVVLRIV  218 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHH
Confidence            321  1223456788999999998888999999999999999999999998643210                0001111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      . ......+.....++.+++.+||+.+|++||++.+++++
T Consensus       219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            1 11112344556689999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-36  Score=295.17  Aligned_cols=267  Identities=20%  Similarity=0.294  Sum_probs=198.1

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .+.+|.|+++.||++.. +++.||+|++...  .....+.+..|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455666666666655 6899999998654  34455678999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC----
Q 012739          237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN----  312 (457)
Q Consensus       237 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~----  312 (457)
                      |.+++.....  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+..+.....    
T Consensus        86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999986532  24888999999999999999999999   99999999999999999999999999875532211    


Q ss_pred             -CccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc---cccCchhH---
Q 012739          313 -GQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL---PRLTSREE---  383 (457)
Q Consensus       313 -~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~---  383 (457)
                       ........++..|+|||.+..  ..++.++||||||+++|||++|+.||........  ......   +.......   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence             111233457778999999865  4588999999999999999999999975432111  000000   00000000   


Q ss_pred             ----Hhh----hcCCc----CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          384 ----AVE----MVDPS----LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       384 ----~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                          ...    ..++.    ...........++.+++.+||+.||++|||+++++++  +++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--p~~~~  300 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH--SFFKQ  300 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC--chHhh
Confidence                000    00000    0112233455689999999999999999999999997  56654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-36  Score=288.93  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=191.5

Q ss_pred             eeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHH---HHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          161 VIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEV---DLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei---~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +||+|+||.||++... +++.||+|.+....   ......+..|.   ..++...||||+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 58899999886532   11122233343   44555689999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......   
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---  150 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence            999999886532    4899999999999999999999998   999999999999999999999999998755332   


Q ss_pred             ccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......|+..|+|||.+.++ .++.++||||||+++|||++|+.||...........           ........   
T Consensus       151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~~~---  215 (278)
T cd05606         151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DRMTLTMA---  215 (278)
T ss_pred             -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-----------HHHhhccC---
Confidence             12334689999999998754 689999999999999999999999975432111100           00000111   


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~  435 (457)
                       ...+...+..+.+++.+|+..+|.+||     ++.+++++  +++++
T Consensus       216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~--~~~~~  260 (278)
T cd05606         216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH--PFFRS  260 (278)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC--ccccC
Confidence             123333456899999999999999999     99999876  55554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=292.23  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=200.8

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      |++.+.||.|++|.||++... +++.+++|++.....  .....+..|+++++.++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999965 688899998865432  23456788999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      + ++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+....... 
T Consensus        81 ~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 D-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             C-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            6 48888887643   35899999999999999999999999   9999999999999999999999999987765432 


Q ss_pred             CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh--------hccccCc--h
Q 012739          313 GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW--------ALPRLTS--R  381 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~--~  381 (457)
                       .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+.......        .+.....  .
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence             122334578889999998776 789999999999999999999999975433211111000        0000000  0


Q ss_pred             hHHhhhcCCcC--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVDPSL--QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+...  ..........++.+++.+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000000  001122346689999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.4e-37  Score=292.98  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=203.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|.+.+.||.|+||.||++... ++..+++|.+...   .....+.+..|+++++.+. ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999975 6899999988653   2233456788999999998 99999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999997654    4999999999999999999999999   9999999999999999999999999988664


Q ss_pred             cccCC------------------ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh
Q 012739          309 DKING------------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL  370 (457)
Q Consensus       309 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~  370 (457)
                      .....                  .......++..|+|||......++.++||||||+++++|++|+.||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            43211                  1223346788999999998888999999999999999999999999854310     


Q ss_pred             hhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHH
Q 012739          371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM----TDVVQS  428 (457)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~evl~~  428 (457)
                                 .......+  .....+...+..+.+++.+||+.+|.+||++    .+++++
T Consensus       229 -----------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 -----------LTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -----------HHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                       00011111  1112233335579999999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=287.29  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      -++|..+++||+|.||+|-+++-+ .++.+|+|++++.   .+.....-..|-++|+..+||.+..+.-.|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356888899999999999999954 6899999999776   233334456799999999999999998899999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||..||.|.-+|....    .+++.....+..+|+.||.|||+++   ||.||||.+|+|+|.+|.+||+||||++.--
T Consensus       247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999998887644    4899889999999999999999998   9999999999999999999999999998532


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                        ..+....++||||.|+|||++.+..|..++|.|.+|+++|||++|+.||...+-.....++.              .-
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--------------~e  383 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--------------ME  383 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--------------hh
Confidence              23455778999999999999999999999999999999999999999998654322111110              00


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      |  +  .+|.....+...|+...|.+||.+|.     .++||.++
T Consensus       384 d--~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 D--L--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             h--c--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            1  1  34555566889999999999999995     36666655

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-37  Score=302.82  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=208.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ...|.+.+.||+|.|+.|.+|++. .+..||||.+.+.  +....+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456888999999999999999964 5899999999765  3333345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+.+|.+.+++.....    +.+..+..++.|+..|++|||+++   |||||||.+|||++.+..+||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999998764    666888999999999999999999   99999999999999999999999999988763


Q ss_pred             ccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                         +....+.+|++.|.|||++.+..| .+.+|+||+|++||.|+.|..||++.....                    .-
T Consensus       208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------------------Lr  264 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------------------LR  264 (596)
T ss_pred             ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------------------cc
Confidence               344667899999999999998776 478999999999999999999998643211                    11


Q ss_pred             CCcCCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          389 DPSLQG--QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       389 d~~l~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ++.+.+  ..+.-...++.+++++++-.+|.+|++++++.++
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            111211  1223334578899999999999999999999876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-36  Score=293.47  Aligned_cols=269  Identities=23%  Similarity=0.299  Sum_probs=198.1

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----  223 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----  223 (457)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45578899999999999999999975 58899999986542  222345678999999999999999999987654    


Q ss_pred             ------eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          224 ------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       224 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                            ..++|+||+++ +|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                  78999999975 7777766532   35899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999986644321 11223346778999998764 4578999999999999999999999975432111111100000


Q ss_pred             ccCc--hhHHhh-----hcC------CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          377 RLTS--REEAVE-----MVD------PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       377 ~~~~--~~~~~~-----~~d------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....  .....+     ..+      ....... ...+..+.+++.+||+.+|.+||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000  000000     000      0000000 1134578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-36  Score=292.92  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=194.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .|...+.||+|+||.||+|+.. ++..+++|.+...   .....+.+.+|+++++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999965 5788999987542   22334567789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+. |+|.+++....   .++++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            996 68887775433   35889999999999999999999998   99999999999999999999999999876532 


Q ss_pred             cCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          311 INGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                           .....++..|+|||.+.   ...++.++|||||||++|+|++|+.||.........  .           .....
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~-----------~~~~~  229 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--Y-----------HIAQN  229 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--H-----------HHhhc
Confidence                 22346788999999874   356888999999999999999999998643211000  0           00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..+.   .........+.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         230 ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            0011   1122345578999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-36  Score=297.04  Aligned_cols=274  Identities=21%  Similarity=0.237  Sum_probs=199.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-C--CcEEEEEEcccC--chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc----CCe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-D--GTVAAIKKLHRD--GKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD----QNH  224 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~----~~~  224 (457)
                      +|.+.+.||+|+||.||++... .  +..+|+|++...  .....+.+..|+.+++.+ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999964 3  678999988643  222345677899999999 59999999987532    245


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++++||+. ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788899885 68998886533    4899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC--ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc-----
Q 012739          305 KMVSDKING--QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP-----  376 (457)
Q Consensus       305 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----  376 (457)
                      +........  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................     
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            866432211  11233568999999998765 5689999999999999999999999975432110000000000     


Q ss_pred             ---ccCch--hHHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          377 ---RLTSR--EEAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       377 ---~~~~~--~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                         .+...  .............   .........+.+++.+||+.+|.+|||+.+++++  ++++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~~~~  300 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAIWHD  300 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhhhcC
Confidence               00000  0000000000000   0011124578999999999999999999999987  88886554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.4e-36  Score=290.88  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             CCCCCceeccCCcEEEEEEEE----cCCcEEEEEEcccCc----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~  225 (457)
                      +|++.+.||+|+||.||++..    .++..+|+|.+....    ....+.+..|+.++..+ +||||+++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999884    357889999886432    12234577899999999 699999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++++|.+++....    .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999987533    4889999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccccCCccccccccCCCccccccccCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ....... .......++..|+|||.+.+..  .+.++||||||+++|||++|..||..........            ..
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------~~  220 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS------------EI  220 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH------------HH
Confidence            6543321 1122346888999999987654  7889999999999999999999996432211000            00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                      .......  ....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       221 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         221 SRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0001110  012223344578999999999999999998888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.9e-36  Score=298.08  Aligned_cols=274  Identities=20%  Similarity=0.242  Sum_probs=200.1

Q ss_pred             cCCC-CCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHH--------------HHHHHHHHHHHHhcCCCCeeeEEE
Q 012739          154 ENFS-EGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQR--------------ERAFRMEVDLLSRLHSPQLVELLG  217 (457)
Q Consensus       154 ~~~~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~hpniv~l~~  217 (457)
                      ++|. +.+.||.|+||.||+|... +++.||+|++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3577999999999999965 68899999886542211              124678999999999999999999


Q ss_pred             EEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                      ++...+..++||||+. |+|.+++....    .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            9999999999999996 68999886533    4889999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccC------------CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          298 VTDFGLAKMVSDKIN------------GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      |+|||++........            ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976641110            1111223467889999998764 478999999999999999999999975543


Q ss_pred             CCcchhhhhhccccCchh--HH--hhh---cCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          365 PGEHVLVSWALPRLTSRE--EA--VEM---VDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~--~~--~~~---~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .+....+...........  ..  ...   .......   .........+.+++.+||+.+|++||++.+++.+  ++++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~--~~~~  317 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH--EYFK  317 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC--cccC
Confidence            211110000000000000  00  000   0000000   0011234578899999999999999999999986  7776


Q ss_pred             hcC
Q 012739          435 NNA  437 (457)
Q Consensus       435 ~~~  437 (457)
                      .+.
T Consensus       318 ~~~  320 (335)
T PTZ00024        318 SDP  320 (335)
T ss_pred             CCC
Confidence            543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=308.41  Aligned_cols=271  Identities=25%  Similarity=0.402  Sum_probs=209.4

Q ss_pred             CceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcC------CeEEEEEE
Q 012739          159 GNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISE  230 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~~~lv~e  230 (457)
                      .+.||+|+||.||+|++ ..|+.||||.++.....+ .+..-+|+++|++++|+|||++++.=.+.      ....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            46799999999999995 569999999997754222 34467899999999999999999875443      35689999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC--CCC--cEEEeeccCccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNF--RAKVTDFGLAKM  306 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgl~~~  306 (457)
                      ||.+|+|...|.+..+ ...|++.+.+.++..+..||.|||+++   |+||||||.||++-  ++|  ..||+|||.++.
T Consensus        98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            9999999999988654 357999999999999999999999999   99999999999983  333  589999999998


Q ss_pred             cccccCCccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      +.+.   .......||..|++||+.. ...|+..+|.|||||++|++.||..||.+...+....-+.|..-.-.. ..+.
T Consensus       174 l~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp-~~v~  249 (732)
T KOG4250|consen  174 LDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP-SGVA  249 (732)
T ss_pred             CCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC-Ccee
Confidence            8764   3577889999999999998 488999999999999999999999999876655322112221111110 0000


Q ss_pred             hhcCCcCC------------CCCCHHHHHHHHHHHHhhcCCCCCCCC--CHHHHHHHHHHhhhhcC
Q 012739          386 EMVDPSLQ------------GQYPKKDLIQIAAIAAVCVQPEAAYRP--LMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       386 ~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~evl~~L~~~~~~~~  437 (457)
                      -..++...            ..........+-..+..+|..+|.+|-  ...+....+..++++.-
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v  315 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV  315 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence            00111111            111233445677788889999999998  88999999999988743

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=332.85  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      -++....+||.|.||.||-|.. ++|...|+|.++.....  ....+.+|+.++..++|||+|+++|+-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            4567778999999999999984 56889999988655322  23457889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||++|+|.+.+...+.    .++.....+..|++.|+.|||+.|   ||||||||+|||++.+|.+|++|||.+..+...
T Consensus      1315 yC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999876543    666666778899999999999999   999999999999999999999999999887654


Q ss_pred             cC--CccccccccCCCccccccccCC---CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          311 IN--GQISTRVLGTTGYLAPEYASTG---KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       311 ~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ..  .......+||+.|||||++.+.   .-.-+.||||||||..||+||+.||...+......+               
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy--------------- 1452 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY--------------- 1452 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh---------------
Confidence            21  1223457899999999999753   345689999999999999999999986544322111               


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       -+...-.+++|.....+-.+++..||+.||++|.++.|++++
T Consensus      1453 -~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 -HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence             112223356777788899999999999999999998888876

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-36  Score=286.98  Aligned_cols=264  Identities=23%  Similarity=0.265  Sum_probs=195.1

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCch--HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCe-----
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK--QRERAFRMEVDLLSRL---HSPQLVELLGYCADQNH-----  224 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~-----  224 (457)
                      |++.+.||+|+||.||+|.... +..+|+|++.....  .....+..|+.+++.+   +|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999864 89999999864422  2223456677777665   69999999999987776     


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .+++|||++ ++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 589988876432  25899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH-
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE-  383 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  383 (457)
                      .......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||........................ 
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence            7764321   122335788899999999989999999999999999999999998754322111000000000000000 


Q ss_pred             -----HhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 -----AVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 -----~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                           ....+.....   ..........+.+++.+||+.+|.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 0000000000   01112335678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-36  Score=297.13  Aligned_cols=274  Identities=20%  Similarity=0.278  Sum_probs=203.3

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC---
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN---  223 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~---  223 (457)
                      ....++|++.+.||+|+||.||++... ++..||+|++...  .......+.+|+.+++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999854 6889999988543  2223345778999999999999999999986543   


Q ss_pred             ---eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          224 ---HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       224 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                         ..++||||+ +++|.+++..     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence               458999999 7799888754     24899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc----
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL----  375 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~----  375 (457)
                      ||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||................    
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9998765332     223457889999998875 468899999999999999999999997543211100000000    


Q ss_pred             ----cccCc--hhHHhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          376 ----PRLTS--REEAVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       376 ----~~~~~--~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                          ..+..  .......+.....   ..........+.+++.+|++.||.+|||+.+++++  ++++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~--~~~~~~~~~  307 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH--PYFEEFHDP  307 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC--ccHhhhcCc
Confidence                00000  0000000000000   01112234578899999999999999999999976  777765443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-36  Score=318.99  Aligned_cols=253  Identities=28%  Similarity=0.411  Sum_probs=191.7

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------  222 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------  222 (457)
                      +-..+|+.+++||+||||.||+++++ ||+.||||+|.... ......+.+|+.++.+|+|||||+++..|.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567788899999999999999965 89999999997764 33335578899999999999999987532100      


Q ss_pred             --------------------------------------------------------------------------------
Q 012739          223 --------------------------------------------------------------------------------  222 (457)
Q Consensus       223 --------------------------------------------------------------------------------  222 (457)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHH
Q 012739          223 ---------------------------------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF  269 (457)
Q Consensus       223 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~  269 (457)
                                                       ..+||-||||+...|.+++..+.-.   -.....++++.+|++||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHH
Confidence                                             1237889999887777777664321   1467789999999999999


Q ss_pred             HHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc------c----------ccCCccccccccCCCccccccccC
Q 012739          270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS------D----------KINGQISTRVLGTTGYLAPEYAST  333 (457)
Q Consensus       270 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~  333 (457)
                      +|++|   +|||||||.|||+++++.|||+|||++....      .          .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998721      0          011113456789999999999976


Q ss_pred             C---CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC-CcCC--CCCCHHHHHHHHHH
Q 012739          334 G---KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD-PSLQ--GQYPKKDLIQIAAI  407 (457)
Q Consensus       334 ~---~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~l~--~~~~~~~~~~l~~l  407 (457)
                      .   .|+.|+|+||||+||+||+.   ||....                ++..+...+. ..+.  ..+..+....-.++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----------------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----------------ERASILTNLRKGSIPEPADFFDPEHPEEASL  850 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchH----------------HHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence            5   49999999999999999985   565321                1111211111 1111  12234445566789


Q ss_pred             HHhhcCCCCCCCCCHHHHHHH
Q 012739          408 AAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       408 i~~cl~~~p~~RPs~~evl~~  428 (457)
                      |.+|++.||.+|||+.|+++.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhc
Confidence            999999999999999999865

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-36  Score=300.61  Aligned_cols=275  Identities=20%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC----------
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ----------  222 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----------  222 (457)
                      .+|.+.+.||.|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999964 5889999998766555556788899999999999999999776543          


Q ss_pred             ----CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEE
Q 012739          223 ----NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAK  297 (457)
Q Consensus       223 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  297 (457)
                          ...++|+||++ ++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||||+||+++ .++.++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                35789999996 6888887542     3889999999999999999999999   99999999999997 456789


Q ss_pred             EeeccCccccccccCCc-cccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc
Q 012739          298 VTDFGLAKMVSDKINGQ-ISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~  375 (457)
                      |+|||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||................
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999997653321111 1123457889999997654 568899999999999999999999997543321111111100


Q ss_pred             cccCc--hhHHhhhc----C-CcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          376 PRLTS--REEAVEMV----D-PSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       376 ~~~~~--~~~~~~~~----d-~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                      +....  ........    . .......     ......++.+++.+||+.+|++|||+.+++++  ++++....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--~~~~~~~~~  309 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH--PYMSCYSCP  309 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC--CccccccCC
Confidence            00000  00000000    0 0000000     11234578899999999999999999999987  888766554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-36  Score=296.26  Aligned_cols=278  Identities=21%  Similarity=0.281  Sum_probs=206.4

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCAD  221 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~  221 (457)
                      ...++....++|.+.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456667789999999999999999999985 468899999987542  2234557789999999999999999998754


Q ss_pred             C------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          222 Q------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       222 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      .      +..+++++++ +++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence            3      3467888887 78998887542     3899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh-
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW-  373 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~-  373 (457)
                      +||+|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. 
T Consensus       159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999998764322     233467889999998865 5688999999999999999999999965432111000000 


Q ss_pred             -------hccccCch--hHHhhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          374 -------ALPRLTSR--EEAVEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       374 -------~~~~~~~~--~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                             ....+...  ......+.......+   .......+.+++.+|++.+|.+||++.+++++  +++++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~f~~~~~  308 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHD  308 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC--hhhhhcCC
Confidence                   00000000  000000000000000   01134578899999999999999999999988  77776444

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=289.80  Aligned_cols=264  Identities=23%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      |.+.+.||+|+||.||+|... +++.+++|++..... .......+|+..++.++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 478899998865422 22233456899999999 999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                       +|+|.+++....  ...+++.++..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             889999887654  235899999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc-----hhHHhh
Q 012739          313 GQISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS-----REEAVE  386 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  386 (457)
                        ......++..|+|||.+. ...++.++|+||||+++|||++|+.||......+..............     ......
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              123345788999999874 456799999999999999999999999754332111100000000000     000000


Q ss_pred             hcCCcCC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQ-------GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..+..+.       ..........+.+++.+||+.+|++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0110000       00001124579999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=293.05  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +.|+.-++||+|+||.||-+... +|+.+|.|++.+.   .+..+.....|-.+|..++.+.||.+--.|...+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45788899999999999999854 6899999988543   1233345678999999999999999998999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ..|.||+|.-+|.+.++  ..+++..++.++.+|+.||++||..+   ||.|||||+|||+|+.|.++|+|+||+..+..
T Consensus       265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999988765  56999999999999999999999999   99999999999999999999999999987754


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   +.....+||.+|||||++.+..|+...|.|||||+||||+.|+.||.....-             .+.+++...+ 
T Consensus       340 g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------------vk~eEvdrr~-  402 (591)
T KOG0986|consen  340 G---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------------VKREEVDRRT-  402 (591)
T ss_pred             C---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------------hhHHHHHHHH-
Confidence            3   3344558999999999999999999999999999999999999999753221             1111221111 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                      ..-..+|+...+.+..++....|++||.+|..     +.+|.++
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            11122567777889999999999999999975     4466555

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-36  Score=295.92  Aligned_cols=270  Identities=21%  Similarity=0.317  Sum_probs=201.8

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHR  225 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~  225 (457)
                      ...+++|++.+.||+|+||.||++... ++..+|+|++...  .....+.+..|+++++.++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999865 6889999987543  22234567789999999999999999999865 5678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++++||+ +++|.+++...     ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999998 67898887642     4788888899999999999999999   9999999999999999999999999987


Q ss_pred             ccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--------
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--------  376 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------  376 (457)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.................        
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            54321     223457888999998765 5789999999999999999999999975432111000000000        


Q ss_pred             ccCchhHHhhhcCCc-CCCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          377 RLTSREEAVEMVDPS-LQGQYPK-----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..... ...+.+... .....+.     .....+.+++.+||+.+|++||++.+++.+  ++++..
T Consensus       232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~--~~~~~~  294 (328)
T cd07856         232 TICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH--PYLAPY  294 (328)
T ss_pred             hccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--Cccccc
Confidence            00000 001111100 0111111     234689999999999999999999999887  555443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-36  Score=297.93  Aligned_cols=260  Identities=21%  Similarity=0.314  Sum_probs=193.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~  223 (457)
                      ..+|...+.||+|+||.||+|... ++..+|+|++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 68999999986532  22234577899999999999999999998654      3


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++|+||+. .+|..++.      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4689999995 47766542      24889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch-
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR-  381 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  381 (457)
                      ++.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||................+ .... 
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~  237 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGPE  237 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHH
Confidence            8764321     223457888999999866 5689999999999999999999999985432111100000000 0000 


Q ss_pred             ----------hHHhhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 ----------EEAVEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ----------~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                                ...............   .......+.+++.+||+.||++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      000000000000000   01234568899999999999999999999977

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-37  Score=283.36  Aligned_cols=281  Identities=21%  Similarity=0.250  Sum_probs=206.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc---C--CcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS---D--GTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~  224 (457)
                      ...|+..+.||+|+||.||+|.-.   +  ...+|+|+++....  .-.....+|+.+++.++||||+.+..+|.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356888999999999999999632   2  33789999976521  122346679999999999999999999876 888


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC----CcEEEe
Q 012739          225 RLLISEYMPNGTLQQHLHRHNN-RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN----FRAKVT  299 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~  299 (457)
                      .++++||.+. +|...|+-+.. +.+.++...+..|++||+.|+.|||++-   |+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999965 88888876443 3357888999999999999999999998   9999999999999877    899999


Q ss_pred             eccCccccccccCCc-cccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCc---------c
Q 012739          300 DFGLAKMVSDKINGQ-ISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE---------H  368 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~---------~  368 (457)
                      |||+++.+.+....- ....++.|..|+|||++.+ ..|+.+.||||.|||+.||+|-++-|......-.         .
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887655433 2345778999999999876 5799999999999999999999988865322100         0


Q ss_pred             hhhhh--------hccccCchhHH---hhhcCCcCCCCC--------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          369 VLVSW--------ALPRLTSREEA---VEMVDPSLQGQY--------PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       369 ~~~~~--------~~~~~~~~~~~---~~~~d~~l~~~~--------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ..+..        .++.+.+..+.   ...+........        ...-.....+|+..+|..||.+|.|+.+.+++ 
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh-  337 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH-  337 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc-
Confidence            00100        11111111111   111110000000        00012247889999999999999999999998 


Q ss_pred             HHhhhhcCCC
Q 012739          430 IPVVKNNAAG  439 (457)
Q Consensus       430 ~~~~~~~~~~  439 (457)
                       ..+++...+
T Consensus       338 -~yF~~d~lp  346 (438)
T KOG0666|consen  338 -PYFTEDPLP  346 (438)
T ss_pred             -cccccCCCC
Confidence             666665544

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-36  Score=293.86  Aligned_cols=269  Identities=22%  Similarity=0.288  Sum_probs=194.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQ-------  222 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-------  222 (457)
                      .++|++.+.||+|+||.||+|... +++.+++|++......  ....+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467889999999999999999965 5889999988544221  223467899999999999999999987543       


Q ss_pred             -CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          223 -NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       223 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                       ...++|+||+. ++|...+....   ..+++.++..++.|+++||.|||+.+   ++|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence             34699999995 46777665432   35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCC---------ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh
Q 012739          302 GLAKMVSDKING---------QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV  371 (457)
Q Consensus       302 gl~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~  371 (457)
                      |+++........         ...+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999865432211         11123456888999998765 45899999999999999999999999754332111111


Q ss_pred             hhhccccCc-----hhHHhhhcCCcCCCCCC-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          372 SWALPRLTS-----REEAVEMVDPSLQGQYP-------KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       372 ~~~~~~~~~-----~~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .........     ........+.......+       ......+.+++.+||+.+|++|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000000     00000000000000000       1122578899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=299.52  Aligned_cols=273  Identities=19%  Similarity=0.298  Sum_probs=205.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe----
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH----  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~----  224 (457)
                      ..++|.+.+.||+|+||.||+|... ++..+|+|++...  .....+.+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4577899999999999999999975 5789999988653  22333557789999999999999999988766554    


Q ss_pred             --EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          225 --RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       225 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                        .++|+||+ +++|.+++..     ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence              89999999 6799998865     24899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc-----
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP-----  376 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----  376 (457)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....+     
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            98865432     233457888999998865 4678999999999999999999999975432111000000000     


Q ss_pred             ---ccCc--hhHHhhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          377 ---RLTS--REEAVEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       377 ---~~~~--~~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                         .+..  .......+.......+   .......+.+++.+||+.+|++|||+.+|+++  +++++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h--~~~~~~~~~~  308 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH--PYLAEYHDPE  308 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC--CCccccCCCc
Confidence               0000  0000000000000011   11235689999999999999999999999988  8887766643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=275.90  Aligned_cols=267  Identities=20%  Similarity=0.354  Sum_probs=207.6

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      +++++...+.     +.||+|+|+.|--++ ..++..+|||++.+..........+|++++.+. .|+||+.++++|.++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3455555543     679999999999888 568999999999877555555677899999888 599999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEEEe
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVT  299 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~  299 (457)
                      ..+|||||.|.||+|.+.|+++.-    +++.++.++..+|+.||++||.+|   |.||||||+|||...-   .-+|||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence            999999999999999999988764    999999999999999999999999   9999999999998543   358999


Q ss_pred             eccCcccccc-----ccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch
Q 012739          300 DFGLAKMVSD-----KINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV  369 (457)
Q Consensus       300 Dfgl~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~  369 (457)
                      ||.|......     ........+.+|+..|||||++.     ...|+.++|.||||+|||-|++|.+||.+....+   
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---  298 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---  298 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---
Confidence            9998754321     11122234578999999999863     3468999999999999999999999998765422   


Q ss_pred             hhhhhccccCc--hhHHhhhcCCcCCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          370 LVSWALPRLTS--REEAVEMVDPSLQGQYPK----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       370 ~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ..|...+.-.  ...+.+.++...- ++|.    ..+.+..+++...+..++.+|.++.+++.+
T Consensus       299 -CGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  299 -CGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             -CCccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence             1232221111  1122222222221 3333    345678899999999999999999999884

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-36  Score=286.81  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      |+..+.||+|+||.||+|+.. +++.+++|.+....  ....+.+..|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999976 48999999987653  223355778999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      + ++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 58999998753   24899999999999999999999999   99999999999999999999999999876643211


Q ss_pred             CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh---hh-
Q 012739          313 GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV---EM-  387 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-  387 (457)
                        ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.............. ....   .. 
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  230 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE-ESWPGVTKLP  230 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH-HHHHhhcccc
Confidence              22334467789999998766 8899999999999999999999999754322111100000000000 0000   00 


Q ss_pred             -cCCcCC---C----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 -VDPSLQ---G----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 -~d~~l~---~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       .+..+.   .    ..-......+.+++.+||+.+|++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             000000   0    0001124579999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=278.54  Aligned_cols=236  Identities=28%  Similarity=0.388  Sum_probs=193.3

Q ss_pred             eccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          162 IGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      ||+|+||.||++... +++.+++|.+.....   .....+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999975 488999998865422   2345688899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST  317 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  317 (457)
                      .+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            99997653    4899999999999999999999998   9999999999999999999999999987664321  1233


Q ss_pred             ccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       318 ~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ...++..|++||.+.+..++.++|+||||+++|+|++|+.||.....   ...             .......  ....+
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~-------------~~~~~~~--~~~~~  213 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI-------------YEKILKD--PLRFP  213 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH-------------HHHHhcC--CCCCC
Confidence            45678899999999888899999999999999999999999964322   000             0111111  11233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPLMTD  424 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs~~e  424 (457)
                      ......+.+++.+||..+|++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            333568899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=289.82  Aligned_cols=285  Identities=24%  Similarity=0.371  Sum_probs=211.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc--hHH-----HHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG--KQR-----ERAFRMEVDLLSRLHSPQLVELLGYCA-DQNH  224 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~-----~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~  224 (457)
                      ++|-.+.+||+|+|+.||+|.+ ...+.||+|+-..+.  ++.     .+...+|.++.+.|+||.||+++++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            4577788999999999999984 567888888754332  111     123567999999999999999999985 5567


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeec
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDF  301 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df  301 (457)
                      +|-|+|||+|.+|+-||..+..    +++.++..|+.||+.||.||... ++||||-||||.|||+-   .-|.+||+||
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            8999999999999999988664    89999999999999999999987 47899999999999994   3578999999


Q ss_pred             cCccccccccCC-----ccccccccCCCccccccccC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh
Q 012739          302 GLAKMVSDKING-----QISTRVLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       302 gl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~  372 (457)
                      ||++.+.+..+.     ...+...||.+|++||.+.-    ...+.|+||||+|||+|..+-|+.||..+....+.    
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI----  693 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI----  693 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH----
Confidence            999999765443     23456789999999998743    35789999999999999999999999865432111    


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HHHhhhhcCCCccccCCCCccc
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS--LIPVVKNNAAGAISFGSSRFQH  450 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~~~~~~~~~~~~~~~~~~~~  450 (457)
                            .....+.....-.+  ..-+....+...+|.+||+.--++|....++...  |..-+++.....+..+.+-+++
T Consensus       694 ------LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~~a~i~~s  765 (775)
T KOG1151|consen  694 ------LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPAGAAIASS  765 (775)
T ss_pred             ------HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCccccccCC
Confidence                  11111111111011  1112345578899999999999999988888764  2233333333333333445555


Q ss_pred             CCCCC
Q 012739          451 QTPSP  455 (457)
Q Consensus       451 ~~~~~  455 (457)
                      |+.++
T Consensus       766 p~~~~  770 (775)
T KOG1151|consen  766 PGASN  770 (775)
T ss_pred             CCCCc
Confidence            55544

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=273.25  Aligned_cols=259  Identities=24%  Similarity=0.309  Sum_probs=201.4

Q ss_pred             HhcCCCCC-ceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc----CCe
Q 012739          152 ATENFSEG-NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD----QNH  224 (457)
Q Consensus       152 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~----~~~  224 (457)
                      .+++|++. ++||-|-.|.|..+..+ +++.+|+|++...     ...++|+++.-.. .|||||.++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35566653 67999999999999864 6889999998543     2346688765544 69999999998743    456


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeec
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDF  301 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df  301 (457)
                      +++|||.|+||.|.+.+++++.  +.+++.++..|+.||+.|+.|||+.+   |.||||||+|+|...   |-.+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999998765  57999999999999999999999999   999999999999964   567999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |+++.....   ....+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||..+....   ..    +.+.. 
T Consensus       209 GFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is----pgMk~-  277 (400)
T KOG0604|consen  209 GFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS----PGMKR-  277 (400)
T ss_pred             ccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC----hhHHh-
Confidence            999875432   33566789999999999999999999999999999999999999998653210   00    00000 


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        .+..-.-.+..+-....+....++|+.+|+.+|++|.|+.+++.+  .++..
T Consensus       278 --rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h--pwi~~  327 (400)
T KOG0604|consen  278 --RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH--PWINQ  327 (400)
T ss_pred             --HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC--chhcc
Confidence              000000001111123456789999999999999999999999987  55544

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=282.33  Aligned_cols=272  Identities=21%  Similarity=0.308  Sum_probs=206.8

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CC----eeeEEEEEEc
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQ----LVELLGYCAD  221 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pn----iv~l~~~~~~  221 (457)
                      ......+|.+...+|+|.||.|..+.+.. +..||+|+++.-..-. ++.+-|+++++++.+  |+    +|.+.++|.-
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            34447899999999999999999998654 6899999997654333 345669999999943  33    7788889999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC----------
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD----------  291 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~----------  291 (457)
                      .++.+||+|.+ |-++.++|..+  +..+++...+..|+.|+++++.+||+.+   ++|-||||+|||+.          
T Consensus       163 rghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence            99999999999 77999999764  4567899999999999999999999999   99999999999983          


Q ss_pred             ----------CCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          292 ----------QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       292 ----------~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                                .+..++|+|||.+..-..     ..+..+.|..|+|||++.+-.++.++||||+||||.||+||...|+.
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                      134589999999875433     23567789999999999999999999999999999999999999987


Q ss_pred             CCCCCcchhhhhhccccCch---hH-H--------------------hhhcCCcC----CCCCCHHHHHHHHHHHHhhcC
Q 012739          362 NRPPGEHVLVSWALPRLTSR---EE-A--------------------VEMVDPSL----QGQYPKKDLIQIAAIAAVCVQ  413 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~---~~-~--------------------~~~~d~~l----~~~~~~~~~~~l~~li~~cl~  413 (457)
                      ........+-..+...+...   .. .                    ....++..    .......+..+|.+|+..||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            55322111111111111110   00 0                    00111000    001223456789999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhhh
Q 012739          414 PEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       414 ~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .||.+|+|++|++++  .++.
T Consensus       392 fDP~~RiTl~EAL~H--pFF~  410 (415)
T KOG0671|consen  392 FDPARRITLREALSH--PFFA  410 (415)
T ss_pred             cCccccccHHHHhcC--HHhh
Confidence            999999999999987  4443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.9e-35  Score=309.63  Aligned_cols=145  Identities=32%  Similarity=0.479  Sum_probs=130.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.++||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++||||+++++++...+..||||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 58899999986542   233356888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ||+.+++|.+++....    .+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997643    3888999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=277.83  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=196.2

Q ss_pred             CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHH-HhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLL-SRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++.+..||.|+||+|+|-.++ .|+..|||++..... .+.++++.|.+.. +.-+.||||+++|.+..++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            344567999999999998865 599999999987654 4456677787654 4457899999999999999999999999


Q ss_pred             CCCcHHHHHhh-hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHR-HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                       ..+|..+-.. ...+...+++..+-.|..-...||.||...-.  |||||+||+|||++..|.+||||||.+..+.+. 
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence             4566654322 11122358888888899999999999987543  999999999999999999999999999876543 


Q ss_pred             CCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          312 NGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                        ...+...|...|||||.+..  ..|+.+|||||||++|||+.||+.||..+...            +..... .-.-|
T Consensus       222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------------feql~~-Vv~gd  286 (361)
T KOG1006|consen  222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------------FEQLCQ-VVIGD  286 (361)
T ss_pred             --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------------HHHHHH-HHcCC
Confidence              23455678889999999853  45999999999999999999999999864321            000001 11112


Q ss_pred             Cc-CCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PS-LQGQYP-KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~-l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +. +..... ......+..++.-|+.+|...||...+++++  .+.+.
T Consensus       287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~--~fyr~  332 (361)
T KOG1006|consen  287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF--PFYRM  332 (361)
T ss_pred             CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC--chhhh
Confidence            22 211111 2356689999999999999999999999887  55554

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.3e-35  Score=274.22  Aligned_cols=220  Identities=21%  Similarity=0.218  Sum_probs=177.9

Q ss_pred             CCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhh
Q 012739          165 GGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR  243 (457)
Q Consensus       165 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  243 (457)
                      |.||.||++... +++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999964 68899999986543     223455555666799999999999999999999999999999999876


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCC
Q 012739          244 HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT  323 (457)
Q Consensus       244 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  323 (457)
                      ..    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++......     .....++.
T Consensus        79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          79 FL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             hc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence            43    3899999999999999999999999   999999999999999999999999988665432     22334567


Q ss_pred             CccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHH
Q 012739          324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQ  403 (457)
Q Consensus       324 ~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  403 (457)
                      .|+|||.+....++.++||||+|+++|||++|+.|+.......                      ........+......
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~  204 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSEE  204 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCHH
Confidence            8999999988889999999999999999999998875321100                      000000122233457


Q ss_pred             HHHHHHhhcCCCCCCCCCHH
Q 012739          404 IAAIAAVCVQPEAAYRPLMT  423 (457)
Q Consensus       404 l~~li~~cl~~~p~~RPs~~  423 (457)
                      +.+++.+|++.||++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            89999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=314.55  Aligned_cols=262  Identities=27%  Similarity=0.364  Sum_probs=213.6

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      .++....++|.++++||+|+||.|..++.+ .+++||+|++.+.   .......|.+|-++|..-+.+=|+.+.-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            455556689999999999999999999975 5889999999763   233445688999999999999999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      .++|+|||||+||+|-.++.+..    ++++..+..++..|+.||+-||+.|   +|||||||+|||+|..|.+||+|||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999998765    4899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCcccccccc----C-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYAS----T-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      .+-.+... ........+|||.|.+||++.    + +.|...+|.||+||++|||+.|..||.....      +      
T Consensus       221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------v------  287 (1317)
T KOG0612|consen  221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------V------  287 (1317)
T ss_pred             hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------H------
Confidence            98777543 234456788999999999984    3 6799999999999999999999999984321      1      


Q ss_pred             cCchhHHhhhcCCcCCCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHHHHhhhh
Q 012739          378 LTSREEAVEMVDPSLQGQYP--KKDLIQIAAIAAVCVQPEAAYRPL---MTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~L~~~~~~  435 (457)
                          ++...+++-.-.-.+|  .+.+....+||.+.+ -+|+.|..   +.++..|  .++.+
T Consensus       288 ----eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H--pFF~g  343 (1317)
T KOG0612|consen  288 ----ETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH--PFFEG  343 (1317)
T ss_pred             ----HHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC--ccccC
Confidence                1222233221111333  346678899999877 56777887   8888887  55554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=298.06  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=210.0

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc-----
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD-----  221 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-----  221 (457)
                      +...+.-|.+.++||.|.+|.||+++. ++++.+|+|+...+. +..++++.|.++++.+ +|||++.++|+|..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334456678889999999999999994 568889999886653 3345678899999998 68999999999853     


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      ++++|||||||.+|+.-+++....  ...+.|..+..|+..++.|+.+||...   ++|||||-.|||++.++.|||+||
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence            568999999999999999987755  457999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |++..++...  ....+..||+.|||||++..     ..|+.++|+||||++..||--|.+|+..+.+.-          
T Consensus       168 GvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------  235 (953)
T KOG0587|consen  168 GVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------  235 (953)
T ss_pred             eeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----------
Confidence            9998876532  23455789999999999864     357889999999999999999999998654421          


Q ss_pred             ccCchhHHhhhc-CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          377 RLTSREEAVEMV-DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       377 ~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                            .+..+. .|....--+.....++.++|..||.+|.++||++.+++++
T Consensus       236 ------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 ------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                  111111 1222223466778899999999999999999999998865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=248.74  Aligned_cols=265  Identities=23%  Similarity=0.269  Sum_probs=202.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +|...++||+|.||+||+|+.. .++.||+|+++.+...  ......+|+.+++.++|.|||++++....++...+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455578999999999999954 5889999998765322  234577899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      | .-+|..|.....+   .++.+.+..++.|+++||.++|+++   +.||||||.|.||+.+|++|++|||+++-++-..
T Consensus        83 c-dqdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             h-hHHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9 4588888876554   4899999999999999999999999   9999999999999999999999999998664321


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCC-CCCCCCCCcchhhhhhccccCchhH--Hhhh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVP-VDPNRPPGEHVLVSWALPRLTSREE--AVEM  387 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  387 (457)
                        .-.+....|..|++|.++.+ .-|+...|+||-|||+.|+.....| |.+.+..++...+.|......+...  +..+
T Consensus       156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence              11233457899999998866 5688999999999999999985544 5555554544555555444433211  1111


Q ss_pred             cCCcCCCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPSLQGQYPK---------KDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~---------~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .|-..-.-|+.         .....-.+++...+.-+|..|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            12111122221         222344678888999999999999998876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=289.55  Aligned_cols=243  Identities=22%  Similarity=0.275  Sum_probs=198.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +..|.....+|.|+|+.|-++... +++..++|++.....    ...+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            456777788999999999998854 588899999976522    223466555554 79999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe-CCCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-DQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgl~~~~~~  309 (457)
                      .+.++-|.+.+....     ....++..|+.+|+.|+.|||++|   +|||||||+|||+ ++.+.++|+|||.++....
T Consensus       397 ~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999998888776643     223778889999999999999999   9999999999999 6899999999999987755


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     ....+-|..|.|||++....|++++|+||||++||+|++|+.||......                .++..   
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------~ei~~---  524 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------IEIHT---  524 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------HHHHH---
Confidence            3     33456788999999999999999999999999999999999999854321                01111   


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      ....+.+....+...++|+.+||+.||.+||+|.++..+  +++
T Consensus       525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h--~w~  566 (612)
T KOG0603|consen  525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH--PWF  566 (612)
T ss_pred             hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC--cch
Confidence            111223335567789999999999999999999999988  676

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=276.60  Aligned_cols=242  Identities=26%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|..+.+||+|+||.|.++..++ .+.+|||+++++-   ..+.+--..|-++|... +-|.++++..+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            4578889999999999999998654 6789999998762   11112223466666665 45788999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+.||+|--.|++.+.    +.+..+..++.+|+-||=+||+++   |+.||||.+|||++.+|.+||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999988664    778889999999999999999999   999999999999999999999999999753


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      -  ..+....+.+||+.|+|||.+...+|...+|.||||++||||+.|++||++.+...                -...+
T Consensus       501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI  562 (683)
T KOG0696|consen  501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAI  562 (683)
T ss_pred             c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence            2  22344567999999999999999999999999999999999999999999754311                11122


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL  421 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  421 (457)
                      .+...  .||...+.+...+....+.++|.+|..
T Consensus       563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            22222  577777888999999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2e-33  Score=261.92  Aligned_cols=237  Identities=28%  Similarity=0.418  Sum_probs=193.8

Q ss_pred             CcEEEEEEEEcC-CcEEEEEEcccCchHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhh
Q 012739          166 GFGVVYKGVLSD-GTVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR  243 (457)
Q Consensus       166 ~~g~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  243 (457)
                      +||.||+|...+ +..+++|++....... .+.+.+|++.++.++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 8899999997664433 56789999999999999999999999999999999999999999999876


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCC
Q 012739          244 HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT  323 (457)
Q Consensus       244 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  323 (457)
                      ...    +++..++.++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++.
T Consensus        81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 RGR----LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             ccC----CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            442    889999999999999999999998   9999999999999999999999999998765431   233456788


Q ss_pred             CccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCH--HHH
Q 012739          324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK--KDL  401 (457)
Q Consensus       324 ~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~  401 (457)
                      .|++||.+....++.++||||||+++|+|++|..||......                ....+.+..........  ...
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~  214 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----------------LELFKKIGKPKPPFPPPEWKIS  214 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCccccccCC
Confidence            999999998888999999999999999999999998752111                11111111111111000  144


Q ss_pred             HHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          402 IQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       402 ~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..+.+++.+|+..+|++||++.+++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhhC
Confidence            589999999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=284.75  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=207.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCc-EEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGT-VAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++++....||-|+||.|-+++.+... .+|+|.+++.   .....+.+..|-.+|...+.|.||+++-.|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45666778999999999999876544 3777777554   3333445677999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |-|-||.|+..|++++.    ++......++..+++|++|||+++   ||.|||||+|.+++.+|-+||.|||+++.+..
T Consensus       500 EaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999998765    888899999999999999999999   99999999999999999999999999998865


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   ....+++||+.|.|||.+.+...+.++|.||||+++|||++|++||...++-....++             ..-+|
T Consensus       573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------------LkGid  636 (732)
T KOG0614|consen  573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------------LKGID  636 (732)
T ss_pred             C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------------Hhhhh
Confidence            3   4467899999999999999999999999999999999999999999876553221111             11111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                         .-.+|........+|+++.++.+|.+|..     ..+|.+|
T Consensus       637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence               12455566668889999999999999975     6777776

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=280.15  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=196.2

Q ss_pred             CceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          159 GNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      .++||.|.||+||-|+. ++|+.||||++.+.  ....+.++++|+.+|+.++||.||.+...|+..+..++|||.+ .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            47899999999999996 47999999988654  2344567999999999999999999999999999999999999 55


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccCccccccccC
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      +..+.|.....  ..|++..-..++.||+.||.|||.++   |+|+||||+|||+..   --.+||||||+++.+...  
T Consensus       648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            65555544322  24888888889999999999999999   999999999999954   357999999999998754  


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......+||+.|+|||++....|...-|+||+|+|+|--++|..||.....-.++.             ....++-   
T Consensus       721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-------------QNAaFMy---  783 (888)
T KOG4236|consen  721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-------------QNAAFMY---  783 (888)
T ss_pred             -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-------------hcccccc---
Confidence             33456889999999999999999999999999999999999999998532211110             0001110   


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ......+......+||...|+..-.+|-+....+.+
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            011223445578889999999999999998887766

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=246.55  Aligned_cols=210  Identities=28%  Similarity=0.451  Sum_probs=175.2

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC-chHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCCeE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSR-LHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~  225 (457)
                      ++...+.+..+..||+|++|.|-+-++ .+|+..|+|++... +.+..+...+|+.+..+ ..+|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444555566677899999999988775 47999999999765 34445567778876555 4789999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      |+.||.| ..+|..+-.+--.+...+++.-+-+|+..+..||.|||++-+  ++|||+||+|||++.+|.+|+||||.+.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 578988877766666779999999999999999999999765  9999999999999999999999999998


Q ss_pred             ccccccCCccccccccCCCccccccccC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      .+.+...   .+...|...|||||.+..    ..|+-|+||||||+++.||.+++.||+.+..
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            7765422   233568888999998853    4799999999999999999999999986544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-35  Score=262.54  Aligned_cols=266  Identities=21%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEc--------CC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQR-ERAFRMEVDLLSRLHSPQLVELLGYCAD--------QN  223 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~~  223 (457)
                      .|....+||+|.||.||+|+.. +++.||+|++-.++ +.. .....+|+++|..++|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445578999999999999954 57778888764432 111 1234679999999999999999887743        23


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      .+|+||.+|+ -+|.-+|.....   .++..++.+++.++..||.|+|...   |+|||+|+.|+||+.+|.+||+|||+
T Consensus        98 t~ylVf~~ce-hDLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCE-HDLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhh-hhHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            5899999995 488888876543   4888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCC--ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc-----
Q 012739          304 AKMVSDKING--QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL-----  375 (457)
Q Consensus       304 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----  375 (457)
                      ++.+....+.  ...++.+.|..|++||.+.+ ..|+++.|||.-|||+.||+||.+-++++.......++....     
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9877543332  23455667999999998765 679999999999999999999999998776554443433322     


Q ss_pred             ---cccCchhHHhhhc--CCcCCCCCC--HHH------HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          376 ---PRLTSREEAVEMV--DPSLQGQYP--KKD------LIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       376 ---~~~~~~~~~~~~~--d~~l~~~~~--~~~------~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                         +...+.. +...+  .|.-.+.+.  ++.      ....++|+..++..||.+|+++.+++.+
T Consensus       251 evWP~~d~lp-L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLP-LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccch-HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence               2222211 11111  111111111  011      2367899999999999999999999877

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.5e-33  Score=290.69  Aligned_cols=273  Identities=20%  Similarity=0.233  Sum_probs=176.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC-----CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEE------EE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD-----GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY------CA  220 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~------~~  220 (457)
                      ..++|.+.++||+|+||.||+|.+.+     +..||+|++........  ...|  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~--~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI--WMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH--HHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     68999998865432111  1111  1122222222222211      24


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCc
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNR----------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK  284 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  284 (457)
                      .....++|+||+++++|.+++......                ........+..++.|++.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567889999999999999998754210                001123345679999999999999998   9999999


Q ss_pred             cCceEeCC-CCcEEEeeccCccccccccCCccccccccCCCccccccccCC----------------------CCCcccc
Q 012739          285 CSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG----------------------KLTTKSD  341 (457)
Q Consensus       285 p~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD  341 (457)
                      |+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 68999999999986543322 223456789999999965322                      2445679


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCC----C--CHHHHHHHHHHHHhhcCCC
Q 012739          342 VYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ----Y--PKKDLIQIAAIAAVCVQPE  415 (457)
Q Consensus       342 V~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~----~--~~~~~~~l~~li~~cl~~~  415 (457)
                      ||||||+||||+++..|++...    ..+.......-.........+.+....+    +  .........+|+.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999999776654210    0000000000000001111111111100    0  0011224568999999999


Q ss_pred             CCCCCCHHHHHHHHHHhhhhcCC
Q 012739          416 AAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       416 p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      |.+|||+.+++++  +++++...
T Consensus       438 P~kR~ta~e~L~H--pff~~~~~  458 (566)
T PLN03225        438 GRQRISAKAALAH--PYFDREGL  458 (566)
T ss_pred             cccCCCHHHHhCC--cCcCCCCc
Confidence            9999999999998  88876443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=280.14  Aligned_cols=267  Identities=18%  Similarity=0.240  Sum_probs=182.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-----------------cCCcEEEEEEcccCchHHHHH--------------HHHH
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-----------------SDGTVAAIKKLHRDGKQRERA--------------FRME  200 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E  200 (457)
                      ..++|.+.++||+|+||.||+|..                 .+++.||||++........+.              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235679999987553322222              2346


Q ss_pred             HHHHHhcCCCCe-----eeEEEEEEc--------CCeEEEEEEeCCCCcHHHHHhhhCCC--------------------
Q 012739          201 VDLLSRLHSPQL-----VELLGYCAD--------QNHRLLISEYMPNGTLQQHLHRHNNR--------------------  247 (457)
Q Consensus       201 i~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------  247 (457)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.+++......                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777643        35689999999999999998753210                    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccc
Q 012739          248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA  327 (457)
Q Consensus       248 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a  327 (457)
                      ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123567888999999999999999998   99999999999999999999999999976543211 11112335789999


Q ss_pred             cccccCCC--------------------C--CcccchHHHHHHHHHHHcCCC-CCCCCCCCCcchhhhhhccccCc-hhH
Q 012739          328 PEYASTGK--------------------L--TTKSDVYSYGVVLLELLTGRV-PVDPNRPPGEHVLVSWALPRLTS-REE  383 (457)
Q Consensus       328 PE~~~~~~--------------------~--s~~sDV~SlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~-~~~  383 (457)
                      ||.+....                    +  ..+.||||+||++|+|++|.. ||..........      ..... ...
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~------~~~~~~~~~  452 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL------RQYDNDLNR  452 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH------hhccchHHH
Confidence            99875322                    1  234799999999999999986 665321111000      00000 000


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEA---AYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~evl~~  428 (457)
                      ..........-...........+|+.+||..+|   .+|+|+.|+++|
T Consensus       453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            000000011111112335578899999999766   689999999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-33  Score=276.06  Aligned_cols=207  Identities=27%  Similarity=0.399  Sum_probs=174.9

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      -|..++.||-|+||.|.++.. ++...+|+|.+.+.+   +......+.|-++|...+.+=||+|+-.|.+++.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            366778999999999999884 457789999987653   2223346789999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++||++-.+|-..+.    +.+..+..++.++..|+++.|..|   +|||||||+|||||.+|.+||+||||+.-+...
T Consensus       710 YIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999877664    888888899999999999999999   999999999999999999999999998533110


Q ss_pred             ---cCC-------------------------------------ccccccccCCCccccccccCCCCCcccchHHHHHHHH
Q 012739          311 ---ING-------------------------------------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLL  350 (457)
Q Consensus       311 ---~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~  350 (457)
                         .+.                                     ...-..+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence               000                                     0112257999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCCcc
Q 012739          351 ELLTGRVPVDPNRPPGEH  368 (457)
Q Consensus       351 elltg~~p~~~~~~~~~~  368 (457)
                      ||+.|+.||-...+.+..
T Consensus       863 em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHhhCCCCccCCCCCcce
Confidence            999999999877665443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=257.93  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=198.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|.++++||+|+|.+|..+++. +.+.+|+|++++.   ..++..-...|-.+..+. +||.+|.+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999964 5788999988764   222333345566666655 79999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |.||++||+|--+++..+    .++++.+..+..+|+.||.|||+.|   |+.||||.+|+|+|..|.+||+|+|+++.-
T Consensus       329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999987776654    3999999999999999999999999   999999999999999999999999999854


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcc-hhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH-VLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  386 (457)
                      -.  .+...++++|||.|.|||.+.+..|...+|.|+||++++||+.|+.||+.-.....+ ....+.++         -
T Consensus       402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq---------v  470 (593)
T KOG0695|consen  402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ---------V  470 (593)
T ss_pred             CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH---------H
Confidence            32  345577899999999999999999999999999999999999999999843321111 11111111         1


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL  421 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  421 (457)
                      ++.+.+  ..|...+.....+++.-|++||.+|..
T Consensus       471 ilekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  471 ILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             Hhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            122222  234445556778899999999999953

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=283.23  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=188.4

Q ss_pred             CCCCceeccCCcE-EEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          156 FSEGNVIGNGGFG-VVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       156 ~~~~~~LG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      |...+++|.|+-| .||+|.. +++.||||++...   -.....+|+..|+.- +|||||++++.-.+.+..||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            3444678999887 5799998 7889999998543   233467899999988 6999999999999999999999999 


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-----CCcEEEeeccCccccc
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-----NFRAKVTDFGLAKMVS  308 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgl~~~~~  308 (457)
                      ..+|.+++...........-...+.+..|++.||++||+.+   ||||||||.||||+.     ..+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            67999999874111111111445678889999999999999   999999999999965     3579999999999886


Q ss_pred             cccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG-RVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......||-+|+|||++....-+.++|||||||++|+.++| .+||...-..+...        +.....+  
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--------l~~~~~L--  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--------LTGNYTL--  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--------hcCccce--
Confidence            54322 234567899999999999988888899999999999999996 99997532110000        0000000  


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                           ..-+...++  +..+||.+|+..+|..||++.+|+.|
T Consensus       733 -----~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 -----VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -----eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                 000111222  78899999999999999999999864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=5.8e-32  Score=236.56  Aligned_cols=260  Identities=18%  Similarity=0.283  Sum_probs=196.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcC--CeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQ--NHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~~lv  228 (457)
                      .++|++.+++|+|-|+.||.|. ..+.+.++||.++.   .+.+.+.+|+++|+.|. ||||+++++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678889999999999999998 45788899999864   34556889999999997 99999999998664  456799


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCcccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMV  307 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~~~~  307 (457)
                      +||+.+.+...+-.       .++..++...+.+++.||.|+|++|   |+|||+||.|++||.. -.++|+|+||+..+
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999888776543       3778899999999999999999999   9999999999999864 57999999999987


Q ss_pred             ccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCC-CCCcchhhhhhccccCchhHH-
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNR-PPGEHVLVSWALPRLTSREEA-  384 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~-  384 (457)
                      .+...   ....+.+..|.-||++.+ ..|+..-|+|||||+|..|+..+.||.... ..++...+..++....-...+ 
T Consensus       184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            65422   233345667899999865 568889999999999999999999997443 333333333332211111000 


Q ss_pred             --hhhcCCcCCC--------C----CC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          385 --VEMVDPSLQG--------Q----YP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       385 --~~~~d~~l~~--------~----~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        .-.+|+.+..        .    .+    .-...+..+|+...|..|-.+|||++|.+.+
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              0012222110        0    00    0113578899999999999999999999877

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-33  Score=250.38  Aligned_cols=266  Identities=21%  Similarity=0.306  Sum_probs=200.3

Q ss_pred             CCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHRL  226 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~~  226 (457)
                      +.+..+.||-|+||.||.+.+ .+|+.|+.|++..-  +-...+.+.+|+++|..++|.|++..++...-.     .+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455678899999999999885 47999999988643  223345677899999999999999998876443     2467


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +++|.| ..+|...|...    ++++...+.-+..||++||.|||+.+   |.||||||.|.|++.+..+||||||+++.
T Consensus       134 V~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence            888988 56787777654    35888888889999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch--hH
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR--EE  383 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  383 (457)
                      -... ....++..+.|..|+|||.+.+ ..|+.+.||||+|||+.||+..+..|+...+..+..++...+......  ..
T Consensus       206 ee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  206 WDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             cchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            5443 2334556677889999999976 579999999999999999999999998776655444443322222111  00


Q ss_pred             H-----hhhcC-----CcCCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          384 A-----VEMVD-----PSLQG----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       384 ~-----~~~~d-----~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .     .-++.     |.+.-    ..+...-.+...+.+.++..+|+.|.+..+.+.++
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            0     01111     11111    11122334567788899999999999999998875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.6e-30  Score=231.85  Aligned_cols=211  Identities=33%  Similarity=0.583  Sum_probs=184.3

Q ss_pred             eccCCcEEEEEEEEcC-CcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHH
Q 012739          162 IGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ  239 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  239 (457)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 889999998766432 34568899999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCccccccccCCccccc
Q 012739          240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTR  318 (457)
Q Consensus       240 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~  318 (457)
                      ++....   ..+++..++.++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            987653   24889999999999999999999998   999999999999999 89999999999986644321  1233


Q ss_pred             cccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCC
Q 012739          319 VLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYP  397 (457)
Q Consensus       319 ~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  397 (457)
                      ..+...|++||.+... .++.+.|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            5578889999999877 888999999999999999                                             


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          398 KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       398 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                          ..+.+++..|++.+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3788999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=249.37  Aligned_cols=272  Identities=21%  Similarity=0.309  Sum_probs=203.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----C---CCeeeEEEEEEc---
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----S---PQLVELLGYCAD---  221 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----h---pniv~l~~~~~~---  221 (457)
                      .+|.+.++||.|.|++||++-+. +.+.||+|+.+.. ..-.+....||++|++++     |   ..||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67889999999999999999854 5778999988654 334455678999999983     3   369999999854   


Q ss_pred             -CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC--------
Q 012739          222 -QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--------  292 (457)
Q Consensus       222 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------  292 (457)
                       +.+.+||+|++ |.+|..+|....-  +.++...+.+|+.||+.||.|||....  |||-||||+|||+..        
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhh
Confidence             56899999999 7899999987543  568889999999999999999999764  999999999999820        


Q ss_pred             --------------------------------------------------------------------------------
Q 012739          293 --------------------------------------------------------------------------------  292 (457)
Q Consensus       293 --------------------------------------------------------------------------------  292 (457)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------CC
Q 012739          293 ------------------------------------------------------------------------------NF  294 (457)
Q Consensus       293 ------------------------------------------------------------------------------~~  294 (457)
                                                                                                    +.
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                          00


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCC---cchhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG---EHVLV  371 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~---~~~~~  371 (457)
                      ++||+|||-+..+..     ..+....|..|+|||++.+..|+..+||||++|+++||+||...|++....+   ++.-+
T Consensus       392 ~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             eEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence            245555655554322     2334457888999999999999999999999999999999999998643321   11111


Q ss_pred             hhhc---ccc-----CchhHHhhhcCCc--C------C-----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 012739          372 SWAL---PRL-----TSREEAVEMVDPS--L------Q-----------GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD  424 (457)
Q Consensus       372 ~~~~---~~~-----~~~~~~~~~~d~~--l------~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  424 (457)
                      ...+   ..+     .......++++..  +      +           =.++.+...++.+++.-||+.+|++|||+.+
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence            1111   111     0111122222221  0      0           0456788899999999999999999999999


Q ss_pred             HHHHHHHhhhhcCC
Q 012739          425 VVQSLIPVVKNNAA  438 (457)
Q Consensus       425 vl~~L~~~~~~~~~  438 (457)
                      .+++  .+|.+-+.
T Consensus       547 cl~h--PwLn~~~~  558 (590)
T KOG1290|consen  547 CLKH--PWLNPVAG  558 (590)
T ss_pred             HhcC--ccccCCCC
Confidence            9988  77776444

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=241.95  Aligned_cols=266  Identities=23%  Similarity=0.280  Sum_probs=200.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~  223 (457)
                      ..+|..++.+|.|.- .|..+.+ -.++.||+|++...  .....+...+|..++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356677788999988 5655553 35889999988554  334445667899999999999999999998543      4


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..|+|||+| ..+|.+.+.-      .++-..+.+|+.|++.|+.|||+.+   |+||||||+||++..+..+||.|||+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence            679999999 6799988873      2777888999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc---
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS---  380 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  380 (457)
                      ++.....   -..+..+.|..|+|||++.+..|.+.+||||+||++.||++|+.-|.+.+.-++..++.........   
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9865432   2456677889999999999988999999999999999999999999865432222211111111000   


Q ss_pred             -------------hh-HH-----hhhcCCcCCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          381 -------------RE-EA-----VEMVDPSLQG--QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       381 -------------~~-~~-----~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                                   +. ..     ..+.|..+..  +.+......+.+++.+||-.||++|.++++++++  ..++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H--PY~~  314 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH--PYIK  314 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC--Ceee
Confidence                         00 00     0011111111  1122334568889999999999999999999998  7776

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=6.5e-31  Score=253.54  Aligned_cols=275  Identities=22%  Similarity=0.254  Sum_probs=206.5

Q ss_pred             echHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC------CCeeeEE
Q 012739          144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS------PQLVELL  216 (457)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h------pniv~l~  216 (457)
                      |.+.-.+..-.+|.+....|+|-|++|.+|... -|..||||+|..+. .-.+.=+.|+++|++|+.      -|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            344444556688999999999999999999965 47899999997663 223334569999999953      4789999


Q ss_pred             EEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-Cc
Q 012739          217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FR  295 (457)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  295 (457)
                      -.|...+++|||+|.+ ..+|.+.|...+. .-.|....+..++.|+..||..|...+   |+|.||||.|||+++. ..
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence            9999999999999998 6899999987653 345888899999999999999999999   9999999999999875 57


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~  375 (457)
                      +||||||.+..+....    .+....+.-|+|||++.+.+|+...|+||+||+||||.||+..|.+.......-+.....
T Consensus       576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            8999999987665431    222334456999999999999999999999999999999999998754422211111100


Q ss_pred             cccC-----------------------------chh--HHhhhcCC------cCCC--CCCH---HHHHHHHHHHHhhcC
Q 012739          376 PRLT-----------------------------SRE--EAVEMVDP------SLQG--QYPK---KDLIQIAAIAAVCVQ  413 (457)
Q Consensus       376 ~~~~-----------------------------~~~--~~~~~~d~------~l~~--~~~~---~~~~~l~~li~~cl~  413 (457)
                      ..+.                             ...  .+...+.|      .+.+  .++.   .....|.+|+..||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            0000                             000  00011111      1111  1333   345688999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 012739          414 PEAAYRPLMTDVVQS  428 (457)
Q Consensus       414 ~~p~~RPs~~evl~~  428 (457)
                      .||++|.|..+.|++
T Consensus       732 LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  732 LDPEKRITVNQALKH  746 (752)
T ss_pred             cChhhcCCHHHHhcC
Confidence            999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=254.47  Aligned_cols=196  Identities=22%  Similarity=0.377  Sum_probs=169.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCch-----HHH---HHHHHHHHHHHhcC---CCCeeeEEEEEEc
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGK-----QRE---RAFRMEVDLLSRLH---SPQLVELLGYCAD  221 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-----~~~---~~~~~Ei~~l~~l~---hpniv~l~~~~~~  221 (457)
                      ..|...+.||+|+||.|++|.++. ...|+||.+.+..-     .+.   -..-.||.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468889999999999999999764 66788998865421     111   12456999999997   9999999999999


Q ss_pred             CCeEEEEEEeCC-CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          222 QNHRLLISEYMP-NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       222 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                      ++.+||+||... +-+|.++|..+..    +++.++..|+.|++.|+++||+++   |||||||-+|+.++.+|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999864 4589999987654    999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCC
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~  360 (457)
                      ||.+......    ....+.||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9998766443    3466789999999999999887 456799999999999999998885

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.1e-29  Score=228.94  Aligned_cols=199  Identities=32%  Similarity=0.523  Sum_probs=173.1

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      |.+.+.||.|++|.||++...+ +..+++|.+...... ..+.+..|++.++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999865 889999999776544 55678899999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +++|.+++.....   .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            9999999876432   1788999999999999999999998   99999999999999999999999999887654321 


Q ss_pred             ccccccccCCCccccccc-cCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          314 QISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                      .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122345678889999998 677788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-31  Score=263.70  Aligned_cols=255  Identities=23%  Similarity=0.353  Sum_probs=206.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ...+|.....+|.|+||.|||+++. .++..|+|.++........-+.+|+-+++.-+||||+.++|.+......|++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3467888899999999999999964 689999999988877777778899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||.+|+|.+.-+...    ++++.++..+..+.++||.|||+++   =+|||||-.|||+++.|.+|++|||.+..++..
T Consensus        93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            999999998765543    5899999999999999999999999   799999999999999999999999998877654


Q ss_pred             cCCccccccccCCCccccccc---cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          311 INGQISTRVLGTTGYLAPEYA---STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ..  ....+.||+.|||||+.   ..+.|..++|||++|+...||---+.|.....+.....+            -....
T Consensus       166 i~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L------------mTkS~  231 (829)
T KOG0576|consen  166 IA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL------------MTKSG  231 (829)
T ss_pred             hh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH------------hhccC
Confidence            32  23457899999999976   457899999999999999999888877553222100000            00011


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +++.-. .-.......+.+|++.|+.++|++||++..++++
T Consensus       232 ~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  232 FQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            121111 1122345578999999999999999999988763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=225.42  Aligned_cols=258  Identities=18%  Similarity=0.306  Sum_probs=190.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEE-EEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGY-CADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~-~~~~~~~~lv~  229 (457)
                      .+.|.+.+.||+|.||.+.++.++. .+.+++|.+... ....+.|.+|..---.| .|.||+.-++. |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4568888999999999999999764 678889988654 34456788887766566 57899888764 67777888999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC--CCCcEEEeeccCcccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNFRAKVTDFGLAKMV  307 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl~~~~  307 (457)
                      ||++.|+|.+-+...     .+.+....+++.|++.|+.|+|+++   +||||||.+||||.  +..++||||||+.+..
T Consensus       102 E~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999877653     3788888999999999999999999   99999999999993  3458999999998765


Q ss_pred             ccccCCccccccccCCCccccccccC---C--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYAST---G--KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      +..     .....-+..|.+||....   +  ...+.+|||.||++++.++||+.||+. ....+...+.|....-....
T Consensus       174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCc
Confidence            432     222334567999997643   2  346789999999999999999999983 33334444444322211111


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .+     |..-..+    ...+..+..+-+..++++|=-..++.+.-.....
T Consensus       248 ~~-----P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  248 AL-----PKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             cC-----chhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            10     1111122    3367788888999999999666666666554444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2e-28  Score=232.20  Aligned_cols=268  Identities=23%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      .....+.|...++||+|.|++||++.+.    ....||+|.+.....  ...+..|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445567899999999999999999853    467899999866532  23478899999999 5899999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeecc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFG  302 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  302 (457)
                      ...+|+||++.....++...       ++..++..+++.++.||.++|.+|   ||||||||.|+|.+. .+.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            99999999999999888865       778899999999999999999999   999999999999975 5678999999


Q ss_pred             Cccccccc-------c--------------------------CCc---------cccccccCCCccccccccC-CCCCcc
Q 012739          303 LAKMVSDK-------I--------------------------NGQ---------ISTRVLGTTGYLAPEYAST-GKLTTK  339 (457)
Q Consensus       303 l~~~~~~~-------~--------------------------~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~  339 (457)
                      |+......       .                          ...         ......||++|+|||++.. ...+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            98622100       0                          000         0112469999999999865 567889


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCCCCCcchh---------------------hhhhccccCchhHH---hhhcC-CcC-C
Q 012739          340 SDVYSYGVVLLELLTGRVPVDPNRPPGEHVL---------------------VSWALPRLTSREEA---VEMVD-PSL-Q  393 (457)
Q Consensus       340 sDV~SlG~il~elltg~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~---~~~~d-~~l-~  393 (457)
                      +||||.|+|++.+++++.||......-....                     ..|....+....+.   .+-++ ..+ .
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999964322110000                     00000000000000   01111 000 0


Q ss_pred             -------C-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          394 -------G-QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       394 -------~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                             . ......+..+++|+.+|+..||.+|.|+++.|++
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                   0 1112234478999999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.1e-28  Score=268.79  Aligned_cols=197  Identities=19%  Similarity=0.238  Sum_probs=139.9

Q ss_pred             hcCC-CCeeeEEEEE-------EcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012739          206 RLHS-PQLVELLGYC-------ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP  277 (457)
Q Consensus       206 ~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~  277 (457)
                      .++| +||++++++|       .+...+++++||+ +++|.++|....   .++++.+++.++.||++||.|||+++   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            3445 5777888877       2334567888987 679999997532   35999999999999999999999999   


Q ss_pred             eEeccCccCceEeCCC-------------------CcEEEeeccCccccccccC--------------CccccccccCCC
Q 012739          278 VIHRDFKCSNVLLDQN-------------------FRAKVTDFGLAKMVSDKIN--------------GQISTRVLGTTG  324 (457)
Q Consensus       278 ivH~Dlkp~NIll~~~-------------------~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~  324 (457)
                      |+||||||+||||+..                   +.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   4455666666553211000              000112457889


Q ss_pred             ccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHH
Q 012739          325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQI  404 (457)
Q Consensus       325 y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  404 (457)
                      |||||++.+..|+.++|||||||+||||++|..|+.....    .....          ....+.+..     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~----------~~~~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL----------RHRVLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH----------HHhhcChhh-----hhcCHHH
Confidence            9999999999999999999999999999998887652110    00000          001111111     1112345


Q ss_pred             HHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          405 AAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       405 ~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..++.+||+.+|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688899999999999999999876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5.9e-27  Score=208.65  Aligned_cols=168  Identities=22%  Similarity=0.253  Sum_probs=128.9

Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....   .++++.+++.++.|++.||.|||+.+         ||+|||++.++.+|+  ||+++.....    
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence            68999997643   35999999999999999999999876         999999999999999  9998765432    


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC-
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ-  393 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  393 (457)
                         ...||+.|||||++.+..++.++|||||||++|||+||+.||......... ..           .......+... 
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~-----------~~~~~~~~~~~~  127 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LE-----------ILLNGMPADDPR  127 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HH-----------HHHHHhccCCcc
Confidence               125889999999999999999999999999999999999999643221110 00           00010011100 


Q ss_pred             -CCCCHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          394 -GQYPKKDLI--QIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       394 -~~~~~~~~~--~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ...+.....  .+.+++.+||+.+|.+||++.++++++..+..+
T Consensus       128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence             011222333  699999999999999999999999999777654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-24  Score=212.87  Aligned_cols=263  Identities=22%  Similarity=0.273  Sum_probs=199.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCC--cEEEEEEcccCchHHHHHHHHHHHHHHhcCC----CCeeeEEEEE-EcCCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDG--TVAAIKKLHRDGKQRERAFRMEVDLLSRLHS----PQLVELLGYC-ADQNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h----pniv~l~~~~-~~~~~~~l  227 (457)
                      +|.+.+.||+|+||.||++.....  ..+|+|.-..........+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999997654  4788887665433322257778888888863    6889999988 57778899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-----CcEEEeecc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-----FRAKVTDFG  302 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg  302 (457)
                      ||+.+ |.+|.++.....  .+.++...++.|+.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99998 889999876554  346999999999999999999999999   9999999999999754     469999999


Q ss_pred             Ccc--ccccccCC----c-c-ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          303 LAK--MVSDKING----Q-I-STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       303 l~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      +++  .+......    . . .....||..|.++....+...+.+.|+||++.++.||+.|..||.........      
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~------  246 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK------  246 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH------
Confidence            999  43222211    1 1 22356999999999999999999999999999999999999999643321111      


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                             ...................+..+.++...+-..+...+|....+...|.+...+.
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  247 -------SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -------HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                   1111111111110011222346666666677799999999999999998888775

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.4e-25  Score=215.86  Aligned_cols=176  Identities=19%  Similarity=0.198  Sum_probs=134.3

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc--CCcEEEEEEcccC-----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS--DGTVAAIKKLHRD-----GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      ....+|.+.+.||+|+||+||+|.+.  +++.+|||++...     .....+.+.+|+++|+.++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34577999999999999999999864  5777899986532     12234568999999999999999853322   24


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-ccCceEeCCCCcEEEeecc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF-KCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg  302 (457)
                      ..++||||++|++|.. +..       ..   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence            5799999999999963 211       11   1357889999999999999   999999 9999999999999999999


Q ss_pred             CccccccccCCcc------ccccccCCCccccccccCCC------CCcccchH
Q 012739          303 LAKMVSDKINGQI------STRVLGTTGYLAPEYASTGK------LTTKSDVY  343 (457)
Q Consensus       303 l~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~~sDV~  343 (457)
                      +++.+........      .....+++.|+|||.+...+      .+...|-|
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9997754322211      14567889999999986432      33456766

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=4.2e-23  Score=199.95  Aligned_cols=257  Identities=28%  Similarity=0.454  Sum_probs=198.5

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCC-CeeeEEEEEEcCCeEEEEEEe
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSP-QLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~  231 (457)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999986  78899988765332   356688999999999988 799999999877778999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVSDK  310 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~~~  310 (457)
                      +.++++.+++...... ..+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||+++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777654321 24888999999999999999999999   99999999999999988 7999999999865543


Q ss_pred             cCCc----cccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCC-CcchhhhhhccccCchh
Q 012739          311 INGQ----ISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP-GEHVLVSWALPRLTSRE  382 (457)
Q Consensus       311 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  382 (457)
                      ....    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||...... .......          
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~----------  225 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----------  225 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH----------
Confidence            2221    3466789999999999987   67899999999999999999999997654321 0000000          


Q ss_pred             HHhhhcCCcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .......+.......    ......+.+++..|+..+|..|.++.+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000000111111    2223578899999999999999999888776

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-25  Score=199.40  Aligned_cols=248  Identities=21%  Similarity=0.340  Sum_probs=191.0

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      .+..+|.+...|..|+|++..+ .++.|++...  .....+.|.+|.-.|+.+.||||++++|.|.....+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            4456788999999999999544 4555665443  223345688899999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEe--eccCccccccccC
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT--DFGLAKMVSDKIN  312 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgl~~~~~~~~~  312 (457)
                      |+|+..|+...+  -..+-.++.+++.++++|++|||+... -|----|.++.+++|++.+.+|+  |--++..      
T Consensus       272 gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq------  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------  342 (448)
T ss_pred             hHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee------
Confidence            999999987543  457788999999999999999999753 23344688999999999988874  2222111      


Q ss_pred             CccccccccCCCccccccccCCCCC---cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLT---TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                         .....-.+.||+||.+...+-+   .++|+|||.+++|||.|...||....+-....                .+--
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------kial  403 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------KIAL  403 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------hhhh
Confidence               1122346789999999776544   47899999999999999999998654422111                1112


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +.++...|+.....+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            33444566666778999999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-23  Score=193.48  Aligned_cols=259  Identities=20%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             cCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      -.|+++++||+|+||..+.|+ +-+++.||||.=...  .+.-+++.|.+..+.|. .++|...+-+..++.+-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            468999999999999999999 458999999965432  23446788999999995 58888888777777778899999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-----CCcEEEeeccCccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-----NFRAKVTDFGLAKM  306 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgl~~~  306 (457)
                      + |-+|.++..-.+   +.++...++.++.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+++.
T Consensus       106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9 789988775544   35899999999999999999999999   999999999999953     34689999999999


Q ss_pred             cccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          307 VSDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       307 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      +.+..+.+     ......||.+||+=....+.+.+.+.|+-|||-+++++|-|..||++-......             
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-------------  245 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-------------  245 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-------------
Confidence            87765443     335578999999999999999999999999999999999999999864432111             


Q ss_pred             hHHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          382 EEAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       382 ~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      +....+-+..-.-   ..-...+.++..-+.-.-..+-++-|..+-+..-+..++.
T Consensus       246 ~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  246 EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            1111111111100   0011234466666666666777788988888777777666

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=6.7e-25  Score=228.17  Aligned_cols=263  Identities=19%  Similarity=0.255  Sum_probs=194.0

Q ss_pred             CCCceeccCCcEEEEEEEEc-CCcEEEEEEcc----c-CchHHH-HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLH----R-DGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~----~-~~~~~~-~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ....++|.|.+|.|+..... .....+.|...    . ...... ..+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776632 33334443322    1 111111 22567888888899999988887776665555569


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |||++ +|..++....    .+...++..++.|++.|+.|+|+.|   +.|||+|++|++++.+|.+||+|||.+....-
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 9999987752    3788889999999999999999999   99999999999999999999999999987755


Q ss_pred             ccCC--ccccccccCCCccccccccCCCCCcc-cchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KING--QISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....  ......+|+..|+|||.+.+..|++. .||||.|+++..|.+|+.||......+.....        . .....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------~-~~~~~  543 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------N-NYSDQ  543 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------h-ccccc
Confidence            4443  45677889999999999999999875 79999999999999999999754433222100        0 00000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .....-........+.+...++.+||+.+|.+|.|+++|++.  ++++.-.+
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d--~W~~~i~~  593 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND--EWIRSIEC  593 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC--hHhhhcce
Confidence            000000001122445578889999999999999999999987  88887554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3e-23  Score=183.41  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=196.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEE-EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..+|.+.++||.|+||.+|.|. ..+|..||||.=....  ...++.-|.++.+.|++ ..|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999999 4679999999765442  23356779999999976 778888888888889999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgl~~~~  307 (457)
                      .+ |-+|.++..-...   .++...++-++-|++.-++|+|.++   ++||||||+|+|..-+   ..+.++||||++.+
T Consensus        92 LL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            99 8899988765432   4888999999999999999999999   9999999999998543   46899999999977


Q ss_pred             ccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          308 SDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       308 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      .+....     .......||.+|.+=....+...+.+.|+-|+|.+|.++.-|..||++-.........          +
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----------E  234 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----------E  234 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----------H
Confidence            553222     2345578999999988888888899999999999999999999999875543221111          1


Q ss_pred             HHhhhcC----CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          383 EAVEMVD----PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       383 ~~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .+.+..-    ..+...+|    .++.-.+.-|-..--++-|...-+-+...-++
T Consensus       235 kI~EkK~s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  235 KISEKKMSTPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             HHHHhhcCCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1111110    11222333    36777777788888888888666555444333

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2e-23  Score=217.55  Aligned_cols=247  Identities=21%  Similarity=0.246  Sum_probs=182.4

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc-hHHHHHHHH---HHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG-KQRERAFRM---EVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~---Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++...+.||.+.|=+|.+|++++|. |+||++.+.. .-..+.|.+   |++ ...+++||.+++.-+-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666788999999999999997777 8888775543 333334443   444 555689999999888777778889999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc-
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~-  309 (457)
                      |+ .-+|.+.|..+.-    +...+...|+.|++.||.-+|..|   |+|||||.+||||+...-+.|+||...+...- 
T Consensus       102 yv-khnLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HH-hhhhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence            98 4589998877543    777888899999999999999999   99999999999999999999999998764421 


Q ss_pred             ----ccCCccccccccCCCccccccccC----------CC-CCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhh
Q 012739          310 ----KINGQISTRVLGTTGYLAPEYAST----------GK-LTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       310 ----~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~  373 (457)
                          .+......+...-.+|.|||.+..          .. .+++.||||+||++.||++ |++||+-.      .+..+
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY  247 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY  247 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH
Confidence                122223344455668999997643          12 5788999999999999998 57777631      11222


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....-...+...+.+.           ...++.++..|++.||..|.++++.++.
T Consensus       248 r~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111111112222111           1157899999999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.4e-22  Score=184.85  Aligned_cols=171  Identities=16%  Similarity=0.140  Sum_probs=133.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHH---------HHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER---------AFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~---------~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      ...+|+..++||.|+||.||+... ++..+|+|.+........+         .+++|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999766 5778999998654222222         167899999999999999999886533


Q ss_pred             --------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC
Q 012739          223 --------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       223 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                              +..+|+|||++|.+|.++..        ++.    ....+++.+|..||..|   ++|||++|.||++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence                    35789999999999988731        332    23559999999999999   99999999999999988


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHH
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL  353 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ell  353 (457)
                       ++|+|||...........              ...+....|..++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988654321110              01334455778999999999987764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=6.1e-22  Score=178.18  Aligned_cols=140  Identities=16%  Similarity=0.168  Sum_probs=108.2

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchH--H------------------------HHHHHHHHHHHHhcCCCCe
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ--R------------------------ERAFRMEVDLLSRLHSPQL  212 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~Ei~~l~~l~hpni  212 (457)
                      .+.||+|+||.||+|...+|+.||+|+++.....  .                        ......|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  0                        0122459999999987776


Q ss_pred             eeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCccCceEeC
Q 012739          213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL-HEHATPPVIHRDFKCSNVLLD  291 (457)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dlkp~NIll~  291 (457)
                      .....+...  ..+|||||++++++...+...    .++++.++..++.|++.+|.+| |+.+   |+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            433332222  238999999887776543322    2588999999999999999999 6888   99999999999998


Q ss_pred             CCCcEEEeeccCccccc
Q 012739          292 QNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       292 ~~~~~kl~Dfgl~~~~~  308 (457)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=8e-21  Score=171.38  Aligned_cols=140  Identities=17%  Similarity=0.167  Sum_probs=110.9

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchH------------------------H--HHHHHHHHHHHHhcCCCCe
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ------------------------R--ERAFRMEVDLLSRLHSPQL  212 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------------------------~--~~~~~~Ei~~l~~l~hpni  212 (457)
                      .+.||+|+||.||+|...+|+.||||++......                        .  ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754210                        0  1124578999999999987


Q ss_pred             eeEEEEEEcCCeEEEEEEeCCCCcHHHH-HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEe
Q 012739          213 VELLGYCADQNHRLLISEYMPNGTLQQH-LHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll  290 (457)
                      .....+....  .+|||||++++++... +..     ..++..+...++.|++.++.+||+ .|   |+||||||+|||+
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence            5544443332  4899999988755433 322     237788899999999999999999 88   9999999999999


Q ss_pred             CCCCcEEEeeccCcccccc
Q 012739          291 DQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~  309 (457)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            8 88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.5e-20  Score=167.85  Aligned_cols=188  Identities=19%  Similarity=0.161  Sum_probs=140.8

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH----HHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR----ERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +...|++|+||+||.+.. ++..++.+.+.....-.    ...+.+|+++|++|. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999997766 78888888876654311    124788999999995 4889999886    3469999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-ccCceEeCCCCcEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF-KCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      .|.+|.+.+..           ....++.|++.+|.++|+.|   |+|||| ||.|||++.++.++|+|||++.......
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99888654321           11346789999999999999   999999 7999999999999999999998554322


Q ss_pred             CC----c-------cccccccCCCccccccccC-CCCC-cccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          312 NG----Q-------ISTRVLGTTGYLAPEYAST-GKLT-TKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       312 ~~----~-------~~~~~~gt~~y~aPE~~~~-~~~s-~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      ..    .       .......++.|++|+...- ...+ ...+.++.|+.+|.++|++.++.....
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0       0111235777888875432 1233 567999999999999999999765443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-22  Score=200.44  Aligned_cols=225  Identities=27%  Similarity=0.371  Sum_probs=181.7

Q ss_pred             eeccCCcEEEEEEE----EcCCcEEEEEEcccCch-HHH-HHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          161 VIGNGGFGVVYKGV----LSDGTVAAIKKLHRDGK-QRE-RAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~----~~~~~~vavK~l~~~~~-~~~-~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|+|.||.|++++    .+.+..+|+|.+++... ... .....|-.++...+ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999865    34577888888765421 111 13456788888887 9999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|...+....    .+++.........++-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++..-...  
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            999988776544    3777777788889999999999999   9999999999999999999999999998764432  


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                          ..+||..|||||++.  .....+|.||||++++||+||..||..                    +....++..  .
T Consensus       152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~--~  203 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA--E  203 (612)
T ss_pred             ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh--c
Confidence                128999999999998  568899999999999999999999984                    111111111  1


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLM  422 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~  422 (457)
                      ...|........+++..++..+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            25567777789999999999999999755

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=1.4e-20  Score=176.80  Aligned_cols=233  Identities=20%  Similarity=0.288  Sum_probs=149.1

Q ss_pred             CCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCC----------CCeeeEEEE---
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHS----------PQLVELLGY---  218 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h----------pniv~l~~~---  218 (457)
                      +...+.||.|+++.||.+.+.+ ++.+|+|......   ....+.+++|.-....+.+          -.++-.++.   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3446789999999999999764 8999999775432   3344556666544444322          112211221   


Q ss_pred             ------EEcC---C-----eEEEEEEeCCCCcHHHHHhh---hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 012739          219 ------CADQ---N-----HRLLISEYMPNGTLQQHLHR---HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR  281 (457)
Q Consensus       219 ------~~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  281 (457)
                            +...   +     ..+++|+-+ .++|.+++..   .......+....++.+..|+++.+++||+.|   +||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                  1111   1     236788887 6788877543   3322223445566778899999999999999   9999


Q ss_pred             cCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccC--------CCCCcccchHHHHHHHHHHH
Q 012739          282 DFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST--------GKLTTKSDVYSYGVVLLELL  353 (457)
Q Consensus       282 Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~SlG~il~ell  353 (457)
                      ||+|+|+|++.+|.+.|+||+.....+...     .....+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999998876554321     11334577999997643        25788999999999999999


Q ss_pred             cCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 012739          354 TGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYR  419 (457)
Q Consensus       354 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R  419 (457)
                      +|+.||+...+......                     .-..+. +.++.+..||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999985432111100                     112455 667799999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=5.4e-21  Score=203.00  Aligned_cols=254  Identities=21%  Similarity=0.278  Sum_probs=184.0

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHR  225 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~  225 (457)
                      .+.....|.+.+.||+|+||+||+|...+|+.||+|.=+....-+.--   =.+++.+|+   -+.|..+..+..-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            344556788899999999999999998889999999876554322110   112233333   12334444444555667


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-------CCCcEEE
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-------QNFRAKV  298 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl  298 (457)
                      +||+||.+.|+|.+++...    +.++|.-.+.++.|++..++.||..+   |||+||||+|+||.       +.--++|
T Consensus       770 ~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             eeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            8999999999999999843    35999999999999999999999999   99999999999993       2346999


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      +|||.+-.+.--..+......++|..+-.+|+..+.+|+.+.|.|.|..+++-||.|+.--..                 
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~-----------------  905 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVK-----------------  905 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhc-----------------
Confidence            999999888765555667778899999999999999999999999999999999999742100                 


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                         ......++..+..-...+.   ..++...+|+.+-..=|...++...|+.++.+
T Consensus       906 ---~g~~~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  906 ---NGSSWMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ---CCcceeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence               0001111111111112222   33344445555555557888888888887765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=9e-21  Score=188.93  Aligned_cols=219  Identities=23%  Similarity=0.353  Sum_probs=165.6

Q ss_pred             HHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 012739          204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF  283 (457)
Q Consensus       204 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl  283 (457)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+....   ..+++.-...+..+++.||.|||...  -..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence            457899999999999999999999999999999999998743   35899999999999999999999865  1399999


Q ss_pred             ccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCC-------CCCcccchHHHHHHHHHHHcCC
Q 012739          284 KCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-------KLTTKSDVYSYGVVLLELLTGR  356 (457)
Q Consensus       284 kp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~SlG~il~elltg~  356 (457)
                      ++.|++++..+.+||+|||+.................-..-|.|||.+.+.       ..+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998766431111112222244569999998763       1467899999999999999999


Q ss_pred             CCCCCCCCCCc-chhhhhhccccCchhHHhhhcCCcCCCCCC-H-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          357 VPVDPNRPPGE-HVLVSWALPRLTSREEAVEMVDPSLQGQYP-K-KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       357 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .||........ ...+...          ...-.+.+++... . +....+..++..||..+|..||++.+|-..++.+.
T Consensus       156 ~~~~~~~~~~~~~eii~~~----------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRV----------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCChHHHHHHH----------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99985432211 1111111          0011122222221 1 33347999999999999999999999999998887


Q ss_pred             hhcC
Q 012739          434 KNNA  437 (457)
Q Consensus       434 ~~~~  437 (457)
                      +...
T Consensus       226 ~~~~  229 (484)
T KOG1023|consen  226 KGGS  229 (484)
T ss_pred             cccc
Confidence            7643

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=9.9e-20  Score=165.49  Aligned_cols=137  Identities=17%  Similarity=0.226  Sum_probs=106.3

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEcCC---e-EEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-----HSPQLVELLGYCADQN---H-RLL  227 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~hpniv~l~~~~~~~~---~-~~l  227 (457)
                      ...+.||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     .||||++++|++.++.   . +.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999996  433333478888665444556789999999999     6799999999998863   3 347


Q ss_pred             EEEe--CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCccCceEeCC----CCcEEEee
Q 012739          228 ISEY--MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL-EFLHEHATPPVIHRDFKCSNVLLDQ----NFRAKVTD  300 (457)
Q Consensus       228 v~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  300 (457)
                      |+||  +.+++|.+++.+.     .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  5579999999652     15444  35577888777 9999999   999999999999963    34899999


Q ss_pred             ccCcc
Q 012739          301 FGLAK  305 (457)
Q Consensus       301 fgl~~  305 (457)
                      |+.+.
T Consensus       153 g~G~~  157 (210)
T PRK10345        153 NIGES  157 (210)
T ss_pred             CCCCc
Confidence            55443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2.6e-18  Score=162.19  Aligned_cols=198  Identities=21%  Similarity=0.233  Sum_probs=140.6

Q ss_pred             CCCCeeeEEEEEEcC---------------------------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHH
Q 012739          208 HSPQLVELLGYCADQ---------------------------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA  260 (457)
Q Consensus       208 ~hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  260 (457)
                      +|||||+++++|.+.                           ...|+||.-+ ..+|..++-.+.     .+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence            699999999876442                           2458899887 458999887643     5566777789


Q ss_pred             HHHHHHHHHHHhcCCCCeEeccCccCceEe--CCCC--cEEEeeccCcccccc---c-cCCccccccccCCCcccccccc
Q 012739          261 LDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNF--RAKVTDFGLAKMVSD---K-INGQISTRVLGTTGYLAPEYAS  332 (457)
Q Consensus       261 ~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgl~~~~~~---~-~~~~~~~~~~gt~~y~aPE~~~  332 (457)
                      .|+++|+.|||.+|   +.|||+|++|||+  ++|+  .+.|+|||++---..   . .+..-.....|....||||+..
T Consensus       348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999999   9999999999998  4443  578999998742111   0 0000112235777899999875


Q ss_pred             CCC------CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHH
Q 012739          333 TGK------LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAA  406 (457)
Q Consensus       333 ~~~------~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  406 (457)
                      ..+      --.|+|.|+.|.+.||+++...||........            +....    ........+..++..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------~~r~Y----qe~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------DTRTY----QESQLPALPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------chhhh----hhhhCCCCcccCChHHHH
Confidence            432      13589999999999999999999986322100            00111    111112344556668999


Q ss_pred             HHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          407 IAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       407 li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      |+...|+.||.+|++.+-....|.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999776666553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.2e-18  Score=155.66  Aligned_cols=134  Identities=24%  Similarity=0.341  Sum_probs=111.9

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK--------QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      +.||+|++|.||+|.. ++..+++|+......        .....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 667788887543211        1123477899999999999988777777777788999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ++|++|.+++...       .+ ++..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988642       12 77889999999999999999   99999999999999 78999999998764

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=3.8e-18  Score=158.76  Aligned_cols=143  Identities=15%  Similarity=0.176  Sum_probs=110.9

Q ss_pred             CCCCCceeccCCcEEEEEEE--EcCCcEEEEEEcccCchH------------------------HHHHHHHHHHHHHhcC
Q 012739          155 NFSEGNVIGNGGFGVVYKGV--LSDGTVAAIKKLHRDGKQ------------------------RERAFRMEVDLLSRLH  208 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~  208 (457)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|++......                        ....+..|+..++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  567999999988643210                        0123568999999997


Q ss_pred             CC--CeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccC
Q 012739          209 SP--QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS  286 (457)
Q Consensus       209 hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~  286 (457)
                      +.  .+.+++++    ...++||||+++++|..+....    ..+...+...++.|++.++.+||+.+.  ++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence            53  34444543    2348999999988887654322    235666778899999999999998874  999999999


Q ss_pred             ceEeCCCCcEEEeeccCccccc
Q 012739          287 NVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       287 NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||+++ ++.++|+|||++....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=7e-18  Score=176.01  Aligned_cols=139  Identities=21%  Similarity=0.313  Sum_probs=112.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC-c------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD-G------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~-~------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      ....|...+.||+|+||.||+|.+.+...++.+++... .      ....+.+.+|+++++.++|++++....++.....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34455678899999999999998755544433333221 1      1123457889999999999999988888877777


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++++|.+++.            ....++.+++.+|.+||+.+   ++||||||+|||+ .++.++|+|||++
T Consensus       411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            899999999999999875            24568899999999999999   9999999999999 6789999999998


Q ss_pred             cc
Q 012739          305 KM  306 (457)
Q Consensus       305 ~~  306 (457)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            75

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=3e-19  Score=174.95  Aligned_cols=174  Identities=24%  Similarity=0.351  Sum_probs=129.6

Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      .++||.|++|...+|.+||..+.. ....++...+.++.|++.|++|   ++   .+|+|+||.||++..+..+||.|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence            357899999999999999976443 2346778888999999999999   67   9999999999999999999999999


Q ss_pred             Ccccccccc----CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccc
Q 012739          303 LAKMVSDKI----NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       303 l~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      +........    .....+...||..||+||.+.+..|+.|+||||||++|+||+. =..+++...          ....
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d  471 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTD  471 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhh
Confidence            987765443    1223456789999999999999999999999999999999997 222222100          0000


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMT  423 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  423 (457)
                      +.     ...+++.+..++|     .=..|+.+++.+.|.+||++.
T Consensus       472 ~r-----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  472 IR-----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hh-----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence            00     0111212222333     235789999999999999433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.1e-17  Score=151.94  Aligned_cols=145  Identities=20%  Similarity=0.180  Sum_probs=111.8

Q ss_pred             HHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH----------------------HHHHHHHHHHHHH
Q 012739          148 ELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ----------------------RERAFRMEVDLLS  205 (457)
Q Consensus       148 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~  205 (457)
                      ++......|.+.+.||+|+||.||++...+|+.+|||++......                      ....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            334444448888999999999999999888999999986543200                      0112567889999


Q ss_pred             hcCCC--CeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 012739          206 RLHSP--QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF  283 (457)
Q Consensus       206 ~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl  283 (457)
                      .+.++  .++..++.    ...++||||+++++|......          .....++.+++.++.++|..+   ++|+||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            99877  44444442    345899999999998765321          234568889999999999998   999999


Q ss_pred             ccCceEeCCCCcEEEeeccCcccccc
Q 012739          284 KCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       284 kp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+||++++++.++|+|||++.....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.5e-17  Score=151.21  Aligned_cols=130  Identities=25%  Similarity=0.388  Sum_probs=105.0

Q ss_pred             eeccCCcEEEEEEEEcCCcEEEEEEcccCc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          161 VIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .||+|+||.||+|.+ ++..+++|......        ......+.+|++++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 66788888754321        111245678999999999887655555555666779999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +|++|.+++....     .      .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875421     1      67889999999999999   99999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=1.5e-18  Score=181.29  Aligned_cols=208  Identities=25%  Similarity=0.372  Sum_probs=142.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .+|..++.|..|+||.||.++++. .+.+|+ ++.+++-     +.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee-------------------
Confidence            578888999999999999999764 567777 4433311     1110  22222333333                   


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc---
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD---  309 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~---  309 (457)
                        |+-...+...+    +++.        +++.+++|||+.+   |+|||+||+|.+|+.-|.+|+.|||+++.-.-   
T Consensus       136 --gDc~tllk~~g----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --GDCATLLKNIG----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --chhhhhcccCC----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence              33333333222    1222        2378999999999   99999999999999999999999999864311   


Q ss_pred             ---------ccCCcc-ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC
Q 012739          310 ---------KINGQI-STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT  379 (457)
Q Consensus       310 ---------~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  379 (457)
                               ....+. ...++||+.|+|||++....|...+|.|++|+|+||.+-|..||....++....   .++    
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg---~vi----  271 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVI----  271 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh---hhh----
Confidence                     011112 234699999999999999999999999999999999999999999765532211   111    


Q ss_pred             chhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 012739          380 SREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP  420 (457)
Q Consensus       380 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP  420 (457)
                        .+.+++.      +-+.....+.++++.+.|+.+|..|.
T Consensus       272 --sd~i~wp------E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  272 --SDDIEWP------EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --hhhcccc------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence              0111111      11223344789999999999999995

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=8.6e-16  Score=132.23  Aligned_cols=135  Identities=21%  Similarity=0.162  Sum_probs=112.8

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..++.+.+  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35679999999999999854 7889998865533  4567889999999976  58999999988888899999999887


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      .+..+           +......++.+++.++.+||......++|+|++|+||++++.+.++++|||++..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543           3456667888999999999986434499999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=4.4e-16  Score=139.97  Aligned_cols=137  Identities=20%  Similarity=0.252  Sum_probs=98.9

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchH--HHHH----------------------HHHHHHHHHhcCCC--Ce
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ--RERA----------------------FRMEVDLLSRLHSP--QL  212 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~hp--ni  212 (457)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999987653211  1011                      13466666666443  24


Q ss_pred             eeEEEEEEcCCeEEEEEEeCCCCcHHH-HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEe
Q 012739          213 VELLGYCADQNHRLLISEYMPNGTLQQ-HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll  290 (457)
                      .+.+++    ...++||||++++.+.. .+....     .. .++..++.+++.++.++|. .+   ++|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            445443    23589999999854321 111111     11 5677899999999999999 88   9999999999999


Q ss_pred             CCCCcEEEeeccCcccccc
Q 012739          291 DQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~  309 (457)
                      + ++.++|+|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=2.9e-15  Score=139.67  Aligned_cols=135  Identities=20%  Similarity=0.251  Sum_probs=103.6

Q ss_pred             Cceec-cCCcEEEEEEEEcCCcEEEEEEcccCc-------------hHHHHHHHHHHHHHHhcCCCCe--eeEEEEEEcC
Q 012739          159 GNVIG-NGGFGVVYKGVLSDGTVAAIKKLHRDG-------------KQRERAFRMEVDLLSRLHSPQL--VELLGYCADQ  222 (457)
Q Consensus       159 ~~~LG-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~hpni--v~l~~~~~~~  222 (457)
                      ...|| .|+.|+||++.. ++..+++|.+...+             ......+.+|++++..+.|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 889999999887 46778888774321             1122457789999999998774  6777765332


Q ss_pred             -C---eEEEEEEeCCC-CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          223 -N---HRLLISEYMPN-GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       223 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                       .   ..++|||++++ .+|.+++...     +++..    .+.+++.+|.+||+.|   |+|+||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 6898887542     24443    3568999999999999   99999999999999999999


Q ss_pred             EeeccCccc
Q 012739          298 VTDFGLAKM  306 (457)
Q Consensus       298 l~Dfgl~~~  306 (457)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.6e-17  Score=173.11  Aligned_cols=256  Identities=22%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc--CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS--DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..|.+.+.||+|.|+.|-.....  ....+|.|.+....  .........|..+-+.+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34566677999999999888753  34556666665443  222234455777777776 99999999999999999999


Q ss_pred             EEeCCCCcHHHHHh-hhCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCccCceEeCCCC-cEEEeeccCcc
Q 012739          229 SEYMPNGTLQQHLH-RHNNRYRPLDWRTRLIIALDCAMALEFLH-EHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~L~~~l~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~  305 (457)
                      ++|..++++.+-+. ...   ...+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||++.
T Consensus       100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999998883 322   13555666778999999999999 888   99999999999999999 99999999999


Q ss_pred             cccc-ccCCcccccccc-CCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          306 MVSD-KINGQISTRVLG-TTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       306 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      .+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|.-..     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-----
Confidence            8876 444445556778 9999999999874 5567899999999999999999999854432211 11111000     


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                             ................++...++..+|..|.+.+++...
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                   000011222334467888889999999999999887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1e-13  Score=140.41  Aligned_cols=142  Identities=20%  Similarity=0.222  Sum_probs=100.4

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHH----------------------------------------HHHH
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRE----------------------------------------RAFR  198 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~  198 (457)
                      .+.||.|++|.||+|++.+|+.||||+.+.......                                        -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999864321100                                        0134


Q ss_pred             HHHHHHHhc----CCCCeeeEEEEE-EcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 012739          199 MEVDLLSRL----HSPQLVELLGYC-ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHE  272 (457)
Q Consensus       199 ~Ei~~l~~l----~hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~  272 (457)
                      .|...+.++    .+.+-+.+-..+ ...+..+|||||++|++|.++......   ..+   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence            455555554    232223333333 234457999999999999887654221   122   3345556655 4788899


Q ss_pred             cCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       273 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      .|   ++|+|++|.||+++.++.++++|||++..+..
T Consensus       276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            88   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.6e-14  Score=133.80  Aligned_cols=207  Identities=22%  Similarity=0.343  Sum_probs=145.3

Q ss_pred             HHHHHhcCCCCeeeEEEEEEcCC-----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012739          201 VDLLSRLHSPQLVELLGYCADQN-----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT  275 (457)
Q Consensus       201 i~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~  275 (457)
                      ..-+-++.|.|||++..||.+..     ...+++|||..|+|.++|+........+......+|+-||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34455667999999999986543     46799999999999999998776667788888889999999999999997 5


Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCccccccccC---CccccccccCCCccccccccCCCCCcccchHHHHHHHHHH
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL  352 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~el  352 (457)
                      |+++|+++..+.|++..+|-+|+.--.-. .......   ........+-++|.+||.=.....+.++|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            88999999999999999998887432111 1110000   0111223467899999987777778899999999999999


Q ss_pred             HcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          353 LTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       353 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      .-+...-......        +..+... ..+.-.+...+           -..++..|++..|..||+|++++.+.
T Consensus       276 ailEiq~tnseS~--------~~~ee~i-a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESK--------VEVEENI-ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcce--------eehhhhh-hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            8887543211110        0000000 00000111111           23467789999999999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=4.4e-14  Score=141.43  Aligned_cols=250  Identities=22%  Similarity=0.228  Sum_probs=181.4

Q ss_pred             cCCCCCceecc--CCcEEEEEEEE---cCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 012739          154 ENFSEGNVIGN--GGFGVVYKGVL---SDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~--G~~g~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~  225 (457)
                      ..+...+.+|.  |.+|.||.+..   .++..+|+|+-+...  ......-.+|+...+.+ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            44566778999  99999999986   357788988743332  22222224466666666 489999988999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEee
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM----ALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTD  300 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  300 (457)
                      ++-+|++ +.+|.++.+....   -++...++.++.+...    ||..+|..+   ++|-|+||.||+...+ ...+++|
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            9999999 5788888876543   2566677777778888    999999998   9999999999999999 8899999


Q ss_pred             ccCccccccccCCcc---ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          301 FGLAKMVSDKINGQI---STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       301 fgl~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      ||+...+.+......   .....|...|++||... +.++..+|+|++|.++++-.++-.+.-..-.      ..|.  .
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~--~  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS--Q  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc--c
Confidence            999988866432221   22346788899999884 5678999999999999999998766543210      1111  1


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +....         +..++-..-..++..++.+|++.+|..|++.+.+...
T Consensus       338 ~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 LRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            11100         1111111122355669999999999999998887654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=3.1e-12  Score=129.52  Aligned_cols=166  Identities=17%  Similarity=0.250  Sum_probs=128.8

Q ss_pred             EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHH
Q 012739          175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR  254 (457)
Q Consensus       175 ~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  254 (457)
                      ..++..|.|...+...........+-++.|+.++||||+++++.+..++..|||+|-+  ..|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHH
Confidence            4467888888877665544556788899999999999999999999999999999998  477777766       3356


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCC
Q 012739          255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG  334 (457)
Q Consensus       255 ~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  334 (457)
                      .....+.||+.||.+||+.++  ++|++|.-..|+++..|..||++|.++....+...  ......---.|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            667788999999999986654  99999999999999999999999999876543221  01111112236666655332


Q ss_pred             CCCcccchHHHHHHHHHHHcC
Q 012739          335 KLTTKSDVYSYGVVLLELLTG  355 (457)
Q Consensus       335 ~~s~~sDV~SlG~il~elltg  355 (457)
                      .  -..|.|-|||+++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=2e-13  Score=139.94  Aligned_cols=146  Identities=16%  Similarity=0.192  Sum_probs=96.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchH----------------------------------HHHH-
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQ----------------------------------RERA-  196 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~~-  196 (457)
                      ...|.. +.||.|++|+||+|++.+ |+.||||++...-..                                  -.+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999987 999999998644111                                  0111 


Q ss_pred             -----HHHHHHHHHhc----CCCCeeeEEEEEEc-CCeEEEEEEeCCCCcHHHHH--hhhCCCCCCCCHHHHHHHHHHHH
Q 012739          197 -----FRMEVDLLSRL----HSPQLVELLGYCAD-QNHRLLISEYMPNGTLQQHL--HRHNNRYRPLDWRTRLIIALDCA  264 (457)
Q Consensus       197 -----~~~Ei~~l~~l----~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~  264 (457)
                           +.+|+..+.++    .+.+.+.+-.++.+ ....+|||||++|+++.++-  ...+.....+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 33344444444    23444444444433 45678999999999998743  2211111123333333344444 


Q ss_pred             HHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeeccCcccccc
Q 012739          265 MALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDFGLAKMVSD  309 (457)
Q Consensus       265 ~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl~~~~~~  309 (457)
                            ...|   ++|+|++|.||+++.++    .++++|||++..+..
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3467   99999999999999888    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.8e-12  Score=113.12  Aligned_cols=130  Identities=17%  Similarity=0.121  Sum_probs=95.3

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCee-eEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-ELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      +.|+.|.++.||++.. .+..+++|....... ....+..|+..++.+.+.+++ +++.+..  ...++||||++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            5689999999999987 477899998755432 122457789999988655544 4544432  3457999999998775


Q ss_pred             HHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA--TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       239 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ..  .       .   ....++.+++++|..||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            43  0       1   11235678999999999987  22359999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=2.4e-12  Score=129.02  Aligned_cols=244  Identities=20%  Similarity=0.202  Sum_probs=175.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE--cCCcEEEEEEcccCchHHHHH--HHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL--SDGTVAAIKKLHRDGKQRERA--FRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|..+..||.|.|+.|++...  .++..+++|.+.+.......+  -..|+-+...+ .|.++++....|......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            45688889999999999999874  368889999886653322222  23466666666 57888888887877777789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKM  306 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~~~  306 (457)
                      -.|||.++++...+...    ..+++..++.+..|++.++.++|++.   ++|+|+||+||++..+ +..++.|||....
T Consensus       344 p~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             chhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            99999999887766332    24788889999999999999999999   9999999999999876 8889999998864


Q ss_pred             cccccCCccccccccCCCcc--ccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          307 VSDKINGQISTRVLGTTGYL--APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      +.-.     ........+++  +++......+-.+.|+||||..+.|.+++..--....        .|           
T Consensus       417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~-----------  472 (524)
T KOG0601|consen  417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS-----------  472 (524)
T ss_pred             ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc-----------
Confidence            3211     11223344455  5555667788899999999999999999875432110        01           


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ..+... .....+. ....+..+...+...++..||.+.++..+.
T Consensus       473 ~~i~~~-~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  473 LTIRSG-DTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             eeeecc-cccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            011110 0011111 225788889999999999999988877654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=2e-10  Score=102.81  Aligned_cols=137  Identities=16%  Similarity=0.171  Sum_probs=97.9

Q ss_pred             CceeccCCcEEEEEEEEcC-------CcEEEEEEcccCc------------h----------HHHHHH----HHHHHHHH
Q 012739          159 GNVIGNGGFGVVYKGVLSD-------GTVAAIKKLHRDG------------K----------QRERAF----RMEVDLLS  205 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~----~~Ei~~l~  205 (457)
                      ...||.|--+.||.|...+       +..+|+|..+...            .          ...+.+    +.|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998643       4789999754210            0          001122    37999999


Q ss_pred             hcCC--CCeeeEEEEEEcCCeEEEEEEeCCCCcHHH-HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 012739          206 RLHS--PQLVELLGYCADQNHRLLISEYMPNGTLQQ-HLHRHNNRYRPLDWRTRLIIALDCAMALEFL-HEHATPPVIHR  281 (457)
Q Consensus       206 ~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~  281 (457)
                      ++..  -++..++++    ..-+|||||+.+..+.. .+..     ..++..+...+..+++.+|..| |..+   +||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9853  456666654    34589999997654322 2221     1245556677889999999999 8888   9999


Q ss_pred             cCccCceEeCCCCcEEEeeccCccccc
Q 012739          282 DFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       282 Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||++.|||++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999997 4689999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.2e-10  Score=107.29  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=107.3

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcC---CeEEEEEEeCC
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHS--PQLVELLGYCADQ---NHRLLISEYMP  233 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~  233 (457)
                      +.|+.|..+.||++...+|..+++|....... .....+..|.++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778899998765432 123457889999999976  4467777776653   25689999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA---------------------------------------  274 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------  274 (457)
                      |.++.+.+..     ..++..+...++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765431     13566677777778888888877421                                       


Q ss_pred             --------------CCCeEeccCccCceEeCC--CCcEEEeeccCccc
Q 012739          275 --------------TPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKM  306 (457)
Q Consensus       275 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgl~~~  306 (457)
                                    ...++|+|+.|.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          234899999999999998  67789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=6.8e-10  Score=109.44  Aligned_cols=170  Identities=18%  Similarity=0.247  Sum_probs=130.5

Q ss_pred             cEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----cCCeEEEEEEeCCCC-cHHHH
Q 012739          167 FGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA----DQNHRLLISEYMPNG-TLQQH  240 (457)
Q Consensus       167 ~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~----~~~~~~lv~e~~~~g-~L~~~  240 (457)
                      -.+.|++.. .||..|++|+++.+..........-++.++++.|+|||++.++|.    .+...++||+|+++. +|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357888884 489999999996553333333445688999999999999998875    456789999999864 67765


Q ss_pred             HhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          241 LHRHNN-----------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       241 l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      -.....           .....++..+|.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            443221           1234678899999999999999999999   99999999999999999999999888766543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP  358 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p  358 (457)
                      ...                |.+.   --.+-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            210                1111   13467999999999999999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=7.1e-10  Score=96.15  Aligned_cols=131  Identities=22%  Similarity=0.370  Sum_probs=95.4

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEE-EcccC---c----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIK-KLHRD---G----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK-~l~~~---~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+++|+-+.+|.+.+.+.. +++| ++.+.   .    .-......+|..++.+++--.|.-..=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774434 5555 33332   1    11113356799999888654444444455566677899999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ++|-.|.+++...           ...++..+-.-+.-||..+   |+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998999888764           1345667777888999999   99999999999997765 99999999863

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.10  E-value=2.1e-09  Score=92.84  Aligned_cols=143  Identities=20%  Similarity=0.268  Sum_probs=102.4

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEE-EcccC-------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIK-KLHRD-------GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK-~l~~~-------~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ...++-+|+-+.|+++.+ .|+...|| ++.+.       ..-..+..++|++.+.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457889999999999998 56666665 33221       1111234678999998886544444444566666667999


Q ss_pred             EeCCC-CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC---cEEEeeccCcc
Q 012739          230 EYMPN-GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF---RAKVTDFGLAK  305 (457)
Q Consensus       230 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl~~  305 (457)
                      ||+++ .++.+++......  +........++..+-+.+.-||..+   |+|+||..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 3788888775431  1222333678888999999999999   99999999999996544   46899999985


Q ss_pred             c
Q 012739          306 M  306 (457)
Q Consensus       306 ~  306 (457)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=2.3e-11  Score=128.27  Aligned_cols=247  Identities=21%  Similarity=0.268  Sum_probs=166.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +.+.+.+.+-+|.++.++.+.-. .+...++|......   ..+.+..+.+-.++-..++|-+++..--+.-....+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            44555667889999999887632 23333444332221   111222233333333334566665554455567789999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      +|..+++|...|+...    +.+.+-.......+..+++|||...   +.|+|++|.|+|...++..+++|||.......
T Consensus       884 ~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             HHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999888755    3555555566677889999999987   89999999999999999999999984322110


Q ss_pred             ------c-----------------------cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCC
Q 012739          310 ------K-----------------------INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       310 ------~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                            .                       ..........+|+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                  0                       00011223568999999999999999999999999999999999999998


Q ss_pred             CCCCCCcchhhhhhccccCchhHHhhhcCCcCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 012739          361 PNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMT  423 (457)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  423 (457)
                      ...+....                ..+...... ..-+........+++...+..+|.+|..+.
T Consensus      1037 a~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            65542111                011111110 122344455778888888899999997766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=1.4e-08  Score=95.84  Aligned_cols=141  Identities=18%  Similarity=0.187  Sum_probs=100.5

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH-HH----------HHHHHHHHHHhcCC--CCeeeEEEEEEc-----
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR-ER----------AFRMEVDLLSRLHS--PQLVELLGYCAD-----  221 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~----------~~~~Ei~~l~~l~h--pniv~l~~~~~~-----  221 (457)
                      +.+-+-....|++... +|+.+.||+........ .+          .+.+|...+..+..  -..+.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455555556777766 67789999775443211 11          36678888877743  223344555532     


Q ss_pred             CCeEEEEEEeCCCC-cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-------C
Q 012739          222 QNHRLLISEYMPNG-TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-------N  293 (457)
Q Consensus       222 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~  293 (457)
                      ....+||+|++++. +|.+++.....  .+.+......++.+++..+.-||..|   |+|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            23578999999876 79998864321  23556777789999999999999999   999999999999975       5


Q ss_pred             CcEEEeeccCccc
Q 012739          294 FRAKVTDFGLAKM  306 (457)
Q Consensus       294 ~~~kl~Dfgl~~~  306 (457)
                      +.+.|+||+.++.
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            7899999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=7.5e-08  Score=93.09  Aligned_cols=262  Identities=18%  Similarity=0.214  Sum_probs=160.9

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEE------EEcCCe-EEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGY------CADQNH-RLLI  228 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~------~~~~~~-~~lv  228 (457)
                      ...+.||+|+-+.+|-.--  -...+.|+..........+.   +..|... .||-+-.=+.+      ..+.+. .-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3457799999999996432  11233455544432222221   2223222 55543321211      112222 5678


Q ss_pred             EEeCCCCc-HHHHHhh--hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          229 SEYMPNGT-LQQHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~-L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      |+.+.+.. ...+..-  +..+....+|.-+++.+..++.+.+.||..|   .+-+|++++|+|+.+++.+.|.|-....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            88887652 2222221  2334456789999999999999999999999   9999999999999999999999876544


Q ss_pred             ccccccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCCc-----chhhhhh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTG-RVPVDPNRPPGE-----HVLVSWA  374 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg-~~p~~~~~~~~~-----~~~~~~~  374 (457)
                      ..   .++....-.+|...|.+||.-.     +..-+...|.|.||+++++|+.| ++||.+-.....     +..+.. 
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-  241 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-  241 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence            33   2334445567889999999754     44567889999999999999887 999975321110     000000 


Q ss_pred             ccccCchhHHhhhcCCcCC---CCCCHH-HHHHHHHHHHhhcCCC--CCCCCCHHHHHHHHHHhhhh
Q 012739          375 LPRLTSREEAVEMVDPSLQ---GQYPKK-DLIQIAAIAAVCVQPE--AAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~---~~~~~~-~~~~l~~li~~cl~~~--p~~RPs~~evl~~L~~~~~~  435 (457)
                       ..+....+    -.+.++   ...|-. .+..+.-|..+|+...  +.-|||++..+..|..+-.+
T Consensus       242 -g~f~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         242 -GRFAYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             -ceeeechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence             00000000    011111   122222 2456777888888654  56899999999888766554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=1.2e-08  Score=91.02  Aligned_cols=126  Identities=21%  Similarity=0.271  Sum_probs=81.8

Q ss_pred             EEEEEEEcCCcEEEEEEcccCc--------------h------------HHHHHHHHHHHHHHhcCCC--CeeeEEEEEE
Q 012739          169 VVYKGVLSDGTVAAIKKLHRDG--------------K------------QRERAFRMEVDLLSRLHSP--QLVELLGYCA  220 (457)
Q Consensus       169 ~Vy~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~hp--niv~l~~~~~  220 (457)
                      .||.|...+|..+|+|..+...              .            ......++|.+.|..+..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999754210              0            0112357899999999765  566666553 


Q ss_pred             cCCeEEEEEEeCC--CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          221 DQNHRLLISEYMP--NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF-LHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       221 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                         .-.|||||++  |..+..+....      ++..+...++.+++..+.. +|..|   ++|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence               2369999998  55555433221      1123445567778775555 57888   9999999999999888 999


Q ss_pred             EeeccCccccc
Q 012739          298 VTDFGLAKMVS  308 (457)
Q Consensus       298 l~Dfgl~~~~~  308 (457)
                      |+|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=4.5e-09  Score=107.31  Aligned_cols=152  Identities=19%  Similarity=0.243  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc-------cccccccCCCcccccccc
Q 012739          260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ-------ISTRVLGTTGYLAPEYAS  332 (457)
Q Consensus       260 ~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~  332 (457)
                      +.+++.||.|+|...+  +||++|.|++|.++.++..||+.|+.+..........       ...-......|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4466699999997554  9999999999999999999999999987654421111       111123456799999999


Q ss_pred             CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhh
Q 012739          333 TGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVC  411 (457)
Q Consensus       333 ~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c  411 (457)
                      ....+.++|+||+|+++|.+.. |+.-+........     +         ......+..-...++...+.++.+=+.++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~---------~~~~~~~~~~~~~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----Y---------SFSRNLLNAGAFGYSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----h---------hhhhcccccccccccccCcHHHHHHHHHH
Confidence            8888999999999999999994 5544443321100     0         00011111111234455666888888999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 012739          412 VQPEAAYRPLMTDVVQ  427 (457)
Q Consensus       412 l~~~p~~RPs~~evl~  427 (457)
                      +..++.-||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            9999999997777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=6.6e-08  Score=88.96  Aligned_cols=136  Identities=21%  Similarity=0.213  Sum_probs=98.5

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc---------hH-------------HHHHHHHHHHHHHhcCCC--C
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG---------KQ-------------RERAFRMEVDLLSRLHSP--Q  211 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~---------~~-------------~~~~~~~Ei~~l~~l~hp--n  211 (457)
                      ..++..||-|--+.||.|....|..+|+|.-+...         ..             .....++|.+.|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999533110         00             112357799999999654  6


Q ss_pred             eeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC
Q 012739          212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD  291 (457)
Q Consensus       212 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  291 (457)
                      |.+.+++    +.-.+||||++|-.|...-         ++....-.++..|++-+.-+-..|   +||+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            6666654    3457999999887665432         123333445555555555555778   99999999999999


Q ss_pred             CCCcEEEeeccCcccc
Q 012739          292 QNFRAKVTDFGLAKMV  307 (457)
Q Consensus       292 ~~~~~kl~Dfgl~~~~  307 (457)
                      ++|.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999865543

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=3.8e-07  Score=82.01  Aligned_cols=138  Identities=14%  Similarity=0.156  Sum_probs=101.2

Q ss_pred             eccCCcEEEEEEEEcCCcEEEEEEcccCc------hHHHHHHHHHHHHHHhcCC--CCeeeEEEEEE-c----CCeEEEE
Q 012739          162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDG------KQRERAFRMEVDLLSRLHS--PQLVELLGYCA-D----QNHRLLI  228 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~-~----~~~~~lv  228 (457)
                      -|+||-+-|++... +|..+.+|+-...-      .-....|.+|...+..|..  -.+.+.+ ++. .    ....+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            47789999999877 44478888765221      1233568889999888843  2255554 332 1    2246799


Q ss_pred             EEeCCC-CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc--EEEeeccCcc
Q 012739          229 SEYMPN-GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR--AKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgl~~  305 (457)
                      +|-+++ -+|.+++.....  .+.+......+..+++..+.-||+.|   +.|+|+.+.|||++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998754 489888865332  24677778889999999999999999   999999999999986666  9999998765


Q ss_pred             c
Q 012739          306 M  306 (457)
Q Consensus       306 ~  306 (457)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=2e-07  Score=84.97  Aligned_cols=105  Identities=25%  Similarity=0.307  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHhcCC--CCeeeEEEEEEcC----CeEEEEEEeCCCC-cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH
Q 012739          196 AFRMEVDLLSRLHS--PQLVELLGYCADQ----NHRLLISEYMPNG-TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE  268 (457)
Q Consensus       196 ~~~~Ei~~l~~l~h--pniv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~  268 (457)
                      ...+|...+..+..  -.+.+.+++....    ...+||+|++++. +|.+++.....    .+......++.+++..+.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence            45667777776632  2345556665442    2458999999875 79998876433    555667789999999999


Q ss_pred             HHHhcCCCCeEeccCccCceEeCCCC---cEEEeeccCcccc
Q 012739          269 FLHEHATPPVIHRDFKCSNVLLDQNF---RAKVTDFGLAKMV  307 (457)
Q Consensus       269 ~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl~~~~  307 (457)
                      -||..|   |+|+|+++.|||++.++   .+.++||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   99999999999998887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.8e-07  Score=95.70  Aligned_cols=141  Identities=20%  Similarity=0.279  Sum_probs=94.8

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH----------------------------------------HHHHHH
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR----------------------------------------ERAFRM  199 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~  199 (457)
                      +.|+.++-|.||+|++.+|+.||||+.+.+-...                                        +-.+..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999976432110                                        011344


Q ss_pred             HHHHHHhcC-----CCCeeeEEE-EEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 012739          200 EVDLLSRLH-----SPQLVELLG-YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH  273 (457)
Q Consensus       200 Ei~~l~~l~-----hpniv~l~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  273 (457)
                      |..-+.++.     .|++ ++=. |+.-.+...|+|||++|-.+.+...-...   .++...+.....++.  +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHH--HHHHHhc
Confidence            555555542     2433 2323 33345677999999999888887433221   255444333333322  2222234


Q ss_pred             CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       274 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |   ++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            6   99999999999999999999999999877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2.8e-06  Score=78.59  Aligned_cols=140  Identities=19%  Similarity=0.171  Sum_probs=84.1

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC--eeeEEEEEEcCCeEEEEEEeCCCCc-
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ--LVELLGYCADQNHRLLISEYMPNGT-  236 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~-  236 (457)
                      ..||.|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   34567788775533  2234678999998886433  4677888877778889999998863 


Q ss_pred             HHHH---------------------HhhhCCCCCCCCHH--HHHHHHH-------HHHH-HHHHHHhc-CCCCeEeccCc
Q 012739          237 LQQH---------------------LHRHNNRYRPLDWR--TRLIIAL-------DCAM-ALEFLHEH-ATPPVIHRDFK  284 (457)
Q Consensus       237 L~~~---------------------l~~~~~~~~~l~~~--~~~~i~~-------qi~~-~l~~LH~~-~~~~ivH~Dlk  284 (457)
                      +...                     |+........+...  .....+.       .+.. ...+|... ..+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2111                     11100001111100  0000000       0001 12222211 23347899999


Q ss_pred             cCceEeCCCCcEEEeeccCcc
Q 012739          285 CSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       285 p~NIll~~~~~~kl~Dfgl~~  305 (457)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=3.3e-06  Score=76.33  Aligned_cols=137  Identities=20%  Similarity=0.205  Sum_probs=90.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHH---------HHHHHHHHhcC---CCCeeeEEEEE-
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAF---------RMEVDLLSRLH---SPQLVELLGYC-  219 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~---hpniv~l~~~~-  219 (457)
                      ..+|...+++-......|.+-.. +|..+++|.........++.|         .+++..+..+.   -.....++.+. 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46778888888877777777666 678899998765433332222         23333333332   22233323222 


Q ss_pred             ----EcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          220 ----ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       220 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                          .-....+|+|||++|..|.++..        ++.    .++..+.+++.-||..|   ++|+|..|.|+++++++ 
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence                22345578999999988766532        222    24456778899999999   99999999999998654 


Q ss_pred             EEEeeccCccc
Q 012739          296 AKVTDFGLAKM  306 (457)
Q Consensus       296 ~kl~Dfgl~~~  306 (457)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=7.9e-06  Score=75.51  Aligned_cols=145  Identities=21%  Similarity=0.241  Sum_probs=84.5

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC--CeeeEEEEEE---cCCeEEEEEEeCC
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP--QLVELLGYCA---DQNHRLLISEYMP  233 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~~~---~~~~~~lv~e~~~  233 (457)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999866 68999987544  3445677888888888432  3556666442   2345789999999


Q ss_pred             CCcHHH----------------HHh---hhCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 012739          234 NGTLQQ----------------HLH---RHNNRYRPLDWRT---------RLII------------ALDCAM-ALEFLHE  272 (457)
Q Consensus       234 ~g~L~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~  272 (457)
                      +..+..                .+.   .......++....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            887776                111   1101111111110         0000            011222 3333332


Q ss_pred             c----CCCCeEeccCccCceEeC-CCCcEEEeeccCccc
Q 012739          273 H----ATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKM  306 (457)
Q Consensus       273 ~----~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~  306 (457)
                      .    ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    234599999999999999 667778999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=5e-08  Score=98.76  Aligned_cols=186  Identities=17%  Similarity=0.177  Sum_probs=135.6

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEEEeCCC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +....-.++|++++++|.+....+....+.+...     ...+-++++|.+.+||| .++.++-+..+...+++++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3334557899999999988654555556655433     33456899999999999 77777777778888999999977


Q ss_pred             C-cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          235 G-TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       235 g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      + +.......   ....+...+...+...-++++++||+.-   =+|+|    ||+..+ +..+..||+....+....  
T Consensus       319 ~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  319 GRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence            6 22111110   0012333444556666778999999864   48988    777765 689999999988776543  


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                       ......+++.|+|||+...+.+..+.|+|++|.-..++--|-+|-.
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence             3455779999999999999999999999999988778877776654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=6.6e-06  Score=84.16  Aligned_cols=140  Identities=17%  Similarity=0.213  Sum_probs=90.3

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH-------------------------------HH------HHHHHHH
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR-------------------------------ER------AFRMEVD  202 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~~------~~~~Ei~  202 (457)
                      +.||.-+.|.||+|++++|+.||||+-+..-+..                               .+      .|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999876432110                               01      1333333


Q ss_pred             HHH----hcCCCC---eeeEEEEE-EcCCeEEEEEEeCCCCcHHHH--HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012739          203 LLS----RLHSPQ---LVELLGYC-ADQNHRLLISEYMPNGTLQQH--LHRHNNRYRPLDWRTRLIIALDCAMALEFLHE  272 (457)
Q Consensus       203 ~l~----~l~hpn---iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  272 (457)
                      -..    .+.|-+   -|.+=.++ .-.....|+||||+|..+.+.  |.+.     .++..++..-+.+...-+-+  .
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l~~~~~~qIf--~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKLVEAYLEQIF--K  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHHHHHHHHHHH--h
Confidence            322    234444   11122222 334568999999999876654  3332     25655555444443322222  2


Q ss_pred             cCCCCeEeccCccCceEeCC----CCcEEEeeccCcccccc
Q 012739          273 HATPPVIHRDFKCSNVLLDQ----NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       273 ~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgl~~~~~~  309 (457)
                      .|   ++|+|-.|.||++..    ++.+.+-|||+......
T Consensus       320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            35   999999999999983    67899999999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.29  E-value=1.3e-05  Score=75.05  Aligned_cols=140  Identities=19%  Similarity=0.166  Sum_probs=84.5

Q ss_pred             eccCCc-EEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeCCCCcHHH
Q 012739          162 IGNGGF-GVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYMPNGTLQQ  239 (457)
Q Consensus       162 LG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  239 (457)
                      |-.|.. ..||+.... +..+++|......   ...+..|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 789998764 4678888775543   234667888888883 3446677887776667899999999877764


Q ss_pred             HH-------------------hhhCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 012739          240 HL-------------------HRHNNRYRPLDW--RTRLIIAL--------------------DCAMALEFLHE----HA  274 (457)
Q Consensus       240 ~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------qi~~~l~~LH~----~~  274 (457)
                      ..                   +.......++..  ........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            31                   110000011110  00000000                    01111222211    12


Q ss_pred             CCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       275 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      .+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3459999999999999998888999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.24  E-value=1.9e-05  Score=72.20  Aligned_cols=152  Identities=19%  Similarity=0.214  Sum_probs=102.2

Q ss_pred             echHHHHHHhcCCCCCce---eccCCcEEEEEEEEcCCcEEEEEEcccCchHH-------------------H-----HH
Q 012739          144 FTYKELETATENFSEGNV---IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR-------------------E-----RA  196 (457)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~---LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------~-----~~  196 (457)
                      .+++.+....++..+...   |..|--+.||+|...++..+|+|+.+......                   .     .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            455566666666655444   55677789999998889999999876432110                   0     11


Q ss_pred             HHHHHHHHHhcC--CCCeeeEEEEEEcCCeEEEEEEeCCCCcH-HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 012739          197 FRMEVDLLSRLH--SPQLVELLGYCADQNHRLLISEYMPNGTL-QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-  272 (457)
Q Consensus       197 ~~~Ei~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-  272 (457)
                      ...|..-|+++.  +-.+.+-+++...    .|||||+..... .-.|..     -++...+...+..++++.+.-|-. 
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence            345777777773  3445555555443    699999954311 001111     123333567778888888888877 


Q ss_pred             cCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       273 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      .+   +||+||..-|||+. ++.+.|+|||-+....
T Consensus       186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            66   99999999999999 8899999999876554

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=5.7e-05  Score=67.99  Aligned_cols=132  Identities=23%  Similarity=0.316  Sum_probs=92.2

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEEEcccCc----------------hHHHHHHHHHHHHHHhcC------CCCeeeE
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG----------------KQRERAFRMEVDLLSRLH------SPQLVEL  215 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------hpniv~l  215 (457)
                      ....||+|+.-.||.  +.+....+||+.....                ....++..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999999997  4455567777775544                122455667777666665      7889999


Q ss_pred             EEEEEcCCeEEEEEEeCCCC------cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          216 LGYCADQNHRLLISEYMPNG------TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      +|+..++...-+|+|.+.+.      +|.+++....     ++. +...   .+-+-..||-+.+   |+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEE
Confidence            99999999999999986532      5778885432     554 3333   3445556777777   999999999999


Q ss_pred             eCCC---C-cEEEee-ccC
Q 012739          290 LDQN---F-RAKVTD-FGL  303 (457)
Q Consensus       290 l~~~---~-~~kl~D-fgl  303 (457)
                      +...   . .+.|+| ||-
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            9432   2 577777 343

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=3.5e-05  Score=84.86  Aligned_cols=78  Identities=18%  Similarity=0.266  Sum_probs=56.7

Q ss_pred             CceeccCCcEEEEEEEEcCC---cEEEEEEcccCc-hHHHHHHHHHHHHHHhcC-CCCe--eeEEEEEEcC---CeEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSDG---TVAAIKKLHRDG-KQRERAFRMEVDLLSRLH-SPQL--VELLGYCADQ---NHRLLI  228 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-hpni--v~l~~~~~~~---~~~~lv  228 (457)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876554   367777764432 122345788999999995 6654  7888887664   467899


Q ss_pred             EEeCCCCc
Q 012739          229 SEYMPNGT  236 (457)
Q Consensus       229 ~e~~~~g~  236 (457)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1.3e-05  Score=71.69  Aligned_cols=105  Identities=25%  Similarity=0.275  Sum_probs=82.4

Q ss_pred             HHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 012739          198 RMEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP  276 (457)
Q Consensus       198 ~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~  276 (457)
                      ..|.-+++.+.+ +++++++|+|..    +++.||...+++...- ..-......+|..+.+|+.++++.+.+|+.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            348888899976 699999999953    6899999877654210 0000112368999999999999999999985544


Q ss_pred             CeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      .+.-.|++++|+-+++++++|++|.+.+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5889999999999999999999999887544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=7.7e-05  Score=69.48  Aligned_cols=73  Identities=18%  Similarity=0.236  Sum_probs=44.8

Q ss_pred             ceeccCCcE-EEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC---CeeeEEEEEEcC---CeEEEEEEeC
Q 012739          160 NVIGNGGFG-VVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP---QLVELLGYCADQ---NHRLLISEYM  232 (457)
Q Consensus       160 ~~LG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp---niv~l~~~~~~~---~~~~lv~e~~  232 (457)
                      +.|+.|+.. .||+.    +..+++|......  ....+..|.++++.+...   -+.+.++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 58875    2356777654321  234678899999888531   344444443322   2358899999


Q ss_pred             CCCcHH
Q 012739          233 PNGTLQ  238 (457)
Q Consensus       233 ~~g~L~  238 (457)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            986653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.95  E-value=0.00014  Score=70.15  Aligned_cols=78  Identities=14%  Similarity=0.081  Sum_probs=56.2

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC---CCeeeEEEEEEc---CCeEEEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS---PQLVELLGYCAD---QNHRLLISE  230 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---pniv~l~~~~~~---~~~~~lv~e  230 (457)
                      ...+.||.|..+.||+....++ .+++|..+..  .....+..|.+.|+.+.-   -.+.++++++..   .+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999876555 4566664321  122467889999998843   367888888754   366899999


Q ss_pred             eCCCCcH
Q 012739          231 YMPNGTL  237 (457)
Q Consensus       231 ~~~~g~L  237 (457)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9988754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.94  E-value=5.3e-05  Score=82.32  Aligned_cols=196  Identities=18%  Similarity=0.211  Sum_probs=139.5

Q ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEcCCeE----EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012739          197 FRMEVDLLSRLHSPQLVELLGYCADQNHR----LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE  272 (457)
Q Consensus       197 ~~~Ei~~l~~l~hpniv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  272 (457)
                      ..-|+..+..+.|+|++.++.|-.+....    .+..+++..-++...+....    .++....+.+..+..+||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence            44577888899999999999987654333    24457787778877776654    37888888899999999999999


Q ss_pred             cCCCCeEeccCccC---ceEeCCCCcEEEe--eccCccccccccCCccccccccCCCccccccccCCCCCcc--cchHHH
Q 012739          273 HATPPVIHRDFKCS---NVLLDQNFRAKVT--DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK--SDVYSY  345 (457)
Q Consensus       273 ~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~--sDV~Sl  345 (457)
                      ..   ..|.-+...   +.-.+.++.+.++  ||+.++.......   ......+..|.++|......++.+  .|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence            86   666655555   5555677778887  9998877654322   222334556888888876665554  799999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 012739          346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDV  425 (457)
Q Consensus       346 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  425 (457)
                      |..+..+..|..+-....                   ....+++.    ..    ...+.+....|+..++++|++..++
T Consensus       379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~----~~----~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDV----LS----TSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHhhhhhcCccccccc-------------------chhhhhcc----cc----chhhhhhhhhhcchhhhhccchhhh
Confidence            999999998876533110                   01111111    11    1156788889999999999999999


Q ss_pred             HHHH
Q 012739          426 VQSL  429 (457)
Q Consensus       426 l~~L  429 (457)
                      +.+.
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            9884

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.90  E-value=0.00012  Score=63.45  Aligned_cols=129  Identities=20%  Similarity=0.218  Sum_probs=87.0

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeee-EEEEEEcCCeEEEEEEeCCCC
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE-LLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      ...+.|++|++|.||++.+. +..+|+|+-..+..  ...+..|+++|..+.--++-+ ++.|-.    -++.|||..|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            44577999999999999984 55788887665533  345778999999887655543 333322    24569999888


Q ss_pred             cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCc-cCceEeCCCCcEEEeeccCccc
Q 012739          236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK-CSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       236 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +|.++-..       .+...    ...+++.---|...|   |-|+.|. |...++.+++.+.|+||..+..
T Consensus        98 ~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG-------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc-------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88765432       12222    234455544555667   9999887 4555555555999999998873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.90  E-value=0.00013  Score=67.91  Aligned_cols=73  Identities=15%  Similarity=0.090  Sum_probs=47.2

Q ss_pred             ceeccCCcEEEEEEEEcC--CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          160 NVIGNGGFGVVYKGVLSD--GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      +.|..|-...+|+....+  +..+++|....... ......+|+.+++.+...+ .+++++.+. .   .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            567888888999998654  67888887654321 1112346888888885433 344444332 2   48999998876


Q ss_pred             H
Q 012739          237 L  237 (457)
Q Consensus       237 L  237 (457)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.88  E-value=7.9e-05  Score=70.34  Aligned_cols=139  Identities=15%  Similarity=0.121  Sum_probs=77.5

Q ss_pred             eccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEEEeCCCCcHHH-
Q 012739          162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLISEYMPNGTLQQ-  239 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L~~-  239 (457)
                      +..|-...+|+... ++..+++|........-.....+|.++++.+....+ .+++....    -++|+||++|..+.. 
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55677789998874 567788887644322211124668888888854333 33443332    368999998866532 


Q ss_pred             -------------H---HhhhCCCCCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCCeEeccCccCce
Q 012739          240 -------------H---LHRHNNRYRPLDWRTRL-IIALD---------CAMALEFLHEH-----ATPPVIHRDFKCSNV  288 (457)
Q Consensus       240 -------------~---l~~~~~~~~~l~~~~~~-~i~~q---------i~~~l~~LH~~-----~~~~ivH~Dlkp~NI  288 (457)
                                   .   |+.......+++..... ....+         +...+..+-..     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                         1   11111111222322111 11111         11112222211     123489999999999


Q ss_pred             EeCCCCcEEEeeccCccc
Q 012739          289 LLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~  306 (457)
                      ++++++ +.|+||+.+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.77  E-value=0.00065  Score=60.85  Aligned_cols=125  Identities=26%  Similarity=0.427  Sum_probs=87.5

Q ss_pred             cCCCCCceeccCCc-EEEEEEEEcCCcEEEEEEccc---Cch------------------HHHHHHHHHHHHHHhcC---
Q 012739          154 ENFSEGNVIGNGGF-GVVYKGVLSDGTVAAIKKLHR---DGK------------------QRERAFRMEVDLLSRLH---  208 (457)
Q Consensus       154 ~~~~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~---  208 (457)
                      .+++.++.||.|.- |.||+++. +|..+|+|.+..   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 99999998 777999999321   100                  11123667777776664   


Q ss_pred             CCCe--eeEEEEEEcC------------------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH
Q 012739          209 SPQL--VELLGYCADQ------------------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE  268 (457)
Q Consensus       209 hpni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~  268 (457)
                      +.++  |+++||..-.                  ....||.||.+...             .+...+    +.++.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHHH
Confidence            4566  8999987322                  12346777775433             123333    446777888


Q ss_pred             HHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       269 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .+|..|   |+=+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            999999   999999999986     3578999864

>PRK05231 homoserine kinase; Provisional

Probab=97.58  E-value=0.0022  Score=62.62  Aligned_cols=155  Identities=19%  Similarity=0.190  Sum_probs=81.2

Q ss_pred             HHHHHHhcCCCC-----CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CCeeeEEE--
Q 012739          147 KELETATENFSE-----GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQLVELLG--  217 (457)
Q Consensus       147 ~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~--  217 (457)
                      +++...-..|.+     .+.|+.|....+|+....+| .+++|+......   ..+..|+.+++.|..  -.+.+.+.  
T Consensus        10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~   85 (319)
T PRK05231         10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARR   85 (319)
T ss_pred             HHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCC
Confidence            344443344543     34566777789999887555 688887752222   223345555555521  11333332  


Q ss_pred             ----EEEcCCeEEEEEEeCCCCcHH-----------HHH---hhhCCC-------CCCCCH-HHHHH------------H
Q 012739          218 ----YCADQNHRLLISEYMPNGTLQ-----------QHL---HRHNNR-------YRPLDW-RTRLI------------I  259 (457)
Q Consensus       218 ----~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~~-------~~~l~~-~~~~~------------i  259 (457)
                          +....+..++++||++|..+.           +.|   +.....       ...+.| .+...            .
T Consensus        86 ~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (319)
T PRK05231         86 DGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAAL  165 (319)
T ss_pred             CCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHH
Confidence                123356678999999886431           111   111110       011112 11111            1


Q ss_pred             H-HHHHHHHHHHHhc----CCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          260 A-LDCAMALEFLHEH----ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       260 ~-~qi~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      . ..+...+..+...    -...++|+|+.|.||+++++...-|+||+.+.
T Consensus       166 l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        166 LEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            1 1111122333211    12349999999999999977666899999875

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.57  E-value=0.0023  Score=63.91  Aligned_cols=75  Identities=17%  Similarity=0.290  Sum_probs=52.0

Q ss_pred             ceeccCCcEEEEEEEEcCC-cEEEEEEcccC----c---hHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEE
Q 012739          160 NVIGNGGFGVVYKGVLSDG-TVAAIKKLHRD----G---KQRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~-~~vavK~l~~~----~---~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lv  228 (457)
                      +.||.|.+..||++...+| +.++||.-...    .   ....+.+..|.+.|+.+.   ..++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998776 48899974311    1   112345666778887763   2456777766  34557899


Q ss_pred             EEeCCCCc
Q 012739          229 SEYMPNGT  236 (457)
Q Consensus       229 ~e~~~~g~  236 (457)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.48  E-value=0.00072  Score=65.46  Aligned_cols=141  Identities=25%  Similarity=0.272  Sum_probs=80.9

Q ss_pred             ceeccCCcEEEEEEEEcC-------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSD-------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~  231 (457)
                      +.|..|-...+|+....+       ++.+++|...... ........|.+++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777999988654       4788888865542 222334668888888753333 345555432    368999


Q ss_pred             CCCCcHHHH-----------------HhhhCCCC-----CCCC--HHHHHH--------------------------HHH
Q 012739          232 MPNGTLQQH-----------------LHRHNNRY-----RPLD--WRTRLI--------------------------IAL  261 (457)
Q Consensus       232 ~~~g~L~~~-----------------l~~~~~~~-----~~l~--~~~~~~--------------------------i~~  261 (457)
                      ++|..+...                 ++......     ....  +..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988765421                 11111110     0111  111100                          111


Q ss_pred             HHHHHHHHHHh------cCCCCeEeccCccCceEeCCC----CcEEEeeccCcc
Q 012739          262 DCAMALEFLHE------HATPPVIHRDFKCSNVLLDQN----FRAKVTDFGLAK  305 (457)
Q Consensus       262 qi~~~l~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl~~  305 (457)
                      .+...+..|-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      123459999999999999885    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.40  E-value=0.004  Score=59.98  Aligned_cols=143  Identities=20%  Similarity=0.152  Sum_probs=83.8

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC--CeeeEEEE------EEcCCeEEEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP--QLVELLGY------CADQNHRLLISE  230 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e  230 (457)
                      .+.|..|....+|+....+ ..+++|+....   ....+..|+.++..+.+-  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778878999987644 46888887542   223456677777777432  24454432      233456789999


Q ss_pred             eCCCCcHHH-----------H---HhhhCCC-------CCCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 012739          231 YMPNGTLQQ-----------H---LHRHNNR-------YRPLDWRTRL----------IIALDCAMALEFLHEH----AT  275 (457)
Q Consensus       231 ~~~~g~L~~-----------~---l~~~~~~-------~~~l~~~~~~----------~i~~qi~~~l~~LH~~----~~  275 (457)
                      |++|..+..           .   ++.....       .....|....          .....+..++.++...    -.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866421           1   1111000       0111222111          0111233444555431    12


Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ..++|+|+.|.||++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998778999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0065  Score=58.96  Aligned_cols=156  Identities=16%  Similarity=0.199  Sum_probs=85.9

Q ss_pred             HHHHHHhcCCCC-----CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC--CeeeEEEE-
Q 012739          147 KELETATENFSE-----GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP--QLVELLGY-  218 (457)
Q Consensus       147 ~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~-  218 (457)
                      +++...-++|.+     .+.++.|....+|+....++ .+++|+......  ......|++++..|...  .+.+++.. 
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            444444444543     45677777789999876545 577787654321  22344566667666321  23444432 


Q ss_pred             -----EEcCCeEEEEEEeCCCCcHH-----------HH---HhhhCCCC----C----CCCHHHHH------------HH
Q 012739          219 -----CADQNHRLLISEYMPNGTLQ-----------QH---LHRHNNRY----R----PLDWRTRL------------II  259 (457)
Q Consensus       219 -----~~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~~~----~----~l~~~~~~------------~i  259 (457)
                           ....+..++++||++|..+.           ..   ++......    .    .-.|....            ..
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                 12245678999999885432           11   11111100    0    01111110            00


Q ss_pred             HHHHHHHHHHHHh----cCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          260 ALDCAMALEFLHE----HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       260 ~~qi~~~l~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ...+...++++..    .....++|+|+.+.||++++++...|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1123344555543    112349999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.38  E-value=0.0009  Score=64.01  Aligned_cols=75  Identities=16%  Similarity=0.263  Sum_probs=48.2

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +..+.++.|....+|+.. .+++.+.+|.-..   .....|..|.+-|+.|.   --.+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678989999999987 5788899997752   22345778888888883   3457788888877777899999988


Q ss_pred             CC
Q 012739          234 NG  235 (457)
Q Consensus       234 ~g  235 (457)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.31  E-value=8.8e-05  Score=82.48  Aligned_cols=162  Identities=14%  Similarity=0.056  Sum_probs=120.7

Q ss_pred             HHHHHHHHHhcCCCCeeeEEEEEE--cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012739          197 FRMEVDLLSRLHSPQLVELLGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA  274 (457)
Q Consensus       197 ~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  274 (457)
                      ...|...++...|+++.....-..  +..+.+.+++|+.+|.+.+.|-+.-.+..+++..-+.....+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            444666667778988776655442  344668999999999999999886666666665555444444355666655543


Q ss_pred             --CCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHH
Q 012739          275 --TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL  352 (457)
Q Consensus       275 --~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~el  352 (457)
                        ....+|+++|+-|.+|..+..++++++|+.+.....  ........+++.|+.|+....-.++.++|+|..|+-+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              234799999999999999999999999999833221  1223445678889999999888999999999999999999


Q ss_pred             HcCCCCCC
Q 012739          353 LTGRVPVD  360 (457)
Q Consensus       353 ltg~~p~~  360 (457)
                      ..|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            99888764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.02  E-value=0.0013  Score=62.61  Aligned_cols=147  Identities=22%  Similarity=0.212  Sum_probs=98.9

Q ss_pred             echHHHHHHhcC---CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC---------chH-----------H--HHHHH
Q 012739          144 FTYKELETATEN---FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD---------GKQ-----------R--ERAFR  198 (457)
Q Consensus       144 ~~~~~~~~~~~~---~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~---------~~~-----------~--~~~~~  198 (457)
                      +.|-.+.....+   +.+++.||-|--+.+|.+...+|++.++|.-...         .+.           .  .-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            344444444433   6778999999999999999999999998843211         000           0  01245


Q ss_pred             HHHHHHHhcCC--CCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 012739          199 MEVDLLSRLHS--PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP  276 (457)
Q Consensus       199 ~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~  276 (457)
                      .|...|+.|..  =-|.+.+++    +.-++|||++.+-.|.+.-+-       .+.   ..+...+..-+.-|...|  
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~---~~ly~~lm~~Iv~la~~G--  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDP---PTLYDDLMGLIVRLANHG--  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CCh---HHHHHHHHHHHHHHHHcC--
Confidence            68888888843  123444443    445899999988777653221       122   223345555566777788  


Q ss_pred             CeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                       +||+|..-=||++++++.++++||--+...
T Consensus       223 -lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             -ceecccchheeEEecCCCEEEeechHhhcc
Confidence             999999999999999999999999765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0082  Score=57.28  Aligned_cols=31  Identities=26%  Similarity=0.508  Sum_probs=25.9

Q ss_pred             CCeEeccCccCceEeCCCCc-EEEeeccCccc
Q 012739          276 PPVIHRDFKCSNVLLDQNFR-AKVTDFGLAKM  306 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfgl~~~  306 (457)
                      +.++|+|+.|.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35999999999999997554 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.00  E-value=0.0089  Score=57.73  Aligned_cols=139  Identities=16%  Similarity=0.267  Sum_probs=77.0

Q ss_pred             EEEEEEEEcCCcEEEEEEcc-cCchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCC--eEEEEEEeCCCCcHHHHHh
Q 012739          168 GVVYKGVLSDGTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQN--HRLLISEYMPNGTLQQHLH  242 (457)
Q Consensus       168 g~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~  242 (457)
                      -.+|.... +++.+++++-. ...........+|..+++.+.-  --+...+++|.++.  ..+.||+|++|..+.+.+.
T Consensus        39 n~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            34444443 37778888221 1222333445678888888853  23445667776655  6799999998743322111


Q ss_pred             hhCC----------------------------C-----CCCC-CHHHHHHH--------HHHHHHHHHHHHhcC-----C
Q 012739          243 RHNN----------------------------R-----YRPL-DWRTRLII--------ALDCAMALEFLHEHA-----T  275 (457)
Q Consensus       243 ~~~~----------------------------~-----~~~l-~~~~~~~i--------~~qi~~~l~~LH~~~-----~  275 (457)
                      ....                            +     ...+ .|......        .-....-..+|+...     .
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence            1000                            0     0000 01111100        001122234444322     3


Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      +.++|+|+.+.|+++++++.+-|.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            45999999999999999999999999998753

>PLN02236 choline kinase

Probab=96.97  E-value=0.0066  Score=59.93  Aligned_cols=142  Identities=13%  Similarity=0.148  Sum_probs=78.8

Q ss_pred             ceeccCCcEEEEEEEEcC-----CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCee-eEEEEEEcCCeEEEEEEeCC
Q 012739          160 NVIGNGGFGVVYKGVLSD-----GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-ELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +.|-.|-.-.+|+....+     +..+++|......... -.-.+|..+++.+..-++. ++++.+...    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345557778899987532     3678888775543211 1125688888888543333 455655332    5899997


Q ss_pred             CCcHHHH-----------------HhhhCCCC--CCCCHHHHHHHHHHH-----------------HHHHHHHH----h-
Q 012739          234 NGTLQQH-----------------LHRHNNRY--RPLDWRTRLIIALDC-----------------AMALEFLH----E-  272 (457)
Q Consensus       234 ~g~L~~~-----------------l~~~~~~~--~~l~~~~~~~i~~qi-----------------~~~l~~LH----~-  272 (457)
                      +.+|...                 ++......  .+..+.++..+..++                 ...+..|.    . 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 11111000  111223332332111                 11122221    1 


Q ss_pred             cCCCCeEeccCccCceEeCC-CCcEEEeeccCccc
Q 012739          273 HATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKM  306 (457)
Q Consensus       273 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~  306 (457)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11234899999999999976 47899999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.022  Score=55.87  Aligned_cols=73  Identities=18%  Similarity=0.248  Sum_probs=45.7

Q ss_pred             eeccCCcEEEEEEEEcCC-cEEEEEEccc-------CchHHHHHHHHHHHHHHhcC--CC-CeeeEEEEEEcCCeEEEEE
Q 012739          161 VIGNGGFGVVYKGVLSDG-TVAAIKKLHR-------DGKQRERAFRMEVDLLSRLH--SP-QLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       161 ~LG~G~~g~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~Ei~~l~~l~--hp-niv~l~~~~~~~~~~~lv~  229 (457)
                      .||.|....||++...++ +.++||.-..       .-.-......-|.+.|+...  -| .+.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999997654 5788885321       11122233455777776663  24 3444543  3445567999


Q ss_pred             EeCCCC
Q 012739          230 EYMPNG  235 (457)
Q Consensus       230 e~~~~g  235 (457)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.58  E-value=0.0037  Score=50.99  Aligned_cols=36  Identities=31%  Similarity=0.278  Sum_probs=24.1

Q ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 012739           40 ILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSS   75 (457)
Q Consensus        40 ~~~~~~~~~ii~~~~~~~~li~~~~~~~~~rr~~~~   75 (457)
                      .++...++.|+++|++++++++++++++++||+|+.
T Consensus        60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~   95 (122)
T PF01102_consen   60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKKS   95 (122)
T ss_dssp             SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred             CccccceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence            788888898988888888777665555555555553

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.57  E-value=0.1  Score=50.55  Aligned_cols=29  Identities=28%  Similarity=0.455  Sum_probs=25.0

Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            34899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.55  E-value=0.025  Score=55.03  Aligned_cols=140  Identities=17%  Similarity=0.199  Sum_probs=91.8

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEEEcccC-----chH-------------------H-HH-HHHHHHHHHHhcCCCC
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD-----GKQ-------------------R-ER-AFRMEVDLLSRLHSPQ  211 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~-----~~~-------------------~-~~-~~~~Ei~~l~~l~hpn  211 (457)
                      +...|..|--+.||.+...+|..+|||+.+..     .+.                   . .+ -...|++-|++++.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567788889999999999999999976421     000                   0 11 1345788888886544


Q ss_pred             eeeEEEEEEcCCeEEEEEEeCCCCcHHH-HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          212 LVELLGYCADQNHRLLISEYMPNGTLQQ-HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       212 iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      |...--+...  .-.|||+|+....-.. .|.     --.++...+..+-.|++.-|.-|...+.  +||.||.--|+|+
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE
Confidence            3221111111  2368999995322111 111     1236666778888888888888877654  9999999999998


Q ss_pred             CCCCcEEEeeccCcccc
Q 012739          291 DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~  307 (457)
                       .+|.+.|+|-+-+...
T Consensus       299 -hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             -ECCEEEEEEccccccC
Confidence             4668999998876543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.44  E-value=0.081  Score=52.94  Aligned_cols=73  Identities=18%  Similarity=0.206  Sum_probs=47.7

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccC----ch---HHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD----GK---QRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~----~~---~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lv  228 (457)
                      .+.||.|....||+... ++..++||.-...    +.   .....-..|.+.|+.+.   ..++.+++.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            46789999999999886 4556888865411    10   11222233566666553   3478888888774  45789


Q ss_pred             EEeCCC
Q 012739          229 SEYMPN  234 (457)
Q Consensus       229 ~e~~~~  234 (457)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=96.38  E-value=0.0077  Score=37.57  Aligned_cols=31  Identities=23%  Similarity=0.289  Sum_probs=17.8

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 012739           45 SIIIIIVSVISVIVLVALLLLVLMLRRLKSS   75 (457)
Q Consensus        45 ~~~~ii~~~~~~~~li~~~~~~~~~rr~~~~   75 (457)
                      +++.|++++++++++++++++.+.+++||.+
T Consensus         4 s~IaIIv~V~vg~~iiii~~~~YaCcykk~~   34 (38)
T PF02439_consen    4 STIAIIVAVVVGMAIIIICMFYYACCYKKHR   34 (38)
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence            4556666666666666666655555554443

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.31  E-value=0.11  Score=50.30  Aligned_cols=29  Identities=21%  Similarity=0.301  Sum_probs=26.9

Q ss_pred             CeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      .++|+|+.+.|||+++++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            49999999999999999999999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.23  E-value=0.012  Score=53.71  Aligned_cols=30  Identities=27%  Similarity=0.441  Sum_probs=21.5

Q ss_pred             CeEeccCccCceEe-CCCCcEEEeeccCccc
Q 012739          277 PVIHRDFKCSNVLL-DQNFRAKVTDFGLAKM  306 (457)
Q Consensus       277 ~ivH~Dlkp~NIll-~~~~~~kl~Dfgl~~~  306 (457)
                      .++|+|+.+.|||+ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            38999999999999 8899999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.21  E-value=0.067  Score=48.80  Aligned_cols=75  Identities=20%  Similarity=0.325  Sum_probs=52.9

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL---HSPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      +.+--|..-..|...+ +...+.+|+-.   ......|..|+.-|..|   +--++.+.+.+-.+.++.|+|+||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4455555555666554 56778888543   33445678887777766   44568888888899999999999998766


Q ss_pred             HH
Q 012739          237 LQ  238 (457)
Q Consensus       237 L~  238 (457)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.10  E-value=0.039  Score=54.11  Aligned_cols=142  Identities=15%  Similarity=0.225  Sum_probs=76.8

Q ss_pred             ceeccCCcEEEEEEEEcC----CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.|..|--..+|+....+    +..+++|....... ..-.-.+|..+++.+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345557677889887543    23788887754432 11123568888888865444 34555553 22   58999876


Q ss_pred             CcHHH--------------H---HhhhCCC-CC-CCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 012739          235 GTLQQ--------------H---LHRHNNR-YR-PLDWRTRLIIALDC----------------------AMALEFLH--  271 (457)
Q Consensus       235 g~L~~--------------~---l~~~~~~-~~-~l~~~~~~~i~~qi----------------------~~~l~~LH--  271 (457)
                      ..|..              .   ++..... .. +--|..+..+..++                      ..-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65421              0   1111100 01 11122222222111                      11111111  


Q ss_pred             --hcC-CCCeEeccCccCceEeCC-CCcEEEeeccCccc
Q 012739          272 --EHA-TPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKM  306 (457)
Q Consensus       272 --~~~-~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~  306 (457)
                        ..+ ...++|+|+.+.|||+++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              111 224899999999999975 57899999998753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.00  E-value=0.014  Score=58.92  Aligned_cols=50  Identities=16%  Similarity=0.242  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEcCC-eEEEEEEeCCCCcHHHHHhhhC
Q 012739          195 RAFRMEVDLLSRLHSPQLVELLGYCADQN-HRLLISEYMPNGTLQQHLHRHN  245 (457)
Q Consensus       195 ~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~  245 (457)
                      .++.-...+++.+.|+|....+++..... ...+|+|++ +.+|.+.+..+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            34566788899999999999998875543 456889998 789999887644

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.93  E-value=0.08  Score=51.67  Aligned_cols=140  Identities=24%  Similarity=0.303  Sum_probs=80.5

Q ss_pred             eccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC---CC---eeeEEEEE--EcC--CeEEEEEEe
Q 012739          162 IGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS---PQ---LVELLGYC--ADQ--NHRLLISEY  231 (457)
Q Consensus       162 LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---pn---iv~l~~~~--~~~--~~~~lv~e~  231 (457)
                      |.+ .-..+|+....+|.. ++|.....  ....++..|+..|..|.-   +=   +..+=|-.  .-.  ...+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 456799998877777 77777654  334456667777777732   21   22222211  122  377889999


Q ss_pred             CCCCcHHH------------H---HhhhCCC--------CCCCCHHH-------------HHHHHHHHHHHHHHHHhcC-
Q 012739          232 MPNGTLQQ------------H---LHRHNNR--------YRPLDWRT-------------RLIIALDCAMALEFLHEHA-  274 (457)
Q Consensus       232 ~~~g~L~~------------~---l~~~~~~--------~~~l~~~~-------------~~~i~~qi~~~l~~LH~~~-  274 (457)
                      ++|..+..            +   ++.....        .....|..             ......++...++.+.+.- 
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99887762            1   1111100        11122320             0112234444444444421 


Q ss_pred             ---CCC---eEeccCccCceEeCCCCc-EEEeeccCcc
Q 012739          275 ---TPP---VIHRDFKCSNVLLDQNFR-AKVTDFGLAK  305 (457)
Q Consensus       275 ---~~~---ivH~Dlkp~NIll~~~~~-~kl~Dfgl~~  305 (457)
                         ...   +||+|+.|.||+++.+.. +.+.|||-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               112   899999999999999885 8999999775

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.90  E-value=0.048  Score=54.24  Aligned_cols=74  Identities=18%  Similarity=0.255  Sum_probs=47.3

Q ss_pred             CceeccCCcEEEEEEEEcC-CcEEEEEEccc------CchHHHHHHHHHHHHHHhcC--CC-CeeeEEEEEEcCCeEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR------DGKQRERAFRMEVDLLSRLH--SP-QLVELLGYCADQNHRLLI  228 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~------~~~~~~~~~~~Ei~~l~~l~--hp-niv~l~~~~~~~~~~~lv  228 (457)
                      .+.||.|....||++...+ ++.++||.-..      +-.-..+...-|.+.|+...  .| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999743 56788884321      11222344556777777663  34 44455433  44556789


Q ss_pred             EEeCCC
Q 012739          229 SEYMPN  234 (457)
Q Consensus       229 ~e~~~~  234 (457)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.89  E-value=0.044  Score=49.67  Aligned_cols=152  Identities=16%  Similarity=0.113  Sum_probs=89.1

Q ss_pred             CCcEEEEEEEEcCCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhh
Q 012739          165 GGFGVVYKGVLSDGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR  243 (457)
Q Consensus       165 G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  243 (457)
                      |+-++...++.+-| ...+|++...... ....|..+.+++.+++  .|+++..-  +.-.+-+++|+|..-..      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            34444445444333 3455666544333 4455777888888875  46777622  33355689999843110      


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCC
Q 012739          244 HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT  323 (457)
Q Consensus       244 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  323 (457)
                             ....   .|..+ +.+|.-.|+.. ...+|+|-.|+||+-|.+|.+||.|-+..-.  .            +.
T Consensus       142 -------~~~N---~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V  195 (308)
T PF07387_consen  142 -------NFSN---FITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QV  195 (308)
T ss_pred             -------chhH---HHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------ee
Confidence                   1100   11111 46677888543 3499999999999999999999999875321  1            11


Q ss_pred             CccccccccCCCCCcccchHHHHHHHHHHHcCC
Q 012739          324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR  356 (457)
Q Consensus       324 ~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~  356 (457)
                      .|.--   .....+.++.+-+|=.-++++....
T Consensus       196 ~~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  196 NMVNI---EYESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             eEEee---eccccChHHHHHHHHHHHHHHHHHH
Confidence            12221   1123466777777777777776543

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.87  E-value=0.04  Score=53.58  Aligned_cols=74  Identities=19%  Similarity=0.267  Sum_probs=57.8

Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      ..+.|++|++. |+++...        +.-.+++++.++.+.+..++-+..+-  ++-|||+.-.||||+ +|.+-|+||
T Consensus       298 ~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             ceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            34567778876 5555432        12568899999999888888887643  489999999999999 999999999


Q ss_pred             cCcccc
Q 012739          302 GLAKMV  307 (457)
Q Consensus       302 gl~~~~  307 (457)
                      -+++.-
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.78  E-value=0.14  Score=49.29  Aligned_cols=71  Identities=14%  Similarity=0.157  Sum_probs=43.5

Q ss_pred             ccCCcEEEEEEEEcC---------CcEEEEEEcccCchH-----HHHHHHHHHHHHHhcC---------C----CCeeeE
Q 012739          163 GNGGFGVVYKGVLSD---------GTVAAIKKLHRDGKQ-----RERAFRMEVDLLSRLH---------S----PQLVEL  215 (457)
Q Consensus       163 G~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~---------h----pniv~l  215 (457)
                      |.|..|.+|++...-         ...++||....+...     ....|.+|+.+.+.+-         .    ....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            788899999987421         235788887633211     1245778887776551         1    223455


Q ss_pred             EEEEEcCCeEEEEEEeCC
Q 012739          216 LGYCADQNHRLLISEYMP  233 (457)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~  233 (457)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            555545556789998764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.58  E-value=0.29  Score=47.89  Aligned_cols=71  Identities=17%  Similarity=0.096  Sum_probs=43.8

Q ss_pred             CCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC--CeeeEE---E--EEEcCCeEEEEEEeCCCCc
Q 012739          165 GGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP--QLVELL---G--YCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       165 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~---~--~~~~~~~~~lv~e~~~~g~  236 (457)
                      +.-..||+....++..+++|..... .....++..|++.+..|...  .++...   |  ....++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4446799998878888999987532 22334566677777766321  122211   1  1233467788999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	457
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-33
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-19
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-19
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 114/295 (38%), Positives = 167/295 (56%), Gaps = 7/295 (2%)
Query: 139 GVVQVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQR-ERAF 197
           G ++ F+ +EL+ A++NFS             YKG L+DGT+ A+K+L  +  Q  E  F
Sbjct: 23  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQF 82
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + EV+++S      L+ L G+C     RLL+  YM NG++   L        PLDW  R 
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 142
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            IAL  A  L +LH+H  P +IHRD K +N+LLD+ F A V DFGLAK++ D  +  +  
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXX 201
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH--VLVSWAL 375
            V GT G++APEY STGK + K+DV+ YGV+LLEL+TG+   D  R   +   +L+ W  
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 376 PRLTSREEAVE-MVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
             L  +E+ +E +VD  LQG Y  +++        +C Q     RP M++VV+ L
Sbjct: 262 GLL--KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 111/295 (37%), Positives = 164/295 (55%), Gaps = 7/295 (2%)
Query: 139 GVVQVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQR-ERAF 197
           G ++ F+ +EL+ A++NF              YKG L+DG + A+K+L  +  Q  E  F
Sbjct: 15  GQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQF 74
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + EV+++S      L+ L G+C     RLL+  YM NG++   L        PLDW  R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            IAL  A  L +LH+H  P +IHRD K +N+LLD+ F A V DFGLAK++  K +  +  
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DXHVXX 193
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH--VLVSWAL 375
            V G  G++APEY STGK + K+DV+ YGV+LLEL+TG+   D  R   +   +L+ W  
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 376 PRLTSREEAVE-MVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
             L  +E+ +E +VD  LQG Y  +++        +C Q     RP M++VV+ L
Sbjct: 254 GLL--KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/282 (36%), Positives = 147/282 (52%), Gaps = 4/282 (1%)
Query: 148 ELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           +LE AT NF              YKGVL DG   A+K+   +  Q    F  E++ LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
             P LV L+G+C ++N  +LI +YM NG L++HL+  +     + W  RL I +  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            +LH  A   +IHRD K  N+LLD+NF  K+TDFG++K  ++     +   V GT GY+ 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
           PEY   G+LT KSDVYS+GVVL E+L  R  +  + P     L  WA+    +  +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQI 268
Query: 388 VDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
           VDP+L  +   + L         C+   +  RP M DV+  L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/282 (36%), Positives = 147/282 (52%), Gaps = 4/282 (1%)
Query: 148 ELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           +LE AT NF              YKGVL DG   A+K+   +  Q    F  E++ LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
             P LV L+G+C ++N  +LI +YM NG L++HL+  +     + W  RL I +  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            +LH  A   +IHRD K  N+LLD+NF  K+TDFG++K  ++     +   V GT GY+ 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
           PEY   G+LT KSDVYS+GVVL E+L  R  +  + P     L  WA+    +  +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQI 268
Query: 388 VDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSL 429
           VDP+L  +   + L         C+   +  RP M DV+  L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/232 (38%), Positives = 131/232 (56%), Gaps = 16/232 (6%)
Query: 144 FTYKELETATENFSEX------XXXXXXXXXXXYKGVLSDGTVAAIKKLHR----DGKQR 193
           F++ EL+  T NF E                  YKG +++ TVA +KKL        ++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVA-VKKLAAMVDITTEEL 73
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++ F  E+ ++++     LVELLG+ +D +   L+  YMPNG+L   L   +    PL W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 132
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
             R  IA   A  + FLHE+     IHRD K +N+LLD+ F AK++DFGLA+        
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
            + +R++GTT Y+APE A  G++T KSD+YS+GVVLLE++TG   VD +R P
Sbjct: 190 VMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/232 (38%), Positives = 130/232 (56%), Gaps = 16/232 (6%)
Query: 144 FTYKELETATENFSEX------XXXXXXXXXXXYKGVLSDGTVAAIKKLHR----DGKQR 193
           F++ EL+  T NF E                  YKG +++ TVA +KKL        ++ 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVA-VKKLAAMVDITTEEL 67
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++ F  E+ ++++     LVELLG+ +D +   L+  YMPNG+L   L   +    PL W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 126
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
             R  IA   A  + FLHE+     IHRD K +N+LLD+ F AK++DFGLA+        
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
            +  R++GTT Y+APE A  G++T KSD+YS+GVVLLE++TG   VD +R P
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/232 (38%), Positives = 130/232 (56%), Gaps = 16/232 (6%)
Query: 144 FTYKELETATENFSEX------XXXXXXXXXXXYKGVLSDGTVAAIKKLHR----DGKQR 193
           F++ EL+  T NF E                  YKG +++ TVA +KKL        ++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVA-VKKLAAMVDITTEEL 73
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++ F  E+ ++++     LVELLG+ +D +   L+  YMPNG+L   L   +    PL W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 132
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
             R  IA   A  + FLHE+     IHRD K +N+LLD+ F AK++DFGLA+        
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
            +  R++GTT Y+APE A  G++T KSD+YS+GVVLLE++TG   VD +R P
Sbjct: 190 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/232 (38%), Positives = 128/232 (55%), Gaps = 16/232 (6%)
Query: 144 FTYKELETATENFSEX------XXXXXXXXXXXYKGVLSDGTVAAIKKLHR----DGKQR 193
           F++ EL+  T NF E                  YKG +++ TVA +KKL        ++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVA-VKKLAAMVDITTEEL 64
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++ F  E+ + ++     LVELLG+ +D +   L+  Y PNG+L   L   +    PL W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPLSW 123
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
             R  IA   A  + FLHE+     IHRD K +N+LLD+ F AK++DFGLA+        
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
              +R++GTT Y APE A  G++T KSD+YS+GVVLLE++TG   VD +R P
Sbjct: 181 VXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 231

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/183 (35%), Positives = 98/183 (53%), Gaps = 6/183 (3%)
Query: 178 GTVAAIKKLHRDGKQRERA--FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G+  A+K L       ER   F  EV ++ RL  P +V  +G      +  +++EY+  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L + LH+   R + LD R RL +A D A  + +LH    PP++HRD K  N+L+D+ + 
Sbjct: 120 SLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYT 177
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            KV DFGL+++ +       S    GT  ++APE         KSDVYS+GV+L EL T 
Sbjct: 178 VKVCDFGLSRLKASXF--LXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 356 RVP 358
           + P
Sbjct: 236 QQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/183 (34%), Positives = 98/183 (53%), Gaps = 6/183 (3%)
Query: 178 GTVAAIKKLHRDGKQRERA--FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G+  A+K L       ER   F  EV ++ RL  P +V  +G      +  +++EY+  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L + LH+   R + LD R RL +A D A  + +LH    PP++HR+ K  N+L+D+ + 
Sbjct: 120 SLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            KV DFGL+++ +       S    GT  ++APE         KSDVYS+GV+L EL T 
Sbjct: 178 VKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 356 RVP 358
           + P
Sbjct: 236 QQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 25/201 (12%)
Query: 174 VLSDGTVAAIKKLHRDGKQRE-------RAFRMEVDLLSRLHSPQLVELLGYCADQNHRL 226
           ++ D +V AIK L     + E       + F+ EV ++S L+ P +V+L G     N   
Sbjct: 40  LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPR 97
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ E++P G L    HR  ++  P+ W  +L + LD A+ +E++ ++  PP++HRD +  
Sbjct: 98  MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSP 153
Query: 287 NVL---LDQN--FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY--ASTGKLTTK 339
           N+    LD+N    AKV DFGL++     ++G     +LG   ++APE   A     T K
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQQSVHSVSG-----LLGNFQWMAPETIGAEEESYTEK 208
Query: 340 SDVYSYGVVLLELLTGRVPVD 360
           +D YS+ ++L  +LTG  P D
Sbjct: 209 ADTYSFAMILYTILTGEGPFD 229

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + R+G   E  F  E +++ +L  P+LV+L G C +Q    L++E+M +G L  +
Sbjct: 35  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E     VIHRD    N L+ +N   KV+D
Sbjct: 94  LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD 147
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 148 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 206 YE-NRSNSEVV 215

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 25/201 (12%)
Query: 174 VLSDGTVAAIKKLHRDGKQRE-------RAFRMEVDLLSRLHSPQLVELLGYCADQNHRL 226
           ++ D +V AIK L     + E       + F+ EV ++S L+ P +V+L G     N   
Sbjct: 40  LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPR 97
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ E++P G L    HR  ++  P+ W  +L + LD A+ +E++ ++  PP++HRD +  
Sbjct: 98  MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSP 153
Query: 287 NVL---LDQN--FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY--ASTGKLTTK 339
           N+    LD+N    AKV DFG ++     ++G     +LG   ++APE   A     T K
Sbjct: 154 NIFLQSLDENAPVCAKVADFGTSQQSVHSVSG-----LLGNFQWMAPETIGAEEESYTEK 208
Query: 340 SDVYSYGVVLLELLTGRVPVD 360
           +D YS+ ++L  +LTG  P D
Sbjct: 209 ADTYSFAMILYTILTGEGPFD 229

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + R+G   E  F  E +++ +L  P+LV+L G C +Q    L+ E+M +G L  +
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E +   VIHRD    N L+ +N   KV+D
Sbjct: 93  LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSD 146
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 147 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 205 YE-NRSNSEVV 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C     R   LI EY+P G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 106 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 159
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 102 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 155
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C     R   LI EY+P G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 130 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 183
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + R+G   E  F  E +++ +L  P+LV+L G C +Q    L+ E+M +G L  +
Sbjct: 37  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E     VIHRD    N L+ +N   KV+D
Sbjct: 96  LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD 149
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 150 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 208 YE-NRSNSEVV 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C     R   LI EY+P G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 104 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 157
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 25/201 (12%)
Query: 174 VLSDGTVAAIKKLHRDGKQRE-------RAFRMEVDLLSRLHSPQLVELLGYCADQNHRL 226
           ++ D +V AIK L     + E       + F+ EV ++S L+ P +V+L G     N   
Sbjct: 40  LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPR 97
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ E++P G L    HR  ++  P+ W  +L + LD A+ +E++ ++  PP++HRD +  
Sbjct: 98  MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSP 153
Query: 287 NVL---LDQN--FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY--ASTGKLTTK 339
           N+    LD+N    AKV DF L++     ++G     +LG   ++APE   A     T K
Sbjct: 154 NIFLQSLDENAPVCAKVADFSLSQQSVHSVSG-----LLGNFQWMAPETIGAEEESYTEK 208
Query: 340 SDVYSYGVVLLELLTGRVPVD 360
           +D YS+ ++L  +LTG  P D
Sbjct: 209 ADTYSFAMILYTILTGEGPFD 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 105 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 158
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 152
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + R+G   E  F  E +++ +L  P+LV+L G C +Q    L+ E+M +G L  +
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E     VIHRD    N L+ +N   KV+D
Sbjct: 93  LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD 146
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 147 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 205 YE-NRSNSEVV 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 98  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 151
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + R+G   E  F  E +++ +L  P+LV+L G C +Q    L+ E+M +G L  +
Sbjct: 32  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E     VIHRD    N L+ +N   KV+D
Sbjct: 91  LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD 144
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 145 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 203 YE-NRSNSEVV 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 170
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 170
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 97  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 150
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 152
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 103 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 156
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI E++P G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+++L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 102 SLREYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 155
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG--YCADQNHRLLISEYMPNG 235
           G + A+K+L   G  ++R F+ E+ +L  LHS  +V+  G  Y   +    L+ EY+P+G
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L+  L RH  R   LD    L+ +      +E+L        +HRD    N+L++    
Sbjct: 96  CLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAH 149
Query: 296 AKVTDFGLAKMVS-DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGLAK++  DK    +         + APE  S    + +SDV+S+GVVL EL T
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG--YCADQNHRLLISEYMPNG 235
           G + A+K+L   G  ++R F+ E+ +L  LHS  +V+  G  Y   +    L+ EY+P+G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L+  L RH  R   LD    L+ +      +E+L    +   +HRD    N+L++    
Sbjct: 99  CLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAH 152
Query: 296 AKVTDFGLAKMVS-DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGLAK++  DK    +         + APE  S    + +SDV+S+GVVL EL T
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 152
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG--YCADQNHRLLISEYMPNG 235
           G + A+K+L   G  ++R F+ E+ +L  LHS  +V+  G  Y   +    L+ EY+P+G
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L+  L RH  R   LD    L+ +      +E+L    +   +HRD    N+L++    
Sbjct: 100 CLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAH 153
Query: 296 AKVTDFGLAKMVS-DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGLAK++  DK    +         + APE  S    + +SDV+S+GVVL EL T
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG--YCADQNHRLLISEYMPNG 235
           G + A+K+L   G  ++R F+ E+ +L  LHS  +V+  G  Y   +    L+ EY+P+G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L+  L RH  R   LD    L+ +      +E+L    +   +HRD    N+L++    
Sbjct: 112 CLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAH 165
Query: 296 AKVTDFGLAKMVS-DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGLAK++  DK    +         + APE  S    + +SDV+S+GVVL EL T
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 12/191 (6%)
Query: 181 AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
            AIK + ++G   E  F  E +++ +L  P+LV+L G C +Q    L+ E+M +G L  +
Sbjct: 54  VAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 112
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L      +      T L + LD    + +L E     VIHRD    N L+ +N   KV+D
Sbjct: 113 LRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD 166
Query: 301 FGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           FG+ + V  D+      T+      + +PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 167 FGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 224
Query: 359 VDPNRPPGEHV 369
            + NR   E V
Sbjct: 225 YE-NRSNSEVV 234

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G V  +K+L R  ++ +R F  EV ++  L  P +++ +G          I+EY+  GTL
Sbjct: 35  GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
           +  +   +++Y    W  R+  A D A  + +LH      +IHRD    N L+ +N    
Sbjct: 95  RGIIKSMDSQY---PWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVV 148
Query: 298 VTDFGLAKMVSDKINGQISTR------------VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           V DFGLA+++ D+       R            V+G   ++APE  +      K DV+S+
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 346 GVVLLELLTGRVPVDPNRPP 365
           G+VL E++ GRV  DP+  P
Sbjct: 209 GIVLCEII-GRVNADPDYLP 227

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC--ADQNHRLLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C  A + +  LI EY+P G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L  H  R   +D    L         +E+L    T   IHRD    N+L++   R
Sbjct: 102 SLRDYLQAHAER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENR 155
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPN 234
           G + A+K L  D G Q    ++ E+D+L  L+   +++  G C DQ  +   L+ EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+ +L RH+     L     L+ A      + +LH       IHR+    NVLLD + 
Sbjct: 103 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDNDR 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             K+ DFGLAK V +   G    RV         + APE     K    SDV+S+GV L 
Sbjct: 155 LVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 351 ELLTGRVPVDPNR-PPGEHV-LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXX 408
           ELLT     D ++ PP + + L+  A  ++T      E+++   +   P K         
Sbjct: 212 ELLTH---CDSSQSPPTKFLELIGIAQGQMTVL-RLTELLERGERLPRPDKCPCEVYHLM 267
Query: 409 XVCVQPEAAYRPLMTDVVQSLIPVVKN 435
             C + EA++RP      ++LIP++K 
Sbjct: 268 KNCWETEASFRP----TFENLIPILKT 290

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPN 234
           G + A+K L  D G Q    ++ E+D+L  L+   +++  G C DQ  +   L+ EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+ +L RH+     L     L+ A      + +LH       IHR+    NVLLD + 
Sbjct: 103 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDR 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             K+ DFGLAK V +   G    RV         + APE     K    SDV+S+GV L 
Sbjct: 155 LVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 351 ELLTGRVPVDPNR-PPGEHV-LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXX 408
           ELLT     D ++ PP + + L+  A  ++T      E+++   +   P K         
Sbjct: 212 ELLTH---CDSSQSPPTKFLELIGIAQGQMTVL-RLTELLERGERLPRPDKCPCEVYHLM 267
Query: 409 XVCVQPEAAYRPLMTDVVQSLIPVVKN 435
             C + EA++RP      ++LIP++K 
Sbjct: 268 KNCWETEASFRP----TFENLIPILKT 290

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPNG 235
           G V A+KKL    ++  R F  E+++L  L    +V+  G C     R   LI EY+P G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L+ +L +H  R   +D    L         +E+L    T   IHR+    N+L++   R
Sbjct: 100 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENR 153
Query: 296 AKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFGL K++  DK   ++         + APE  +  K +  SDV+S+GVVL EL T
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
           D  Q     R E  L + L  P ++ L G C  + +  L+ E+   G L + L     R 
Sbjct: 45  DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRI 102
Query: 249 RP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--------NFRAK 297
            P   ++W      A+  A  + +LH+ A  P+IHRD K SN+L+ Q        N   K
Sbjct: 103 PPDILVNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           +TDFGLA+    + +        G   ++APE       +  SDV+SYGV+L ELLTG V
Sbjct: 157 ITDFGLAR----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
Query: 358 P 358
           P
Sbjct: 213 P 213

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 130/286 (45%), Gaps = 36/286 (12%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN--HRLLISEYMPN 234
           G + A+K L  D G Q    ++ E+D+L  L+   +++  G C D       L+ EY+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+ +L RH+     L     L+ A      + +LH       IHRD    NVLLD + 
Sbjct: 120 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDR 171
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             K+ DFGLAK V +   G    RV         + APE     K    SDV+S+GV L 
Sbjct: 172 LVKIGDFGLAKAVPE---GHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 351 ELLTGRVPVDPNR-PPGEHV-LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXX 408
           ELLT     D ++ PP + + L+  A  ++T      E+++   +   P K         
Sbjct: 229 ELLTH---CDSSQSPPTKFLELIGIAQGQMTVL-RLTELLERGERLPRPDKCPAEVYHLM 284
Query: 409 XVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSRFQHQTPS 454
             C + EA++RP      ++LIP++K            ++Q Q PS
Sbjct: 285 KNCWETEASFRP----TFENLIPILKTV--------HEKYQGQAPS 318

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 14/234 (5%)
Query: 129 TTAYNYVRDKGVVQVFTYKELETATENFSEXXXXXXXXXXXXYKGVLSDGTVAAIKKLHR 188
           T   N +R +G      Y E+E +    S             YKG         I K+  
Sbjct: 13  TQEKNKIRPRGQRDSSYYWEIEASEVMLS--TRIGSGSFGTVYKGKWHGDVAVKILKVVD 70
Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
              ++ +AFR EV +L +     ++  +GY    N   +++++    +L +HLH    ++
Sbjct: 71  PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKF 129
Query: 249 RPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV 307
           +      +LI IA   A  +++LH      +IHRD K +N+ L +    K+ DFGLA + 
Sbjct: 130 QMF----QLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182
Query: 308 SDKINGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           S     Q   +  G+  ++APE          + +SDVYSYG+VL EL+TG +P
Sbjct: 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 90/178 (50%), Gaps = 10/178 (5%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E   + +L  P+LV+  G C+ +    +++EY+ NG L  +L  H
Sbjct: 38  KMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH 97
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
                P      L +  D    + FL  H     IHRD    N L+D++   KV+DFG+ 
Sbjct: 98  GKGLEP---SQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
           + V  D+    + T+      + APE     K ++KSDV+++G+++ E+ + G++P D
Sbjct: 152 RYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 284 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 341
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 395
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + +N   KV DFGLA+++ D    + + R        + APE A  G+ T KSDV+S+G+
Sbjct: 396 VGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 348 VLLELLT-GRVP 358
           +L EL T GRVP
Sbjct: 453 LLTELTTKGRVP 464

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 201 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 258
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 312
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + +N   KV DFGLA+++ D    + + R        + APE A  G+ T KSDV+S+G+
Sbjct: 313 VGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 348 VLLELLT-GRVP 358
           +L EL T GRVP
Sbjct: 370 LLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 201 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 258
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 312
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + +N   KV DFGLA+++ D    + + R        + APE A  G+ T KSDV+S+G+
Sbjct: 313 VGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 348 VLLELLT-GRVP 358
           +L EL T GRVP
Sbjct: 370 LLTELTTKGRVP 381

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++   + ++E
Sbjct: 25  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXI-VTE 82
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 83  YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 136
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 137 VGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 194
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 195 LTELTTKGRVP 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGLA+++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 28  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 85
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 86  YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 139
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 140 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 197
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 198 LTELTTKGRVP 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    ++ E
Sbjct: 201 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGE 258
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 312
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + +N   KV DFGLA+++ D    + + R        + APE A  G+ T KSDV+S+G+
Sbjct: 313 VGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 348 VLLELLT-GRVP 358
           +L EL T GRVP
Sbjct: 370 LLTELTTKGRVP 381

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           +LS +  P ++ + G   D     +I +Y+  G L   L +      P+        A +
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAE 114
Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
             +ALE+LH   +  +I+RD K  N+LLD+N   K+TDFG AK V D     ++  + GT
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGT 166
Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             Y+APE  ST       D +S+G+++ E+L G  P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 38  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 97
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 98  RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 151
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 152 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 209
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 210 TNSETAEHI 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 114 RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 168 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 226 TNSETAEHI 234

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 45  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 104
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 105 RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 158
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 159 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 216
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 217 TNSETAEHI 225

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++   ++I E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-E 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ EY+   TL+  +H       P+  +  + +  D   AL F H++    +IHRD K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           N+L+      KV DFG+A+ ++D  N    T  V+GT  YL+PE A    +  +SDVYS 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 346 GVVLLELLTGRVPVDPNRP 364
           G VL E+LTG  P   + P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 39  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 98
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 99  RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 153 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 211 TNSETAEHI 219

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++   ++I E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-E 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 16/184 (8%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGT 236
           G   A+K +  D   +  AF  E  ++++L    LV+LLG   ++   L +++EYM  G+
Sbjct: 216 GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L  +L          D    L  +LD   A+E+L  +     +HRD    NVL+ ++  A
Sbjct: 274 LVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 328
Query: 297 KVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           KV+DFGL K  S  +  G++  +      + APE     K +TKSDV+S+G++L E+ + 
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSF 382
Query: 355 GRVP 358
           GRVP
Sbjct: 383 GRVP 386

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 24  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 81
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 82  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 135
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 136 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 193
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 194 LTELTTKGRVP 204

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 34  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 93
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 94  RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 148 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 206 TNSETAEHI 214

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 28  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 86
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 87  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 141
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 142 VGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 349 LLELLT-GRVP---VDPNR 363
           L E+ T G  P   +DP++
Sbjct: 200 LWEIATYGMSPYPGIDPSQ 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 32  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 89
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 90  YMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN------YVHRDLRAANIL 143
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 144 VGENLVCKVADFGLARLIEDNEWTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 202 LTELTTKGRVP 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 16/184 (8%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGT 236
           G   A+K +  D   +  AF  E  ++++L    LV+LLG   ++   L +++EYM  G+
Sbjct: 44  GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L  +L          D    L  +LD   A+E+L  +     +HRD    NVL+ ++  A
Sbjct: 102 LVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 156
Query: 297 KVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           KV+DFGL K  S  +  G++  +      + APE     K +TKSDV+S+G++L E+ + 
Sbjct: 157 KVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSF 210
Query: 355 GRVP 358
           GRVP
Sbjct: 211 GRVP 214

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 26  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 83
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 84  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 137
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 138 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 196 LTELTTKGRVP 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 32  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 89
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 90  YMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN------YVHRDLRAANIL 143
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 144 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 202 LTELTTKGRVP 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHR----LLISEYMPNGTLQQHLHRHNNRYRPLD 252
           FR E    + L+ P +V +      +        ++ EY+   TL+  +H       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMT 114
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
            +  + +  D   AL F H++    +IHRD K +N+++      KV DFG+A+ ++D  N
Sbjct: 115 PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 313 GQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
               T  V+GT  YL+PE A    +  +SDVYS G VL E+LTG  P   + P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 114 RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
Query: 305 KMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD-- 360
           + V  D+    + ++      +  PE     K ++KSD++++GV++ E+ + G++P +  
Sbjct: 168 RYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
Query: 361 PNRPPGEHV 369
            N    EH+
Sbjct: 226 TNSETAEHI 234

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 11/186 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV +  +L  P ++EL  Y  D N+  L+ E   NG + ++L    NR +P         
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHF 117
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
                  + +LH H    ++HRD   SN+LL +N   K+ DFGLA  +  K+  +    +
Sbjct: 118 MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTL 172
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN---RPPGEHVLVSWALP 376
            GT  Y++PE A+      +SDV+S G +   LL GR P D +       + VL  + +P
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232
Query: 377 RLTSRE 382
              S E
Sbjct: 233 SFLSIE 238

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ EY+   TL+  +H       P+  +  + +  D   AL F H++    +IHRD K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           N+++      KV DFG+A+ ++D  N    T  V+GT  YL+PE A    +  +SDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 346 GVVLLELLTGRVPVDPNRP 364
           G VL E+LTG  P   + P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL +++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ EY+   TL+  +H       P+  +  + +  D   AL F H++    +IHRD K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           N+++      KV DFG+A+ ++D  N    T  V+GT  YL+PE A    +  +SDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 346 GVVLLELLTGRVPVDPNRP 364
           G VL E+LTG  P   + P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 182 AIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL 241
           AIK++  + +++  AF +E+  LSR++ P +V+L G C   N   L+ EY   G+L   L
Sbjct: 36  AIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL 91
Query: 242 HRHNNRYRPLDWRTR---LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA-K 297
           H       PL + T    +   L C+  + +LH      +IHRD K  N+LL       K
Sbjct: 92  HGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 147
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFG A  +   +     T   G+  ++APE       + K DV+S+G++L E++T R 
Sbjct: 148 ICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 358 PVDPNRPPGEHVLVSWAL 375
           P D    P   ++  WA+
Sbjct: 203 PFDEIGGPAFRIM--WAV 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ EY+   TL+  +H       P+  +  + +  D   AL F H++    +IHRD K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           N+++      KV DFG+A+ ++D  N    T  V+GT  YL+PE A    +  +SDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 346 GVVLLELLTGRVPVDPNRP 364
           G VL E+LTG  P   + P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 86  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 145 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 197
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 198 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 249
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 250 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 300
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 301 ILDKLIRN 308

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 16/184 (8%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGT 236
           G   A+K +  D   +  AF  E  ++++L    LV+LLG   ++   L +++EYM  G+
Sbjct: 29  GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L  +L          D    L  +LD   A+E+L  +     +HRD    NVL+ ++  A
Sbjct: 87  LVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 141
Query: 297 KVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           KV+DFGL K  S  +  G++  +      + APE     K +TKSDV+S+G++L E+ + 
Sbjct: 142 KVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSF 195
Query: 355 GRVP 358
           GRVP
Sbjct: 196 GRVP 199

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 28  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 86
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 87  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 141
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 142 VGENHLVKVADFGLSRLMT----GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 197
Query: 347 VVLLELLT-GRVP---VDPNR 363
           V+L E+ T G  P   +DP++
Sbjct: 198 VLLWEIATYGMSPYPGIDPSQ 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ ++   +LV+L    +++    +++E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIVTE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    ++ E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVCE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 202 WMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 259
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 260 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 313
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + +N   KV DFGL +++ D    + + R        + APE A  G+ T KSDV+S+G+
Sbjct: 314 VGENLVCKVADFGLGRLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 370
Query: 348 VLLELLT-GRVP 358
           +L EL T GRVP
Sbjct: 371 LLTELTTKGRVP 382

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 59  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 117
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 118 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 182 AIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL 241
           AIK++  + +++  AF +E+  LSR++ P +V+L G C   N   L+ EY   G+L   L
Sbjct: 35  AIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL 90
Query: 242 HRHNNRYRPLDWRTR---LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA-K 297
           H       PL + T    +   L C+  + +LH      +IHRD K  N+LL       K
Sbjct: 91  HGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFG A  +   +     T   G+  ++APE       + K DV+S+G++L E++T R 
Sbjct: 147 ICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 358 PVDPNRPPGEHVLVSWAL 375
           P D    P   ++  WA+
Sbjct: 202 PFDEIGGPAFRIM--WAV 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +H+ ++  
Sbjct: 76  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 134
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 135 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++
Sbjct: 188 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 32  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 90
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 91  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 145
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 146 VGENHLVKVADFGLSRLMT----GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201
Query: 347 VVLLELLT 354
           V+L E+ T
Sbjct: 202 VLLWEIAT 209

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 35  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 93
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 94  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 149 VGENHLVKVADFGLSRLMT----GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204
Query: 347 VVLLELLT 354
           V+L E+ T
Sbjct: 205 VLLWEIAT 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    +++E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L     +Y  L     +   +   MA +E ++       +HRD   +N+L
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLAAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 31  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 89
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 90  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 144
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 145 VGENHLVKVADFGLSRLMT----GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 200
Query: 347 VVLLELLT 354
           V+L E+ T
Sbjct: 201 VLLWEIAT 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 35  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 93
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 94  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 349 LLELLT 354
           L E+ T
Sbjct: 207 LWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 35  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 93
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 94  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 349 LLELLT 354
           L E+ T
Sbjct: 207 LWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 34  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 93  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 147
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 205
Query: 349 LLELLT 354
           L E+ T
Sbjct: 206 LWEIAT 211

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K+ ++G   E  F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L   
Sbjct: 39  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 98
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
            +R++    +  L +  D   A+E+L    +   +HRD    N L++     KV+DFGL+
Sbjct: 99  RHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 305 KMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
           + V D  +   S+R  G+     +  PE     K ++KSD++++GV++ E+ + G++P +
Sbjct: 153 RYVLD--DEYTSSR--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208
Query: 361 --PNRPPGEHV 369
              N    EH+
Sbjct: 209 RFTNSETAEHI 219

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           ++ EY+   TL+  +H       P+  +  + +  D   AL F H++    +IHRD K +
Sbjct: 110 IVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 162
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLAPEYASTGKLTTKSDVYSY 345
           N+++      KV DFG+A+ ++D  N    T  V+GT  YL+PE A    +  +SDVYS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 346 GVVLLELLTGRVPVDPNRP 364
           G VL E+LTG  P   + P
Sbjct: 223 GCVLYEVLTGEPPFTGDSP 241

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 30  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 88  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 142
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 143 SDTLSCKIADFGLARLIED---AEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 32  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 90
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 91  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 145
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 349 LLELLT 354
           L E+ T
Sbjct: 204 LWEIAT 209

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 38  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 95
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 96  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 150
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 151 SDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 207
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 208 LTEIVTHGRIP 218

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 30/268 (11%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPN 234
           G + A+K L    G Q    ++ E+++L  L+   +V+  G C DQ  +   L+ EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+ +L RH      L     L+ A      + +LH       IHR     NVLLD + 
Sbjct: 98  GSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDR 149
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             K+ DFGLAK V +   G    RV         + APE     K    SDV+S+GV L 
Sbjct: 150 LVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLY 206
Query: 351 ELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ-YPKKDLXXXXXXXX 409
           ELLT     D N+ P  H   +  +     +   + + +   +G+  P+ D         
Sbjct: 207 ELLT---YCDSNQSP--HTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHL 261
Query: 410 V--CVQPEAAYRPLMTDVVQSLIPVVKN 435
           +  C + EA++RP      Q+L+P+++ 
Sbjct: 262 MKNCWETEASFRP----TFQNLVPILQT 285

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 40  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 97
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 98  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 152
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 153 SDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 209
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 210 LTEIVTHGRIP 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 30/268 (11%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLISEYMPN 234
           G + A+K L    G Q    ++ E+++L  L+   +V+  G C DQ  +   L+ EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+ +L RH      L     L+ A      + +LH       IHR     NVLLD + 
Sbjct: 97  GSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDR 148
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVL----GTTGYLAPEYASTGKLTTKSDVYSYGVVLL 350
             K+ DFGLAK V +   G    RV         + APE     K    SDV+S+GV L 
Sbjct: 149 LVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLY 205
Query: 351 ELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ-YPKKDLXXXXXXXX 409
           ELLT     D N+ P  H   +  +     +   + + +   +G+  P+ D         
Sbjct: 206 ELLT---YCDSNQSP--HTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHL 260
Query: 410 V--CVQPEAAYRPLMTDVVQSLIPVVKN 435
           +  C + EA++RP      Q+L+P+++ 
Sbjct: 261 MKNCWETEASFRP----TFQNLVPILQT 284

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 36  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 93
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 94  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 148
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 149 SDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 206 LTEIVTHGRIP 216

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 32  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 90
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 91  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 145
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 349 LLELLT 354
           L E+ T
Sbjct: 204 LWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 43  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 101
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 102 EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 156
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 157 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 214
Query: 349 LLELLT 354
           L E+ T
Sbjct: 215 LWEIAT 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 30  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 88  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 142
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 143 SDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 45/279 (16%)
Query: 171 YKGVLSDGTV-----AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNH 224
           YKG+L   +       AIK L     +++R  F  E  ++ +     ++ L G  +    
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDF 283
            ++I+EYM NG L + L   +  +  L    +L+  L   A  +++L   A    +HRD 
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVL----QLVGMLRGIAAGMKYL---ANMNYVHRDL 173
Query: 284 KCSNVLLDQNFRAKVTDFGLAKMVSDK-------INGQISTRVLGTTGYLAPEYASTGKL 336
              N+L++ N   KV+DFGL++++ D          G+I  R      + APE  S  K 
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAPEAISYRKF 227
Query: 337 TTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
           T+ SDV+S+G+V+ E++T G  P              W L    S  E ++ ++   +  
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPY-------------WEL----SNHEVMKAINDGFRLP 270
Query: 396 YPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVK 434
            P             C Q E A RP   D+V  L  +++
Sbjct: 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 39  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 96
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 97  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 151
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 152 SDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 208
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 209 LTEIVTHGRIP 219

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 16/184 (8%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGT 236
           G   A+K +  D   +  AF  E  ++++L    LV+LLG   ++   L +++EYM  G+
Sbjct: 35  GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 92
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L  +L          D    L  +LD   A+E+L  +     +HRD    NVL+ ++  A
Sbjct: 93  LVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 147
Query: 297 KVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           KV+DFGL K  S  +  G++  +      + APE       +TKSDV+S+G++L E+ + 
Sbjct: 148 KVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSDVWSFGILLWEIYSF 201
Query: 355 GRVP 358
           GRVP
Sbjct: 202 GRVP 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I 
Sbjct: 28  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIII 86
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 87  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 141
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 142 VGENHLVKVADFGLSRLMT----GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 197
Query: 347 VVLLELLT-GRVP---VDPNR 363
           V+L E+ T G  P   +DP++
Sbjct: 198 VLLWEIATYGMSPYPGIDPSQ 218

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 177 DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           D  + A+K L    +   + F+ E +LL+ L    +V   G C +    L++ EYM +G 
Sbjct: 70  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 237 LQQHLHRHNNRYR-----------PLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
           L + L  H    +           PL     L +A   A  + +L   A    +HRD   
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLAT 186
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N L+ Q    K+ DFG+++ +      ++  R +    ++ PE     K TT+SDV+S+
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 346 GVVLLELLT-GRVP 358
           GVVL E+ T G+ P
Sbjct: 247 GVVLWEIFTYGKQP 260

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 36  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 93
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 94  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 148
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 149 SDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 206 LTEIVTHGRIP 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     AF  E  ++ +L   +LV+L    +++    ++ E
Sbjct: 35  WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVME 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA-LEFLHEHATPPVIHRDFKCSNVL 289
           YM  G L   L     +Y  L     +   +   MA +E ++       +HRD + +N+L
Sbjct: 93  YMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN------YVHRDLRAANIL 146
Query: 290 LDQNFRAKVTDFGLAKMVSD-KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGLA+++ D +   +   +      + APE A  G+ T KSDV+S+G++
Sbjct: 147 VGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L EL T GRVP
Sbjct: 205 LTELTTKGRVP 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 32  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 89
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 90  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 144
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 145 SDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 201
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 202 LTEIVTHGRIP 212

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 35  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 92
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 93  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 147
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 148 SDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 204
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 205 LTEIVTHGRIP 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 31  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 88
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 89  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 143
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 144 SDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 200
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 201 LTEIVTHGRIP 211

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 35  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 93
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 94  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 349 LLELLT 354
           L E+ T
Sbjct: 207 LWEIAT 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 30  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 88  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 142
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 143 SDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 30  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     ++    L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 88  YMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 142
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 143 SDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 276 YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 334
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHR+    N L
Sbjct: 335 EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCL 389
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 390 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 447
Query: 349 LLELLT 354
           L E+ T
Sbjct: 448 LWEIAT 453

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
            D  + A+K L    +   + F+ E +LL+ L    +V   G C +    L++ EYM +G
Sbjct: 46  QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 105
Query: 236 TLQQHLHRHNNRYR-----------PLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK 284
            L + L  H    +           PL     L +A   A  + +L   A    +HRD  
Sbjct: 106 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLA 162
Query: 285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYS 344
             N L+ Q    K+ DFG+++ +      ++  R +    ++ PE     K TT+SDV+S
Sbjct: 163 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 222
Query: 345 YGVVLLELLT-GRVP 358
           +GVVL E+ T G+ P
Sbjct: 223 FGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
            D  + A+K L    +   + F+ E +LL+ L    +V   G C +    L++ EYM +G
Sbjct: 40  QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 99
Query: 236 TLQQHLHRHNNRYR-----------PLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK 284
            L + L  H    +           PL     L +A   A  + +L   A    +HRD  
Sbjct: 100 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLA 156
Query: 285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYS 344
             N L+ Q    K+ DFG+++ +      ++  R +    ++ PE     K TT+SDV+S
Sbjct: 157 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 216
Query: 345 YGVVLLELLT-GRVP 358
           +GVVL E+ T G+ P
Sbjct: 217 FGVVLWEIFTYGKQP 231

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 25  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 82
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     L     L +A   A  + F+ E      IHRD + +N+L+
Sbjct: 83  YMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 137
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 138 SDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 194
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 195 LTEIVTHGRIP 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I 
Sbjct: 31  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIII 89
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 90  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 144
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYG 346
           + +N   KV DFGL+++++    G   T   G      + APE  +  K + KSDV+++G
Sbjct: 145 VGENHLVKVADFGLSRLMT----GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 200
Query: 347 VVLLELLT 354
           V+L E+ T
Sbjct: 201 VLLWEIAT 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 178 GTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLV------ELLGYCADQNHRLLIS 229
           G   AIK+  ++   K RER + +E+ ++ +L+ P +V      + L   A  +  LL  
Sbjct: 40  GEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 98
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EY   G L+++L++  N     +   R +++ D + AL +LHE+    +IHRD K  N++
Sbjct: 99  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR---IIHRDLKPENIV 154
Query: 290 LD---QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           L    Q    K+ D G AK +     G++ T  +GT  YLAPE     K T   D +S+G
Sbjct: 155 LQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 211
Query: 347 VVLLELLTGRVPVDPNRPP 365
            +  E +TG  P  PN  P
Sbjct: 212 TLAFECITGFRPFLPNWQP 230

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 178 GTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLV------ELLGYCADQNHRLLIS 229
           G   AIK+  ++   K RER + +E+ ++ +L+ P +V      + L   A  +  LL  
Sbjct: 39  GEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EY   G L+++L++  N     +   R +++ D + AL +LHE+    +IHRD K  N++
Sbjct: 98  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR---IIHRDLKPENIV 153
Query: 290 LD---QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           L    Q    K+ D G AK +     G++ T  +GT  YLAPE     K T   D +S+G
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 347 VVLLELLTGRVPVDPNRPP 365
            +  E +TG  P  PN  P
Sbjct: 211 TLAFECITGFRPFLPNWQP 229

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 91/186 (48%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +++
Sbjct: 49  YVGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVT 107
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EYMP G L  +L R  NR   +     L +A   + A+E+L +      IHRD    N L
Sbjct: 108 EYMPYGNLLDYL-RECNR-EEVTAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 162
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +    + KSDV+++GV+
Sbjct: 163 VGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNTFSIKSDVWAFGVL 220
Query: 349 LLELLT 354
           L E+ T
Sbjct: 221 LWEIAT 226

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I 
Sbjct: 35  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIII 93
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + ++    L +A   + A+E+L +      IHRD    N L
Sbjct: 94  EFMTYGNLLDYL-RECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 349 LLELLT 354
           L E+ T
Sbjct: 207 LWEIAT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I+
Sbjct: 237 YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHR+    N L
Sbjct: 296 EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCL 350
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 351 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 349 LLELLT 354
           L E+ T
Sbjct: 409 LWEIAT 414

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++I+EYM NG+L   L +++ R+  
Sbjct: 72  KQR-RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 130
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L      +++L + +    +HRD    N+L++ N   KV+DFG+++++ D
Sbjct: 131 I----QLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + APE  +  K T+ SDV+SYG+V+ E+++
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++E M NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
            AIK L     +++R  F  E  ++ +   P ++ L G        ++I+E+M NG+L  
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 240 HLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            L +++ ++  +    +L+  L   A  +++L   A    +HRD    N+L++ N   KV
Sbjct: 124 FLRQNDGQFTVI----QLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKV 176
Query: 299 TDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           +DFGL++ + D  +    T  LG      + APE     K T+ SDV+SYG+V+ E+++
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I 
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIII 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 10/186 (5%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           Y+GV    ++  A+K L  D  + E  F  E  ++  +  P LV+LLG C  +    +I 
Sbjct: 30  YEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIII 88
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+M  G L  +L R  NR + +     L +A   + A+E+L +      IHRD    N L
Sbjct: 89  EFMTYGNLLDYL-RECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 290 LDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           + +N   KV DFGL++ M  D        +      + APE  +  K + KSDV+++GV+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 349 LLELLT 354
           L E+ T
Sbjct: 202 LWEIAT 207

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 28/248 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++E M NG+L   L +H+ ++  
Sbjct: 88  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 147 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++ G  P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------- 251
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    S ++ ++ VD   +   P             C Q +   RP    +V 
Sbjct: 252 -----WEM----SNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 428 SLIPVVKN 435
            L  +++N
Sbjct: 303 ILDKLIRN 310

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 180 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 231
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 292 RGAPPYPD 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 121 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 233 RGAPPYPD 240

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 121 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 233 RGAPPYPD 240

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 66  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 125
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 126 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 177
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 178 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 238 RGAPPYPD 245

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 62  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 121
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 122 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 174 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 234 RGAPPYPD 241

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  A+K L + G     AF  E +L+ +L   +LV L      Q    +I+E
Sbjct: 26  WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITE 83
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM NG+L   L   +     L     L +A   A  + F+ E      IHR+ + +N+L+
Sbjct: 84  YMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANILV 138
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++
Sbjct: 139 SDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 195
Query: 349 LLELLT-GRVP 358
           L E++T GR+P
Sbjct: 196 LTEIVTHGRIP 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 59  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 118
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 119 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 171 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 231 RGAPPYPD 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 88/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++E M NG+L   L +H+ ++  
Sbjct: 59  KQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 117
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 118 I----QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + +PE  +  K T+ SDV+SYG+VL E+++
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 62  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 121
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  ++FL   A+   +HRD    N +LD+ F  
Sbjct: 122 NFIRNETHNPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 174 KVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 234 RGAPPYPD 241

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++I+EYM NG+L   L +++ R+  
Sbjct: 57  KQR-RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 115
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L      +++L + +    +HRD    N+L++ N   KV+DFG+++++ D
Sbjct: 116 I----QLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLED 168
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + APE  +  K T+ SDV+SYG+V+ E+++
Sbjct: 169 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++I+EYM NG+L   L +++ R+  
Sbjct: 51  KQR-RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 109
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L      +++L + +    +HRD    N+L++ N   KV+DFG+++++ D
Sbjct: 110 I----QLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLED 162
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                 +TR       + APE  +  K T+ SDV+SYG+V+ E+++
Sbjct: 163 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P ++ L G        ++++EYM NG+L   L +++ ++  
Sbjct: 65  KQR-RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   +  +++L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 124 I----QLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 310 KINGQISTRVLGT-TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 +TR       + APE  +  K T+ SDV+SYG+V+ E+++ G  P         
Sbjct: 177 DPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY-------- 228
Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
                W +    + ++ ++ V+   +   P             C Q E   RP   ++V 
Sbjct: 229 -----WEM----TNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVN 279
Query: 428 SLIPVVKNNA 437
            L  +++N A
Sbjct: 280 MLDKLIRNPA 289

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           KQR R F  E  ++ +   P +V L G        +++ E+M NG L   L +H+ ++  
Sbjct: 86  KQR-RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 251 LDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           +    +L+  L   A  + +L +      +HRD    N+L++ N   KV+DFGL++++ D
Sbjct: 145 I----QLVGMLRGIAAGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIED 197
Query: 310 K-------INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDP 361
                     G+I  R      + APE     K T+ SDV+SYG+V+ E+++ G  P   
Sbjct: 198 DPEAVYTTTGGKIPVR------WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-- 249
Query: 362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPL 421
                      W +    S ++ ++ ++   +   P             C Q E A RP 
Sbjct: 250 -----------WDM----SNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPK 294
Query: 422 MTDVVQSLIPVVKN 435
              +V  L  +++N
Sbjct: 295 FEQIVGILDKMIRN 308

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  +  T  AIK L + G     +F  E  ++ +L   +LV+L    +++    +++E
Sbjct: 26  WMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPI-YIVTE 83
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL 290
           YM  G+L   L   +   R L     + +A   A  + ++        IHRD + +N+L+
Sbjct: 84  YMNKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILV 138
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVV 348
                 K+ DFGLA+++ D    + + R        + APE A  G+ T KSDV+S+G++
Sbjct: 139 GNGLICKIADFGLARLIEDN---EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 349 LLELLT-GRVP 358
           L EL+T GRVP
Sbjct: 196 LTELVTKGRVP 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           +  AIK L     +R+R  F  E  ++ +   P ++ L G   +    ++++E+M NG L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 238 QQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
              L  ++ ++  +    +L+  L   A  + +L E +    +HRD    N+L++ N   
Sbjct: 105 DSFLRLNDGQFTVI----QLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVC 157
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           KV+DFGL++ + +  +    T  LG      + APE  +  K T+ SD +SYG+V+ E++
Sbjct: 158 KVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217
Query: 354 T 354
           +
Sbjct: 218 S 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 51  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 110 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 162
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 163 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 26/191 (13%)
Query: 181 AAIKKLHR-DGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           AAIK++     K   R F  E+++L +L H P ++ LLG C  + +  L  EY P+G L 
Sbjct: 45  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 104
Query: 239 QHLHRH------------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
             L +             N+    L  +  L  A D A  +++L +      IHRD    
Sbjct: 105 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 161
Query: 287 NVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVY 343
           N+L+ +N+ AK+ DFGL++   +   K  G++  R      ++A E  +    TT SDV+
Sbjct: 162 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVW 215
Query: 344 SYGVVLLELLT 354
           SYGV+L E+++
Sbjct: 216 SYGVLLWEIVS 226

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 51  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 110 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 162
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 163 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 93/170 (54%), Gaps = 10/170 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++   
Sbjct: 50  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETKF--- 105
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           + +  + IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S   
Sbjct: 106 EMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWS 162
Query: 312 NGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 ++ G+  ++APE      +   + +SDVY++G+VL EL+TG++P
Sbjct: 163 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 48  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 106
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 107 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 159
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 160 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 26/191 (13%)
Query: 181 AAIKKLHR-DGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           AAIK++     K   R F  E+++L +L H P ++ LLG C  + +  L  EY P+G L 
Sbjct: 55  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 239 QHLHRH------------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
             L +             N+    L  +  L  A D A  +++L +      IHRD    
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 171
Query: 287 NVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVY 343
           N+L+ +N+ AK+ DFGL++   +   K  G++  R      ++A E  +    TT SDV+
Sbjct: 172 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVW 225
Query: 344 SYGVVLLELLT 354
           SYGV+L E+++
Sbjct: 226 SYGVLLWEIVS 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 60  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 119
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 120 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 172 KVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 232 RGAPPYPD 239

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 105 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 18/179 (10%)
Query: 182 AIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
           AIK L     +R+R  F  E  ++ +   P ++ L G        ++++EYM NG+L   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 241 LHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           L  H+ ++  +    +L+  L      + +L +      +HRD    NVL+D N   KV+
Sbjct: 141 LRTHDGQFTIM----QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVS 193
Query: 300 DFGLAKMVSDKINGQISTRVLGTTG-----YLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           DFGL++++ D  +   +T    T G     + APE  +    ++ SDV+S+GVV+ E+L
Sbjct: 194 DFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 18/179 (10%)
Query: 182 AIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
           AIK L     +R+R  F  E  ++ +   P ++ L G        ++++EYM NG+L   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 241 LHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           L  H+ ++  +    +L+  L      + +L +      +HRD    NVL+D N   KV+
Sbjct: 141 LRTHDGQFTIM----QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVS 193
Query: 300 DFGLAKMVSDKINGQISTRVLGTTG-----YLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           DFGL++++ D  +   +T    T G     + APE  +    ++ SDV+S+GVV+ E+L
Sbjct: 194 DFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 133 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 185
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           +  AIK L     +R+R  F  E  ++ +   P ++ L G   +    ++++E+M NG L
Sbjct: 43  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 238 QQHLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
              L  ++ ++  +    +L+  L   A  + +L E +    +HRD    N+L++ N   
Sbjct: 103 DSFLRLNDGQFTVI----QLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVC 155
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           KV+DFGL++ + +  +    T  LG      + APE  +  K T+ SD +SYG+V+ E++
Sbjct: 156 KVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215
Query: 354 T 354
           +
Sbjct: 216 S 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 93/171 (54%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 73  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 131
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 132 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 184
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 185 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETKF--- 117
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           + +  + IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA   S   
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 312 NGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 ++ G+  ++APE      +   + +SDVY++G+VL EL+TG++P
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
            D  + A+K L        + F  E +LL+ L    +V+  G C + +  +++ EYM +G
Sbjct: 41  QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100
Query: 236 TLQQHLHRHN---------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
            L + L  H          N    L     L IA   A  + +L   A+   +HRD    
Sbjct: 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 157
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           N L+ +N   K+ DFG+++ V      ++    +    ++ PE     K TT+SDV+S G
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217
Query: 347 VVLLELLT-GRVP 358
           VVL E+ T G+ P
Sbjct: 218 VVLWEIFTYGKQP 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 92/171 (53%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY +      +++++    +L  HLH    ++  +
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA + S  
Sbjct: 105 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 121 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 297 KVTDFGLAKMVSDK----INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           KV DFGLA+ + DK    ++ +   ++     ++A E   T K TTKSDV+S+GV+L EL
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 353 LTGRVPVDPN 362
           +T   P  P+
Sbjct: 231 MTRGAPPYPD 240

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 59  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 118
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 119 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 171 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 231 RGAPPYPD 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 56  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 116 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 167
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 228 RGAPPYPD 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 79  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 138
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 139 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 190
Query: 297 KVTDFGLAKMVSDK----INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           KV DFGLA+ + DK    ++ +   ++     ++A E   T K TTKSDV+S+GV+L EL
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248
Query: 353 LTGRVPVDPN 362
           +T   P  P+
Sbjct: 249 MTRGAPPYPD 258

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 60  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 119
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 120 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 172 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 232 RGAPPYPD 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 121 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           KV DFGLA+ + DK    +  +        ++A E   T K TTKSDV+S+GV+L EL+T
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 355 GRVPVDPN 362
              P  P+
Sbjct: 233 RGAPPYPD 240

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 92/171 (53%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA   S  
Sbjct: 105 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 157
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 53  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 112
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 113 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 164
Query: 297 KVTDFGLAKMVSDK----INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           KV DFGLA+ + DK    ++ +   ++     ++A E   T K TTKSDV+S+GV+L EL
Sbjct: 165 KVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 222
Query: 353 LTGRVPVDPN 362
           +T   P  P+
Sbjct: 223 MTRGAPPYPD 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 58  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 118 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 169
Query: 297 KVTDFGLAKMVSDK----INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           KV DFGLA+ + DK    ++ +   ++     ++A E   T K TTKSDV+S+GV+L EL
Sbjct: 170 KVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
Query: 353 LTGRVPVDPN 362
           +T   P  P+
Sbjct: 228 MTRGAPPYPD 237

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
            AIK L     +++R  F  E  ++ +   P ++ L G        ++I+E+M NG+L  
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 240 HLHRHNNRYRPLDWRTRLIIAL-DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            L +++ ++  +    +L+  L   A  +++L   A    +HR     N+L++ N   KV
Sbjct: 98  FLRQNDGQFTVI----QLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKV 150
Query: 299 TDFGLAKMVSDKINGQISTRVLGT---TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           +DFGL++ + D  +    T  LG      + APE     K T+ SDV+SYG+V+ E+++
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 32/201 (15%)
Query: 179 TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T+ A+K L  +     +A F+ E  L++   +P +V+LLG CA      L+ EYM  G L
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 238 QQHLHRH-------------NNRYR-------PLDWRTRLIIALDCAMALEFLHEHATPP 277
            + L                + R R       PL    +L IA   A  + +L E     
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 194
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD----KINGQISTRVLGTTGYLAPEYAST 333
            +HRD    N L+ +N   K+ DFGL++ +      K +G  +  +     ++ PE    
Sbjct: 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI----RWMPPESIFY 250
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
            + TT+SDV++YGVVL E+ +
Sbjct: 251 NRYTTESDVWAYGVVLWEIFS 271

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 181 AAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCA-DQNHRLLISEYMPNGTLQ 238
            A+K L+R     E + F  E  ++     P ++ LLG C   +   L++  YM +G L+
Sbjct: 80  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 139
Query: 239 QHLHR--HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
             +    HN   + L     +   L  A  +++L   A+   +HRD    N +LD+ F  
Sbjct: 140 NFIRNETHNPTVKDL-----IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 191
Query: 297 KVTDFGLAKMVSDK----INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           KV DFGLA+ + DK    ++ +   ++     ++A E   T K TTKSDV+S+GV+L EL
Sbjct: 192 KVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 353 LTGRVPVDPN 362
           +T   P  P+
Sbjct: 250 MTRGAPPYPD 259

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 92/171 (53%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA   S  
Sbjct: 133 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 185
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 92/171 (53%), Gaps = 12/171 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY + +    +++++    +L  HLH    ++  +
Sbjct: 66  QQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 124
Query: 252 DWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
               +LI IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA   S  
Sbjct: 125 ----KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 177
Query: 311 INGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                  ++ G+  ++APE          + +SDVY++G+VL EL+TG++P
Sbjct: 178 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 91/170 (53%), Gaps = 10/170 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+ +AF+ EV +L +     ++  +GY +      +++++    +L  HLH    ++   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKF--- 117
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           + +  + IA   A  +++LH  +   +IHRD K +N+ L ++   K+ DFGLA   S   
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 312 NGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 ++ G+  ++APE      +   + +SDVY++G+VL EL+TG++P
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 22/196 (11%)
Query: 178 GTVAAIKKLHRDGKQRERAF------RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY 231
           G   A+K L+R   Q+ R+       R E+  L     P +++L    +  +   ++ EY
Sbjct: 41  GHKVAVKILNR---QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           +  G L  ++ + N R   LD +    +       +++ H H    V+HRD K  NVLLD
Sbjct: 98  VSGGELFDYICK-NGR---LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLD 150
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT--KSDVYSYGVVL 349
            +  AK+ DFGL+ M+SD   G+      G+  Y APE  S G+L    + D++S GV+L
Sbjct: 151 AHMNAKIADFGLSNMMSD---GEFLRXSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVIL 206
Query: 350 LELLTGRVPVDPNRPP 365
             LL G +P D +  P
Sbjct: 207 YALLCGTLPFDDDHVP 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 26/191 (13%)
Query: 181 AAIKKLHR-DGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           AAIK++     K   R F  E+++L +L H P ++ LLG C  + +  L  EY P+G L 
Sbjct: 52  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 111
Query: 239 QHLHRH------------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
             L +             N+    L  +  L  A D A  +++L +      IHR+    
Sbjct: 112 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRNLAAR 168
Query: 287 NVLLDQNFRAKVTDFGLAK---MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVY 343
           N+L+ +N+ AK+ DFGL++   +   K  G++  R      ++A E  +    TT SDV+
Sbjct: 169 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVW 222
Query: 344 SYGVVLLELLT 354
           SYGV+L E+++
Sbjct: 223 SYGVLLWEIVS 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 11/181 (6%)
Query: 181 AAIKKLH---RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
            AIK +    R+ ++  + F  EV   S+L    +V ++    + +   L+ EY+   TL
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
            +++  H     PL   T +         ++  H+     ++HRD K  N+L+D N   K
Sbjct: 99  SEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLK 151
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFG+AK +S+    Q +  VLGT  Y +PE A        +D+YS G+VL E+L G  
Sbjct: 152 IFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 358 P 358
           P
Sbjct: 211 P 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 178 GTVAAIKKLHRDGKQRERAF------RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY 231
           G   A+K L+R   Q+ R+       + E+  L     P +++L    +      ++ EY
Sbjct: 36  GHKVAVKILNR---QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           +  G L  ++ +H  R   ++ R      L    A+++ H H    V+HRD K  NVLLD
Sbjct: 93  VSGGELFDYICKHG-RVEEMEARRLFQQILS---AVDYCHRHM---VVHRDLKPENVLLD 145
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT--KSDVYSYGVVL 349
            +  AK+ DFGL+ M+SD   G+      G+  Y APE  S G+L    + D++S GV+L
Sbjct: 146 AHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVIL 201
Query: 350 LELLTGRVPVDPNRPP 365
             LL G +P D    P
Sbjct: 202 YALLCGTLPFDDEHVP 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           T  A+K + + G     AF  E +++  L   +LV+L      +    +I+E+M  G+L 
Sbjct: 40  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLL 97
Query: 239 QHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
             L       +PL    +LI  +   A  + F+ +      IHRD + +N+L+  +   K
Sbjct: 98  DFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 151
Query: 298 VTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           + DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++L+E++T 
Sbjct: 152 IADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 208
Query: 355 GRVP 358
           GR+P
Sbjct: 209 GRIP 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 178 GTVAAIKKLHRDGKQRERAF------RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY 231
           G   A+K L+R   Q+ R+       + E+  L     P +++L    +      ++ EY
Sbjct: 36  GHKVAVKILNR---QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           +  G L  ++ +H  R   ++ R      L    A+++ H H    V+HRD K  NVLLD
Sbjct: 93  VSGGELFDYICKHG-RVEEMEARRLFQQILS---AVDYCHRHM---VVHRDLKPENVLLD 145
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT--KSDVYSYGVVL 349
            +  AK+ DFGL+ M+SD   G+      G+  Y APE  S G+L    + D++S GV+L
Sbjct: 146 AHMNAKIADFGLSNMMSD---GEFLRDSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVIL 201
Query: 350 LELLTGRVPVDPNRPP 365
             LL G +P D    P
Sbjct: 202 YALLCGTLPFDDEHVP 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
            D  + A+K L        + F+ E +LL+ L    +V+  G C D +  +++ EYM +G
Sbjct: 43  KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 102
Query: 236 TLQQHLHRHN-NRYRPLDWRTR-----------LIIALDCAMALEFLHEHATPPVIHRDF 283
            L + L  H  +    +D + R           L IA   A  + +L   A+   +HRD 
Sbjct: 103 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDL 159
Query: 284 KCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVY 343
              N L+  N   K+ DFG+++ V      ++    +    ++ PE     K TT+SDV+
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 219
Query: 344 SYGVVLLELLT-GRVP 358
           S+GV+L E+ T G+ P
Sbjct: 220 SFGVILWEIFTYGKQP 235

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 178 GTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLISEYMPN 234
           G   A+K L    G       + E+++L  L+   +V+  G C +   N   LI E++P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+++L ++ N+   ++ + +L  A+     +++L    +   +HRD    NVL++   
Sbjct: 110 GSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 163
Query: 295 RAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           + K+ DFGL K + +DK    +         + APE     K    SDV+S+GV L ELL
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 354 T 354
           T
Sbjct: 224 T 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  ++ T  A+K L + G    +AF  E +L+  L   +LV L      +    +I+E
Sbjct: 30  WMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITE 88
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           YM  G+L   L         L    +LI  +   A  + ++        IHRD + +NVL
Sbjct: 89  YMAKGSLLDFLKSDEGGKVLL---PKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVL 142
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + ++   K+ DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G+
Sbjct: 143 VSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGI 199
Query: 348 VLLELLT-GRVPVDPNR 363
           +L E++T G++P  P R
Sbjct: 200 LLYEIVTYGKIPY-PGR 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 178 GTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLISEYMPN 234
           G   A+K L    G       + E+++L  L+   +V+  G C +   N   LI E++P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L+++L ++ N+   ++ + +L  A+     +++L    +   +HRD    NVL++   
Sbjct: 98  GSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 151
Query: 295 RAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
           + K+ DFGL K + +DK    +         + APE     K    SDV+S+GV L ELL
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211
Query: 354 T 354
           T
Sbjct: 212 T 212

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           T  A+K + + G     AF  E +++  L   +LV+L      +    +I+E+M  G+L 
Sbjct: 213 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLL 270
Query: 239 QHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
             L       +PL    +LI  +   A  + F+ +      IHRD + +N+L+  +   K
Sbjct: 271 DFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324
Query: 298 VTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT- 354
           + DFGLA+++ D    + + R        + APE  + G  T KSDV+S+G++L+E++T 
Sbjct: 325 IADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
Query: 355 GRVP 358
           GR+P
Sbjct: 382 GRIP 385

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 87/172 (50%), Gaps = 12/172 (6%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLIS-EYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           E D++SRL  P  V+L  +C   + +L     Y  NG L +++ +  +     D      
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRF 141
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
              +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +  
Sbjct: 142 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
            +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 247

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 10/163 (6%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +E  +L+ L  P  +  L  C     RL  + EY+  G L  H+ +      P      +
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAV 123
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
             A + ++ L FLH+     +I+RD K  NV+LD     K+ DFG+ K     ++G  + 
Sbjct: 124 FYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTR 178
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
              GT  Y+APE  +        D ++YGV+L E+L G+ P D
Sbjct: 179 EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 72  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 131
Query: 240 HLHRH------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
            L R           RPL+ R  L  +   A  + FL   A+   IHRD    NVLL   
Sbjct: 132 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 188
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
             AK+ DFGLA+ + +  N  +         ++APE       T +SDV+SYG++L E+ 
Sbjct: 189 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248
Query: 354 TGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL 392
           +    +  N  PG  +LV+    +L   ++  +M  P+ 
Sbjct: 249 S----LGLNPYPG--ILVNSKFYKLV--KDGYQMAQPAF 279

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 41  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 100
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 101 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 157
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 158 LAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDV 217
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 218 WSFGVVLWEIAT 229

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 240 HLHRH------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
            L R           RPL+ R  L  +   A  + FL   A+   IHRD    NVLL   
Sbjct: 140 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 196
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
             AK+ DFGLA+ + +  N  +         ++APE       T +SDV+SYG++L E+ 
Sbjct: 197 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256
Query: 354 TGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL 392
           +    +  N  PG  +LV+    +L   ++  +M  P+ 
Sbjct: 257 S----LGLNPYPG--ILVNSKFYKLV--KDGYQMAQPAF 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 32  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 91
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 92  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 148
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 149 LAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDV 208
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 209 WSFGVVLWEIAT 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 94/189 (49%), Gaps = 18/189 (9%)
Query: 178 GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNG 235
           G V A+K++ R G K+  +   M++D++ + H  P +V+  G         +  E M  G
Sbjct: 50  GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--G 107
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           T  + L +      P     ++ +A+    AL +L E     VIHRD K SN+LLD+  +
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVAI--VKALYYLKEKHG--VIHRDVKPSNILLDERGQ 163
Query: 296 AKVTDFGLA-KMVSDKINGQISTRVLGTTGYLAPEYASTGKLT-----TKSDVYSYGVVL 349
            K+ DFG++ ++V DK       R  G   Y+APE       T      ++DV+S G+ L
Sbjct: 164 IKLCDFGISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 350 LELLTGRVP 358
           +EL TG+ P
Sbjct: 220 VELATGQFP 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           + G+Q  +A    +  +  L    +V LLG C   + +L +++Y+P G+L  H+ +H   
Sbjct: 71  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA 129
Query: 248 YRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
             P   L+W  ++      A  + +L EH    ++HR+    NVLL    + +V DFG+A
Sbjct: 130 LGPQLLLNWGVQI------AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 180
Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            ++       + +       ++A E    GK T +SDV+SYGV + EL+T
Sbjct: 181 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 133
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 134 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 186
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 187 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 112
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 113 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 165
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 166 SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 133
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 134 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 184
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 185 PSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 160
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 161 SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +    +  SD+++ G ++ +L+ G  P
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 143 VFTYKELETATENFSEXXXXXXXXXXXXY----KGVLSDG--TVAAIKKLHRDGKQRER- 195
           VF   E E A E  +             Y    KGV+ D   T  AIK ++     RER 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH------RHNNRYR 249
            F  E  ++   +   +V LLG  +     L+I E M  G L+ +L        +N    
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 250 PLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           P      + +A + A  + +L+ +     +HRD    N ++ ++F  K+ DFG+ + + +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
               +   + L    +++PE    G  TT SDV+S+GVVL E+ T
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 124
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 125 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 177
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 178 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EYMP G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    KV DFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           + G+Q  +A    +  +  L    +V LLG C   + +L +++Y+P G+L  H+ +H   
Sbjct: 53  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA 111
Query: 248 YRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
             P   L+W  ++      A  + +L EH    ++HR+    NVLL    + +V DFG+A
Sbjct: 112 LGPQLLLNWGVQI------AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162
Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
            ++       + +       ++A E    GK T +SDV+SYGV + EL+T
Sbjct: 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EYMP G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    KV DFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE 230
           + G  ++ T  A+K L + G    +AF  E +L+  L   +LV L      +    +I+E
Sbjct: 29  WMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           +M  G+L   L         L    +LI  +   A  + ++        IHRD + +NVL
Sbjct: 88  FMAKGSLLDFLKSDEGGKVLL---PKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVL 141
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGV 347
           + ++   K+ DFGLA+++ D    + + R        + APE  + G  T KS+V+S+G+
Sbjct: 142 VSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGI 198
Query: 348 VLLELLT-GRVPVDPNR 363
           +L E++T G++P  P R
Sbjct: 199 LLYEIVTYGKIPY-PGR 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 18/188 (9%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGT 94
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 95  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGEL 147
Query: 297 KVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           K+ DFG +      ++   S R  + GT  YL PE         K D++S GV+  E L 
Sbjct: 148 KIADFGWS------VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 201
Query: 355 GRVPVDPN 362
           G+ P + N
Sbjct: 202 GKPPFEAN 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 112
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 113 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 165
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 109
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 110 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 160
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 161 PSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 110
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 111 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 163
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 160
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 161 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFGLAK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 112
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 113 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 165
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 166 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 108
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +         
Sbjct: 109 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT 165
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
            +S    GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 166 TLS----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 94
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 95  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 147
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG     S        T + GT  YL PE         K D++S GV+  E L G+
Sbjct: 148 KIADFGW----SVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
Query: 357 VPVDPN 362
            P + N
Sbjct: 204 PPFEAN 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 110
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 111 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 161
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 162 PSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 47  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 107 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 163
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 224 WSFGVVLWEIAT 235

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 115
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 116 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +       SD+++ G ++ +L+ G  P
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 114
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 115 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 219

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 138
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 139 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 243

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 138
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 139 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +       SD+++ G ++ +L+ G  P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 34  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 93
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 94  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 146
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG     S        T + GT  YL PE         K D++S GV+  E L G+
Sbjct: 147 KIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202
Query: 357 VPVDPN 362
            P + N
Sbjct: 203 PPFEAN 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 160
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +       SD+++ G ++ +L+ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 135
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +       SD+++ G ++ +L+ G  P
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 39  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 98
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 99  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 151
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG     S        T + GT  YL PE         K D++S GV+  E L G+
Sbjct: 152 KIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207
Query: 357 VPVDPN 362
            P + N
Sbjct: 208 PPFEAN 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 108
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 109 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 159
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 160 PSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 108
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 109 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 161
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 140
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 141 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 245

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 160
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 135
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 240

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT  Y++PE  +       SD+++ G ++ +L+ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 135
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 240

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 112
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 113 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 217

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           T  A+K + + G     AF  E +++  L   +LV+L      +    +I+E+M  G+L 
Sbjct: 207 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLL 264
Query: 239 QHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
             L       +PL    +LI  +   A  + F+ +      IHRD + +N+L+  +   K
Sbjct: 265 DFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 318
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GR 356
           + DFGLA+     +  +   +      + APE  + G  T KSDV+S+G++L+E++T GR
Sbjct: 319 IADFGLAR-----VGAKFPIK------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367
Query: 357 VP 358
           +P
Sbjct: 368 IP 369

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 41  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 100
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 101 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 157
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 158 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 217
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 218 WSFGVVLWEIAT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 47  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106
Query: 229 SEYMPNGTLQQHLHR------HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 163
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 224 WSFGVVLWEIAT 235

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P G + + L + +      D 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDE 112
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 113 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 165
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 137
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 242

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 110
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG     S     
Sbjct: 111 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS 163
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 135
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 240

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 158
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 159 PSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 113
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 218

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 34  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 93
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 94  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 150
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 151 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 210
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 211 WSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 40  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 99
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 100 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 156
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 157 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 216
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 217 WSFGVVLWEIAT 228

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P G + + L + +      D 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDE 112
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 113 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 163
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 164 PSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 107
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 108 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 158
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 159 PSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 18/188 (9%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 97
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 98  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 150
Query: 297 KVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           K+ DFG +      ++   S R  + GT  YL PE         K D++S GV+  E L 
Sbjct: 151 KIADFGWS------VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 204
Query: 355 GRVPVDPN 362
           G+ P + N
Sbjct: 205 GKPPFEAN 212

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 40  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 99
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 100 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 156
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 157 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 216
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 217 WSFGVVLWEIAT 228

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 39  ILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 98
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +   R  + RT   I  + A AL + H   +  VIHRD K  N+LL  N   
Sbjct: 99  VYRELQKLS---RFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSNGEL 151
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG     S        T + GT  YL PE         K D++S GV+  E L G 
Sbjct: 152 KIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGM 207
Query: 357 VPVD 360
            P +
Sbjct: 208 PPFE 211

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 32  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 91
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 92  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 144
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG     S        T + GT  YL PE         K D++S GV+  E L G+
Sbjct: 145 KIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200
Query: 357 VPVDPN 362
            P + N
Sbjct: 201 PPFEAN 206

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 110
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ DFG +      ++ 
Sbjct: 111 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHA 161
Query: 314 QISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
             S R  + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 162 PSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARFYA 140
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 141 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 191
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 119
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 120 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK    ++ G+  T +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-L 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 69  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 128
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 129 MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 185
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 186 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 245
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 246 WSFGVVLWEIAT 257

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 134
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 135 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 239

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 39  ILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 98
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +   R  + RT   I  + A AL + H   +  VIHRD K  N+LL  N   
Sbjct: 99  VYRELQKLS---RFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSNGEL 151
Query: 297 KVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           K+ DFG +      ++   S R  + GT  YL PE         K D++S GV+  E L 
Sbjct: 152 KIADFGWS------VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 205
Query: 355 GRVPVD 360
           G  P +
Sbjct: 206 GMPPFE 211

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 37  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 96
Query: 229 SEYMPNGTLQQHLHR------HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 97  MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 153
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N ++ ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 154 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 213
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 214 WSFGVVLWEIAT 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E D++SRL  P  V+L     D         Y  NG L +++ +  +     D       
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY 134
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +   ALE+LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   
Sbjct: 135 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +GT  Y++PE  +       SD+++ G ++ +L+ G   + P R   E+++
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLI 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 168
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 169 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 219
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 171 YKGV-LSDGTVA----AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH 224
           YKG+ + +G       AIK L+   G +    F  E  +++ +  P LV LLG C     
Sbjct: 55  YKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTI 114
Query: 225 RLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           +L +++ MP+G L +++H H +       L+W       +  A  + +L E     ++HR
Sbjct: 115 QL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEERR---LVHR 164
Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMVS------DKINGQISTRVLGTTGYLAPEYASTGK 335
           D    NVL+      K+TDFGLA+++       +   G++  +      ++A E     K
Sbjct: 165 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------WMALECIHYRK 218
Query: 336 LTTKSDVYSYGVVLLELLT-GRVPVD 360
            T +SDV+SYGV + EL+T G  P D
Sbjct: 219 FTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 140
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 141 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 191
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    +VTDFGLAK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 133
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK    ++ G+  T +
Sbjct: 134 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-L 184
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    KV DFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 171 YKGV-LSDGTVA----AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH 224
           YKG+ + +G       AIK L+   G +    F  E  +++ +  P LV LLG C     
Sbjct: 32  YKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTI 91
Query: 225 RLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           +L +++ MP+G L +++H H +       L+W  ++      A  + +L E     ++HR
Sbjct: 92  QL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEERR---LVHR 141
Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSD 341
           D    NVL+      K+TDFGLA+++        +        ++A E     K T +SD
Sbjct: 142 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 201
Query: 342 VYSYGVVLLELLT-GRVPVD 360
           V+SYGV + EL+T G  P D
Sbjct: 202 VWSYGVTIWELMTFGGKPYD 221

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           E   R EV++ S L  P ++ L GY  D     LI EY P GT+ + L + +      D 
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDE 109
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +       + A AL + H   +  VIHRD K  N+LL      K+ +FG     S     
Sbjct: 110 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPS 162
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
              T + GT  YL PE         K D++S GV+  E L G+ P + N
Sbjct: 163 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  SP + +  G         +I EY+  G+    L        PLD     
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIA 122
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            I  +    L++LH       IHRD K +NVLL ++   K+ DFG+A  ++D    QI  
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 176
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE        +K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 177 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIP 232
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
           +            P+L+G Y K            C+  E ++RP   ++++
Sbjct: 233 KNNP---------PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 9/161 (5%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +ME D+L  ++ P +V+L      +    LI +++  G L     R +      +   + 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKF 130
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +A + A+AL+ LH      +I+RD K  N+LLD+    K+TDFGL+K   D      S 
Sbjct: 131 YLA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              GT  Y+APE  +    T  +D +S+GV++ E+LTG +P
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 30/209 (14%)
Query: 181 AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            A+K L       ER A   E+ ++++L S   +V LLG C       LI EY   G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 239 QHLHRHNNRYRP-------------------LDWRTRLIIALDCAMALEFLHEHATPPVI 279
            +L     ++                     L +   L  A   A  +EFL        +
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV 194
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD    NVL+      K+ DFGLA+ +    N  +         ++APE    G  T K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 340 SDVYSYGVVLLELLTGRV------PVDPN 362
           SDV+SYG++L E+ +  V      PVD N
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDAN 283

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  SP + +  G         +I EY+  G+    L        PLD     
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIA 107
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            I  +    L++LH       IHRD K +NVLL ++   K+ DFG+A  ++D    QI  
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 161
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE        +K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIP 217
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
           +            P+L+G Y K            C+  E ++RP   ++++
Sbjct: 218 KNNP---------PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 12/192 (6%)
Query: 172 KGVLSDG--TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           KGV+ D   T  AIK ++     RER  F  E  ++   +   +V LLG  +     L+I
Sbjct: 34  KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 93
Query: 229 SEYMPNGTLQQHLH------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
            E M  G L+ +L        +N    P      + +A + A  + +L+ +     +HRD
Sbjct: 94  MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 150
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
               N  + ++F  K+ DFG+ + + +    +   + L    +++PE    G  TT SDV
Sbjct: 151 LAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 210
Query: 343 YSYGVVLLELLT 354
           +S+GVVL E+ T
Sbjct: 211 WSFGVVLWEIAT 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 16/223 (7%)
Query: 143 VFTYKELETATENFSEXXXXXXXXXXXXYKGVLSD------GTVAAIKKLHRDGKQRER- 195
           VF   E E + E  +             Y+G   D       T  A+K ++     RER 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR-----HNNRYRP 250
            F  E  ++       +V LLG  +     L++ E M +G L+ +L        NN  RP
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 251 LDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
                 +I +A + A  + +L+       +HRD    N ++  +F  K+ DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
               +   + L    ++APE    G  TT SD++S+GVVL E+
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV L      ++    + EY+  G L  H+ R     R L        + + ++AL +
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNY 136
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+APE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPE 191
Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVD-------PNRPPGEHVL-----VSWALPR 377
                      D ++ GV++ E++ GR P D       P++   +++          +PR
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 251
Query: 378 LTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ--SLIPVVKN 435
             S + A   V  S   + PK+ L          +Q    +R +  D+++   ++P  K 
Sbjct: 252 SMSVKAAS--VLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 309
Query: 436 NAAGAISFGSSRFQHQ 451
           N +G   FG   F  Q
Sbjct: 310 NISG--EFGLDNFDSQ 323

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++   E   R EV++ S L  P ++ L GY  D     LI EY P GT
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 97
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           + + L + +      D +       + A AL + H   +  VIHRD K  N+LL      
Sbjct: 98  VYRELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 150
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ +FG     S        T + GT  YL PE         K D++S GV+  E L G+
Sbjct: 151 KIANFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
Query: 357 VPVDPN 362
            P + N
Sbjct: 207 PPFEAN 212

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 16/223 (7%)
Query: 143 VFTYKELETATENFSEXXXXXXXXXXXXYKGVLSD------GTVAAIKKLHRDGKQRER- 195
           VF   E E + E  +             Y+G   D       T  A+K ++     RER 
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR-----HNNRYRP 250
            F  E  ++       +V LLG  +     L++ E M +G L+ +L        NN  RP
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 251 LDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
                 +I +A + A  + +L+       +HRD    N ++  +F  K+ DFG+ + + +
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
               +   + L    ++APE    G  TT SD++S+GVVL E+
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  SP + +  G         +I EY+  G+    L        PLD     
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIA 107
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            I  +    L++LH       IHRD K +NVLL ++   K+ DFG+A  ++D    QI  
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 161
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE        +K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIP 217
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
           +            P+L+G Y K            C+  E ++RP   ++++
Sbjct: 218 KNNP---------PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +ME D+L  ++ P +V+L      +    LI +++  G L     R +      +   + 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKF 130
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +A + A+AL+ LH   +  +I+RD K  N+LLD+    K+TDFGL+K   D  + + + 
Sbjct: 131 YLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAY 184
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              GT  Y+APE  +    T  +D +S+GV++ E+LTG +P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +ME D+L  ++ P +V+L      +    LI +++  G L     R +      +   + 
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKF 131
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +A + A+AL+ LH   +  +I+RD K  N+LLD+    K+TDFGL+K   D  + + + 
Sbjct: 132 YLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAY 185
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              GT  Y+APE  +    T  +D +S+GV++ E+LTG +P
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  SP + +  G         +I EY+  G+    L        PLD     
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIA 127
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            I  +    L++LH       IHRD K +NVLL ++   K+ DFG+A  ++D    QI  
Sbjct: 128 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 181
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE        +K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIP 237
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
           +            P+L+G Y K            C+  E ++RP   ++++
Sbjct: 238 KNNP---------PTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELLK 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P L +L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV L      ++    + EY+  G L  H+ R     R L        + + ++AL +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNY 168
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+APE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 223
Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVD-------PNRPPGEHVL-----VSWALPR 377
                      D ++ GV++ E++ GR P D       P++   +++          +PR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283
Query: 378 LTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ--SLIPVVKN 435
             S + A   V  S   + PK+ L          +Q    +R +  D+++   ++P  K 
Sbjct: 284 SLSVKAAS--VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 341
Query: 436 NAAGAISFGSSRFQHQ 451
           N +G   FG   F  Q
Sbjct: 342 NISG--EFGLDNFDSQ 355

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+  L  L  P +++L          +++ EY   G L  ++          D   R   
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTE--DEGRRFFQ 115
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
            + CA  +E+ H H    ++HRD K  N+LLD N   K+ DFGL+ +++D   G      
Sbjct: 116 QIICA--IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTS 167
Query: 320 LGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVDPNRPP 365
            G+  Y APE  + GKL    + DV+S G+VL  +L GR+P D    P
Sbjct: 168 CGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K ++     RER  F  E  ++       +V LLG  +     L++ E M +G L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 238 QQHLHR-----HNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           + +L        NN  RP      +I +A + A  + +L+       +HRD    N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA 164
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +F  K+ DFG+ + + +    +   + L    ++APE    G  TT SD++S+GVVL E
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 352 L 352
           +
Sbjct: 225 I 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV L      ++    + EY+  G L  H+ R     R L        + + ++AL +
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNY 121
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+APE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPE 176
Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVD-------PNRPPGEHVL-----VSWALPR 377
                      D ++ GV++ E++ GR P D       P++   +++          +PR
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 378 LTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ--SLIPVVKN 435
             S + A   V  S   + PK+ L          +Q    +R +  D+++   ++P  K 
Sbjct: 237 SLSVKAAS--VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 294
Query: 436 NAAGAISFGSSRFQHQ 451
           N +G   FG   F  Q
Sbjct: 295 NISG--EFGLDNFDSQ 308

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV L      ++    + EY+  G L  H+ R     R L        + + ++AL +
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNY 125
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LHE     +I+RD K  NVLLD     K+TD+G+ K       G  ++   GT  Y+APE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPE 180
Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVD-------PNRPPGEHVL-----VSWALPR 377
                      D ++ GV++ E++ GR P D       P++   +++          +PR
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 378 LTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ--SLIPVVKN 435
             S + A   V  S   + PK+ L          +Q    +R +  D+++   ++P  K 
Sbjct: 241 SLSVKAAS--VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 298
Query: 436 NAAGAISFGSSRFQHQ 451
           N +G   FG   F  Q
Sbjct: 299 NISG--EFGLDNFDSQ 312

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+  L  L  P +++L      ++  +++ EY  N      + R     +      + II
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           +     A+E+ H H    ++HRD K  N+LLD++   K+ DFGL+ +++D   G      
Sbjct: 123 S-----AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTS 171
Query: 320 LGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS---WA 374
            G+  Y APE  S GKL    + DV+S GV+L  +L  R+P D    P     +S   + 
Sbjct: 172 CGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 230
Query: 375 LPRLTS 380
           LP+  S
Sbjct: 231 LPKFLS 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P L +L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P L +L     D ++  ++ EY P G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    KVTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 11/183 (6%)
Query: 178 GTVAAIKKLHRDG-KQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + A+K L +   K R+R   +ME D+L+ ++ P +V+L      +    LI +++  G
Sbjct: 56  GHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGG 115
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L     R +      +   +  +A + A+ L+ LH      +I+RD K  N+LLD+   
Sbjct: 116 DL---FTRLSKEVMFTEEDVKFYLA-ELALGLDHLHSLG---IIYRDLKPENILLDEEGH 168
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+TDFGL+K   D      S    GT  Y+APE  +    +  +D +SYGV++ E+LTG
Sbjct: 169 IKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226
Query: 356 RVP 358
            +P
Sbjct: 227 SLP 229

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+  L  L  P +++L      ++  +++ EY  N      + R     +      + II
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           +     A+E+ H H    ++HRD K  N+LLD++   K+ DFGL+ +++D   G      
Sbjct: 124 S-----AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTS 172
Query: 320 LGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS---WA 374
            G+  Y APE  S GKL    + DV+S GV+L  +L  R+P D    P     +S   + 
Sbjct: 173 CGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 231
Query: 375 LPRLTS 380
           LP+  S
Sbjct: 232 LPKFLS 237

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 181 AAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQN---HRLLISEYMPNGT 236
            AIK L R  + Q+  AF  E  L+  L+ P ++ L+G         H LL   YM +G 
Sbjct: 52  CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL--PYMCHGD 109
Query: 237 LQQHLH--RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           L Q +   + N   + L     +   L  A  +E+L E      +HRD    N +LD++F
Sbjct: 110 LLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESF 161
Query: 295 RAKVTDFGLAKMVSDK--INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
             KV DFGLA+ + D+   + Q          + A E   T + TTKSDV+S+GV+L EL
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 353 LTGRVP----VDP 361
           LT   P    +DP
Sbjct: 222 LTRGAPPYRHIDP 234

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+  L  L  P +++L      ++  +++ EY  N      + R     +      + II
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           +     A+E+ H H    ++HRD K  N+LLD++   K+ DFGL+ +++D   G      
Sbjct: 114 S-----AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTS 162
Query: 320 LGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS---WA 374
            G+  Y APE  S GKL    + DV+S GV+L  +L  R+P D    P     +S   + 
Sbjct: 163 CGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 221
Query: 375 LPRLTS 380
           LP+  S
Sbjct: 222 LPKFLS 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 16/223 (7%)
Query: 143 VFTYKELETATENFSEXXXXXXXXXXXXYKGVLSD------GTVAAIKKLHRDGKQRER- 195
           VF   E E + E  +             Y+G   D       T  A+K ++     RER 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR-----HNNRYRP 250
            F  E  ++       +V LLG  +     L++ E M +G L+ +L        NN  RP
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 251 LDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
                 +I +A + A  + +L+       +HRD    N ++  +F  K+ DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
               +   + L    ++APE    G  TT SD++S+GVVL E+
Sbjct: 183 TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 83/194 (42%), Gaps = 24/194 (12%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 65  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 124
Query: 240 HLHRHNNRY-------------------RPLDWRTRLIIALDCAMALEFLHEHATPPVIH 280
            L R                        RPL+ R  L  +   A  + FL   A+   IH
Sbjct: 125 FLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIH 181
Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKS 340
           RD    NVLL     AK+ DFGLA+ + +  N  +         ++APE       T +S
Sbjct: 182 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 241
Query: 341 DVYSYGVVLLELLT 354
           DV+SYG++L E+ +
Sbjct: 242 DVWSYGILLWEIFS 255

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+  L  L  P +++L      ++  +++ EY  N      + R     +      + II
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           +     A+E+ H H    ++HRD K  N+LLD++   K+ DFGL+ +++D   G      
Sbjct: 118 S-----AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTS 166
Query: 320 LGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS---WA 374
            G+  Y APE  S GKL    + DV+S GV+L  +L  R+P D    P     +S   + 
Sbjct: 167 CGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 225
Query: 375 LPRLTS 380
           LP+  S
Sbjct: 226 LPKFLS 231

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 31  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 90  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 143
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 144 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 356 RVPVDP------NRPP 365
           R P+ P      +RPP
Sbjct: 200 RYPIPPPDAKEDSRPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           ++ G   AI++++   + ++     E+ ++    +P +V  L      +   ++ EY+  
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L   +         +D      +  +C  ALEFLH +    VIHRD K  N+LL  + 
Sbjct: 102 GSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 153
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K+TDFG    ++ + + +  + ++GT  ++APE  +      K D++S G++ +E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 355 GRVP 358
           G  P
Sbjct: 212 GEPP 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+ ++  L  P LV L     D+    ++ + +  G L+ HL + N  ++     T  + 
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKE---ETVKLF 120
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
             +  MAL++L       +IHRD K  N+LLD++    +TDF +A M+  +   QI+T +
Sbjct: 121 ICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITT-M 174
Query: 320 LGTTGYLAPEYASTGKLTTKS---DVYSYGVVLLELLTGRVP 358
            GT  Y+APE  S+ K    S   D +S GV   ELL GR P
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 168
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 169 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 219
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 45  VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 104
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 105 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 155
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 156 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 214 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 252

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 172 VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 232 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 283 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 341 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 379

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 50  VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 109
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 110 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 160
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 161 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 219 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 257

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 95  VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 155 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 206 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 264 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 302

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 41  VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 101 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 151
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 210 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 248

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 41  GLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 99
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L     +  P +   ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 100 SLDQVLK--EAKRIPEEILGKVSIAV--LRGLAYLREKHQ--IMHRDVKPSNILVNSRGE 153
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y+APE       + +SD++S G+ L+EL  G
Sbjct: 154 IKLCDFG----VSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 210 RYPIPP 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 7/180 (3%)
Query: 176 SDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           +D T+ A+K          +A F  E  +L +   P +V L+G C  +    ++ E +  
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G     L     R R    +T L +  D A  +E+L        IHRD    N L+ +  
Sbjct: 197 GDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKN 250
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K++DFG+++  +D +             + APE  + G+ +++SDV+S+G++L E  +
Sbjct: 251 VLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 174 VLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           V S G + A+KK+    +QR      EV ++       +VE+       +   ++ E++ 
Sbjct: 52  VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 111
Query: 234 NGTLQQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            G L   + H   N  +         IA  C   L+ L       VIHRD K  ++LL  
Sbjct: 112 GGALTDIVTHTRMNEEQ---------IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 162
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           + R K++DFG    VS ++  +    ++GT  ++APE  S      + D++S G++++E+
Sbjct: 163 DGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220
Query: 353 LTGRVPVDPNRPPGEHVLVSWALPR--LTSREEAVEMVDPSLQG 394
           + G  P   N PP    L +  + R  L  R + +  V PSL+G
Sbjct: 221 VDGEPPYF-NEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 259

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           ++ G   AI++++   + ++     E+ ++    +P +V  L      +   ++ EY+  
Sbjct: 43  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L   +         +D      +  +C  ALEFLH +    VIHRD K  N+LL  + 
Sbjct: 103 GSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K+TDFG    ++ + + +  + ++GT  ++APE  +      K D++S G++ +E++ 
Sbjct: 155 SVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 212
Query: 355 GRVP 358
           G  P
Sbjct: 213 GEPP 216

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 16/223 (7%)
Query: 143 VFTYKELETATENFSEXXXXXXXXXXXXYKGVLSD------GTVAAIKKLHRDGKQRER- 195
           VF   E E + E  +             Y+G   D       T  A+K ++     RER 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR-----HNNRYRP 250
            F  E  ++       +V LLG  +     L++ E M +G L+ +L        NN  RP
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 251 LDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
                 +I +A + A  + +L+       +HRD    N ++  +F  K+ DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
               +   + L    ++APE    G  TT SD++S+GVVL E+
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           ++ G   AI++++   + ++     E+ ++    +P +V  L      +   ++ EY+  
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L   +         +D      +  +C  ALEFLH +    VIHRD K  N+LL  + 
Sbjct: 102 GSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 153
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K+TDFG    ++ + + +  + ++GT  ++APE  +      K D++S G++ +E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 355 GRVP 358
           G  P
Sbjct: 212 GEPP 215

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 13/189 (6%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G   A+KK+    +QR      EV ++   H   +V++       +   ++ E++  G L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 238 QQHL-HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
              + H   N            + L    AL +LH      VIHRD K  ++LL  + R 
Sbjct: 130 TDIVTHTRMNE------EQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRI 180
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K++DFG    VS ++  +    ++GT  ++APE  S     T+ D++S G++++E++ G 
Sbjct: 181 KLSDFGFCAQVSKEVPKR--KXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238
Query: 357 VPVDPNRPP 365
            P   N PP
Sbjct: 239 PPYF-NEPP 246

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 89/184 (48%), Gaps = 10/184 (5%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           ++ G   AI++++   + ++     E+ ++    +P +V  L      +   ++ EY+  
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L   +         +D      +  +C  ALEFLH +    VIHRD K  N+LL  + 
Sbjct: 102 GSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 153
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K+TDFG    ++ +   + ST V GT  ++APE  +      K D++S G++ +E++ 
Sbjct: 154 SVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 355 GRVP 358
           G  P
Sbjct: 212 GEPP 215

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARFYA 142
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 143 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 193
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 10/190 (5%)
Query: 173 GVLSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
             L DG   A+KK+      D K R    + E+DLL +L+ P +++      + N   ++
Sbjct: 52  ACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
            E    G L + +     + R +  RT     +    ALE +H      V+HRD K +NV
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANV 167
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
            +      K+ D GL +  S K     S  ++GT  Y++PE         KSD++S G +
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 349 LLELLTGRVP 358
           L E+   + P
Sbjct: 226 LYEMAALQSP 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 148
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 149 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 16/185 (8%)
Query: 180 VAAIKKLHRDGKQRE---RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++E      R E+++ S L  P ++ +  Y  D+    L+ E+ P G 
Sbjct: 42  IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 101
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L + L +H       D +       + A AL + HE     VIHRD K  N+L+      
Sbjct: 102 LYKELQKHGR----FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGEL 154
Query: 297 KVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
           K+ DFG +          +  R + GT  YL PE         K D++  GV+  E L G
Sbjct: 155 KIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209
Query: 356 RVPVD 360
             P D
Sbjct: 210 MPPFD 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 7/180 (3%)
Query: 176 SDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           +D T+ A+K          +A F  E  +L +   P +V L+G C  +    ++ E +  
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G     L     R R    +T L +  D A  +E+L        IHRD    N L+ +  
Sbjct: 197 GDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKN 250
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K++DFG+++  +D +             + APE  + G+ +++SDV+S+G++L E  +
Sbjct: 251 VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 16/185 (8%)
Query: 180 VAAIKKLHRDGKQRE---RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++E      R E+++ S L  P ++ +  Y  D+    L+ E+ P G 
Sbjct: 41  IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 100
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L + L +H       D +       + A AL + HE     VIHRD K  N+L+      
Sbjct: 101 LYKELQKHGR----FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGEL 153
Query: 297 KVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
           K+ DFG +          +  R + GT  YL PE         K D++  GV+  E L G
Sbjct: 154 KIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
Query: 356 RVPVD 360
             P D
Sbjct: 209 MPPFD 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 171 YKGVLSDGTVAAI------KKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL----GYCA 220
           YKG+ ++ TV         +KL +  +QR   F+ E + L  L  P +V           
Sbjct: 43  YKGLDTETTVEVAWCELQDRKLTKSERQR---FKEEAEXLKGLQHPNIVRFYDSWESTVK 99
Query: 221 DQNHRLLISEYMPNGTLQQHLHRHN-NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
            +   +L++E   +GTL+ +L R    + + L    R I+       L+FLH   TPP+I
Sbjct: 100 GKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILK-----GLQFLHTR-TPPII 153
Query: 280 HRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT 338
           HRD KC N+ +       K+ D GLA +         +  V+GT  + APE     K   
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFXAPEXYEE-KYDE 208
Query: 339 KSDVYSYGVVLLELLTGRVP 358
             DVY++G   LE  T   P
Sbjct: 209 SVDVYAFGXCXLEXATSEYP 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 109/262 (41%), Gaps = 32/262 (12%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 240 HLHR---------HNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
            L R         +N  + P   L  R  L  +   A  + FL   A+   IHRD    N
Sbjct: 140 FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 196
Query: 288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGV 347
           VLL     AK+ DFGLA+ + +  N  +         ++APE       T +SDV+SYG+
Sbjct: 197 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 256
Query: 348 VLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXX 407
           +L E+ +    +  N  PG  +LV+    +L   ++  +M  P+     PK         
Sbjct: 257 LLWEIFS----LGLNPYPG--ILVNSKFYKLV--KDGYQMAQPAFA---PKN----IYSI 301
Query: 408 XXVCVQPEAAYRPLMTDVVQSL 429
              C   E  +RP    +   L
Sbjct: 302 MQACWALEPTHRPTFQQICSFL 323

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  E D+++  +SP +V+L     D  +  ++ EYMP G L   +  ++    P  W   
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAK- 177
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
                +  +AL+ +H      +IHRD K  N+LLD++   K+ DFG   M  D+      
Sbjct: 178 -FYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHC 232
Query: 317 TRVLGTTGYLAPEY----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              +GT  Y++PE        G    + D +S GV L E+L G  P
Sbjct: 233 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 93  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 151
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 152 SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 205
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 206 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 262 RYPIPP 267

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   + P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV+L     D ++  ++ EY P G +  HL R      P     R   A    +  E+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP---HARFYAA-QIVLTFEY 157
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH   +  +I+RD K  N+L+DQ    KV DFG AK V  +     +  + GT  YLAPE
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPE 209
Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
              +       D ++ GV++ E+  G  P   ++P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 168
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK    ++ G   T +
Sbjct: 169 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWT-L 219
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+++DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 107/260 (41%), Gaps = 30/260 (11%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH----------ATPPVIHRDFKCSNVL 289
            L R +   R L+      IA   A   + LH            A+   IHRD    NVL
Sbjct: 140 FLRRKS---RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L     AK+ DFGLA+ + +  N  +         ++APE       T +SDV+SYG++L
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXX 409
            E+ +    +  N  PG  +LV+    +L   ++  +M  P+     PK           
Sbjct: 257 WEIFS----LGLNPYPG--ILVNSKFYKLV--KDGYQMAQPAFA---PKN----IYSIMQ 301
Query: 410 VCVQPEAAYRPLMTDVVQSL 429
            C   E  +RP    +   L
Sbjct: 302 ACWALEPTHRPTFQQICSFL 321

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 177 DGTVAAIKKLH---RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           DG    IK+++      K+RE + R EV +L+ +  P +V+      +     ++ +Y  
Sbjct: 48  DGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106
Query: 234 NGTLQQHLHRHNNRY----RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
            G L + ++          + LDW  ++       +AL+ +H+     ++HRD K  N+ 
Sbjct: 107 GGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHDRK---ILHRDIKSQNIF 157
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L ++   ++ DFG+A++++  +  +++   +GT  YL+PE         KSD+++ G VL
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215
Query: 350 LELLT 354
            EL T
Sbjct: 216 YELCT 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 31  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 90  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 143
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 144 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 200 RYPIPP 205

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K ++     RER  F  E  ++       +V LLG  +     L++ E M +G L
Sbjct: 47  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 106
Query: 238 QQHLHR-----HNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           + +L        NN  RP      +I +A + A  + +L+       +HRD    N ++ 
Sbjct: 107 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA 163
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +F  K+ DFG+ + + +    +   + L    ++APE    G  TT SD++S+GVVL E
Sbjct: 164 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 223
Query: 352 L 352
           +
Sbjct: 224 I 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 31  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 90  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 143
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 144 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 200 RYPIPP 205

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 178 GTVAAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + A+K++     ++E +   M++D++ R    P +V+  G    +    +  E M   
Sbjct: 47  GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS 106
Query: 236 --TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
                ++++   +   P +   ++ +A     AL  L E+    +IHRD K SN+LLD++
Sbjct: 107 FDKFYKYVYSVLDDVIPEEILGKITLA--TVKALNHLKENLK--IIHRDIKPSNILLDRS 162
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY----ASTGKLTTKSDVYSYGVVL 349
              K+ DFG++  + D I     TR  G   Y+APE     AS      +SDV+S G+ L
Sbjct: 163 GNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219
Query: 350 LELLTGRVP 358
            EL TGR P
Sbjct: 220 YELATGRFP 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 19/169 (11%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  E D+++  +SP +V+L     D  +  ++ EYMP G L   +  ++    P  W  R
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW-AR 171
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
              A +  +AL+ +H       IHRD K  N+LLD++   K+ DFG       K+N +  
Sbjct: 172 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM----KMNKEGM 223
Query: 317 TR---VLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVP 358
            R    +GT  Y++PE   +    G    + D +S GV L E+L G  P
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  E D+++  +SP +V+L     D  +  ++ EYMP G L   +  ++    P  W  R
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW-AR 176
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
              A +  +AL+ +H       IHRD K  N+LLD++   K+ DFG    ++ +   +  
Sbjct: 177 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 317 TRVLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVP 358
           T V GT  Y++PE   +    G    + D +S GV L E+L G  P
Sbjct: 233 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 17/190 (8%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 34  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 92
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 93  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 146
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++  +++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 147 IKLCDFG----VSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202
Query: 356 RVPVDPNRPP 365
           R P    RPP
Sbjct: 203 RYP----RPP 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 31  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 90  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 143
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 144 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 200 RYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 31  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 90  SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 143
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 144 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 200 RYPIPP 205

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ ++  G  P   ++P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 19/169 (11%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  E D+++  +SP +V+L     D  +  ++ EYMP G L   +  ++    P  W  R
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW-AR 176
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
              A +  +AL+ +H       IHRD K  N+LLD++   K+ DFG       K+N +  
Sbjct: 177 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM----KMNKEGM 228
Query: 317 TR---VLGTTGYLAPEYAST----GKLTTKSDVYSYGVVLLELLTGRVP 358
            R    +GT  Y++PE   +    G    + D +S GV L E+L G  P
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 10/163 (6%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +E  +L+    P  +  L  C     RL  + EY+  G L  H+ +      P      +
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAV 445
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
             A + A+ L FL       +I+RD K  NV+LD     K+ DFG+ K   +  +G  + 
Sbjct: 446 FYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTK 500
Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
              GT  Y+APE  +        D +++GV+L E+L G+ P +
Sbjct: 501 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 218 YCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
           +C  Q       + EY+  G L  H+   +      D       A +  + L+FLH    
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKG- 139
Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +++RD K  N+LLD++   K+ DFG+ K   + +    +    GT  Y+APE     K
Sbjct: 140 --IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 336 LTTKSDVYSYGVVLLELLTGRVPV 359
                D +S+GV+L E+L G+ P 
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 58  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 117 SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 170
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 171 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 356 RVPVDP 361
           R P+ P
Sbjct: 227 RYPIPP 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 106/260 (40%), Gaps = 30/260 (11%)
Query: 182 AIKKLHRDGKQRER-AFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           A+K L       E+ A   E+ ++S L     +V LLG C      L+I+EY   G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 240 HLHRHNNRYRP----------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
            L R +               L  R  L  +   A  + FL   A+   IHRD    NVL
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 196
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L     AK+ DFGLA+ + +  N  +         ++APE       T +SDV+SYG++L
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXX 409
            E+ +    +  N  PG  +LV+    +L   ++  +M  P+     PK           
Sbjct: 257 WEIFS----LGLNPYPG--ILVNSKFYKLV--KDGYQMAQPAFA---PKN----IYSIMQ 301
Query: 410 VCVQPEAAYRPLMTDVVQSL 429
            C   E  +RP    +   L
Sbjct: 302 ACWALEPTHRPTFQQICSFL 321

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 134
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+D+    +VTDFG AK V  +     +  +
Sbjct: 135 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXL 185
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           +  I K   +    ++ FR EV ++  L+ P +V+L      +    LI EY   G +  
Sbjct: 42  IKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD 100
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R++         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 101 YLVAHG-RMKEKEARSKF---RQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIA 153
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   +  + G++ T   G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 154 DFGFSNEFT--VGGKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210
Query: 359 VD 360
            D
Sbjct: 211 FD 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 89/184 (48%), Gaps = 10/184 (5%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           ++ G   AI++++   + ++     E+ ++    +P +V  L      +   ++ EY+  
Sbjct: 43  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L   +         +D      +  +C  ALEFLH +    VIHR+ K  N+LL  + 
Sbjct: 103 GSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKSDNILLGMDG 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             K+TDFG    ++ +   + ST V GT  ++APE  +      K D++S G++ +E++ 
Sbjct: 155 SVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 212
Query: 355 GRVP 358
           G  P
Sbjct: 213 GEPP 216

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 203 LLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
            L++LHS         C     RL  + EY+  G L  H+ +      P      +  A 
Sbjct: 82  FLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA 128
Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
           + A+ L FL       +I+RD K  NV+LD     K+ DFG+ K   +  +G  +    G
Sbjct: 129 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCG 183
Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           T  Y+APE  +        D +++GV+L E+L G+ P +
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 218 YCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT 275
           +C  Q       + EY+  G L  H+   +      D       A +  + L+FLH    
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKG- 138
Query: 276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK 335
             +++RD K  N+LLD++   K+ DFG+ K   + +    +    GT  Y+APE     K
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 336 LTTKSDVYSYGVVLLELLTGRVPV 359
                D +S+GV+L E+L G+ P 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 472
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 473 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 473
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 474 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 530
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 531 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 64  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 121
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 122 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 172
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 173 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K ++     RER  F  E  ++       +V LLG  +     L++ E M +G L
Sbjct: 49  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 108
Query: 238 QQHLHR-----HNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           + +L        NN  RP      +I +A + A  + +L+       +HR+    N ++ 
Sbjct: 109 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVA 165
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +F  K+ DFG+ + + +    +   + L    ++APE    G  TT SD++S+GVVL E
Sbjct: 166 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 225
Query: 352 L 352
           +
Sbjct: 226 I 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL-QQHLHRHNNRYRPLDWRTRLI 258
           E+ LL  L  P +++L     D+ +  L++E+   G L +Q ++RH  ++   D      
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAAN--- 150
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVTDFGLAKMVSDKINGQI 315
           I       + +LH+H    ++HRD K  N+LL+        K+ DFGL+   S   + ++
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKL 205
Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             R LGT  Y+APE     K   K DV+S GV++  LL G  P
Sbjct: 206 RDR-LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 179 TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K ++     RER  F  E  ++       +V LLG  +     L++ E M +G L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 238 QQHLHR-----HNNRYRPLDWRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           + +L        NN  RP      +I +A + A  + +L+       +HR+    N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVA 164
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +F  K+ DFG+ + + +    +   + L    ++APE    G  TT SD++S+GVVL E
Sbjct: 165 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 352 L 352
           +
Sbjct: 225 I 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT  YLAP    +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 10/184 (5%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQLVELLGYCADQNHRLL--ISE 230
           SDG +   K+L   G   E   +M   EV+LL  L  P +V       D+ +  L  + E
Sbjct: 29  SDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP--PVIHRDFKCSNV 288
           Y   G L   + +     + LD    L +     +AL+  H  +     V+HRD K +NV
Sbjct: 88  YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
            LD     K+ DFGLA++++   +   +   +GT  Y++PE  +      KSD++S G +
Sbjct: 148 FLDGKQNVKLGDFGLARILNH--DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 349 LLEL 352
           L EL
Sbjct: 206 LYEL 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  SP +    G         +I EY+  G+    L     +  PL+     
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-----KPGPLEETYIA 119
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            I  +    L++LH       IHRD K +NVLL +    K+ DFG+A  ++D    QI  
Sbjct: 120 TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 173
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE         K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 174 NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIP 229
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQ 427
           + +          P+L+GQ+ K            C+  +  +RP   ++++
Sbjct: 230 KNSP---------PTLEGQHSK----PFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 60  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 117
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 118 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 168
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 60  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 117
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 118 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 168
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 84  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 141
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 142 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 192
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           L+R H P L +L       +    + E++  G L  H+ +     R  D       A + 
Sbjct: 79  LARNH-PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEI 133
Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
             AL FLH+     +I+RD K  NVLLD     K+ DFG+ K      NG  +    GT 
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTP 188
Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            Y+APE           D ++ GV+L E+L G  P +
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R          R R   A +   ALE+LH   
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGA-EIVSALEYLH--- 127
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTPEYLAPEVLED 184
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 128
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 129 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 185
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 186 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R          R R   A +   ALE+LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGA-EIVSALEYLH--- 122
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTPEYLAPEVLED 179
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 82  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 139
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 140 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 190
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 191 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 10/184 (5%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQLVELLGYCADQNHRLL--ISE 230
           SDG +   K+L   G   E   +M   EV+LL  L  P +V       D+ +  L  + E
Sbjct: 29  SDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP--PVIHRDFKCSNV 288
           Y   G L   + +     + LD    L +     +AL+  H  +     V+HRD K +NV
Sbjct: 88  YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
            LD     K+ DFGLA++++   +   +   +GT  Y++PE  +      KSD++S G +
Sbjct: 148 FLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 349 LLEL 352
           L EL
Sbjct: 206 LYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 10/184 (5%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLHSPQLVELLGYCADQNHRLL--ISE 230
           SDG +   K+L   G   E   +M   EV+LL  L  P +V       D+ +  L  + E
Sbjct: 29  SDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87
Query: 231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP--PVIHRDFKCSNV 288
           Y   G L   + +     + LD    L +     +AL+  H  +     V+HRD K +NV
Sbjct: 88  YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
            LD     K+ DFGLA++++   +   +   +GT  Y++PE  +      KSD++S G +
Sbjct: 148 FLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 349 LLEL 352
           L EL
Sbjct: 206 LYEL 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 114
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 130
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 130
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 11/189 (5%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
           YK +  + G + AIK++  +   +E     E+ ++ +  SP +V+  G         ++ 
Sbjct: 46  YKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EY   G++   +   N      +  T L   L     LE+LH       IHRD K  N+L
Sbjct: 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK---GLEYLHFMRK---IHRDIKAGNIL 157
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L+    AK+ DFG+A  ++D +  +    V+GT  ++APE          +D++S G+  
Sbjct: 158 LNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215
Query: 350 LELLTGRVP 358
           +E+  G+ P
Sbjct: 216 IEMAEGKPP 224

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R        + R R   A +   ALE+LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGA-EIVSALEYLH--- 122
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTPEYLAPEVLED 179
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           QRE+   ME+ +   L    +V   G+  D +   ++ E     +L + LH+        
Sbjct: 58  QREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP 115
Query: 252 DWRTRL-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           + R  L  I L C    ++LH +    VIHRD K  N+ L+++   K+ DFGLA  V  +
Sbjct: 116 EARYYLRQIVLGC----QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--E 166
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
            +G+    + GT  Y+APE  S    + + DV+S G ++  LL G+ P +
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R        + R R   A +   ALE+LH   
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGA-EIVSALEYLH--- 125
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTPEYLAPEVLED 182
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R        + R R   A +   ALE+LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGA-EIVSALEYLH--- 122
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTPEYLAPEVLED 179
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R        + R R   A +   ALE+LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGA-EIVSALEYLH--- 122
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
           +  V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTPEYLAPEVLED 179
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R        + R R   A +   ALE+LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGA-EIVSALEYLHSR- 124
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM-VSDKINGQISTRVLGTTGYLAPEYAST 333
              V++RD K  N++LD++   K+TDFGL K  +SD   G       GT  YLAPE    
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTPEYLAPEVLED 179
Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D +  GVV+ E++ GR+P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L  ++ P LV+L     D ++  ++ EY+  G +  HL R      P     R   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYA 147
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A    +  E+LH   +  +I+RD K  N+L+DQ    +VTDFG AK V  +     +  +
Sbjct: 148 A-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
            GT   LAPE   +       D ++ GV++ E+  G  P   ++P
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 108
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 109 ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 165
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 166 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 114
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 171
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSR-LHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + A+K++      Q ++   M++D+  R +  P  V   G    +    +  E M + 
Sbjct: 76  GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DT 134
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L +   +  ++ + +       IA+    ALE LH   +  VIHRD K SNVL++   +
Sbjct: 135 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQ 192
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA----STGKLTTKSDVYSYGVVLLE 351
            K+ DFG++  + D +   I     G   Y+APE      +    + KSD++S G+ ++E
Sbjct: 193 VKMCDFGISGYLVDSVAKTIDA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249
Query: 352 LLTGRVPVDPNRPPGEHV--LVSWALPRLTSREEAVEMVD 389
           L   R P D    P + +  +V    P+L + + + E VD
Sbjct: 250 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 289

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 110
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 111 ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E +++ +L +P +V ++G C  ++  +L+ E    G L ++L +  NR+     + + II
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHV----KDKNII 120
Query: 260 AL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQIS 316
            L    +M +++L E      +HRD    NVLL     AK++DFGL+K + +D+   +  
Sbjct: 121 ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T       + APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH   
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSED-RARFYGA-EIVSALDYLHSEK 271
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE     
Sbjct: 272 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH   
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSED-RARFYGA-EIVSALDYLHSEK 268
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE     
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH   
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGA-EIVSALDYLHSEK 130
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE     
Sbjct: 131 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH   
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGA-EIVSALDYLHSEK 129
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE     
Sbjct: 130 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 216 LGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           L Y    + RL  + EY   G L  HL R   R    D R R   A +   AL++LH   
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGA-EIVSALDYLHSEK 128
Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
              V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE     
Sbjct: 129 N--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D +  GVV+ E++ GR+P
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 13/184 (7%)
Query: 178 GTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G V A K +H + K   R +  R E+ +L   +SP +V   G         +  E+M  G
Sbjct: 50  GLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 108
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L Q L +      P     ++ IA+     L +L E     ++HRD K SN+L++    
Sbjct: 109 SLDQVLKKAGRI--PEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGE 162
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFG    VS ++   ++   +GT  Y++PE       + +SD++S G+ L+E+  G
Sbjct: 163 IKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218
Query: 356 RVPV 359
           R P+
Sbjct: 219 RYPI 222

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 12/183 (6%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            +  I K   +    ++ FR EV ++  L+ P +V+L      +    LI EY   G + 
Sbjct: 44  AIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF 102
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            +L  H  R +  + R++         A+++ H+     ++HRD K  N+LLD +   K+
Sbjct: 103 DYLVAHG-RMKEKEARSKF---RQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRV 357
            DFG +   +  + G++     G   Y APE     K    + DV+S GV+L  L++G +
Sbjct: 156 ADFGFSNEFT--VGGKLDA-FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 358 PVD 360
           P D
Sbjct: 213 PFD 215

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 178 GTVAAIKKLHRD-GKQRERAFRMEVDLLSR-LHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + A+K++      Q ++   M++D+  R +  P  V   G    +    +  E M + 
Sbjct: 32  GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DT 90
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           +L +   +  ++ + +       IA+    ALE LH   +  VIHRD K SNVL++   +
Sbjct: 91  SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQ 148
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA----STGKLTTKSDVYSYGVVLLE 351
            K+ DFG++  + D +   I     G   Y+APE      +    + KSD++S G+ ++E
Sbjct: 149 VKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
Query: 352 LLTGRVPVDPNRPPGEHV--LVSWALPRLTSREEAVEMVD 389
           L   R P D    P + +  +V    P+L + + + E VD
Sbjct: 206 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G + A+K + +    R+ +   E+ +L ++    +V L        H  L+ + +  G L
Sbjct: 34  GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNF 294
                R   R    +    L+I      A+++LHE+    ++HRD K  N+L    ++N 
Sbjct: 94  ---FDRILERGVYTEKDASLVIQ-QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENS 146
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           +  +TDFGL+KM   + NG +ST   GT GY+APE  +    +   D +S GV+   LL 
Sbjct: 147 KIMITDFGLSKM---EQNGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 355 GRVP 358
           G  P
Sbjct: 203 GYPP 206

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 30/240 (12%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E+ +LS+  S  + +  G     +   +I EY+  G+    L     R  P D     
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-----RAGPFDEFQIA 123
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS- 316
            +  +    L++LH       IHRD K +NVLL +    K+ DFG+A  ++D    QI  
Sbjct: 124 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 177
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
              +GT  ++APE        +K+D++S G+  +EL  G  P     P    + V + +P
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIP 233
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
           +            P+L G + K            C+  + ++RP   ++++    +VKN+
Sbjct: 234 KNNP---------PTLVGDFTK----SFKEFIDACLNKDPSFRPTAKELLKHKF-IVKNS 279

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 45  VKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 103
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 104 YLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIA 156
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   +  +  ++ T   G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 157 DFGFSNEFT--VGNKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 359 VD 360
            D
Sbjct: 214 FD 215

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 44  VKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 102
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 103 YLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIA 155
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   +     ++ T   G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 156 DFGFSNEFT--FGNKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 359 VD 360
            D
Sbjct: 213 FD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 44  VKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 102
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 103 YLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIA 155
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   +     ++ T   G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 156 DFGFSNEFT--FGNKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 359 VD 360
            D
Sbjct: 213 FD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 44  VRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 102
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 103 YLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIA 155
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   ++   G       G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 156 DFGFS---NEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 359 VD 360
            D
Sbjct: 213 FD 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 179 TVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K L  +    E R    E ++L +++ P +++L G C+     LLI EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 QQHLHRHNNRYRP---------------------LDWRTRLIIALDCAMALEFLHEHATP 276
           +  L R + +  P                     L     +  A   +  +++L E +  
Sbjct: 114 RGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS-- 170
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            ++HRD    N+L+ +  + K++DFGL++ V ++ +    ++      ++A E       
Sbjct: 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIY 229
Query: 337 TTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
           TT+SDV+S+GV+L E++T G  P  P  PP
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPY-PGIPP 258

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 53  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 107
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 108 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 164
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 165 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 218
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 219 RIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 61  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 115
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 116 ASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 172
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 173 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 226
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 227 RIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 61  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 115
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 116 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 172
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 173 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 226
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 227 RIYTHQSDVWSFGVLLWEIFT 247

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 44  VRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 102
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+ 
Sbjct: 103 YLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIA 155
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRVP 358
           DFG +   +     ++ T   G+  Y APE     K    + DV+S GV+L  L++G +P
Sbjct: 156 DFGFSNEFT--FGNKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 359 VD 360
            D
Sbjct: 213 FD 214

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 54  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 108
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 109 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 165
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 166 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 219
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 220 RIYTHQSDVWSFGVLLWEIFT 240

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 84/188 (44%), Gaps = 18/188 (9%)
Query: 181 AAIKKLH--RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            AIK L    +G  RE  FR E  L +RL  P +V LLG         +I  Y  +G L 
Sbjct: 42  VAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 100
Query: 239 QHL---HRHNNRYRPLDWRT---------RLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           + L     H++     D RT          + +    A  +E+L  H    V+H+D    
Sbjct: 101 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR 157
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           NVL+      K++D GL + V      ++    L    ++APE    GK +  SD++SYG
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 217
Query: 347 VVLLELLT 354
           VVL E+ +
Sbjct: 218 VVLWEVFS 225

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 50  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 104
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 105 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 161
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 162 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 215
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 216 RIYTHQSDVWSFGVLLWEIFT 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 102 TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 156
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 213
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 267
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 268 RIYTHQSDVWSFGVLLWEIFT 288

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLL 227
           Y  + SD  +  A+K L       ER A   E+ +LS L +   +V LLG C      L+
Sbjct: 68  YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 127
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--------------IALDCAMALEFLHEH 273
           I+EY   G L   L R  + +        ++               +   A  + FL   
Sbjct: 128 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--- 184
Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
           A+   IHRD    N+LL      K+ DFGLA+ + +  N  +         ++APE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+SYG+ L EL +
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 84/188 (44%), Gaps = 18/188 (9%)
Query: 181 AAIKKLH--RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            AIK L    +G  RE  FR E  L +RL  P +V LLG         +I  Y  +G L 
Sbjct: 59  VAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 117
Query: 239 QHL---HRHNNRYRPLDWRT---------RLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           + L     H++     D RT          + +    A  +E+L  H    V+H+D    
Sbjct: 118 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR 174
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           NVL+      K++D GL + V      ++    L    ++APE    GK +  SD++SYG
Sbjct: 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 347 VVLLELLT 354
           VVL E+ +
Sbjct: 235 VVLWEVFS 242

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 181 AAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
            A+K   +D     +  F  E  ++  L  P +V+L+G   ++    +I E  P G L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGH 101
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L R+ N  + L   T ++ +L    A+ +L    +   +HRD    N+L+      K+ 
Sbjct: 102 YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLG 155
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           DFGL++ + D+   + S   L    +++PE  +  + TT SDV+ + V + E+L+ G+ P
Sbjct: 156 DFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT----LQQHLHRHNNRYRPLDWRT 255
           E+  +S+ H P +V        ++   L+ + +  G+    ++  + +  ++   LD  T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS---DKIN 312
              I  +    LE+LH++     IHRD K  N+LL ++   ++ DFG++  ++   D   
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 313 GQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
            ++    +GT  ++APE     +    K+D++S+G+  +EL TG  P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 181 AAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
            A+K   +D     +  F  E  ++  L  P +V+L+G   ++    +I E  P G L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGH 97
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L R+ N  + L   T ++ +L    A+ +L    +   +HRD    N+L+      K+ 
Sbjct: 98  YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLG 151
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           DFGL++ + D+   + S   L    +++PE  +  + TT SDV+ + V + E+L+ G+ P
Sbjct: 152 DFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 180 VAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           + AIK + ++  + +E +   E+ +L ++  P +V L        H  LI + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL---LDQNFR 295
             +      Y   D    +   LD   A+++LH+     ++HRD K  N+L   LD++ +
Sbjct: 105 DRI-VEKGFYTERDASRLIFQVLD---AVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 157
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
             ++DFGL+KM      G + +   GT GY+APE  +    +   D +S GV+   LL G
Sbjct: 158 IMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 356 RVP 358
             P
Sbjct: 215 YPP 217

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I+E+   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 228 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 272
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 273 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 181 AAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
            A+K   +D     +  F  E  ++  L  P +V+L+G   ++    +I E  P G L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGH 113
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
           +L R+ N  + L   T ++ +L    A+ +L    +   +HRD    N+L+      K+ 
Sbjct: 114 YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLG 167
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           DFGL++ + D+   + S   L    +++PE  +  + TT SDV+ + V + E+L+ G+ P
Sbjct: 168 DFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT----LQQHLHRHNNRYRPLDWRT 255
           E+  +S+ H P +V        ++   L+ + +  G+    ++  + +  ++   LD  T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS---DKIN 312
              I  +    LE+LH++     IHRD K  N+LL ++   ++ DFG++  ++   D   
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 313 GQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
            ++    +GT  ++APE     +    K+D++S+G+  +EL TG  P
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 180 VAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           + AIK + ++  + +E +   E+ +L ++  P +V L        H  LI + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL---LDQNFR 295
             +      Y   D    +   LD   A+++LH+     ++HRD K  N+L   LD++ +
Sbjct: 105 DRI-VEKGFYTERDASRLIFQVLD---AVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 157
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
             ++DFGL+KM      G + +   GT GY+APE  +    +   D +S GV+   LL G
Sbjct: 158 IMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 356 RVP 358
             P
Sbjct: 215 YPP 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 12/183 (6%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G + 
Sbjct: 43  AVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+
Sbjct: 102 DYLVAHG-RMKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKI 154
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRV 357
            DFG +   ++   G       G   Y APE     K    + DV+S GV+L  L++G +
Sbjct: 155 ADFGFS---NEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 358 PVD 360
           P D
Sbjct: 212 PFD 214

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLL 227
           Y  + SD  +  A+K L       ER A   E+ +LS L +   +V LLG C      L+
Sbjct: 61  YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 120
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--------------IALDCAMALEFLHEH 273
           I+EY   G L   L R  + +        ++               +   A  + FL   
Sbjct: 121 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--- 177
Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
           A+   IHRD    N+LL      K+ DFGLA+ + +  N  +         ++APE    
Sbjct: 178 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 237
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+SYG+ L EL +
Sbjct: 238 CVYTFESDVWSYGIFLWELFS 258

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            +  I K   +GK  E +   E+ +L ++  P +V L        H  LI + +  G L 
Sbjct: 47  AIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL---LDQNFR 295
             +      Y   D    +   LD   A+++LH+     ++HRD K  N+L   LD++ +
Sbjct: 105 DRI-VEKGFYTERDASRLIFQVLD---AVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 157
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
             ++DFGL+KM      G + +   GT GY+APE  +    +   D +S GV+   LL G
Sbjct: 158 IMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 356 RVP 358
             P
Sbjct: 215 YPP 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLL 227
           Y  + SD  +  A+K L       ER A   E+ +LS L +   +V LLG C      L+
Sbjct: 68  YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 127
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--------------IALDCAMALEFLHEH 273
           I+EY   G L   L R  + +        ++               +   A  + FL   
Sbjct: 128 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--- 184
Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
           A+   IHRD    N+LL      K+ DFGLA+ + +  N  +         ++APE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+SYG+ L EL +
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLL 227
           Y  + SD  +  A+K L       ER A   E+ +LS L +   +V LLG C      L+
Sbjct: 63  YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 122
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--------------IALDCAMALEFLHEH 273
           I+EY   G L   L R  + +        ++               +   A  + FL   
Sbjct: 123 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--- 179
Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
           A+   IHRD    N+LL      K+ DFGLA+ + +  N  +         ++APE    
Sbjct: 180 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 239
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+SYG+ L EL +
Sbjct: 240 CVYTFESDVWSYGIFLWELFS 260

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 171 YKGVLSDGTV-AAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLL 227
           Y  + SD  +  A+K L       ER A   E+ +LS L +   +V LLG C      L+
Sbjct: 45  YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI--------------IALDCAMALEFLHEH 273
           I+EY   G L   L R  + +        ++               +   A  + FL   
Sbjct: 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--- 161
Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
           A+   IHRD    N+LL      K+ DFGLA+ + +  N  +         ++APE    
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+SYG+ L EL +
Sbjct: 222 CVYTFESDVWSYGIFLWELFS 242

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 180 VAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           + AIK + ++  + +E +   E+ +L ++  P +V L        H  LI + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL---LDQNFR 295
             +      Y   D    +   LD   A+++LH+     ++HRD K  N+L   LD++ +
Sbjct: 105 DRI-VEKGFYTERDASRLIFQVLD---AVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 157
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
             ++DFGL+KM      G + +   GT GY+APE  +    +   D +S GV+   LL G
Sbjct: 158 IMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 356 RVP 358
             P
Sbjct: 215 YPP 217

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 179 TVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K L  +    E R    E ++L +++ P +++L G C+     LLI EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 QQHLHRHNNRYRP---------------------LDWRTRLIIALDCAMALEFLHEHATP 276
           +  L R + +  P                     L     +  A   +  +++L E    
Sbjct: 114 RGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            ++HRD    N+L+ +  + K++DFGL++ V ++ +    ++      ++A E       
Sbjct: 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIY 229
Query: 337 TTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
           TT+SDV+S+GV+L E++T G  P  P  PP
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPY-PGIPP 258

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           R E  +L  +     +  L Y      +L LI +Y+  G L  HL   + R R  +   +
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQ 162
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQI 315
           + +  +  +ALE LH+     +I+RD K  N+LLD N    +TDFGL+K  V+D+   + 
Sbjct: 163 IYVG-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ER 216
Query: 316 STRVLGTTGYLAPEYASTGKL--TTKSDVYSYGVVLLELLTGRVP 358
           +    GT  Y+AP+    G        D +S GV++ ELLTG  P
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 106/271 (39%), Gaps = 32/271 (11%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 238 QQHLHRHNNRYRP-----------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
             +L    N + P           L     +  +   A  +EFL   A+   IHRD    
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYG 346
           N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+G
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 347 VVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXX 406
           V+L E+ +               L +   P +   EE    +    + + P         
Sbjct: 238 VLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 282
Query: 407 XXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
               C   E + RP  +++V+ L  +++ NA
Sbjct: 283 TMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 46  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 100
Query: 232 MPNGTLQQHLHR---------HNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L           +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 101 ASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 157
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 211
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFT 232

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 79/184 (42%), Gaps = 14/184 (7%)
Query: 180 VAAIKKLHRDGKQRE---RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K L +   ++E      R E+++ + LH P ++ L  Y  D+    LI EY P G 
Sbjct: 50  IVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGE 109
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L + L +        D +    I  + A AL + H      VIHRD K  N+LL      
Sbjct: 110 LYKELQKSCT----FDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGEL 162
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           K+ DFG +          +     GT  YL PE         K D++  GV+  ELL G 
Sbjct: 163 KIADFGWSVHAPSLRRKTMC----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGN 218
Query: 357 VPVD 360
            P +
Sbjct: 219 PPFE 222

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 61  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 115
Query: 232 MPNGTLQQHL---------HRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L         + +N  + P   L  +  +  A   A  +E+L   A+   I
Sbjct: 116 ASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 172
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 173 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFD 226
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 227 RIYTHQSDVWSFGVLLWEIFT 247

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 55  REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKFSLD 109
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 110 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTX 166
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 167 XKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 260

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I+E+   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 228 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 272
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 273 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+E+    E+ +   L +P +V   G+  D +   ++ E     +L   L  H  R    
Sbjct: 85  QKEK-MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVT 140
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           +   R  +       +++LH +    VIHRD K  N+ L+ +   K+ DFGLA  +  + 
Sbjct: 141 EPEARYFMR-QTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EF 194
Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           +G+    + GT  Y+APE       + + D++S G +L  LL G+ P +
Sbjct: 195 DGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 107/270 (39%), Gaps = 31/270 (11%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 238 QQHLHRHNNR---YRPLDWRTRLII-------ALDCAMALEFLHEHATPPVIHRDFKCSN 287
             +L    N    Y+P D     +        +   A  +EFL   A+   IHRD    N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARN 178
Query: 288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGV 347
           +LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+GV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 348 VLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXX 407
           +L E+ +               L +   P +   EE    +    + + P          
Sbjct: 239 LLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 408 XXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
              C   E + RP  +++V+ L  +++ NA
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K   +    ++ FR EV ++  L+ P +V+L      +    L+ EY   G +  
Sbjct: 37  VKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD 95
Query: 240 HLHRHN-NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
           +L  H   + +    + R I++     A+++ H+     ++HRD K  N+LLD +   K+
Sbjct: 96  YLVAHGWMKEKEARAKFRQIVS-----AVQYCHQKF---IVHRDLKAENLLLDADMNIKI 147
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRV 357
            DFG +   +     ++ T   G+  Y APE     K    + DV+S GV+L  L++G +
Sbjct: 148 ADFGFSNEFT--FGNKLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 204
Query: 358 PVD 360
           P D
Sbjct: 205 PFD 207

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 238 QQHLHRHNNRYRP--------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
             +L    N + P        L     +  +   A  +EFL   A+   IHRD    N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L +    K+ DFGLA+ +    +            ++APE       T +SDV+S+GV+L
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXX 409
            E+ +               L +   P +   EE    +    + + P            
Sbjct: 237 WEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 281
Query: 410 VCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
            C   E + RP  +++V+ L  +++ NA
Sbjct: 282 DCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I+E+   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 228 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 272
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 273 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 179 TVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           T  A+K L  +    E R    E ++L +++ P +++L G C+     LLI EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 QQHLHRHNNRYRP---------------------LDWRTRLIIALDCAMALEFLHEHATP 276
           +  L R + +  P                     L     +  A   +  +++L E    
Sbjct: 114 RGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            ++HRD    N+L+ +  + K++DFGL++ V ++ +    ++      ++A E       
Sbjct: 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 337 TTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
           TT+SDV+S+GV+L E++T G  P  P  PP
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPY-PGIPP 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E ++L  +  P +V+L+          LI EY+  G L   L R           T  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TAC 124
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-NGQIS 316
               + +MAL  LH+     +I+RD K  N++L+     K+TDFGL K   + I +G ++
Sbjct: 125 FYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVT 178
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               GT  Y+APE           D +S G ++ ++LTG  P
Sbjct: 179 HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+E+    E+ +   L +P +V   G+  D +   ++ E     +L   L  H  R    
Sbjct: 85  QKEK-MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVT 140
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           +   R  +       +++LH +    VIHRD K  N+ L+ +   K+ DFGLA  +  + 
Sbjct: 141 EPEARYFMR-QTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EF 194
Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           +G+    + GT  Y+APE       + + D++S G +L  LL G+ P +
Sbjct: 195 DGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 228 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 272
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 273 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+E+    E+ +   L +P +V   G+  D +   ++ E     +L   L  H  R    
Sbjct: 85  QKEK-MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVT 140
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           +   R  +       +++LH +    VIHRD K  N+ L+ +   K+ DFGLA  +  + 
Sbjct: 141 EPEARYFMR-QTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EF 194
Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           +G+    + GT  Y+APE       + + D++S G +L  LL G+ P +
Sbjct: 195 DGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 435 REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLD 489
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L    +   +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 547 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 640

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 178 GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G + A+K + +   K +E +   E+ +L ++    +V L       NH  L+ + +  G 
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE 106
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQN 293
           L   +      Y   D  T +   LD   A+ +LH      ++HRD K  N+L    D+ 
Sbjct: 107 LFDRI-VEKGFYTEKDASTLIRQVLD---AVYYLHRMG---IVHRDLKPENLLYYSQDEE 159
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            +  ++DFGL+KM      G + +   GT GY+APE  +    +   D +S GV+   LL
Sbjct: 160 SKIMISDFGLSKMEG---KGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216
Query: 354 TGRVP 358
            G  P
Sbjct: 217 CGYPP 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G   + N   +I E    G L+  L     R   LD
Sbjct: 83  REK-FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLD 137
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 138 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 194
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 195 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 254 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 288

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E ++L  +  P +V+L+          LI EY+  G L   L R           T  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TAC 124
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-NGQIS 316
               + +MAL  LH+     +I+RD K  N++L+     K+TDFGL K   + I +G ++
Sbjct: 125 FYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVT 178
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               GT  Y+APE           D +S G ++ ++LTG  P
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 39/201 (19%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLISEY 231
           T  A+K L  D  +++ +     DL+S +   +++        LLG C       +I EY
Sbjct: 61  TKVAVKMLKSDATEKDLS-----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 115
Query: 232 MPNGTLQQHLHRH------------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
              G L+++L               +N    L  +  +  A   A  +E+L   A+   I
Sbjct: 116 ASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCI 172
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMV------SDKINGQISTRVLGTTGYLAPEYAST 333
           HRD    NVL+ ++   K+ DFGLA+ +          NG++  +      ++APE    
Sbjct: 173 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK------WMAPEALFD 226
Query: 334 GKLTTKSDVYSYGVVLLELLT 354
              T +SDV+S+GV+L E+ T
Sbjct: 227 RIYTHQSDVWSFGVLLWEIFT 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 67/139 (48%), Gaps = 23/139 (16%)
Query: 230 EYMPNGTLQQHLHRHN-NRYRPLDWRT-RLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           EY  NGTL   +H  N N+ R   WR  R I+      AL ++H      +IHRD K  N
Sbjct: 95  EYCENGTLYDLIHSENLNQQRDEYWRLFRQILE-----ALSYIHSQG---IIHRDLKPMN 146
Query: 288 VLLDQNFRAKVTDFGLAKMV----------SDKINGQIS--TRVLGTTGYLAPEYA-STG 334
           + +D++   K+ DFGLAK V          S  + G     T  +GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 335 KLTTKSDVYSYGVVLLELL 353
               K D+YS G++  E++
Sbjct: 207 HYNEKIDMYSLGIIFFEMI 225

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 60  REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLD 114
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 115 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 172 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 265

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 237 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 281
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 282 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G   + N   +I E    G L+  L     R   LD
Sbjct: 58  REK-FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLD 112
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L    +   +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 113 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 169
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 170 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 229 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 263

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV +L  L  P +++L  +  D+ +  L+ E    G L   +  H  ++  +D     +I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVD---AAVI 141
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGLAKMVSDKINGQIS 316
                  + +LH+H    ++HRD K  N+LL+   +    K+ DFGL+ +     N +  
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKM 195
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              LGT  Y+APE     K   K DV+S GV+L  LL G  P
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+L+   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 89  EQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE--TRPRP 146
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G   + N   +I E    G L+  L     R   LD
Sbjct: 57  REK-FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLD 111
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L    +   +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 112 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 168
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 169 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 228 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 262

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+L+   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 75  EQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 132
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G   + N   +I E    G L+  L     R   LD
Sbjct: 52  REK-FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLD 106
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 107 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 164 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 55  REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLD 109
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 110 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 167 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 260

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 238 QQHLHRHNNRYRP--------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
             +L    N + P        L     +  +   A  +EFL   A+   IHRD    N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L +    K+ DFGLA+ +    +            ++APE       T +SDV+S+GV+L
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXX 409
            E+ +               L +   P +   EE    +    + + P            
Sbjct: 237 WEIFS---------------LGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTML 281
Query: 410 VCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
            C   E + RP  +++V+ L  +++ NA
Sbjct: 282 DCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 171 YKGV-LSDGTVAAIKKLHRDGKQR--ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL 227
           YKG+  + G   A+K++  D ++     A R E+ L+  L    +V L      +N   L
Sbjct: 22  YKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTENKLTL 80
Query: 228 ISEYMPNGTLQQHLHRH--NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
           + E+M N  L++++      N  R L+              L F HE+    ++HRD K 
Sbjct: 81  VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKP 136
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYS 344
            N+L+++  + K+ DFGLA+     +N   S+ V+ T  Y AP+     +  +T  D++S
Sbjct: 137 QNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWS 194
Query: 345 YGVVLLELLTGRVPVDP 361
            G +L E++TG+ P+ P
Sbjct: 195 CGCILAEMITGK-PLFP 210

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            +AA K +    ++    + +E+D+L+    P +V+LL     +N+  ++ E+   G + 
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
             +       RPL      ++      AL +LH++    +IHRD K  N+L   +   K+
Sbjct: 123 AVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKL 176
Query: 299 TDFGLAKMVSDKINGQISTR--VLGTTGYLAPE--YASTGK---LTTKSDVYSYGVVLLE 351
            DFG    VS K    I  R   +GT  ++APE     T K      K+DV+S G+ L+E
Sbjct: 177 ADFG----VSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 232
Query: 352 L 352
           +
Sbjct: 233 M 233

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           Q+E+    E+ +   L +P +V   G+  D +   ++ E     +L   L  H  R    
Sbjct: 69  QKEK-MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVT 124
Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           +   R  +       +++LH +    VIHRD K  N+ L+ +   K+ DFGLA  +  + 
Sbjct: 125 EPEARYFMR-QTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EF 178
Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           +G+    + GT  Y+APE       + + D++S G +L  LL G+ P +
Sbjct: 179 DGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 55  REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLD 109
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D   
Sbjct: 110 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 167 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 260

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 237 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 281
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 282 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            +AA K +    ++    + +E+D+L+    P +V+LL     +N+  ++ E+   G + 
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
             +       RPL      ++      AL +LH++    +IHRD K  N+L   +   K+
Sbjct: 123 AVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKL 176
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK---LTTKSDVYSYGVVLLEL 352
            DFG++   +  I  + S   +GT  ++APE     T K      K+DV+S G+ L+E+
Sbjct: 177 ADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 12/183 (6%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            V  I K   +    ++ FR EV +   L+ P +V+L      +    L+ EY   G + 
Sbjct: 43  AVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVF 101
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            +L  H  R +  + R +         A+++ H+     ++HRD K  N+LLD +   K+
Sbjct: 102 DYLVAHG-RXKEKEARAKF---RQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKI 154
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTT-KSDVYSYGVVLLELLTGRV 357
            DFG +   +    G       G   Y APE     K    + DV+S GV+L  L++G +
Sbjct: 155 ADFGFSNEFT---FGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 358 PVD 360
           P D
Sbjct: 212 PFD 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
            +AA K +    ++    + +E+D+L+    P +V+LL     +N+  ++ E+   G + 
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
             +       RPL      ++      AL +LH++    +IHRD K  N+L   +   K+
Sbjct: 123 AVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKL 176
Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK---LTTKSDVYSYGVVLLEL 352
            DFG++   +  I  Q     +GT  ++APE     T K      K+DV+S G+ L+E+
Sbjct: 177 ADFGVSAKNTRXI--QRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 180 VAAIKKLHRDGKQRERAFR---MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           V AIKK+   GKQ    ++    EV  L +L  P  ++  G    ++   L+ EY   G+
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 139
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
               L  H    +PL       +       L +LH H    +IHRD K  N+LL +    
Sbjct: 140 ASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 193
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELL 353
           K+ DFG A +++       +   +GT  ++APE       G+   K DV+S G+  +EL 
Sbjct: 194 KLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 354 TGRVPV 359
             + P+
Sbjct: 248 ERKPPL 253

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 171 YKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN----- 223
           YKG  +  G +AAIK +   G + E   + E+++L +  H   +    G    +N     
Sbjct: 41  YKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99
Query: 224 -HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
               L+ E+   G++   +          +W     I  +    L  LH+H    VIHRD
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQHK---VIHRD 154
Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-----LT 337
            K  NVLL +N   K+ DFG++  + D+  G+ +T  +GT  ++APE  +  +       
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNT-FIGTPYWMAPEVIACDENPDATYD 212
Query: 338 TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW-ALPRLTSRE 382
            KSD++S G+  +E+  G  P+    P     L+     PRL S++
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 11/187 (5%)
Query: 176 SDGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           S G    IK +++D  Q        E+++L  L  P ++++     D ++  ++ E    
Sbjct: 45  SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G L + +     R + L       +      AL + H   +  V+H+D K  N+L     
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTS 161
Query: 295 R---AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
                K+ DFGLA++     + + ST   GT  Y+APE      +T K D++S GVV+  
Sbjct: 162 PHSPIKIIDFGLAELFK---SDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYF 217
Query: 352 LLTGRVP 358
           LLTG +P
Sbjct: 218 LLTGCLP 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR--ETRPRP 131
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV+LL +L  P +++L     D +   ++ E    G L   + +   R+   D   R+I 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD-AARIIK 128
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVSDKINGQIS 316
            +     + ++H+H    ++HRD K  N+LL+   ++   K+ DFGL+       N ++ 
Sbjct: 129 QV--FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            R+ GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV+LL +L  P +++L     D +   ++ E    G L   + +   R+   D   R+I 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD-AARIIK 128
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVSDKINGQIS 316
            +     + ++H+H    ++HRD K  N+LL+   ++   K+ DFGL+       N ++ 
Sbjct: 129 QV--FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            R+ GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 26/194 (13%)
Query: 180 VAAIKKL---HR----DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM 232
           + AIKK+   HR    DG  R  A R E+ LL  L  P ++ LL     +++  L+ ++M
Sbjct: 37  IVAIKKIKLGHRSEAKDGINRT-ALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
               L+  +  ++    P   +  +++ L     LE+LH+H    ++HRD K +N+LLD+
Sbjct: 95  ET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ---GLEYLHQHW---ILHRDLKPNNLLLDE 147
Query: 293 NFRAKVTDFGLAKMVSDKING---QISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVV 348
           N   K+ DFGLAK           Q+ TR      Y APE     ++     D+++ G +
Sbjct: 148 NGVLKLADFGLAKSFGSPNRAYXHQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCI 202
Query: 349 LLELLTGRVPVDPN 362
           L ELL  RVP  P 
Sbjct: 203 LAELLL-RVPFLPG 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 27/197 (13%)
Query: 177 DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLIS 229
           +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I 
Sbjct: 55  EAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 109
Query: 230 EYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATPP 277
           EY   G L+++L              NR     + ++  +      A  +E+L   A+  
Sbjct: 110 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQK 166
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
            IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       T
Sbjct: 167 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 226
Query: 338 TKSDVYSYGVVLLELLT 354
            +SDV+S+GV++ E+ T
Sbjct: 227 HQSDVWSFGVLMWEIFT 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 178
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 239 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 283
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 284 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 315

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 57  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 111
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 112 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 168
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 169 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 228
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 229 THQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 52  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 106
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 107 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 163
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 164 KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 223
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 224 THQSDVWSFGVLMWEIFT 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE--TRPRP 146
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 237 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 281
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 282 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 171 YKGV-LSDG----TVAAIKKLHRDGKQR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNH 224
           YKG+ + DG       AIK L  +   +  +    E  +++ + SP +  LLG C     
Sbjct: 34  YKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTV 93
Query: 225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK 284
           +L +++ MP G L  H+  +  R    D    L   +  A  + +L +     ++HRD  
Sbjct: 94  QL-VTQLMPYGCLLDHVRENRGRLGSQD---LLNWCMQIAKGMSYLEDVR---LVHRDLA 146
Query: 285 CSNVLLDQNFRAKVTDFGLAKMVS-DKI-----NGQISTRVLGTTGYLAPEYASTGKLTT 338
             NVL+      K+TDFGLA+++  D+       G++  +      ++A E     + T 
Sbjct: 147 ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WMALESILRRRFTH 200
Query: 339 KSDVYSYGVVLLELLT-GRVPVD 360
           +SDV+SYGV + EL+T G  P D
Sbjct: 201 QSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L +++S  +V L      ++   L+   M  G L+ H++       P + R     
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYA 292
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A  C   LE LH      +++RD K  N+LLD +   +++D GLA  V +   GQ     
Sbjct: 293 AEICC-GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGR 345
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT GY+APE     + T   D ++ G +L E++ G+ P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 181 AAIKKLHRDGKQRE-RAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL-ISEYMPNGTL 237
            A+K L       E RA   E+ +L  + H   +V LLG C      L+ I E+   G L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 238 QQHLHRHNNRYRP------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
             +L    N + P            L     +  +   A  +EFL   A+   IHRD   
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 213
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSY 345
            N+LL +    K+ DFGLA+ +    +            ++APE       T +SDV+S+
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 346 GVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLXXXX 405
           GV+L E+ +               L +   P +   EE    +    + + P        
Sbjct: 274 GVLLWEIFS---------------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 318
Query: 406 XXXXVCVQPEAAYRPLMTDVVQSLIPVVKNNA 437
                C   E + RP  +++V+ L  +++ NA
Sbjct: 319 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV+LL +L  P +++L     D +   ++ E    G L   + +   R+   D   R+I 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD-AARIIK 128
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVSDKINGQIS 316
            +   +   ++H+H    ++HRD K  N+LL+   ++   K+ DFGL+       N ++ 
Sbjct: 129 QVFSGIT--YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            R+ GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 182 DRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 111 KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 222
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 283 THQSDVWSFGVLMWEIFT 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 39/204 (19%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS------DKINGQISTRVLGTTGYLAPEY 330
             IHRD    NVL+ +N   K+ DFGLA+ ++      +  NG++  +      ++APE 
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK------WMAPEA 230
Query: 331 ASTGKLTTKSDVYSYGVVLLELLT 354
                 T +SDV+S+GV++ E+ T
Sbjct: 231 LFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 177 DGTVAAIKKLHRDGKQRERAFR---MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP 233
           +  V AIKK+   GKQ    ++    EV  L +L  P  ++  G    ++   L+ EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
            G+    L  H    +PL       +       L +LH H    +IHRD K  N+LL + 
Sbjct: 99  -GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEP 151
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLL 350
              K+ DFG A +++       +   +GT  ++APE       G+   K DV+S G+  +
Sbjct: 152 GLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 351 ELLTGRVPV 359
           EL   + P+
Sbjct: 206 ELAERKPPL 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE--TRPRP 146
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  +L +++S  +V L      ++   L+   M  G L+ H++       P + R     
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYA 292
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A  C   LE LH      +++RD K  N+LLD +   +++D GLA  V +   GQ     
Sbjct: 293 AEICC-GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGR 345
Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +GT GY+APE     + T   D ++ G +L E++ G+ P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 131
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 132
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
            FR E D+L       +  L     D+NH  L+ +Y   G L   L +  ++  P D   
Sbjct: 120 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL-PED-MA 177
Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
           R  I  +  +A++ +H+      +HRD K  NVLLD N   ++ DFG    ++D    Q 
Sbjct: 178 RFYIG-EMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 233
Query: 316 STRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVP 358
           S  V GT  Y++PE         GK   + D +S GV + E+L G  P
Sbjct: 234 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV +L +L  P +++L  +  D+ +  L+ E    G L   +     ++  +D     +I
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVD---AAVI 126
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGLAKMVSDKINGQIS 316
                    +LH+H    ++HRD K  N+LL+   R    K+ DFGL+     ++ G++ 
Sbjct: 127 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMK 181
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            R LGT  Y+APE     K   K DV+S GV+L  LL G  P
Sbjct: 182 ER-LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
            FR E D+L       +  L     D+NH  L+ +Y   G L   L +  ++  P D   
Sbjct: 136 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL-PED-MA 193
Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
           R  I  +  +A++ +H+      +HRD K  NVLLD N   ++ DFG    ++D    Q 
Sbjct: 194 RFYIG-EMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 249
Query: 316 STRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVP 358
           S  V GT  Y++PE         GK   + D +S GV + E+L G  P
Sbjct: 250 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 66  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 123
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 181 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 237

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 81  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 138
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 195
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 196 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 252

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 178 GTVAAIKKLHR--DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNG 235
           G + AIKK     D K  ++    E+ LL +L    LV LL  C  +    L+ E++ + 
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH- 108
Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           T+   L    N    LD++            + F H H    +IHRD K  N+L+ Q+  
Sbjct: 109 TILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGV 162
Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSYGVVLLELLT 354
            K+ DFG A+ ++    G++    + T  Y APE      K     DV++ G ++ E+  
Sbjct: 163 VKLCDFGFARTLA--APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 355 GR--VPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG 394
           G    P D +     H+++   L  L  R + +   +P   G
Sbjct: 221 GEPLFPGDSDIDQLYHIMM--CLGNLIPRHQELFNKNPVFAG 260

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE--TRPRP 132
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 190 MAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 175 LSDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLISEYM 232
           L +G   A+K + +  G  R R FR EV+ L +    + ++EL+ +  D     L+ E +
Sbjct: 35  LQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKL 93
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
             G++  H+ +  +     + R    +  D A AL+FLH   T  + HRD K  N+L + 
Sbjct: 94  QGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLH---TKGIAHRDLKPENILCES 146
Query: 293 NFR---AKVTDFGLAKMVSDKINGQIS-------TRVLGTTGYLAPEYAS--TGKLT--- 337
             +    K+ DF L   +  K+N   +       T   G+  Y+APE     T + T   
Sbjct: 147 PEKVSPVKICDFDLGSGM--KLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYD 204
Query: 338 TKSDVYSYGVVLLELLTGRVP 358
            + D++S GVVL  +L+G  P
Sbjct: 205 KRCDLWSLGVVLYIMLSGYPP 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           EV +L +L  P +++L  +  D+ +  L+ E    G L   +     ++  +D     +I
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVD---AAVI 109
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGLAKMVSDKINGQIS 316
                    +LH+H    ++HRD K  N+LL+   R    K+ DFGL+     ++ G++ 
Sbjct: 110 MKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMK 164
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            R LGT  Y+APE     K   K DV+S GV+L  LL G  P
Sbjct: 165 ER-LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 101 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 158
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 215
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 216 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 272

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 91  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 148
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 206 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 262

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 92  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 149
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 263

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           +Q E  F ME  ++S+ +   +V  +G       R ++ E M  G L+  L     R RP
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR--ETRPRP 172
Query: 251 -----LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFG 302
                L     L +A D A   ++L E+     IHRD    N LL        AK+ DFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +A+ +      +     +    ++ PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  + + +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEEDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 11/169 (6%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E  ++ +L +P +V L+G C  +   +L+ E    G L + L        P+     L+ 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLH 117
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
            +  +M +++L E      +HRD    NVLL     AK++DFGL+K +    +   + R 
Sbjct: 118 QV--SMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARS 171
Query: 320 LGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
            G     + APE  +  K +++SDV+SYGV + E L+ G+ P    + P
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 31/196 (15%)
Query: 182 AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQ 239
           A+K + +  G  R R FR EV++L +    + V  L    ++  R  L+ E M  G++  
Sbjct: 42  AVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 240 HLH--RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNF 294
           H+H  RH N           ++  D A AL+FLH      + HRD K  N+L +   Q  
Sbjct: 101 HIHKRRHFNELEA------SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 295 RAKVTDFGLAKMVSDKINGQ---ISTRVL----GTTGYLAPE----YASTGKLTTK-SDV 342
             K+ DFGL   +  K+NG    IST  L    G+  Y+APE    ++    +  K  D+
Sbjct: 152 PVKICDFGLGSGI--KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 343 YSYGVVLLELLTGRVP 358
           +S GV+L  LL+G  P
Sbjct: 210 WSLGVILYILLSGYPP 225

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 128
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 129 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 179
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
            EY   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   ++ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 133 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 184 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 73  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 132 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 183 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 123 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 173
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 123 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 173
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 133 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 184 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 121
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 122 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 172
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 173 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 126 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 123 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 173
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 126 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 128 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 92  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 150
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 151 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 202 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 108/258 (41%), Gaps = 52/258 (20%)
Query: 177 DGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           D    AIK++    ++  RE+  R EV  L++L  P +V       ++N    +    P 
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 235 GTL--QQHLHRHNNRYRPLDW---------RTRLI---IALDCAMALEFLHEHATPPVIH 280
             L  Q  L R  N     DW         R R +   I L  A A+EFLH      ++H
Sbjct: 88  VYLYIQMQLCRKENLK---DWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMH 141
Query: 281 RDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRV---------LGTTGYLAPEY 330
           RD K SN+    +   KV DFGL   M  D+    + T +         +GT  Y++PE 
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 331 ASTGKLTTKSDVYSYGVVLLELL------TGRV------------PVDPNRPPGEHVLVS 372
                 + K D++S G++L ELL        RV            P+   + P E+V+V 
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ 261
Query: 373 WAL-PRLTSREEAVEMVD 389
             L P    R EA+ +++
Sbjct: 262 DMLSPSPMERPEAINIIE 279

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 247
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 248 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 298
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 129 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 180 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 126 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 129 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 180 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 435 REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLD 489
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L    +   +HRD    NVL+      K+ DFGL++ + D   
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 547 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 640

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 120 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 171 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 129 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 180 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 77  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 133 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 187 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+++L +L+ P ++++  +   +++ +++ E M  G L   +   N R +    +     
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-VGNKRLKEATCKLYFYQ 261
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
            L   +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     + 
Sbjct: 262 ML---LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLM 312
Query: 317 TRVLGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
             + GT  YLAPE      T       D +S GV+L   L+G  P   +R
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNW--- 122
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 123 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
           AL +LH      VIHRD K  ++LL  + R K++DFG    +S  +  +    ++GT  +
Sbjct: 153 ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXLVGTPYW 207
Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
           +APE  S     T+ D++S G++++E++ G  P   + P
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL 227
           YK   S G + A+K++  D +       A R E+ LL  LH P +V L+     +    L
Sbjct: 38  YKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTL 96
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           + E+M    L++ L  +    +    +  L   L     +   H+H    ++HRD K  N
Sbjct: 97  VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHR---ILHRDLKPQN 149
Query: 288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSYG 346
           +L++ +   K+ DFGLA+     +     T  + T  Y AP+    + K +T  D++S G
Sbjct: 150 LLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 347 VVLLELLTGRVPVDPN 362
            +  E++TG+ P+ P 
Sbjct: 208 CIFAEMITGK-PLFPG 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K     K  + +   EV LL +L  P +++L  +  D+ +  L+ E    G L  
Sbjct: 80  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 139
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNF 294
            +     R+  +D   R+I  +     + ++H++    ++HRD K  N+LL     D N 
Sbjct: 140 EIISRK-RFSEVD-AARIIRQV--LSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 192
Query: 295 RAKVTDFGLA------KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           R  + DFGL+      K + DKI         GT  Y+APE    G    K DV+S GV+
Sbjct: 193 R--IIDFGLSTHFEASKKMKDKI---------GTAYYIAPEVLH-GTYDEKCDVWSTGVI 240
Query: 349 LLELLTGRVPVD 360
           L  LL+G  P +
Sbjct: 241 LYILLSGCPPFN 252

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K     K  + +   EV LL +L  P +++L  +  D+ +  L+ E    G L  
Sbjct: 79  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 138
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNF 294
            +     R+  +D   R+I  +     + ++H++    ++HRD K  N+LL     D N 
Sbjct: 139 EIISRK-RFSEVD-AARIIRQV--LSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 191
Query: 295 RAKVTDFGLA------KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           R  + DFGL+      K + DKI         GT  Y+APE    G    K DV+S GV+
Sbjct: 192 R--IIDFGLSTHFEASKKMKDKI---------GTAYYIAPEVLH-GTYDEKCDVWSTGVI 239
Query: 349 LLELLTGRVPVD 360
           L  LL+G  P +
Sbjct: 240 LYILLSGCPPFN 251

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL 227
           YK   S G + A+K++  D +       A R E+ LL  LH P +V L+     +    L
Sbjct: 38  YKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTL 96
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           + E+M    L++ L  +    +    +  L   L     +   H+H    ++HRD K  N
Sbjct: 97  VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHR---ILHRDLKPQN 149
Query: 288 VLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSYG 346
           +L++ +   K+ DFGLA+     +     T  + T  Y AP+    + K +T  D++S G
Sbjct: 150 LLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 347 VVLLELLTGRVPVDPN 362
            +  E++TG+ P+ P 
Sbjct: 208 CIFAEMITGK-PLFPG 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K     K  + +   EV LL +L  P +++L  +  D+ +  L+ E    G L  
Sbjct: 62  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 121
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNF 294
            +     R+  +D   R+I        + ++H++    ++HRD K  N+LL     D N 
Sbjct: 122 EII-SRKRFSEVD-AARII--RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 174
Query: 295 RAKVTDFGLA------KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           R  + DFGL+      K + DKI         GT  Y+APE    G    K DV+S GV+
Sbjct: 175 R--IIDFGLSTHFEASKKMKDKI---------GTAYYIAPEVLH-GTYDEKCDVWSTGVI 222
Query: 349 LLELLTGRVPVD 360
           L  LL+G  P +
Sbjct: 223 LYILLSGCPPFN 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 101 EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 156
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 157 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 211 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W  +
Sbjct: 64  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 122
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 123 I------AEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 174 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +E  +L+++HS  +V L      +    L+   M  G ++ H++  +           + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
                   LE LH+     +I+RD K  NVLLD +   +++D GLA  +     GQ  T+
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK---AGQTKTK 347
Query: 319 -VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
              GT G++APE     +     D ++ GV L E++  R P    R  GE V
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKV 396

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 32/221 (14%)
Query: 178 GTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G + AIKK      D   ++ A R E+ +L +L  P LV LL     +    L+ EY  +
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 235 GTLQQHLHRHN-----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
             L + L R+      +  + + W+T          A+ F H+H     IHRD K  N+L
Sbjct: 87  TVLHE-LDRYQRGVPEHLVKSITWQT--------LQAVNFCHKHNC---IHRDVKPENIL 134
Query: 290 LDQNFRAKVTDFGLAKMV---SDKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSY 345
           + ++   K+ DFG A+++   SD  + +++TR      Y +PE      +     DV++ 
Sbjct: 135 ITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDTQYGPPVDVWAI 189
Query: 346 GVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTSREEAV 385
           G V  ELL+G VP+ P +   + + L+   L  L  R + V
Sbjct: 190 GCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 30/190 (15%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K     K  + +   EV LL +L  P +++L  +  D+ +  L+ E    G L  
Sbjct: 56  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 115
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNF 294
            +     R+  +D   R+I  +     + ++H++    ++HRD K  N+LL     D N 
Sbjct: 116 EIISRK-RFSEVD-AARIIRQV--LSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 168
Query: 295 RAKVTDFGLA------KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           R  + DFGL+      K + DKI         GT  Y+APE    G    K DV+S GV+
Sbjct: 169 R--IIDFGLSTHFEASKKMKDKI---------GTAYYIAPEVLH-GTYDEKCDVWSTGVI 216
Query: 349 LLELLTGRVP 358
           L  LL+G  P
Sbjct: 217 LYILLSGCPP 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 66/124 (53%), Gaps = 8/124 (6%)
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           E+   GTL+Q + +   R   LD    L +       ++++H   +  +IHRD K SN+ 
Sbjct: 114 EFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIF 168
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
           L    + K+ DFGL  + S K +G+  TR  GT  Y++PE  S+     + D+Y+ G++L
Sbjct: 169 LVDTKQVKIGDFGL--VTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 225
Query: 350 LELL 353
            ELL
Sbjct: 226 AELL 229

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 133 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 184 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
           RE+ F  E   + +   P +V+L+G    +N   +I E    G L+  L     R   LD
Sbjct: 55  REK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKFSLD 109
Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
             + ++ A   + AL +L        +HRD    NVL+      K+ DFGL++ + D   
Sbjct: 110 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 166
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT------------------ 354
            + S   L    ++APE  +  + T+ SDV+ +GV + E+L                   
Sbjct: 167 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 355 ---GRVPVDPNRPPGEHVLVS--WAL-----PRLT 379
               R+P+ PN PP  + L++  WA      PR T
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 260

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 66/139 (47%), Gaps = 23/139 (16%)
Query: 230 EYMPNGTLQQHLHRHN-NRYRPLDWRT-RLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           EY  N TL   +H  N N+ R   WR  R I+      AL ++H      +IHRD K  N
Sbjct: 95  EYCENRTLYDLIHSENLNQQRDEYWRLFRQILE-----ALSYIHSQG---IIHRDLKPMN 146
Query: 288 VLLDQNFRAKVTDFGLAKMV----------SDKINGQIS--TRVLGTTGYLAPEYA-STG 334
           + +D++   K+ DFGLAK V          S  + G     T  +GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 335 KLTTKSDVYSYGVVLLELL 353
               K D+YS G++  E++
Sbjct: 207 HYNEKIDMYSLGIIFFEMI 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 127 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 178 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +E  +L+++HS  +V L      +    L+   M  G ++ H++  +           + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
                   LE LH+     +I+RD K  NVLLD +   +++D GLA  +     GQ  T+
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK---AGQTKTK 347
Query: 319 -VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
              GT G++APE     +     D ++ GV L E++  R P    R  GE V
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKV 396

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 128 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 130 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 181 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 129 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 180 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +E  +L+++HS  +V L      +    L+   M  G ++ H++  +           + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
                   LE LH+     +I+RD K  NVLLD +   +++D GLA  +     GQ  T+
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK---AGQTKTK 347
Query: 319 -VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
              GT G++APE     +     D ++ GV L E++  R P    R  GE V
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKV 396

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W   
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNW--- 123
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 124 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 178 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
             Y   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFGLAK++  +      
Sbjct: 126 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +E  +L+++HS  +V L      +    L+   M  G ++ H++  +           + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
                   LE LH+     +I+RD K  NVLLD +   +++D GLA  +     GQ  T+
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK---AGQTKTK 347
Query: 319 -VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
              GT G++APE     +     D ++ GV L E++  R P    R  GE V
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEKV 396

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR 318
           IA+    ALE LH   +  VIHRD K SNVL++   + K  DFG++  + D +   I   
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA- 197
Query: 319 VLGTTGYLAPEYA----STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV--LVS 372
             G   Y APE      +    + KSD++S G+  +EL   R P D    P + +  +V 
Sbjct: 198 --GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255
Query: 373 WALPRLTSREEAVEMVD 389
              P+L + + + E VD
Sbjct: 256 EPSPQLPADKFSAEFVD 272

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 92
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L   +A  F H H    V+HRD K  N+L++   
Sbjct: 93  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHSHR---VLHRDLKPQNLLINTEG 147
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 148 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205
Query: 354 TGR 356
           T R
Sbjct: 206 TRR 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD--- 252
            FR E D+L    S  +  L     D N+  L+ +Y   G L   L +  +R  P +   
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL-PEEMAR 178
Query: 253 -WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG-LAKMVSDK 310
            +   ++IA+D    L +         +HRD K  N+L+D N   ++ DFG   K++ D 
Sbjct: 179 FYLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228
Query: 311 INGQISTRV-LGTTGYLAPEY-----ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             G + + V +GT  Y++PE         G+   + D +S GV + E+L G  P
Sbjct: 229 --GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 78/181 (43%), Gaps = 13/181 (7%)
Query: 182 AIKKLHRDG---KQRERAFRMEVD-LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           A+K L +     K+ E+    E + LL  +  P LV L       +    + +Y+  G L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
             HL R      P   R R   A + A AL +LH      +++RD K  N+LLD      
Sbjct: 127 FYHLQRERCFLEP---RARFYAA-EIASALGYLHSLN---IVYRDLKPENILLDSQGHIV 179
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           +TDFGL K   +  +   ++   GT  YLAPE           D +  G VL E+L G  
Sbjct: 180 LTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
Query: 358 P 358
           P
Sbjct: 238 P 238

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLSFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 92
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 93  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 147
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 148 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205
Query: 354 TGR 356
           T R
Sbjct: 206 TRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 89
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 90  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 144
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 145 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202
Query: 354 TGR 356
           T R
Sbjct: 203 TRR 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 12/188 (6%)
Query: 182 AIKKLHRDGKQRERAFRM-EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH 240
           AIK L +  ++ +    M E  ++ +L +P +V L+G C  +   +L+ E    G L + 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKF 425
Query: 241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD 300
           L        P+     L+  +  +M +++L E      +HR+    NVLL     AK++D
Sbjct: 426 LVGKREEI-PVSNVAELLHQV--SMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISD 479
Query: 301 FGLAKMVSDKINGQISTRVLGT--TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRV 357
           FGL+K +    +   + R  G     + APE  +  K +++SDV+SYGV + E L+ G+ 
Sbjct: 480 FGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 358 PVDPNRPP 365
           P    + P
Sbjct: 539 PYKKMKGP 546

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV-------ELLGYCADQNHRLLI 228
            +    A+K L  D  +++ +     DL+S +   +++        LLG C       +I
Sbjct: 65  KEAVTVAVKMLKDDATEKDLS-----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 229 SEYMPNGTLQQHLHRHN----------NRY--RPLDWRTRLIIALDCAMALEFLHEHATP 276
             Y   G L+++L              NR     + ++  +      A  +E+L   A+ 
Sbjct: 120 VGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
             IHRD    NVL+ +N   K+ DFGLA+ +++    + +T       ++APE       
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 337 TTKSDVYSYGVVLLELLT 354
           T +SDV+S+GV++ E+ T
Sbjct: 237 THQSDVWSFGVLMWEIFT 254

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 141
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 142 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 354 TGR 356
           T R
Sbjct: 200 TRR 202

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G +AA K +    ++    + +E+++L+    P +V+LLG         ++ E+ P G +
Sbjct: 36  GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 95
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
              +   +   R L      ++      AL FLH   +  +IHRD K  NVL+      +
Sbjct: 96  DAIMLELD---RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR 149
Query: 298 VTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLTT-----KSDVYSYGVVLL 350
           + DFG    VS K    +  R   +GT  ++APE      +       K+D++S G+ L+
Sbjct: 150 LADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 205
Query: 351 EL 352
           E+
Sbjct: 206 EM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G +AA K +    ++    + +E+++L+    P +V+LLG         ++ E+ P G +
Sbjct: 44  GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
              +   +   R L      ++      AL FLH   +  +IHRD K  NVL+      +
Sbjct: 104 DAIMLELD---RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR 157
Query: 298 VTDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGKLTT-----KSDVYSYGVVLL 350
           + DFG    VS K    +  R   +GT  ++APE      +       K+D++S G+ L+
Sbjct: 158 LADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213
Query: 351 EL 352
           E+
Sbjct: 214 EM 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L   +A  F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQH------LHRH 244
           K +   F+ E+ +++ + +   +   G   + +   +I EYM N ++ +       L ++
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
              + P+    ++I  +  ++   F + H    + HRD K SN+L+D+N R K++DFG +
Sbjct: 144 YTCFIPI----QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 305 K-MVSDKINGQISTRVLGTTGYLAPEYAS--TGKLTTKSDVYSYGVVLLELLTGRVP 358
           + MV  KI G       GT  ++ PE+ S  +     K D++S G+ L  +    VP
Sbjct: 200 EYMVDKKIKGS-----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 23/151 (15%)
Query: 237 LQQHLHRHNNRYRPLDWRT-------RLIIALDCAMA---LEFLHEHATPPVIHRDFKCS 286
           L  H H H + Y  L  +T       RL ++  C +A   +E       P + HRDFK  
Sbjct: 83  LITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSR 142
Query: 287 NVLLDQNFRAKVTDFGLAKM---VSDKINGQISTRVLGTTGYLAPEYASTGKLT------ 337
           NVL+  N +  + D GLA M    SD ++   + RV GT  Y+APE       T      
Sbjct: 143 NVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEVLDEQIRTDCFESY 201
Query: 338 TKSDVYSYGVVLLELLTGRVP---VDPNRPP 365
             +D++++G+VL E+    +    V+  RPP
Sbjct: 202 KWTDIWAFGLVLWEIARRTIVNGIVEDYRPP 232

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEG 142
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 354 TGR 356
           T R
Sbjct: 201 TRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  MDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 142
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 354 TGR 356
           T R
Sbjct: 201 TRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEG 141
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 354 TGR 356
           T R
Sbjct: 200 TRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 142
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 354 TGR 356
           T R
Sbjct: 201 TRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 89
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 90  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 144
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 145 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202
Query: 354 TGR 356
           T R
Sbjct: 203 TRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 13/189 (6%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           LS+    AIK++     +  +    E+ L   L    +V+ LG  ++     +  E +P 
Sbjct: 44  LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103
Query: 235 GTLQQHLHRHNNRYRPL--DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
           G+L   L    +++ PL  + +T           L++LH++    ++HRD K  NVL++ 
Sbjct: 104 GSLSALLR---SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINT 157
Query: 293 -NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVL 349
            +   K++DFG +K ++  IN    T   GT  Y+APE    G       +D++S G  +
Sbjct: 158 YSGVLKISDFGTSKRLAG-INPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215
Query: 350 LELLTGRVP 358
           +E+ TG+ P
Sbjct: 216 IEMATGKPP 224

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 86
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 87  MDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEG 141
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 354 TGR 356
           T R
Sbjct: 200 TRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 141
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 354 TGR 356
           T R
Sbjct: 200 TRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 141
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 354 TGR 356
           T R
Sbjct: 200 TRR 202

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+  +D++ G ++TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+  +D++ G ++TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+  +D++ G ++TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 28/149 (18%)
Query: 226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH------EHATPPVI 279
           LL+ EY PNG+L ++L  H +     DW +   +A      L +LH      +H  P + 
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVS--------DKINGQISTRVLGTTGYLAPEYA 331
           HRD    NVL+  +    ++DFGL+  ++        ++ N  IS   +GT  Y+APE  
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE--VGTIRYMAPEVL 200
Query: 332 STG-------KLTTKSDVYSYGVVLLELL 353
                         + D+Y+ G++  E+ 
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 13/189 (6%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           LS+    AIK++     +  +    E+ L   L    +V+ LG  ++     +  E +P 
Sbjct: 30  LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 89
Query: 235 GTLQQHLHRHNNRYRPL--DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
           G+L   L    +++ PL  + +T           L++LH++    ++HRD K  NVL++ 
Sbjct: 90  GSLSALLR---SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINT 143
Query: 293 -NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVL 349
            +   K++DFG +K ++  IN    T   GT  Y+APE    G       +D++S G  +
Sbjct: 144 YSGVLKISDFGTSKRLAG-INPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 201
Query: 350 LELLTGRVP 358
           +E+ TG+ P
Sbjct: 202 IEMATGKPP 210

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 124
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
               +  A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 125 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 182 AIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQ 239
           A+K + +  G  R R FR EV++L +    + V  L    ++  R  L+ E M  G++  
Sbjct: 42  AVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 240 HLH--RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNF 294
           H+H  RH N           ++  D A AL+FLH      + HRD K  N+L +   Q  
Sbjct: 101 HIHKRRHFNELEA------SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 295 RAKVTDFGLAKMVSDKINGQ---ISTRVL----GTTGYLAPE----YASTGKLTTK-SDV 342
             K+ DF L   +  K+NG    IST  L    G+  Y+APE    ++    +  K  D+
Sbjct: 152 PVKICDFDLGSGI--KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 343 YSYGVVLLELLTGRVP 358
           +S GV+L  LL+G  P
Sbjct: 210 WSLGVILYILLSGYPP 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 129
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK------ 310
               +  A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 130 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 184 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
            I + M  G L  HL +H   +   D R     A +  + LE +H      V++RD K +
Sbjct: 268 FILDLMNGGDLHYHLSQHGV-FSEADMR---FYAAEIILGLEHMHNRF---VVYRDLKPA 320
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSY 345
           N+LLD++   +++D GLA   S K         +GT GY+APE    G    + +D +S 
Sbjct: 321 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 376
Query: 346 GVVLLELLTGRVPVDPNRPPGEH 368
           G +L +LL G  P   ++   +H
Sbjct: 377 GCMLFKLLRGHSPFRQHKTKDKH 399

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I++ MP G L  ++  H +       L+W   
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 122
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 123 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 177 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
            I + M  G L  HL +H   +   D R     A +  + LE +H      V++RD K +
Sbjct: 269 FILDLMNGGDLHYHLSQHGV-FSEADMR---FYAAEIILGLEHMHNRF---VVYRDLKPA 321
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSY 345
           N+LLD++   +++D GLA   S K         +GT GY+APE    G    + +D +S 
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 346 GVVLLELLTGRVPVDPNRPPGEH 368
           G +L +LL G  P   ++   +H
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L+  +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  MDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L+  +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 196 AFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR 254
           A R E  +L ++   P ++ L+      +   L+ + M  G L  +L     +    +  
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKE 201
Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
           TR I+      A+ FLH +    ++HRD K  N+LLD N + +++DFG +  +     G+
Sbjct: 202 TRSIMR-SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GE 254
Query: 315 ISTRVLGTTGYLAPEYASTGKLTT------KSDVYSYGVVLLELLTGRVP 358
               + GT GYLAPE        T      + D+++ GV+L  LL G  P
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L+  +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  QDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 87
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L+  +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 88  MDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 142
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 354 TGR 356
           T R
Sbjct: 201 TRR 203

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
            I + M  G L  HL +H   +   D R     A +  + LE +H      V++RD K +
Sbjct: 269 FILDLMNGGDLHYHLSQHGV-FSEADMR---FYAAEIILGLEHMHNRF---VVYRDLKPA 321
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSY 345
           N+LLD++   +++D GLA   S K         +GT GY+APE    G    + +D +S 
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 346 GVVLLELLTGRVPVDPNRPPGEH 368
           G +L +LL G  P   ++   +H
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
            I + M  G L  HL +H   +   D R     A +  + LE +H      V++RD K +
Sbjct: 269 FILDLMNGGDLHYHLSQHGV-FSEADMR---FYAAEIILGLEHMHNRF---VVYRDLKPA 321
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSY 345
           N+LLD++   +++D GLA   S K         +GT GY+APE    G    + +D +S 
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 346 GVVLLELLTGRVPVDPNRPPGEH 368
           G +L +LL G  P   ++   +H
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI------NGQIS--TRVLGTTGYLAPE 329
           VIHRD K SN+L++ N   KV DFGLA+++ +         GQ S  T  + T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 330 YAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL 375
              T  K +   DV+S G +L EL   R P+ P R     +L+ + +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGI 238

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 211
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 195
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI------NGQIS--TRVLGTTGYLAPE 329
           VIHRD K SN+L++ N   KV DFGLA+++ +         GQ S  T  + T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 330 YAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL 375
              T  K +   DV+S G +L EL   R P+ P R     +L+ + +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGI 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 166 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 217
Query: 326 LAPEYASTGK-LTTKSDVYSYGVVLLELLTGR 356
            APE            D++S G ++ ELLTGR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           V  I K     K  + +   EV LL +L  P + +L  +  D+ +  L+ E    G L  
Sbjct: 56  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFD 115
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNF 294
            +     R+  +D   R+I  +     + + H++    ++HRD K  N+LL     D N 
Sbjct: 116 EIISRK-RFSEVD-AARIIRQV--LSGITYXHKN---KIVHRDLKPENLLLESKSKDANI 168
Query: 295 RAKVTDFGLA------KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           R  + DFGL+      K   DKI         GT  Y+APE    G    K DV+S GV+
Sbjct: 169 R--IIDFGLSTHFEASKKXKDKI---------GTAYYIAPEVLH-GTYDEKCDVWSTGVI 216
Query: 349 LLELLTGRVP 358
           L  LL+G  P
Sbjct: 217 LYILLSGCPP 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 29/191 (15%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCA------DQNHRLLI 228
           G   AIKKL+R  +     +RA+R E+ LL  +    ++ LL          D     L+
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 229 SEYMPN--GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
             +M    G L +H     +R +         +       L ++H      +IHRD K  
Sbjct: 109 MPFMGTDLGKLMKHEKLGEDRIQ--------FLVYQMLKGLRYIHAAG---IIHRDLKPG 157
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSY 345
           N+ ++++   K+ DFGLA+    ++ G + TR      Y APE   +  + T   D++S 
Sbjct: 158 NLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSV 212
Query: 346 GVVLLELLTGR 356
           G ++ E++TG+
Sbjct: 213 GCIMAEMITGK 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-D 88
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 143
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +       V  T  Y APE     K  +T  D++S G +  E++
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 354 TGR 356
           T R
Sbjct: 202 TRR 204

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 71  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 127 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 177
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 233
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292
Query: 396 YPK 398
           +P+
Sbjct: 293 FPQ 295

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 234

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 65  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 120
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 121 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 171
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 172 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 227
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 228 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 286
Query: 396 YPK 398
           +P+
Sbjct: 287 FPQ 289

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 116 YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 171
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 172 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 222
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 223 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 278
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 279 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 337
Query: 396 YPK 398
           +P+
Sbjct: 338 FPQ 340

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 71  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 127 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 177
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 233
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292
Query: 396 YPK 398
           +P+
Sbjct: 293 FPQ 295

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WY 211
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 254

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 75  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 130
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 131 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 181
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 182 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 237
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 238 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 296
Query: 396 YPK 398
           +P+
Sbjct: 297 FPQ 299

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W   
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW--- 124
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 125 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 30/194 (15%)
Query: 177 DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--------------- 221
           DG    IK++  + ++ ER    EV  L++L    +V   G C D               
Sbjct: 35  DGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSR 89
Query: 222 -QNHRLLIS-EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI 279
            +   L I  E+   GTL+Q + +   R   LD    L +       ++++H   +  +I
Sbjct: 90  SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH---SKKLI 144
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           +RD K SN+ L    + K+ DFGL  + S K +G+   R  GT  Y++PE  S+     +
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGK-RXRSKGTLRYMSPEQISSQDYGKE 201
Query: 340 SDVYSYGVVLLELL 353
            D+Y+ G++L ELL
Sbjct: 202 VDLYALGLILAELL 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 234

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 17/188 (9%)
Query: 177 DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLISEYMPN 234
           +  V  + K+     ++ R F  E   L     P ++ +LG C      H  LI+ +MP 
Sbjct: 34  NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR-DFKCSNVLLDQN 293
           G+L   LH   N    +D    +  ALD A  + FL  H   P+I R      +V++D++
Sbjct: 94  GSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFL--HTLEPLIPRHALNSRSVMIDED 149
Query: 294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK---SDVYSYGVVLL 350
             A+++      M   K + Q   R+     ++APE        T    +D++S+ V+L 
Sbjct: 150 MTARIS------MADVKFSFQSPGRMYA-PAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 351 ELLTGRVP 358
           EL+T  VP
Sbjct: 203 ELVTREVP 210

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 73  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 128
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 129 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 179
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 180 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 235
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 236 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 294
Query: 396 YPK 398
           +P+
Sbjct: 295 FPQ 297

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 234

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W   
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW--- 124
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
               +  A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 125 ---CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 179 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 134 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 236

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 141 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 239

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 142 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 133 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 231

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 134 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 144 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 236

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 50  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 105
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 106 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 156
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 157 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 212
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 213 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 271
Query: 396 YPK 398
           +P+
Sbjct: 272 FPQ 274

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+ K+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 28  GEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 140
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 141 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198
Query: 354 TGR 356
           T R
Sbjct: 199 TRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+ K+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L++ +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 45  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 100
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 101 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 151
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 152 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 207
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 208 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 266
Query: 396 YPK 398
           +P+
Sbjct: 267 FPQ 269

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP---LDWRTR 256
           E  +++ + +P +  LLG C     +L I + MP G L  ++  H +       L+W  +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN---- 312
           +      A  + +L +     ++HRD    NVL+      K+TDFG AK++  +      
Sbjct: 130 I------AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 313 --GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD 360
             G++  + +     L   Y      T +SDV+SYGV + EL+T G  P D
Sbjct: 181 EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 56  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 111
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 112 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 162
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 163 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 218
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 219 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 277
Query: 396 YPK 398
           +P+
Sbjct: 278 FPQ 280

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT 337
           + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE     +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 338 TKS-DVYSYGVVLLELLTGRVPVD 360
            +  DV+S G+VL  +L G +P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 49  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 104
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 105 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 155
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 211
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 212 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 396 YPK 398
           +P+
Sbjct: 271 FPQ 273

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 42  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 97
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 98  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 148
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 149 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 204
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 205 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 263
Query: 396 YPK 398
           +P+
Sbjct: 264 FPQ 266

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 49  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 104
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 105 YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 155
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 211
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 212 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 396 YPK 398
           +P+
Sbjct: 271 FPQ 273

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI------NGQISTRV--LGTTGYLAPE 329
           VIHRD K SN+L++ N   KV DFGLA+++ +         GQ S  V  + T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 330 YAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL 375
              T  K +   DV+S G +L EL   R P+ P R     +L+ + +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGI 238

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+KK+  D +       A R E+ LL  L+ P +V+LL     +N   L+ E++ +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-H 84
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
             L+  +        PL      +  L     L F H H    V+HRD K  N+L++   
Sbjct: 85  QDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELL 353
             K+ DFGLA+     +  +  T  + T  Y APE     K  +T  D++S G +  E++
Sbjct: 140 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 354 TGR 356
           T R
Sbjct: 198 TRR 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 236

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 396 YPK 398
           +P+
Sbjct: 259 FPQ 261

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 396 YPK 398
           +P+
Sbjct: 259 FPQ 261

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 41  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 96
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 97  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 147
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 148 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 203
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 204 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 262
Query: 396 YPK 398
           +P+
Sbjct: 263 FPQ 265

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 396 YPK 398
           +P+
Sbjct: 259 FPQ 261

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ D+GLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 38  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 93
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 94  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 144
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 145 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 200
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 201 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 259
Query: 396 YPK 398
           +P+
Sbjct: 260 FPQ 262

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 64/139 (46%), Gaps = 23/139 (16%)
Query: 230 EYMPNGTLQQHLHRHN-NRYRPLDWRT-RLIIALDCAMALEFLHEHATPPVIHRDFKCSN 287
           EY  N TL   +H  N N+ R   WR  R I+      AL ++H      +IHR+ K  N
Sbjct: 95  EYCENRTLYDLIHSENLNQQRDEYWRLFRQILE-----ALSYIHSQG---IIHRNLKPXN 146
Query: 288 VLLDQNFRAKVTDFGLAKMV----------SDKINGQIS--TRVLGTTGYLAPEYA-STG 334
           + +D++   K+ DFGLAK V          S  + G     T  +GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTG 206
Query: 335 KLTTKSDVYSYGVVLLELL 353
               K D YS G++  E +
Sbjct: 207 HYNEKIDXYSLGIIFFEXI 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 67/158 (42%), Gaps = 23/158 (14%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVI 279
           LI+ +   G+L   L     +   + W     IA   A  L +LHE          P + 
Sbjct: 99  LITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLA-KMVSDKINGQISTRVLGTTGYLAPEYASTG---- 334
           HRD K  NVLL  N  A + DFGLA K  + K  G    +V GT  Y+APE         
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQ 212
Query: 335 -KLTTKSDVYSYGVVLLELLT----GRVPVDPNRPPGE 367
                + D+Y+ G+VL EL +       PVD    P E
Sbjct: 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 200 EVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           E+++L R    P ++ L     D  +  +++E M  G L   + R     +    R    
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ----KFFSEREASA 120
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVL-LDQNFR---AKVTDFGLAKMVSDKINGQ 314
           +       +E+LH      V+HRD K SN+L +D++      ++ DFG AK +  + NG 
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGL 176
Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPV--DPNRPPGE 367
           + T    T  ++APE           D++S GV+L  +LTG  P    P+  P E
Sbjct: 177 LMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 177 DGTV--AAIKKLHRD-GKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHR-----LL 227
           DGT    A+K +  D   QRE   F  E   +     P ++ LLG C + + +     ++
Sbjct: 59  DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118
Query: 228 ISEYMPNGTLQQHL--HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
           I  +M  G L  +L   R     + +  +T L   +D A+ +E+L        +HRD   
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAA 175
Query: 286 SNVLLDQNFRAKVTDFGLAKMVSDKI---NGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
            N +L  +    V DFGL+K +        G+I+        ++A E  +    T+KSDV
Sbjct: 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PVKWIAIESLADRVYTSKSDV 232
Query: 343 YSYGVVLLELLT-GRVP 358
           +++GV + E+ T G  P
Sbjct: 233 WAFGVTMWEIATRGMTP 249

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 175 LSDGTVAAIKK-LHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC----ADQNHRLLIS 229
           L DG   A+K+ L  + + RE A R E D+    + P ++ L+ YC      ++   L+ 
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQR-EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
            +   GTL   + R  ++   L     L + L     LE +H        HRD K +N+L
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA---HRDLKPTNIL 166
Query: 290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVL-------GTTGYLAPEYASTGK---LTTK 339
           L    +  + D G        + G      L        T  Y APE  S      +  +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 340 SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS 372
           +DV+S G VL  ++ G  P D     G+ V ++
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 19/171 (11%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQN--HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           E+ +L +L  P +V+L+    D N  H  ++ E +  G + +         +PL      
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPLSEDQAR 140
Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ--I 315
               D    +E+LH      +IHRD K SN+L+ ++   K+ DFG    VS++  G   +
Sbjct: 141 FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG----VSNEFKGSDAL 193
Query: 316 STRVLGTTGYLAPEYAS-TGKLTTKS--DVYSYGVVLLELLTGRVPVDPNR 363
            +  +GT  ++APE  S T K+ +    DV++ GV L   + G+ P    R
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 47/197 (23%)
Query: 237 LQQHLHRHNNRYRPLDWRTR------------LIIALDCAMALEFLHEHATPPVIHRDFK 284
           +Q  L R  N     DW  R            L I +  A A+EFLH      ++HRD K
Sbjct: 138 IQMQLCRKENLK---DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLK 191
Query: 285 CSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRV---------LGTTGYLAPEYASTG 334
            SN+    +   KV DFGL   M  D+    + T +         +GT  Y++PE     
Sbjct: 192 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN 251
Query: 335 KLTTKSDVYSYGVVLLELLTG--------RVPVD----------PNRPPGEHVLVSWAL- 375
             + K D++S G++L ELL          R+  D            + P EH++V   L 
Sbjct: 252 NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS 311
Query: 376 PRLTSREEAVEMVDPSL 392
           P  T R EA ++++ ++
Sbjct: 312 PSPTERPEATDIIENAI 328

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DFGL +   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 200 EVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           EVD+L ++   P +++L           L+ + M  G L  +L     +    +  TR I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 259 I--ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +   L+   AL  L+      ++HRD K  N+LLD +   K+TDFG +  +     G+  
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 180
Query: 317 TRVLGTTGYLAPEYASTGK------LTTKSDVYSYGVVLLELLTGRVP 358
             V GT  YLAPE               + D++S GV++  LL G  P
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 16/185 (8%)
Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
           D  +R+ +  +E+ LL     P ++ L     D  H  L++E M  G L   + R     
Sbjct: 61  DKSKRDPSEEIEI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ---- 115
Query: 249 RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL-LDQNFR---AKVTDFGLA 304
           +    R    +       +E+LH      V+HRD K SN+L +D++      ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPV--DPN 362
           K +  + NG + T    T  ++APE           D++S G++L  +L G  P    P+
Sbjct: 173 KQLRAE-NGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS 230
Query: 363 RPPGE 367
             P E
Sbjct: 231 DTPEE 235

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 200 EVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           EVD+L ++   P +++L           L+ + M  G L  +L     +    +  TR I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 259 I--ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +   L+   AL  L+      ++HRD K  N+LLD +   K+TDFG +  +     G+  
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 180
Query: 317 TRVLGTTGYLAPEYASTGK------LTTKSDVYSYGVVLLELLTGRVP 358
             V GT  YLAPE               + D++S GV++  LL G  P
Sbjct: 181 RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +       + T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 238

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +       + T  
Sbjct: 141 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 116/243 (47%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +D + + R    E+ ++ +L    +V L       G   D  
Sbjct: 37  YQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDVV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 396 YPK 398
           +P+
Sbjct: 259 FPQ 261

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 200 EVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           EVD+L ++   P +++L           L+ + M  G L  +L     +    +  TR I
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 116
Query: 259 I--ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +   L+   AL  L+      ++HRD K  N+LLD +   K+TDFG +  +     G+  
Sbjct: 117 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 167
Query: 317 TRVLGTTGYLAPEYASTGK------LTTKSDVYSYGVVLLELLTGRVP 358
             V GT  YLAPE               + D++S GV++  LL G  P
Sbjct: 168 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 16/185 (8%)
Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
           D  +R+ +  +E+ LL     P ++ L     D  H  L++E M  G L   + R     
Sbjct: 61  DKSKRDPSEEIEI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ---- 115
Query: 249 RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL-LDQNFR---AKVTDFGLA 304
           +    R    +       +E+LH      V+HRD K SN+L +D++      ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPV--DPN 362
           K +  + NG + T    T  ++APE           D++S G++L  +L G  P    P+
Sbjct: 173 KQLRAE-NGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS 230
Query: 363 RPPGE 367
             P E
Sbjct: 231 DTPEE 235

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY---RPLDWR 254
           R E+  +S L  P LV L     D N  ++I E+M  G L + +   +N+      +++ 
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261
Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKIN 312
            ++   L C M     HE+     +H D K  N++    ++   K+ DFGL   +  K +
Sbjct: 262 RQVCKGL-CHM-----HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +++T   GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 313 VKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY---RPLDWR 254
           R E+  +S L  P LV L     D N  ++I E+M  G L + +   +N+      +++ 
Sbjct: 96  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 155
Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKIN 312
            ++   L C M     HE+     +H D K  N++    ++   K+ DFGL   +  K +
Sbjct: 156 RQVCKGL-CHM-----HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 206
Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            +++T   GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 207 VKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+  FGLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTG 324
            L+++H   +  V+HRD K SN+L++     K+ DFGLA++   +  +    T  + T  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRP--PGEHVL 370
           Y APE     K  TKS D++S G +L E+L+       NRP  PG+H L
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-------NRPIFPGKHYL 254

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 200 EVDLLSRLHS---PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           EV LL RL +   P +V L+  CA       I   +    + Q L  + ++  P      
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 257 LIIAL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            I  L       L+FLH +    ++HRD K  N+L+      K+ DFGLA++ S ++   
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 175
Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
             T V+ T  Y APE        T  D++S G +  E+ 
Sbjct: 176 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 20/140 (14%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD-----CAMALEFLHEHATPPVIHR 281
           LI++Y  NG+L  +L     +   LD ++ L +A       C +  E       P + HR
Sbjct: 112 LITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 282 DFKCSNVLLDQNFRAKVTDFGLA-KMVSDKINGQI--STRVLGTTGYLAPEYASTG---- 334
           D K  N+L+ +N    + D GLA K +SD     I  +TRV GT  Y+ PE         
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLDESLNRN 225
Query: 335 --KLTTKSDVYSYGVVLLEL 352
             +    +D+YS+G++L E+
Sbjct: 226 HFQSYIMADMYSFGLILWEV 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 3/105 (2%)
Query: 250 PLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD 309
           P+     +  +   A  +EFL   ++   IHRD    N+LL +N   K+ DFGLA+ +  
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             +            ++APE       +TKSDV+SYGV+L E+ +
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ DF LA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
           G   A K +   G + +   + E+ ++++L    L++L      +N  +L+ EY+  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL-LDQNFRA 296
              +   +     LD  T L +   C   +  +H+     ++H D K  N+L ++++ + 
Sbjct: 174 FDRIIDESYNLTELD--TILFMKQICE-GIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 297 -KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            K+ DFGLA+    +   +++    GT  +LAPE  +   ++  +D++S GV+   LL+G
Sbjct: 228 IKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 356 RVP 358
             P
Sbjct: 285 LSP 287

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ D GLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 1/98 (1%)
Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           HRD K  N+L+  +  A + DFG+A   +D+   Q+   V GT  Y APE  S    T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 340 SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR 377
           +D+Y+   VL E LTG  P   ++       ++ A+PR
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPR 253

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ D GLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCA--------DQNHR 225
           +  G   A+K+L  + +++ RA   EV  + +L   P +V+     +         Q   
Sbjct: 50  VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC 285
           LL++E +  G L + L +  +R  PL   T L I      A++ +H    PP+IHRD K 
Sbjct: 110 LLLTE-LCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKV 166
Query: 286 SNVLLDQNFRAKVTDFGLAKMVS 308
            N+LL      K+ DFG A  +S
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTIS 189

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++  R E+ +L RL  P +++L           L+ E +  G L   +      Y   D 
Sbjct: 92  KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDA 150
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGLAKMVSDK 310
              +   L+   A+ +LHE+    ++HRD K  N+L      +   K+ DFGL+K+V  +
Sbjct: 151 ADAVKQILE---AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR 363
           +   +   V GT GY APE         + D++S G++   LL G  P    R
Sbjct: 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           R G  RE   R EV++L  +  P ++ L     ++   +LI E +  G L   L    + 
Sbjct: 54  RRGVSREEIER-EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL 112
Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGL 303
               D  T+ +        L+ +H   +  + H D K  N+ LLD+N    R K+ DFG+
Sbjct: 113 TE--DEATQFL-----KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  +     G     + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 166 AHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 22/203 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRM-EVDLLSRLHSPQLVELLGYCADQN--HRLLISEYMPN 234
           G + AIK  +     R    +M E ++L +L+   +V+L     +    H++LI E+ P 
Sbjct: 34  GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---- 290
           G+L   L   +N Y  L     LI+  D    +  L E+    ++HR+ K  N++     
Sbjct: 94  GSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGE 149
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG--------KLTTKSDV 342
           D     K+TDFG A+ + D    +    + GT  YL P+             K     D+
Sbjct: 150 DGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 343 YSYGVVLLELLTGRVPVDPNRPP 365
           +S GV      TG +P  P   P
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGP 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SN+ ++++   K+ D GLA+   D++ G ++TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WY 188
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 22/203 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRM-EVDLLSRLHSPQLVELLGYCADQN--HRLLISEYMPN 234
           G + AIK  +     R    +M E ++L +L+   +V+L     +    H++LI E+ P 
Sbjct: 34  GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---- 290
           G+L   L   +N Y  L     LI+  D    +  L E+    ++HR+ K  N++     
Sbjct: 94  GSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGE 149
Query: 291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG--------KLTTKSDV 342
           D     K+TDFG A+ + D    +    + GT  YL P+             K     D+
Sbjct: 150 DGQSVYKLTDFGAARELEDD---EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 343 YSYGVVLLELLTGRVPVDPNRPP 365
           +S GV      TG +P  P   P
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGP 229

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SNV ++++   ++ DFGLA+   +++ G ++TR      Y
Sbjct: 135 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WY 186
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELL G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SNV ++++   ++ DFGLA+   +++ G ++TR      Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           R G  RE   R EV++L  +  P ++ L     ++   +LI E +  G L   L    + 
Sbjct: 47  RRGVSREEIER-EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL 105
Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGL 303
               D  T+ +        L+ +H   +  + H D K  N+ LLD+N    R K+ DFG+
Sbjct: 106 TE--DEATQFL-----KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  +     G     + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 159 AHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+++H   +  +IHRD K SNV ++++   ++ DFGLA+   +++ G ++TR      Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGR 356
            APE         ++ D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           R G  RE   R EV++L  +  P ++ L     ++   +LI E +  G L   L    + 
Sbjct: 68  RRGVSREEIER-EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL 126
Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGL 303
               D  T+ +        L+ +H   +  + H D K  N+ LLD+N    R K+ DFG+
Sbjct: 127 TE--DEATQFL-----KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 179
Query: 304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  +     G     + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 180 AHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           E+ ++++LH P+L+ L     D+   +LI E++  G L   +   + +    +    +  
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNFRAKVTDFGLAKMVSDKIN-GQIS 316
           A +    L+ +HEH+   ++H D K  N++ +  +    K+ DFGLA     K+N  +I 
Sbjct: 158 ACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIV 207
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                T  + APE      +   +D+++ GV+   LL+G  P
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA--------TPPV 278
           LI+ +   G+L  +L     +   + W     +A   +  L +LHE           P +
Sbjct: 90  LITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSI 144
Query: 279 IHRDFKCSNVLLDQNFRAKVTDFGLA-KMVSDKINGQISTRVLGTTGYLAPEYASTG--- 334
            HRDFK  NVLL  +  A + DFGLA +    K  G    +V GT  Y+APE        
Sbjct: 145 AHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYMAPEVLEGAINF 203
Query: 335 --KLTTKSDVYSYGVVLLELLT----GRVPVDPNRPPGE 367
                 + D+Y+ G+VL EL++       PVD    P E
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFE 242

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R  K  E   R  ++  S  H P +V          H  ++ EY   G L +
Sbjct: 46  LVAVKYIERGEKIDENVKREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 240 HLHRHNNRYRPLDWR---TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--F 294
            +  +  R+   + R    +LI  +  A A++         V HRD K  N LLD +   
Sbjct: 105 RIC-NAGRFSEDEARFFFQQLISGVSYAHAMQ---------VAHRDLKLENTLLDGSPAP 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELL 353
           R K+ DFG +K  +  ++ Q  + V GT  Y+APE     +   K +DV+S GV L  +L
Sbjct: 155 RLKIADFGYSK--ASVLHSQPKSAV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 354 TGRVPV-DPNRP 364
            G  P  DP  P
Sbjct: 212 VGAYPFEDPEEP 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 16/185 (8%)
Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
           D  +R+    +E+ LL     P ++ L     D  +  +++E    G L   + R     
Sbjct: 56  DKSKRDPTEEIEI-LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ---- 110
Query: 249 RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL-LDQNFR---AKVTDFGLA 304
           +    R    +       +E+LH      V+HRD K SN+L +D++      ++ DFG A
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPV--DPN 362
           K +  + NG + T    T  ++APE           D++S GV+L   LTG  P    P+
Sbjct: 168 KQLRAE-NGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD 225
Query: 363 RPPGE 367
             P E
Sbjct: 226 DTPEE 230

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 33/243 (13%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +    + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ 395
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM     + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 396 YPK 398
           +P+
Sbjct: 259 FPQ 261

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 200 EVDLLSRLHS---PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           EV LL RL +   P +V L+  CA       I   +    + Q L  + ++  P      
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 257 LIIAL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            I  L       L+FLH +    ++HRD K  N+L+      K+ DFGLA++ S ++   
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 167
Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
               V+ T  Y APE        T  D++S G +  E+ 
Sbjct: 168 -LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 114
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 115 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 174
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 175 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLI 228
           G   A+KKL R  + +   +RA+R E+ LL  ++   ++ LL     Q          L+
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 105
Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
            E M +  L Q +H   +  R     + L+  + C +     H H+   +IHRD K SN+
Sbjct: 106 MELM-DANLCQVIHMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNI 155
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           ++  +   K+ DFGLA+  S      + T  + T  Y APE           D++S G +
Sbjct: 156 VVKSDCTLKILDFGLARTASTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 212
Query: 349 LLELLTGRV 357
           + EL+ G V
Sbjct: 213 MGELVKGSV 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 65  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 119
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 120 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 179
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 180 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 152
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 213 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 112/238 (47%), Gaps = 24/238 (10%)
Query: 171 YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC------ADQNH 224
           ++  L +    AIKK+ +D + + R    E+ ++  +  P +V+L  +        D+  
Sbjct: 57  FQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRT-RLIIALDCAMALEFLHEHATPPVIHRDF 283
             L+ EY+P     + ++R +  Y  L      L+I L     L  L    +  + HRD 
Sbjct: 113 LNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDI 167
Query: 284 KCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGKLTTKS 340
           K  N+LLD  +   K+ DFG AK++   I G+ +   + +  Y APE  + +T   TT  
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVSXICSRYYRAPELIFGATN-YTTNI 223
Query: 341 DVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK 398
           D++S G V+ EL+ G+ P+ P     + ++    +    SRE+   M    ++ ++P+
Sbjct: 224 DIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ 280

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R  K  E   R  ++  S  H P +V          H  ++ EY   G L +
Sbjct: 45  LVAVKYIERGEKIDENVKREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE 103
Query: 240 HLHRHNNRYRPLDWR---TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--F 294
            +  +  R+   + R    +LI  +    A++         V HRD K  N LLD +   
Sbjct: 104 RIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAP 153
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELL 353
           R K+ DFG +K  S  ++ Q  + V GT  Y+APE     +   K +DV+S GV L  +L
Sbjct: 154 RLKICDFGYSK--SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210
Query: 354 TGRVPV-DPNRP 364
            G  P  DP  P
Sbjct: 211 VGAYPFEDPEEP 222

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 116
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 117 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 176
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 177 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 85  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 139
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 199
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 200 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 33/232 (14%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +    + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPETVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 215 LLGYCADQN-------HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A  N          L+S+Y  +G+L  +L+R+      +     + +AL  A  L
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGL 113
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA---KMVSDKINGQISTRV 319
             LH         P + HRD K  N+L+ +N    + D GLA      +D I+   + RV
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 320 LGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLEL 352
            GT  Y+APE           +   ++D+Y+ G+V  E+
Sbjct: 174 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+FLH H    V+HRD K  N+L+  + + K+ DFGLA++ S ++     T V+ T  Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWY 185
Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELL 353
            APE        T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 49  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 107
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 108 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 154 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210
Query: 354 TGRVP 358
           +G  P
Sbjct: 211 SGASP 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+FLH H    V+HRD K  N+L+  + + K+ DFGLA++ S ++     T V+ T  Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWY 185
Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELL 353
            APE        T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 200 EVDLLSRLHS---PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           EV LL RL +   P +V L+  CA       I   +    + Q L  + ++  P      
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 257 LIIAL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            I  L       L+FLH +    ++HRD K  N+L+      K+ DFGLA++ S ++   
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 167
Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
               V+ T  Y APE        T  D++S G +  E+ 
Sbjct: 168 -LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 49  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 107
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 108 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 154 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210
Query: 354 TGRVP 358
           +G  P
Sbjct: 211 SGASP 215

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            L+FLH H    V+HRD K  N+L+  + + K+ DFGLA++ S ++     T V+ T  Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWY 185
Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELL 353
            APE        T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 33/232 (14%)
Query: 171 YKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQN 223
           Y+  L D G + AIKK+ +    + R    E+ ++ +L    +V L       G   D+ 
Sbjct: 37  YQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----ALEFLHEHATPPV 278
           +  L+ +Y+P    +  + RH +R +    +T  +I +   M     +L ++H      +
Sbjct: 93  YLNLVLDYVPATVYR--VARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHSFG---I 143
Query: 279 IHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGK 335
            HRD K  N+LLD +    K+ DFG AK +   + G+ +   + +  Y APE  + +T  
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPELIFGAT-D 199
Query: 336 LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
            T+  DV+S G VL ELL G+ P+ P     + ++    +    +RE+  EM
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 200 EVDLLSRLHS---PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           EV LL RL +   P +V L+  CA       I   +    + Q L  + ++  P      
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 257 LIIAL--DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
            I  L       L+FLH +    ++HRD K  N+L+      K+ DFGLA++ S ++   
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 167
Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
               V+ T  Y APE        T  D++S G +  E+ 
Sbjct: 168 -LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG-YCADQNHRLLISEYMP 233
           G   AIKKL R  +     +RA+R E+ LL  +    ++ LL  +    + R     Y+ 
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM--ALEFLHEHATPPVIHRDFKCSNVLLD 291
              +Q  L +       +++    I  L   M   L+++H      V+HRD K  N+ ++
Sbjct: 126 MPFMQTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 178
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLL 350
           ++   K+ DFGLA+    ++ G + TR      Y APE   S        D++S G ++ 
Sbjct: 179 EDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMA 233
Query: 351 ELLTGR 356
           E+LTG+
Sbjct: 234 EMLTGK 239

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYR-PLDWRTRLIIALDCAMALE 268
           P +V+L     DQ H  L+ E +  G L + + +  +       +  R +++     A+ 
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVS 120
Query: 269 FLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            +H+     V+HRD K  N+L    + N   K+ DFG A++     N  + T    T  Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCF-TLHY 175
Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            APE  +        D++S GV+L  +L+G+VP
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDL-LSRLHSPQLVELLGYCADQNH----RLLISEYM 232
           G   A+K L+   K R+     EVD        P +V +L    + +H     L+I E M
Sbjct: 54  GQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-- 290
             G L   +    ++      R    I  D   A++FLH H    + HRD K  N+L   
Sbjct: 109 EGGELFSRIQERGDQ--AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTS 163
Query: 291 -DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
            +++   K+TDFG AK   +     + T    T  Y+APE     K     D++S GV++
Sbjct: 164 KEKDAVLKLTDFGFAK---ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 350 LELLTGRVPVDPN 362
             LL G  P   N
Sbjct: 220 YILLCGFPPFYSN 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 178 GTVAAIKKLHRDGKQRERAFRMEVDL-LSRLHSPQLVELLGYCADQNH----RLLISEYM 232
           G   A+K L+   K R+     EVD        P +V +L    + +H     L+I E M
Sbjct: 35  GQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 89
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-- 290
             G L   +    ++      R    I  D   A++FLH H    + HRD K  N+L   
Sbjct: 90  EGGELFSRIQERGDQ--AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTS 144
Query: 291 -DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVL 349
            +++   K+TDFG AK   +     + T    T  Y+APE     K     D++S GV++
Sbjct: 145 KEKDAVLKLTDFGFAK---ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 350 LELLTGRVPVDPN 362
             LL G  P   N
Sbjct: 201 YILLCGFPPFYSN 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 29/185 (15%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH 244
           K  R G  RE   R EV +L  +  P ++ L     ++   +LI E +  G L   L   
Sbjct: 50  KSSRRGVSREDIER-EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 108
Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHA-------TPPVIHRDFKCSNV-LLDQNF-- 294
                          +L    A EFL +         +  + H D K  N+ LLD+N   
Sbjct: 109 E--------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 295 -RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELL 353
            R K+ DFGLA  +     G     + GT  ++APE  +   L  ++D++S GV+   LL
Sbjct: 155 PRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 354 TGRVP 358
           +G  P
Sbjct: 212 SGASP 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLG-YCADQNHRLLISEYMP 233
           G   AIKKL R  +     +RA+R E+ LL  +    ++ LL  +    + R     Y+ 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM--ALEFLHEHATPPVIHRDFKCSNVLLD 291
              +Q  L +       L +    I  L   M   L+++H      V+HRD K  N+ ++
Sbjct: 108 MPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLL 350
           ++   K+ DFGLA+    ++ G + TR      Y APE   S        D++S G ++ 
Sbjct: 161 EDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 351 ELLTGR 356
           E+LTG+
Sbjct: 216 EMLTGK 221

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 56/230 (24%)
Query: 179 TVAAIKKLHRDG------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM 232
            + AIK ++++       K  ER  + EV L+ +LH P +  L     D+ +  L+ E  
Sbjct: 52  AIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 233 PNGTLQQHLHR---------------------------------HNNRYRPLDW--RTRL 257
             G L   L+                                  H  R   LD+  R +L
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFR-ESLDFVQREKL 169
Query: 258 I--IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--FRAKVTDFGLAKMVSDKING 313
           I  I      AL +LH      + HRD K  N L   N  F  K+ DFGL+K      NG
Sbjct: 170 ISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 314 Q---ISTRVLGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVP 358
           +   ++T+  GT  ++APE  +T   +   K D +S GV+L  LL G VP
Sbjct: 227 EYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           R G  RE   R EV +L ++  P ++ L     ++   +LI E +  G L   L +  + 
Sbjct: 54  RRGVCREEIER-EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL 112
Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGL 303
               +  + +   LD    + +LH   T  + H D K  N+ LLD+N      K+ DFGL
Sbjct: 113 SEE-EATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  + D +  +    + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 166 AHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 178 GTVAAIKKLHR-DGKQRER--AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
           G V A+K +++ D  +R     FR E D+L       + +L     D+N+  L+ EY   
Sbjct: 86  GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145
Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G L   L +   R  P +   R  +A +  MA++ +H       +HRD K  N+LLD+  
Sbjct: 146 GDLLTLLSKFGERI-PAE-MARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 295 RAKVTDFGLAKMVSDKINGQISTRV-LGTTGYLAPEYAST-------GKLTTKSDVYSYG 346
             ++ DFG    +  + +G + + V +GT  YL+PE           G    + D ++ G
Sbjct: 200 HIRLADFG--SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 347 VVLLELLTGRVP 358
           V   E+  G+ P
Sbjct: 258 VFAYEMFYGQTP 269

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 178 GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLI 228
           G   A+KKL R  + +   +RA+R E+ LL  ++   ++ LL     Q          L+
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
            E M +  L Q +H   +  R     + L+  + C +     H H+   +IHRD K SN+
Sbjct: 108 MELM-DANLCQVIHMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNI 157
Query: 289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVV 348
           ++  +   K+ DFGLA+         + T  + T  Y APE           D++S G +
Sbjct: 158 VVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCI 214
Query: 349 LLELLTGRV 357
           + EL+ G V
Sbjct: 215 MGELVKGCV 223

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R G++     + E+     L  P +V          H  ++ EY   G L +
Sbjct: 46  LVAVKYIER-GEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 240 HLHRHNNRYRPLDWR---TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--F 294
            +  +  R+   + R    +LI  +    A++         V HRD K  N LLD +   
Sbjct: 105 RIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAP 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELL 353
           R K+ DFG +K  S  ++ Q  + V GT  Y+APE     +   K +DV+S GV L  +L
Sbjct: 155 RLKICDFGYSK--SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 354 TGRVPV-DPNRP 364
            G  P  DP  P
Sbjct: 212 VGAYPFEDPEEP 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 178 GTVAAIKKLH---RDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHR--LLISEY 231
           G V A+KK+    ++    +R FR E+ +L+ L     +V LL      N R   L+ +Y
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M       H     N   P+    +  +       +++LH      ++HRD K SN+LL+
Sbjct: 93  METDL---HAVIRANILEPVH---KQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLN 143
Query: 292 QNFRAKVTDFGLA------KMVSDKI-------------NGQISTRVLGTTGYLAPE-YA 331
                KV DFGL+      + V++ I             +  I T  + T  Y APE   
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203
Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVPVDP 361
            + K T   D++S G +L E+L G+ P+ P
Sbjct: 204 GSTKYTKGIDMWSLGCILGEILCGK-PIFP 232

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +  +   A  +EFL   A+   IHRD    N+LL +    K+ DFGLA+ +    +    
Sbjct: 194 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 250
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
                   ++APE       T +SDV+S+GV+L E+ +               L +   P
Sbjct: 251 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYP 295
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            +   EE    +    + + P             C   E + RP  +++V+ L  +++ N
Sbjct: 296 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 355
Query: 437 A 437
           A
Sbjct: 356 A 356

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +  +   A  +EFL   A+   IHRD    N+LL +    K+ DFGLA+ +    +    
Sbjct: 201 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 257
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
                   ++APE       T +SDV+S+GV+L E+ +               L +   P
Sbjct: 258 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYP 302
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            +   EE    +    + + P             C   E + RP  +++V+ L  +++ N
Sbjct: 303 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 362
Query: 437 A 437
           A
Sbjct: 363 A 363

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +  +   A  +EFL   A+   IHRD    N+LL +    K+ DFGLA+ +    +    
Sbjct: 203 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 259
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
                   ++APE       T +SDV+S+GV+L E+ +               L +   P
Sbjct: 260 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYP 304
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            +   EE    +    + + P             C   E + RP  +++V+ L  +++ N
Sbjct: 305 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 364
Query: 437 A 437
           A
Sbjct: 365 A 365

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +  +   A  +EFL   A+   IHRD    N+LL +    K+ DFGLA+ +    +    
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
                   ++APE       T +SDV+S+GV+L E+ +               L +   P
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYP 297
Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLXXXXXXXXVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            +   EE    +    + + P             C   E + RP  +++V+ L  +++ N
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
Query: 437 A 437
           A
Sbjct: 358 A 358

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 215 LLGYCA-DQNHR------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A D   R       LI+ Y   G+L  +L     +   LD  + L I L  A  L
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGL 118
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST----R 318
             LH         P + HRD K  N+L+ +N +  + D GLA M S   N Q+      R
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN-QLDVGNNPR 177
Query: 319 VLGTTGYLAPEY------ASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPP 365
           V GT  Y+APE               + D++++G+VL E+    V    V+  +PP
Sbjct: 178 V-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 215 LLGYCA-DQNHR------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A D   R       LI+ Y   G+L  +L     +   LD  + L I L  A  L
Sbjct: 93  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGL 147
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST----R 318
             LH         P + HRD K  N+L+ +N +  + D GLA M S   N Q+      R
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN-QLDVGNNPR 206
Query: 319 VLGTTGYLAPEY------ASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPP 365
           V GT  Y+APE               + D++++G+VL E+    V    V+  +PP
Sbjct: 207 V-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 261

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 76/181 (41%), Gaps = 21/181 (11%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +   L  P +V L    +++ H  LI + +  G L + + 
Sbjct: 58  KKLSARDHQKLER----EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI- 112
Query: 243 RHNNRYRPLDWRTRLIIALDCAMAL--EFLHEHATPPVIHRDFKCSNVLLDQNFRA---K 297
                Y   D       A  C   +    LH H    V+HRD K  N+LL    +    K
Sbjct: 113 VAREYYSEAD-------ASHCIQQILEAVLHCHQMG-VVHRDLKPENLLLASKLKGAAVK 164
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFGLA  V  +          GT GYL+PE           D+++ GV+L  LL G  
Sbjct: 165 LADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 222
Query: 358 P 358
           P
Sbjct: 223 P 223

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 35/199 (17%)
Query: 176 SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY---CADQNHRLL----I 228
           S G   AIKK+ +D + R R  ++  DL + LH P +V+L  Y     +++ R +    +
Sbjct: 46  STGMSVAIKKVIQDPRFRNRELQIMQDL-AVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104
Query: 229 SEYMPNGTLQQHLHRH-NNRYR------PLDWRT---RLIIALDCAMALEFLHEHATPPV 278
            EY+P+      LHR   N YR      P+  +    +LI ++ C      LH  +   V
Sbjct: 105 MEYVPDT-----LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC------LHLPSVN-V 152
Query: 279 IHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK-L 336
            HRD K  NVL+++ +   K+ DFG AK +S     + +   + +  Y APE     +  
Sbjct: 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHY 209
Query: 337 TTKSDVYSYGVVLLELLTG 355
           TT  D++S G +  E++ G
Sbjct: 210 TTAVDIWSVGCIFAEMMLG 228

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 215 LLGYCA-DQNHR------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           +LG+ A D   R       LI+ Y   G+L  +L     +   LD  + L I L  A  L
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGL 118
Query: 268 EFLH-----EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST----R 318
             LH         P + HRD K  N+L+ +N +  + D GLA M S   N Q+      R
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN-QLDVGNNPR 177
Query: 319 VLGTTGYLAPEY------ASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPP 365
           V GT  Y+APE               + D++++G+VL E+    V    V+  +PP
Sbjct: 178 V-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 79/189 (41%), Gaps = 15/189 (7%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R     E   R  ++  S  H P +V          H  +I EY   G L +
Sbjct: 47  LVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIMEYASGGELYE 105
Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--FRAK 297
              R  N  R  +   R          + + H      + HRD K  N LLD +   R K
Sbjct: 106 ---RICNAGRFSEDEARFFFQ-QLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLK 158
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELLTGR 356
           + DFG +K  S  ++ Q  + V GT  Y+APE     +   K +DV+S GV L  +L G 
Sbjct: 159 ICDFGYSK--SSVLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 357 VPV-DPNRP 364
            P  DP  P
Sbjct: 216 YPFEDPEEP 224

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 21/192 (10%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R  K  E   R  ++  S  H P +V          H  ++ EY   G L +
Sbjct: 46  LVAVKYIERGEKIDENVKREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 240 HLHRHNNRYRPLDWR---TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--F 294
            +  +  R+   + R    +LI  +    A++         V HRD K  N LLD +   
Sbjct: 105 RIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAP 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELL 353
           R K+  FG +K  S  ++ Q  + V GT  Y+APE     +   K +DV+S GV L  +L
Sbjct: 155 RLKICAFGYSK--SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 354 TGRVPV-DPNRP 364
            G  P  DP  P
Sbjct: 212 VGAYPFEDPEEP 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 8/165 (4%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            + E  +   L  P +VELL   +      ++ E+M    L   + +  +          
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKING 313
                    AL + H++    +IHRD K  NVLL   + +   K+ DFG+A  + +  +G
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE--SG 187
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            ++   +GT  ++APE           DV+  GV+L  LL+G +P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 21/181 (11%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +   L  P +V L    +++ H  LI + +  G L + + 
Sbjct: 47  KKLSARDHQKLER----EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI- 101
Query: 243 RHNNRYRPLDWRTRLIIALDCAMAL--EFLHEHATPPVIHRDFKCSNVLLDQNFRA---K 297
                Y   D       A  C   +    LH H    V+HR+ K  N+LL    +    K
Sbjct: 102 VAREYYSEAD-------ASHCIQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVK 153
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFGLA  V  +          GT GYL+PE           D+++ GV+L  LL G  
Sbjct: 154 LADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
Query: 358 P 358
           P
Sbjct: 212 P 212

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
           S Y+    ++  LH+  +  +PL               L+++H   +  VIHRD K SN+
Sbjct: 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNL 189
Query: 289 LLDQNFRAKVTDFGLAK--MVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSY 345
           L+++N   K+ DFG+A+    S   +    T  + T  Y APE   S  + T   D++S 
Sbjct: 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 346 GVVLLELLTGR 356
           G +  E+L  R
Sbjct: 250 GCIFGEMLARR 260

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV 288
           S Y+    ++  LH+  +  +PL               L+++H   +  VIHRD K SN+
Sbjct: 134 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNL 190
Query: 289 LLDQNFRAKVTDFGLAK--MVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSY 345
           L+++N   K+ DFG+A+    S   +    T  + T  Y APE   S  + T   D++S 
Sbjct: 191 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 250
Query: 346 GVVLLELLTGR 356
           G +  E+L  R
Sbjct: 251 GCIFGEMLARR 261

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 36/135 (26%)
Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK-------- 310
           I  +  +   F+HE     +IHRD K +N LL+Q+   KV DFGLA+ ++ +        
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 311 -------------INGQISTRVLGTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELL--- 353
                        +  Q+++ V+ T  Y APE     +  TKS D++S G +  ELL   
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 354 -------TGRVPVDP 361
                  T R P+ P
Sbjct: 250 QSHINDPTNRFPLFP 264

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G   A+KK+      R   FR+E +   + L SP++V L G   +     +  E +  G+
Sbjct: 83  GFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHEHATPPVIHRDFKCSNVLLDQNF- 294
           L Q + +      P D   R +  L  A+  LE+LH   T  ++H D K  NVLL  +  
Sbjct: 137 LGQLIKQMGCL--PED---RALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGS 188
Query: 295 RAKVTDFGLAKMVS-DKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
           RA + DFG A  +  D +   + T   + GT  ++APE         K D++S   ++L 
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 352 LLTGRVP 358
           +L G  P
Sbjct: 249 MLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G   A+KK+      R   FR+E +   + L SP++V L G   +     +  E +  G+
Sbjct: 99  GFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHEHATPPVIHRDFKCSNVLLDQNF- 294
           L Q + +      P D   R +  L  A+  LE+LH   T  ++H D K  NVLL  +  
Sbjct: 153 LGQLIKQMGCL--PED---RALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGS 204
Query: 295 RAKVTDFGLAKMVS-DKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
           RA + DFG A  +  D +   + T   + GT  ++APE         K D++S   ++L 
Sbjct: 205 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 264
Query: 352 LLTGRVP 358
           +L G  P
Sbjct: 265 MLNGCHP 271

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G   A+KK+      R   FR+E +   + L SP++V L G   +     +  E +  G+
Sbjct: 97  GFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 150
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHEHATPPVIHRDFKCSNVLLDQNF- 294
           L Q + +      P D   R +  L  A+  LE+LH   T  ++H D K  NVLL  +  
Sbjct: 151 LGQLIKQMGCL--PED---RALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGS 202
Query: 295 RAKVTDFGLAKMVS-DKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
           RA + DFG A  +  D +   + T   + GT  ++APE         K D++S   ++L 
Sbjct: 203 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 262
Query: 352 LLTGRVP 358
           +L G  P
Sbjct: 263 MLNGCHP 269

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
           R G  RE   R EV +L ++    ++ L     ++   +LI E +  G L   L +  + 
Sbjct: 54  RRGVSREEIER-EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES- 111
Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGL 303
              L               + +LH   T  + H D K  N+ LLD+N      K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           A  + D +  +    + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 166 AHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 61/228 (26%)
Query: 181 AAIKKLHR---DGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE-YMPNGT 236
            AIKK++R   D    +R  R E+ +L+RL S  ++ L        H L+I E  +    
Sbjct: 56  VAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRL--------HDLIIPEDLLKFDE 106
Query: 237 LQQHLHRHNNRYRPLDWRTRLI--------IALDCAMALEFLHEHATPPVIHRDFKCSNV 288
           L   L   ++  + L ++T +         I  +  +  +F+HE     +IHRD K +N 
Sbjct: 107 LYIVLEIADSDLKKL-FKTPIFLTEQHVKTILYNLLLGEKFIHESG---IIHRDLKPANC 162
Query: 289 LLDQNFRAKVTDFGLAKMV-SDK-----------------------INGQISTRVLGTTG 324
           LL+Q+   K+ DFGLA+ + SDK                       +  Q+++ V+ T  
Sbjct: 163 LLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVV-TRW 221
Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELL----------TGRVPVDP 361
           Y APE     +  T S D++S G +  ELL          T R P+ P
Sbjct: 222 YRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFP 269

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 269 FLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           +LH   T  + H D K  N+ LLD+N      K+ DFGLA  + D +  +    + GT  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 21/192 (10%)
Query: 180 VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           + A+K + R  K  E   R  ++  S  H P +V          H  ++ EY   G L +
Sbjct: 46  LVAVKYIERGEKIDENVKREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 240 HLHRHNNRYRPLDWR---TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--F 294
            +  +  R+   + R    +LI  +    A++         V HRD K  N LLD +   
Sbjct: 105 RIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAP 154
Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELL 353
           R K+  FG +K  S  ++ Q    V GT  Y+APE     +   K +DV+S GV L  +L
Sbjct: 155 RLKICAFGYSK--SSVLHSQPKDTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 354 TGRVPV-DPNRP 364
            G  P  DP  P
Sbjct: 212 VGAYPFEDPEEP 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +  +L  P +V L     +++   L+ + +  G L + + 
Sbjct: 42  KKLSARDFQKLER----EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI- 96
Query: 243 RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA---KVT 299
                Y   D    +   L+   ++ + H +    ++HR+ K  N+LL    +    K+ 
Sbjct: 97  VAREFYSEADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           DFGLA  V+D    +      GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 151 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 269 FLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           +LH   T  + H D K  N+ LLD+N      K+ DFGLA  + D +  +    + GT  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +  +L  P +V L     +++   L+ + +  G L + + 
Sbjct: 42  KKLSARDFQKLER----EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI- 96
Query: 243 RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA---KVT 299
                Y   D    +   L+   ++ + H +    ++HR+ K  N+LL    +    K+ 
Sbjct: 97  VAREFYSEADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           DFGLA  V+D    +      GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 151 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 269 FLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           +LH   T  + H D K  N+ LLD+N      K+ DFGLA  + D +  +    + GT  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 18/195 (9%)
Query: 171 YKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLL 227
           +KG    +  V  + K+     ++ R F  E   L     P ++ +LG C      H  L
Sbjct: 27  WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86
Query: 228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR-DFKCS 286
           I+ + P G+L   LH   N    +D    +  ALD A    FL  H   P+I R      
Sbjct: 87  ITHWXPYGSLYNVLHEGTNFV--VDQSQAVKFALDXARGXAFL--HTLEPLIPRHALNSR 142
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTK---SDVY 343
           +V +D++  A+++   +      K + Q   R      ++APE        T    +D +
Sbjct: 143 SVXIDEDXTARISXADV------KFSFQSPGRXYA-PAWVAPEALQKKPEDTNRRSADXW 195
Query: 344 SYGVVLLELLTGRVP 358
           S+ V+L EL+T  VP
Sbjct: 196 SFAVLLWELVTREVP 210

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +  +L  P +V L     +++   L+ + +  G L + + 
Sbjct: 41  KKLSARDFQKLER----EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI- 95
Query: 243 RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA---KVT 299
                Y   D    +   L+   ++ + H +    ++HR+ K  N+LL    +    K+ 
Sbjct: 96  VAREFYSEADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 149
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           DFGLA  V+D    +      GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 150 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 269 FLHEHATPPVIHRDFKCSNV-LLDQNF---RAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
           +LH   T  + H D K  N+ LLD+N      K+ DFGLA  + D +  +    + GT  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 184 KKLH-RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLH 242
           KKL  RD ++ ER    E  +  +L  P +V L     +++   L+ + +  G L + + 
Sbjct: 65  KKLSARDFQKLER----EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI- 119
Query: 243 RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA---KVT 299
                Y   D    +   L+   ++ + H +    ++HR+ K  N+LL    +    K+ 
Sbjct: 120 VAREFYSEADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173
Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           DFGLA  V+D    +      GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 174 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
           D  +AL  LH      ++H D K +N+ L    R K+ DFGL   +     G++     G
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---G 218
Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
              Y+APE    G   T +DV+S G+ +LE+
Sbjct: 219 DPRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 278 VIHRDFKCSNVLLDQNFRA---KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
           V+HRD K  N+LL    +    K+ DFGLA  V    + Q      GT GYL+PE     
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKE 181
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D+++ GV+L  LL G  P
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPP 205

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRA---KVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           +H+H    ++HRD K  N+LL    +    K+ DFGLA  V  +          GT GYL
Sbjct: 146 IHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYL 200
Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +PE           D+++ GV+L  LL G  P
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRA--KVTDFGLAKMVSDKINGQISTRVLGTT 323
            L+ LH++    +IH D K  N+LL Q  R+  KV DFG +     ++   I +R     
Sbjct: 212 CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF---- 264
Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
            Y APE     +     D++S G +L ELLTG  P+ P    G+ +
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQL 308

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRA--KVTDFGLAKMVSDKINGQISTRVLGTT 323
            L+ LH++    +IH D K  N+LL Q  R+  KV DFG +     ++   I +R     
Sbjct: 212 CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF---- 264
Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
            Y APE     +     D++S G +L ELLTG  P+ P    G+ +
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQL 308

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRA--KVTDFGLAKMVSDKINGQISTRVLGTT 323
            L+ LH++    +IH D K  N+LL Q  R+  KV DFG +     ++   I +R     
Sbjct: 212 CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF---- 264
Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
            Y APE     +     D++S G +L ELLTG  P+ P    G+ +
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQL 308

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 11/94 (11%)
Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNF---RAKVTDFGLAKMVSDKINGQISTR-VLGTTG 324
           +LH++    ++H D K  N+LL   +     K+ DFG+++    KI      R ++GT  
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELREIMGTPE 198
Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           YLAPE  +   +TT +D+++ G++   LLT   P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 226 LLISEYMPNGTLQQHLHR----HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR 281
           ++I  +M +G L   L       N    PL    R ++ + C M  E+L   ++   IHR
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM--EYL---SSRNFIHR 161
Query: 282 DFKCSNVLLDQNFRAKVTDFGLAKMV--SDKINGQISTRVLGTTGYLAPEYASTGKLTTK 339
           D    N +L ++    V DFGL++ +   D      ++++     +LA E  +    T  
Sbjct: 162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVH 219
Query: 340 SDVYSYGVVLLELLT-GRVP 358
           SDV+++GV + E++T G+ P
Sbjct: 220 SDVWAFGVTMWEIMTRGQTP 239

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 11/180 (6%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q     + E+     +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIV 107
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
            + +  + ++   ++     +  L   M +   H H+   +IHRD K SN+++  +   K
Sbjct: 108 MELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLK 166
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFGLA+         + T  + T  Y APE           D++S GV++ E++ G V
Sbjct: 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 11/180 (6%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q     + E+     +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIV 107
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
            + +  + ++   ++     +  L   M +   H H+   +IHRD K SN+++  +   K
Sbjct: 108 MELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLK 166
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFGLA+         + T  + T  Y APE           D++S GV++ E++ G V
Sbjct: 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 278 VIHRDFKCSNVLLDQNFRA---KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
           ++HRD K  N+LL    +    K+ DFGLA  V    + Q      GT GYL+PE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKD 181
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D+++ GV+L  LL G  P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPP 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 278 VIHRDFKCSNVLLDQNFRA---KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
           ++HRD K  N+LL    +    K+ DFGLA  V    + Q      GT GYL+PE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKD 181
Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
                 D+++ GV+L  LL G  P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPP 205

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLSQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DATLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLSQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLSQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DATLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 111 M-DANLXQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 9/180 (5%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           T   +K L +  +    +F     ++S+L    LV   G C   +  +L+ E++  G+L 
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            +L ++ N    L W  +L +A   A A+ FL E+    +IH +    N+LL +    K 
Sbjct: 101 TYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 299 TDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTG 355
            +    K+    I+  +  +  +     ++ PE     K L   +D +S+G  L E+ +G
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 45/205 (21%)
Query: 185 KLHRDGKQRERAFRMEVDLLSRLHSPQL-----VELLGYCADQNHRLLISEYMPNG-TLQ 238
           K+ R+ K+  R+ ++E D+L ++ +  +     V+  G     +H  LI E  P G +L 
Sbjct: 66  KVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLY 123
Query: 239 QHLHRHN-NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD------ 291
           + + R+N N +   D      I L C   L+ L+      + H D K  N+LLD      
Sbjct: 124 EIITRNNYNGFHIED------IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 292 --------------QNFRAKVT-----DFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                         Q +R K T     DFG A   SD     I+TR      Y APE   
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTR-----QYRAPEVIL 232
Query: 333 TGKLTTKSDVYSYGVVLLELLTGRV 357
                  SD++S+G VL EL TG +
Sbjct: 233 NLGWDVSSDMWSFGCVLAELYTGSL 257

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 20/187 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G   A+KK+      R   FR E +   + L SP++V L G   +     +  E +  G+
Sbjct: 118 GFQCAVKKV------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGS 171
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           L Q +        P D   R +  L  A+  LE+LH      ++H D K  NVLL  +  
Sbjct: 172 LGQLVKEQG--CLPED---RALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGS 223
Query: 296 -AKVTDFGLAKMVS-DKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            A + DFG A  +  D +   + T   + GT  ++APE         K DV+S   ++L 
Sbjct: 224 HAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLH 283
Query: 352 LLTGRVP 358
           +L G  P
Sbjct: 284 MLNGCHP 290

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L        IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 126 --YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 181 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 11/180 (6%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL 237
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q     + E+     +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIV 107
Query: 238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK 297
            + +  + ++   ++     +  L   M +   H H+   +IHRD K SN+++  +   K
Sbjct: 108 MELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLK 166
Query: 298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           + DFGLA+         + T  + T  Y APE           D++S G ++ E++ G V
Sbjct: 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 125
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L        IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 126 --YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 181 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 9/180 (5%)
Query: 179 TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQ 238
           T   +K L +  +    +F     ++S+L    LV   G C   +  +L+ E++  G+L 
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD 100
Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
            +L ++ N    L W  +L +A   A A+ FL E+    +IH +    N+LL +    K 
Sbjct: 101 TYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 299 TDFGLAKMVSDKINGQISTR--VLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTG 355
            +    K+    I+  +  +  +     ++ PE     K L   +D +S+G  L E+ +G
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 178 GTVAAIKKLHRDGKQRERAFRME-VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           G   A+KK+      R   FR E +   + L SP++V L G   +     +  E +  G+
Sbjct: 99  GFQCAVKKV------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAM-ALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
           L Q +        P D   R +  L  A+  LE+LH      ++H D K  NVLL  +  
Sbjct: 153 LGQLVKEQG--CLPED---RALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGS 204
Query: 296 -AKVTDFGLAKMVS-DKINGQISTR--VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            A + DFG A  +  D +   + T   + GT  ++APE         K DV+S   ++L 
Sbjct: 205 HAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLH 264
Query: 352 LLTG 355
           +L G
Sbjct: 265 MLNG 268

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K++  D         A R E+ LL  L    +V L           L+ E+  +  
Sbjct: 29  IVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD 86
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L+++    N    P   ++ L   L     L F H      V+HRD K  N+L+++N   
Sbjct: 87  LKKYFDSCNGDLDPEIVKSFLFQLLK---GLGFCHSRN---VLHRDLKPQNLLINRNGEL 140
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTG 355
           K+ DFGLA+     +    +  V  T  Y  P+     KL +T  D++S G +  EL   
Sbjct: 141 KLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 356 RVPVDP 361
             P+ P
Sbjct: 199 ARPLFP 204

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 112 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 162
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 163 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 353 LTGRV 357
           + G V
Sbjct: 220 IKGGV 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 119
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L        IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 120 --YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 175 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 199 MEVDLLSRLHS-PQLVELLGYCADQNHRLL-ISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           ME+ LL+     P ++    YC++   R L I+  + N  LQ  +   N     L  +  
Sbjct: 75  MEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 257 L-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-------------QNFRAKVTDFG 302
              I+L   +A    H H+   +IHRD K  N+L+              +N R  ++DFG
Sbjct: 133 YNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 303 LAKMVSDKINGQISTRV-----LGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLT 354
           L K +    +GQ   R       GT+G+ APE    ++  +LT   D++S G V   +L+
Sbjct: 192 LCKKLD---SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 199 MEVDLLSRLHS-PQLVELLGYCADQNHRLL-ISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           ME+ LL+     P ++    YC++   R L I+  + N  LQ  +   N     L  +  
Sbjct: 75  MEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 257 L-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-------------QNFRAKVTDFG 302
              I+L   +A    H H+   +IHRD K  N+L+              +N R  ++DFG
Sbjct: 133 YNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 303 LAKMVSDKINGQISTRV-----LGTTGYLAPEY---ASTGKLTTKSDVYSYGVVLLELLT 354
           L K +    +GQ   R       GT+G+ APE    ++  +LT   D++S G V   +L+
Sbjct: 192 LCKKLD---SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT-LQQHLHRHNNRYRPL-DWRTR 256
           +E+ +LSR+    ++++L    +Q    L+ E   +G  L   + RH     PL  +  R
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
            +++     A+ +L       +IHRD K  N+++ ++F  K+ DFG A  +     G++ 
Sbjct: 138 QLVS-----AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLF 186
Query: 317 TRVLGTTGYLAPE 329
               GT  Y APE
Sbjct: 187 YTFCGTIEYCAPE 199

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 111 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 161
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 162 DCTLKILDFGLARTAGTSF---MMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 353 LTGRV 357
           + G V
Sbjct: 219 IKGGV 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 149 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 198
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 199 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 256 MVRHKILF-----PGRDYIDQW 272

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L        IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 116 --YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 171 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 119
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L    +   IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 120 --YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 175 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L        IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 116 --YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 170
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 171 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 111 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 149 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 198
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 199 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 256 MVRHKILF-----PGRDYIDQW 272

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F  EV+ +  L    L+ L G       ++ ++E  P G+L   L +H   +  L   +R
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV---SDKING 313
              A+  A  + +L    +   IHRD    N+LL      K+ DFGL + +    D    
Sbjct: 116 --YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
           Q   +V     + APE   T   +  SD + +GV L E+ T
Sbjct: 171 QEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKL 336
           V+HRD K  N+L+++    K+ DFGLA+     I  +  T  + T  Y AP+    + K 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 337 TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +T  D++S G +  E++ G  P+ P     + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLM 211

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 112 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 161
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 162 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 219 MVRHKILF-----PGRDYIDQW 235

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 111 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 111 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 205
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 112 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 161
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 162 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 219 MVRHKILF-----PGRDYIDQW 235

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 105 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 154
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 155 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 211
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 212 MVRHKILF-----PGRDYIDQW 228

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 110 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 159
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 160 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 216
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 217 MVRHKILF-----PGRDYIDQW 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 104 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 153
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 211 MVRHKILF-----PGRDYIDQW 227

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++ 
Sbjct: 105 M-DANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVK 154
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 155 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 211
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 212 MVRHKILF-----PGRDYIDQW 228

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 205
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 225
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 238
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 191
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 171 YKGV--LSDGTVA--AIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL 226
           YKG   L+D  VA   I+  H +G     A R EV LL  L    +V L      +    
Sbjct: 19  YKGKSKLTDNLVALKEIRLEHEEGAPC-TAIR-EVSLLKDLKHANIVTLHDIIHTEKSLT 76
Query: 227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           L+ EY+ +  L+Q+L    N    ++     +        L + H      V+HRD K  
Sbjct: 77  LVFEYL-DKDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQ 129
Query: 287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSY 345
           N+L+++    K+ DFGLA+  S  I  +     + T  Y  P+    +   +T+ D++  
Sbjct: 130 NLLINERGELKLADFGLARAKS--IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187
Query: 346 GVVLLELLTGRVPVDPNRPPGEHV 369
           G +  E+ TGR P+ P     E +
Sbjct: 188 GCIFYEMATGR-PLFPGSTVEEQL 210

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 218
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 191
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 206
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 219
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 233
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 213
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 189
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 190 HGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 43/212 (20%)
Query: 171 YKGV-LSDGTVAAIKKLHRD----GKQRERAFR--MEVDLLSRLHS--PQLVELLGYCAD 221
           Y G+ +SD    AIK + +D      +     R  MEV LL ++ S    ++ LL +   
Sbjct: 25  YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 84
Query: 222 QNHRLLISEYMP-----------NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            +  +LI E M             G LQ+ L R         W+            LE +
Sbjct: 85  PDSFVLILERMEPVQDLFDFITERGALQEELARS------FFWQV-----------LEAV 127
Query: 271 HEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
                  V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 183
Query: 330 YASTGKLTTKS-DVYSYGVVLLELLTGRVPVD 360
           +    +   +S  V+S G++L +++ G +P +
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 191
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 190
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKL 336
           V+HRD K  N+L+++    K+ DFGLA+     I  +  T  + T  Y AP+    + K 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 337 TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +T  D++S G +  E++ G  P+ P     + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNG-APLFPGVSEADQLM 211

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-YASTGKL 336
           V+HRD K  N+L+++    K+ DFGLA+     I  +  T  + T  Y AP+    + K 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 337 TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
           +T  D++S G +  E++ G  P+ P     + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLM 211

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 194 ERAFRMEVDLLSRLHSPQLVELLG--YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
           E   + E+ LL RL    +++L+   Y  ++    ++ EY   G +Q+ L     +  P+
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPV 108
Query: 252 ----DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV 307
                +  +LI  L      E+LH      ++H+D K  N+LL      K++  G+A+ +
Sbjct: 109 CQAHGYFCQLIDGL------EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 308 SDKINGQISTRVLGTTGYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVD 360
                        G+  +  PE A+     +  K D++S GV L  + TG  P +
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 21/185 (11%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 113 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 163
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         +    + T  Y APE           D++S G ++ E+
Sbjct: 164 DCTLKILDFGLARTAGTSF---MMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 220
Query: 353 LTGRV 357
           + G V
Sbjct: 221 IKGGV 225

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 278 VIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
           V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  PE+    + 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186
Query: 337 TTKS-DVYSYGVVLLELLTGRVPVD 360
             +S  V+S G++L +++ G +P +
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 39/170 (22%)
Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
           YC  +N  ++I+  MP    +  L   N+    L ++      L+   AL+ +H+     
Sbjct: 87  YCFRKNDHVVIA--MPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIHQFG--- 137
Query: 278 VIHRDFKCSNVLLDQNFRA-KVTDFGLAKMVSD-KIN----------------------- 312
           ++HRD K SN L ++  +   + DFGLA+   D KI                        
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 313 ---GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVP 358
               Q++ R  GT G+ APE  +     TT  D++S GV+ L LL+GR P
Sbjct: 198 SRRQQVAPRA-GTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +         LD      +       ++ LH      +IHRD K SN+++ 
Sbjct: 111 M-DANLXQVIQME------LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 199 MEVDLLSRLHS----PQLVELLGYCADQNHRLLISEY-MPNGTLQQHLHRHNNRYRPLDW 253
           +EV LL ++ +    P ++ LL +   Q   +L+ E  +P     Q L  +     PL  
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP----AQDLFDYITEKGPLGE 138
Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKIN 312
                       A++  H      V+HRD K  N+L+D +   AK+ DFG   ++ D   
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--- 192
Query: 313 GQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVD 360
            +  T   GT  Y  PE+ S  +     + V+S G++L +++ G +P +
Sbjct: 193 -EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 34/184 (18%)
Query: 199 MEVDLLSRLHS-PQLVELLGYCADQNHRLL-ISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           ME+ LL+     P ++    YC++   R L I+  + N  LQ  +   N     L  +  
Sbjct: 57  MEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 257 L-IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-------------QNFRAKVTDFG 302
              I+L   +A    H H+   +IHRD K  N+L+              +N R  ++DFG
Sbjct: 115 YNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 303 LAKMVSDKINGQISTRV-----LGTTGYLAPEYASTG-------KLTTKSDVYSYGVVLL 350
           L K +    +GQ S R       GT+G+ APE            +LT   D++S G V  
Sbjct: 174 LCKKLD---SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 351 ELLT 354
            +L+
Sbjct: 231 YILS 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 8/165 (4%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            + E  +   L  P +VELL   +      ++ E+M    L   + +  +          
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKING 313
                    AL + H++    +IHRD K   VLL   + +   K+  FG+A  + +  +G
Sbjct: 135 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SG 189
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            ++   +GT  ++APE           DV+  GV+L  LL+G +P
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 8/165 (4%)
Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            + E  +   L  P +VELL   +      ++ E+M    L   + +  +          
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKING 313
                    AL + H++    +IHRD K   VLL   + +   K+  FG+A  + +  +G
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SG 187
Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            ++   +GT  ++APE           DV+  GV+L  LL+G +P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +         LD      +       ++ LH      +IHRD K SN+++ 
Sbjct: 111 M-DANLXQVIQME------LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 218 MVRHKILF-----PGRDYIDQW 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRLLISEY 231
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q          L+ E 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD 291
           M +  L Q +         LD      +       ++ LH      +IHRD K SN+++ 
Sbjct: 104 M-DANLXQVIQME------LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE 351
            +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E
Sbjct: 154 SDXTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 352 LLTGRVPVDPNRPPGEHVLVSW 373
           ++  ++       PG   +  W
Sbjct: 211 MVRHKILF-----PGRDYIDQW 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 14/186 (7%)
Query: 180 VAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGT 236
           + A+K++  D         A R E+ LL  L    +V L           L+ E+  +  
Sbjct: 29  IVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD 86
Query: 237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA 296
           L+++    N    P   ++ L   L     L F H      V+HRD K  N+L+++N   
Sbjct: 87  LKKYFDSCNGDLDPEIVKSFLFQLLK---GLGFCHSRN---VLHRDLKPQNLLINRNGEL 140
Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTG 355
           K+ +FGLA+     +    +  V  T  Y  P+     KL +T  D++S G +  EL   
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 356 RVPVDP 361
             P+ P
Sbjct: 199 GRPLFP 204

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 104
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 105 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 155
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 156 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 212
Query: 353 LTGRVPVDPNRPPGEHVLVSW 373
           +  ++       PG   +  W
Sbjct: 213 VCHKILF-----PGRDYIDQW 228

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 27/198 (13%)
Query: 173 GVLSDGTVAAIKKLHR---DGKQR---------ERAFRMEVDLLSRLHSPQLVEL----L 216
           GV S+G   AIK++     DG+           +R  R E+ LL+  H P ++ L    +
Sbjct: 41  GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFV 99
Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
            +     H+L +   +    L Q +H       P   +  +   L   + L  LHE    
Sbjct: 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL---LGLHVLHEAG-- 154
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            V+HRD    N+LL  N    + DF LA+  +   N    T  +    Y APE     K 
Sbjct: 155 -VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKG 210
Query: 337 TTK-SDVYSYGVVLLELL 353
            TK  D++S G V+ E+ 
Sbjct: 211 FTKLVDMWSAGCVMAEMF 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 19/179 (10%)
Query: 186 LHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHN 245
           + RD + + +AF+ EV    +     +V  +G C    H  +I+      TL   +    
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---R 121
Query: 246 NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK 305
           +    LD      IA +    + +LH      ++H+D K  NV  D N +  +TDFGL  
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 306 MVSDKINGQISTRVLGTTGY---LAPEY-------ASTGKL--TTKSDVYSYGVVLLEL 352
           +      G+   ++    G+   LAPE            KL  +  SDV++ G +  EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 181 AAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCADQN-----HRLLISEYM 232
            AIKKL R  + +   +RA+R E+ L+  ++   ++ LL     Q        + I   +
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 115
Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
            +  L Q +    +  R     + L+  + C +     H H+   +IHRD K SN+++  
Sbjct: 116 MDANLCQVIQMELDHER----MSYLLYQMLCGIK----HLHSAG-IIHRDLKPSNIVVKS 166
Query: 293 NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLEL 352
           +   K+ DFGLA+         + T  + T  Y APE           D++S G ++ E+
Sbjct: 167 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 223
Query: 353 LTGRVPVDPNRPPGEHVLVSW 373
           +  ++       PG   +  W
Sbjct: 224 VCHKILF-----PGRDYIDQW 239

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 27/198 (13%)
Query: 173 GVLSDGTVAAIKKLHR---DGKQR---------ERAFRMEVDLLSRLHSPQLVEL----L 216
           GV S+G   AIK++     DG+           +R  R E+ LL+  H P ++ L    +
Sbjct: 41  GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFV 99
Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
            +     H+L +   +    L Q +H       P   +  +   L   + L  LHE    
Sbjct: 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL---LGLHVLHEAG-- 154
Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            V+HRD    N+LL  N    + DF LA+  +   N    T  +    Y APE     K 
Sbjct: 155 -VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKG 210
Query: 337 TTK-SDVYSYGVVLLELL 353
            TK  D++S G V+ E+ 
Sbjct: 211 FTKLVDMWSAGCVMAEMF 228
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	457
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-158
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-156
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-148
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-85
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-72
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-68
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-67
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-66
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-65
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-63
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-55
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-32
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-29
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-26
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-24
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-17
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  449 bits (1158), Expect = e-158
 Identities = 110/288 (38%), Positives = 158/288 (54%), Gaps = 4/288 (1%)

Query: 142 QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
                 +LE AT NF    +IG+G FG VYKGVL DG   A+K+   +  Q    F  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
           + LS    P LV L+G+C ++N  +LI +YM NG L++HL+  +     + W  RL I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
             A  L +LH      +IHRD K  N+LLD+NF  K+TDFG++K  ++     +ST V G
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR 381
           T GY+ PEY   G+LT KSDVYS+GVVL E+L  R  +  + P     L  WA+    + 
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263

Query: 382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
            +  ++VDP+L  +   + L +    A  C+   +  RP M DV+  L
Sbjct: 264 -QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  444 bits (1144), Expect = e-156
 Identities = 122/294 (41%), Positives = 178/294 (60%), Gaps = 5/294 (1%)

Query: 139 GVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ-RERAF 197
           G ++ F+ +EL+ A++NFS  N++G GGFG VYKG L+DGT+ A+K+L  +  Q  E  F
Sbjct: 15  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74

Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + EV+++S      L+ L G+C     RLL+  YM NG++   L        PLDW  R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            IAL  A  L +LH+H  P +IHRD K +N+LLD+ F A V DFGLAK++  K    ++T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 193

Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH--VLVSWAL 375
            V GT G++APEY STGK + K+DV+ YGV+LLEL+TG+   D  R   +   +L+ W  
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
             L  + +   +VD  LQG Y  +++ Q+  +A +C Q     RP M++VV+ L
Sbjct: 254 GLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  424 bits (1093), Expect = e-148
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 19/299 (6%)

Query: 141 VQVFTYKELETATENFSE------GNVIGNGGFGVVYKGVLSDGTVAAIKKL----HRDG 190
              F++ EL+  T NF E      GN +G GGFGVVYKG + + T  A+KKL        
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70

Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           ++ ++ F  E+ ++++     LVELLG+ +D +   L+  YMPNG+L   L   +    P
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PP 129

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK 310
           L W  R  IA   A  + FLHE+     IHRD K +N+LLD+ F AK++DFGLA+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
               +++R++GTT Y+APE    G++T KSD+YS+GVVLLE++TG   VD +R     +L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243

Query: 371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           +          +   + +D  +        +  + ++A+ C+  +   RP +  V Q L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  262 bits (671), Expect = 8e-85
 Identities = 71/308 (23%), Positives = 110/308 (35%), Gaps = 30/308 (9%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
              + L   +       V   G FG V+K  L +  VA +K      KQ       EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVA-VKIFPIQDKQ-SWQNEYEVYS 71

Query: 204 LSRLHSPQLVELLGYC----ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           L  +    +++ +G      +      LI+ +   G+L   L  +      + W     I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHI 126

Query: 260 ALDCAMALEFLHEHA-------TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
           A   A  L +LHE          P + HRD K  NVLL  N  A + DFGLA       +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 313 GQISTRVLGTTGYLAPEYASTG-----KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE 367
              +   +GT  Y+APE              + D+Y+ G+VL EL +     D       
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 368 HVLVSWALPRLTSREEAVEMV-----DPSLQGQYPKKD-LIQIAAIAAVCVQPEAAYRPL 421
                  + +  S E+  E+V      P L+  + K   +  +      C   +A  R  
Sbjct: 247 LPFEEE-IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 422 MTDVVQSL 429
              V + +
Sbjct: 306 AGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  228 bits (583), Expect = 8e-72
 Identities = 83/318 (26%), Positives = 141/318 (44%), Gaps = 32/318 (10%)

Query: 117 HVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLS 176
           H   ++ +          +  +G +      +++    + +    IG G FG V++    
Sbjct: 3   HHHHHHPMSDYDIPTTENLYFQGAMD---GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW- 58

Query: 177 DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN 234
            G+  A+K L       +R   F  EV ++ RL  P +V  +G      +  +++EY+  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF 294
           G+L + LH+   R   LD R RL +A D A  + +LH    PP++HR+ K  N+L+D+ +
Sbjct: 119 GSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176

Query: 295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
             KV DFGL+++ +       S    GT  ++APE         KSDVYS+GV+L EL T
Sbjct: 177 TVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 355 GRVP---VDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVC 411
            + P   ++P +       V  A+     R E    ++P +        +I+       C
Sbjct: 235 LQQPWGNLNPAQ-------VVAAVGFKCKRLEIPRNLNPQV------AAIIE------GC 275

Query: 412 VQPEAAYRPLMTDVVQSL 429
              E   RP    ++  L
Sbjct: 276 WTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  218 bits (558), Expect = 2e-68
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 40/300 (13%)

Query: 145 TYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD-------GKQRERA 196
             +    A         IG GGFG+V+KG  + D +V AIK L            ++ + 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           F+ EV ++S L+ P +V+L G   +     ++ E++P G L   L        P+ W  +
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVK 124

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-----NFRAKVTDFGLAKMVSDKI 311
           L + LD A+ +E++     PP++HRD +  N+ L          AKV DFGL++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS- 182

Query: 312 NGQISTRVLGTTGYLAPE--YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
                + +LG   ++APE   A     T K+D YS+ ++L  +LTG  P D        +
Sbjct: 183 ----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KI 236

Query: 370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                +     R    E   P L      +++I++      C   +   RP  + +V+ L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRL------RNVIEL------CWSGDPKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  217 bits (556), Expect = 8e-68
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 27/277 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           +      V+G G FGVV K       VA IK++  + +++   F +E+  LSR++ P +V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDVA-IKQIESESERKA--FIVELRQLSRVNHPNIV 64

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           +L G C   N   L+ EY   G+L   LH              +   L C+  + +LH  
Sbjct: 65  KLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 274 ATPPVIHRDFKCSNVLLDQNFR-AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
               +IHRD K  N+LL       K+ DFG A  +         T   G+  ++APE   
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL 392
               + K DV+S+G++L E++T R P D    P     + WA+    +R   ++ +   +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHN-GTRPPLIKNLPKPI 233

Query: 393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                 + L+        C   + + RP M ++V+ +
Sbjct: 234 ------ESLMT------RCWSKDPSQRPSMEEIVKIM 258

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  216 bits (552), Expect = 6e-67
 Identities = 61/318 (19%), Positives = 112/318 (35%), Gaps = 39/318 (12%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
               E     +N     +IG G +G VYKG L D    A+K      +Q     +  +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60

Query: 204 LSRLHSPQLVELLGYC-----ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +  +    +   +          +   LL+ EY PNG+L ++L  H       DW +   
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCR 115

Query: 259 IALDCAMALEFLHE------HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
           +A      L +LH       H  P + HRD    NVL+  +    ++DFGL+  ++    
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 313 GQI------STRVLGTTGYLAPEYA-------STGKLTTKSDVYSYGVVLLELLTGRVPV 359
            +       +   +GT  Y+APE                + D+Y+ G++  E+      +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 360 DPNRPPGEHVLV-SWALPRLTSREEAVEMVD-----PSLQGQYPKKD--LIQIAAIAAVC 411
            P     E+ +     +    + E+   +V      P     + +    +  +      C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 412 VQPEAAYRPLMTDVVQSL 429
              +A  R       + +
Sbjct: 296 WDQDAEARLTAQXAEERM 313

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  212 bits (543), Expect = 5e-66
 Identities = 72/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQ 211
              + G  IG+G FG VYKG    G VA +K L+      Q+ +AF+ EV +L +     
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           ++  +GY        +++++    +L  HLH    +    + +  + IA   A  +++LH
Sbjct: 82  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLH 137

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE-- 329
                 +IHRD K +N+ L ++   K+ DFGLA   S         ++ G+  ++APE  
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 330 -YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV 388
               +   + +SDVY++G+VL EL+TG++P              +    + +R++ +EMV
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP--------------Y--SNINNRDQIIEMV 238

Query: 389 D-----PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                 P L  +       ++  + A C++ +   RP    ++  +
Sbjct: 239 GRGSLSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  212 bits (541), Expect = 5e-66
 Identities = 78/290 (26%), Positives = 117/290 (40%), Gaps = 41/290 (14%)

Query: 155 NFSE---GNVIGNGGFGVVYKGVLSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRL 207
           +F+E     +IG GGFG VY+       VA +K        D  Q     R E  L + L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDEVA-VKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
             P ++ L G C  + +  L+ E+   G L + L       + +     +  A+  A  +
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQ--------NFRAKVTDFGLAKMVSDKINGQISTRV 319
            +LH+ A  P+IHRD K SN+L+ Q        N   K+TDFGLA+              
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSA 174

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT 379
            G   ++APE       +  SDV+SYGV+L ELLTG VP            V++ +    
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-RGIDGLA---VAYGVAMNK 230

Query: 380 SREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                                L++       C  P+   RP  T+++  L
Sbjct: 231 LALPIPSTCPEPF------AKLME------DCWNPDPHSRPSFTNILDQL 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  210 bits (536), Expect = 3e-65
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 37/285 (12%)

Query: 155 NFSE---GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHS 209
           +F +      +     G ++KG      +  +K L       ++ R F  E   L     
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 210 PQLVELLGYCAD--QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           P ++ +LG C      H  LI+ +MP G+L   LH   N    +D    +  ALD A  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGM 124

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            FLH    P +        +V++D++  A+++   +            S   +    ++A
Sbjct: 125 AFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVA 176

Query: 328 PE---YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
           PE             +D++S+ V+L EL+T  VP   +    E   +   +     R   
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNME---IGMKVALEGLRPTI 232

Query: 385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              + P +        L++I      C+  + A RP    +V  L
Sbjct: 233 PPGISPHV------SKLMKI------CMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  208 bits (531), Expect = 5e-64
 Identities = 68/299 (22%), Positives = 108/299 (36%), Gaps = 39/299 (13%)

Query: 145 TYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLH--RDGKQRERAFRMEVD 202
             +E +   E    G +IG G FG VY G    G VA I+ +   RD + + +AF+ EV 
Sbjct: 24  FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEVA-IRLIDIERDNEDQLKAFKREVM 81

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
              +     +V  +G C    H  +I+      TL   +         LD      IA +
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQE 138

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS---TRV 319
               + +LH      ++H+D K  NV  D N +  +TDFGL  +      G+        
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 320 LGTTGYLAPEYASTGKL---------TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
            G   +LAPE                +  SDV++ G +  EL     P    +P      
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEA--- 250

Query: 371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           + W +        +   +   +       D++        C   E   RP  T ++  L
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEI------SDILL------FCWAFEQEERPTFTKLMDML 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 4e-63
 Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 34/284 (11%)

Query: 159 GNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           G V+G G FG   K      G V  +K+L R  ++ +R F  EV ++  L  P +++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
                     I+EY+  GTL+  +   +       W  R+  A D A  + +LH      
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---N 128

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD------------KINGQISTRVLGTTGY 325
           +IHRD    N L+ +N    V DFGLA+++ D            K + +    V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV 385
           +APE  +      K DV+S+G+VL E++          P      ++    R        
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---RGFLDRYCP 245

Query: 386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
               PS               I   C   +   RP    +   L
Sbjct: 246 PNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWL 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  191 bits (486), Expect = 1e-57
 Identities = 70/308 (22%), Positives = 121/308 (39%), Gaps = 42/308 (13%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL--LSRL 207
            T   + +    +G G +G V++G      VA +K       + E+++  E +L     L
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGENVA-VKIFS---SRDEKSWFRETELYNTVML 59

Query: 208 HSPQLVELLGYCADQNHR----LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
               ++  +       H      LI+ Y   G+L  +L         LD  + L I L  
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSI 114

Query: 264 AMALEFLHE-----HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN--GQIS 316
           A  L  LH         P + HRD K  N+L+ +N +  + D GLA M S   N     +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 317 TRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPPGE 367
              +GT  Y+APE               + D++++G+VL E+    V    V+  +PP  
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 368 HVLVSWALPRLTSREEAVEMVD-----PSLQGQYPKKD-LIQIAAIAAVCVQPEAAYRPL 421
            V     +P   S E+  ++V      P++  ++     L  +A +   C     + R  
Sbjct: 235 DV-----VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 422 MTDVVQSL 429
              + ++L
Sbjct: 290 ALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  191 bits (486), Expect = 3e-57
 Identities = 67/308 (21%), Positives = 113/308 (36%), Gaps = 42/308 (13%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--LLSRL 207
            T  +       IG G +G V+ G      VA +K         E ++  E +      +
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA-VKVFF---TTEEASWFRETEIYQTVLM 88

Query: 208 HSPQLVELLGYC----ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
               ++  +              LI++Y  NG+L  +L         LD ++ L +A   
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSS 143

Query: 264 AMALEFLHE-----HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ--IS 316
              L  LH         P + HRD K  N+L+ +N    + D GLA       N      
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 317 TRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPPGE 367
              +GT  Y+ PE        +  +    +D+YS+G++L E+    V    V+  + P  
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263

Query: 368 HVLVSWALPRLTSREEAVEMVD-----PSLQGQYPKKD-LIQIAAIAAVCVQPEAAYRPL 421
            +     +P   S E+  E+V      PS   ++   + L Q+  +   C     A R  
Sbjct: 264 DL-----VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

Query: 422 MTDVVQSL 429
              V ++L
Sbjct: 319 ALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  186 bits (475), Expect = 2e-55
 Identities = 65/308 (21%), Positives = 117/308 (37%), Gaps = 42/308 (13%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--LLSRL 207
            T          IG G FG V++G      VA +K       + ER++  E +      L
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKWRGEEVA-VKIFS---SREERSWFREAEIYQTVML 93

Query: 208 HSPQLVELLGYCADQN----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
               ++  +      N       L+S+Y  +G+L  +L+R+      +     + +AL  
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALST 148

Query: 264 AMALEFLHEHAT-----PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ--IS 316
           A  L  LH         P + HRD K  N+L+ +N    + D GLA       +      
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 317 TRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPPGE 367
              +GT  Y+APE           +   ++D+Y+ G+V  E+          +  + P  
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 368 HVLVSWALPRLTSREEAVEMVD-----PSLQGQYPKKDLIQ-IAAIAAVCVQPEAAYRPL 421
            +     +P   S EE  ++V      P++  ++   + ++ +A I   C     A R  
Sbjct: 269 DL-----VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 422 MTDVVQSL 429
              + ++L
Sbjct: 324 ALRIKKTL 331

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  156 bits (397), Expect = 9e-44
 Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 17/226 (7%)

Query: 140 VVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVA-AIKKLHRDGKQRER-AF 197
           + +     +     E+   G  IG G FG V+ G L       A+K          +  F
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF 159

Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
             E  +L +   P +V L+G C  +    ++ E +  G     L         L  +T L
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLL 216

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +  D A  +E+L        IHRD    N L+ +    K++DFG+++  +D     +  
Sbjct: 217 QMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYA 269

Query: 318 RVLGTTGY----LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
              G         APE  + G+ +++SDV+S+G++L E  + G  P
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  153 bits (389), Expect = 2e-43
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIK--KLHRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
              IG G F  VYKG+        A    +  +  K   + F+ E ++L  L  P +V  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 216 LGYCAD---QNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
                        + L++E M +GTL+ +L R     + +  +            L+FLH
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH 146

Query: 272 EHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
              TPP+IHRD KC N+ +       K+ D GLA +         +  V+GT  ++APE 
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 201

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                     DVY++G+ +LE+ T   P
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYP 228

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  150 bits (380), Expect = 2e-42
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
              +    IG+G FG+V+ G   +    AIK + R+G   E  F  E +++ +L  P+LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMALEFLHE 272
           +L G C +Q    L++E+M +G L  +L      +        L+ + LD    + +L E
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET----LLGMCLDVCEGMAYLEE 122

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-----KINGQISTRVLGTTGYLA 327
                VIHRD    N L+ +N   KV+DFG+ + V D         +   +      + +
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WAS 173

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           PE  S  + ++KSDV+S+GV++ E+ + G++P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  150 bits (380), Expect = 3e-42
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 21/230 (9%)

Query: 136 RDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER 195
           ++        Y   E   ++ +    +G G FGVV  G        AIK + ++G   E 
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSED 64

Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
            F  E  ++  L   +LV+L G C  Q    +I+EYM NG L  +L    +R++      
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--- 121

Query: 256 RLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD----- 309
            L+ +  D   A+E+L        +HRD    N L++     KV+DFGL++ V D     
Sbjct: 122 -LLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177

Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            +  +   R      +  PE     K ++KSD++++GV++ E+ + G++P
Sbjct: 178 SVGSKFPVR------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  149 bits (379), Expect = 8e-42
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 11/210 (5%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL----HRDGKQRERAFRMEVDLLSRLH 208
            NF     IG G F  VY+   L DG   A+KK+      D K R    + E+DLL +L+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLN 90

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P +++      + N   ++ E    G L + +     + R +  RT     +    ALE
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            +H      V+HRD K +NV +      K+ D GL +  S K      + V GT  Y++P
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLV-GTPYYMSP 205

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E         KSD++S G +L E+   + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  149 bits (379), Expect = 1e-41
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 27/243 (11%)

Query: 159 GNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
            + +G G FG V          + G + A+K+L   G  ++R F+ E+ +L  LHS  +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 214 ELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +  G       +   L+ EY+P+G L+  L RH  R   LD    L+ +      +E+L 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG 144

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL----- 326
                  +HRD    N+L++     K+ DFGLAK++    +  +        G       
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWY 197

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSRE--E 383
           APE  S    + +SDV+S+GVVL EL T       P        ++             E
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLE 255

Query: 384 AVE 386
            +E
Sbjct: 256 LLE 258

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  148 bits (376), Expect = 2e-41
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 14/202 (6%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           +G GG   VY           AIK +        +  +R F  EV   S+L    +V ++
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
               + +   L+ EY+   TL +++  H     PL   T +         ++  H+    
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR-- 131

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL 336
            ++HRD K  N+L+D N   K+ DFG+AK +S+    Q +  VLGT  Y +PE A     
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189

Query: 337 TTKSDVYSYGVVLLELLTGRVP 358
              +D+YS G+VL E+L G  P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  147 bits (373), Expect = 2e-41
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           E  +    +G+G FGVV  G        A+K + ++G   E  F  E   + +L  P+LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           +  G C+ +    +++EY+ NG L  +L  H    + L+    L +  D    + FL  H
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH 123

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-----KINGQISTRVLGTTGYLAP 328
                IHRD    N L+D++   KV+DFG+ + V D      +  +   +      + AP
Sbjct: 124 Q---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAP 174

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           E     K ++KSDV+++G+++ E+ + G++P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  148 bits (376), Expect = 2e-41
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 18/239 (7%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLS 205
             +    +++     +G GGF  V     L DG   A+K++    +Q     + E D+  
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 206 RLHSPQLVELLGYCADQNHR----LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
             + P ++ L+ YC  +        L+  +   GTL   + R  ++   L     L + L
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL- 320
                LE +H        HRD K +N+LL    +  + D G        + G      L 
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 321 ------GTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
                  T  Y APE     S   +  ++DV+S G VL  ++ G  P D     G+ V 
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  146 bits (371), Expect = 6e-41
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 19/220 (8%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVA-AIKKLHRDGKQRERAFRMEVDLL 204
           Y + E    + +  + +G G +G VY+GV    ++  A+K L ++       F  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVM 63

Query: 205 SRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
             +  P LV+LLG C  +    +I+E+M  G L  +L   N   + +     L +A   +
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 121

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-----KINGQISTRV 319
            A+E+L +      IHRD    N L+ +N   KV DFGL+++++          +   + 
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                + APE  +  K + KSDV+++GV+L E+ T G  P
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (370), Expect = 7e-41
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 11/218 (5%)

Query: 149 LETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG---KQRERAFRMEVDLL 204
           + +  E++     IG G +G   K    SDG +   K+L        +++     EV+LL
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLL 59

Query: 205 SRLHSPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
             L  P +V       D+ +  L  + EY   G L   + +     + LD    L +   
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 263 CAMALEFLHEHATPP--VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
             +AL+  H  +     V+HRD K +NV LD     K+ DFGLA++++   +   +   +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFV 177

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           GT  Y++PE  +      KSD++S G +L EL     P
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  146 bits (370), Expect = 1e-40
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 28/244 (11%)

Query: 159 GNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
              +G G FG V          + G V A+KKL    ++  R F  E+++L  L    +V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 214 ELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +  G C     R   LI EY+P G+L+ +L +H  R   +D    L         +E+L 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTG 324
                  IHRD    N+L++   R K+ DFGL K++         K  G+          
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------ 182

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE-- 382
           + APE  +  K +  SDV+S+GVVL EL T              ++ +    ++      
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 383 EAVE 386
           E ++
Sbjct: 243 ELLK 246

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (371), Expect = 3e-40
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 12/209 (5%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKL---HRDGKQRERAFRMEVDLLSRLHS 209
           E +     IG G FG         DG    IK++       K+RE + R EV +L+ +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANMKH 82

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P +V+      +     ++ +Y   G L + ++              L   +   +AL+ 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKH 140

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H+     ++HRD K  N+ L ++   ++ DFG+A++++  +       + GT  YL+PE
Sbjct: 141 VHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSPE 195

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                    KSD+++ G VL EL T +  
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (365), Expect = 4e-40
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 19/211 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           E       +G G FG V+ G  +  T  A+K L + G     AF  E +L+ +L   +LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            L      Q    +I+EYM NG+L   L         L     L +A   A  + F+ E 
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-----KINGQISTRVLGTTGYLAP 328
                IHRD + +N+L+      K+ DFGLA+++ D     +   +   +      + AP
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAP 179

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           E  + G  T KSDV+S+G++L E++T GR+P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  144 bits (365), Expect = 4e-40
 Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 17/221 (7%)

Query: 141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRME 200
              F         +       IG G FG V  G      VA +K +  D     +AF  E
Sbjct: 8   QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVA-VKCIKNDAT--AQAFLAE 64

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLI-SEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
             ++++L    LV+LLG   ++   L I +EYM  G+L  +L R   R   L     L  
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR-SVLGGDCLLKF 122

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTR 318
           +LD   A+E+L  +     +HRD    NVL+ ++  AKV+DFGL K   S +  G++  +
Sbjct: 123 SLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 179

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                 + APE     K +TKSDV+S+G++L E+ + GRVP
Sbjct: 180 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (366), Expect = 5e-40
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 28/230 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRL 207
                   +G G FG V          + G   A+K L  + G       + E+++L  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 208 HSPQLVELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +   +V+  G C +       LI E++P+G+L+++L ++ N+   ++ + +L  A+    
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICK 137

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTR 318
            +++L        +HRD    NVL++   + K+ DFGL K +         K +      
Sbjct: 138 GMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
                 + APE     K    SDV+S+GV L ELLT       P     +
Sbjct: 195 ------WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  144 bits (366), Expect = 1e-39
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 26/280 (9%)

Query: 117 HVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVL- 175
           +   ++     PTT   Y +             +    +      +G G FG V      
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYD 63

Query: 176 ----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR--LLIS 229
               + G V A+KKL    ++  R F  E+++L  L    +V+  G C     R   LI 
Sbjct: 64  PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123

Query: 230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
           EY+P G+L+ +L +H  R   +D    L         +E+L        IHRD    N+L
Sbjct: 124 EYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNIL 177

Query: 290 LDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTGYLAPEYASTGKLTTKSDV 342
           ++   R K+ DFGL K++         K  G+          + APE  +  K +  SDV
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WYAPESLTESKFSVASDV 231

Query: 343 YSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
           +S+GVVL EL T              ++ +    ++    
Sbjct: 232 WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (361), Expect = 2e-39
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 36/231 (15%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
             +F E  V+G G FG V K     D    AIKK+    ++       EV LL+ L+   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63

Query: 212 LVELLGYCADQNHRL-------------LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
           +V       ++ + +             +  EY  NGTL   +H  N             
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWR 120

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI------- 311
           +      AL ++H      +IHRD K  N+ +D++   K+ DFGLAK V   +       
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 312 ------NGQISTRVLGTTGYLAPE-YASTGKLTTKSDVYSYGVVLLELLTG 355
                 +  +++ + GT  Y+A E    TG    K D+YS G++  E++  
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  142 bits (361), Expect = 4e-39
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 159 GNVIGNGGFGVVYKGV--LSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQL 212
           G ++G GG   V+          VA +K L     RD     R FR E    + L+ P +
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVA-VKVLRADLARDPSFYLR-FRREAQNAAALNHPAI 74

Query: 213 VELLGYCADQNHRLLIS----EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           V +      +     +     EY+   TL+  +H       P+  +  + +  D   AL 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALN 130

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST-RVLGTTGYLA 327
           F H++    +IHRD K +N+++      KV DFG+A+ ++D  N    T  V+GT  YL+
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE A    +  +SDVYS G VL E+LTG  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  141 bits (358), Expect = 5e-39
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
            +F E  +IG+GGFG V+K     DG    IK++       E+A R EV  L++L    +
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAER-EVKALAKLDHVNI 66

Query: 213 VELLGYCADQNHRLLIS----------------EYMPNGTLQQHLHRHNNRYRPLDWRTR 256
           V   G     ++    S                E+   GTL+Q + +       LD    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLA 124

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           L +       ++++H      +I+RD K SN+ L    + K+ DFGL   +    N    
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKR 178

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           TR  GT  Y++PE  S+     + D+Y+ G++L ELL     
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  142 bits (360), Expect = 6e-39
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 26/218 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG-----TVAAIKKLHRD-GKQRERAFRMEVDLLSRL 207
             F +  V+G+G FG VYKG+            AIK+L      +  +    E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            +P +  LLG C       LI++ MP G L  ++  H +    +  +  L   +  A  +
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 130

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD------KINGQISTRVLG 321
            +L +     ++HRD    NVL+      K+TDFGLAK++           G++  +   
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
              ++A E       T +SDV+SYGV + EL+T G  P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (357), Expect = 8e-39
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 159 GNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLV 213
             VIG G FG VY G L D        A+K L+R     E + F  E  ++     P ++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 214 ELLGYCAD-QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
            LLG C   +   L++  YM +G L+  +    +       +  +   L  A  +++L  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL------ 326
                 +HRD    N +LD+ F  KV DFGLA+     +  +    V   TG        
Sbjct: 147 KK---FVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWM 199

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           A E   T K TTKSDV+S+GV+L EL+T G  P
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (358), Expect = 1e-38
 Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 17/210 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-H 208
           ++F   + +G+G +G V+K     DG + A+K+        K R R    EV    ++  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQ 115

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P  V L     +     L +E     +LQQH          L          D  +AL 
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALA 171

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            LH      ++H D K +N+ L    R K+ DFGL   +     G    +  G   Y+AP
Sbjct: 172 HLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--AGAGEVQE-GDPRYMAP 225

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E    G   T +DV+S G+ +LE+      
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNMEL 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  141 bits (357), Expect = 1e-38
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 16/204 (7%)

Query: 161 VIGNGGFGVVYKG--VLSDGTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLVE 214
           ++G GG G VY+    + +  VA +K +      D   R R  + E     RL  P +V 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVA-LKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVP 98

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
           +  +        +    +    L   L R      PL     + I      AL+  H   
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG 334
                HRD K  N+L+  +  A + DFG+A   +D+   Q+    +GT  Y+APE  S  
Sbjct: 155 ---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSES 210

Query: 335 KLTTKSDVYSYGVVLLELLTGRVP 358
             T ++D+Y+   VL E LTG  P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (356), Expect = 1e-38
 Identities = 70/218 (32%), Positives = 97/218 (44%), Gaps = 23/218 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDGKQRER-AFRMEVDLLSRLH 208
                  VIG G FGVVY G   D        AIK L R  + ++  AF  E  L+  L+
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 209 SPQLVELLGYCADQN-HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            P ++ L+G          ++  YM +G L Q +       R    +  +   L  A  +
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGM 137

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL- 326
           E+L E      +HRD    N +LD++F  KV DFGLA+ + D+        V        
Sbjct: 138 EYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE----YYSVQQHRHARL 190

Query: 327 -----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                A E   T + TTKSDV+S+GV+L ELLT G  P
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  141 bits (358), Expect = 1e-38
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 24/222 (10%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVA-----AIKKLHRDGKQRERA-FRMEVDL 203
           E      +   VIG G FG VYKG+L   +       AIK L     +++R  F  E  +
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           + +     ++ L G  +     ++I+EYM NG L + L   +           + +    
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGI 156

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT- 322
           A  +++L        +HRD    N+L++ N   KV+DFGL++++ D      +T   G  
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGK 211

Query: 323 -----TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                T   APE  S  K T+ SDV+S+G+V+ E++T G  P
Sbjct: 212 IPIRWT---APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (357), Expect = 2e-38
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 159 GNVIGNGGFGVVYKGVL---SDGTVA-AIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLV 213
             +IG+G  G V  G L       V  AIK L     +R+R  F  E  ++ +   P ++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            L G        ++++EYM NG+L   L  H+ +         + +       + +L + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL 170

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL-----AP 328
                +HRD    NVL+D N   KV+DFGL++++ D  +   +T    T G +     AP
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAP 223

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           E  +    ++ SDV+S+GVV+ E+L  G  P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  144 bits (364), Expect = 2e-38
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 17/218 (7%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
           F         +       IG G FG V  G      VA +K +  D   +   F  E  +
Sbjct: 183 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVA-VKCIKNDATAQA--FLAEASV 239

Query: 204 LSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           +++L    LV+LLG   ++   L +++EYM  G+L  +L R   R   L     L  +LD
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR-SVLGGDCLLKFSLD 297

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLG 321
              A+E+L  +     +HRD    NVL+ ++  AKV+DFGL K   S +  G++  +   
Sbjct: 298 VCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--- 351

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
              + APE     K +TKSDV+S+G++L E+ + GRVP
Sbjct: 352 ---WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (356), Expect = 2e-38
 Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 27/231 (11%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRERA-FRM 199
            E E A E  +    +G G FG+VY+GV          T  AIK ++     RER  F  
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 200 EVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------NNRYRPLDW 253
           E  ++   +   +V LLG  +     L+I E M  G L+ +L         N    P   
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
              + +A + A  + +L+ +     +HRD    N ++ ++F  K+ DFG+ + + +    
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--- 191

Query: 314 QISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                  G  G L     +PE    G  TT SDV+S+GVVL E+ T    P
Sbjct: 192 --DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (364), Expect = 2e-38
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 19/223 (8%)

Query: 142 QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEV 201
           + +     E   E+      +G G FG V+    +  T  A+K + + G     AF  E 
Sbjct: 176 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEA 234

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
           +++  L   +LV+L      +    +I+E+M  G+L   L   ++          +  + 
Sbjct: 235 NVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSA 291

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-----NGQIS 316
             A  + F+ +      IHRD + +N+L+  +   K+ DFGLA+++ D         +  
Sbjct: 292 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            +      + APE  + G  T KSDV+S+G++L+E++T GR+P
Sbjct: 349 IK------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (355), Expect = 3e-38
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 30/225 (13%)

Query: 159 GNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQL 212
              +G G FG V            G + A+K L  D G Q    ++ E+D+L  L+   +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 213 VELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           ++  G C D       L+ EY+P G+L+ +L RH+     +     L+ A      + +L
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTT 323
           H       IHRD    NVLLD +   K+ DFGLAK V +       + +G          
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----- 202

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE 367
            + APE     K    SDV+S+GV L ELLT       P     E
Sbjct: 203 -WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (356), Expect = 3e-38
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 24/220 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRL--HS 209
             +S    IG+GG   V++ +     + AIK ++ +    Q   ++R E+  L++L  HS
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
            +++ L  Y     +  ++ E   N  L   L +     + +D   R     +   A+  
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHT 123

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H+H    ++H D K +N L+      K+ DFG+A  +       +    +GT  Y+ PE
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 330 -----------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                        S  K++ KSDV+S G +L  +  G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (354), Expect = 4e-38
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 24/220 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRE--RAFRMEVDLLSRL--HS 209
             +S    IG+GG   V++ +     + AIK ++ +    +   ++R E+  L++L  HS
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
            +++ L  Y     +  ++ E   N  L   L +     + +D   R     +   A+  
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHT 142

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H+H    ++H D K +N L+      K+ DFG+A  +       +    +GT  Y+ PE
Sbjct: 143 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 330 -----------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                        S  K++ KSDV+S G +L  +  G+ P
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 6e-38
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 19/224 (8%)

Query: 142 QVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVA-AIKKLHRDGKQRERAFRME 200
               Y + E    + +  + +G G +G VY+GV    ++  A+K L ++       F  E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 266

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
             ++  +  P LV+LLG C  +    +I+E+M  G L  +L   N   + +     L +A
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMA 324

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-----NGQI 315
              + A+E+L +      IHR+    N L+ +N   KV DFGL+++++          + 
Sbjct: 325 TQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
             +      + APE  +  K + KSDV+++GV+L E+ T G  P
Sbjct: 382 PIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 6e-38
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 28/225 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQ 211
            +F     +G GGFGVV++     D    AIK++    ++  R     EV  L++L  P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 212 LVELLGYCADQNHRLLIS------------EYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
           +V       ++N    +             +      L+  ++         +    L I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS----------D 309
            L  A A+EFLH      ++HRD K SN+    +   KV DFGL   +            
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT 354
                  T  +GT  Y++PE       + K D++S G++L ELL 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (350), Expect = 7e-38
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 26/217 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLH 208
           E+     ++G G FG VY+GV      +    A+K   +D     +  F  E  ++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI-IALDCAMAL 267
            P +V+L+G   ++    +I E  P G L  +L R+ N  + L     L+  +L    A+
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT----LVLYSLQICKAM 126

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-----NGQISTRVLGT 322
            +L        +HRD    N+L+      K+ DFGL++ + D+        ++  +    
Sbjct: 127 AYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK---- 179

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
             +++PE  +  + TT SDV+ + V + E+L+ G+ P
Sbjct: 180 --WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (348), Expect = 1e-37
 Identities = 59/317 (18%), Positives = 106/317 (33%), Gaps = 71/317 (22%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKK--LHRDGKQRERAFRMEVDLLSRL-H 208
           T  F E   IG+G FG V+K V   DG + AIK+      G   E+    EV   + L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              +V      A+ +H L+ +EY   G+L   +  +              + L     L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQN-------------------FRAKVTDFGLAKMVSD 309
           ++H  +   ++H D K SN+ + +                       K+ D G    +S 
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 310 KINGQISTRVLGTTGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
                      G + +LA E       +        K+D+++  + ++          P 
Sbjct: 187 P-----QVEE-GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL--PR 232

Query: 363 RPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPK--KDLIQIAAIAAVCVQPEAAYRP 420
                H +    LPR+                   +   +L+       V + P+   RP
Sbjct: 233 NGDQWHEIRQGRLPRIPQ--------------VLSQEFTELL------KVMIHPDPERRP 272

Query: 421 LMTDVVQSLIPVVKNNA 437
               +V+    V+ + +
Sbjct: 273 SAMALVKH--SVLLSAS 287

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (351), Expect = 1e-37
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 31/234 (13%)

Query: 139 GVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDG-----TVAAIKKLHRD-GKQ 192
           G ++V   +  +       +  V+G+G FG V+KGV             IK +    G+Q
Sbjct: 1   GAMKVLA-RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 57

Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
             +A    +  +  L    +V LLG C       L+++Y+P G+L  H+ +H     P  
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 253 WRTRLI-IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-- 309
               L+   +  A  + +L EH    ++HR+    NVLL    + +V DFG+A ++    
Sbjct: 117 ----LLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 310 ----KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                   +   +      ++A E    GK T +SDV+SYGV + EL+T G  P
Sbjct: 170 KQLLYSEAKTPIK------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (350), Expect = 1e-37
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDG-KQRERA-FRME 200
           +++         G ++G G FG V +G L          A+K +  D   QRE   F  E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 201 VDLLSRLHSPQLVELLGYCADQN-----HRLLISEYMPNGTLQQHL--HRHNNRYRPLDW 253
              +     P ++ LLG C + +       ++I  +M  G L  +L   R     + +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING 313
           +T L   +D A+ +E+L        +HRD    N +L  +    V DFGL+K +      
Sbjct: 147 QTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG--- 200

Query: 314 QISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                  G    +     A E  +    T+KSDV+++GV + E+ T G  P
Sbjct: 201 --DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (353), Expect = 1e-37
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 21/220 (9%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVA----AIKKLHRDGKQRERA-FRMEVDLL 204
           E    N S   V+G G FG V  G L   +      AIK L     +++R  F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 205 SRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            +   P ++ L G        ++++EYM NG+L   L +H+ +         + +    A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-----V 319
             +++L +      +HRD    N+L++ N   KV+DFGL +++ D      +TR     +
Sbjct: 158 SGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
             T    +PE  +  K T+ SDV+SYG+VL E+++ G  P
Sbjct: 215 RWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (350), Expect = 2e-37
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 28/232 (12%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRD--GKQRERAFRME 200
           +++    + F+ G ++G G FG V +  L          A+K L  D         F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 201 VDLLSRLHSPQLVELLGYCADQ------NHRLLISEYMPNGTLQQHL--HRHNNRYRPLD 252
              +     P + +L+G              ++I  +M +G L   L   R       L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
            +T +   +D A  +E+L        IHRD    N +L ++    V DFGL++ +     
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-- 190

Query: 313 GQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                   G    L     A E  +    T  SDV+++GV + E++T G+ P
Sbjct: 191 ---DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  137 bits (348), Expect = 2e-37
 Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 27/214 (12%)

Query: 158 EGNVIGNGGFGVVYKGVLSDGTVA---AIKKLHRD--GKQRERAFRMEVDLLSRLHSPQL 212
           E   +G+G FG V KG      V    A+K L  +      +     E +++ +L +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V ++G C  ++  +L+ E    G L ++L ++    R +  +  + +    +M +++L E
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE 135

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTGY 325
                 +HRD    NVLL     AK++DFGL+K +         + +G+   +      +
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK------W 186

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            APE  +  K ++KSDV+S+GV++ E  + G+ P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (356), Expect = 2e-37
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 19/233 (8%)

Query: 132 YNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK 191
                 K   Q       E   E+      +G G FG V+ G  +  T  AIK L     
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM 221

Query: 192 QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPL 251
             E AF  E  ++ +L   +LV+L    +++    +++EYM  G+L   L     +Y  L
Sbjct: 222 SPE-AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--L 277

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
                + +A   A  + ++        +HRD + +N+L+ +N   KV DFGLA+++ D  
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

Query: 312 -----NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                  +   +      + APE A  G+ T KSDV+S+G++L EL T GRVP
Sbjct: 335 YTARQGAKFPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (345), Expect = 4e-37
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 162 IGNGGFGVVYKGVL--SDGTVA-AIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLG 217
           +G G FG V +GV       +  AIK L +  ++ +      E  ++ +L +P +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPP 277
            C  +   +L+ E    G L + L         +       +    +M +++L E     
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN--- 130

Query: 278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG------TTGYLAPEYA 331
            +HRD    NVLL     AK++DFGL+K +    +   + R  G           APE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWY----APECI 185

Query: 332 STGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +  K +++SDV+SYGV + E L+ G+ P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (346), Expect = 6e-37
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG-----TVAAIKKLHRD-GKQRERAFRMEVDLLSRL 207
             F +  V+G+G FG VYKG+            AIK+L      +  +    E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            +P +  LLG C   +   LI++ MP G L  ++  H +    +  +  L   +  A  +
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 130

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD------KINGQISTRVLG 321
            +L +     ++HRD    NVL+      K+TDFGLAK++           G++  +   
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
              ++A E       T +SDV+SYGV + EL+T G  P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 8e-37
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 21/212 (9%)

Query: 159 GNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLV 213
             VIG G FG VY G L D        A+K L+R     E + F  E  ++     P ++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 214 ELLGYCAD-QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
            LLG C   +   L++  YM +G L+  +    +       +  +   L  A  ++FL  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL-----A 327
                 +HRD    N +LD+ F  KV DFGLA+ + DK    +  +   T   L     A
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMA 264

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            E   T K TTKSDV+S+GV+L EL+T G  P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (355), Expect = 1e-36
 Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 19/230 (8%)

Query: 135 VRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRE 194
              K   Q       E   E+      +G G FG V+ G  +  T  AIK L       E
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 307

Query: 195 RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR 254
            AF  E  ++ +L   +LV+L    +++    +++EYM  G+L   L     +Y  L   
Sbjct: 308 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--LRLP 363

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI--- 311
             + +A   A  + ++        +HRD + +N+L+ +N   KV DFGLA+++ D     
Sbjct: 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

Query: 312 --NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
               +   +      + APE A  G+ T KSDV+S+G++L EL T GRVP
Sbjct: 421 RQGAKFPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (348), Expect = 1e-36
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRL--HS 209
             +S    IG+GG   V++ +     + AIK ++ +    Q   ++R E+  L++L  HS
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
            +++ L  Y     +  ++ E   N  L   L +     + +D   R     +   A+  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHT 170

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           +H+H    ++H D K +N L+      K+ DFG+A  +       +    +G   Y+ PE
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 330 -----------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                        S  K++ KSDV+S G +L  +  G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (341), Expect = 1e-36
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 24/226 (10%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRDGKQRER-AFR 198
            + ++ E   E    G  IG G FG V++G+           AIK          R  F 
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64

Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLI 258
            E   + +   P +V+L+G    +N   +I E    G L+  L         LD  + ++
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI-----NG 313
            A   + AL +L        +HRD    NVL+  N   K+ DFGL++ + D        G
Sbjct: 121 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           ++  +      ++APE  +  + T+ SDV+ +GV + E+L  G  P
Sbjct: 178 KLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (343), Expect = 2e-36
 Identities = 62/273 (22%), Positives = 103/273 (37%), Gaps = 46/273 (16%)

Query: 114 NGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKG 173
           +  H  S + + A  +        K           E   +  + G  +G G FG V   
Sbjct: 5   HHHHHHSQDPMLAGVSEYELPEDPK----------WEFPRDKLTLGKPLGEGAFGQVVMA 54

Query: 174 VLSD--------GTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHS-PQLVELLGYCADQN 223
                           A+K L  D  +++      E++++  +     ++ LLG C    
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114

Query: 224 HRLLISEYMPNGTLQQHL--HRHNNRY----------RPLDWRTRLIIALDCAMALEFLH 271
              +I EY   G L+++L   R                 + ++  +      A  +E+L 
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 174

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL----- 326
                  IHRD    NVL+ +N   K+ DFGLA+ +++     I      T G L     
Sbjct: 175 SQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN-----IDYYKKTTNGRLPVKWM 226

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           APE       T +SDV+S+GV++ E+ T G  P
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (340), Expect = 2e-36
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 30/223 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVA--------AIKKLHRDGKQRERAFRMEVDLLS 205
           E+      +G G F  ++KGV  +             +K L +  +    +F     ++S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +L    LV   G C   +  +L+ E++  G+L  +L ++ N    ++   +L +A   A 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAA 124

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFR--------AKVTDFGLAKMVSDKINGQIST 317
           A+ FL E+    +IH +    N+LL +            K++D G++  V  K   Q   
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181

Query: 318 RVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLT-GRVP 358
                  ++ PE     K     +D +S+G  L E+ + G  P
Sbjct: 182 P------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 2e-36
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 28/220 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSR 206
           ++      +G+G FGVV +G            A+K L  D     +    F  EV+ +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
           L    L+ L G         +++E  P G+L   L +H   +      T    A+  A  
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLG---TLSRYAVQVAEG 133

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRV 319
           + +L        IHRD    N+LL      K+ DFGL + +         + + ++    
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA- 189

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                + APE   T   +  SD + +GV L E+ T G+ P
Sbjct: 190 -----WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  140 bits (354), Expect = 3e-36
 Identities = 71/322 (22%), Positives = 125/322 (38%), Gaps = 36/322 (11%)

Query: 48  IIIVSVISVIVLVALLLLVLMLRRLKSSSEDSHGSSFKDNKSGSSRFIAHMTINSTCSPD 107
            + V+  S+ +   +  L+    RL + +  S     +     +   I  +  N      
Sbjct: 296 PLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEK---- 351

Query: 108 VKGWCFNGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGF 167
                     VRS+ V  +        + ++    + + ++ E   E    G  IG G F
Sbjct: 352 --------QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403

Query: 168 GVVYKGVLSDG----TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELLGYCADQ 222
           G V++G+           AIK          R  F  E   + +   P +V+L+G    +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 462

Query: 223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD 282
           N   +I E    G L+  L         LD  + ++ A   + AL +L        +HRD
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR---FVHRD 516

Query: 283 FKCSNVLLDQNFRAKVTDFGLAKMVSD-----KINGQISTRVLGTTGYLAPEYASTGKLT 337
               NVL+  N   K+ DFGL++ + D        G++  +      ++APE  +  + T
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINFRRFT 570

Query: 338 TKSDVYSYGVVLLELLT-GRVP 358
           + SDV+ +GV + E+L  G  P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  134 bits (340), Expect = 3e-36
 Identities = 69/245 (28%), Positives = 91/245 (37%), Gaps = 37/245 (15%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
              S G  +G G FG V +               A+K L       ER A   E+ +LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 207 LHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH--------------NNRYRPL 251
           L +   +V LLG C      L+I+EY   G L   L R                +    L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
           D    L  +   A  + FL        IHRD    N+LL      K+ DFGLA+ + +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN-- 197

Query: 312 NGQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
               S  V+     L     APE       T +SDV+SYG+ L EL + G  P  P  P 
Sbjct: 198 ---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPV 253

Query: 366 GEHVL 370
                
Sbjct: 254 DSKFY 258

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (336), Expect = 7e-36
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 158 EGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELL 216
           +  V+G G +G+VY G  LS+    AIK++     +  +    E+ L   L    +V+ L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA--LDCAMALEFLHEHA 274
           G  ++     +  E +P G+L   L       +  +          L+    L++LH++ 
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE---GLKYLHDNQ 142

Query: 275 TPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE---Y 330
              ++HRD K  NVL++  +   K++DFG +K ++       +    GT  Y+APE    
Sbjct: 143 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              G     +D++S G  ++E+ TG+ P
Sbjct: 198 GPRGY-GKAADIWSLGCTIIEMATGKPP 224

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  133 bits (337), Expect = 1e-35
 Identities = 65/241 (26%), Positives = 90/241 (37%), Gaps = 33/241 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
            N   G  +G G FG V +               A+K L       E+ A   E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 207 LHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY----------RPLDWRT 255
           L     +V LLG C      L+I+EY   G L   L R +                  R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
            L  +   A  + FL        IHRD    NVLL     AK+ DFGLA+ + +      
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-----D 217

Query: 316 STRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHV 369
           S  ++     L     APE       T +SDV+SYG++L E+ + G  P  P        
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKF 276

Query: 370 L 370
            
Sbjct: 277 Y 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  138 bits (349), Expect = 2e-35
 Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 32/235 (13%)

Query: 161 VIGNGGFGVVYKG---VLSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELL 216
            I +GG G +Y      ++   V  +K L   G    +A    E   L+ +  P +V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVV-LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 217 GYCADQNHRL-----LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
            +    +        ++ EY+   +L++   +       L     +   L+   AL +LH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
                 +++ D K  N++L +  + K+ D G    ++          + GT G+ APE  
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV 249

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVP-----VDPNRPPGEHVLVSWALPRLTSR 381
                T  +D+Y+ G  L  L           VD        +    +  RL  R
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRR 303

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (339), Expect = 2e-35
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 36/228 (15%)

Query: 159 GNVIGNGGFGVVYKGVL--------SDGTVAAIKKLHRDGKQRER-AFRMEVDLLSRLHS 209
           G  +G G FG V             +  T  A+K L  D  +++      E++++  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 210 -PQLVELLGYCADQNHRLLISEYMPNGTLQQHL--HRHNNRY----------RPLDWRTR 256
              ++ LLG C       +I EY   G L+++L   R                 L  +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           +  A   A  +E+L        IHRD    NVL+ ++   K+ DFGLA+ +       I 
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHH-----ID 245

Query: 317 TRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                T G L     APE       T +SDV+S+GV+L E+ T G  P
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  133 bits (337), Expect = 2e-35
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 36/233 (15%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDGKQRER-AFRMEVDLL 204
           +  + G  +G G FG V                   A+K L  D  +++      E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 205 SRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY------------RPL 251
             +     ++ LLG C       +I EY   G L+++L                     +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
            ++  +      A  +E+L        IHRD    NVL+ +N   K+ DFGLA+ +++  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN-- 255

Query: 312 NGQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
              I      T G L     APE       T +SDV+S+GV++ E+ T G  P
Sbjct: 256 ---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (335), Expect = 2e-35
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 159 GNVIGNGGFGVVYKGVLSDG---TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHS-PQLV 213
            +VIG G FG V K  +        AAIK++     + +   F  E+++L +L   P ++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NNRYRPLDWRTRLIIAL 261
            LLG C  + +  L  EY P+G L   L +             N+    L  +  L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
           D A  +++L +      IHRD    N+L+ +N+ AK+ DFGL++             V  
Sbjct: 150 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKK 198

Query: 322 TTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           T G L     A E  +    TT SDV+SYGV+L E+++ G  P
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 41/238 (17%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
           +N   G  +G G FG V K            T  A+K L  +    E      E ++L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL--HRHNNRY---------------- 248
           ++ P +++L G C+     LLI EY   G+L+  L   R                     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 249 --RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
             R L     +  A   +  +++L E     ++HRD    N+L+ +  + K++DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 307 VSDKINGQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           V +       + V  + G +     A E       TT+SDV+S+GV+L E++T G  P
Sbjct: 200 VYE-----EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 3e-35
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 27/219 (12%)

Query: 159 GNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
              +G+G FG VY+G +S           A+K L     +++   F ME  ++S+ +   
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRH---NNRYRPLDWRTRLIIALDCAMALE 268
           +V  +G       R ++ E M  G L+  L       ++   L     L +A D A   +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 269 FLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
           +L E+     IHRD    N LL        AK+ DFG+A+ +        S    G    
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----ASYYRKGGCAM 206

Query: 326 L-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           L      PE    G  T+K+D +S+GV+L E+ + G +P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (334), Expect = 3e-35
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 17/217 (7%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLS 205
            E        +    +G G FG V++      G   A+KK+  +  + E     E+   +
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACA 105

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            L SP++V L G   +     +  E +  G+L Q +     +   L     L        
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALE 161

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTR---VLG 321
            LE+LH      ++H D K  NVLL  +  RA + DFG A  +     G+       + G
Sbjct: 162 GLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           T  ++APE         K D++S   ++L +L G  P
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (333), Expect = 3e-35
 Identities = 57/232 (24%), Positives = 85/232 (36%), Gaps = 35/232 (15%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
           +    G  +G G FG V +         +     A+K L       E  A   E+ +L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 207 LHS-PQLVELLGYCADQN-HRLLISEYMPNGTLQQHLHRH------------NNRYRPLD 252
           +     +V LLG C       ++I E+   G L  +L               +     L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
               +  +   A  +EFL        IHRD    N+LL +    K+ DFGLA+ +     
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK--- 200

Query: 313 GQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
                 V      L     APE       T +SDV+S+GV+L E+ + G  P
Sbjct: 201 --DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  131 bits (331), Expect = 4e-35
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLH 208
           E+F  G  +G G FG VY         + A+K L +          +  R EV++ S L 
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-EVEIQSHLR 67

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P ++ L GY  D     LI EY P GT+ + L + +   +  + RT   I    A AL 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITE-LANALS 123

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           + H      VIHRD K  N+LL      K+ DFG +       + + +  + GT  YL P
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGTLDYLPP 176

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E         K D++S GV+  E L G+ P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (331), Expect = 4e-35
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 34/225 (15%)

Query: 159 GNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
              +G G FG V+           D  + A+K L +D     R  F+ E +LL+ L    
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NNRYRPLDWRTRLII 259
           +V+  G C D +  +++ EYM +G L + L  H                  L     L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
           A   A  + +L        +HRD    N L+  N   K+ DFG+++ V          RV
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRV 191

Query: 320 LGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
            G    L      PE     K TT+SDV+S+GV+L E+ T G+ P
Sbjct: 192 -GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (333), Expect = 5e-35
 Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 33/224 (14%)

Query: 159 GNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
              +G G FG V+     +        + A+K L ++  +  R  F+ E +LL+ L    
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQH 104

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRH-----------NNRYRPLDWRTRLIIA 260
           +V   G C +    L++ EYM +G L + L  H           +    PL     L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
              A  + +L        +HRD    N L+ Q    K+ DFG+++     I      RV 
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRV- 216

Query: 321 GTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           G    L      PE     K TT+SDV+S+GVVL E+ T G+ P
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  132 bits (333), Expect = 7e-35
 Identities = 68/245 (27%), Positives = 96/245 (39%), Gaps = 42/245 (17%)

Query: 159 GNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRER-AFRMEVDLLSRLHS-P 210
           G V+G+G FG V                 A+K L       ER A   E+ ++++L S  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHL--HRHNNRYRPLDWRTR------------ 256
            +V LLG C       LI EY   G L  +L   R       +++  +            
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 257 -----LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
                L  A   A  +EFL   +    +HRD    NVL+      K+ DFGLA+ +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS-- 224

Query: 312 NGQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPP 365
               S  V+     L     APE    G  T KSDV+SYG++L E+ + G  P  P  P 
Sbjct: 225 ---DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PGIPV 280

Query: 366 GEHVL 370
             +  
Sbjct: 281 DANFY 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  136 bits (344), Expect = 8e-35
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 20/223 (8%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQ 211
            +     +G GGFG V + +    G   AIK+  ++   K RER    E+ ++ +L+ P 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPN 73

Query: 212 LVELL------GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +V            A  +  LL  EY   G L+++L++  N    L       +  D + 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISS 132

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRA---KVTDFGLAKMVSDKINGQISTRVLGT 322
           AL +LHE+    +IHRD K  N++L    +    K+ D G AK +        +  V GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV-GT 186

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
             YLAPE     K T   D +S+G +  E +TG  P  PN  P
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (340), Expect = 2e-34
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 161 VIGNGGFGVVYKGVL--SDGTVA-AIKKLHRDGKQRER-AFRMEVDLLSRLHSPQLVELL 216
            +G G FG V +GV       +  AIK L +  ++ +      E  ++ +L +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
           G C  +   +L+ E    G L + L         +       +    +M +++L E    
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN-- 456

Query: 277 PVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD-------KINGQISTRVLGTTGYLAPE 329
             +HR+    NVLL     AK++DFGL+K +         +  G+   +      + APE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPE 509

Query: 330 YASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
             +  K +++SDV+SYGV + E L+ G+ P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  129 bits (326), Expect = 2e-34
 Identities = 63/225 (28%), Positives = 86/225 (38%), Gaps = 33/225 (14%)

Query: 159 GNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
              +G   FG VYKG L            AIK L    +   R  FR E  L +RL  P 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NNRYRPLDWRTRLII 259
           +V LLG         +I  Y  +G L + L                     L+    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
               A  +E+L  H    V+H+D    NVL+      K++D GL + V            
Sbjct: 134 VAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-----ADYYK 185

Query: 320 LGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           L     L     APE    GK +  SD++SYGVVL E+ + G  P
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (331), Expect = 2e-34
 Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 27/261 (10%)

Query: 117 HVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLS 176
             + + +  +   T YN                E   +N +    +G+G FG VY+G +S
Sbjct: 34  EYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 93

Query: 177 DG------TVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS 229
                      A+K L     +++   F ME  ++S+ +   +V  +G       R ++ 
Sbjct: 94  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153

Query: 230 EYMPNGTLQQHLHRH---NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS 286
           E M  G L+  L       ++   L     L +A D A   ++L E+     IHRD    
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 210

Query: 287 NVLLD---QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL-----APEYASTGKLTT 338
           N LL        AK+ DFG+A+ +             G    L      PE    G  T+
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMARDIYR-----AGYYRKGGCAMLPVKWMPPEAFMEGIFTS 265

Query: 339 KSDVYSYGVVLLELLT-GRVP 358
           K+D +S+GV+L E+ + G +P
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMP 286

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  131 bits (330), Expect = 2e-34
 Identities = 40/230 (17%), Positives = 74/230 (32%), Gaps = 21/230 (9%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVLSDGTVA------AIKKLHRDGKQRERAFRME 200
            E +  ++     +++G G F  VY+    D   A       +K                
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL-HRHNNRYRPLDWRTRLII 259
           ++ L        ++       QN  +L+ E    GTL   +    N   + +     +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----------DQNFRAKVTDFGLAKMVS 308
           A+     +E +H+     +IH D K  N +L           D +    + D G +  + 
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               G I T    T+G+   E  S      + D +     +  +L G   
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (325), Expect = 7e-34
 Identities = 65/246 (26%), Positives = 97/246 (39%), Gaps = 41/246 (16%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDGKQRERA-FR 198
              LE    N      IG G FG V++            T+ A+K L  +     +A F+
Sbjct: 39  LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98

Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH-------------- 244
            E  L++   +P +V+LLG CA      L+ EYM  G L + L                 
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 245 ------NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
                 +    PL    +L IA   A  + +L E      +HRD    N L+ +N   K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKI 215

Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYL-----APEYASTGKLTTKSDVYSYGVVLLELL 353
            DFGL++ +                  +      PE     + TT+SDV++YGVVL E+ 
Sbjct: 216 ADFGLSRNIYS-----ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

Query: 354 T-GRVP 358
           + G  P
Sbjct: 271 SYGLQP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (323), Expect = 1e-33
 Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 24/234 (10%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLS 205
           + +E          V+  GGF  VY+   +  G   A+K+L  + +++ RA   EV  + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 206 RL-HSPQLVELLGYCADQNHR-------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           +L   P +V+     +             L+   +  G L + L +  +R  PL   T L
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVL 139

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            I      A++ +H    PP+IHRD K  N+LL      K+ DFG A  +S   +   S 
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 318 RVL----------GTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           +             T  Y  PE     S   +  K D+++ G +L  L   + P
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  130 bits (328), Expect = 1e-33
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 22/215 (10%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL--HSPQL 212
           +F   +V+G+G  G +    + D    A+K++     +       EV LL     H P +
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEH-PNV 80

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           +       D+  + +  E     TLQ+++ + +  +  L+  T   +       L  LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT---LLQQTTSGLAHLHS 136

Query: 273 HATPPVIHRDFKCSNVLL-----DQNFRAKVTDFGLAKMVS-DKINGQISTRVLGTTGYL 326
                ++HRD K  N+L+         +A ++DFGL K ++  + +    + V GT G++
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 327 APEY---ASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           APE          T   D++S G V   +++    
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (319), Expect = 2e-33
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 14/210 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLH 208
           E+F  GN++G G F  VY+   +  G   AIK + +         +R  + EV +  +L 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P ++EL  Y  D N+  L+ E   NG + ++L      +   +   R  +       + 
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMH-QIITGML 126

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH H    ++HRD   SN+LL +N   K+ DFGLA     K+  +    + GT  Y++P
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISP 181

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E A+      +SDV+S G +   LL GR P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (316), Expect = 5e-33
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLH 208
           ++F  G  +G G FG VY      +  + A+K L +          +  R E+++ S L 
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLR 72

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P ++ +  Y  D+    L+ E+ P G L + L +H    R  + R+   +  + A AL 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFME-ELADALH 128

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLA 327
           + HE     VIHRD K  N+L+      K+ DFG +          +  R + GT  YL 
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGTLDYLP 180

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE         K D++  GV+  E L G  P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (317), Expect = 1e-32
 Identities = 47/230 (20%), Positives = 93/230 (40%), Gaps = 34/230 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAF---------------- 197
            ++     +  G F  +      D    A+KK  +   +++R F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 198 -RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH-----NNRYRPL 251
            + E+ +++ + +   +   G   + +   +I EYM N ++ +          N      
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI 311
               + II      +  ++H      + HRD K SN+L+D+N R K++DFG ++ + D  
Sbjct: 150 IQVIKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-- 204

Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTT---KSDVYSYGVVLLELLTGRVP 358
             +I     GT  ++ PE+ S  + +    K D++S G+ L  +    VP
Sbjct: 205 -KKIKGSR-GTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVP 251

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (312), Expect = 3e-32
 Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 25/232 (10%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL 207
           T+   +   +++G G    V++G     G + AIK  +     +  +   R E ++L +L
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKL 64

Query: 208 HSPQLVELLGYCADQNHRL--LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +   +V+L     +   R   LI E+ P G+L   L   +N Y  L     LI+  D   
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVG 123

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
            +  L E+    ++HR+ K  N++     D     K+TDFG A+ + D  + Q  +   G
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY-G 177

Query: 322 TTGYLAPE--------YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
           T  YL P+             K     D++S GV      TG +P  P   P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (311), Expect = 3e-32
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLH 208
             +  G  +G GGF   ++        V A K + +       QRE+   ME+ +   L 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA 73

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              +V   G+  D +   ++ E     +L +   R        +   R  +     +  +
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLR-QIVLGCQ 129

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH +    VIHRD K  N+ L+++   K+ DFGLA  V  + +G+    + GT  Y+AP
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAP 184

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           E  S    + + DV+S G ++  LL G+ P +
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (312), Expect = 6e-32
 Identities = 64/292 (21%), Positives = 118/292 (40%), Gaps = 24/292 (8%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAF-RMEVDLL 204
           K  E   ++F + + +G G  GVV+K      G V A K +H + K   R     E+ +L
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 205 SRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
              +SP +V   G         +  E+M  G+L Q L +       +  +    +++   
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVI 141

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             L +L E     ++HRD K SN+L++     K+ DFG    VS ++   ++   +GT  
Sbjct: 142 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRS 195

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
           Y++PE       + +SD++S G+ L+E+  GR P+ P       ++    +    +    
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
                     ++                +P  A   L+  +V    P + + 
Sbjct: 256 RPRTPGRPLNKFGMDS------------RPPMAIFELLDYIVNEPPPKLPSG 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (314), Expect = 6e-32
 Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 25/232 (10%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL 207
           T+   +   +++G G    V++G     G + AIK  +     +  +   R E ++L +L
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKL 64

Query: 208 HSPQLVELLGYCADQNHRL--LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
           +   +V+L     +   R   LI E+ P G+L   L   +N Y  L     LI+  D   
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG 123

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
            +  L E+    ++HR+ K  N++     D     K+TDFG A+ + D  + Q  +   G
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY-G 177

Query: 322 TTGYLAPE--------YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP 365
           T  YL P+             K     D++S GV      TG +P  P   P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 8e-32
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 15/210 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLH 208
             +  G  +G GGF   ++        V A K + +       QRE+   ME+ +   L 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA 99

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              +V   G+  D +   ++ E     +L +   R        +   R  +     +  +
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLR-QIVLGCQ 155

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH +    VIHRD K  N+ L+++   K+ DFGLA  V  + +G+    + GT  Y+AP
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAP 210

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E  S    + + DV+S G ++  LL G+ P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  126 bits (317), Expect = 2e-31
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 14/210 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHS 209
             F +  V+G GGFG V    +   G + A KKL +     ++ E     E  +L +++S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 210 PQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
             +V L  Y  +    L L+   M  G L+ H++       P   R     A +    LE
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA-EICCGLE 300

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            LH      +++RD K  N+LLD +   +++D GLA  V +     I  RV GT GY+AP
Sbjct: 301 DLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAP 354

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E     + T   D ++ G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (305), Expect = 5e-31
 Identities = 31/255 (12%), Positives = 54/255 (21%), Gaps = 42/255 (16%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA---FRMEVDL 203
            L            +  G   VV+    +      A+K      +               
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 204 LSRLHSPQLVELLGYC--------------------------ADQNHRLLISEYMP--NG 235
            +RL      E                                   + LL+         
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 236 TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR 295
            L   L                I+          L       ++H  F   N+ +  + R
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232

Query: 296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY--ASTGKLTTKSDVYSYGVVLLELL 353
             + D      V     G           Y   E+  AST   T   + +  G+ +  + 
Sbjct: 233 LMLGDVSALWKV-----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 354 TGRVPVDPNRPPGEH 368
              +P     P  + 
Sbjct: 288 CLFLPFGLVTPGIKG 302

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (305), Expect = 1e-30
 Identities = 34/246 (13%), Positives = 69/246 (28%), Gaps = 52/246 (21%)

Query: 156 FSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQ--------RERAFRM------- 199
              G V+G        +      G    +   +   +         +E   R+       
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 200 -------------EVDLLSRLHSPQLVELLGYCADQNHR----LLISEYMPNGTLQQHLH 242
                          DL+      +++ +     D        L         T  + L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 243 RHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG 302
            H++ ++ L    RL + L     L  LH +    ++H   +  +++LDQ     +T F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 303 LAKMVSDKINGQISTRVLGTTGYLAPEYAS----------TGKLTTKSDVYSYGVVLLEL 352
                        S       G+  PE  +             +T   D ++ G+ +  +
Sbjct: 257 HLVRDGA------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 353 LTGRVP 358
               +P
Sbjct: 311 WCADLP 316

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  118 bits (298), Expect = 2e-30
 Identities = 63/257 (24%), Positives = 113/257 (43%), Gaps = 18/257 (7%)

Query: 149 LETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER-AFRMEVD-LLS 205
           +E   ++      +G G +GVV K   +  G + A+K++      +E+    M++D  + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            +  P  V   G    +    +  E M + +L +   +  ++ + +       IA+    
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
           ALE LH   +  VIHRD K SNVL++   + K+ DFG++  + D +         G   Y
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPY 175

Query: 326 LAPE----YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE--HVLVSWALPRLT 379
           +APE      +    + KSD++S G+ ++EL   R P D    P +    +V    P+L 
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235

Query: 380 SR---EEAVEMVDPSLQ 393
           +     E V+     L+
Sbjct: 236 ADKFSAEFVDFTSQCLK 252

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 2e-30
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            + ++    IG G  G VY  + ++ G   AI++++   + ++     E+ ++    +P 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V  L      +   ++ EY+  G+L   +         +D      +  +C  ALEFLH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH 133

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPE 329
            +    VIHRD K  N+LL  +   K+TDFG       +I  + S R  ++GT  ++APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             +      K D++S G++ +E++ G  P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  119 bits (300), Expect = 2e-30
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 14/255 (5%)

Query: 138 KGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER- 195
            G +++   +  +   E+  +   IG G +G V K V    G + A+K++     ++E+ 
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65

Query: 196 AFRMEVD-LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR 254
              M++D ++     P +V+  G    +    +  E M     + + + ++     +   
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
               I L    AL  L E+    +IHRD K SN+LLD++   K+ DFG++  + D I   
Sbjct: 126 ILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK- 182

Query: 315 ISTRVLGTTGYLAPE----YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL 370
             TR  G   Y+APE     AS      +SDV+S G+ L EL TGR P        + + 
Sbjct: 183 --TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 371 --VSWALPRLTSREE 383
             V    P+L++ EE
Sbjct: 241 QVVKGDPPQLSNSEE 255

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  119 bits (299), Expect = 5e-30
 Identities = 34/250 (13%), Positives = 69/250 (27%), Gaps = 53/250 (21%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA--------------- 196
                 G V+G        +      G    +   +   +    A               
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 197 -------------FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM----PNGTLQQ 239
                        F    DL+      +++ +     D         Y        T  +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
            L  H++ ++ L    RL + L     L  LH +    ++H   +  +++LDQ     +T
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLT 248

Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-----------GKLTTKSDVYSYGVV 348
            F        +           + G+  PE  +              +T   D ++ G+V
Sbjct: 249 GFEHLVRDGAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 349 LLELLTGRVP 358
           +  +    +P
Sbjct: 303 IYWIWCADLP 312

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  119 bits (301), Expect = 2e-29
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 13/211 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHS 209
           + F +  V+G GGFG V+   +   G + A KKL++     ++  +   +E  +L+++HS
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 210 PQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLD-WRTRLIIALDCAMAL 267
             +V L  Y  +    L L+   M  G ++ H++  +         R     A      L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           E LH+     +I+RD K  NVLLD +   +++D GLA  +      +      GT G++A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFMA 357

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE     +     D ++ GV L E++  R P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (292), Expect = 2e-29
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
                    IG G  G+V        G   A+K +    +QR      EV ++       
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +VE+           ++ E++  G L   + +       L+      +      AL +LH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH 158

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPE 329
                 VIHRD K  ++LL  + R K++DFG       +I+  +  R  ++GT  ++APE
Sbjct: 159 AQG---VIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPE 211

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             S     T+ D++S G++++E++ G  P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  115 bits (290), Expect = 3e-29
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 45/278 (16%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSP 210
            E F++   IG G FG V+KG+      V AIK +  +  + E    + E+ +LS+  SP
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 211 QLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
            + +  G    ++ +L +I EY+  G+    L        PLD      I  +    L++
Sbjct: 81  YVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDY 134

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLA 327
           LH       IHRD K +NVLL ++   K+ DFG    V+ ++      R   +GT  ++A
Sbjct: 135 LHSEK---KIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMA 187

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP---VDPNRPPGEHVLVSWALPRLTSREEA 384
           PE        +K+D++S G+  +EL  G  P   + P +     VL       L  +   
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLF------LIPKNNP 236

Query: 385 VEMVDPSLQGQYPK--KDLIQIAAIAAVCVQPEAAYRP 420
                P+L+G Y K  K+ +        C+  E ++RP
Sbjct: 237 -----PTLEGNYSKPLKEFV------EACLNKEPSFRP 263

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (295), Expect = 4e-29
 Identities = 48/226 (21%), Positives = 79/226 (34%), Gaps = 33/226 (14%)

Query: 156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVE 214
                ++G G  G V       G   A+K++            ME+ LL+     P ++ 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL---IIALDCAMALEFLH 271
                       +  E   N  LQ  +   N     L  +       +    A  +  LH
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 272 EHATPPVIHRDFKCSNVLLD-------------QNFRAKVTDFGLAKMVSDKINGQISTR 318
                 +IHRD K  N+L+              +N R  ++DFGL K +    +   +  
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 319 --VLGTTGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTG 355
               GT+G+ APE         +  +LT   D++S G V   +L+ 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 4e-29
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 15/211 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLH 208
           E+F  G ++G G F  V      +     AIK L +       +       E D++SRL 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P  V+L     D         Y  NG L +++ +        +  TR   A +   ALE
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTA-EIVSALE 144

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           +LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   +GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 329 EYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           E   T K   KS D+++ G ++ +L+ G  P
Sbjct: 202 ELL-TEKSACKSSDLWALGCIIYQLVAGLPP 231

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  117 bits (294), Expect = 5e-29
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 30/229 (13%)

Query: 147 KELETATENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG--KQRERA-FRM 199
           KE+    ++F    VIG G F  V     K     G V A+K +++    K+ E + FR 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 200 EVDLLSRLHSPQLVELLGYCA--DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           E D+L       + +L  + A  D+N+  L+ EY   G L   L +   R  P +   R 
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAE-MARF 166

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +A +  MA++ +H       +HRD K  N+LLD+    ++ DFG    +  + +G + +
Sbjct: 167 YLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL--RADGTVRS 220

Query: 318 RVL-GTTGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            V  GT  YL+PE          TG    + D ++ GV   E+  G+ P
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  117 bits (295), Expect = 8e-29
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 26/223 (11%)

Query: 149 LETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK---KLHRDGKQRERAFRME 200
           ++ +T  FS+      V+G G FG V        G   A+K   K     K  + +   E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR--TRLI 258
           V LL +L  P +++L  +  D+ +  L+ E    G L   +     R+  +D     R +
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQV 135

Query: 259 IALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQI 315
           ++      + ++H++    ++HRD K  N+LL    ++   ++ DFGL+         + 
Sbjct: 136 LS-----GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKK 184

Query: 316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               +GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 8e-29
 Identities = 65/262 (24%), Positives = 106/262 (40%), Gaps = 25/262 (9%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER-AFRMEVDLL 204
           +  +    +      +G+G  G V+K      G V A+K++ R G + E     M++D++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 205 SRLH-SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
            + H  P +V+  G         +  E M     +           P+  R    + +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAI 133

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
             AL +L E     VIHRD K SN+LLD+  + K+ DFG++  + D        R  G  
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188

Query: 324 GYLAPE-----YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL---VSWAL 375
            Y+APE       +      ++DV+S G+ L+EL TG+ P    +   E VL   +    
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQEEP 247

Query: 376 PRLTSRE----EAVEMVDPSLQ 393
           P L        +    V   L 
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLT 269

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  118 bits (297), Expect = 1e-28
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKG-VLSDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHS 209
            +FS   +IG GGFG VY       G + A+K L +     KQ E     E  +LS + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 210 ---PQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
              P +V +  Y      +L  I + M  G L  HL +H           R   A +  +
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAA-EIIL 303

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
            LE +H      V++RD K +N+LLD++   +++D GLA   S     +    V GT GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASV-GTHGY 356

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +APE    G     S D +S G +L +LL G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (294), Expect = 1e-28
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 149 LETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEV 201
           + +   + SE       +G+G +G V            AIK + +             EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR--TRLII 259
            +L  L  P +++L  +  D+ +  L+ E    G L   +     ++  +D     + ++
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVL 146

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQIS 316
           +      + +LH+H    ++HRD K  N+LL   +++   K+ DFGL+ +  +    +  
Sbjct: 147 S-----GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKM 195

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              LGT  Y+APE     K   K DV+S GV+L  LL G  P
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (284), Expect = 2e-28
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 15/209 (7%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            E F     +G G +G VYK +    G + AIK++    +   +    E+ ++ +  SP 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+  G         ++ EY   G++   +   N     L       I       LE+LH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPE 329
                  IHRD K  N+LL+    AK+ DFG    V+ ++   ++ R  V+GT  ++APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPE 195

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                     +D++S G+  +E+  G+ P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  114 bits (287), Expect = 5e-28
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 147 KELETATENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG--KQRERA-FRM 199
           K++    E+F    VIG G FG V     K       V A+K L++    K+ E A FR 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123

Query: 200 EVDLLSRLHSPQLVELLGYCADQ-NHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           E D+L    S  +  L  + A Q ++ L L+ +Y   G L   L +  +R  P +   R 
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL-PEE-MARF 179

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
            +A +  +A++ +H+      +HRD K  N+L+D N   ++ DFG    + +  +G + +
Sbjct: 180 YLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQS 233

Query: 318 RVL-GTTGYLAPE-----YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            V  GT  Y++PE         G+   + D +S GV + E+L G  P
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  113 bits (283), Expect = 5e-28
 Identities = 59/254 (23%), Positives = 91/254 (35%), Gaps = 51/254 (20%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRERAFRMEVDLLSR 206
            + +     IG G +GVV   +      + AIK     K+ +   +     + EV L+ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM- 265
           LH P +  L     D+ +  L+ E    G L   L+   +          +   +     
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 266 -----------------------------------ALEFLHEHATPPVIHRDFKCSNVLL 290
                                              AL +LH      + HRD K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201

Query: 291 --DQNFRAKVTDFGLAKMVSDKINGQIS--TRVLGTTGYLAPE--YASTGKLTTKSDVYS 344
             +++F  K+ DFGL+K      NG+    T   GT  ++APE    +      K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 345 YGVVLLELLTGRVP 358
            GV+L  LL G VP
Sbjct: 262 AGVLLHLLLMGAVP 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (280), Expect = 7e-28
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            E +     +G+G FG VYK      G +AA K +    ++    + +E+++L+    P 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+LLG         ++ E+ P G +   +   +   R L      ++      AL FLH
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH 134

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYLAPE 329
                 +IHRD K  NVL+      ++ DFG    VS K    +  R   +GT  ++APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 330 -----YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                         K+D++S G+ L+E+     P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 3e-27
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 36/233 (15%)

Query: 149 LETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR-------------DG 190
           +        E       +G+G +G V      +  +  AIK + +             + 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
           ++       E+ LL  L  P +++L     D+ +  L++E+   G L + +   + ++  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDE 145

Query: 251 LDWR--TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAK 305
            D     + I++      + +LH+H    ++HRD K  N+LL   +     K+ DFGL+ 
Sbjct: 146 CDAANIMKQILS-----GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS 197

Query: 306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             S           LGT  Y+APE     K   K DV+S GV++  LL G  P
Sbjct: 198 FFSK---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (276), Expect = 4e-27
 Identities = 58/271 (21%), Positives = 89/271 (32%), Gaps = 73/271 (26%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKK--LHRDGKQRERAFRMEVDLLSRLHSP 210
            +F     +G GGFGVV++     D    AIK+  L      RE+  R EV  L++L  P
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHP 64

Query: 211 QLVELLGYCA-----------------------------------------DQNHRLLIS 229
            +V                                                D        
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 230 EYMPNGTLQQHLH---------------RHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
             +   + + +L+                        +    L I +  A A+EFLH   
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 275 TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV----------SDKINGQISTRVLGTTG 324
              ++HRD K SN+    +   KV DFGL   +          +        T  +GT  
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
           Y++PE       + K D++S G++L ELL  
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (282), Expect = 4e-27
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLS 205
              F+E      ++G G FG V K          A+K +++     +       EV+LL 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWR--TRLIIALDC 263
           +L  P +++L     D +   ++ E    G L   + +   R+   D     + + +   
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFS--- 132

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
              + ++H+H    ++HRD K  N+LL   +++   K+ DFGL+               +
Sbjct: 133 --GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRI 184

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 1e-26
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 25/221 (11%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSP 210
              F    ++GNG +G VYKG  +  G +AAIK +   G + E   + E+++L +  H  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHR 81

Query: 211 QLVELLG-----YCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            +    G          + +L L+ E+   G++   +         L       I  +  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKEEWIAYICREIL 139

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGT 322
             L  LH+H    VIHRD K  NVLL +N   K+ DFG    VS +++  +  R   +GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTVGRRNTFIGT 192

Query: 323 TGYLAPEYASTGKLT-----TKSDVYSYGVVLLELLTGRVP 358
             ++APE  +  +        KSD++S G+  +E+  G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG----KQRERAFRMEVDLLSRLHSPQLVEL 215
            IG G FG V     +D   + A+K +++       +    F+ E+ ++  L  P LV L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNL 80

Query: 216 LGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
             + + Q+   + ++ + +  G L+ HL ++       +   +L I  +  MAL++L   
Sbjct: 81  --WYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFIC-ELVMALDYLQNQ 134

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YA 331
               +IHRD K  N+LLD++    +TDF +A M+         T + GT  Y+APE   +
Sbjct: 135 R---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEMFSS 188

Query: 332 STGKLTTKS-DVYSYGVVLLELLTGRVP 358
             G   + + D +S GV   ELL GR P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (266), Expect = 3e-26
 Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 23/216 (10%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
             + ++     N IG G +G V   V        A KK+ +   +    F+ E++++  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLIIALDCAM 265
             P ++ L     D     L+ E    G L     R  H   +R  D    +   L    
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKDVLS--- 117

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
           A+ + H+     V HRD K  N L      +   K+ DFGLA        G++    +GT
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGT 171

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             Y++P+    G    + D +S GV++  LL G  P
Sbjct: 172 PYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  108 bits (272), Expect = 4e-26
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 29/226 (12%)

Query: 147 KELETATENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG--KQRERA-FRM 199
           ++L    E++    VIG G FG V     K       V A+K L +    K+ + A F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118

Query: 200 EVDLLSRLHSPQLVELLGYCADQ-NHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           E D+++  +SP +V+L  + A Q +  L ++ EYMP G L   +    + Y   +   R 
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARF 172

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
             A +  +AL+ +H       IHRD K  N+LLD++   K+ DFG    ++    G +  
Sbjct: 173 YTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRC 226

Query: 318 RVL-GTTGYLAPE-YASTGKLT--TKS-DVYSYGVVLLELLTGRVP 358
               GT  Y++PE   S G      +  D +S GV L E+L G  P
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (272), Expect = 4e-26
 Identities = 54/245 (22%), Positives = 102/245 (41%), Gaps = 35/245 (14%)

Query: 138 KGVVQVFTYKELETA-----TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLH 187
               +VF + +L         +   +       +G+G  G V            AI+ + 
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 188 RD--------GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQ 239
           +                   E+++L +L+ P ++++  +   +++  ++ E M  G L  
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD 228

Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRA 296
            +  +  R +      +L       +A+++LHE+    +IHRD K  NVLL   +++   
Sbjct: 229 KVVGNK-RLKEAT--CKLYF-YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281

Query: 297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELL 353
           K+TDFG +K++ +     +   + GT  YLAPE      T       D +S GV+L   L
Sbjct: 282 KITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

Query: 354 TGRVP 358
           +G  P
Sbjct: 339 SGYPP 343

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (268), Expect = 5e-26
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM---EVDLLSRLH 208
            + FS+   IG+G FG VY    + +  V AIKK+   GKQ    ++    EV  L +L 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P  ++  G    ++   L+ EY   G+    L  H    +PL       +       L 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLA 168

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR--VLGTTGYL 326
           +LH H    +IHRD K  N+LL +    K+ DFG A          ++     +GT  ++
Sbjct: 169 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWM 217

Query: 327 APEYASTGKLTT---KSDVYSYGVVLLELLTGRVP 358
           APE            K DV+S G+  +EL   + P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (270), Expect = 6e-26
 Identities = 37/218 (16%), Positives = 73/218 (33%), Gaps = 17/218 (7%)

Query: 153 TENFSEGNVIGNG--GFGVVYKGV-LSDGTVAAIKK--LHRDGKQRERAFRMEVDLLSRL 207
              +    VIG G      V        G    +++  L     +     + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
           + P +V         N   +++ +M  G+ +  +  H      ++      I      AL
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN-----GQISTRVLGT 322
           +++H       +HR  K S++L+  + +  ++       +                 +  
Sbjct: 142 DYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 323 TGYLAPEYASTGKL--TTKSDVYSYGVVLLELLTGRVP 358
             +L+PE           KSD+YS G+   EL  G VP
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (265), Expect = 6e-26
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 12/211 (5%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLH-RDGKQRERAFRMEVDLLSRLHSP 210
            + F     +G+G FG V+     S G    IK ++    +        E+++L  L  P
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            ++++     D ++  ++ E    G L + +     R + L       +      AL + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 271 HEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           H      V+H+D K  N+L      +   K+ DFGLA++       + ST   GT  Y+A
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMA 194

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           PE      +T K D++S GVV+  LLTG +P
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (268), Expect = 6e-26
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 154 ENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG----KQRERAFRMEVDLLS 205
           + F     +G G FG V     K     G   A+K L +      KQ E     E  +L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQ 96

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            ++ P LV+L     D ++  ++ EY+  G +  HL R     R  +   R   A    +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAA-QIVL 152

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTG 324
             E+LH      +I+RD K  N+L+DQ    +VTDFG AK V  +      T  L GT  
Sbjct: 153 TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 203

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
            LAPE     K   K+ D ++ GV++ E+  G  P
Sbjct: 204 ALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (262), Expect = 2e-25
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 35/230 (15%)

Query: 152 ATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK---------KLHRDGKQRERAF 197
           +T  F E      ++G G   VV + +        A+K             + ++   A 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 198 RMEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWR 254
             EVD+L ++   P +++L           L+ + M  G L                + R
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---FDYLTEKVTLSEKETR 127

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
             +   L+    +  LH+     ++HRD K  N+LLD +   K+TDFG +  +     G+
Sbjct: 128 KIMRALLE---VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GE 178

Query: 315 ISTRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               V GT  YLAPE        +      + D++S GV++  LL G  P
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (263), Expect = 2e-25
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 45/227 (19%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           T N  +      V+G+G F  V+       G + A+K + +    R+ +   E+ +L ++
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL------ 261
               +V L        H  L+ + +  G L              D     I+        
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGEL-------------FDR----ILERGVYTEK 106

Query: 262 DCAM-------ALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKI 311
           D ++       A+++LHE+    ++HRD K  N+L    ++N +  +TDFGL+KM  +  
Sbjct: 107 DASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161

Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            G +ST   GT GY+APE  +    +   D +S GV+   LL G  P
Sbjct: 162 -GIMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  105 bits (264), Expect = 2e-25
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 161 VIGNGGFGVVY---KGVLSD-GTVAAIKKLH-----RDGKQRERAFRMEVDLLSRLHSPQ 211
           V+G GG+G V+   K   ++ G + A+K L      R+ K      + E ++L  +  P 
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPF 82

Query: 212 LVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           +V+L    A Q   +L LI EY+  G L   L R        D      +A + +MAL  
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED-TACFYLA-EISMALGH 136

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAP 328
           LH+     +I+RD K  N++L+     K+TDFGL K   + I+    T    GT  Y+AP
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEYMAP 190

Query: 329 EYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           E         ++ D +S G ++ ++LTG  P
Sbjct: 191 EIL-MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (262), Expect = 3e-25
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 154 ENFSEGNVIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG----KQRERAFRMEVDLLS 205
           ++F     +G G FG V+    +    +G   A+K L ++     KQ E     E  +LS
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLS 61

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            +  P ++ + G   D     +I +Y+  G L   L R + R+ P     +   A +  +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRF-PNP-VAKFYAA-EVCL 117

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTG 324
           ALE+LH      +I+RD K  N+LLD+N   K+TDFG AK V D       T  L GT  
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD 168

Query: 325 YLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           Y+APE   + K   KS D +S+G+++ E+L G  P
Sbjct: 169 YIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTP 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  104 bits (262), Expect = 3e-25
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 23/208 (11%)

Query: 161 VIGNGGFGVVY---KGVLSD-GTVAAIKKLHRDG-KQRERA-FRMEVDLLSRLHSPQLVE 214
           V+G G FG V+   K   SD   + A+K L +   K R+R   +ME D+L  ++ P +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 215 LLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           L  + A Q   +L LI +++  G L   L +        +   +  +A + A+AL+ LH 
Sbjct: 91  L--HYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEE-DVKFYLA-ELALALDHLHS 144

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEYA 331
                +I+RD K  N+LLD+    K+TDFGL+K   + I+ +       GT  Y+APE  
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 332 STGKLTTKS-DVYSYGVVLLELLTGRVP 358
              +  T+S D +S+GV++ E+LTG +P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (260), Expect = 4e-25
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 15/216 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSPQ 211
           +++    VIG+G   VV            AIK+++ +  Q        E+  +S+ H P 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 212 LVELLGYCADQNHRL-LISEYMPNGTL----QQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
           +V            L L+ + +  G++    +  + +  ++   LD  T   I  +    
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR---VLGTT 323
           LE+LH++     IHRD K  N+LL ++   ++ DFG++  ++   +   +      +GT 
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 324 GYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVP 358
            ++APE     +    K+D++S+G+  +EL TG  P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  105 bits (264), Expect = 4e-25
 Identities = 50/224 (22%), Positives = 102/224 (45%), Gaps = 16/224 (7%)

Query: 142 QVFTYKELETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA 196
           + +  + +E    +  +       +G+G FGVV++ V  + G V   K ++      +  
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94

Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            + E+ ++++LH P+L+ L     D+   +LI E++  G L   +   + +    +    
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKINGQ 314
           +  A +    L+ +HEH+   ++H D K  N++    +    K+ DFGLA  ++     +
Sbjct: 155 MRQACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 205

Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           I      T  + APE      +   +D+++ GV+   LL+G  P
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (264), Expect = 5e-25
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)

Query: 141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRME 200
           V     K  E     ++   VIGNG FGVV++  L +    AIKK+ +D   +    R E
Sbjct: 27  VLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD---KRFKNR-E 82

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRL------LISEYMPNGTLQQHLHRHNNRYRPLDWR 254
           + ++  +  P +V+L  +      +       L+ EY+P  T+ +    +    + +   
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML 141

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKM-VSDKIN 312
              +       +L ++H      + HRD K  N+LLD      K+ DFG AK+ ++ + N
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 313 -GQISTR-------VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
              I +R       + G T Y           TT  D++S G V+ EL+ G+
Sbjct: 199 VSYICSRYYRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQGQ 239

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (258), Expect = 5e-25
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 21/214 (9%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHS 209
            E ++   ++G G FG V K          A+K +++     +       EV+LL +L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLIIALDCAMAL 267
           P +++L     D +   ++ E    G L           R+   D    +         +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQVFS---GI 134

Query: 268 EFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
            ++H+H    ++HRD K  N+LL   +++   K+ DFGL+               +GT  
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAY 188

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 189 YIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 7e-25
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 18/209 (8%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVEL 215
              +G G +G V   V        A+K +         E   + E+ +   L+   +V+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKF 70

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLHEH 273
            G+  + N + L  EY   G L   +          D +     ++A      + +LH  
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA-----GVVYLHGI 124

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE    
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK- 180

Query: 334 GKL--TTKSDVYSYGVVLLELLTGRVPVD 360
            +       DV+S G+VL  +L G +P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  103 bits (259), Expect = 7e-25
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 24/217 (11%)

Query: 153 TENFSE-----GNVIGNGGFGVVYKGV-LSDGTVAA---IKKLHRDGKQRERAFRMEVDL 203
            ENF+         +G G F VV + +  S G   A   +KK  R    R      E+ +
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH-EIAV 81

Query: 204 LSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL-HRHNNRYRPLDWRTRLIIAL 261
           L      P+++ L     + +  +LI EY   G +               D    +   L
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTR 318
           +    + +LH++    ++H D K  N+LL         K+ DFG+++ +           
Sbjct: 142 E---GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELRE 192

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
           ++GT  YLAPE  +   +TT +D+++ G++   LLT 
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (260), Expect = 8e-25
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 24/227 (10%)

Query: 148 ELETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRERAF 197
           ++      F +      VIG G F VV + +    G   A+K     K            
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 198 RMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRL 257
           + E  +   L  P +VELL   +      ++ E+M    L   + +  +           
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQ 314
                   AL + H++    +IHRD K   VLL   + +   K+  FG+A  + +  +G 
Sbjct: 134 HYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGL 188

Query: 315 ISTRVLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           ++   +GT  ++APE       GK     DV+  GV+L  LL+G +P
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (256), Expect = 2e-24
 Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 23/215 (10%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRERAFRMEVDLLSRLHSP-- 210
           G+++G G +G V + +        A+K     KL R         + E+ LL RL     
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNV 68

Query: 211 -QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMAL 267
            QLV++L Y  ++    ++ EY   G  +        R+           +I       L
Sbjct: 69  IQLVDVL-YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----GL 122

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           E+LH      ++H+D K  N+LL      K++  G+A+ +             G+  +  
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 328 PEYASTGKL--TTKSDVYSYGVVLLELLTGRVPVD 360
           PE A+        K D++S GV L  + TG  P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  103 bits (258), Expect = 2e-24
 Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 30/218 (13%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
              IG+G FGV           + A+K + R     E   R E+     L  P +V    
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKE 83

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLHEHAT 275
                 H  +I EY   G L + +     R+   + R   + +++      + + H    
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLS-----GVSYCHSMQ- 136

Query: 276 PPVIHRDFKCSNVLLDQNF--RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE---- 329
             + HRD K  N LLD +   R K+ DFG +K      + Q  + V GT  Y+APE    
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTV-GTPAYIAPEVLLR 191

Query: 330 --YASTGKLTTKSDVYSYGVVLLELLTGRVPV-DPNRP 364
             Y   GK    +DV+S GV L  +L G  P  DP  P
Sbjct: 192 QEYD--GK---IADVWSCGVTLYVMLVGAYPFEDPEEP 224

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (255), Expect = 3e-24
 Identities = 41/212 (19%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 154 ENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH 208
           +   E       +G G FG+V++ V  S       K +   G  +    + E+ +L+   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-EISILNIAR 59

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              ++ L          ++I E++    + + ++         +  + +    +   AL+
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQ 116

Query: 269 FLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           FLH H    + H D +  N++    ++   K+ +FG A+ +     G     +     Y 
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYY 170

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           APE      ++T +D++S G ++  LL+G  P
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  102 bits (256), Expect = 3e-24
 Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 161 VIGNGGFGVVY---KGVLSD-GTVAAIKKLHRD-----GKQRERAFRMEVDLLSRL-HSP 210
           V+G G +G V+   K    D G + A+K L +       K  E   R E  +L  +  SP
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSP 119

Query: 211 QLVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            LV L  + A Q   +L LI +Y+  G L  HL +            ++ +  +  +ALE
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEH-EVQIYVG-EIVLALE 173

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            LH+     +I+RD K  N+LLD N    +TDFGL+K        +      GT  Y+AP
Sbjct: 174 HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229

Query: 329 E---YASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +      +G    K+ D +S GV++ ELLTG  P
Sbjct: 230 DIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  104 bits (261), Expect = 3e-24
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 16/224 (7%)

Query: 142 QVFTYKELETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA 196
           + +  + +E   ++  +       +G G FGVV++    + G   A K +    +  +  
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200

Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            R E+  +S L  P LV L     D N  ++I E+M  G L + +   +N+    +    
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKINGQ 314
           +         L  +HE+     +H D K  N++    ++   K+ DFGL   +      Q
Sbjct: 261 MRQVCK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQ 311

Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (254), Expect = 4e-24
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHSPQLVE 214
              IG G F  V     +  G   AIK + +   +    ++ FR EV ++  L+ P +V+
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 78

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLHE 272
           L      +    LI EY   G +  +L  H  R +  + R+  R I++     A+++ H+
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVS-----AVQYCHQ 132

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                ++HRD K  N+LLD +   K+ DFG +   +    G++     G   Y APE   
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPELFQ 186

Query: 333 TGKLTT--KSDVYSYGVVLLELLTGRVPVD 360
            GK     + DV+S GV+L  L++G +P D
Sbjct: 187 -GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  102 bits (257), Expect = 4e-24
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 42/224 (18%)

Query: 153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
             ++++  VIGNG FGVVY+  L D G + AIKK+ +D   +    R E+ ++ +L    
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNR-ELQIMRKLDHCN 108

Query: 212 LVELLGYCADQNHRL------LISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLII--ALD 262
           +V L  +      +       L+ +Y+P  T+ +    ++   + L     +L +     
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKM-VSDKIN-GQISTR- 318
              +L ++H      + HRD K  N+LLD +    K+ DFG AK  V  + N   I +R 
Sbjct: 167 --RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221

Query: 319 ------VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
                 + G T Y           T+  DV+S G VL ELL G+
Sbjct: 222 YRAPELIFGATDY-----------TSSIDVWSAGCVLAELLLGQ 254

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (253), Expect = 4e-24
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 30/223 (13%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR--------DGKQRERAFRMEVDL 203
            + +     +G+G  G V            AIK + +                   E+++
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLIIAL 261
           L +L+ P ++++  +   +++  ++ E M  G L     +   N R +      +L    
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL---FDKVVGNKRLKEAT--CKLYF-Y 121

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTR 318
              +A+++LHE+    +IHRD K  NVLL   +++   K+TDFG +K++ +     +   
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 175

Query: 319 VLGTTGYLAPE---YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           + GT  YLAPE      T       D +S GV+L   L+G  P
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (253), Expect = 5e-24
 Identities = 73/324 (22%), Positives = 125/324 (38%), Gaps = 61/324 (18%)

Query: 150 ETATENFSE-----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLH-RDGKQRERAFRMEVD 202
           ++ +  F +      +V+G G    V   + L      A+K +  + G  R R FR EV+
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVE 62

Query: 203 LLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
           +L +      ++EL+ +  +++   L+ E M  G++  H+H+  + +  L+      +  
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASV---VVQ 118

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV------SDKIN 312
           D A AL+FLH      + HRD K  N+L    +Q    K+ DF L   +      S    
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 313 GQISTRVLGTTGYLAPE-----YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE 367
            ++ T   G+  Y+APE              + D++S GV+L  LL+G  P       G 
Sbjct: 176 PELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-----GR 229

Query: 368 HVLVSWALPRLTSREEAVEMVDPSLQGQY-------PK-----KDLIQ----------IA 405
                              + +   +G+Y              KDLI           ++
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289

Query: 406 AIAAVC---VQPEAAYRPLMTDVV 426
           A   +    VQ  A    L T +V
Sbjct: 290 AAQVLQHPWVQGCAPENTLPTPMV 313

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (253), Expect = 5e-24
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 17/205 (8%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELL 216
              +G G F +  K V        A+K +    K+ E   + E+  L      P +V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
               DQ H  L+ E +  G L + + +  + +   +      I      A+  +H+    
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEASY---IMRKLVSAVSHMHDVG-- 126

Query: 277 PVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
            V+HRD K  N+L    + N   K+ DFG A++     N  + T    T  Y APE  + 
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPC-FTLHYAAPELLNQ 183

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVP 358
                  D++S GV+L  +L+G+VP
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVP 208

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (254), Expect = 5e-24
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 34/229 (14%)

Query: 152 ATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLH---RDGKQRERAFR 198
           A + F +     +VIG G   VV + V  + G   A+K              ++   A R
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 199 MEVDLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRT 255
            E  +L ++   P ++ L+      +   L+ + M  G L                + R+
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---FDYLTEKVALSEKETRS 204

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
            +   L+   A+ FLH +    ++HRD K  N+LLD N + +++DFG +  +     G+ 
Sbjct: 205 IMRSLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEK 255

Query: 316 STRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              + GT GYLAPE        +      + D+++ GV+L  LL G  P
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  101 bits (253), Expect = 6e-24
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 27/209 (12%)

Query: 161 VIGNGGFGVV----YKGVLSDGTVAAIKKLHRDG-KQRERAFRM--EVDLLSRLHSPQLV 213
           ++G G FG V     K     G   A+K L ++    ++       E  +L     P L 
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 214 ELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
            L    A Q H RL  + EY   G L  HL R   R    + R R   A +   ALE+LH
Sbjct: 69  AL--KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEE-RARFYGA-EIVSALEYLH 122

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEY 330
                 V++RD K  N++LD++   K+TDFGL K   + I+   + +   GT  YLAPE 
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 176

Query: 331 ASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
                   ++ D +  GVV+ E++ GR+P
Sbjct: 177 L-EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (252), Expect = 7e-24
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 18/209 (8%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVEL 215
              +G G +G V   V        A+K +         E   + E+ +   L+   +V+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKF 70

Query: 216 LGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLHEH 273
            G+  + N + L  EY   G L   +          D +     ++A      + +LH  
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA-----GVVYLHGI 124

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE    
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK- 180

Query: 334 GKL--TTKSDVYSYGVVLLELLTGRVPVD 360
            +       DV+S G+VL  +L G +P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLHSPQLV 213
           G+ +G G FG V  G     G   A+K L+R          +  R E+  L     P ++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHII 74

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLH 271
           +L    +      ++ EY+  G L  ++ +H  R   ++ R   + I++     A+++ H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILS-----AVDYCH 128

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
            H    V+HRD K  NVLLD +  AK+ DFGL+ M+SD     + T   G+  Y APE  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAPEVI 182

Query: 332 STGKL--TTKSDVYSYGVVLLELLTGRVPVD 360
           S G+L    + D++S GV+L  LL G +P D
Sbjct: 183 S-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (250), Expect = 1e-23
 Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 25/218 (11%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRER-AFRMEV 201
            +   +    G  +G+G F +V K    S G   A K     +     +   R     EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
            +L ++    ++ L     ++   +LI E +  G L   L          +  + +   L
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQIL 125

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQIST 317
           D    + +LH      + H D K  N++L          K+ DFGLA  + D   G    
Sbjct: 126 D---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFK 176

Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            + GT  ++APE  +   L  ++D++S GV+   LL+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 26/219 (11%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK---KLHRDGKQRERAFRMEVDLL 204
           +  FS+       +G G F VV + V  + G   A K         +  ++    E  + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARIC 59

Query: 205 SRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLIIALD 262
            +L  P +V L     +++   L+ + +  G L            Y   D    +   L+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILE 116

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRV 319
              ++ + H +    ++HR+ K  N+LL    +    K+ DFGLA  V+D    +     
Sbjct: 117 ---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGF 167

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 33/231 (14%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM------ 199
           KE E     +  G ++G+GGFG VY G+ +SD    AIK + +D                
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 200 EVDLLSRLHS--PQLVELLGYCADQNHRLLISEY-MPNGTLQQHLHRHNNRYRPLDWRT- 255
           EV LL ++ S    ++ LL +    +  +LI E   P   L   +         L     
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELA 151

Query: 256 ----RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDK 310
                 ++      A+   H      V+HRD K  N+L+D N    K+ DFG   ++ D 
Sbjct: 152 RSFFWQVLE-----AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 202

Query: 311 INGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVD 360
                +    GT  Y  PE+    +     + V+S G++L +++ G +P +
Sbjct: 203 --TVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 21/214 (9%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRERA-FRMEVDLLS 205
            +++  G  +G+G F +V K      G   A K     +L    +   R     EV++L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            +  P ++ L     ++   +LI E +  G L   L    +     +    L   LD   
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILD--- 119

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQISTRVLG 321
            + +LH      + H D K  N++L      N R K+ DFG+A  +     G     + G
Sbjct: 120 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFG 173

Query: 322 TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
           T  ++APE  +   L  ++D++S GV+   LL+G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 30/230 (13%)

Query: 144 FTYKELETATENFSE-----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAF 197
             ++  E      ++       V+G G  G V +      G   A+K L+       +A 
Sbjct: 14  VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKAR 69

Query: 198 RMEVDLLSRLHS-PQLVELLGYCADQNHR----LLISEYMPNGTLQQH-LHRHNNRYRPL 251
           + EVD   +    P +V +L    + +H     L+I E M  G L      R +  +   
Sbjct: 70  Q-EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128

Query: 252 DWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVS 308
           +      I  D   A++FLH H    + HRD K  N+L    +++   K+TDFG AK  +
Sbjct: 129 EAAE---IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182

Query: 309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 + T    T  Y+APE     K     D++S GV++  LL G  P
Sbjct: 183 ---QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 37/222 (16%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD-------GKQRERAFRMEVDLLSRLHS- 209
           G ++G GGFG V+ G  L+D    AIK + R+                 EV LL ++ + 
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAG 94

Query: 210 ---PQLVELLGYCADQNHRLLISEY-MPNGTLQQHLHRHNNRYRPLDWRT-----RLIIA 260
              P ++ LL +   Q   +L+ E  +P   L  ++         L           ++A
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVA 150

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRV 319
                A++  H      V+HRD K  N+L+D +   AK+ DFG   ++ D      +   
Sbjct: 151 -----AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD 199

Query: 320 LGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVD 360
            GT  Y  PE+ S  +     + V+S G++L +++ G +P +
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (250), Expect = 5e-23
 Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 161 VIGNGGFG----VVYKGVLSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLV 213
           ++G G FG    V  K     G   A+K L ++    K        E  +L     P L 
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 214 ELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
            L    + Q H RL  + EY   G L  HL R   R    D R R   A +   AL++LH
Sbjct: 212 AL--KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSED-RARFYGA-EIVSALDYLH 265

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPEY 330
                 V++RD K  N++LD++   K+TDFGL K   + I    + +   GT  YLAPE 
Sbjct: 266 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 320

Query: 331 ASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
                   ++ D +  GVV+ E++ GR+P
Sbjct: 321 L-EDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 25/218 (11%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLH------RDGKQRERAFRMEV 201
            +   +    G  +G+G F +V K    S G   A K +                   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
            +L ++  P ++ L     ++   +LI E +  G L   L          +  + +   L
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQIL 125

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQIST 317
           D    + +LH      + H D K  N++L          K+ DFGLA  + D   G    
Sbjct: 126 D---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFK 176

Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
            + GT  ++APE  +   L  ++D++S GV+   LL+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 54/290 (18%), Positives = 106/290 (36%), Gaps = 22/290 (7%)

Query: 79  SHGSSFKDNKSGSSRFIAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAPTTAYNYVRDK 138
            H         G+         NS       G         + ++    P  +       
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63

Query: 139 GVVQV----FTYKELETATENFSE------GNVIGNGGFGVVYKGV-LSDGTVAAIKKLH 187
             +      F ++ +       +         ++G G FG V+K    + G   A K + 
Sbjct: 64  VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123

Query: 188 RDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNR 247
             G + +   + E+ ++++L    L++L      +N  +L+ EY+  G L   +   +  
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN 183

Query: 248 YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAK 305
              LD    +    +    +  +H+     ++H D K  N+L       + K+ DFGLA+
Sbjct: 184 LTELDTILFMKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

Query: 306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG 355
                   +      GT  +LAPE  +   ++  +D++S GV+   LL+G
Sbjct: 238 RYKP---REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 53/234 (22%), Positives = 85/234 (36%), Gaps = 51/234 (21%)

Query: 153 TENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRER-AFRMEV 201
            EN  +    G  +G+G F VV K    S G   A K     +     +   R     EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA- 260
            +L  +  P ++ L     ++   +LI E +  G L                    +   
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDF--------------LAEK 108

Query: 261 -----LDCAM-------ALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLA 304
                 +           + +LH      + H D K  N++L        R K+ DFGLA
Sbjct: 109 ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             +     G     + GT  ++APE  +   L  ++D++S GV+   LL+G  P
Sbjct: 166 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.5 bits (248), Expect = 9e-23
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLHSPQLV 213
           G+ +G G FG V  G     G   A+K L+R          +  R E+  L     P ++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHII 79

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLH 271
           +L    +  +   ++ EY+  G L  ++ ++  R    + R   + I++      +++ H
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILS-----GVDYCH 133

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
            H    V+HRD K  NVLLD +  AK+ DFGL+ M+SD     + T   G+  Y APE  
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAPEVI 187

Query: 332 STGKL--TTKSDVYSYGVVLLELLTGRVPVD 360
           S G+L    + D++S GV+L  LL G +P D
Sbjct: 188 S-GRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE----RAFRMEVDLLSRLH 208
           E + +   IG G +GVV+K      G + AIKK     +        A R E+ +L +L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALR-EIRMLKQLK 60

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P LV LL     +    L+ EY  + T+   L R+         ++     L    A+ 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ---AVN 116

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING---QISTR------- 318
           F H+H     IHRD K  N+L+ ++   K+ DFG A++++   +    +++TR       
Sbjct: 117 FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           ++G T Y               DV++ G V  ELL+G 
Sbjct: 174 LVGDTQY-----------GPPVDVWAIGCVFAELLSGV 200

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 36/214 (16%)

Query: 161 VIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--------LLSRLH 208
           V+G G FG V     KG      + A+K L    K+       +V+        L     
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 209 SPQLVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            P L +L  +   Q   RL  + EY+  G L  H+ +                A + A+ 
Sbjct: 80  PPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP-HAVFYAA-EIAIG 133

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGY 325
           L FL       +I+RD K  NV+LD     K+ DFG+ K   + I   ++T+   GT  Y
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDY 187

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +APE     +   KS D +++GV+L E+L G+ P
Sbjct: 188 IAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 46/266 (17%)

Query: 114 NGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSE----GNVIGNGGFGV 169
           +G  + + N+   + ++            V  Y    +  +  S+     + +G G   +
Sbjct: 9   SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68

Query: 170 VYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI 228
           VY+          A+K L +     ++  R E+ +L RL  P +++L           L+
Sbjct: 69  VYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126

Query: 229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL------DCAM-------ALEFLHEHAT 275
            E +  G L              D     I+        D A        A+ +LHE+  
Sbjct: 127 LELVTGGEL-------------FDR----IVEKGYYSERDAADAVKQILEAVAYLHENG- 168

Query: 276 PPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
             ++HRD K  N+L      +   K+ DFGL+K+V       +   V GT GY APE   
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILR 223

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVP 358
                 + D++S G++   LL G  P
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP 249

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 23/222 (10%)

Query: 147 KELETATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEV 201
           ++L   +  F++       IG G + V  + +  +     A+K +    K +      E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTE-EI 66

Query: 202 DLLSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
           ++L R    P ++ L     D  +  +++E M  G L   + R    +   +      + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASA---VL 122

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLAKMVSDKINGQIS 316
                 +E+LH      V+HRD K SN+L           ++ DFG AK +  + NG + 
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLM 178

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           T    T  ++APE           D++S GV+L  +LTG  P
Sbjct: 179 TPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER------AFRMEVDLLSR 206
           + + + + +G G F  VYK    +   + AIKK+    +   +      A R E+ LL  
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
           L  P ++ LL     +++  L+ ++M    L+  +  ++    P   +  +++ L     
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQ---G 124

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           LE+LH+H    ++HRD K +N+LLD+N   K+ DFGLAK          + +V+ T  Y 
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVV-TRWYR 179

Query: 327 APE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
           APE  + +        D+++ G +L ELL   
Sbjct: 180 APELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 36/214 (16%)

Query: 161 VIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--------LLSRLH 208
           ++G G FG V    +K         AIK L    K+       +V+        L     
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 209 SPQLVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            P L  +  +C  Q    L  + EY+  G L  H+         L  R     A +  + 
Sbjct: 77  HPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLS-RATFYAA-EIILG 130

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGY 325
           L+FLH      +++RD K  N+LLD++   K+ DFG+ K   + + G   T    GT  Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDY 184

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +APE    G+    S D +S+GV+L E+L G+ P
Sbjct: 185 IAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER----AFRMEVDLLSRLHS 209
           E + +   +G G +GVVYK   S G + A+K++  D  + E     A R E+ LL  LH 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD-AEDEGIPSTAIR-EISLLKELHH 78

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P +V L+     +    L+ E+M    L++ L  +    +    +  L   L     +  
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR---GVAH 134

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H+H    ++HRD K  N+L++ +   K+ DFGLA+     +    +  V+ T  Y AP+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVV-TLWYRAPD 189

Query: 330 -------YASTGKLTTKSDVYSYGVVLLELLTGR 356
                  Y      +T  D++S G +  E++TG+
Sbjct: 190 VLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIK-----KLHRDGKQRERAF---RMEVDLLS 205
            +S  + +G+G FG V+  V         +K     K+  D    +       +E+ +LS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGT-LQQHLHRHNNRYRPLDWRT-RLIIALDC 263
           R+    ++++L    +Q    L+ E   +G  L   + RH     PL     R +++   
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS--- 141

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
             A+ +L       +IHRD K  N+++ ++F  K+ DFG A  +         T   GT 
Sbjct: 142 --AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTI 193

Query: 324 GYLAPEYASTGKLTT--KSDVYSYGVVLLELLTGRVPVD 360
            Y APE    G      + +++S GV L  L+    P  
Sbjct: 194 EYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 33/219 (15%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER------AFRMEVDLLSR 206
           + + +   IG G +G V+K        + A+K++  D    +       A R E+ LL  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALR-EICLLKE 57

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
           L    +V L           L+ E+     L+++    N    P   ++ L   L     
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK---G 113

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L F H      V+HRD K  N+L+++N   K+ +FGLA+     +    S  V+ T  Y 
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVV-TLWYR 168

Query: 327 APE-------YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            P+       Y      +T  D++S G +  EL     P
Sbjct: 169 PPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 18/215 (8%)

Query: 153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            + F    + G G FG V  G     G   AIKK+ +D + R R  +  +  L+ LH P 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 212 LVELLGYCADQNHR-------LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
           +V+L  Y      R        ++ EY+P+ TL +    +  R          +      
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
            ++  LH   +  V HRD K  NVL++  +   K+ DFG AK +S     + +   + + 
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS---PSEPNVAYICSR 195

Query: 324 GYLAPE--YASTGKLTTKSDVYSYGVVLLELLTGR 356
            Y APE  + +    TT  D++S G +  E++ G 
Sbjct: 196 YYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 35/218 (16%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE----RAFRMEVDLLSRLH 208
           E +    ++G G +G+V K      G + AIKK        +     A R E+ LL +L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMR-EIKLLKQLR 82

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              LV LL  C  +    L+ E++ + T+   L    N       +  L   ++    + 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN---GIG 138

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING---QISTR------- 318
           F H H    +IHRD K  N+L+ Q+   K+ DFG A+ ++        +++TR       
Sbjct: 139 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 319 VLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           ++G   Y               DV++ G ++ E+  G 
Sbjct: 196 LVGDVKY-----------GKAVDVWAIGCLVTEMFMGE 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 161 VIGNGGFGVVY----KGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--------LLSRLH 208
           V+G G FG V     K     G + A+K L    K+       +V+        L    +
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVL----KKDVILQDDDVECTMTEKRILSLARN 82

Query: 209 SPQLVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            P L +L  +C  Q   RL  + E++  G L  H+ +   R      R R   A +   A
Sbjct: 83  HPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA-RARFYAA-EIISA 136

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGY 325
           L FLH+     +I+RD K  NVLLD     K+ DFG+ K   + I   ++T    GT  Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDY 190

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +APE      L   + D ++ GV+L E+L G  P
Sbjct: 191 IAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 66/211 (31%), Positives = 93/211 (44%), Gaps = 30/211 (14%)

Query: 161 VIGNGGFGVVY----KGVLSDGTVAAIKKLHRDG----KQRERAFRMEVD-LLSRLHSPQ 211
           VIG G FG V     K    +    A+K L +      K+ +     E + LL  +  P 
Sbjct: 45  VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLKNVKHPF 100

Query: 212 LVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           LV L  + + Q   +L  + +Y+  G L  HL R   R      R R   A + A AL +
Sbjct: 101 LVGL--HFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEP-RARFYAA-EIASALGY 154

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAP 328
           LH      +++RD K  N+LLD      +TDFGL K   + I    +T    GT  YLAP
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAP 208

Query: 329 EYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           E     +   ++ D +  G VL E+L G  P
Sbjct: 209 EVL-HKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 36/267 (13%), Positives = 70/267 (26%), Gaps = 59/267 (22%)

Query: 161 VIGNGGFGVVYKGVLSD---GTVAAIKKLH----RDGKQRERAFRMEVDLLSRLHSPQLV 213
             G       ++ +  D       A+  +           +         LSR+  P + 
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQE-TLSRTLRLSRIDKPGVA 94

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            +L     +   L+++E++  G+LQ+                 +      A A +  H  
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA 148

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               V       S V +  +    +                           +       
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA---- 179

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ 393
                + D+   G  L  LL  R P+           ++ A      +      +D  + 
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRS---GLAPAERDTAGQPIEPADIDRDIP 233

Query: 394 GQYPKKDLIQIAAIAAVCVQPEAAYRP 420
                    QI+A+AA  VQ +   R 
Sbjct: 234 F--------QISAVAARSVQGDGGIRS 252

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 45/231 (19%)

Query: 151 TATENFSE----GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDL 203
                F+E       +G G F VV + V +  G   A   ++      +  +    E  +
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL-- 261
              L  P +V L    +++ H  LI + +  G L              +     I+A   
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL-------------FED----IVAREY 106

Query: 262 ----DCAM-------ALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV 307
               D +        A+   H+     V+HR+ K  N+LL    +    K+ DFGLA  V
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163

Query: 308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             +   Q      GT GYL+PE           D+++ GV+L  LL G  P
Sbjct: 164 --EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 97.8 bits (243), Expect = 6e-22
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 154 ENFSEGNVIGNGGFGVV----YKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD------- 202
            +F+   V+G G FG V     KG      + A+K L    K+       +V+       
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL----KKDVVIQDDDVECTMVEKR 393

Query: 203 -LLSRLHSPQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
            L      P L +L   C     RL  + EY+  G L  H+ +      P         A
Sbjct: 394 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAA 449

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
            + A+ L FL       +I+RD K  NV+LD     K+ DFG+ K   + I   ++T+  
Sbjct: 450 -EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTF 502

Query: 321 -GTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
            GT  Y+APE     +   KS D +++GV+L E+L G+ P
Sbjct: 503 CGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 16/229 (6%)

Query: 136 RDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQ 192
           +  G    F        ++N+     +G G F VV + V  + G   A K ++      +
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70

Query: 193 RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
             +    E  +  +L  P +V L     +++   L+ + +  G L + +      Y   D
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEAD 129

Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSD 309
               +   L+   ++ + H +    ++HR+ K  N+LL    +    K+ DFGLA  V+D
Sbjct: 130 ASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

Query: 310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
               +      GT GYL+PE       +   D+++ GV+L  LL G  P
Sbjct: 184 ---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.1 bits (235), Expect = 7e-22
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRER----AFRMEVDLLSRLHS 209
           E +     IG G +GVVYK   + G   A+KK+  + K+ E       R E+ +L  L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIR-EISILKELKH 59

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             +V+L      +   +L+ E++    L++ L         +  ++ L+  L+    + +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLN---GIAY 115

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H+     V+HRD K  N+L+++    K+ DFGLA+     +  + +  ++ T  Y AP+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIV-TLWYRAPD 170

Query: 330 -------YASTGKLTTKSDVYSYGVVLLELLTGR 356
                  Y      +T  D++S G +  E++ G 
Sbjct: 171 VLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)

Query: 161 VIGNGGFG----VVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVD--------LLSRLH 208
           VIG G +     V  K       + A+K +    K+       ++D             +
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVV----KKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 209 SPQLVELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            P LV L  +   Q   RL  + EY+  G L  H+ R   R  P +   R   A + ++A
Sbjct: 69  HPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE-HARFYSA-EISLA 122

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGY 325
           L +LHE     +I+RD K  NVLLD     K+TD+G+ K   + +    +T    GT  Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNY 176

Query: 326 LAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +APE    G+    S D ++ GV++ E++ GR P
Sbjct: 177 IAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 31/221 (14%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE----RAFRMEVDLLS 205
           +++  F +   +GNG +  VYKG+  + G   A+K++  D    E     A R E+ L+ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD--SEEGTPSTAIR-EISLMK 58

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
            L    +V L      +N   L+ E+M N  L++++        P      L+       
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYF-QWQ 116

Query: 266 ---ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
               L F HE+    ++HRD K  N+L+++  + K+ DFGLA+     +N   S+ V+ T
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVV-T 171

Query: 323 TGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGR 356
             Y AP+       Y      +T  D++S G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 48/237 (20%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM------------------ 199
            + IG G +GVV      +D T  A+K L +    R+  F                    
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 200 --------EVDLLSRLHSP---QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY 248
                   E+ +L +L  P   +LVE+L    +++H  ++ E +  G + +         
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLD-DPNEDHLYMVFELVNQGPVMEVPTL--KPL 134

Query: 249 RPLDWRT--RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
                R   + +I       +E+LH      +IHRD K SN+L+ ++   K+ DFG++  
Sbjct: 135 SEDQARFYFQDLIK-----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 307 VSDKINGQISTRVLGTTGYLAPEYASTGKLT---TKSDVYSYGVVLLELLTGRVPVD 360
                +  +S  V GT  ++APE  S  +        DV++ GV L   + G+ P  
Sbjct: 187 FKGS-DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 55/274 (20%), Positives = 88/274 (32%), Gaps = 69/274 (25%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
           +    G  +G G FG V +         +     A+K L       E  A   E+ +L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 207 LHS-PQLVELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPL------------- 251
           +     +V LLG C      L +I E+   G L  +L    N + P              
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 252 ------DWRTRL----------IIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----- 290
                 D + RL                  +L  + E   P  +++DF     L+     
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 291 -------------------------DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY 325
                                     +    K+ DFGLA+ +    +            +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVP 358
           +APE       T +SDV+S+GV+L E+ + G  P
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 161 VIGNGGFG----VVYKGVLSDGTVAAIKKLHRDG-KQRERAFRMEVD---LLSRLHSPQL 212
           VIG G +     V  K       + A++ + ++     E    ++ +        + P L
Sbjct: 59  VIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 213 VELLGYCADQNH-RL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           V L  +   Q   RL  + EY+  G L  H+ R   R  P +   R   A + ++AL +L
Sbjct: 116 VGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE-HARFYSA-EISLALNYL 169

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL-GTTGYLAPE 329
           HE     +I+RD K  NVLLD     K+TD+G+ K   + +    +T    GT  Y+APE
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 223

Query: 330 YASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
               G+    S D ++ GV++ E++ GR P
Sbjct: 224 IL-RGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLHSPQLV 213
              +G G FG V            A+K + R          R  R E+  L  L  P ++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHII 72

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT--RLIIALDCAMALEFLH 271
           +L          +++ EY   G L  ++     R    + R   + II      A+E+ H
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIIC-----AIEYCH 125

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
            H    ++HRD K  N+LLD N   K+ DFGL+ +++D     + T   G+  Y APE  
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSC-GSPNYAAPEVI 179

Query: 332 STGKL--TTKSDVYSYGVVLLELLTGRVPVD 360
           + GKL    + DV+S G+VL  +L GR+P D
Sbjct: 180 N-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 24/210 (11%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELL 216
             V+G G  G V +          A+K L        +A R EV+L  R    P +V ++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARR-EVELHWRASQCPHIVRIV 121

Query: 217 GYCAD----QNHRLLISEYMPNGTLQQH-LHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
               +    +   L++ E +  G L      R +  +   +      I      A+++LH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE---IMKSIGEAIQYLH 178

Query: 272 EHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
                 + HRD K  N+L      N   K+TDFG AK  +   +  ++T    T  Y+AP
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC-YTPYYVAP 232

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E     K     D++S GV++  LL G  P
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKG-VLSDGTVAAIKKLHRDGKQRE----RAFRMEVDLLSRLH 208
           E + + + +G G +  VYKG       + A+K++  +    E     A R EV LL  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE--HEEGAPCTAIR-EVSLLKDLK 58

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              +V L      +    L+ EY+    L+Q+L    N     + +  L   L     L 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR---GLA 114

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           + H      V+HRD K  N+L+++    K+ DFGLA+  S          V+ T  Y  P
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVV-TLWYRPP 169

Query: 329 E--YASTGKLTTKSDVYSYGVVLLELLTGR 356
           +    ST   +T+ D++  G +  E+ TGR
Sbjct: 170 DILLGST-DYSTQIDMWGVGCIFYEMATGR 198

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 58/252 (23%)

Query: 149 LETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           LET+++ +S G  +G G FG+V +    + G   A+KK+ +D +      R E+D++  L
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNR-ELDIMKVL 57

Query: 208 HSPQLVELLGYCADQNHRL--------------------------------------LIS 229
               +++L+ Y                                              +I 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 230 EYMPNGTLQQHLHRHNNRYRPL-DWRTRLIIA-LDCAMALEFLHEHATPPVIHRDFKCSN 287
           EY+P+ TL + L       R +      + I  L  A+   F+H      + HRD K  N
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG--FIHSLG---ICHRDIKPQN 171

Query: 288 VLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE--YASTGKLTTKSDVYS 344
           +L++      K+ DFG AK +   I  + S   + +  Y APE    +T + T   D++S
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL---IPSEPSVAYICSRFYRAPELMLGAT-EYTPSIDLWS 227

Query: 345 YGVVLLELLTGR 356
            G V  EL+ G+
Sbjct: 228 IGCVFGELILGK 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 35/220 (15%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER----AFRMEVDLLSRLH 208
           + +     +G G +G VYK +        AIK++  +  + E     A R EV LL  L 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-HEEEGVPGTAIR-EVSLLKELQ 91

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              ++EL       +   LI EY      +  L ++ ++   +  R            + 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRA-----KVTDFGLAKMVSDKINGQISTRVLGTT 323
           F H       +HRD K  N+LL  +  +     K+ DFGLA+     I  Q +  ++ T 
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEII-TL 201

Query: 324 GYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGR 356
            Y  PE       Y      +T  D++S   +  E+L   
Sbjct: 202 WYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 25/220 (11%)

Query: 152 ATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRM------EVDLL 204
           AT  +     IG G +G VYK      G   A+K +            +      EV LL
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALL 65

Query: 205 SRLHS---PQLVELL----GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
            RL +   P +V L+        D+  ++ L+ E++    L+ +L +      P +    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           L+        L+FLH +    ++HRD K  N+L+      K+ DFGLA++ S      ++
Sbjct: 125 LMRQFLRG--LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALT 177

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
             V+ T  Y APE        T  D++S G +  E+   +
Sbjct: 178 PVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKG--VLSDGTVAAIKKLHRDGKQRER----AFRMEVDLLSRL 207
           + +     IG G +G V+K   + + G   A+K++       E       R EV +L  L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIR-EVAVLRHL 68

Query: 208 HS---PQLVELL----GYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII 259
            +   P +V L         D+  +L L+ E++    L  +L +      P +    ++ 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 260 ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV 319
            L     L+FLH H    V+HRD K  N+L+  + + K+ DFGLA++ S      +++ V
Sbjct: 128 QLLRG--LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVV 180

Query: 320 LGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR 356
           + T  Y APE        T  D++S G +  E+   +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE----RAFRMEVDLLSRLH 208
             + +   IG G FG V+K      G   A+KK+  +  ++E     A R E+ +L  L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALR-EIKILQLLK 74

Query: 209 SPQLVELLGYCADQNHRL--------LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIA 260
              +V L+  C  +            L+ ++  +  L   L     ++   + +  + + 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI---ST 317
           L+    L ++H +    ++HRD K +NVL+ ++   K+ DFGLA+  S   N Q    + 
Sbjct: 134 LN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 318 RVLGTTGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGR 356
           RV+ T  Y  PE       Y          D++  G ++ E+ T  
Sbjct: 188 RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 39/240 (16%)

Query: 135 VRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR----- 188
           +R KG  +    K      + +     +G+G +G V   +    G   AIKKL R     
Sbjct: 5   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64

Query: 189 -DGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQNHRLLISEYMP---NGTLQ 238
              K   RA+R E+ LL  +    ++ LL          +     L+  +M       + 
Sbjct: 65  IFAK---RAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 120

Query: 239 QHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
                   +Y        L+  +     L+++H   +  V+HRD K  N+ ++++   K+
Sbjct: 121 LKFSEEKIQY--------LVYQMLKG--LKYIH---SAGVVHRDLKPGNLAVNEDCELKI 167

Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRV 357
            DFGLA+    ++ G + TR      Y APE   S        D++S G ++ E+LTG+ 
Sbjct: 168 LDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 36/238 (15%)

Query: 136 RDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR------ 188
           RD     V       T  + +     IG+G  G+V     +      AIKKL R      
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 189 DGKQRERAFRMEVDLLSRLHSPQLVELL------GYCADQNHRLLISEYMP---NGTLQQ 239
             K   RA+R E+ L+  ++   ++ LL          +     ++ E M       +Q 
Sbjct: 67  HAK---RAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122

Query: 240 HLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT 299
            L      Y        L+  + C   ++ LH   +  +IHRD K SN+++  +   K+ 
Sbjct: 123 ELDHERMSY--------LLYQMLCG--IKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 169

Query: 300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           DFGLA+         + T  + T  Y APE           D++S G ++ E++ G V
Sbjct: 170 DFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 23/209 (11%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYC 219
           IG+G FG +Y G  ++ G   AIK      K +     +E  +   +     +  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 220 ADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
           A+ ++ +++ E + P+  L+      N   R    +T L++A      +E++H       
Sbjct: 75  AEGDYNVMVMELLGPS--LEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126

Query: 279 IHRDFKCSNVLLDQNFRAK---VTDFGLAKMVSDKINGQ-ISTR----VLGTTGYLAPEY 330
           IHRD K  N L+    +     + DFGLAK   D    Q I  R    + GT  Y A   
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASIN 185

Query: 331 ASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
              G   + + D+ S G VL+    G +P
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 36/222 (16%)

Query: 158 EGNVIGNGGFGVVYKGV---LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE 214
           EG  +G G +G VYK       D    A+K++   G     A R E+ LL  L  P ++ 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS-ACR-EIALLRELKHPNVIS 82

Query: 215 LLGYCADQNHRL--LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM-----AL 267
           L         R   L+ +Y  +  L   +  H                +   +      +
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRA----KVTDFGLAKMVSD--KINGQISTRVLG 321
            +LH +    V+HRD K +N+L+          K+ D G A++ +   K    +   V+ 
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 322 TTGYLAPE-------YASTGKLTTKSDVYSYGVVLLELLTGR 356
           T  Y APE       Y      T   D+++ G +  ELLT  
Sbjct: 198 TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 52/221 (23%), Positives = 88/221 (39%), Gaps = 36/221 (16%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLS 205
            + +     IG+G  G+V            AIKKL R        K   RA+R E+ L+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYR-ELVLMK 116

Query: 206 RLHSPQLVELL------GYCADQNHRLLISEYMP---NGTLQQHLHRHNNRYRPLDWRTR 256
            ++   ++ LL          +     L+ E M       +Q  L      Y        
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-------- 168

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           L+  + C   ++ LH   +  +IHRD K SN+++  +   K+ DFGLA+         + 
Sbjct: 169 LLYQMLCG--IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMM 220

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           T  + T  Y APE           D++S G ++ E++  ++
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 82.6 bits (203), Expect = 8e-17
 Identities = 80/467 (17%), Positives = 136/467 (29%), Gaps = 120/467 (25%)

Query: 19  HHKHYLHNNSVSDQSHVHRHAILSFHSIIIIIVSVISVIVLVALLLLVLMLRRLKSSSED 78
           HH H+  +    +  + ++  +  F    +       V           M + + S  E 
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQD---------MPKSILSKEEI 51

Query: 79  SHGSSFKDNKSGSSRF----------IAHMTINSTCSPDVKGWCFNGGHVRSNNVLPAAP 128
            H    KD  SG+ R           +    +      +   +  +          P+  
Sbjct: 52  DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-KFLMSPIKTEQRQ--PSMM 108

Query: 129 TTAYNYVRDK--GVVQVFT---------YKELETATENF-SEGNVI--GNGGFGVVYKGV 174
           T  Y   RD+     QVF          Y +L  A        NV+  G  G G   K  
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW 165

Query: 175 LSDGTVAAIKKLHRDGKQRERAFRMEVDLLS--RLHSP-QLVELLGYCADQNHRLLISEY 231
           +      A+       K  +     ++  L+    +SP  ++E+L     Q    L+ + 
Sbjct: 166 V------ALDVC-LSYK-VQCKMDFKIFWLNLKNCNSPETVLEML-----QK---LLYQI 209

Query: 232 MPNGTLQQHLHRHNNRYRPLDWRT---RLIIALDCAMALEFLHEHATPPVIHR-DFKCSN 287
            PN T  +  H  N + R    +    RL+ +      L  L         +  +  C  
Sbjct: 210 DPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268

Query: 288 VLLDQNFRAKVTDFG-------------------------LAKMVSDKING------QIS 316
           +L  +    +VTDF                          L K +  +           +
Sbjct: 269 LLTTRF--KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326

Query: 317 TRVLGTTGYLAPEYAST---------GKLTTKSDVYSYGVVLLELLTGR--------VPV 359
            R L        +  +T          KLTT  +  S  V  LE    R         P 
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES-SLNV--LEPAEYRKMFDRLSVFPP 383

Query: 360 DPNRPPGEHVLVS-WA-LPRLTSREEAVEMVDPSLQGQYPKKDLIQI 404
             + P    +L   W  + +        ++   SL  + PK+  I I
Sbjct: 384 SAHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 25/219 (11%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQ 211
            ++  G  IG G FGV+++G  L +    AIK   R  +      R E      L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67

Query: 212 LVELLGYCADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
           +  +  +  +  H +L+ + + P+  L+  L       R    +T  + A      ++ +
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCG---RKFSVKTVAMAAKQMLARVQSI 122

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAK-----VTDFGLAKMVSDKINGQ-ISTR----VL 320
           HE +   +++RD K  N L+ +          V DFG+ K   D +  Q I  R    + 
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179

Query: 321 GTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
           GT  Y        G+  + + D+ + G V +  L G +P
Sbjct: 180 GTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 23/209 (11%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYC 219
           IG+G FG +Y G  +      AIK  +   K +      E  +   L     +  +  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 220 ADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPV 278
            + ++ +L+ + + P+  L+      N   R L  +T L++A      +EF+H  +    
Sbjct: 73  VEGDYNVLVMDLLGPS--LEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 279 IHRDFKCSNVLLDQNFRAK---VTDFGLAKMVSDKINGQ-ISTR----VLGTTGYLAPEY 330
           +HRD K  N L+    RA    + DFGLAK   D    Q I  R    + GT  Y A   
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVN 183

Query: 331 ASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
              G   + + D+ S G VL+  L G +P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 35/218 (16%)

Query: 161 VIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRE------------RAFRMEVDLLSRLH 208
            I +G +G V  GV S+G   AIK++                    R  R E+ LL+  H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFH 87

Query: 209 SPQLVELLG-YCADQNHRL----LISEYMPNGTLQQHLHR--HNNRYRPLDWRTRLII-A 260
            P ++ L   +   +   +    L++E M     +  L +  H+ R        +  +  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYH 142

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVL 320
           +     L  LH      V+HRD    N+LL  N    + DF LA+  +        T  +
Sbjct: 143 ILL--GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT---ADANKTHYV 194

Query: 321 GTTGYLAPEY-ASTGKLTTKSDVYSYGVVLLELLTGRV 357
               Y APE        T   D++S G V+ E+   + 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 49/237 (20%), Positives = 103/237 (43%), Gaps = 32/237 (13%)

Query: 133 NYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGK 191
           N  R +      ++       +++     +G G +  V++ + +++     +K L     
Sbjct: 15  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-- 72

Query: 192 QRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR--LLISEYMPNGTLQQHLHRHNNRY 248
           ++++  R E+ +L  L   P ++ L     D   R   L+ E++ N   +Q        Y
Sbjct: 73  KKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------Y 124

Query: 249 RPL-DWRTRLII--ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA-KVTDFGLA 304
           + L D+  R  +   L    AL++ H      ++HRD K  NV++D   R  ++ D+GLA
Sbjct: 125 QTLTDYDIRFYMYEILK---ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

Query: 305 KMVS--DKINGQISTRVLGTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           +      + N ++++R      +  PE     ++   S D++S G +L  ++  + P
Sbjct: 179 EFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 36/221 (16%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLS 205
              + +   +G+G +G V   V    G   AIKKL+R        K   RA+R E+ LL 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYR-ELRLLK 79

Query: 206 RLHSPQLVELLG-YCADQNHRL-----LISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLI 258
            +    ++ LL  +  D+         L+  +M    L + +         L + R + +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH-----EKLGEDRIQFL 133

Query: 259 I-ALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST 317
           +  +     L ++H      +IHRD K  N+ ++++   K+ DFGLA+    ++ G + T
Sbjct: 134 VYQMLKG--LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188

Query: 318 RVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRV 357
           R      Y APE   +  + T   D++S G ++ E++TG+ 
Sbjct: 189 RW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 50/259 (19%), Positives = 95/259 (36%), Gaps = 59/259 (22%)

Query: 147 KELETATENFSEGNV--------------IGNGGFGVVYKGV---------LSDGTVAAI 183
           + + T+ E    G V                    G++Y+                  ++
Sbjct: 21  QSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSL 80

Query: 184 KKLHRDGKQ-------RERAFRMEVDLLSRLHSPQLV---ELLGYCADQN-HRLLISEYM 232
           K   +DG+        +  A  ++V+   +L+S  L+     +G+   Q+ +R L+   +
Sbjct: 81  KLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL 140

Query: 233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ 292
             G   Q     + +   L  R+ L +A     ALEFLHE+     +H +    N+ +D 
Sbjct: 141 --GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP 194

Query: 293 NFRAKVT--DFGLAKMVSDKINGQISTR------VLGTTGYLAPEYAST----GK-LTTK 339
             +++VT   +G A          ++          G       E+ S     G   + +
Sbjct: 195 EDQSQVTLAGYGFAFRYCPS-GKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRR 248

Query: 340 SDVYSYGVVLLELLTGRVP 358
           SD+ S G  +L+ L G +P
Sbjct: 249 SDLQSLGYCMLKWLYGFLP 267

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 40/223 (17%)

Query: 153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR------DGKQRERAFRMEVDLLS 205
            E +   + +G+G +G V     +  G   A+KKL R        K   R +R E+ LL 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYR-ELRLLK 83

Query: 206 RLHSPQLVELL------GYCADQNHRLLISEYMP---NGTLQ-QHLHRHNNRYRPLDWRT 255
            +    ++ LL          + N   L++  M    N  ++ Q L   + ++       
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------- 136

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI 315
            LI  +     L+++H   +  +IHRD K SN+ ++++   K+ DFGLA+  +D++ G +
Sbjct: 137 -LIYQILRG--LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 316 STRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRV 357
           +TR      Y APE   +        D++S G ++ ELLTGR 
Sbjct: 191 ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 25/218 (11%)

Query: 155 NFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQL 212
           NF  G  IG G FG +  G  L      AIK      +       +E     +L     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67

Query: 213 VELLGYCADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
            ++  +     +  ++ E + P+  L + L    +R   L  +T L+IA+     +E++H
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGPS--L-EDLFDLCDRTFSL--KTVLMIAIQLISRMEYVH 122

Query: 272 EHATPPVIHRDFKCSNVLL--DQNFRAK---VTDFGLAKMVSDKINGQ-ISTR----VLG 321
                 +I+RD K  N L+    N   +   + DF LAK   D    + I  R    + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179

Query: 322 TTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVP 358
           T  Y        GK  + + D+ + G + +  L G +P
Sbjct: 180 TARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 25/208 (12%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL--HSPQ----LV 213
           VIG G FG V K          A+K + R+ K+  R    E+ +L  L          ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRH--NNRYRPLDWRTRLIIALDCAMALEFLH 271
            +L     +NH  +  E      L  +L+     N+++          A      L+ LH
Sbjct: 163 HMLENFTFRNHICMTFEL-----LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRA--KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           ++    +IH D K  N+LL Q  R+  KV DFG +     ++   I +R      Y APE
Sbjct: 218 KNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPE 269

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRV 357
                +     D++S G +L ELLTG  
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYP 297

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 49/239 (20%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHSPQLV 213
           +IG G +G VY     +     AIKK++R      D K   R  R E+ +L+RL S  ++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILR-EITILNRLKSDYII 88

Query: 214 ELLGYCADQNHRL-----LISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLII-ALDCAMA 266
            L       +        ++ E          L +       L +   + I+  L     
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLG-- 141

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
             F+H      +IHRD K +N LL+Q+   KV DFGLA+ ++ + +  I   +       
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 327 APEYASTGKLT--------------------TKS-DVYSYGVVLLELLTGRVPVDPNRP 364
                   +LT                    TKS D++S G +  ELL        +  
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 59/293 (20%), Positives = 106/293 (36%), Gaps = 54/293 (18%)

Query: 114 NGGHVRSNNVLPAAPTTAYNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKG 173
           N G   + +           +   K    +          + +   ++IG G +G V + 
Sbjct: 13  NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEA 72

Query: 174 V-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHSPQLVELL----GYCADQ 222
               +  V AIKK+ R      D K   R  R E+ +L+RL+   +V++L        ++
Sbjct: 73  YDKLEKRVVAIKKILRVFEDLIDCK---RILR-EIAILNRLNHDHVVKVLDIVIPKDVEK 128

Query: 223 NHRL-LISEYMPNGTLQQHLHRHNNRYRPL-DWRTRLII-ALDCAMALEFLHEHATPPVI 279
              L ++ E            +       L +   + ++  L     ++++H      ++
Sbjct: 129 FDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLV--GVKYVHSAG---IL 178

Query: 280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT----------------- 322
           HRD K +N L++Q+   KV DFGLA+ V    NG     +                    
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238

Query: 323 --TGYL------APEYASTGKLTTKS-DVYSYGVVLLELLTGRVPVDPNRPPG 366
             TG++      APE     +  T++ DV+S G +  ELL             
Sbjct: 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHR-----DGKQRERAFRMEVDLLSR 206
              ++  + IG G +G+V       +    AIKK+         +   R  R E+ +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLR-EIKILLR 81

Query: 207 LHSPQLVELL-----GYCADQNHRLLISEYMP---NGTLQ-QHLHRHNNRYRPLDWRTRL 257
                ++ +                ++ + M       L+ QHL   +  Y         
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------F 133

Query: 258 IIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS-DKINGQIS 316
           +  +     L+++H   +  V+HRD K SN+LL+     K+ DFGLA++   D  +    
Sbjct: 134 LYQILRG--LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 317 TRVLGTTGYLAPEYASTGKLTTKS-DVYSYGVVLLELLTGRV 357
           T  + T  Y APE     K  TKS D++S G +L E+L+ R 
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 53/237 (22%)

Query: 159 GNVIGNGGFGVVYKGVLSDGT------VAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
           G  IG GGFG +Y   ++            +K    D          E+    R   P+ 
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL----FTELKFYQRAAKPEQ 95

Query: 213 VELL-----------------GYCADQN--HRLLISEYMPNGTLQQHLHRHNNRYRPLDW 253
           ++                   G        +R +I +    G+  Q ++  N +      
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR-- 151

Query: 254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT--DFGLAKMVSDKI 311
           +T L ++L     LE++HEH     +H D K SN+LL+     +V   D+GLA     + 
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 312 NGQ-ISTR----VLGTTGYLAPEYAST----GK-LTTKSDVYSYGVVLLELLTGRVP 358
             +  +        GT      E+ S     G   + + D+   G  +++ LTG +P
Sbjct: 209 VHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL--HSPQ----L 212
           ++IG G FG V K     +    AIK + ++ K      ++EV LL  +  H  +    +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 213 VELLGYCADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           V L  +   +NH  L+ E +  N  L   L   N  +R +        A     AL FL 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYN--LYDLLR--NTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRA--KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
                 +IH D K  N+LL    R+  K+ DFG +  +  +I   I +R      Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE 228

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRV 357
                      D++S G +L+E+ TG  
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 46/228 (20%), Positives = 83/228 (36%), Gaps = 38/228 (16%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           G  IG+GGFG++Y     +     A   +  + ++    F  E+    R+     ++   
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWI 100

Query: 218 YCADQNHRLLISEYMPNGTLQQHLHRHN---------------NRYRPLDWRTRLIIALD 262
                ++ L I  +  +G  +     +                 +       T L + + 
Sbjct: 101 ERKQLDY-LGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT--DFGLAKMVSDKINGQ-ISTRV 319
               LE++HE+     +H D K +N+LL      +V   D+GL+       N +      
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 320 ----LGTTGYLAPEYAST----GK-LTTKSDVYSYGVVLLELLTGRVP 358
                GT      E+ S     G  L+ +SDV   G  +L  L G++P
Sbjct: 217 RKGHNGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 49/210 (23%), Positives = 77/210 (36%), Gaps = 45/210 (21%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELL 216
             V+G G  G V +          A+K L     Q     R EV+L  R    P +V ++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 77

Query: 217 GYCAD----QNHRLLISEYMPNGTL-QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
               +    +   L++ E +  G L  +   R +  +   +      I      A+++LH
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE---IMKSIGEAIQYLH 134

Query: 272 EHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
                 + HRD K  N+L      N   K+TDFG AK  + +              Y   
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------KY--- 175

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                 K     D++S GV++  LL G  P
Sbjct: 176 -----DK---SCDMWSLGVIMYILLCGYPP 197

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 39/220 (17%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKL-----HRDGKQRERAFRMEVDLLSRLHSPQLVE 214
           ++G G +GVV        G + AIKK+             R  R E+ +L       ++ 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL---RTLR-EIKILKHFKHENIIT 73

Query: 215 LLG-YCADQNHRL----LISEYMPNGT-LQQHLHRHNNRYRPL-DWRTRLII-ALDCAMA 266
           +      D         +I E M   T L + +       + L D   +  I     A  
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELM--QTDLHRVI-----STQMLSDDHIQYFIYQTLRA-- 124

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--TG 324
           ++ LH      VIHRD K SN+L++ N   KV DFGLA+++ +            +    
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 325 YL------APEY-ASTGKLTTKSDVYSYGVVLLELLTGRV 357
           ++      APE   ++ K +   DV+S G +L EL   R 
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 161 VIGNGGFGVVYKGVLSD-GTVAAIKKL----HRDGKQRERAFRMEVDLLSRLHSPQLVEL 215
            +G GG G+V+  V +D     AIKK+     +  K    A R E+ ++ RL    +V++
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK---HALR-EIKIIRRLDHDNIVKV 73

Query: 216 LGYCADQNHRL--------------LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLII-A 260
                    +L              ++ EYM     +  L     +   L+   RL +  
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQ 128

Query: 261 LDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMV-SDKINGQISTR 318
           L     L+++H   +  V+HRD K +N+ ++ ++   K+ DFGLA+++     +    + 
Sbjct: 129 LLRG--LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 319 VLGTTGYLAPE-YASTGKLTTKSDVYSYGVVLLELLTGRV 357
            L T  Y +P    S    T   D+++ G +  E+LTG+ 
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 51/232 (21%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHR------DGKQRERAFRMEVDLLSRLHS-PQ 211
             +G G +G+V+K +    G V A+KK+        D +   R FR E+ +L+ L     
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFR-EIMILTELSGHEN 70

Query: 212 LVELLG-YCADQNHRL-LISEYMPNGTLQQHLHR--HNNRYRPL-DWRTRLII-ALDCAM 265
           +V LL    AD +  + L+ +YM     +  LH     N    L     + ++  L    
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRAN---ILEPVHKQYVVYQLIKV- 121

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT--- 322
            +++LH   +  ++HRD K SN+LL+     KV DFGL++   +      +  +      
Sbjct: 122 -IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 323 ----------TGYL------APEYA-STGKLTTKSDVYSYGVVLLELLTGRV 357
                     T Y+      APE    + K T   D++S G +L E+L G+ 
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 4e-11
 Identities = 31/204 (15%), Positives = 53/204 (25%), Gaps = 45/204 (22%)

Query: 152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK--------QRERAFRMEVDL 203
            TE       IG G FG V++ +     V AIK +  +G         +       E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 204 LSRLH---------SPQLVELLGY--CADQNHRLLISEYMPNGTLQQHLHRHNNRYRP-- 250
              L          +   + L            LL+  +    + +   +   + ++   
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 251 ---------------------LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL 289
                                    T   I      +L            HRD    NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVL 194

Query: 290 LDQNFRAKVTDFGLAKMVSDKING 313
           L +    K+      K  +    G
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCG 218

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 35/220 (15%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-------- 211
            +G G F  V+    + + T  A+K + R  K    A   E+ LL R++           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 212 ---LVELLGY----CADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
              +++LL +      +  H +++ E +  N  L   + ++ +R  PL    + I +   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLI-YVKQI-SKQL 140

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA------KVTDFGLAKMVSDKINGQIST 317
            + L+++H      +IH D K  NVL++           K+ D G A    +     I T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 318 RVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV 357
           R      Y +PE          +D++S   ++ EL+TG  
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 51/276 (18%), Positives = 79/276 (28%), Gaps = 87/276 (31%)

Query: 162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA 220
           +G G F  V+    +      A+K +       E A   E+ LL  + +          +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRN----------S 93

Query: 221 DQNH------RLLISEYM---PNGT--------LQQHLH--RHNNRYRPLDWRTRLIIAL 261
           D N         L+ ++     NGT        L  HL      + Y+ L       I  
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLL------------------------------- 290
                L++LH      +IH D K  N+LL                               
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 291 ------------------DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
                              +  + K+ D G A  V       I TR      Y + E   
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH 368
                T +D++S   +  EL TG    +P+      
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT 302

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 57/231 (24%)

Query: 161 VIGNGGFGVVYKGV--LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL------HSPQL 212
            +G G FG V + +   + G   A+K + ++  +   A R E+ +L  L       + + 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 213 VELLGYCADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLI--IALDCAMALEF 269
           V++L +     H  ++ E +  +      +    N + P       I  +A     ++ F
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLS--TYDFIK--ENGFLPFR--LDHIRKMAYQICKSVNF 133

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRA-------------------KVTDFGLAKMVSDK 310
           LH +    + H D K  N+L  Q+                      KV DFG A    + 
Sbjct: 134 LHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 311 INGQISTRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTG 355
            +  +STR      Y APE      +      +   DV+S G +L+E   G
Sbjct: 191 HSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 48/231 (20%), Positives = 81/231 (35%), Gaps = 53/231 (22%)

Query: 161 VIGNGGFGVVYKGV--LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP------QL 212
            +G G FG V + +      +  A+K + R+  +   A R+E+++L ++           
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 213 VELLGYCADQNHRLLISEYM-PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           V +  +     H  +  E +  N    + L    N ++P        +A     AL FLH
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKN--TFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRA-------------------KVTDFGLAKMVSDKIN 312
           E+    + H D K  N+L   +                      +V DFG A    +   
Sbjct: 141 ENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197

Query: 313 GQISTRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTGRV 357
             ++TR      Y  PE      +          DV+S G +L E   G  
Sbjct: 198 TIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRGFT 237

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 58/236 (24%), Positives = 92/236 (38%), Gaps = 63/236 (26%)

Query: 161 VIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-----HSPQLVE 214
            +G+G FG V     + +    A+K + R+ K+  R+ ++E D+L ++     ++  +V+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100

Query: 215 LLGYCADQNHRLLISEYMPNGTLQQHLHRH--NNRYRPLDWRTRLI--IALDCAMALEFL 270
             G     +H  LI E      L   L+     N Y         I    ++   AL +L
Sbjct: 101 YHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFH--IEDIKLYCIEILKALNYL 153

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRA-------------------------KVTDFGLAK 305
            + +   + H D K  N+LLD  +                           K+ DFG A 
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 306 MVSDKINGQISTRVLGTTGYLAPE------YASTGKLTTKSDVYSYGVVLLELLTG 355
             SD     I+TR      Y APE      +         SD++S+G VL EL TG
Sbjct: 211 FKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* Length = 306

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 20/135 (14%), Positives = 40/135 (29%), Gaps = 15/135 (11%)

Query: 177 DGTVAAIKKLHR-DGKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQNHRLLISEYMP 233
            G +     +       ++R      + ++ L +   +     G         ++     
Sbjct: 96  QGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL---- 151

Query: 234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN 293
              L + +            R  L +     M    ++   TP +IH D    + L + N
Sbjct: 152 ---LSEAVEDQVFPLLDESLRDYLTLRFQSYMT-HPVYTRYTPRLIHGDLSPDHFLTNLN 207

Query: 294 FRAK----VTDFGLA 304
            R      + DFG A
Sbjct: 208 SRQTPLTGIIDFGDA 222

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	457
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.07
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.53
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.35
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.35
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.21
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.84
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.44
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.13
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.65
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.53
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.38
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.34
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.71
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	90.71
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	89.64
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.25
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.0
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.27
1zza_A	90	Stannin, AG8_1; helix, membrane protein; NMR {Homo	84.75
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	84.07
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	83.27
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	83.25

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-59  Score=451.46  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=219.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56778899999999999999864      477899999987766667789999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          228 ISEYMPNGTLQQHLHRHN---------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      |||||++|+|.++|....         .....++|.+++.|+.|++.||.|||+++   ||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999998643         23346999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccc
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      +|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......            
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------------  237 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------------  237 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence            99999987755444344455679999999999999999999999999999999999 89999754221            


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                           ++...+........|..++.++.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       238 -----~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          238 -----EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                 11111111112234555667899999999999999999999999999988764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.7e-59  Score=452.98  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=212.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|.+.++||+|+||+||+|++.      ++..||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677789999999999999864      478899999987766667789999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          228 ISEYMPNGTLQQHLHRHNN-----------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      |||||++|+|.++|.....           ...+++|.+++.|+.|++.||.|||+++   ||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999987532           1246999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||......          
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----------  267 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----------  267 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----------
Confidence            9999999997755444444556789999999999999999999999999999999999 89999753221          


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                             ++...+........|..++.++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus       268 -------~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 -------EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                   11111111112234455667899999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.6e-59  Score=448.10  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=216.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      .++++.++||+|+||+||+|.+.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999863      46789999997543 333467999999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC
Q 012739          227 LISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                      ||||||++|+|.++|.....            ....++|.+++.|+.||+.||.|||+++   ||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999976432            1246899999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~  373 (457)
                      .+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||.....         
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---------  253 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------  253 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------
Confidence            999999999998765544445566789999999999999999999999999999999999 8999975422         


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                              .++...+........|.+++..+.+|+.+||+.||++||||.||+++|+.+
T Consensus       254 --------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 --------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    112222222222344556677899999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=436.50  Aligned_cols=262  Identities=27%  Similarity=0.465  Sum_probs=206.9

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..+++.+.++||+|+||+||+|++.+  .||||+++..  .....+.|.+|+++|++++|||||+++|++.+ +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34678888999999999999998754  5899988644  34455679999999999999999999998865 5689999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |||++|+|.++|.....   .+++.+++.|+.|++.||.|||+++   ||||||||+|||+++++.+||+|||+++....
T Consensus       111 Ey~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999976543   5999999999999999999999998   99999999999999999999999999987755


Q ss_pred             ccCCccccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..........+||+.|||||++.+   +.|+.++|||||||+||||+||+.||........   ....        ....
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~--------~~~~  253 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFM--------VGRG  253 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHH--------HHTT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHH--------HhcC
Confidence            444444566789999999999853   4699999999999999999999999975432110   0000        0001


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ...+.+ ...+.+++..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       254 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            111211 23344566789999999999999999999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-57  Score=445.38  Aligned_cols=275  Identities=24%  Similarity=0.366  Sum_probs=226.3

Q ss_pred             echHHHHHHhcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCC-CCeeeE
Q 012739          144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHS-PQLVEL  215 (457)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h-pniv~l  215 (457)
                      +...+++...++|++.+.||+|+||+||+|.+..      ++.||||++.... ....+.|.+|+++|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3345667778899999999999999999998643      3579999997654 3445679999999999965 999999


Q ss_pred             EEEEEc-CCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 012739          216 LGYCAD-QNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD  282 (457)
Q Consensus       216 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D  282 (457)
                      +|+|.+ ++..+||||||++|+|.++|+....            ....+++.+++.++.||+.||.|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            999976 4578999999999999999986432            1245899999999999999999999999   99999


Q ss_pred             CccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 012739          283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDP  361 (457)
Q Consensus       283 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~  361 (457)
                      |||+|||+++++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997765444444556789999999999999999999999999999999998 8999975


Q ss_pred             CCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .....                .+...+....+...|..++.++.+++.+||+.||++|||+.||+++|+++++.++
T Consensus       291 ~~~~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          291 VKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCHHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            43211                1111111122223444556689999999999999999999999999999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.6e-57  Score=438.81  Aligned_cols=251  Identities=21%  Similarity=0.385  Sum_probs=204.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++++.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+++|+.++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999964 6899999998654  33445678999999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ||+||+|.++|.....  ..+++.+++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++.+...
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999976432  35789999999999999999999999   999999999999999999999999999876532


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                        .......+||+.|||||++.+..|+.++|||||||+||||+||+.||......   ...             ..+...
T Consensus       179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~-------------~~i~~~  240 (350)
T 4b9d_A          179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLV-------------LKIISG  240 (350)
T ss_dssp             --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH-------------HHHHHT
T ss_pred             --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH-------------HHHHcC
Confidence              12234578999999999999999999999999999999999999999754221   000             011110


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .. ...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       241 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 SF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            10 11223345589999999999999999999999886

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-56  Score=436.52  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=216.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +.|++.++||+|+||+||+|.+. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 68999999997654444456889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++...     .+++.++..++.||+.||+|||+++   ||||||||+|||++.+|.+||+|||+++.+.... 
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999999752     3999999999999999999999999   9999999999999999999999999998775432 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......   ..          ..+.....+.+
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----------~~i~~~~~~~~  290 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----------KMIRDNLPPRL  290 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----------HHHHHSSCCCC
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----------HHHHcCCCCCC
Confidence             23456789999999999999999999999999999999999999997532210   00          01111111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        ..+...+.++.+|+.+||+.||++|||+.|++++  .++++...
T Consensus       291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~~~~  332 (346)
T 4fih_A          291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAGP  332 (346)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGCCC
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcCCCC
Confidence              2223445689999999999999999999999998  88887544

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.9e-56  Score=429.42  Aligned_cols=258  Identities=22%  Similarity=0.254  Sum_probs=212.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ..|.+.++||+|+||.||+|++. +|+.||||++.....     ..+|+.+|+.++|||||++++++.+++..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999975 589999999965421     246999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCcccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~~~~  311 (457)
                      +||+|.++|....    .+++.++..++.|++.||+|||+++   ||||||||+|||++.+| .+||+|||+++.+....
T Consensus       133 ~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          133 EGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             TTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999998764    4999999999999999999999999   99999999999999987 69999999998775432


Q ss_pred             CCc---cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          312 NGQ---ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       312 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...   .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...........+..             . 
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------------~-  271 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------------E-  271 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------------S-
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------------C-
Confidence            211   22346899999999999999999999999999999999999999986543221111100             0 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+.+ ...+...+..+.+|+.+||+.||.+|||+.|++++|...+++...
T Consensus       272 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          272 PPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             CCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             CCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            0000 123344556899999999999999999999999999999988665

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-56  Score=428.20  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=211.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.++||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+++|+.++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46899999999999999999964 68999999996542   223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |||+||+|.++|....    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999998764    4999999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..........+||+.|||||++.+..|+.++|||||||++|||+||+.||......   ...             ..+..
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~-------------~~i~~  248 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIF-------------AKIIK  248 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHc
Confidence            44444556789999999999999999999999999999999999999999753221   000             01111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..  ..++...+.++.+|+.+||+.||++|||+.|++.+
T Consensus       249 ~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          249 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            11  12333445589999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-55  Score=417.83  Aligned_cols=251  Identities=25%  Similarity=0.469  Sum_probs=201.5

Q ss_pred             CCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHRLLIS  229 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lv~  229 (457)
                      ++.++||+|+||+||+|.+. ++..||+|++...  .....+.|.+|+++|+.++|||||+++++|.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45578999999999999975 5889999998644  33445678999999999999999999999864    35689999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~~~  308 (457)
                      |||++|+|.+++....    .+++..+..++.||+.||.|||+++ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999998754    4999999999999999999999875 4599999999999997 48999999999998643


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .    ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......                .+...+
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----------------~~~~~i  242 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYRRV  242 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHHHH
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----------------HHHHHH
Confidence            2    23456789999999998865 69999999999999999999999997432210                011111


Q ss_pred             CCcC-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSL-QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .... ....+...+.++.+|+.+||+.||++|||+.|++++  +++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H--p~~~~  288 (290)
T 3fpq_A          243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH--AFFQE  288 (290)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGC-
T ss_pred             HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC--ccccC
Confidence            1110 011122233478999999999999999999999987  66665

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-55  Score=437.92  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=216.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +.|++.++||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 58999999997655444556889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      +||+|.+++...     .+++.++..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+++.+.... 
T Consensus       231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999653     3999999999999999999999999   9999999999999999999999999998775432 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......   ..          ..+.....+.+
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----------~~i~~~~~~~~  367 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----------KMIRDNLPPRL  367 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----------HHHHHSCCCCC
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----------HHHHcCCCCCC
Confidence             23456789999999999999999999999999999999999999997532211   00          01111111111


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        ......+.++.+|+.+||+.||++|||+.|++++  .++++..-
T Consensus       368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~~~~  409 (423)
T 4fie_A          368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAGP  409 (423)
T ss_dssp             --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGCCC
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcCCCC
Confidence              1222345589999999999999999999999998  88887543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8e-55  Score=420.75  Aligned_cols=274  Identities=23%  Similarity=0.310  Sum_probs=206.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----HRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~lv~  229 (457)
                      ++|.+.++||+|+||+||+|++ +|+.||||++..... ....++.|+..+..++|||||+++++|.+++    ..||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4567788999999999999998 689999999965432 2223455777778899999999999997654    579999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-----TPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      |||++|+|.++|...     +++|.+++.++.|++.||.|||++.     .++||||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999763     4899999999999999999999871     234999999999999999999999999999


Q ss_pred             cccccccCC--ccccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          305 KMVSDKING--QISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       305 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      +........  ......+||+.|||||++.+.      .++.++|||||||+||||+||+.||........ ....+.. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~~-  233 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVP-  233 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSC-
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhccc-
Confidence            876543221  123346799999999998754      478899999999999999999988764322110 0111100 


Q ss_pred             ccCchhHHh-hhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          377 RLTSREEAV-EMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       377 ~~~~~~~~~-~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ......... .+.+..++...+     .+.+..+.+|+.+||+.||++||||.||++.|+++.++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            001111111 122333333333     356678999999999999999999999999999987763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-54  Score=410.54  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ....+.+.+|+++|+.++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 68999999986542   223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+ +|+|.+++....    .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 789999997754    4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   ......+||+.|||||++.+..| +.++|||||||++|||+||+.||......   .+..          .+.. -
T Consensus       165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~----------~i~~-~  227 (275)
T 3hyh_A          165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK----------NISN-G  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----------HHHH-T
T ss_pred             C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----------HHHc-C
Confidence            2   23455789999999999998876 57999999999999999999999753211   0000          0000 0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..    .++...+.++.+|+.+||+.||++|||+.|++++  ++++.
T Consensus       228 ~~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k~  268 (275)
T 3hyh_A          228 VY----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFKV  268 (275)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHHT
T ss_pred             CC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--ccccc
Confidence            11    2233345578999999999999999999999997  77764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.4e-55  Score=419.19  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|++.+.||+|+||+||+|+..    .++.||+|++....  ......+.+|+++|+.++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999852    47789999986542  1222357789999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |||||+||+|.++|....    .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999998765    4999999999999999999999999   999999999999999999999999999865


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...  .......+||+.|||||++.+..|+.++|||||||+||||+||+.||......   ...             ..+
T Consensus       177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~-------------~~i  238 (304)
T 3ubd_A          177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETM-------------TMI  238 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHH
T ss_pred             cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHH-------------HHH
Confidence            432  22345678999999999999999999999999999999999999999753221   000             011


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHHHHhhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQSLIPVVKN  435 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~L~~~~~~  435 (457)
                      ....  ..+|...+.++.+|+.+||+.||++|||+     +|++++  +++++
T Consensus       239 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H--p~f~~  287 (304)
T 3ubd_A          239 LKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH--SFFST  287 (304)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS--GGGTT
T ss_pred             HcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC--ccccC
Confidence            1111  12333455689999999999999999984     677765  55553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-52  Score=403.23  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=194.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--------
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQN--------  223 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--------  223 (457)
                      ++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|+.++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999974 689999999875543 33456889999999999999999999986544        


Q ss_pred             ----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEe
Q 012739          224 ----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT  299 (457)
Q Consensus       224 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  299 (457)
                          ..|+|||||++|+|.+++..... ....++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999976432 234567778999999999999999999   9999999999999999999999


Q ss_pred             eccCccccccccCC----------ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch
Q 012739          300 DFGLAKMVSDKING----------QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV  369 (457)
Q Consensus       300 Dfgl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~  369 (457)
                      |||+++.+......          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....    . 
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~-  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----E-  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----H-
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----H-
Confidence            99999877543211          11234679999999999999999999999999999999996   775210    0 


Q ss_pred             hhhhhccccCchhHHhhhcCCcCCCCCCH---HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          370 LVSWALPRLTSREEAVEMVDPSLQGQYPK---KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ..          .......+    ..++.   .....+.+|+.+||+.||.+|||+.|++++  +++++..
T Consensus       233 ~~----------~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~~  287 (299)
T 4g31_A          233 RV----------RTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDLD  287 (299)
T ss_dssp             HH----------HHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC-
T ss_pred             HH----------HHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCCC
Confidence            00          00111111    12222   233467889999999999999999999986  7777643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4e-50  Score=391.50  Aligned_cols=288  Identities=39%  Similarity=0.638  Sum_probs=242.7

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      .+.++....++|++.+.||+|+||.||+|.+.+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            34455567789999999999999999999988899999999877665566778999999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++|+|.+++.........+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999765544456999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      +...............||+.|+|||.+.+..++.++||||||+++|||+||+.||....+........|..... .....
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  265 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQL  265 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccH
Confidence            87554333333445678999999999988999999999999999999999999998765544433333332111 11223


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+++.+....+.+.+..+.+++.+||+.||++|||+.|++++|+.+++-.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            3445566666778889999999999999999999999999999999988743

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=402.90  Aligned_cols=274  Identities=21%  Similarity=0.278  Sum_probs=208.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CCe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD------QNH  224 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~  224 (457)
                      ++|++++.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999974 6999999999654  23344568899999999999999999998753      367


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|||||||+ |+|.+++....    ++++.++..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 78999997643    5999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccc--CCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc-
Q 012739          305 KMVSDKI--NGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS-  380 (457)
Q Consensus       305 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  380 (457)
                      +.+....  ........+||+.|||||++.+. .|+.++||||+||++|||++|+.||...........+......... 
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            8764321  22334567899999999998775 5699999999999999999999999865432211111111000000 


Q ss_pred             ---------hhHHhhhcCCcCCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          381 ---------REEAVEMVDPSLQGQ---YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       381 ---------~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                               .......+.+.....   .......++.+|+.+||+.||.+|||+.|++++  +++++..
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~~  352 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLAKYH  352 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGTTTC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhCcCC
Confidence                     000001111110000   001224578999999999999999999999998  8887643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.4e-50  Score=394.59  Aligned_cols=272  Identities=22%  Similarity=0.273  Sum_probs=203.9

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~  225 (457)
                      ...++|++.++||+|+||+||+|+.+    .++.||+|++.....  ...+.+|+++|+.+ +||||++++++|.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34678999999999999999999853    467899999865532  34577899999998 699999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLA  304 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~  304 (457)
                      ||||||+++|+|.+++.       .+++.++..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||++
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999984       3899999999999999999999999   9999999999999876 89999999999


Q ss_pred             cccccccC--------------------------CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCC
Q 012739          305 KMVSDKIN--------------------------GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRV  357 (457)
Q Consensus       305 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~  357 (457)
                      +...+...                          ....+..+||+.|||||++.+. .|+.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211                          0112345799999999999775 58999999999999999999999


Q ss_pred             CCCCCCCCCcc-hhhhhhcc-------------------cc--CchhHHhhh---cC---CcC---------CCCCCHHH
Q 012739          358 PVDPNRPPGEH-VLVSWALP-------------------RL--TSREEAVEM---VD---PSL---------QGQYPKKD  400 (457)
Q Consensus       358 p~~~~~~~~~~-~~~~~~~~-------------------~~--~~~~~~~~~---~d---~~l---------~~~~~~~~  400 (457)
                      ||......... ..+.....                   ..  .......+.   .+   +.+         ..+.....
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            99754321110 00000000                   00  000000000   00   000         00111223


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          401 LIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       401 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      +.++.+|+.+||+.||.+|||++|+++|  +++++-
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H--p~f~~i  359 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH--PFFKDM  359 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS--GGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCCC
Confidence            4578999999999999999999999988  777653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.6e-49  Score=410.28  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=213.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+..|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            67999999999999999999975 68999999997766666677889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC--CcEEEeeccCccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--FRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgl~~~~~~~  310 (457)
                      +||+|.++|....   ..+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       237 ~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999996543   25999999999999999999999999   9999999999999854  89999999999987543


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                         ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........   ...          + ...+.
T Consensus       311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~----------i-~~~~~  373 (573)
T 3uto_A          311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRN----------V-KSCDW  373 (573)
T ss_dssp             ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHH----------H-HTTCC
T ss_pred             ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHH----------H-HhCCC
Confidence               234556899999999999999999999999999999999999999975432110   000          0 00011


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+........+.++.+|+.+||+.||.+|||+.|+++|  .++++
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H--pw~~~  416 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLTP  416 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTSC
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cCcCC
Confidence            11111112334578999999999999999999999987  66654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-48  Score=382.10  Aligned_cols=289  Identities=42%  Similarity=0.731  Sum_probs=239.7

Q ss_pred             eeeechHHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH-HHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012739          141 VQVFTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ-RERAFRMEVDLLSRLHSPQLVELLGYC  219 (457)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~  219 (457)
                      ...+++.++....++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            5668899999999999999999999999999999888999999999765322 223588999999999999999999999


Q ss_pred             EcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEe
Q 012739          220 ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT  299 (457)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  299 (457)
                      .+.+..++||||+++|+|.+++........++++..++.++.|++.||.|||+...++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998876666679999999999999999999999911129999999999999999999999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCCcchhhhhhccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNR--PPGEHVLVSWALPR  377 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~  377 (457)
                      |||+++...... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||....  .........|....
T Consensus       177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999998764332 223445569999999999988899999999999999999999999996321  11122233333222


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                      . .........+..+...++......+.+++.+||+.||.+|||+.||+++|+.
T Consensus       256 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 L-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             T-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             h-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            2 2233445566666777888899999999999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-48  Score=406.36  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHH---HHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAF---RMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~---~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ++|++.++||+|+||+||+|+.. +|+.||+|++.+..   ......+   +.++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999975 58999999986431   1111222   34567777889999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      |||||++||+|.++|....    .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++.
T Consensus       269 lVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999998765    4999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      +...    .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||............             .
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-------------~  404 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------R  404 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-------------H
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------H
Confidence            6542    2345789999999999964 57999999999999999999999999753322111100             0


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVK  434 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~  434 (457)
                      .....  ...++...+.++.+|+.+||+.||.+|++     +.||++|  .+++
T Consensus       405 ~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H--pfF~  454 (689)
T 3v5w_A          405 MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES--PFFR  454 (689)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS--GGGT
T ss_pred             hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC--cccc
Confidence            00011  11233445568999999999999999998     6888877  5554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-47  Score=379.73  Aligned_cols=264  Identities=23%  Similarity=0.383  Sum_probs=218.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      .++|.+.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999863        34579999997653 34456789999999999 899999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      +..++||||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999987542            1235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcch
Q 012739          291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHV  369 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~  369 (457)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||......    
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----  312 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  312 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            9999999999999987655433333444567889999999999999999999999999999999 99999753221    


Q ss_pred             hhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                                   +....+........+..++..+.+++.+||+.+|.+||++.|+++.|++++...
T Consensus       313 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          313 -------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             -------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                         111111111122334445568999999999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-47  Score=370.84  Aligned_cols=273  Identities=24%  Similarity=0.296  Sum_probs=215.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----HRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~lv  228 (457)
                      .++|++.++||+|+||.||+|++. ++.||+|++..... .......|+.+++.++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467888999999999999999874 78999999966533 3344566999999999999999999997744    47999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeccCccCceEeCCCCcEEE
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH----------ATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      |||+++|+|.+++...     .+++..++.++.|++.||.|||+.          +   |+||||||+|||++.++.+||
T Consensus       101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred             EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence            9999999999999763     389999999999999999999998          8   999999999999999999999


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~  373 (457)
                      +|||+++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||..............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987765433333445679999999999976     3567789999999999999999999986544322222211


Q ss_pred             hccccCchhHHhh-hcCCcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          374 ALPRLTSREEAVE-MVDPSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       374 ~~~~~~~~~~~~~-~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ... ......... ..........     ....+..+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus       253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          253 IGQ-HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HCS-SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hcc-CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            111 111112211 1222222222     2245677999999999999999999999999999987754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=370.44  Aligned_cols=263  Identities=24%  Similarity=0.423  Sum_probs=214.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|++.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467888999999999999999974    3456999999765 34445678999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++.....   .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999976432   5999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          308 SDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       308 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....                 ....
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~  264 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------------RDVI  264 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHH
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHH
Confidence            5432211 2233456788999999998999999999999999999999 9999975322                 1111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+++..+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            11111222233444556899999999999999999999999999999987655

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=377.25  Aligned_cols=272  Identities=24%  Similarity=0.372  Sum_probs=221.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      ..++|.+.+.||+|+||.||+|...        .+..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3467888999999999999999863        23579999997653 34446788999999999 99999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      .+..++||||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999987542            1235899999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 012739          290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEH  368 (457)
Q Consensus       290 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~  368 (457)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----  299 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  299 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            99999999999999987755433333445567889999999999999999999999999999999 9999974321    


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCcccc
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISF  443 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~  443 (457)
                                   ......+........+..+..++.+|+.+||+.+|++|||+.||+++|++++........+.
T Consensus       300 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  361 (382)
T 3tt0_A          300 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY  361 (382)
T ss_dssp             -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred             -------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence                         11111111222222333445689999999999999999999999999999998765544444

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=361.85  Aligned_cols=264  Identities=26%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|.+.++||+|+||.||+|.+. ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56788899999999999999975 58899999987776677778999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus        90 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           90 KGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             TTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999987433   5899999999999999999999999   99999999999999999999999999987644322


Q ss_pred             Cc------------cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          313 GQ------------ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       313 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ..            ......||+.|+|||.+.+..++.++||||||+++|||++|..||............         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------  234 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------  234 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence            11            112457999999999999999999999999999999999999998754332111100         


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        ......+...    +..++..+.+++.+||+.||++|||+.++++.|+++.+....
T Consensus       235 --~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          235 --NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             --CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence              0011111111    222334789999999999999999999999999998876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-47  Score=377.71  Aligned_cols=275  Identities=25%  Similarity=0.378  Sum_probs=221.9

Q ss_pred             echHHHHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeE
Q 012739          144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVEL  215 (457)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l  215 (457)
                      +...+++...++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+++++.+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            344566677889999999999999999999842      35789999997653 34446789999999999 78999999


Q ss_pred             EEEEEcCC-eEEEEEEeCCCCcHHHHHhhhCCC-----------------------------------------------
Q 012739          216 LGYCADQN-HRLLISEYMPNGTLQQHLHRHNNR-----------------------------------------------  247 (457)
Q Consensus       216 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  247 (457)
                      ++++.+.+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998754 489999999999999999875431                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          248 ---------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       248 ---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                                     ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122899999999999999999999999   99999999999999999999999999987654433


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      ........||+.|+|||++.+..++.++||||||+++|||+| |+.||........                ....+...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~~~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEG  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHHHT
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------HHHHHHcC
Confidence            334455678999999999999999999999999999999998 9999975432211                11111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .....+.....++.+++.+||+.||.+|||+.|++++|+++++.++
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  358 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  358 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence            1112233344579999999999999999999999999999987653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-47  Score=380.12  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=215.5

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34567888999999999999999986 68999999987653 33334688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....   .+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999986542   4899999999999999999999999   9999999999999999999999999998654


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ............+++.|+|||.+.+..++.++||||||+++|||+| |..||.....                 ....+.
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------------~~~~~~  327 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------------QQTREF  327 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------HHHHHH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHH
Confidence            3221111122335778999999998899999999999999999998 9999975321                 111122


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +........+..++..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            222222233444566899999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.1e-47  Score=370.15  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=206.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|++.++||+|+||.||+|.+. +++    .||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888899999999999999964 343    36888875442 334467899999999999999999999998765 789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |+||+.+|+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999987543   5899999999999999999999999   999999999999999999999999999877


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......                 ....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISS  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------HHHH
Confidence            55433333444567889999999999999999999999999999999 99999754321                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .+........+..+...+.+++.+||+.+|.+||++.+++++|+++.++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~  281 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence            111122222334455689999999999999999999999999999988643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-45  Score=355.29  Aligned_cols=284  Identities=36%  Similarity=0.624  Sum_probs=230.9

Q ss_pred             eeeechHHHHHHhcCCCCC------ceeccCCcEEEEEEEEcCCcEEEEEEcccC----chHHHHHHHHHHHHHHhcCCC
Q 012739          141 VQVFTYKELETATENFSEG------NVIGNGGFGVVYKGVLSDGTVAAIKKLHRD----GKQRERAFRMEVDLLSRLHSP  210 (457)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~hp  210 (457)
                      ...|++.++..++.+|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568899999999998877      8999999999999987 6889999988653    223346688999999999999


Q ss_pred             CeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       211 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      ||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            999999999999999999999999999999975432 246899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh
Q 012739          291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL  370 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~  370 (457)
                      +.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999987654333333445679999999998865 589999999999999999999999986543322111


Q ss_pred             hhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      +.....  .........+++.+ ...+...+..+.+++.+||+.+|.+|||+.+|+++|+++.
T Consensus       246 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            111000  00111223344433 3456778889999999999999999999999999999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-46  Score=361.37  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=214.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999995 46899999998766555556788999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.+++...     .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999764     3899999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........             .......+.
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------------~~~~~~~~~  235 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------------LIATNGTPE  235 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHHHCSCC
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhCCCCC
Confidence              22345679999999999999999999999999999999999999997532211000             000111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                        ...+...+..+.+|+.+||+.||++|||+.|++++  ++++..
T Consensus       236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--~~~~~~  276 (297)
T 3fxz_A          236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH--QFLKIA  276 (297)
T ss_dssp             --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGC
T ss_pred             --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhccc
Confidence              12233455689999999999999999999999987  666653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-46  Score=364.11  Aligned_cols=267  Identities=30%  Similarity=0.498  Sum_probs=207.6

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ....+|++.+.||+|+||.||+|+. .++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788899999999999999987 68889999986653  34446788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999999976331 124899999999999999999999975 359999999999999999999999999997554


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......                ......
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----------------~~~~~~  252 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----------------VVAAVG  252 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----------------HHHHHH
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence            321  22344679999999999999999999999999999999999999997532210                000110


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ........+...+..+.+|+.+||+.+|.+|||+.++++.|++++++...
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            01111233444556899999999999999999999999999999987443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=369.40  Aligned_cols=270  Identities=27%  Similarity=0.409  Sum_probs=217.5

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCAD  221 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~  221 (457)
                      +....++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999974      34789999997653 3345678999999999999999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNR--------------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHR  281 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  281 (457)
                      .+..++||||+++|+|.+++......                    ...+++.+++.++.|++.||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            99999999999999999999874321                    146899999999999999999999999   9999


Q ss_pred             cCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCC
Q 012739          282 DFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVD  360 (457)
Q Consensus       282 Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~  360 (457)
                      ||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987654433333445678899999999998899999999999999999999 999997


Q ss_pred             CCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          361 PNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .....                 .....+........+..++..+.+++.+||+.+|.+||++.++++.|+++.++.+.
T Consensus       279 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          279 GMAHE-----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             TSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             CCChH-----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            43211                 11111111111123334456899999999999999999999999999999887654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-46  Score=364.21  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=217.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      ..++|.+.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            457788899999999999999986      235789999997653 3445678899999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNN--------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK  284 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  284 (457)
                      .++||||+++++|.+++.....                    ....+++.+++.++.|++.||.|||+++   ++|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999987543                    1234899999999999999999999999   9999999


Q ss_pred             cCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 012739          285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNR  363 (457)
Q Consensus       285 p~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~  363 (457)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654333223344567889999999998899999999999999999999 999997543


Q ss_pred             CCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          364 PPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...                 ....+........+...+..+.+++.+||+.||.+||++.+++++|++++.+
T Consensus       258 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PER-----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGG-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHH-----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            211                 1111111111223334456899999999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-46  Score=374.09  Aligned_cols=261  Identities=26%  Similarity=0.453  Sum_probs=204.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..+|.+.+.||+|+||.||+|++.    ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            367999999999999999999865    5778999999765 33445678999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....   ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999997643   35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          308 SDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       308 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....                 ....
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------------~~~~  260 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------------QDVI  260 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------HHHH
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence            5432111 1122345778999999999999999999999999999998 9999974321                 1111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..+........+..++..+.+++.+||+.+|.+||++.+|++.|++++++.
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            222222222333445668999999999999999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=374.28  Aligned_cols=266  Identities=26%  Similarity=0.382  Sum_probs=217.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||+|.+.      ++..||||++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999953      4668999999655 344455688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC---cEEEe
Q 012739          226 LLISEYMPNGTLQQHLHRHNNR---YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF---RAKVT  299 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  299 (457)
                      ++||||+++|+|.+++......   ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999876532   235899999999999999999999999   99999999999998554   59999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.....              
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------------  292 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------------  292 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------
Confidence            9999986654433333445678999999999999999999999999999999998 9999975322              


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                         ......+........+..++..+.+|+.+||+.+|.+|||+.+|+++|+.+.++...
T Consensus       293 ---~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          293 ---QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             ---HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             ---HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence               111111111112223334455799999999999999999999999999998887443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-46  Score=356.28  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=214.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357888899999999999999998899999999976533 2356889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            9999999997644   35899999999999999999999999   99999999999999999999999999986643211


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......                 .....+...
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~  223 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTG  223 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTT
T ss_pred             -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHhcC
Confidence             12233456778999999998999999999999999999999 99999753221                 111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .....+...+..+.+++.+||+.+|++|||+.+++++|+++.+.
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          224 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            11222333455799999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-46  Score=365.42  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=209.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999976 689999999865432 223558899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999986543    4999999999999999999999999   999999999999999999999999999876544


Q ss_pred             cCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+              ..
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~--------------~~  223 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW--------------KE  223 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHH--------------HT
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHH--------------hc
Confidence            33334456789999999999987775 78999999999999999999999754332111 1111              11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..............+.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h--~~~~~  267 (323)
T 3tki_A          224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD--RWYNK  267 (323)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--TTTTC
T ss_pred             ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC--hhhcc
Confidence            111111112344578899999999999999999999987  66654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-46  Score=356.78  Aligned_cols=260  Identities=26%  Similarity=0.424  Sum_probs=212.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|++.+.||+|+||.||++.+.++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            35678889999999999999999988889999999765322 35688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....   .+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999976432   4999999999999999999999999   9999999999999999999999999998664321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......                 .....+..
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~  236 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQ  236 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHT
T ss_pred             c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----------------HHHHHHhc
Confidence            1 11233456788999999998899999999999999999998 99999753221                 11111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ......+...+..+.+++.+||+.+|.+|||+.+++++|++++.+.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            1112223333458999999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.5e-47  Score=363.74  Aligned_cols=275  Identities=25%  Similarity=0.379  Sum_probs=213.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~  225 (457)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|+++++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788899999999999999984     3588999999987776667789999999999999999999999854  3568


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++|+|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999987542   4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc---h
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS---R  381 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  381 (457)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+......    ...........   .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhH
Confidence            76543211 2223345777899999999999999999999999999999999998642110    00000000000   0


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ....+.+........+..++.++.+++.+||+.||++|||+.|+++.|+++.++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            11122222222233444556689999999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-46  Score=353.18  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=212.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888999999999999999998888999999976532 2356889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999998754   24899999999999999999999999   99999999999999999999999999986644321


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                       .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......                 ....+...
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~  221 (268)
T 3sxs_A          160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----------------VVLKVSQG  221 (268)
T ss_dssp             -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----------------HHHHHHTT
T ss_pred             -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----------------HHHHHHcC
Confidence             12233456778999999998899999999999999999999 999997532210                 00000111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .....+...+..+.+++.+||+.+|.+|||+.+++++|+++.++.
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            111122233457999999999999999999999999999887653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-46  Score=363.20  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=211.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..+|++.+.||+|+||.||+|.+ .+++.||+|++...  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788999999999999999997 57999999998654  3344566889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999998764    3899999999999999999999999   99999999999999999999999999986643


Q ss_pred             ccCCccccccccCCCccccccccCCCCC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   ......+||+.|+|||++.+..++ .++|||||||++|||++|+.||.......   ..             ..+.
T Consensus       167 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~-------------~~i~  227 (328)
T 3fe3_A          167 G---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LR-------------ERVL  227 (328)
T ss_dssp             S---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------HHHH
T ss_pred             C---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHH
Confidence            2   234567899999999999888775 79999999999999999999997532210   00             0011


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....  ..+...+..+.+|+.+||+.||.+|||+.|++++  ++++.
T Consensus       228 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h--~~~~~  270 (328)
T 3fe3_A          228 RGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD--RWINA  270 (328)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC--TTTTT
T ss_pred             hCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC--HhhcC
Confidence            1111  1222344578999999999999999999999987  66664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.4e-46  Score=359.88  Aligned_cols=268  Identities=26%  Similarity=0.414  Sum_probs=219.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGK-QRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999985      2467899999976533 3446688999999999 9999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNR--------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      ..++||||+++|+|.+++......              ...+++.+++.++.|++.||.|||+.+   ++||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            999999999999999999875431              235899999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 012739          290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEH  368 (457)
Q Consensus       290 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~  368 (457)
                      ++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987765433333445567889999999999999999999999999999999 9999975432111 


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                                     ....+........+...+..+.+++.+||+.||.+|||+.++++.|++++.+...
T Consensus       257 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             ---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             ---------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence                           1111111111122233445899999999999999999999999999999987543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-46  Score=364.85  Aligned_cols=269  Identities=22%  Similarity=0.337  Sum_probs=200.2

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcCC----cEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      ....++|++.+.||+|+||.||+|.+...    ..||+|++...  .....+.+.+|+++++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            34457899999999999999999996543    27999998765  3344567899999999999999999999998776


Q ss_pred             eE------EEEEEeCCCCcHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          224 HR------LLISEYMPNGTLQQHLHRHNN--RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       224 ~~------~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      ..      ++||||+++|+|.+++.....  ....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      999999999999999976542  2235899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  374 (457)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   .   
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~---  249 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---Y---  249 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H---
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---H---
Confidence            99999999987654433333344567889999999999999999999999999999999 9999975432110   0   


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                             .....    ......+...+..+.+|+.+||+.||.+|||+.++++.|+++++....
T Consensus       250 -------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          250 -------NYLIG----GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             -------HHHHT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             -------HHHhc----CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence                   00001    111122334455899999999999999999999999999999987544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-46  Score=364.46  Aligned_cols=270  Identities=26%  Similarity=0.386  Sum_probs=215.0

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      +...++|.+.+.||+|+||.||+|...      ++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            334578899999999999999999962      35689999997543 23345688999999999 89999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNR-------------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRD  282 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D  282 (457)
                      .+..++||||+++|+|.+++......                   ...+++.+++.++.|++.||.|||+.+   |+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence            99999999999999999999875431                   134899999999999999999999999   99999


Q ss_pred             CccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 012739          283 FKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDP  361 (457)
Q Consensus       283 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~  361 (457)
                      |||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987755433333445667889999999998999999999999999999998 9999975


Q ss_pred             CCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .....                .....+........+...+..+.+|+.+||+.||.+|||+.+++++|+.++.....
T Consensus       278 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          278 IPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             CCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             CCcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            43211                11111111122223334456899999999999999999999999999999886543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-45  Score=358.16  Aligned_cols=268  Identities=22%  Similarity=0.344  Sum_probs=219.2

Q ss_pred             eechHHHHHHhcC----------CCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC
Q 012739          143 VFTYKELETATEN----------FSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ  211 (457)
Q Consensus       143 ~~~~~~~~~~~~~----------~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn  211 (457)
                      .++++++..+.+.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3667777777654          666789999999999999976 69999999987665555667889999999999999


Q ss_pred             eeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC
Q 012739          212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD  291 (457)
Q Consensus       212 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  291 (457)
                      |+++++++...+..++||||+++++|.+++...     .+++.++..++.|++.||.|||+.+   |+||||||+|||++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999998642     4899999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh
Q 012739          292 QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV  371 (457)
Q Consensus       292 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~  371 (457)
                      .++.+||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH
T ss_pred             CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence            99999999999998765422  12345679999999999999999999999999999999999999997532210   00


Q ss_pred             hhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          372 SWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       372 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                                ........+.+  ..+...+..+.+++.+||+.||++|||+.+++++  .++.+..
T Consensus       251 ----------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h--p~~~~~~  302 (321)
T 2c30_A          251 ----------KRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH--PFLLQTG  302 (321)
T ss_dssp             ----------HHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGGGCC
T ss_pred             ----------HHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC--hhhccCC
Confidence                      11111111111  1122334579999999999999999999999987  6666543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-45  Score=355.75  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=211.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|... ++..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467899999999999999999964 6889999988543   234446788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    ++++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999998764    4999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........  .....           ...
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~-----------~~~  228 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHI-----------QDS  228 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHH-----------SSC
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHh-----------hcc
Confidence            3321 223446799999999999999999999999999999999999999975322100  00000           000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHhhhhcCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-LMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~~~~  438 (457)
                      .+......+.+.+..+.+++.+||+.||.+|| ++.++.+.|++++.+...
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            00110112223445899999999999999998 999999999998887654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.7e-46  Score=363.07  Aligned_cols=278  Identities=24%  Similarity=0.385  Sum_probs=217.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA--DQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~  226 (457)
                      ++|++.+.||+|+||.||+|.+     .++..||+|++........+.+.+|+++++.++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999984     358899999998777666777999999999999999999999986  456789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            99999999999999987543   4899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh-ccccCchhHH
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA-LPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  384 (457)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......   ....+. ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC----CCHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhcccccccccHHHH
Confidence            6543221 1223456788899999999999999999999999999999999998642110   000000 0011111222


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                      ...+........+..++..+.+|+.+||+.||.+|||+.+++++|+.++......+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            33333333334455566789999999999999999999999999999988766533

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-45  Score=359.70  Aligned_cols=265  Identities=23%  Similarity=0.385  Sum_probs=215.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc--------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      .++|.+.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467888999999999999999863        46789999997653 34456688999999999 899999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNR------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                      +..++||||+++|+|.+++......            ...+++.+++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            9999999999999999999875421            234899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcch
Q 012739          291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHV  369 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~  369 (457)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            9999999999999987654332223344567889999999988899999999999999999999 99999753211    


Q ss_pred             hhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                                   +....+........+..++..+.+++.+||+.+|.+|||+.++++.|++++....
T Consensus       267 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 -------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             -------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                         0111111111112233345589999999999999999999999999999988644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.1e-46  Score=363.92  Aligned_cols=259  Identities=26%  Similarity=0.445  Sum_probs=206.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcE----EEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTV----AAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++|++.+.||+|+||.||+|.+. ++..    ||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            56888899999999999999964 3443    7788775432 2223456789999999999999999999864 56899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999997643   25889999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......                 ...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~  228 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----------------VPD  228 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----------------HHH
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----------------HHH
Confidence            65444444455678889999999998999999999999999999999 999998543211                 111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+........+..++..+.+++.+||+.||.+||++.+++++|+++.++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            11111111222234446889999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-45  Score=373.03  Aligned_cols=254  Identities=29%  Similarity=0.442  Sum_probs=210.9

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-eEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-HRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lv~e  230 (457)
                      ..++|++.+.||+|+||.||+|.+. ++.||||+++...  ..+.+.+|+.+|+.++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999984 7799999997653  3456889999999999999999999987655 7899999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....
T Consensus       268 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            9999999999987543  34789999999999999999999999   999999999999999999999999999854322


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                           .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......                 ....+.
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i~  400 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVE  400 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----------------HHHHHH
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHH
Confidence                 222357889999999999999999999999999999999 999997543321                 111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .......+..++..+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            1222234445566899999999999999999999999999988754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-46  Score=381.95  Aligned_cols=265  Identities=24%  Similarity=0.409  Sum_probs=216.8

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      +.++...++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+|+.++||||+++++++. .+..+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34455567889999999999999999999889999999997653 33567899999999999999999999986 56789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999975421  24888999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ...... .......++..|+|||.+....++.++||||||+++|||+| |+.||......                 +..
T Consensus       334 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----------------~~~  395 (454)
T 1qcf_A          334 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------EVI  395 (454)
T ss_dssp             BCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHH
T ss_pred             cCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHH
Confidence            643211 11223446788999999998999999999999999999999 99999753221                 111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..+........+..++..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus       396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            111111222334445668999999999999999999999999999887654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-45  Score=350.82  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34678889999999999999998643    4579999987643 334456889999999999999999999985 45789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            9999999999999998653   35899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ..          ...
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----------~i~  231 (281)
T 1mp8_A          166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----------RIE  231 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----------HHH
T ss_pred             cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----------HHH
Confidence            654321 12233456788999999998899999999999999999997 9999975432110   00          000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .    ......+...+..+.+++.+||+.||++|||+.++++.|++++++
T Consensus       232 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          232 N----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1    111122334456899999999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-45  Score=358.88  Aligned_cols=274  Identities=25%  Similarity=0.379  Sum_probs=220.1

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELL  216 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~  216 (457)
                      ...++....++|++.+.||+|+||.||+|.+      .+++.||+|++.... ....+.+.+|+.+++.+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3345555678899999999999999999984      246789999997653 33445688999999999 789999999


Q ss_pred             EEEEcCC-eEEEEEEeCCCCcHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 012739          217 GYCADQN-HRLLISEYMPNGTLQQHLHRHNNR------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDF  283 (457)
Q Consensus       217 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl  283 (457)
                      +++...+ ..++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.+   ++||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9987654 589999999999999999875432            123889999999999999999999999   999999


Q ss_pred             ccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q 012739          284 KCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPN  362 (457)
Q Consensus       284 kp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~  362 (457)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333445668899999999999999999999999999999998 99999754


Q ss_pred             CCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          363 RPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .....  ..          ........    ...+......+.+++.+||+.||.+|||+.+++++|+++++.+.
T Consensus       255 ~~~~~--~~----------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          255 KIDEE--FC----------RRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCSHH--HH----------HHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             chhHH--HH----------HHhccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            32110  00          00111111    12222334579999999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-45  Score=358.81  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=207.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999975 58999999986542   223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999998754    4899999999999999999999999   99999999999999999999999999986432


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...             ..+..
T Consensus       158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~-------------~~i~~  219 (337)
T 1o6l_A          158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF-------------ELILM  219 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHHHH
T ss_pred             C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHH-------------HHHHc
Confidence            2  12345578999999999999999999999999999999999999999753211   000             00111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ..  ..++...+.++.+|+.+||+.||.+||     ++.|++++
T Consensus       220 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          220 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            11  123334456899999999999999999     89999887

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-45  Score=381.02  Aligned_cols=264  Identities=25%  Similarity=0.438  Sum_probs=219.3

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++....+|.+.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||++++++|.+.+..++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            33445678889999999999999999865 88999999976533 34668899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       294 v~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999986432  35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .... ........++..|+|||.+.+..++.++||||||++||||+| |..||......                 .+.+
T Consensus       369 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~~~  430 (495)
T 1opk_A          369 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYE  430 (495)
T ss_dssp             TTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHH
T ss_pred             cCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence            4321 112233456788999999998999999999999999999999 99999754321                 1112


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.++++.
T Consensus       431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            22222333444455668999999999999999999999999999987653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-45  Score=360.16  Aligned_cols=271  Identities=24%  Similarity=0.388  Sum_probs=219.6

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYC  219 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~  219 (457)
                      ++++...++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344556788999999999999999999864      36789999997653 33445688999999999999999999999


Q ss_pred             EcCCeEEEEEEeCCCCcHHHHHhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC
Q 012739          220 ADQNHRLLISEYMPNGTLQQHLHRHNN------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN  293 (457)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  293 (457)
                      .+.+..++||||+++|+|.+++.....      ...++++.+++.++.|++.||.|||+++   |+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence            999999999999999999999976421      1235789999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 012739          294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       294 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~  372 (457)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------  247 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------  247 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------
Confidence            9999999999987654433333344567889999999998999999999999999999999 89998743211       


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                                .....+........+...+..+.+++.+||+.||.+|||+.+++++|++++.+..
T Consensus       248 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~  302 (322)
T 1p4o_A          248 ----------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  302 (322)
T ss_dssp             ----------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             ----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence                      1111110011112233445579999999999999999999999999998877643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.1e-45  Score=346.99  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=198.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ----RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|.+ .++.+|+|++......    ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35788889999999999999997 4889999998754322    235688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC--------CCcEEEee
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--------NFRAKVTD  300 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D  300 (457)
                      |||+++++|.+++..     ..+++..++.++.|++.||.|||+++..+++||||||+|||++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999853     35899999999999999999999988666889999999999986        77899999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......               
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------  220 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---------------  220 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---------------
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------
Confidence            99998654322    23456899999999999999999999999999999999999999753211               


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                       ...............+...+..+.+++.+||+.+|.+|||+.|++++|+++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          221 -AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             011111122222233444556899999999999999999999999999754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=355.86  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=207.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ..+|.+.+.||+|+||.||+|....     +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778999999999999998643     2359999987653 334456889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999998643   35899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          307 VSDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......                 ..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----------------~~  259 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----------------EV  259 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HH
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----------------HH
Confidence            65432111 1223446788999999999999999999999999999999 99999643211                 11


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ...+........+...+..+.+++.+||+.+|.+||++.++++.|+++++....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            111111111122334456899999999999999999999999999999986443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-45  Score=355.20  Aligned_cols=272  Identities=23%  Similarity=0.315  Sum_probs=207.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|...+++.||+|++......  ....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            4678889999999999999999988999999998654322  23567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |++ ++|.+++....   ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            996 58888887643   35899999999999999999999999   999999999999999999999999999876432


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch-----hHH
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR-----EEA  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~  384 (457)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................     ...
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            1  22344578999999999876 568999999999999999999999998654433221111110000000     000


Q ss_pred             hhhcCCcCC--CC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSLQ--GQ-----YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....+....  ..     .......++.+|+.+||+.||++|||+.|++++  +++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~  306 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH--PYFKD  306 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC--ccccc
Confidence            000000000  00     011234578999999999999999999999987  66665

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-45  Score=353.57  Aligned_cols=265  Identities=26%  Similarity=0.441  Sum_probs=220.0

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++....+|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            33456778889999999999999999764 8889999997653 344668899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999976432  45899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......                 ...+
T Consensus       162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~~~~  223 (288)
T 3kfa_A          162 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYE  223 (288)
T ss_dssp             CSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHH
T ss_pred             cCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence            5432 122334557889999999998999999999999999999999 99999754321                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .+........+...+..+.+|+.+||+.||.+|||+.++++.|++++++..
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            111122223334445689999999999999999999999999999988743

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=359.57  Aligned_cols=252  Identities=22%  Similarity=0.375  Sum_probs=202.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lv  228 (457)
                      ..+|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|+.+++.++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4568889999999999999999988999999998654  33445678999999999976  9999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||+ .+++|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++...
T Consensus        88 ~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            995 5889999998754    4899999999999999999999999   99999999999997 6789999999998775


Q ss_pred             cccCCccccccccCCCccccccccC-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-----------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      ............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....             
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------------  225 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------------  225 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------------
Confidence            5433333456689999999999864           6789999999999999999999999974221             


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ........+++.....++......+.+|+.+||+.||.+|||+.|++++
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          226 --QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence              1112233334444334444445689999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-45  Score=346.33  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=213.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||+|+||.||+|...++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3578888999999999999999988899999999765332 356889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-  158 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  158 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-
Confidence            99999999987532   5899999999999999999999999   9999999999999999999999999998664321 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                      ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......                 .....+...
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~i~~~  221 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTG  221 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTT
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHhcC
Confidence            112233457788999999998899999999999999999999 89998753211                 111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .....+...+..+.+++.+||+.+|.+||++.+++++|+++.+.
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          222 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11122233455799999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-45  Score=347.70  Aligned_cols=265  Identities=25%  Similarity=0.394  Sum_probs=214.8

Q ss_pred             cCCCCCc-eeccCCcEEEEEEEEc---CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGN-VIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555555 8999999999999853   57789999997653 34456788999999999999999999999 45568999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999997533   35999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......                 +...
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~  224 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMA  224 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHH
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHH
Confidence            33221 11233456889999999988889999999999999999999 99999754321                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCccc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAIS  442 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~  442 (457)
                      .+........+...+..+.+++.+||+.+|.+||++.+++++|++++.....+++.
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  280 (287)
T 1u59_A          225 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  280 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence            11111112333445568999999999999999999999999999999987665443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-45  Score=350.08  Aligned_cols=263  Identities=25%  Similarity=0.476  Sum_probs=198.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ...+|++.+.||+|+||.||+|+..+  .+|+|++...  .....+.+.+|+.+++.++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            35678999999999999999998643  5999988654  344456789999999999999999999965 455689999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            9999999999996543   35899999999999999999999999   99999999999999999999999999986654


Q ss_pred             ccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ...........||+.|+|||.+.   +..++.++||||||+++|||++|+.||........  .....         ...
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~---------~~~  241 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMV---------GRG  241 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHH---------HHT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHh---------ccc
Confidence            33333345567999999999986   66789999999999999999999999975432110  00000         000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+.+ ......++..+.+|+.+||+.+|.+|||+.++++.|+++.++
T Consensus       242 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          242 SLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             SCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             ccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            111111 112233456899999999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=350.07  Aligned_cols=275  Identities=22%  Similarity=0.324  Sum_probs=214.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--eEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN--HRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~lv  228 (457)
                      .++|.+.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            356888999999999999999976 48999999987543 233456788999999999999999999997655  78999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe----CCCCcEEEeeccCc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLA  304 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgl~  304 (457)
                      |||+++++|.+++..... ...+++.+++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999987543 234899999999999999999999999   9999999999999    88889999999999


Q ss_pred             cccccccCCccccccccCCCcccccccc--------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh-hhhc
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAS--------TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV-SWAL  375 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~-~~~~  375 (457)
                      +......   ......||+.|+|||++.        +..++.++|||||||++|||+||+.||............ ....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8765432   234467999999999886        578899999999999999999999999754332211111 0000


Q ss_pred             cccCc--------hh-HHhhhc-CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          376 PRLTS--------RE-EAVEMV-DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       376 ~~~~~--------~~-~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .....        .. ...... +-......+......+.+++.+||+.||++|||++|++++..+-..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            00000        00 000000 0011224567788899999999999999999999999999876544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.4e-45  Score=361.45  Aligned_cols=248  Identities=21%  Similarity=0.322  Sum_probs=206.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH------HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ------RERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999975 5889999998654321      245688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  301 (457)
                      ++||||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997543    4999999999999999999999999   99999999999998877    7999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .           
T Consensus       164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~-----------  226 (361)
T 2yab_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---T-----------  226 (361)
T ss_dssp             SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H-----------
T ss_pred             CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---H-----------
Confidence            999876542   22345679999999999999999999999999999999999999997532210   0           


Q ss_pred             hHHhhhcCCcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ...+.....  .++    ...+..+.+|+.+||..||.+|||+.|++++
T Consensus       227 --~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          227 --LANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --HHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              001111000  111    1234578999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-45  Score=374.69  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++...++|++.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            3344577888999999999999999998888899999976532 34568899999999999999999999876 678999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       257 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999999975422  34899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      .... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....                 .+....
T Consensus       332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~  393 (452)
T 1fmk_A          332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQ  393 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHH
T ss_pred             CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHH
Confidence            3221 12233456788999999998999999999999999999999 9999975321                 111111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      +........+..++..+.+|+.+||+.+|++|||+.++++.|++++....
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            11222223344556689999999999999999999999999999886543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.3e-45  Score=359.98  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=205.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457899999999999999999975 68999999985432     113456889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc---EEEeeccC
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGL  303 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl  303 (457)
                      +||||+++++|.+++.........+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999988765444456899999999999999999999999   999999999999986654   99999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      +......  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    ....           
T Consensus       180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-----------  242 (351)
T 3c0i_A          180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE-----------  242 (351)
T ss_dssp             CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH-----------
T ss_pred             eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH-----------
Confidence            9876542  1223456799999999999999999999999999999999999999975211    0000           


Q ss_pred             HhhhcCCcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AVEMVDPSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        .+.....  ..+    ...+..+.+|+.+||+.||++|||+.|++++
T Consensus       243 --~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 --GIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --HHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0000000  011    1224578999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.3e-45  Score=358.40  Aligned_cols=265  Identities=27%  Similarity=0.387  Sum_probs=215.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      ..++|.+.+.||+|+||.||+|....      ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35778889999999999999999643      2479999987653 33456688999999999 8999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNN----------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN  293 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  293 (457)
                      ..++||||+++|+|.+++.....          ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999976421          1235899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 012739          294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       294 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~  372 (457)
                      +.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||........     
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----  275 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-----  275 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence            9999999999987654433333444567889999999998999999999999999999999 9999975432111     


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                 ....+........+...+..+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus       276 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          276 -----------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -----------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                       0111111111122223345799999999999999999999999999998775

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.6e-45  Score=354.26  Aligned_cols=269  Identities=22%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      +....++|.+.+.||+|+||.||+|...    .+..||+|++...  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3344577889999999999999999864    2457999998754  334446688999999999999999999999775


Q ss_pred             C-----eEEEEEEeCCCCcHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc
Q 012739          223 N-----HRLLISEYMPNGTLQQHLHRHN--NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       223 ~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      +     ..++||||+++++|.+++....  .....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            4     3599999999999999996532  23346999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  374 (457)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   ..   
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---  259 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY---  259 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH---
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH---
Confidence            99999999987654332233344567889999999999999999999999999999999 888987533211   00   


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                             .....    ......+...+..+.+++.+||+.+|.+|||+.+++++|++++++..
T Consensus       260 -------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          260 -------DYLLH----GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -------HHHHT----TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------HHHHc----CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                   00111    11112233445589999999999999999999999999999988643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=357.20  Aligned_cols=259  Identities=26%  Similarity=0.437  Sum_probs=203.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcE----EEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTV----AAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ..+|++.++||+|+||.||+|.+. +++.    |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367888999999999999999964 3443    577777543 2334567889999999999999999999998765 78


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +|+||+.+|+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999999987543   5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......                 ..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~  229 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS  229 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HH
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HH
Confidence            755433333444567889999999999999999999999999999999 999997543211                 11


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+........+...+..+.+++.+||+.||.+||++.|+++.|+++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11111112223334555899999999999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-45  Score=349.16  Aligned_cols=265  Identities=27%  Similarity=0.442  Sum_probs=214.1

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++...++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            3444578889999999999999999998888999999876532 34568899999999999999999999874 468999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            999999999999975421  24899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......                 +....
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~  222 (279)
T 1qpc_A          161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----------------EVIQN  222 (279)
T ss_dssp             SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHH
T ss_pred             Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----------------HHHHH
Confidence            4221 12233456789999999988899999999999999999999 99999753221                 11111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      +........+...+..+.+++.+||+.+|++|||+.++++.|++++.....
T Consensus       223 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            111111122333455899999999999999999999999999999876543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=361.38  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=204.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~  226 (457)
                      ..++|++.++||+|+||.||+|+.. +++.||+|++....   ....+.+..|..+++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999975 58999999987542   22334577899999988 7999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999998764    3999999999999999999999999   99999999999999999999999999975


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..             ...
T Consensus       174 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~-------------~~~  235 (353)
T 3txo_A          174 GICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL-------------FEA  235 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------HHH
T ss_pred             cccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH-------------HHH
Confidence            4322  22345578999999999999989999999999999999999999999754221   00             011


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHHHhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM------TDVVQSLIPVVK  434 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~L~~~~~  434 (457)
                      +.....  .++......+.+|+.+||+.||.+||++      .+++++  .+++
T Consensus       236 i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h--p~f~  285 (353)
T 3txo_A          236 ILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH--PFFK  285 (353)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS--GGGT
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC--Cccc
Confidence            111111  2233345579999999999999999998      778776  4444

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-44  Score=348.46  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEc----CCeEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR--LHSPQLVELLGYCAD----QNHRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~----~~~~~  226 (457)
                      .++|++.+.||+|+||.||+|+. +++.||+|++....   ...+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46789999999999999999988 78999999986542   3345556666666  799999999998654    34689


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH--------EHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      +||||+++|+|.+++..     ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999954     24999999999999999999999        777   999999999999999999999


Q ss_pred             eeccCccccccccCCc--cccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcC----------CCCCC
Q 012739          299 TDFGLAKMVSDKINGQ--ISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTG----------RVPVD  360 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg----------~~p~~  360 (457)
                      +|||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998665432211  12335799999999999876      566799999999999999999          77776


Q ss_pred             CCCCCCcchhhhhhccccCchhHHhhhcCCcCCC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          361 PNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG-QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ..............       ........+.+.. ..+...+..+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       235 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSFEDMRK-------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCHHHHHH-------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcchhhhhH-------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            43332211100000       0000001111111 12345678999999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.5e-45  Score=349.18  Aligned_cols=271  Identities=21%  Similarity=0.286  Sum_probs=204.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|+||.||+|...+++.||+|++......  ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            468889999999999999999988999999998655322  235678899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ ++|.+++....   ..+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LD-QDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CS-EEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            96 49999887643   35899999999999999999999999   9999999999999999999999999998664321


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc----hhHHhh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS----REEAVE  386 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  386 (457)
                        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................    ......
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence              12334578999999999875 46899999999999999999999999754321111000000000000    000000


Q ss_pred             hcCCcCCC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQG-------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..++.+..       ........++.+|+.+||+.||++|||+.|++++  .++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~  286 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH--AYFKE  286 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGGC
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC--cchhh
Confidence            11111110       1112234578999999999999999999999987  66654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.3e-45  Score=351.74  Aligned_cols=271  Identities=22%  Similarity=0.370  Sum_probs=211.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~  225 (457)
                      .+|++.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     368899999987543 23346688999999999999999999999876  678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999999976543   4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc--ccCchh
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP--RLTSRE  382 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~  382 (457)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.....    .......+  ......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence            76543221 223445688889999999999999999999999999999999998653110    00000000  000111


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .....+........+...+..+.+|+.+||+.||.+|||+.++++.|+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            2222222222333444556689999999999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-44  Score=361.85  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=204.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|++.++||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357888999999999999999975 47889999987542   22224577899999887 89999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|..++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            999999999999998754    4999999999999999999999999   999999999999999999999999999853


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH-hh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA-VE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  386 (457)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........        ....... ..
T Consensus       204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--------~~~~~~~~~~  273 (396)
T 4dc2_A          204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQV  273 (396)
T ss_dssp             CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHH
T ss_pred             ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc--------hhhHHHHHHH
Confidence            221  223456789999999999999999999999999999999999999997533211100        0000000 01


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM------TDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  428 (457)
                      +....  ..++.....++.+|+.+||+.||.+||++      .||+++
T Consensus       274 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          274 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             Hhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            11111  12334455689999999999999999985      577665

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-44  Score=351.68  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=210.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcE--EEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTV--AAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.+.||+|+||.||+|... ++..  +++|.+.... ....+.+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888899999999999999965 4554  4899886542 33345688999999999 999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          229 SEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      |||+++++|.+++....            .....+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999998654            23346999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......          
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------  248 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------  248 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----------
Confidence            99999998754322   11233456889999999988889999999999999999998 99999753221          


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                             .....+........+...+..+.+|+.+||+.+|.+|||+.+++++|++++++...
T Consensus       249 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          249 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             -------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                   11111111112223334456899999999999999999999999999999998554

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-44  Score=362.17  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLH--SPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.+++.+.  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458889999999999999999888999999998654  3444567899999999996  599999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      | +.+++|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 56889999998754    4899999999999999999999999   99999999999995 58999999999987754


Q ss_pred             ccCCccccccccCCCccccccccC-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST-----------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......             
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------------  273 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------------  273 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------------
Confidence            433333455679999999999865           46899999999999999999999999743210             


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ......++++.....++......+.+|+.+||+.||.+|||+.|++++
T Consensus       274 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 --ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             --HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence              012223333333333333335579999999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.2e-45  Score=353.63  Aligned_cols=273  Identities=27%  Similarity=0.407  Sum_probs=215.1

Q ss_pred             CCCCceeccCCcEEEEEEEEc-----CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEE
Q 012739          156 FSEGNVIGNGGFGVVYKGVLS-----DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLL  227 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~l  227 (457)
                      |++.+.||+|+||.||++.+.     +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            378899999999999998753     58899999997654 3445668999999999999999999999987  467899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++++|.+++...     .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999763     3899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ...... .......+|..|+|||.+.+..++.++||||||+++|||+||+.||....... .....+.. .........+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQ-GQMTVLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCC-HHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccc-cchhHHHHHH
Confidence            543221 12334567888999999999899999999999999999999999986421100 00000000 0000112223


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.++...
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            3333333344455567899999999999999999999999999999887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=352.22  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999975 689999999865421   22355778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999998754    4899999999999999999999999   99999999999999999999999999986543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......                .....+..
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~  217 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILN  217 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHH
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHh
Confidence            2     34567999999999999999999999999999999999999999753211                00111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVK  434 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~  434 (457)
                      ..+  .++.....++.+++.+||+.||.+||     ++.+++++  .+++
T Consensus       218 ~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h--p~f~  263 (318)
T 1fot_A          218 AEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH--PWFK  263 (318)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS--GGGS
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC--cccc
Confidence            111  22333445899999999999999999     89999877  4544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.8e-44  Score=347.33  Aligned_cols=272  Identities=24%  Similarity=0.339  Sum_probs=204.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..+|++.+.||+|+||.||+|.. .++..||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688999999999999999996 46899999998653   334456688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999999765444456899999999999999999999999   9999999999999999999999999988664


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ..             ..+.
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~-------------~~~~  251 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LC-------------KKIE  251 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HH-------------HHHH
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HH-------------HHhh
Confidence            321  1233456899999999999999999999999999999999999999753221000 00             0000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCcccc
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISF  443 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~  443 (457)
                      ............+..+.+++.+||+.||.+|||+.+|++.|+++......+.++.
T Consensus       252 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~  306 (310)
T 2wqm_A          252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH  306 (310)
T ss_dssp             TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred             cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence            1111111112334579999999999999999999999999999998887755443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=353.12  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH------HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ------RERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|.+.+.||+|+||.||+|... ++..||+|++......      ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888999999999999999975 5889999988654221      245688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  301 (457)
                      ++||||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999997543    5999999999999999999999999   99999999999998887    8999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |+++.....   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   ...         
T Consensus       163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---------  227 (326)
T 2y0a_A          163 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---------  227 (326)
T ss_dssp             TTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---------
T ss_pred             CCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---------
Confidence            999876432   12345679999999999999999999999999999999999999997532110   000         


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                       .. ......+........+..+.+|+.+||+.||.+|||+.|++++  .+++
T Consensus       228 -~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~  276 (326)
T 2y0a_A          228 -NV-SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH--PWIK  276 (326)
T ss_dssp             -HH-HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS--TTTS
T ss_pred             -HH-HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC--CCcc
Confidence             00 0001011000111234578999999999999999999999986  4444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.4e-44  Score=344.45  Aligned_cols=267  Identities=18%  Similarity=0.222  Sum_probs=214.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  ..+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46788999999999999999996 568999999886542  223477899999999 79999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc-----EEEeeccCcc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR-----AKVTDFGLAK  305 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgl~~  305 (457)
                      |+ +++|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.     +||+|||+++
T Consensus        87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 999999998653   25999999999999999999999999   999999999999987776     9999999998


Q ss_pred             ccccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          306 MVSDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       306 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ........     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||................    .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~  235 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----E  235 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----H
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH----h
Confidence            77543222     12345679999999999999999999999999999999999999998654322211111100    0


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        .......+.+...    .+..+.+++.+||+.+|++||++.+|++.|++++++...
T Consensus       236 --~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          236 --KKQSTPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             --HHHHSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             --hccCccHHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence              0000000011112    345899999999999999999999999999999987543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-44  Score=351.60  Aligned_cols=278  Identities=21%  Similarity=0.296  Sum_probs=197.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357889999999999999999964 589999999865432 223567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          231 YMPNGTLQQHLHRHNN--RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |++ |+|.+++.....  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 699999876432  2235899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc--hhHH-
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS--REEA-  384 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~-  384 (457)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........  .... 
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            321  22344578999999999876 46899999999999999999999999754321111100000000000  0000 


Q ss_pred             -hhhcCCcCCC------------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          385 -VEMVDPSLQG------------QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       385 -~~~~d~~l~~------------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                       .....+.+..            ..+......+.+|+.+||+.||++|||+.|++++  +++++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~~~~  302 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH--PWFAEYYH  302 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGGCC
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC--hhhhcccc
Confidence             0000000000            0011233479999999999999999999999998  77776433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=349.29  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=197.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.++||+|+||+||+|.+. +++.||||++...  .......+..|+..+..+ +||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367899999999999999999976 6899999988654  223333444555555554 999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+ +++|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 7799999887643   5999999999999999999999999   9999999999999999999999999987664


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..   .......||+.|+|||++.+ .++.++|||||||++|||++|..|+....     .              ...+.
T Consensus       209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~--------------~~~~~  265 (311)
T 3p1a_A          209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G--------------WQQLR  265 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H--------------HHHHT
T ss_pred             cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H--------------HHHHh
Confidence            32   22344569999999999876 79999999999999999999977765311     0              00111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .......++...+..+.+++.+||+.||++|||+.|++++  +++++
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h--p~~~~  310 (311)
T 3p1a_A          266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL--PVLRQ  310 (311)
T ss_dssp             TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGSC
T ss_pred             ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC--ccccC
Confidence            1111111112234589999999999999999999999986  56554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-44  Score=342.42  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=208.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ--NHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|++ +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35788899999999999999998 48889999987652  34456789999999999999999999999877  788999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+.+ ++++||||||+|||++.++.++|+|||+.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999976432  35899999999999999999999875 459999999999999999999999999875432


Q ss_pred             cccCCccccccccCCCccccccccCCCCCc---ccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTT---KSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                             .....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......                ....
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~  221 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----------------EIGM  221 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----------------HHHH
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----------------HHHH
Confidence                   23346899999999998765554   799999999999999999999743221                0111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ...........+...+..+.+++..||+.||++|||+.++++.|+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111122223334455689999999999999999999999999998865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-44  Score=356.31  Aligned_cols=258  Identities=20%  Similarity=0.274  Sum_probs=199.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467889999999999999999976 6899999999764322 24578899999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc--EEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR--AKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgl~~~~~~  309 (457)
                      +++|+|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            99999999997754    3999999999999999999999999   999999999999987765  99999999875432


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcc-cchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTK-SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........            ....+.
T Consensus       171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------------~~~~~~  235 (361)
T 3uc3_A          171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK------------TIQRIL  235 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH------------HHHHHH
T ss_pred             c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH------------HHHHHh
Confidence            2   22344579999999999988887665 8999999999999999999986443221111            111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ............+..+.+|+.+||+.||.+|||+.|++++  .++.+
T Consensus       236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--p~f~~  280 (361)
T 3uc3_A          236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH--SWFLK  280 (361)
T ss_dssp             TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--HHHHT
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC--cchhc
Confidence            1111111111234578999999999999999999999998  66654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-44  Score=355.09  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=208.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|++......   ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999997 56899999998653211   1246889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+ +|+|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            999 789999987754    4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   ......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..........                 .+
T Consensus       161 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------------~i  220 (336)
T 3h4j_B          161 G---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------------KV  220 (336)
T ss_dssp             S---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------CC
T ss_pred             C---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------HH
Confidence            3   23445679999999999988776 689999999999999999999997543221100                 00


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ... ....+...+..+.+|+.+||+.||.+|||+.|++++  ++++..
T Consensus       221 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h--p~~~~~  265 (336)
T 3h4j_B          221 NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD--PWFNVN  265 (336)
T ss_dssp             CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC--HHHHTT
T ss_pred             HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC--hhhccC
Confidence            000 012233345578999999999999999999999998  677653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=363.97  Aligned_cols=260  Identities=21%  Similarity=0.261  Sum_probs=209.0

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ...++|++.+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34577999999999999999999864 68899999986543  3344568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeeccCc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLA  304 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl~  304 (457)
                      ||||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++
T Consensus        88 v~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999999998754    4999999999999999999999999   99999999999998   5688999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .....          +
T Consensus       161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~----------i  225 (444)
T 3soa_A          161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQ----------I  225 (444)
T ss_dssp             BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH----------H
T ss_pred             EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHH----------H
Confidence            8765431  2234567999999999999999999999999999999999999999753211   00000          0


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .. -...+........+.++.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       226 ~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h--p~~~~  273 (444)
T 3soa_A          226 KA-GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH--PWISH  273 (444)
T ss_dssp             HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--CTTHH
T ss_pred             Hh-CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC--ccccC
Confidence            00 00011111112334579999999999999999999999987  55544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-44  Score=352.51  Aligned_cols=264  Identities=26%  Similarity=0.389  Sum_probs=210.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE------cCCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||+|.+      .++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46789999999999999999984      24778999999654 344456788999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEe
Q 012739          226 LLISEYMPNGTLQQHLHRHNNR---YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVT  299 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  299 (457)
                      ++||||+++++|.+++......   ...+++.+++.++.|++.||.|||+.+   ++||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999876432   235899999999999999999999999   999999999999984   4569999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhcccc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      |||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......             
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------------  252 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------------  252 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------------
Confidence            9999986644333333344568899999999988899999999999999999998 99998753211             


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                          .....+........+..++..+.+++.+||+.||.+||++.+++++|+.+.++.
T Consensus       253 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          253 ----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             ----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                111111111111223334558999999999999999999999999999888764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-44  Score=351.77  Aligned_cols=263  Identities=17%  Similarity=0.230  Sum_probs=212.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++.....  .+.+..|+.+++.+ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36788899999999999999996 5688999999865432  23478899999999 99999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc-----EEEeeccCcc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR-----AKVTDFGLAK  305 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgl~~  305 (457)
                      |+ +++|.+++....   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 999999998753   35999999999999999999999999   999999999999999887     9999999998


Q ss_pred             ccccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          306 MVSDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       306 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      .+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...............      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i------  232 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI------  232 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH------
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH------
Confidence            765432221     124568999999999999999999999999999999999999999865432211111110      


Q ss_pred             hhHHhhhcC-CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          381 REEAVEMVD-PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       381 ~~~~~~~~d-~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                       ........ ..+..    ..+ ++.+++..||+.+|.+||++.+|++.|++++++.
T Consensus       233 -~~~~~~~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          233 -GDTKRATPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             -HHHHHHSCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -HhhhccCCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence             00000000 00001    123 8999999999999999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-44  Score=355.72  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=206.3

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..++|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999975 5889999998654  234446688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEEEeeccCcc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgl~~  305 (457)
                      |||+++|+|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999987643    4899999999999999999999999   9999999999999765   459999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .....          +.
T Consensus       180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~----------i~  243 (362)
T 2bdw_A          180 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----------IK  243 (362)
T ss_dssp             CCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----------HH
T ss_pred             EecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----------HH
Confidence            76532   2234567999999999999999999999999999999999999999753211   00000          00


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      . -...+........+.++.+|+.+||+.||++|||+.+++++
T Consensus       244 ~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 A-GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             H-TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             h-CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 00000011112335579999999999999999999999876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-44  Score=357.92  Aligned_cols=258  Identities=21%  Similarity=0.322  Sum_probs=211.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            367889999999999999999975 5889999999776555566789999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC--CCcEEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgl~~~~~~  309 (457)
                      +++|+|.+++....   ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999987543   35899999999999999999999999   999999999999974  57899999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....          .. ....
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----------~i-~~~~  266 (387)
T 1kob_A          204 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ----------NV-KRCD  266 (387)
T ss_dssp             T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----------HH-HHCC
T ss_pred             C---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH----------HH-HhCC
Confidence            2   2233457999999999999999999999999999999999999999753211   0000          00 0011


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+........+.++.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~  310 (387)
T 1kob_A          267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH--PWLKG  310 (387)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS--TTTSS
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC--ccccC
Confidence            111111222344589999999999999999999999987  56654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3e-44  Score=343.12  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=206.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|.+.+.||+|+||.||+|.+.+    +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678888999999999999998643    235999998765 334456789999999999999999999998754 5689


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            9999999999999987543   4899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||........   .          .....
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~----------~~~~~  229 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I----------GVLEK  229 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H----------HHHHH
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H----------HHHhc
Confidence            54321 12234457889999999998899999999999999999998 9999974322110   0          00001


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .    .....+...+..+.+++.+||+.+|++||++.+++++|+++++.
T Consensus       230 ~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          230 G----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            0    01112223445799999999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=351.09  Aligned_cols=266  Identities=22%  Similarity=0.310  Sum_probs=210.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----cCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA----DQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~----~~~~~~l  227 (457)
                      .++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46789999999999999999997 578999999987766666677899999999999999999999986    3457899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++.........+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999875544567999999999999999999999999   999999999999999999999999998765


Q ss_pred             ccccCCc-------cccccccCCCccccccccCCC---CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          308 SDKINGQ-------ISTRVLGTTGYLAPEYASTGK---LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       308 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      .......       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||...........       
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------  257 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------  257 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-------
Confidence            3321111       112345799999999987544   78999999999999999999999953111000000       


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                          .....    ......+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus       258 ----~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          258 ----LAVQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             ----HHHHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             ----HHhhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                00000    1111112233458999999999999999999999999998876543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.6e-44  Score=352.24  Aligned_cols=260  Identities=23%  Similarity=0.383  Sum_probs=207.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|..+++.+ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888899999999999999975 5889999998754   233445678899999988 899999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999998754    4999999999999999999999999   9999999999999999999999999998543


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh-hh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV-EM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  387 (457)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........        ....... .+
T Consensus       162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~i  231 (345)
T 3a8x_A          162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVI  231 (345)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHH
T ss_pred             CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHHH
Confidence            22  1234557899999999999999999999999999999999999999975322111000        0000110 11


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHHHhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM------TDVVQSLIPVVK  434 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~L~~~~~  434 (457)
                      ....  ..++...+..+.+|+.+||+.||.+||++      .+++++  .+++
T Consensus       232 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h--p~f~  280 (345)
T 3a8x_A          232 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH--PFFR  280 (345)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS--GGGT
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC--CccC
Confidence            1111  12333445689999999999999999995      677765  4544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=353.38  Aligned_cols=276  Identities=21%  Similarity=0.321  Sum_probs=204.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----CCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-----QNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-----~~~~~l  227 (457)
                      .++|++.+.||+|+||.||+|+. +++.||+|++....... .....|+..+..++||||+++++.+..     ....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            36788899999999999999987 78999999986543222 112334444556899999999986532     336789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeccCccCceEeCCCCcEEE
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH---------ATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      ||||+++|+|.+++....     .++..++.++.|++.||.|||+.         +   |+||||||+|||++.++.+||
T Consensus        90 v~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred             EEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence            999999999999997643     68899999999999999999998         7   999999999999999999999


Q ss_pred             eeccCccccccccC------CccccccccCCCccccccccC-------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCC
Q 012739          299 TDFGLAKMVSDKIN------GQISTRVLGTTGYLAPEYAST-------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP  365 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~  365 (457)
                      +|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987643211      112234579999999999976       46678999999999999999998887644332


Q ss_pred             Ccc-hhhhhhccccCchhHHhh-hcCCcCCCCC------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          366 GEH-VLVSWALPRLTSREEAVE-MVDPSLQGQY------PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       366 ~~~-~~~~~~~~~~~~~~~~~~-~~d~~l~~~~------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ... .................. .........+      ....+..+.+|+.+||+.||++|||+.|+++.|++++..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            211 111100111111111111 1111111222      23467789999999999999999999999999999998765


Q ss_pred             C
Q 012739          438 A  438 (457)
Q Consensus       438 ~  438 (457)
                      .
T Consensus       322 ~  322 (336)
T 3g2f_A          322 R  322 (336)
T ss_dssp             C
T ss_pred             h
Confidence            5

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=348.66  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=196.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--------------------------HHHHHHHHHHHHHh
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--------------------------RERAFRMEVDLLSR  206 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------------------------~~~~~~~Ei~~l~~  206 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|++......                          ..+.+.+|+++++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            67888999999999999999964 5889999998654211                          12457889999999


Q ss_pred             cCCCCeeeEEEEEEc--CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCc
Q 012739          207 LHSPQLVELLGYCAD--QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK  284 (457)
Q Consensus       207 l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  284 (457)
                      ++||||+++++++.+  .+..++||||+++++|.+++..     .++++.+++.++.|++.||.|||+.+   |+|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            999999999999986  5688999999999999876432     35999999999999999999999999   9999999


Q ss_pred             cCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCC---CCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK---LTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       285 p~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                      |+|||++.++.+||+|||+++......  .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998765421  2234567999999999997655   47889999999999999999999975


Q ss_pred             CCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ....   ...          .....   ...........+..+.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~~~---~~~----------~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          243 ERIM---CLH----------SKIKS---QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSHH---HHH----------HHHHH---CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ccHH---HHH----------HHHhc---ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            3210   000          00000   001001111234579999999999999999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.8e-45  Score=349.24  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-C-------cEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-G-------TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578888999999999999998653 3       4699999977666666779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc--------E
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR--------A  296 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~  296 (457)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            999999999999999998743   24899999999999999999999999   999999999999988887        9


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||++.....      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+........  ..    
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~----  228 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KL----  228 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH----
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HH----
Confidence            9999999875533      223457899999999987 7799999999999999999996655443211100  00    


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                             .... ...    ..+...+.++.+++.+||+.||.+|||+.+++++|++++....
T Consensus       229 -------~~~~-~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          229 -------QFYE-DRH----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             -------HHHH-TTC----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             -------HHhh-ccC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                   0000 011    1111223468899999999999999999999999999887543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=351.73  Aligned_cols=254  Identities=19%  Similarity=0.308  Sum_probs=210.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467889999999999999999975 57889999987553 3445688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC--CCcEEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgl~~~~~~  309 (457)
                      +++|+|.+++....   ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999996543   35899999999999999999999999   999999999999987  78999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ..             ..+..
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~-------------~~i~~  217 (321)
T 1tki_A          157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II-------------ENIMN  217 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH-------------HHHHH
T ss_pred             C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH-------------HHHHc
Confidence            2   22345678999999999999889999999999999999999999997532210   00             01111


Q ss_pred             CcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          390 PSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       390 ~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...  ..+    ...+.++.+|+.+||+.||.+|||+.|++++  +++++.
T Consensus       218 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h--p~~~~~  264 (321)
T 1tki_A          218 AEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH--PWLKQK  264 (321)
T ss_dssp             TCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--HHHHSC
T ss_pred             CCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--hhhccC
Confidence            111  011    1234578999999999999999999999997  666653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.4e-44  Score=342.92  Aligned_cols=254  Identities=29%  Similarity=0.538  Sum_probs=205.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH---HH----HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ---RE----RAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~----~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++......   ..    +.+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67888899999999999999974 6899999998654221   11    56889999999999999999999997665  


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc-----EEEee
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR-----AKVTD  300 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D  300 (457)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+.+ ++++||||||+|||++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            69999999999999887643   35999999999999999999999975 45999999999999988776     99999


Q ss_pred             ccCccccccccCCccccccccCCCccccccc--cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYA--STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL  378 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  378 (457)
                      ||+++....     ......||+.|+|||.+  ....++.++||||||+++|||++|+.||..........         
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---------  238 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------  238 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH---------
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH---------
Confidence            999975433     23456799999999998  45668899999999999999999999997543321100         


Q ss_pred             CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          379 TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       379 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                           .............+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       239 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 -----INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                 1111111222233444556899999999999999999999999999764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-44  Score=345.16  Aligned_cols=261  Identities=24%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             hcCCCCCc-eeccCCcEEEEEEEEc---CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          153 TENFSEGN-VIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       153 ~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|++....  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999643   46789999987653  22346688999999999999999999999 556789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            9999999999999998743    4899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......                 ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~  229 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EV  229 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HH
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HH
Confidence            6443221 11223456788999999988889999999999999999999 99999753221                 11


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ...+........+...+..+.+++.+||+.||.+||++.++++.|++++.+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            111111111223344556899999999999999999999999999999987443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-44  Score=356.67  Aligned_cols=276  Identities=16%  Similarity=0.248  Sum_probs=209.3

Q ss_pred             hcCCCCCceeccC--CcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNG--GFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|++.++||+|  +||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4678889999999  99999999976 68999999986543  3444668889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++.....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999987532  35899999999999999999999999   999999999999999999999999998655


Q ss_pred             ccccC-----CccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh-hhhccccC
Q 012739          308 SDKIN-----GQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV-SWALPRLT  379 (457)
Q Consensus       308 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~  379 (457)
                      .....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............ ....+.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            32211     112233478999999999987  67999999999999999999999999764432211100 00000000


Q ss_pred             chh------------------HHhhhc---------CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          380 SRE------------------EAVEMV---------DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       380 ~~~------------------~~~~~~---------d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ...                  .....+         .......++......+.+|+.+||+.||.+|||+.|++++  .+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h--p~  336 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH--SF  336 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS--GG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC--HH
Confidence            000                  000000         0000011233445689999999999999999999999987  55


Q ss_pred             hhh
Q 012739          433 VKN  435 (457)
Q Consensus       433 ~~~  435 (457)
                      +++
T Consensus       337 f~~  339 (389)
T 3gni_B          337 FKQ  339 (389)
T ss_dssp             GGG
T ss_pred             HHH
Confidence            554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.5e-45  Score=369.67  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=212.8

Q ss_pred             hHHHHHHhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 012739          146 YKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQR---ERAFRMEVDLLSRLHSPQLVELLGYCAD  221 (457)
Q Consensus       146 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~hpniv~l~~~~~~  221 (457)
                      +.++....++|++.++||+|+||+||+|+... ++.||+|++.......   ...+.+|..++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555567899999999999999999999764 7889999986532111   2237889999999999999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      .+..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999998643   24999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |+++...... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||........   ...   
T Consensus       220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~---  292 (437)
T 4aw2_A          220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGK---  292 (437)
T ss_dssp             TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---
T ss_pred             hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHh---
Confidence            9997664322 12234468999999999986     56799999999999999999999999975432110   000   


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHHHhhhh
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~~~~~~  435 (457)
                       +....  ....-+...    ...+.++.+|+.+||..+|++  ||++.|++++  +++++
T Consensus       293 -i~~~~--~~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H--pff~~  344 (437)
T 4aw2_A          293 -IMNHK--ERFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH--PFFSG  344 (437)
T ss_dssp             -HHTHH--HHCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS--GGGTT
T ss_pred             -hhhcc--ccccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC--CccCC
Confidence             00000  011111111    123457899999999998888  9999999998  67654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=357.44  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=205.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            66888999999999999999975 48899999986542   223356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+.+|+|..++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999997643    4999999999999999999999999   99999999999999999999999999987643


Q ss_pred             ccCCccccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .   ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||..............           ..
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----------~~  233 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-----------FE  233 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-----------HH
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-----------Hh
Confidence            2   23456789999999999864   4689999999999999999999999975433221111111           00


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-MTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~  428 (457)
                      ...    ..++...+..+.+|+.+||+.||.+||+ +.+++++
T Consensus       234 ~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          234 TTV----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             HCC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             hcc----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            011    1233344568999999999999999998 7777664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.4e-44  Score=344.73  Aligned_cols=271  Identities=21%  Similarity=0.261  Sum_probs=205.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|+||+||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999975 58899999986542  3334567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++ +|.+++....   ..+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9965 6666665533   25999999999999999999999999   999999999999999999999999999876432


Q ss_pred             cCCccccccccCCCccccccccCCC-CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh-hhhhccccCc--hhHHhh
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL-VSWALPRLTS--REEAVE  386 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~  386 (457)
                        ........||+.|+|||++.+.. ++.++|||||||++|||++|..||........... +.........  ......
T Consensus       155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence              12234567899999999997765 89999999999999999999988754322111000 0000000000  000000


Q ss_pred             hcC---------CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVD---------PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d---------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+         ..............+.+|+.+||+.||++|||+.|++++  +++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~  288 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSD  288 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC--ccccc
Confidence            000         000011122345688999999999999999999999987  66654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-44  Score=354.88  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999975 689999999865421   23356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999998754    3899999999999999999999999   99999999999999999999999999987643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..             ...+..
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~-------------~~~i~~  252 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI-------------YEKIVS  252 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------HHHHHH
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HH-------------HHHHHc
Confidence            2     34567999999999999999999999999999999999999999753211   00             001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                      ..  ..++...+..+.+|+.+||+.||.+||+     +.+|+++
T Consensus       253 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            11  1223334558999999999999999998     8888876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=343.81  Aligned_cols=262  Identities=30%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC-C---cEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE-EEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD-G---TVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR-LLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~-~lv  228 (457)
                      .|...++||+|+||.||+|.+.+ +   ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35566899999999999998643 2   369999987643 34456788999999999999999999999766554 999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+.+|+|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999997643   35899999999999999999999999   9999999999999999999999999998664


Q ss_pred             cccC--CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKIN--GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....  ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+........                ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~  239 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTH  239 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHH
Confidence            4321  1223345678899999999999999999999999999999996666543221110                111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+........+...+..+.+++.+||+.||.+|||+.++++.|++++++...
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            1111111122333445899999999999999999999999999999988654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=345.06  Aligned_cols=264  Identities=23%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEcC----C
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR--LHSPQLVELLGYCADQ----N  223 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~----~  223 (457)
                      ....++|++.+.||+|+||.||+|+.. ++.||+|++.....   ..+..|.+++..  ++||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344578999999999999999999984 89999999864422   233445555554  4999999999999877    7


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEeccCccCceEeCCCCc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH--------ATPPVIHRDFKCSNVLLDQNFR  295 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~ivH~Dlkp~NIll~~~~~  295 (457)
                      ..++||||+++|+|.+++...     .+++..++.++.|++.||.|||+.        +   ++||||||+|||++.++.
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred             ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence            899999999999999999653     489999999999999999999998        7   999999999999999999


Q ss_pred             EEEeeccCccccccccCCc--cccccccCCCccccccccCCCCCcc------cchHHHHHHHHHHHcC----------CC
Q 012739          296 AKVTDFGLAKMVSDKINGQ--ISTRVLGTTGYLAPEYASTGKLTTK------SDVYSYGVVLLELLTG----------RV  357 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDV~SlG~il~elltg----------~~  357 (457)
                      +||+|||+++.........  ......||+.|+|||++.+..++.+      +|||||||++|||+||          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999997664432211  1234579999999999987766665      9999999999999999          45


Q ss_pred             CCCCCCCCCcchhhhhhccccCchhHHhh-hcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 012739          358 PVDPNRPPGEHVLVSWALPRLTSREEAVE-MVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIP  431 (457)
Q Consensus       358 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  431 (457)
                      ||.........            ...... .....+....+     ..++.++.+|+.+||+.||.+|||+.+|+++|++
T Consensus       261 p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          261 PYHDLVPSDPS------------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             TTTTTSCSSCC------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cHhhhcCCCCc------------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            55432221111            011111 11122222232     3678889999999999999999999999999999


Q ss_pred             hhhhcC
Q 012739          432 VVKNNA  437 (457)
Q Consensus       432 ~~~~~~  437 (457)
                      +.+...
T Consensus       329 l~~~~~  334 (337)
T 3mdy_A          329 MSESQD  334 (337)
T ss_dssp             HHHTTT
T ss_pred             HHhhcc
Confidence            988654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.9e-44  Score=351.26  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE----cCCcEEEEEEcccCc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++....    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36788899999999999999997    478999999987642    2233457789999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++++|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999998754    3899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      +.....  ........||+.|+|||++.+..++.++||||||+++|||++|+.||......   ..             .
T Consensus       169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~-------------~  230 (327)
T 3a62_A          169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KT-------------I  230 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH-------------H
T ss_pred             cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HH-------------H
Confidence            754322  12234567999999999999999999999999999999999999999753211   00             0


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVK  434 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~  434 (457)
                      ..+....  ...+......+.+|+.+||+.||.+||     ++.|++++  .+++
T Consensus       231 ~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h--p~f~  281 (327)
T 3a62_A          231 DKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH--PFFR  281 (327)
T ss_dssp             HHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS--GGGS
T ss_pred             HHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC--Cccc
Confidence            0111111  122333455899999999999999999     78888876  5544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.9e-44  Score=345.14  Aligned_cols=262  Identities=28%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCA-DQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~l  227 (457)
                      .+|++.++||+|+||.||+|.+.+    ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457888999999999999998643    2358999887643 344567889999999999999999999864 5567899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....   ..+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            999999999999997643   35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCC--ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          308 SDKING--QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTG-RVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       308 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||..........             ..
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-------------~~  245 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------YL  245 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-------------HH
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------------HH
Confidence            543221  123345678899999999999999999999999999999995 55554332211100             00


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ....    ....+...+..+.+++.+||+.+|.+|||+.++++.|++++.+..+
T Consensus       246 ~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          246 LQGR----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             HTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             hcCC----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            0111    1111223345799999999999999999999999999999987554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=345.71  Aligned_cols=256  Identities=29%  Similarity=0.491  Sum_probs=201.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.+.||+|+||.||+|+. .++.||+|++....  ..+.+.+|+++++.++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            5678889999999999999998 47889999986542  34568899999999999999999998874  4789999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCCeEeccCccCceEeCCCCc-EEEeeccCcccccc
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE---HATPPVIHRDFKCSNVLLDQNFR-AKVTDFGLAKMVSD  309 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgl~~~~~~  309 (457)
                      +|+|.+++..... ...+++..++.++.|+++||.|||+   ++   |+||||||+|||++.++. +||+|||++.....
T Consensus        83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999976432 2347899999999999999999999   66   999999999999988886 79999999976543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........  ...+         .......
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~---------~~~~~~~  222 (307)
T 2eva_A          159 H-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMW---------AVHNGTR  222 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHH---------HHHTTCC
T ss_pred             c-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHH---------HHhcCCC
Confidence            2     2334689999999999999999999999999999999999999975332111  0111         0111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      +.+    +...+..+.+++.+||+.||.+|||+.++++.|+++.+....
T Consensus       223 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          223 PPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             CCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            122    223345799999999999999999999999999999887554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-44  Score=351.49  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN-------  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-------  223 (457)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467888999999999999999976 78999999987543 334466899999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEeCCCCcHHHHHhhhCCCCCCCCH
Q 012739          224 --------------------------------------------------HRLLISEYMPNGTLQQHLHRHNNRYRPLDW  253 (457)
Q Consensus       224 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~  253 (457)
                                                                        ..++||||+++++|.+++..... .....+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              37999999999999999987543 334677


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC----------ccccccccCC
Q 012739          254 RTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING----------QISTRVLGTT  323 (457)
Q Consensus       254 ~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~gt~  323 (457)
                      ..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            789999999999999999999   999999999999999999999999999877543211          1223457999


Q ss_pred             CccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHH
Q 012739          324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQ  403 (457)
Q Consensus       324 ~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  403 (457)
                      .|+|||.+.+..++.++||||||+++|||++|..|+...     .             ......... ............
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~-------------~~~~~~~~~-~~~~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V-------------RIITDVRNL-KFPLLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H-------------HHHHHHHTT-CCCHHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H-------------HHHHHhhcc-CCCcccccCChh
Confidence            999999999999999999999999999999987664310     0             000000010 001111234457


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          404 IAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       404 l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      +.+|+.+||+.||.+|||+.|++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhc
Confidence            8999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=358.16  Aligned_cols=262  Identities=29%  Similarity=0.433  Sum_probs=199.5

Q ss_pred             CCCCCceeccCCcEEEEEEEEcC--C--cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSD--G--TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHRLLI  228 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lv  228 (457)
                      .|.+.+.||+|+||.||+|.+.+  +  ..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            45667899999999999998642  2  36899988654 33455678999999999999999999998754 5678999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999997643   35889999999999999999999999   9999999999999999999999999998664


Q ss_pred             cccCCc--cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          309 DKINGQ--ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       309 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||..........             ...
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-------------~~~  310 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------YLL  310 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-------------HHH
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-------------HHH
Confidence            432111  1233557889999999999999999999999999999999 677776433221110             000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                      ..    .....+..++..+.+++.+||+.+|++|||+.++++.|++++......
T Consensus       311 ~~----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          311 QG----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             TT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             cC----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            00    011122334458999999999999999999999999999999876653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=378.60  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=213.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..++|++.+.||+|+||.||+|.+.++..||||++..... ..+.|.+|+++|+.++||||+++++++.+ +..+|||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3456777889999999999999998888899999976532 34568899999999999999999999876 678999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.+++.....  ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999976422  24899999999999999999999999   9999999999999999999999999998764321


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      . .......++..|+|||.+....++.++||||||++||||+| |+.||.....                 .++...+..
T Consensus       418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~  479 (535)
T 2h8h_A          418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVER  479 (535)
T ss_dssp             H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHHHHHHHT
T ss_pred             e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHc
Confidence            1 11223456788999999998999999999999999999999 9999975321                 111111122


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ......+..++..+.+|+.+||+.||++|||+.+|++.|++++....
T Consensus       480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            22223344556689999999999999999999999999999886543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-44  Score=355.42  Aligned_cols=271  Identities=20%  Similarity=0.257  Sum_probs=208.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCchHHH-----------HHHHHHHHHHHhcCCCCeeeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRE-----------RAFRMEVDLLSRLHSPQLVEL  215 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~hpniv~l  215 (457)
                      .++|++.+.||+|+||.||+|.+..      ++.||+|++........           ..+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999999754      47899999876542211           123346667788899999999


Q ss_pred             EEEEEcC----CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC
Q 012739          216 LGYCADQ----NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD  291 (457)
Q Consensus       216 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  291 (457)
                      ++++...    ...+|||||+ +++|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            9998764    4589999999 999999998743   35999999999999999999999999   99999999999998


Q ss_pred             --CCCcEEEeeccCccccccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          292 --QNFRAKVTDFGLAKMVSDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       292 --~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                        .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998765432211     12345699999999999999999999999999999999999999985322


Q ss_pred             CCcchhhhhhccccCchhHHhhhcCCcCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          365 PGEHVLVSWALPRLTSREEAVEMVDPSLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ...  ........  .......++++.+. ..+    +.++.+++..||+.+|++||++.+|++.|++++++...
T Consensus       267 ~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          267 DPK--YVRDSKIR--YRENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             CHH--HHHHHHHH--HHHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CHH--HHHHHHHH--hhhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            111  11110000  00112222222221 122    34799999999999999999999999999999987443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7e-44  Score=339.73  Aligned_cols=254  Identities=20%  Similarity=0.310  Sum_probs=209.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34678999999999999999999754 67899999876554556678999999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~~  307 (457)
                      |+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999998754    3899999999999999999999999   9999999999999   78899999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...   .......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.......   .             ...+
T Consensus       160 ~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-------------~~~~  219 (277)
T 3f3z_A          160 KPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---V-------------MLKI  219 (277)
T ss_dssp             CTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-------------HHHH
T ss_pred             cCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---H-------------HHHH
Confidence            532   223456799999999998654 8999999999999999999999997532210   0             0000


Q ss_pred             cCCcCCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          388 VDPSLQGQYPK----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       388 ~d~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .....  ..+.    ..+..+.+++.+||+.||.+|||+.+++++  +++++.
T Consensus       220 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h--~~~~~~  268 (277)
T 3f3z_A          220 REGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH--EWFEKQ  268 (277)
T ss_dssp             HHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS--HHHHHH
T ss_pred             HhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC--HHHhcc
Confidence            00000  1111    234589999999999999999999999987  676653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.7e-44  Score=344.81  Aligned_cols=272  Identities=24%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999975 48999999886553  2334567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999998876543    4899999999999999999999999   999999999999999999999999999876532


Q ss_pred             cCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH-H----
Q 012739          311 INGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE-A----  384 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~----  384 (457)
                      .  .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........................ .    
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 S--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2  22344578999999999875 67899999999999999999999999764432221111111111100000 0    


Q ss_pred             -----hhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          385 -----VEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       385 -----~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                           ....++......   ....+..+.+|+.+||+.||.+|||+.|++++  +++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~  291 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH--PYFENI  291 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS--GGGTTC
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC--hHHHhc
Confidence                 000000000000   01234578999999999999999999999987  777764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-44  Score=355.45  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNH  224 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~  224 (457)
                      ....++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            344578999999999999999999975 58899999986542   22334567889999877 99999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|+||||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999998754    3899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      +.....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....          . 
T Consensus       166 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----------~-  229 (345)
T 1xjd_A          166 KENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH----------S-  229 (345)
T ss_dssp             BCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----------H-
T ss_pred             hhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH----------H-
Confidence            864322  12245578999999999999999999999999999999999999999753221   0000          0 


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMT-DVVQS  428 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~~  428 (457)
                      .....+    .++......+.+|+.+||+.||.+||++. +++++
T Consensus       230 i~~~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          230 IRMDNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HHHCCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHhCCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            001111    22333455899999999999999999998 77654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-44  Score=356.19  Aligned_cols=273  Identities=23%  Similarity=0.323  Sum_probs=210.7

Q ss_pred             eechHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----CCCeeeEE
Q 012739          143 VFTYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----SPQLVELL  216 (457)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----hpniv~l~  216 (457)
                      .+++.+.....++|.+.++||+|+||.||+|... +++.||+|++... ....+.+..|+.+++.+.     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3455555566789999999999999999999974 6889999999654 334456778999999996     99999999


Q ss_pred             EEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC----
Q 012739          217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ----  292 (457)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----  292 (457)
                      +++...+..++||||+ +++|.+++.....  ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.    
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            9999999999999999 9999999987543  35899999999999999999999999   999999999999975    


Q ss_pred             ---------------------CCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHH
Q 012739          293 ---------------------NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLE  351 (457)
Q Consensus       293 ---------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~e  351 (457)
                                           ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999864432     345678999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh--------hcC-CcCCCCCC--------------------HHHHH
Q 012739          352 LLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE--------MVD-PSLQGQYP--------------------KKDLI  402 (457)
Q Consensus       352 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~d-~~l~~~~~--------------------~~~~~  402 (457)
                      |++|+.||...................... ....        .++ ..+...++                    .....
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKN-MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHH-HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHH-HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            999999997643221111111111111000 0000        000 00000000                    01125


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          403 QIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       403 ~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .+.+|+.+||+.||.+|||+.|++++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            78899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=376.68  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             CCCCc-eeccCCcEEEEEEEEc---CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          156 FSEGN-VIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       156 ~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      +.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+++|+.++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33334 7999999999999864   45679999997653 3345678999999999999999999999976 56899999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++|+|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       416 ~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             CCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999997543   35999999999999999999999999   999999999999999999999999999876433


Q ss_pred             cCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          311 ING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       311 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||......                 ++...+
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------~~~~~i  552 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFI  552 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----------------HHHHHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHH
Confidence            211 11223345689999999999999999999999999999998 99999754321                 111222


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ........+..++..+.+|+.+||+.+|++||++.+|++.|+.++...+.
T Consensus       553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            22222344455667899999999999999999999999999999887554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.5e-44  Score=339.45  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=210.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999975 68899999986442 3344668899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++...    ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999988653    34899999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+.              .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~--------------~  223 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK--------------E  223 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHH--------------T
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhh--------------h
Confidence            32233445678999999999987765 78999999999999999999999754332111 11110              0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...........+..+.+++.+||+.||.+|||+.|++++  .++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~~~  268 (276)
T 2yex_A          224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD--RWYNKP  268 (276)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--TTTTCC
T ss_pred             cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC--ccccCh
Confidence            000001112334578999999999999999999999986  555543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.5e-45  Score=366.23  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=209.8

Q ss_pred             HHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 012739          148 ELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSPQLVELLGYCADQN  223 (457)
Q Consensus       148 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~  223 (457)
                      ++....++|.+.++||+|+||.||+|+.. +++.||+|++......   ..+.+.+|+.+++.++||||++++++|.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999975 5889999998653211   1234778999999999999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..|+||||+++|+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999753     3899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCC----CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGK----LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT  379 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  379 (457)
                      ++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||........   ..    .+.
T Consensus       215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~----~i~  286 (410)
T 3v8s_A          215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS----KIM  286 (410)
T ss_dssp             CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH----HHH
T ss_pred             eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HH----HHH
Confidence            98764321 12234578999999999997655    88999999999999999999999975332110   00    000


Q ss_pred             chhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHHHhhhh
Q 012739          380 SREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAY--RPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       380 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~~~~~~  435 (457)
                      ....  . +.  +  ......+.++.+|+.+||+.+|.+  ||++.||+++  .++++
T Consensus       287 ~~~~--~-~~--~--p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H--p~f~~  335 (410)
T 3v8s_A          287 NHKN--S-LT--F--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH--LFFKN  335 (410)
T ss_dssp             THHH--H-CC--C--CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS--GGGCC
T ss_pred             hccc--c-cc--C--CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC--ccccC
Confidence            0000  0 00  0  001123457999999999999998  9999999998  66664

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=356.18  Aligned_cols=252  Identities=20%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          159 GNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      .+.||+|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999964 6899999999877666667799999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe--CCCCcEEEeeccCccccccccCCcc
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKINGQI  315 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgl~~~~~~~~~~~~  315 (457)
                      .+++....   ..+++.+++.++.|++.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++......   .
T Consensus       174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            99987643   24899999999999999999999999   9999999999999  677899999999998765432   2


Q ss_pred             ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCC
Q 012739          316 STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQ  395 (457)
Q Consensus       316 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  395 (457)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...          ..... ...+...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~----------~i~~~-~~~~~~~  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLN----------NILAC-RWDLEDE  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----------HHHHT-CCCSCSG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------HHHhc-cCCCChh
Confidence            334569999999999999999999999999999999999999997542210   000          00000 0000001


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          396 YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       396 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .......++.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h--p~~~~  348 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH--PWLSD  348 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--HHHHC
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cCcCC
Confidence            111234579999999999999999999999986  55544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-44  Score=351.76  Aligned_cols=269  Identities=24%  Similarity=0.295  Sum_probs=208.9

Q ss_pred             HHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 012739          148 ELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-----GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD  221 (457)
Q Consensus       148 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~  221 (457)
                      .+....++|++.+.||+|+||.||+|... ++..||+|++...     .....+.+.+|+++++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34667788999999999999999999974 5788999988643     22344678899999999999999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNNR------------------------------------YRPLDWRTRLIIALDCAM  265 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~  265 (457)
                      .+..++||||+++|+|.+++......                                    ...+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998531100                                    112457788899999999


Q ss_pred             HHHHHHhcCCCCeEeccCccCceEeCCCC--cEEEeeccCccccccccCCc--cccccccCCCccccccccC--CCCCcc
Q 012739          266 ALEFLHEHATPPVIHRDFKCSNVLLDQNF--RAKVTDFGLAKMVSDKINGQ--ISTRVLGTTGYLAPEYAST--GKLTTK  339 (457)
Q Consensus       266 ~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~  339 (457)
                      ||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+.......  ......||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998776  89999999998764422211  2345679999999999865  678999


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCC--CCCHHHHHHHHHHHHhhcCCCCC
Q 012739          340 SDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG--QYPKKDLIQIAAIAAVCVQPEAA  417 (457)
Q Consensus       340 sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~~p~  417 (457)
                      +||||||+++|||++|+.||.......                ....+.......  .........+.+|+.+||+.+|.
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD----------------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999997533210                111111111111  11112345799999999999999


Q ss_pred             CCCCHHHHHHHHHHhhhhcC
Q 012739          418 YRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       418 ~RPs~~evl~~L~~~~~~~~  437 (457)
                      +||++.+++++  +++++..
T Consensus       321 ~Rps~~~~l~h--p~~~~~~  338 (345)
T 3hko_A          321 ERFDAMRALQH--PWISQFS  338 (345)
T ss_dssp             TSCCHHHHHHS--HHHHTTS
T ss_pred             HCCCHHHHhcC--hhhccCh
Confidence            99999999997  7777644

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.2e-43  Score=336.22  Aligned_cols=262  Identities=20%  Similarity=0.298  Sum_probs=212.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999975 5889999998654  3344466889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc---EEEeeccCccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGLAKM  306 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl~~~  306 (457)
                      ||+++++|.+++....    .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999999988764    4899999999999999999999999   999999999999976655   99999999976


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....   .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ...          ....
T Consensus       158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~----------~~~~  221 (284)
T 3kk8_A          158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA----------QIKA  221 (284)
T ss_dssp             CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----------HHHH
T ss_pred             cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHH----------HHHh
Confidence            6432   22344679999999999999999999999999999999999999997532210   000          0000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                       .............+..+.+++.+||+.||++|||+.|++++  +++++...-+
T Consensus       222 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~~~~~~  272 (284)
T 3kk8_A          222 -GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV--PWICNRERVA  272 (284)
T ss_dssp             -TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS--HHHHSCCCGG
T ss_pred             -ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC--ccccCChhHH
Confidence             00001111112234579999999999999999999999998  8888765533

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=352.38  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=195.6

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567899999999999999999976 47889999987543  33557889999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl~~~~  307 (457)
                      |+++++|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999997643    4899999999999999999999999   999999999999975   889999999999866


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....          .....
T Consensus       202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~----------~i~~~  266 (349)
T 2w4o_A          202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFR----------RILNC  266 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHH----------HHHTT
T ss_pred             Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHH----------HHHhC
Confidence            432   22345679999999999999999999999999999999999999997543210  0000          00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                       ............+..+.+|+.+||+.||++|||+.|++++  +++.+..
T Consensus       267 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~~~~  313 (349)
T 2w4o_A          267 -EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH--PWVTGKA  313 (349)
T ss_dssp             -CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTTSTT
T ss_pred             -CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC--cccCCCc
Confidence             0011111222345589999999999999999999999987  6666543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-44  Score=350.71  Aligned_cols=262  Identities=27%  Similarity=0.413  Sum_probs=197.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----e
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----H  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~  224 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   .......+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788999999999999999996 56889999999764   2333456889999999999999999999987654    3


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++++|.+++....    ++++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999998754    4899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          305 KMVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       305 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      +........ .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........  ....          
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~----------  231 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQH----------  231 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH----------
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH----------
Confidence            876543221 223345789999999999999999999999999999999999999975332100  0000          


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH-HHHHhhhh
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ-SLIPVVKN  435 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~-~L~~~~~~  435 (457)
                      ...  ............+.++.+++.+||+.||++||++.++++ .|.++...
T Consensus       232 ~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          232 VRE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHC--CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             hcC--CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            000  000000001123457999999999999999997666554 45454443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-43  Score=344.36  Aligned_cols=265  Identities=25%  Similarity=0.392  Sum_probs=212.3

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC---
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSR--LHSPQLVELLGYCADQN---  223 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~---  223 (457)
                      -....++|.+.+.||+|+||.||+|+. +++.||+|++....   ...+.+|.+++..  ++||||+++++++....   
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            345567899999999999999999998 58999999986432   3456778888887  79999999999998876   


Q ss_pred             -eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCccCceEeCCCC
Q 012739          224 -HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH--------EHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       224 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                       ..++||||+++|+|.+++...     .+++.+++.++.|++.||.|||        +.+   |+||||||+|||++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence             789999999999999999763     4899999999999999999999        777   99999999999999999


Q ss_pred             cEEEeeccCccccccccCCc--cccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcC----------C
Q 012739          295 RAKVTDFGLAKMVSDKINGQ--ISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTG----------R  356 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg----------~  356 (457)
                      .+||+|||++..........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998765432211  23445799999999998765      344789999999999999999          6


Q ss_pred             CCCCCCCCCCcchhhhhhccccCchhHHh-hhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          357 VPVDPNRPPGEHVLVSWALPRLTSREEAV-EMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       357 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      .||..........            .... ......+....+     .++...+.+|+.+||+.||++|||+.+|+++|+
T Consensus       265 ~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          265 LPYYDLVPSDPSV------------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CTTTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cCccccCcCcccH------------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            6776433221110            1111 111222222222     366788999999999999999999999999999


Q ss_pred             HhhhhcC
Q 012739          431 PVVKNNA  437 (457)
Q Consensus       431 ~~~~~~~  437 (457)
                      ++.++..
T Consensus       333 ~i~~~~~  339 (342)
T 1b6c_B          333 QLSQQEG  339 (342)
T ss_dssp             HHHHTTC
T ss_pred             HHHHHhc
Confidence            9988753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-43  Score=337.29  Aligned_cols=256  Identities=29%  Similarity=0.453  Sum_probs=208.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|... ++..||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467888999999999999999875 477899999865422   1235688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998764    3899999999999999999999999   9999999999999999999999999986543


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .           ......
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-----------~~~~~~  222 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y-----------KRISRV  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-----------HHHHHT
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---H-----------HHHHhC
Confidence            32    23445789999999999999999999999999999999999999975322100   0           001111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                      ..    ..+......+.+|+.+||+.+|.+|||+.|++++  .++++....
T Consensus       223 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~~~~~  267 (279)
T 3fdn_A          223 EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITANSSK  267 (279)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHHHCSS
T ss_pred             CC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC--ccccCCccC
Confidence            11    2233344578999999999999999999999998  888876553

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-44  Score=353.19  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=205.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~  226 (457)
                      ..++|++.+.||+|+||.||+|+... ++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34689999999999999999999764 7889999986542   12335577899999888 8999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999998754    3999999999999999999999999   99999999999999999999999999986


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..             ...
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~-------------~~~  232 (353)
T 2i0e_A          171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL-------------FQS  232 (353)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------HHH
T ss_pred             cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HH-------------HHH
Confidence            4321  12345578999999999999999999999999999999999999999753211   00             011


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                      +....  ..++...+.++.+|+.+||+.||.+||+     +.+++++
T Consensus       233 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          233 IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  1233344568999999999999999995     5777776

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-44  Score=341.68  Aligned_cols=253  Identities=29%  Similarity=0.448  Sum_probs=202.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-CeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-NHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||.||++.. .++.||+|.+....  ..+.+.+|+.+++.++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788899999999999999987 58899999997653  345688999999999999999999997554 478999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            999999999976432  23789999999999999999999999   999999999999999999999999998765432 


Q ss_pred             CCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                          .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......                 .....+..
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~  229 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEK  229 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTT
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhc
Confidence                223457889999999998999999999999999999998 99999753221                 11111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ......+...+..+.+++.+||+.||.+||++.++++.|+++..+
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            122233334456899999999999999999999999999988664

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-44  Score=341.37  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=203.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            356888999999999999999974 58899999986553 2334678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~~  307 (457)
                      |+++|+|.+++.........+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999999765433456999999999999999999999999   9999999999999   55688999999999865


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...   .......||+.|+|||.+. ..++.++||||||+++|||++|+.||.........              .....
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--------------~~~~~  239 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--------------QKATY  239 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------------HHHHH
T ss_pred             CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--------------hhhcc
Confidence            432   2234567899999999885 56899999999999999999999999753221000              00111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+...... ......+.+|+.+||+.||++|||+.|++++  +++++
T Consensus       240 ~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h--p~f~~  284 (285)
T 3is5_A          240 KEPNYAVEC-RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH--EWFKQ  284 (285)
T ss_dssp             CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS--GGGGC
T ss_pred             CCccccccc-CcCCHHHHHHHHHHccCChhhCcCHHHHhcC--HHhhc
Confidence            111111110 1123478899999999999999999999986  55543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=352.38  Aligned_cols=275  Identities=25%  Similarity=0.370  Sum_probs=215.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-----cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--eE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-----SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN--HR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~  225 (457)
                      ..+|++.+.||+|+||.||++.+     .+++.||+|++........+.+.+|+++++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999984     358899999998776666678999999999999999999999986644  78


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999987542   4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC---ch
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT---SR  381 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~  381 (457)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+||..||.....    ...........   ..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhH
Confidence            76543221 112334567789999999988899999999999999999999999863210    00000000000   00


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ....+.+........+..++.++.+++.+||+.||.+|||+.++++.|+++.++.+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11112222222222344455689999999999999999999999999999887643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.4e-44  Score=349.10  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=195.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--------cC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCA--------DQ  222 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~--------~~  222 (457)
                      ..+|++.++||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999964 68999999987776666777899999999996 999999999984        34


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      ...++||||+. |+|.+++..... ..++++.+++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            45799999995 799999876332 235999999999999999999999875 349999999999999999999999999


Q ss_pred             CccccccccCCc----------cccccccCCCccccccc---cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch
Q 012739          303 LAKMVSDKINGQ----------ISTRVLGTTGYLAPEYA---STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV  369 (457)
Q Consensus       303 l~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~  369 (457)
                      ++..........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||.......   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            998765422111          11245689999999998   56778999999999999999999999997432210   


Q ss_pred             hhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                                       ..........+......+.+|+.+||+.||.+|||+.|++++|+++........
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~  314 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP  314 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence                             001111111111122358899999999999999999999999999988655433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=356.68  Aligned_cols=277  Identities=21%  Similarity=0.315  Sum_probs=216.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--eEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN--HRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~lv  228 (457)
                      ..+|.+.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357888999999999999999976 48999999987543 223456788999999999999999999998755  78999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe----CCCCcEEEeeccCc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKVTDFGLA  304 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgl~  304 (457)
                      |||+++|+|.+++..... ...+++.+++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999976432 234899999999999999999999999   9999999999999    78888999999999


Q ss_pred             cccccccCCccccccccCCCccccccccC--------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh-hhhhc
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAST--------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL-VSWAL  375 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~-~~~~~  375 (457)
                      +......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........... .....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            8765432   2344679999999999864        5678899999999999999999999975443221111 10000


Q ss_pred             cccCc---------hhHHhhhc-CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          376 PRLTS---------REEAVEMV-DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       376 ~~~~~---------~~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .....         ........ +.......+......+.+++.+||+.||++||++.++++.|++++.+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            00000         00000000 001122445778889999999999999999999999999999998863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.3e-44  Score=350.56  Aligned_cols=246  Identities=27%  Similarity=0.411  Sum_probs=201.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +.|...+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999996 568899999986542   333456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+. |+|.+++....   .++++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9996 68888886543   35899999999999999999999999   99999999999999999999999999986543


Q ss_pred             ccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                            .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.......   ..          .....
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~----------~~~~~  267 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL----------YHIAQ  267 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----------HHHHH
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HH----------HHHHh
Confidence                  23457999999999984   5778999999999999999999999997532110   00          01111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...+.+   .+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus       268 ~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             SCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            111111   112234578999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=338.60  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=187.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688899999999999999997 46899999998654221   2356889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....   .++++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999997643   35899999999999999999999999   99999999999999999999999999987643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........                ....
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~~  226 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------KVVL  226 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCS
T ss_pred             CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------HHhh
Confidence            21  12234568999999999999899999999999999999999999997543221100                0000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ...  ..+...+..+.+++.+||+.||++|||+.+++++  .++.+..
T Consensus       227 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~~~  270 (278)
T 3cok_A          227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH--PFMSRNS  270 (278)
T ss_dssp             SCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--TTTC---
T ss_pred             ccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC--ccccCCC
Confidence            000  1222344578999999999999999999999987  6665543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.2e-44  Score=376.86  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=204.4

Q ss_pred             ceeccCCcEEEEEEEEc---CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|+++|+.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   46789999997643  2335678999999999999999999999975 457899999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC-
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING-  313 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~-  313 (457)
                      |+|.+++....    .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999997643    4899999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....                 .++...+....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGE  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence            22333456789999999999999999999999999999998 9999975322                 11222222222


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ....+..++.++.+|+..||+.||++||++.+|++.|+++..+.
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            33444556678999999999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=350.45  Aligned_cols=259  Identities=18%  Similarity=0.215  Sum_probs=212.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEE------EcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGV------LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH---SPQLVELLGYCADQ  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~  222 (457)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|++.....   ..+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45678899999999999999994      44688999999976543   34667778887776   89999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---------
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNN-RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---------  292 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---------  292 (457)
                      +..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            999999999999999999986432 2346999999999999999999999999   999999999999998         


Q ss_pred             --CCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh
Q 012739          293 --NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL  370 (457)
Q Consensus       293 --~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~  370 (457)
                        ++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+||+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999987654434444566789999999999999999999999999999999999999986432210    


Q ss_pred             hhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHHHHhhhhcCC
Q 012739          371 VSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYR-PLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~evl~~L~~~~~~~~~  438 (457)
                        +             .....+. .++  ....+.+++..|++.+|.+| |+++++.+.|++++.+...
T Consensus       293 --~-------------~~~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          293 --C-------------KPEGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             --E-------------EECSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             --e-------------eechhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence              0             0111111 111  24467889999999999999 6899999999999987543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.1e-44  Score=342.40  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=205.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCA--DQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~l  227 (457)
                      .++|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888999999999999999975 6899999998654  2344566889999999999999999999874  4678999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA--TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.+  ..+++||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999876544456999999999999999999999976  2349999999999999999999999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ......  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   ...          ....
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----------~~i~  229 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----------GKIR  229 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----------HHHH
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH----------HHHh
Confidence            664321  1223456899999999999989999999999999999999999999753210   000          0111


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL  429 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  429 (457)
                      ....    ...+...+..+.+++.+||+.+|.+||++.|+++++
T Consensus       230 ~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          230 EGKF----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             hccc----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1111    122333455899999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-43  Score=346.65  Aligned_cols=255  Identities=22%  Similarity=0.324  Sum_probs=185.9

Q ss_pred             CceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          159 GNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .+.||+|+||.||+|... +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 5899999998643   2345678999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC---cEEEeeccCccccccccCC
Q 012739          237 LQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF---RAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       237 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl~~~~~~~~~~  313 (457)
                      |.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+++.....  .
T Consensus        93 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~  163 (325)
T 3kn6_A           93 LFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N  163 (325)
T ss_dssp             HHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence            999998753    4999999999999999999999999   99999999999997665   8999999999865432  2


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh-hcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE-MVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l  392 (457)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........          ...+... +.....
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------~~~~~~~~i~~~~~  233 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT----------SAVEIMKKIKKGDF  233 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC----------CHHHHHHHHTTTCC
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc----------cHHHHHHHHHcCCC
Confidence            22345678999999999999999999999999999999999999998543321100          0011111 111111


Q ss_pred             C--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          393 Q--GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       393 ~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .  .......+.++.+|+.+||+.||.+|||+.|++++  +++++..
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h--~w~~~~~  278 (325)
T 3kn6_A          234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN--EWLQDGS  278 (325)
T ss_dssp             CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC--GGGCTTC
T ss_pred             CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC--hhhccCc
Confidence            1  11112345689999999999999999999999987  7777643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-43  Score=362.38  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=208.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999975 689999999865421   22356889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999997533    4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .   ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......   .             ...+.
T Consensus       169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~-------------~~~i~  229 (476)
T 2y94_A          169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L-------------FKKIC  229 (476)
T ss_dssp             T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H-------------HHHHH
T ss_pred             c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H-------------HHHHh
Confidence            2   22445679999999999988766 689999999999999999999997543210   0             01111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +...  ..+......+.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       230 ~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h--p~~~~  272 (476)
T 2y94_A          230 DGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH--EWFKQ  272 (476)
T ss_dssp             TTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC--HHHHT
T ss_pred             cCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC--HHhhh
Confidence            1111  1222234578999999999999999999999987  66654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=360.27  Aligned_cols=268  Identities=23%  Similarity=0.292  Sum_probs=211.2

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHSPQLVELLGYCA  220 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~  220 (457)
                      .+++.....++|++.++||+|+||.||+++.. +++.||+|++......   ..+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34445556688999999999999999999975 6899999999653211   2234788999999999999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                      +.+..|+||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999987542   4899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCcccccccc-------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYAS-------TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~  373 (457)
                      ||+++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||........   .. 
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~-  280 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YG-  280 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH-
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HH-
Confidence            999987644211 1233468999999999987       46789999999999999999999999975432110   00 


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHHHHHhhhh
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYR---PLMTDVVQSLIPVVKN  435 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~evl~~L~~~~~~  435 (457)
                         .+.....  ....+..    +...+.++.+|+.+||. +|.+|   |++.|++++  .++++
T Consensus       281 ---~i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H--pff~~  333 (412)
T 2vd5_A          281 ---KIVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH--PFFFG  333 (412)
T ss_dssp             ---HHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS--GGGTT
T ss_pred             ---HHHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC--CCcCC
Confidence               0000000  0101111    12234589999999999 99988   589999887  66653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-43  Score=348.58  Aligned_cols=260  Identities=21%  Similarity=0.324  Sum_probs=207.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......    ..+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999975 5889999999665322    34588888887 7999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC----CcEEEeeccCcc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN----FRAKVTDFGLAK  305 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl~~  305 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||+..+    +.+||+|||+++
T Consensus        96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999997643    4999999999999999999999999   9999999999998443    359999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............           .
T Consensus       169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----------i  235 (342)
T 2qr7_A          169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-----------I  235 (342)
T ss_dssp             ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH-----------H
T ss_pred             cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH-----------H
Confidence            764432  223456789999999999888899999999999999999999999975322111111100           0


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ..-...+...+....+..+.+|+.+||+.||++|||+.+++++  .++.++.
T Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h--p~~~~~~  285 (342)
T 2qr7_A          236 GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH--PWIVHWD  285 (342)
T ss_dssp             HHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS--HHHHTGG
T ss_pred             ccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC--CeecCcc
Confidence            0011112222233445689999999999999999999999997  7776543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.5e-44  Score=339.90  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--------
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--------  221 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------  221 (457)
                      ....+|++.+.||+|+||.||+|... +++.||+|++....    ..+.+|+++++.++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34567899999999999999999986 68999999997653    245679999999999999999998854        


Q ss_pred             --------CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC
Q 012739          222 --------QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN  293 (457)
Q Consensus       222 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  293 (457)
                              ....++||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+|||++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                    4457999999999999999976432  35899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh
Q 012739          294 FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       294 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~  373 (457)
                      +.+||+|||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....          
T Consensus       159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------  225 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------  225 (284)
T ss_dssp             TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred             CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence            999999999998765432   2334568999999999999999999999999999999999998864210          


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                              .......+..+...+    +..+.+++.+||+.||.+|||+.|++++|..+.+..+
T Consensus       226 --------~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 --------KFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --------HHHHHHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --------HHHHHhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                    000111111222223    3478899999999999999999999999988876544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-43  Score=338.54  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=204.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467899999999999999999976 6899999998754  234455678899999999 99999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC--------------
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN--------------  293 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--------------  293 (457)
                      ||||+++++|.+++.........+++.+++.++.|++.||.|||+++   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999875433346899999999999999999999999   9999999999999844              


Q ss_pred             -----CcEEEeeccCccccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCc
Q 012739          294 -----FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE  367 (457)
Q Consensus       294 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~  367 (457)
                           ..+||+|||++......      ....||+.|+|||.+.+. .++.++||||||+++|+|++|..|+....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                 47999999999876542      234589999999999765 66789999999999999999998764211    


Q ss_pred             chhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          368 HVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ..           ........+    ..+...+..+.+++.+||+.||++|||+.+++++  +++++
T Consensus       236 -~~-----------~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h--~~~~~  285 (289)
T 1x8b_A          236 -QW-----------HEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH--SVLLS  285 (289)
T ss_dssp             -HH-----------HHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC--TTC--
T ss_pred             -HH-----------HHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC--hHhhh
Confidence             00           011111111    2233344589999999999999999999999987  55543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-43  Score=341.12  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=201.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999975 68899999987542   22336688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999998754    4899999999999999999999999   9999999999999999999999999987664


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      .... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......   ....          ......
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----------~~~~~~  251 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGA----------HINQAI  251 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHH----------HHHSCC
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHH----------HhccCC
Confidence            4321 2233456899999999999999999999999999999999999999753211   0000          000000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHhhhhcCC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-LMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~~~~  438 (457)
                      ..  ....+...+..+.+++.+||+.||++|| ++.++++.|++++.....
T Consensus       252 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          252 PR--PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             CC--GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             CC--ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            00  0012223344799999999999999999 999999999998877543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.9e-43  Score=335.10  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=213.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            366888899999999999999976 4788999988654   233446688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999987654    4899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......                ......
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~  228 (294)
T 2rku_A          167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------------TYLRIK  228 (294)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHH
T ss_pred             cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHh
Confidence            321  22344678999999999999999999999999999999999999997532110                001111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCCc
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGA  440 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  440 (457)
                      ....  ..+......+.+++.+||+.||++|||+.+++++  .++.+...++
T Consensus       229 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~--~~~~~~~~~~  276 (294)
T 2rku_A          229 KNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSGYIPA  276 (294)
T ss_dssp             TTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTSCCCS
T ss_pred             hccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC--hheecCCcCC
Confidence            1111  1223334578999999999999999999999997  7777655543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9e-43  Score=334.98  Aligned_cols=267  Identities=21%  Similarity=0.299  Sum_probs=210.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC-ADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46789999999999999999996 5789999998865432  23578899999999988766655554 66778899999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~~  307 (457)
                      |+ +++|.+++....   ..+++.+++.++.|++.||.|||+++   ++||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 999999997543   25999999999999999999999999   9999999999999   48899999999999876


Q ss_pred             ccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          308 SDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       308 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||................      .
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~  232 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------E  232 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH------H
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc------c
Confidence            5432211     1245679999999999999999999999999999999999999998644322211111100      0


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .......+.+...+    +..+.+++.+||+.||.+|||+.+|++.|++++.+...
T Consensus       233 ~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          233 KKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHSCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccCCchHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            00000000111223    34799999999999999999999999999999988654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-43  Score=340.96  Aligned_cols=258  Identities=22%  Similarity=0.356  Sum_probs=208.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467889999999999999999975 689999999976654455678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~~  307 (457)
                      |+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999997754    4899999999999999999999999   9999999999999   78899999999998754


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   ....          .....
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----------~i~~~  222 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----------KIKEG  222 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----------HHHHC
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----------HHHcC
Confidence            322    233456899999999999999999999999999999999999999753221   0000          00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                       ...+........+..+.+++.+||+.||++|||+.+++++  .++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~~  268 (304)
T 2jam_A          223 -YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH--PWIDGN  268 (304)
T ss_dssp             -CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS--HHHHSS
T ss_pred             -CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--ccccCC
Confidence             0011112222344589999999999999999999999987  566543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.6e-43  Score=336.25  Aligned_cols=268  Identities=20%  Similarity=0.291  Sum_probs=207.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYC-ADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~~lv~  229 (457)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+++++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 5688999998654321  23477899999999987766666655 6778889999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKM  306 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~  306 (457)
                      ||+ +++|.+++.....   .+++.+++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999 9999999975432   4999999999999999999999999   9999999999999   7899999999999987


Q ss_pred             cccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          307 VSDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       307 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||................      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------  231 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------  231 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH------
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh------
Confidence            6543221     12335679999999999999999999999999999999999999998654332221111100      


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ........+.+...+    +..+.+++.+||+.+|++|||+.++++.|++++++...
T Consensus       232 ~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHHSCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cccccchhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            000000000011122    34799999999999999999999999999999987553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-43  Score=362.18  Aligned_cols=275  Identities=20%  Similarity=0.249  Sum_probs=192.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----CCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-----QNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-----~~~  224 (457)
                      .++|++.++||+|+||.||+|... +++.||||++...  .....+.+.+|+++|+.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999865 6899999998653  34445678899999999999999999999843     357


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|+||||+ +++|.+++....    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 679999987543    4999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC-------------------------ccccccccCCCccccccc-cCCCCCcccchHHHHHHHHHHHc----
Q 012739          305 KMVSDKING-------------------------QISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLT----  354 (457)
Q Consensus       305 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~SlG~il~ellt----  354 (457)
                      +........                         ...+..+||+.|+|||++ ....++.++|||||||+||||+|    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            876432211                         123456789999999976 56679999999999999999999    


Q ss_pred             -------CCCCCCCCCCCCcc-----------------hh---hhhhcc--------ccCc--hhHHhhhcCCcCCC---
Q 012739          355 -------GRVPVDPNRPPGEH-----------------VL---VSWALP--------RLTS--REEAVEMVDPSLQG---  394 (457)
Q Consensus       355 -------g~~p~~~~~~~~~~-----------------~~---~~~~~~--------~~~~--~~~~~~~~d~~l~~---  394 (457)
                             |+++|.+.......                 ..   +.....        .+..  .......+......   
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   55555433210000                 00   000000        0000  00000001000000   


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          395 QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       395 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ........++.+|+.+||+.||++|||+.|++++  .++++..
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H--p~f~~~~  404 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH--PFFKEVR  404 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTTC
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC--HhhhhcC
Confidence            0111235578999999999999999999999998  8887643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-44  Score=364.55  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.++||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357889999999999999999964 5889999998653   223335577899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++..
T Consensus       227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999997754    48999999999999999999998 88   999999999999999999999999999864


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...             ..+
T Consensus       300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~-------------~~i  361 (446)
T 4ejn_A          300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF-------------ELI  361 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHH
T ss_pred             cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH-------------HHH
Confidence            322  22345578999999999999999999999999999999999999999753221   000             000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVK  434 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~  434 (457)
                      ....  ..++......+.+|+.+||+.||.+||     ++.|++++  .+++
T Consensus       362 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h--p~f~  409 (446)
T 4ejn_A          362 LMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH--RFFA  409 (446)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS--GGGT
T ss_pred             HhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC--cccc
Confidence            0111  122333455899999999999999999     99999986  4544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-43  Score=350.83  Aligned_cols=272  Identities=22%  Similarity=0.345  Sum_probs=210.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357889999999999999999975 6889999998765 33445668899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++.....
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999998754    389999999999999999999996 8   99999999999999999999999999976543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh---------------
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA---------------  374 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~---------------  374 (457)
                      .    ......||+.|+|||++.+..++.++||||||+++|||++|+.||...............               
T Consensus       185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            2    233457899999999999999999999999999999999999999754321100000000               


Q ss_pred             ----------ccccCchhHHh-hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          375 ----------LPRLTSREEAV-EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       375 ----------~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                                ........... ...........+...+.++.+|+.+||+.||.+|||+.|++++  .++++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~~  332 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH--AFIKRSD  332 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS--HHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhhcch
Confidence                      00000000000 0000011111112234579999999999999999999999998  7777643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.9e-44  Score=353.88  Aligned_cols=245  Identities=26%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDL-LSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++....   ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357888999999999999999975 47889999986543   2223445566665 577899999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999999998754    4899999999999999999999999   999999999999999999999999999864


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .             ....+
T Consensus       190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~-------------~~~~i  251 (373)
T 2r5t_A          190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---E-------------MYDNI  251 (373)
T ss_dssp             BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---H-------------HHHHH
T ss_pred             ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H-------------HHHHH
Confidence            322  22345678999999999999999999999999999999999999999753211   0             01111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD  424 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  424 (457)
                      +...+  .++......+.+|+.+||+.||.+||++.+
T Consensus       252 ~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          252 LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             Hhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            11111  222334457999999999999999999853

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-43  Score=343.71  Aligned_cols=252  Identities=20%  Similarity=0.307  Sum_probs=205.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH------HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ------RERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            466889999999999999999975 5889999988654221      245688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  301 (457)
                      ++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999997643    4899999999999999999999999   99999999999999888    7999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++.......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......   .....        
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~--------  229 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLAN--------  229 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH--------
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHH--------
Confidence            9998765421   234457999999999999999999999999999999999999999753211   00000        


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                        ... ....+........+..+.+|+.+||+.||++|||+.|++++
T Consensus       230 --i~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          230 --ITS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --HHh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              000 00000000011233578999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-43  Score=351.08  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             cCCCCC-ceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHH-HhcCCCCeeeEEEEEEc----CCeEE
Q 012739          154 ENFSEG-NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLL-SRLHSPQLVELLGYCAD----QNHRL  226 (457)
Q Consensus       154 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~----~~~~~  226 (457)
                      ++|.+. ++||+|+||+||++... +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    .+..|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999975 5889999998643     2456788876 45589999999998865    56789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccC
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGL  303 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  303 (457)
                      |||||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999976432  35899999999999999999999999   999999999999987   78999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ++.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............          ..
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----------~~  277 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KT  277 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----------HH
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----------HH
Confidence            9865432   2234567899999999999999999999999999999999999999764432110000          00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....-...+........+.++.+|+.+||+.||++|||+.|++++  .++.+
T Consensus       278 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h--p~~~~  327 (400)
T 1nxk_A          278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH--PWIMQ  327 (400)
T ss_dssp             HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--HHHHT
T ss_pred             HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC--ccccC
Confidence            000000001111112344579999999999999999999999997  55554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-43  Score=343.34  Aligned_cols=267  Identities=21%  Similarity=0.343  Sum_probs=202.3

Q ss_pred             cCCCCC-ceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEG-NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|.+. +.||+|+||.||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            557664 78999999999999954 6899999999766544556788999999885 79999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc---EEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl~~~~  307 (457)
                      |+++++|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999998754    4899999999999999999999999   999999999999988776   999999998765


Q ss_pred             ccccC-----CccccccccCCCccccccccC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          308 SDKIN-----GQISTRVLGTTGYLAPEYAST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       308 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+..    |....
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~  240 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----WDRGE  240 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C----
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----ccccc
Confidence            42211     111234569999999999865     56899999999999999999999999865432211    10000


Q ss_pred             cCc--hhHHhh-hcCCcCCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          378 LTS--REEAVE-MVDPSLQGQYPK----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ~~~--~~~~~~-~~d~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...  .....+ +.....  ..+.    ..+..+.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       241 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h--p~~~~  301 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH--PWVQG  301 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--TTCC-
T ss_pred             cchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC--hhhcC
Confidence            000  000111 111111  1221    234579999999999999999999999987  66654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-43  Score=364.15  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=211.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|.+.++||+|+||.||+|+.. +++.||+|++.....   .....+..|+.+++.++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888999999999999999975 589999999865422   22356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.........+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999876544457999999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............            ...+..
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~------------~~~i~~  407 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------KQRVLE  407 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH------------HHHHHH
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH------------HHHHhh
Confidence            32  1234468999999999999999999999999999999999999999864321111000            001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHHHHhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQSLIPVVK  434 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~L~~~~~  434 (457)
                      ..  ..++...+..+.+|+.+||+.||.+||++     .+|+++  .+++
T Consensus       408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H--pff~  453 (543)
T 3c4z_A          408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH--PLFR  453 (543)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS--GGGT
T ss_pred             cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC--cccc
Confidence            11  12334445689999999999999999975     677765  4444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=343.20  Aligned_cols=275  Identities=23%  Similarity=0.248  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc-----hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEcC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG-----KQRERAFRMEVDLLSRL---HSPQLVELLGYCADQ  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~  222 (457)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....     ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996 468999999986432     11123455677766666   599999999999775


Q ss_pred             C-----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          223 N-----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       223 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                      .     ..++||||+. ++|.+++.....  ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            5     5799999996 699999976443  34899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      |+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......
T Consensus       161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999866432   2234567899999999999999999999999999999999999999754322111111000000


Q ss_pred             cCchhH------HhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          378 LTSREE------AVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       378 ~~~~~~------~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ......      ....+.+....   ....+....+.+|+.+||+.||++|||+.|++++  .++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--~~~~~~~  304 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH--SYLHKDE  304 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--TTC----
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC--ccccCCC
Confidence            000000      00000000000   0011234578999999999999999999999987  6776644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7e-43  Score=334.14  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=210.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|... ++..||+|++.....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999975 577899999865421   12356889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998754    4899999999999999999999999   99999999999999999999999999875543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .    ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   .             ....+..
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~-------------~~~~~~~  226 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---E-------------THRRIVN  226 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H-------------HHHHHHT
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---H-------------HHHHHhc
Confidence            2    223457899999999999999999999999999999999999999753211   0             0011111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..  ..++...+..+.+++.+||+.||.+||++.+++++  .++++...
T Consensus       227 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h--~~~~~~~~  271 (284)
T 2vgo_A          227 VD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH--PWVKANSR  271 (284)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC--HHHHHHCC
T ss_pred             cc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC--HHHHhhcc
Confidence            11  12233344578999999999999999999999997  77776443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.1e-43  Score=338.92  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=210.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .+.|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888899999999999999864 68899999986543 3345678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++..     ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999864     24899999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ..          ........+
T Consensus       173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----------~~~~~~~~~  237 (303)
T 3a7i_A          173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL----------FLIPKNNPP  237 (303)
T ss_dssp             B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----------HHHHHSCCC
T ss_pred             c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH----------HHhhcCCCC
Confidence            2  12344578999999999999999999999999999999999999997432110   00          001111112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+...+    +..+.+|+.+||+.+|.+|||+.+++++  .++.+...
T Consensus       238 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~~~  279 (303)
T 3a7i_A          238 TLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH--KFILRNAK  279 (303)
T ss_dssp             CCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC--HHHHHHCC
T ss_pred             CCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC--hhhhcCCC
Confidence            222233    4479999999999999999999999997  45544433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-43  Score=353.68  Aligned_cols=273  Identities=23%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC--e
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQN--H  224 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~--~  224 (457)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999964 6899999998643  3444556788999999997 999999999997544  7


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|+||||++ ++|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999996 6999998763     4899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccc-------------------CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          305 KMVSDKI-------------------NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       305 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      +.+....                   .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8653210                   1122344689999999999876 6799999999999999999999999976432


Q ss_pred             CCcchhhhhhccccCchhHHhhh---------------c---CCcCCCCC------------CHHHHHHHHHHHHhhcCC
Q 012739          365 PGEHVLVSWALPRLTSREEAVEM---------------V---DPSLQGQY------------PKKDLIQIAAIAAVCVQP  414 (457)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~---------------~---d~~l~~~~------------~~~~~~~l~~li~~cl~~  414 (457)
                      ......+...... .........               .   .......+            ......++.+|+.+||+.
T Consensus       237 ~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          237 MNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            2111111100000 000000000               0   00000000            012245789999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhhhh
Q 012739          415 EAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       415 ~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ||++|||+.|++++  .+++.
T Consensus       316 dP~~R~t~~e~l~H--p~~~~  334 (388)
T 3oz6_A          316 NPNKRISANDALKH--PFVSI  334 (388)
T ss_dssp             SGGGSCCHHHHTTS--TTTTT
T ss_pred             CcccCCCHHHHhCC--HHHHH
Confidence            99999999999998  66654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-43  Score=338.60  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=194.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788899999999999999997 468899999987652  222233555666688899999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||++ |+|.+++.........+++..++.++.|++.||.|||++ +   ++||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9996 599888876444445699999999999999999999998 8   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccc----cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          309 DKINGQISTRVLGTTGYLAPEYA----STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ...   ......||+.|+|||.+    .+..++.++||||||+++|||+||+.||........               ..
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~  223 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------------QL  223 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---------------HH
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---------------HH
Confidence            432   22334689999999996    566789999999999999999999999975322110               11


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ............+...+..+.+++.+||+.||++|||+.|++++  ++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h--p~f~~  272 (290)
T 3fme_A          224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH--PFFTL  272 (290)
T ss_dssp             HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS--HHHHH
T ss_pred             HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC--ccccc
Confidence            11111111111122334579999999999999999999999996  56654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.7e-43  Score=341.50  Aligned_cols=256  Identities=22%  Similarity=0.366  Sum_probs=211.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..+|.+.+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467888999999999999999975 4788999988654   234456688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999987754    4899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ...           .. ...
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-----------~~-~~~  256 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYL-----------RI-KKN  256 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH-----------HH-HHT
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HHH-----------HH-hcC
Confidence            321  22344678999999999999999999999999999999999999997532110  000           00 000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ..    ..+......+.+|+.+||+.||++|||+.|++++  .++.+..
T Consensus       257 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~--~~~~~~~  299 (335)
T 2owb_A          257 EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSGY  299 (335)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTSC
T ss_pred             CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC--ccccCCC
Confidence            11    1222334578999999999999999999999987  6776543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-43  Score=335.23  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=202.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK------QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356888999999999999999976 589999998865421      1246688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  301 (457)
                      ++||||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999997654    4899999999999999999999999   99999999999998877    8999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ...         
T Consensus       157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---------  221 (283)
T 3bhy_A          157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT---------  221 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---------
T ss_pred             ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH---------
Confidence            9998764321   2334568999999999999999999999999999999999999997532110   000         


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       .. ...............+..+.+++.+||+.||.+|||+.+++++
T Consensus       222 -~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          222 -NI-SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -HH-HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -Hh-HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence             00 0000001000011224578999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-43  Score=365.80  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=211.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|.+.++||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356889999999999999999975 68999999986532   22234578899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999976432  35899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+          .......
T Consensus       338 ~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i----------~~~i~~~  404 (576)
T 2acx_A          338 EG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----------ERLVKEV  404 (576)
T ss_dssp             TT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH----------HHHHHHC
T ss_pred             cC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH----------HHHhhcc
Confidence            32   2234468999999999999999999999999999999999999999864322111000          0001111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhh
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKN  435 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~  435 (457)
                      .    ..++...+.++.+|+.+||+.||.+||     ++.||+++  .++++
T Consensus       405 ~----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H--pfF~~  450 (576)
T 2acx_A          405 P----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH--PLFKK  450 (576)
T ss_dssp             C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS--GGGTT
T ss_pred             c----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC--hhhcc
Confidence            1    123334456899999999999999999     78999887  56554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=350.92  Aligned_cols=266  Identities=19%  Similarity=0.228  Sum_probs=200.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCchHH-----------HHHHHHHHHHHHhcCCCCeeeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDGKQR-----------ERAFRMEVDLLSRLHSPQLVELLG  217 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~hpniv~l~~  217 (457)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367888999999999999999975    57889999887653211           123567888999999999999999


Q ss_pred             EEEc----CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC
Q 012739          218 YCAD----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN  293 (457)
Q Consensus       218 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  293 (457)
                      ++..    ....++||||+ +++|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            9987    77899999999 999999997654    5999999999999999999999999   9999999999999887


Q ss_pred             C--cEEEeeccCccccccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 012739          294 F--RAKVTDFGLAKMVSDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG  366 (457)
Q Consensus       294 ~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~  366 (457)
                      +  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876543211     11245679999999999999999999999999999999999999996422111


Q ss_pred             cchhhhhhccccCchhHHhhhcCCcCCC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          367 EHVLVSWALPRLTSREEAVEMVDPSLQG-QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ....  ...      ......+...+.. ..+...+.++.+++.+||+.||++||++.+|++.|+++.-
T Consensus       268 ~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAVQ--TAK------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHH--HHH------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHH--HHH------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1000  000      0000001100000 0001234489999999999999999999999999877544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=348.38  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=205.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK--------QRERAFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.....        .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999996 4688999999865421        1223467799999999999999999999999


Q ss_pred             CeEEEEEEeCCCC-cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeec
Q 012739          223 NHRLLISEYMPNG-TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF  301 (457)
Q Consensus       223 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  301 (457)
                      +..++||||+.+| +|.+++....    .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999997644    4999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |++......   .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....                
T Consensus       175 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------  235 (335)
T 3dls_A          175 GSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------  235 (335)
T ss_dssp             TTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred             ccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence            999876543   22344679999999999988877 8899999999999999999999964110                


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                            ......  ..+...+.++.+|+.+||+.||++|||+.+++++  .++++
T Consensus       236 ------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h--p~~~~  280 (335)
T 3dls_A          236 ------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD--PWVTQ  280 (335)
T ss_dssp             ------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC--TTTTC
T ss_pred             ------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC--ccccC
Confidence                  000001  1111234479999999999999999999999997  55543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-43  Score=343.14  Aligned_cols=265  Identities=22%  Similarity=0.371  Sum_probs=206.6

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEcCCe
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLH--SPQLVELLGYCADQNH  224 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~~  224 (457)
                      +....++|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|+.+++.++  ||||+++++++.+.+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34445779999999999999999999888999999998654  3444567889999999997  5999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||| +.+++|.+++....    .+++.+++.++.|++.||.|||+.+   ++||||||+|||++ ++.+||+|||++
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~  173 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA  173 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecccc
Confidence            999999 55889999998753    4899999999999999999999999   99999999999996 489999999999


Q ss_pred             cccccccCCccccccccCCCccccccccC-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAST-----------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~  373 (457)
                      ................||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......        
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------  245 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------  245 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--------
Confidence            87654433233345678999999999865           47888999999999999999999999743210        


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                             ........++.....++......+.+++.+||+.||.+||++.|++++  .+++....+
T Consensus       246 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h--~~~~~~~~~  302 (313)
T 3cek_A          246 -------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH--PYVQIQTHP  302 (313)
T ss_dssp             -------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHCC---
T ss_pred             -------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC--ccccCCCCc
Confidence                   011222333333333333345589999999999999999999999998  677665443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=350.45  Aligned_cols=266  Identities=17%  Similarity=0.224  Sum_probs=208.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC---------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeee----------
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD---------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVE----------  214 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~----------  214 (457)
                      ++|.+.+.||+|+||.||+|....         ++.||+|.+...     +.+.+|+++++.++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578889999999999999999763         789999998654     34778999999999999887          


Q ss_pred             -----EEEEEEc-CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          215 -----LLGYCAD-QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       215 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                           +++++.. .+..++||||+ +++|.+++....  ...+++.+++.++.|++.||.|||+++   |+||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                 6777765 78899999999 999999998652  235999999999999999999999999   99999999999


Q ss_pred             EeCCCC--cEEEeeccCccccccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 012739          289 LLDQNF--RAKVTDFGLAKMVSDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDP  361 (457)
Q Consensus       289 ll~~~~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~  361 (457)
                      |++.++  .+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  99999999998765432211     12345799999999999999999999999999999999999999985


Q ss_pred             CCCCCcchhhhhhccccCchhHHhhhcCCcCCC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          362 NRPPGEHVLVSWALPRLTSREEAVEMVDPSLQG-QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .......... ..       ........+.... ......+..+.+|+.+||+.||.+||++.+|++.|++++++...
T Consensus       271 ~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          271 CLPNTEDIMK-QK-------QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GTTCHHHHHH-HH-------HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CCcCHHHHHH-HH-------HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            4321111100 00       0001111110000 00112245899999999999999999999999999999988654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.2e-43  Score=337.28  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc--CCc--EEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS--DGT--VAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|++...   .....+.+.+|+++++.++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357888999999999999999863  233  6899988654   2334567889999999999999999999998765 7


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++|+||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            89999999999999998753   24899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ......... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||......                ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~  233 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QI  233 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HH
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----------------HH
Confidence            765432211 2234567888999999988889999999999999999999 99999754221                00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ...+.........+...+..+.+++.+||+.+|.+|||+.++++.|+++.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence            111111111112233445689999999999999999999999999998876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-42  Score=333.21  Aligned_cols=253  Identities=25%  Similarity=0.458  Sum_probs=201.1

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~l  227 (457)
                      .|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677788999999999999975 5778999988654  34445678899999999999999999999865    456899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEEEeeccCccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKM  306 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~  306 (457)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||+.+ ++++||||||+|||++ .++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998754    4899999999999999999999875 3499999999999997 789999999999975


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....    ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.......                ....
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~  240 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYR  240 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHH
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----------------HHHH
Confidence            4332    234457999999999886 458999999999999999999999997532211                0111


Q ss_pred             hcCCc-CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPS-LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~-l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+... .....+......+.+++.+||+.||.+|||+.+++++  .++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h--~~f~~  288 (290)
T 1t4h_A          241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH--AFFQE  288 (290)
T ss_dssp             HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGC-
T ss_pred             HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC--ccccc
Confidence            11110 0111122223479999999999999999999999987  55554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-43  Score=344.98  Aligned_cols=272  Identities=24%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367888999999999999999975 48899999885542  333456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus       104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999988766543    4999999999999999999999999   99999999999999999999999999986643


Q ss_pred             ccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh------
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE------  382 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  382 (457)
                      ..  .......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.......................      
T Consensus       177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            21  223445789999999998765 789999999999999999999999976432211111100000000000      


Q ss_pred             --HHhhhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          383 --EAVEMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 --~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        .......+.+....+     ...+..+.+|+.+||+.||.+|||+.|++++  ++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h--p~f~~  312 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH--DFFQM  312 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC--chhcc
Confidence              000001111111111     1235689999999999999999999999987  66654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-43  Score=345.80  Aligned_cols=272  Identities=19%  Similarity=0.254  Sum_probs=198.1

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3467899999999999999999864 6889999999755322  234577899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe-----CCCCcEEEeeccC
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL-----DQNFRAKVTDFGL  303 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~Dfgl  303 (457)
                      |||++ |+|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99996 59999998754    3899999999999999999999999   9999999999999     4556699999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc--
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS--  380 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  380 (457)
                      ++......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................  
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            98764321  223445689999999999774 5899999999999999999999999754321111100000000000  


Q ss_pred             hhHHhh--hcC---CcCCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 REEAVE--MVD---PSLQGQ-----YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 ~~~~~~--~~d---~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ......  ...   +.....     .+.....++.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~  324 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH--PYFSH  324 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC--cccCC
Confidence            000000  000   000000     011134578999999999999999999999987  66655

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=348.91  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=204.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE----cCCcEEEEEEcccCc----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36788999999999999999997    368999999986532    12233466799999999 6999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||+++++|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999998754    4899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ++....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.............         
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---------  275 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---------  275 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---------
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH---------
Confidence            986643221 22344679999999999975  457899999999999999999999997543321111000         


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHH
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSL  429 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L  429 (457)
                      ... ....+    .++......+.+|+.+||+.||.+||     ++.|++++.
T Consensus       276 ~~~-~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          276 RRI-LKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHH-HHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHH-hccCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            000 01111    23334455789999999999999999     999999873

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=344.11  Aligned_cols=272  Identities=22%  Similarity=0.298  Sum_probs=200.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHH-HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRE-RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~-~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|.+.+.||+|+||.||+|... +++.||+|++........ ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999975 688999999865432221 2345799999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      ++ |+|.+++....   ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-  153 (324)
T ss_dssp             CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence            96 69999987754   35899999999999999999999999   999999999999999999999999999765432 


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc--------cccCchh
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL--------PRLTSRE  382 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  382 (457)
                       ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....        +......
T Consensus       154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence             122344578999999999876 678999999999999999999999997643221111110000        0000001


Q ss_pred             HHhhhcCCcCCCC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          383 EAVEMVDPSLQGQ----YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       383 ~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .......+.....    ........+.+|+.+||+.||.+|||+.|++++  +++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhhc
Confidence            1111111111100    011234578999999999999999999999997  777654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-42  Score=342.61  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--------hHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--------KQRERAFRMEVDLLSRL-HSPQLVELL  216 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l-~hpniv~l~  216 (457)
                      ........+|.+.+.||+|+||.||+|.+. +|+.||||++....        ....+.+.+|+.+++.+ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455678999999999999999999985 69999999886542        11134578899999999 899999999


Q ss_pred             EEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          217 GYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      +++...+..++||||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999998654    4999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccC------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL  370 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~  370 (457)
                      ||+|||++..+...   .......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......   ..
T Consensus       240 kl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LM  313 (365)
T ss_dssp             EECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH
T ss_pred             EEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HH
Confidence            99999999876543   22345679999999998853      36889999999999999999999999753211   00


Q ss_pred             hhhhccccCchhHHhhhcCCcCCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          371 VSWALPRLTSREEAVEMVDPSLQGQYP--KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...             +.........+  ...+..+.+++.+||+.||++|||+.+++++
T Consensus       314 ~~~-------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRM-------------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHH-------------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHH-------------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000             00000000000  1123478999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5e-43  Score=342.41  Aligned_cols=266  Identities=18%  Similarity=0.274  Sum_probs=210.3

Q ss_pred             hHHHHHHhcCCCCC-ceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012739          146 YKELETATENFSEG-NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRL-HSPQLVELLGYCA  220 (457)
Q Consensus       146 ~~~~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~  220 (457)
                      ++..+...++|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            34456667778877 89999999999999975 58999999986542  22345688899999999 4699999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEE
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAK  297 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  297 (457)
                      +.+..++||||+++|+|.+++....  ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999986532  245899999999999999999999999   999999999999987   78999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR  377 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  377 (457)
                      |+|||+++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........        
T Consensus       175 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------  243 (327)
T 3lm5_A          175 IVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--------  243 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------
T ss_pred             EeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--------
Confidence            9999999876432   12344679999999999999999999999999999999999999997532211000        


Q ss_pred             cCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          378 LTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                           . ...................+.+++.+||+.||.+|||+.+++++  +++++
T Consensus       244 -----~-i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h--~~~~~  293 (327)
T 3lm5_A          244 -----N-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH--SWLQQ  293 (327)
T ss_dssp             -----H-HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC--GGGCC
T ss_pred             -----H-HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC--Hhhcc
Confidence                 0 01111111112223345579999999999999999999999988  67665

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=333.32  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=205.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLHSPQLVELLGYCA--DQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~  225 (457)
                      .++|.+.+.||+|+||.||++... ++..+|+|++....    ....+.+.+|+.+++.++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999974 58899999986542    123456889999999999999999999984  45678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||++++ |.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999765 7777766432  45899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ...............||+.|+|||.+.+..  ++.++||||||+++|||++|+.||......   ...          ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----------~~  224 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLF----------EN  224 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----------HH
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHH----------HH
Confidence            765433333344567999999999987643  478999999999999999999999753210   000          00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      + .....    ..+..+...+.+++.+||+.||.+|||+.|++++  .++++...
T Consensus       225 i-~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~~~  272 (305)
T 2wtk_C          225 I-GKGSY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH--SWFRKKHP  272 (305)
T ss_dssp             H-HHCCC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS--HHHHSCCC
T ss_pred             H-hcCCC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC--cccccCCC
Confidence            0 00111    1222344578999999999999999999999998  77776444

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.2e-43  Score=331.67  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=200.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367888999999999999999976 689999999865421   2235688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999998754    3899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ..   .......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......   ...          ..... 
T Consensus       163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----------~~~~~-  225 (276)
T 2h6d_A          163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF----------KKIRG-  225 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----------HHHHH-
T ss_pred             CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH----------HHhhc-
Confidence            32   12334568999999999987765 68999999999999999999999753211   000          00000 


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      -..    ..+......+.+++.+||+.||.+|||+.+++++  +++++.
T Consensus       226 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h--~~~~~~  268 (276)
T 2h6d_A          226 GVF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH--EWFKQD  268 (276)
T ss_dssp             CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS--HHHHTT
T ss_pred             Ccc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC--hhhccC
Confidence            001    1222334578999999999999999999999997  677654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-44  Score=355.54  Aligned_cols=244  Identities=16%  Similarity=0.197  Sum_probs=192.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC---chHHHHHHHHHH---HHHHhcCCCCeeeEE-------EE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD---GKQRERAFRMEV---DLLSRLHSPQLVELL-------GY  218 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~hpniv~l~-------~~  218 (457)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46688889999999999999996 46999999998643   334456788999   555566899999998       77


Q ss_pred             EEcCCe-----------------EEEEEEeCCCCcHHHHHhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012739          219 CADQNH-----------------RLLISEYMPNGTLQQHLHRHNN---RYRPLDWRTRLIIALDCAMALEFLHEHATPPV  278 (457)
Q Consensus       219 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i  278 (457)
                      +.+.+.                 .++||||+ +|+|.+++.....   ....+++..++.++.|++.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665543                 78999999 6899999986432   1123446888899999999999999999   9


Q ss_pred             EeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCC-----------CCCcccchHHHHH
Q 012739          279 IHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-----------KLTTKSDVYSYGV  347 (457)
Q Consensus       279 vH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~SlG~  347 (457)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985432     2345567 999999999877           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 012739          348 VLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ  427 (457)
Q Consensus       348 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  427 (457)
                      ++|||++|+.||...........                +.. . ...+    +..+.+|+.+||+.||++|||+.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~----------------~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEW----------------IFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGG----------------GGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhh----------------hhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999975432211100                000 0 0123    347999999999999999999999998


Q ss_pred             H
Q 012739          428 S  428 (457)
Q Consensus       428 ~  428 (457)
                      +
T Consensus       360 h  360 (377)
T 3byv_A          360 T  360 (377)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.7e-43  Score=358.38  Aligned_cols=261  Identities=23%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~  223 (457)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999865 5889999999754  334456688999999999999999999999654      4


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..|+||||+++ +|.+.+..      .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            67999999965 56666642      3889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc--------
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL--------  375 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------  375 (457)
                      ++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+....        
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9876432   23455689999999999999999999999999999999999999997643211111110000        


Q ss_pred             cccCchhHHhhhcCC---------------cCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          376 PRLTSREEAVEMVDP---------------SLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~---------------~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..+.  ......++.               .+....   ......++.+|+.+||+.||++|||+.|++++
T Consensus       288 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQ--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSC--HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcc--hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000  000011110               000000   11225679999999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.4e-43  Score=355.13  Aligned_cols=260  Identities=21%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--------KQRERAFRMEVDLLSRLHSPQLVELLGYCA  220 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~  220 (457)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++....        ......+.+|+.+++.++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345688999999999999999999965 57899999986432        111224788999999999999999999986


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEE
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAK  297 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k  297 (457)
                      . +..++||||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.+   +.+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence            4 45799999999999999886543    4999999999999999999999999   9999999999999654   4599


Q ss_pred             EeeccCccccccccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      |+|||+++.....   .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||.........  ... 
T Consensus       283 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~-  356 (419)
T 3i6u_A          283 ITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ-  356 (419)
T ss_dssp             ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHH-
T ss_pred             EeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHH-
Confidence            9999999876532   2234567999999999985   367889999999999999999999999754322111  000 


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                               ... .............+..+.+|+.+||+.||++|||+.|++++  +++++
T Consensus       357 ---------i~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h--p~~~~  405 (419)
T 3i6u_A          357 ---------ITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH--PWLQD  405 (419)
T ss_dssp             ---------HHT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGCC
T ss_pred             ---------Hhc-CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC--cccCC
Confidence                     000 00000000001234579999999999999999999999987  55543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-43  Score=343.62  Aligned_cols=277  Identities=23%  Similarity=0.263  Sum_probs=203.4

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHH-----HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQR-----ERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.......     .+.+.+|+++++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 58999999987542211     2357789999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++ +|.+++....   ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999975 8988886543   35888999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc---
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS---  380 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  380 (457)
                      +......  .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||...........+.........   
T Consensus       160 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          160 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            8764322  22345678999999999865 45899999999999999999999998754321110000000000000   


Q ss_pred             --hhHHhhhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 --REEAVEMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 --~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                        .....+.+........+     ......+.+|+.+||+.||.+|||+.|++++  .++++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~~~~  300 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPG  300 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSC
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhcCCC
Confidence              00000000000000111     2234689999999999999999999999998  78876544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=332.21  Aligned_cols=260  Identities=23%  Similarity=0.397  Sum_probs=204.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      +|....+||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455668999999999999964 588999999977655556778999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeeccCccccccccC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      +++|.+++..... ...+++..+..++.|++.||.|||+.+   ++|+||||+|||++. ++.+||+|||++....... 
T Consensus       103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999987532 234678999999999999999999999   999999999999987 8999999999998764321 


Q ss_pred             CccccccccCCCccccccccCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                       .......|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||..........   +        ........+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~--------~~~~~~~~~  245 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---F--------KVGMFKVHP  245 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---H--------HHHHHCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---H--------hhccccccc
Confidence             1233457899999999987643  8899999999999999999999996432110000   0        000111112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                          ..+...+..+.+++.+||+.||++||++.+++++  ++++...
T Consensus       246 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~~  286 (295)
T 2clq_A          246 ----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD--EFLKVSS  286 (295)
T ss_dssp             ----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS--GGGCC--
T ss_pred             ----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC--hhhhhcc
Confidence                2333445589999999999999999999999987  6766543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.1e-43  Score=353.88  Aligned_cols=274  Identities=21%  Similarity=0.260  Sum_probs=201.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~  224 (457)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467899999999999999999975 5788999999754  334456788999999999999999999999765     57


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|+||||++ ++|.+++....    .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999995 69999997643    4999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCC--------------------ccccccccCCCccccccc-cCCCCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 012739          305 KMVSDKING--------------------QISTRVLGTTGYLAPEYA-STGKLTTKSDVYSYGVVLLELLTGRVPVDPNR  363 (457)
Q Consensus       305 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~SlG~il~elltg~~p~~~~~  363 (457)
                      +........                    ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            876543211                    123567899999999986 56679999999999999999998665554211


Q ss_pred             CCC------cc-------------------hh---hhhhcc--------ccCchh--HHhhhcCCcCCCC---CCHHHHH
Q 012739          364 PPG------EH-------------------VL---VSWALP--------RLTSRE--EAVEMVDPSLQGQ---YPKKDLI  402 (457)
Q Consensus       364 ~~~------~~-------------------~~---~~~~~~--------~~~~~~--~~~~~~d~~l~~~---~~~~~~~  402 (457)
                      ...      ..                   ..   +.....        .+....  .....+.......   .......
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence            000      00                   00   000000        000000  0000111000000   0012345


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          403 QIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       403 ~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+.+|+.+||+.||.+|||+.|++++  .++++.
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~  368 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDH--PYLKDV  368 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTC--GGGTTT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC--hhhhhc
Confidence            78999999999999999999999998  777764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-42  Score=356.78  Aligned_cols=259  Identities=21%  Similarity=0.336  Sum_probs=207.7

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ..++|++.++||+|+||.||+|... +++.||+|++....  ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3567999999999999999999975 68999999985431  22345688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeeccCcc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl~~  305 (457)
                      |||+.+|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+++
T Consensus       100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999997754    4999999999999999999999999   99999999999994   56689999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......   ....          +.
T Consensus       173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----------i~  235 (486)
T 3mwu_A          173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKR----------VE  235 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----------HH
T ss_pred             ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----------HH
Confidence            66432   22345679999999999875 59999999999999999999999997532210   0000          00


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      . .............+..+.+|+.+||+.||.+|||+.+++++  +++++..
T Consensus       236 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h--p~~~~~~  284 (486)
T 3mwu_A          236 T-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH--PWIQKYS  284 (486)
T ss_dssp             H-TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC--HHHHHTC
T ss_pred             h-CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC--HhhccCc
Confidence            0 00001001112345579999999999999999999999998  7777643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-43  Score=346.35  Aligned_cols=268  Identities=20%  Similarity=0.289  Sum_probs=201.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~  223 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467889999999999999999974 6899999998653  333445688999999999999999999999765      3


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..|+||||+ +++|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 88999998762     4899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc------
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP------  376 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------  376 (457)
                      ++.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....      
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9875432     344678999999999877 7899999999999999999999999985432111111100000      


Q ss_pred             --ccCch--hHHhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          377 --RLTSR--EEAVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       377 --~~~~~--~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                        .+...  ......+.....   ..........+.+|+.+||+.||.+|||+.|++++  +++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h--p~f~~~  314 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESL  314 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTT
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--hHHHhh
Confidence              00000  000000100000   01112335579999999999999999999999997  677653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-42  Score=358.83  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=201.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|... ++..+|+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999975 68899999986542  223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccCccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGLAKM  306 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl~~~  306 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999987764    3899999999999999999999999   999999999999976   45599999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....   .......||+.|+|||++. ..++.++|||||||++|+|++|..||.......   ....          +..
T Consensus       189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----------i~~  251 (494)
T 3lij_A          189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRK----------VEK  251 (494)
T ss_dssp             CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----------HHH
T ss_pred             CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----------HHh
Confidence            6543   2234567999999999886 569999999999999999999999997543210   0000          000


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ....+........+..+.+|+.+||+.+|.+|||+.|++++  +++++
T Consensus       252 -~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h--p~~~~  297 (494)
T 3lij_A          252 -GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH--PWIKE  297 (494)
T ss_dssp             -TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC--HHHHH
T ss_pred             -CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC--ccccc
Confidence             00000000011234578999999999999999999999987  45543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-43  Score=350.86  Aligned_cols=271  Identities=24%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-------
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-------  221 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-------  221 (457)
                      +...++|++.+.||+|+||.||+|.. .+++.||+|++..+...    ..+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999986 46899999998655322    2469999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012739          222 -------------------------------QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL  270 (457)
Q Consensus       222 -------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  270 (457)
                                                     ....++||||++ |+|.+.+.........+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 688888876433445699999999999999999999


Q ss_pred             HhcCCCCeEeccCccCceEeC-CCCcEEEeeccCccccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHH
Q 012739          271 HEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVV  348 (457)
Q Consensus       271 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~i  348 (457)
                      |+.+   |+||||||+|||++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   99999999999997 68999999999998764432   23445789999999998764 58999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc--------C-----CCCCCHHHHHHHHHHHHhhcCCC
Q 012739          349 LLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS--------L-----QGQYPKKDLIQIAAIAAVCVQPE  415 (457)
Q Consensus       349 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--------l-----~~~~~~~~~~~l~~li~~cl~~~  415 (457)
                      +|||++|+.||......+....+........ ...... .++.        +     ...++...+..+.+|+.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPT-KEQMIR-MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-HHHHHH-HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHHH-hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999986432211111111000000 000000 0110        0     00122334567999999999999


Q ss_pred             CCCCCCHHHHHHHHHHhhhh
Q 012739          416 AAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       416 p~~RPs~~evl~~L~~~~~~  435 (457)
                      |.+|||+.|++++  .++++
T Consensus       310 P~~R~t~~e~l~h--p~f~~  327 (383)
T 3eb0_A          310 PDLRINPYEAMAH--PFFDH  327 (383)
T ss_dssp             GGGSCCHHHHHTS--GGGHH
T ss_pred             hhhCCCHHHHhcC--HHHHH
Confidence            9999999999986  55543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-42  Score=342.25  Aligned_cols=277  Identities=20%  Similarity=0.223  Sum_probs=207.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--------C
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCAD--------Q  222 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~  222 (457)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788899999999999999997 4689999999865432  223457789999999999999999999876        4


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      +..++||||++ ++|.+.+....   ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            56899999996 57877776543   24999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCC--ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC
Q 012739          303 LAKMVSDKING--QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT  379 (457)
Q Consensus       303 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  379 (457)
                      +++.+......  .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876532211  22345678999999999876 5689999999999999999999999986432211111111000000


Q ss_pred             c----hh---HHhhhcCCcCCCCCCH-H------HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 012739          380 S----RE---EAVEMVDPSLQGQYPK-K------DLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAG  439 (457)
Q Consensus       380 ~----~~---~~~~~~d~~l~~~~~~-~------~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  439 (457)
                      .    ..   ...+.+.......... +      ....+.+|+.+||+.||.+|||+.|++++  +++++...+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~~~  321 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDPMP  321 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGSSSCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC--CCcCCCCCc
Confidence            0    00   0000000000000010 0      13468899999999999999999999998  888765543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=333.34  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34567999999999999999999975 48999999986543  2345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999997543   35899999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   .. +         .......
T Consensus       178 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~-~---------~~~~~~~  242 (314)
T 3com_A          178 TM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI-F---------MIPTNPP  242 (314)
T ss_dssp             TB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH-H---------HHHHSCC
T ss_pred             hc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH-H---------HHhcCCC
Confidence            32  12334578999999999999999999999999999999999999997432110   00 0         0001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +.+  ..+...+..+.+++.+||+.||.+|||+.+++++  .++++
T Consensus       243 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--~~~~~  284 (314)
T 3com_A          243 PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH--PFVRS  284 (314)
T ss_dssp             CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS--HHHHT
T ss_pred             ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC--HHHhc
Confidence            111  1223345589999999999999999999999986  45544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.5e-42  Score=354.03  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=206.6

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-------------QRERAFRMEVDLLSRLHSPQLVELLG  217 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~hpniv~l~~  217 (457)
                      ..++|.+.++||+|+||.||+|... ++..+|+|++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999975 578999999865421             22356889999999999999999999


Q ss_pred             EEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC---
Q 012739          218 YCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF---  294 (457)
Q Consensus       218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---  294 (457)
                      ++.+.+..++||||+++|+|.+++....    .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999997754    3999999999999999999999999   99999999999998776   


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      .+||+|||++......   .......||+.|+|||++. ..++.++|||||||++|+|++|..||.......   ..   
T Consensus       187 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---  256 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---II---  256 (504)
T ss_dssp             SEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---
T ss_pred             cEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---
Confidence            6999999999876543   2234567999999999986 469999999999999999999999997533210   00   


Q ss_pred             ccccCchhHHhhhcCCcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                                ..+.....  .++    ...+.++.+|+.+||+.||.+|||+.|++++  +++++...
T Consensus       257 ----------~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h--~~~~~~~~  310 (504)
T 3q5i_A          257 ----------KKVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS--RWIKKYAN  310 (504)
T ss_dssp             ----------HHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHHTCC
T ss_pred             ----------HHHHcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC--Hhhhhchh
Confidence                      00000000  011    1234579999999999999999999999998  77776443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-42  Score=335.42  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=203.8

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3567899999999999999999976 488999999876655556778899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+++++|.+++.....   .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999876443   4899999999999999999999999   999999999999999999999999987643221


Q ss_pred             cCCccccccccCCCccccccc-----cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          311 INGQISTRVLGTTGYLAPEYA-----STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      .  .......||+.|+|||.+     .+..++.++||||||+++|+|++|+.||........  .           ....
T Consensus       171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-----------~~~~  235 (302)
T 2j7t_A          171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L-----------LKIA  235 (302)
T ss_dssp             H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-----------HHHH
T ss_pred             c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H-----------HHHh
Confidence            1  112345689999999998     467789999999999999999999999975322100  0           0000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....+.  ...+...+..+.+++.+||+.||.+|||+.+++++  +++++
T Consensus       236 ~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h--~~~~~  281 (302)
T 2j7t_A          236 KSDPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH--PFVSS  281 (302)
T ss_dssp             HSCCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS--TTTTT
T ss_pred             ccCCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC--hHHhh
Confidence            000111  11223345589999999999999999999999986  45443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.5e-43  Score=359.33  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=210.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.++||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467889999999999999999975 68999999985432   33456788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAK  305 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~  305 (457)
                      |||+.+|+|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999997644    4899999999999999999999999   9999999999999   567899999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......   ....          +.
T Consensus       178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----------i~  240 (484)
T 3nyv_A          178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKK----------VE  240 (484)
T ss_dssp             HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----------HH
T ss_pred             Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----------HH
Confidence            76543   22345679999999999866 69999999999999999999999997542210   0000          00


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      . -...+........+..+.+|+.+||+.+|.+|||+.|++++  +++++..
T Consensus       241 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h--~~~~~~~  289 (484)
T 3nyv_A          241 K-GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH--EWIQTYT  289 (484)
T ss_dssp             H-CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--HHHHHHT
T ss_pred             c-CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC--hhhcccc
Confidence            0 00001001112345689999999999999999999999998  7777643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.3e-42  Score=341.03  Aligned_cols=271  Identities=21%  Similarity=0.263  Sum_probs=198.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN------  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------  223 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367899999999999999999864 5889999998653  3344466889999999999999999999997654      


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||++ ++|.+++..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence            7899999996 578888752      3889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh--------c
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA--------L  375 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~  375 (457)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...        .
T Consensus       174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9865432   1234467899999999999999999999999999999999999999754321110000000        0


Q ss_pred             cccCch-h------------HHhhhcCCcCCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          376 PRLTSR-E------------EAVEMVDPSLQGQ---YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       376 ~~~~~~-~------------~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..+... .            .....+.......   .+......+.+|+.+||+.||.+|||+.|++++  ++++.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h--p~~~~~~~  327 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH--PYINVWYD  327 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS--HHHHTTCC
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC--cchhhhcC
Confidence            000000 0            0000000000000   112346789999999999999999999999998  77775433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.6e-43  Score=347.53  Aligned_cols=259  Identities=13%  Similarity=0.054  Sum_probs=187.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch---HHHHHHHHHHHHHHhc--CCCCeeeEE-------EEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK---QRERAFRMEVDLLSRL--HSPQLVELL-------GYCA  220 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~hpniv~l~-------~~~~  220 (457)
                      .+|.+.+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            44778899999999999999965 688999999977532   3345577885555444  699988865       4544


Q ss_pred             cC-----------------CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 012739          221 DQ-----------------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR------LIIALDCAMALEFLHEHATPP  277 (457)
Q Consensus       221 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~  277 (457)
                      ..                 ...++||||++ |+|.+++.....   .+.+..+      +.++.|++.||.|||+++   
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            33                 33799999998 899999987532   2444555      678899999999999999   


Q ss_pred             eEeccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcC
Q 012739          278 VIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTG  355 (457)
Q Consensus       278 ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg  355 (457)
                      |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||+||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999866432     224457799999999987  7899999999999999999999


Q ss_pred             CCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          356 RVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       356 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      +.||..............         .........+........+..+.+|+.+||+.||++|||+.+++++  +++++
T Consensus       290 ~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~  358 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET--PEFLQ  358 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS--HHHHH
T ss_pred             CCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--HHHHH
Confidence            999986543211100000         0000001111111112345589999999999999999999999986  66655

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-42  Score=336.96  Aligned_cols=261  Identities=16%  Similarity=0.266  Sum_probs=203.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEc--CCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCAD--QNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~--~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   .+.+.+|+.+++.++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6788999999999999999986 468999999987543   345788999999997 9999999999987  67789999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~  308 (457)
                      ||+++++|.+++..       +++.++..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998853       889999999999999999999999   99999999999999776 89999999998664


Q ss_pred             cccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH---
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA---  384 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  384 (457)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... . ...... .....   
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~-~~~~~~-~~~~~~~~  256 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-V-RIAKVL-GTEDLYDY  256 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-H-HHHHHH-CHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-H-HHHHhc-CCchhhhH
Confidence            432   2344578999999999877 678999999999999999999999996433211100 0 000000 00000   


Q ss_pred             ------------hhhcCC--------cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 ------------VEMVDP--------SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ------------~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                                  .+....        ......+.....++.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h--p~f~~  325 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH--PYFYT  325 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC--ccHhh
Confidence                        000000        01111122245689999999999999999999999987  55554

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-42  Score=350.77  Aligned_cols=270  Identities=22%  Similarity=0.259  Sum_probs=205.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL------HSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~hpniv~l~~~~~~~~~~  225 (457)
                      ..+|++.++||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457889999999999999999865 4889999999764 33345677788888887      577999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc--EEEeeccC
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR--AKVTDFGL  303 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgl  303 (457)
                      ++||||+. ++|.+++.....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999995 799999987543  35899999999999999999999999   999999999999999887  99999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc---
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS---  380 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  380 (457)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.........   
T Consensus       249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            9764332     33467899999999999999999999999999999999999999764322111100000000000   


Q ss_pred             --hhHHhhhcCCc--------------------------------CCCC----CCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 012739          381 --REEAVEMVDPS--------------------------------LQGQ----YPKKDLIQIAAIAAVCVQPEAAYRPLM  422 (457)
Q Consensus       381 --~~~~~~~~d~~--------------------------------l~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~  422 (457)
                        .......++..                                ....    .+......+.+|+.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence              00000000000                                0000    011124578999999999999999999


Q ss_pred             HHHHHHHHHhhhhc
Q 012739          423 TDVVQSLIPVVKNN  436 (457)
Q Consensus       423 ~evl~~L~~~~~~~  436 (457)
                      .|++++  .++++.
T Consensus       404 ~e~L~H--pw~~~~  415 (429)
T 3kvw_A          404 GQALRH--PWLRRR  415 (429)
T ss_dssp             HHHHTS--TTTC--
T ss_pred             HHHhCC--hhhccC
Confidence            999998  777764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-42  Score=367.67  Aligned_cols=260  Identities=24%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      ...++|++.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345778899999999999999998742    4579999987643 334466889999999999999999999985 4568


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence            99999999999999998643   25899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......                 +.
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----------------~~  601 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DV  601 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HH
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----------------HH
Confidence            7654321 12233457789999999998899999999999999999997 99999753221                 01


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+........+..++..+.+++.+||+.||.+|||+.++++.|++++.+
T Consensus       602 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          602 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            011101111123334456899999999999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.8e-42  Score=350.01  Aligned_cols=265  Identities=20%  Similarity=0.288  Sum_probs=209.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.++||+|+||.||+|.+ .+++.||||++.....  ...+..|+++++.++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46789999999999999999996 4689999998765432  2247789999999987 566667677788889999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe---CCCCcEEEeeccCcccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL---DQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl~~~~  307 (457)
                      |+ +++|.+++.....   .+++.+++.|+.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        84 ~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 9999999976432   5999999999999999999999999   9999999999999   68899999999999877


Q ss_pred             ccccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          308 SDKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       308 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      ......     .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.................     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-----~  231 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-----K  231 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH-----H
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh-----c
Confidence            553321     122356799999999999999999999999999999999999999986544322211111100     0


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .....+ ..+...+    +.++.+|+..||+.+|++||++.+|++.|++++.+.
T Consensus       232 ~~~~~~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          232 KVATSI-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHSCH-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccH-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000000 0011122    347999999999999999999999999999998753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.7e-42  Score=328.59  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=209.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---------hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---------KQRERAFRMEVDLLSRLH-SPQLVELLGYCA  220 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~  220 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....         ....+.+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578899999999999999999975 58899999986542         122345788999999995 999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                      ..+..++||||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999998754    4899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCcccccccc------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYAS------TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      ||++......   .......|++.|+|||.+.      ...++.++||||||+++|+|++|+.||......   ....  
T Consensus       168 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~--  239 (298)
T 1phk_A          168 FGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR--  239 (298)
T ss_dssp             CTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH--
T ss_pred             ccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH--
Confidence            9999876432   2234467899999999884      456899999999999999999999999743211   0000  


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                              .... .............+..+.+++.+||+.||.+|||+.+++++  +++++..
T Consensus       240 --------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h--~~~~~~~  291 (298)
T 1phk_A          240 --------MIMS-GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH--PFFQQYV  291 (298)
T ss_dssp             --------HHHH-TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS--GGGCTTC
T ss_pred             --------HHhc-CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC--hHhhhcc
Confidence                    0000 00011111112345689999999999999999999999986  6776544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=339.64  Aligned_cols=264  Identities=25%  Similarity=0.427  Sum_probs=202.5

Q ss_pred             hHHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc--
Q 012739          146 YKELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCAD--  221 (457)
Q Consensus       146 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~--  221 (457)
                      +.++....++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.+ +||||+++++++..  
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344456688999999999999999999974 688999999865432 335678899999999 89999999999976  


Q ss_pred             ----CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          222 ----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       222 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                          .+..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                568899999999999999998643  235899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~  372 (457)
                      |+|||++.......  .......||+.|+|||.+.     +..++.++||||||+++|+|++|+.||........   . 
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-  243 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---L-  243 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H-
T ss_pred             EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H-
Confidence            99999988664321  1223457899999999986     56789999999999999999999999974321100   0 


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                               ........+.+   .+...+..+.+++.+||+.||.+||++.+++++  .++++
T Consensus       244 ---------~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h--p~~~~  292 (326)
T 2x7f_A          244 ---------FLIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH--PFIRD  292 (326)
T ss_dssp             ---------HHHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS--HHHHC
T ss_pred             ---------HHhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC--hHHhh
Confidence                     00011111111   112234479999999999999999999999986  55554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-42  Score=369.24  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=207.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|++.++||+|+||.||+|... +++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467889999999999999999975 57889999987532   22234577899999887 79999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....    .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998764    3999999999999999999999999   999999999999999999999999999864


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      ...  .......+||+.|+|||++.+..|+.++||||||++||||++|+.||......                .....+
T Consensus       493 ~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i  554 (674)
T 3pfq_A          493 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSI  554 (674)
T ss_dssp             CCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHH
T ss_pred             ccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence            322  22345678999999999999999999999999999999999999999753221                111111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM-----TDVVQS  428 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  428 (457)
                      +...+  .++.....++.+|+.+||+.||.+||++     .||+++
T Consensus       555 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          555 MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            22111  3444556689999999999999999997     777765

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-42  Score=337.17  Aligned_cols=275  Identities=21%  Similarity=0.268  Sum_probs=206.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEE--cCCcEEEEEEcccCchH--HHHHHHHHHHHHHhc---CCCCeeeEEEEEE----
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVL--SDGTVAAIKKLHRDGKQ--RERAFRMEVDLLSRL---HSPQLVELLGYCA----  220 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~hpniv~l~~~~~----  220 (457)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  46889999988643211  112355677777666   8999999999987    


Q ss_pred             -cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEe
Q 012739          221 -DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVT  299 (457)
Q Consensus       221 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  299 (457)
                       .....++||||++ |+|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence             5667899999997 699999987543  34899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT  379 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  379 (457)
                      |||+++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999866432   123456789999999999999999999999999999999999999985432111000000000000


Q ss_pred             chhHH-------hhhcC---CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          380 SREEA-------VEMVD---PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       380 ~~~~~-------~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      . ...       ...+.   ...........+..+.+|+.+||+.||++|||+.+++++  .++++...
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~~~~~  305 (326)
T 1blx_A          240 E-EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQDLER  305 (326)
T ss_dssp             G-GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTTCCC
T ss_pred             c-ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC--ccccccch
Confidence            0 000       00000   000011122344578999999999999999999999987  77776544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.4e-42  Score=343.17  Aligned_cols=264  Identities=19%  Similarity=0.239  Sum_probs=204.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC--------CCCeeeEEEEEE---
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH--------SPQLVELLGYCA---  220 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------hpniv~l~~~~~---  220 (457)
                      .++|++.++||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999864 5889999999754 334456788999999995        788999999987   


Q ss_pred             -cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCC----
Q 012739          221 -DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNF----  294 (457)
Q Consensus       221 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~----  294 (457)
                       .....++||||+ +++|.+++.....  ..+++..++.++.|++.||.|||++ +   |+||||||+|||++.++    
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence             566889999999 6677777765432  3599999999999999999999998 8   99999999999998775    


Q ss_pred             ---------------------------------------------cEEEeeccCccccccccCCccccccccCCCccccc
Q 012739          295 ---------------------------------------------RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE  329 (457)
Q Consensus       295 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE  329 (457)
                                                                   .+||+|||++......     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         7999999999876432     34457899999999


Q ss_pred             cccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchh---hhh---hccccCchh-----HHhhhcCCc-----C-
Q 012739          330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVL---VSW---ALPRLTSRE-----EAVEMVDPS-----L-  392 (457)
Q Consensus       330 ~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~---~~~---~~~~~~~~~-----~~~~~~d~~-----l-  392 (457)
                      ++.+..++.++|||||||++|||+||+.||...........   ...   .........     .....+...     + 
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            99999999999999999999999999999986543321100   000   000000000     000000000     0 


Q ss_pred             -------------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          393 -------------QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       393 -------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                                   ....+......+.+|+.+||+.||++|||+.|++++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                         013456778899999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.5e-43  Score=346.71  Aligned_cols=280  Identities=21%  Similarity=0.255  Sum_probs=206.3

Q ss_pred             chHHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc-----------hHHHHHHHHHHHHHHhcCCCCee
Q 012739          145 TYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG-----------KQRERAFRMEVDLLSRLHSPQLV  213 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~Ei~~l~~l~hpniv  213 (457)
                      ...++....++|.+.+.||+|+||.||+|...++..||+|++....           ....+.+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3467788889999999999999999999998889999999885431           12236688999999999999999


Q ss_pred             eEEEEEEc-----CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          214 ELLGYCAD-----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       214 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                      ++++++..     ....++||||++ |+|.+++....   ..+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            99999843     346899999996 68888887543   35899999999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCc
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE  367 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~  367 (457)
                      |++.++.+||+|||+++.....   .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999754432   22344678999999999876 7799999999999999999999999986432111


Q ss_pred             chhhhhhccccCc-------hhHHhhhcCCcCCCC-------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhh
Q 012739          368 HVLVSWALPRLTS-------REEAVEMVDPSLQGQ-------YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVV  433 (457)
Q Consensus       368 ~~~~~~~~~~~~~-------~~~~~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  433 (457)
                      .............       .......+...+...       ........+.+|+.+||+.||.+|||+.|++++  +++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f  320 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH--PYF  320 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGG
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC--chh
Confidence            1100000000000       001111111111110       111234578999999999999999999999997  777


Q ss_pred             hhc
Q 012739          434 KNN  436 (457)
Q Consensus       434 ~~~  436 (457)
                      ++.
T Consensus       321 ~~~  323 (362)
T 3pg1_A          321 ESL  323 (362)
T ss_dssp             TTT
T ss_pred             hhc
Confidence            754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-42  Score=336.13  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=197.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK--------QRERAFRMEVDLLSRLHSPQLVELLGYCADQ  222 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~  222 (457)
                      ..++|.+.+.||+|+||.||+|... +++.||+|.+.....        .....+.+|+++++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4567999999999999999999975 578999999865321        1123478899999999999999999999776


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc---EEEe
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVT  299 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~  299 (457)
                      + .++||||+++++|.+++....    .+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 899999999999999987543    4899999999999999999999999   999999999999987664   9999


Q ss_pred             eccCccccccccCCccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          300 DFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       300 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |||++......   .......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.........  ...   
T Consensus       160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~---  231 (322)
T 2ycf_A          160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ---  231 (322)
T ss_dssp             CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHH---
T ss_pred             cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHH---
Confidence            99999876432   2233457899999999873   567899999999999999999999999754332111  000   


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                             .... ............+..+.+|+.+||+.||++||++.+++++
T Consensus       232 -------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          232 -------ITSG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -------HHHT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------HHhC-ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                   0000 0000000001234578999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-41  Score=336.96  Aligned_cols=275  Identities=18%  Similarity=0.229  Sum_probs=209.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~  225 (457)
                      ..+|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467999999999999999999965 57889999987543 33446688999999999999999999999654     468


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+. |+|.+++...     .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999996 6999998753     3899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc---
Q 012739          306 MVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS---  380 (457)
Q Consensus       306 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  380 (457)
                      ........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........   
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            76543221 12345689999999998654 55899999999999999999999999765432221111110000000   


Q ss_pred             -----hhHHhhhcCCcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          381 -----REEAVEMVDPSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       381 -----~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                           ................     ......++.+|+.+||+.||.+|||+.|++++  .++++.-.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~~~~~~~  322 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLEQYYD  322 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTTCC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cchhhccC
Confidence                 0000000000000011     11234578999999999999999999999998  78877533

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-41  Score=333.01  Aligned_cols=269  Identities=20%  Similarity=0.288  Sum_probs=208.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE--cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC------CeeeEEEEEEcCCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL--SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP------QLVELLGYCADQNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp------niv~l~~~~~~~~~  224 (457)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.... ...+.+.+|+.+++.++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46789999999999999999986  368899999996543 3345678899999998765      49999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC------------
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ------------  292 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------  292 (457)
                      .++||||+ +++|.+++.....  .++++.+++.++.|++.||.|||+++   |+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8999999977542  35899999999999999999999999   999999999999987            


Q ss_pred             -------CCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC
Q 012739          293 -------NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP  365 (457)
Q Consensus       293 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~  365 (457)
                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   678999999999764332     33457899999999999999999999999999999999999999754322


Q ss_pred             CcchhhhhhccccCc------------------------h-hHHhhhcCCcC-CCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 012739          366 GEHVLVSWALPRLTS------------------------R-EEAVEMVDPSL-QGQYPKKDLIQIAAIAAVCVQPEAAYR  419 (457)
Q Consensus       366 ~~~~~~~~~~~~~~~------------------------~-~~~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~R  419 (457)
                      ...............                        . ........+.. ....+......+.+|+.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            111111110000000                        0 00000011100 012234567789999999999999999


Q ss_pred             CCHHHHHHHHHHhhhh
Q 012739          420 PLMTDVVQSLIPVVKN  435 (457)
Q Consensus       420 Ps~~evl~~L~~~~~~  435 (457)
                      ||+.|++++  +++++
T Consensus       321 pt~~ell~h--p~f~~  334 (339)
T 1z57_A          321 ITLREALKH--PFFDL  334 (339)
T ss_dssp             CCHHHHTTS--GGGGG
T ss_pred             cCHHHHhcC--HHHHH
Confidence            999999987  55554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-43  Score=338.15  Aligned_cols=272  Identities=21%  Similarity=0.362  Sum_probs=190.5

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999854 68899999986543 23345678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          229 SEYMPNGTLQQHLHRHN----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      |||+++++|.+++....    .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999987521    12345899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccC---CccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          305 KMVSDKIN---GQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       305 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............  .......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~  246 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQNDPPS  246 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSSCCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccCCCc
Confidence            76643211   112234578999999999865 56899999999999999999999999764332111000  0000000


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        ......++.....    .+..+.+++.+||+.||.+|||+.+++++  +++++
T Consensus       247 --~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h--~~~~~  293 (303)
T 2vwi_A          247 --LETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH--KFFQK  293 (303)
T ss_dssp             --TTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS--TTC--
T ss_pred             --cccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC--hhhhc
Confidence              0000011111122    33478999999999999999999999987  55554

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-42  Score=347.39  Aligned_cols=270  Identities=22%  Similarity=0.319  Sum_probs=200.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------eEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN------HRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------~~~l  227 (457)
                      .+|.+.++||+|+||.||+|+...+..+|+|++......    ..+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468889999999999999999887777999988654322    236999999999999999999985433      3789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEEEeeccCccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKM  306 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~  306 (457)
                      ||||+++ ++.+.+.........+++..+..++.|++.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999976 444444332222346999999999999999999999999   99999999999998 799999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ....   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....... ......
T Consensus       192 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p-~~~~~~  267 (394)
T 4e7w_A          192 LIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP-SREQIK  267 (394)
T ss_dssp             CCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CHHHHH
T ss_pred             ccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHHHHH
Confidence            6432   223446789999999998664 58999999999999999999999998643221111111100000 000000


Q ss_pred             h----hcCCcC---C-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          386 E----MVDPSL---Q-----GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       386 ~----~~d~~l---~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .    .....+   .     ..++...+.++.+|+.+||+.||.+|||+.|++++  .++++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~  329 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH--PFFDELR  329 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS--GGGSTTT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC--hhhhhhc
Confidence            0    000000   0     01122244589999999999999999999999987  7777543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=335.19  Aligned_cols=274  Identities=21%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA-----------  220 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-----------  220 (457)
                      .++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+++++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4678899999999999999999764 8899999997776666677899999999999999999999873           


Q ss_pred             ---cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcE
Q 012739          221 ---DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRA  296 (457)
Q Consensus       221 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  296 (457)
                         +.+..++||||++ |+|.+++..     .++++..++.++.|++.||.|||+.+   ++||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence               4467899999997 699999864     24899999999999999999999999   99999999999997 57799


Q ss_pred             EEeeccCccccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          297 KVTDFGLAKMVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      ||+|||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999876432111 12234567899999998865 77899999999999999999999999864321111111111


Q ss_pred             ccccCchhHHhhhc-----------C-CcCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          375 LPRLTSREEAVEMV-----------D-PSLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       375 ~~~~~~~~~~~~~~-----------d-~~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .+.... ....+..           . +... .......+.++.+|+.+||+.||.+|||+.|++++  .++++...
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~~~  314 (320)
T 2i6l_A          241 IPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH--PYMSIYSF  314 (320)
T ss_dssp             SCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--HHHHTTCC
T ss_pred             cCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC--cccccccC
Confidence            111000 0000000           0 0000 00111234589999999999999999999999997  77775443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=342.82  Aligned_cols=278  Identities=20%  Similarity=0.283  Sum_probs=190.7

Q ss_pred             cCCCC-CceeccCCcEEEEEEEEc---CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeEEE
Q 012739          154 ENFSE-GNVIGNGGFGVVYKGVLS---DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCA--DQNHRLL  227 (457)
Q Consensus       154 ~~~~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~l  227 (457)
                      +.|.+ .++||+|+||.||+|...   ++..||+|++.....  ...+.+|+.+++.++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 568999999999999965   478899999975532  235778999999999999999999995  4778999


Q ss_pred             EEEeCCCCcHHHHHhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe----CCCCcEEE
Q 012739          228 ISEYMPNGTLQQHLHRHN-----NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL----DQNFRAKV  298 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl  298 (457)
                      ||||+. ++|.+++....     .....+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 68888876432     12235899999999999999999999999   9999999999999    77899999


Q ss_pred             eeccCccccccccCC-ccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCc------chh
Q 012739          299 TDFGLAKMVSDKING-QISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE------HVL  370 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~------~~~  370 (457)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........      ...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999876543211 22345679999999999977 4589999999999999999999999975432100      000


Q ss_pred             hh-------------hh-ccccCchhHHhhhcCCcCCCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 012739          371 VS-------------WA-LPRLTSREEAVEMVDPSLQGQYP---------KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ  427 (457)
Q Consensus       371 ~~-------------~~-~~~~~~~~~~~~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  427 (457)
                      ..             |. ...+.........+.........         ......+.+|+.+||+.||.+|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00             00 00000000010111100000000         011346889999999999999999999999


Q ss_pred             HHHHhhhhcCCC
Q 012739          428 SLIPVVKNNAAG  439 (457)
Q Consensus       428 ~L~~~~~~~~~~  439 (457)
                      +  .++.+...+
T Consensus       334 h--p~f~~~~~~  343 (405)
T 3rgf_A          334 D--PYFLEDPLP  343 (405)
T ss_dssp             S--GGGTSSSCC
T ss_pred             C--hhhccCCCC
Confidence            8  888875543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.7e-42  Score=348.76  Aligned_cols=267  Identities=24%  Similarity=0.342  Sum_probs=199.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------CeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------NHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~~~  226 (457)
                      .+|++.+.||+|+||.||+|++. +++.||||++.....    ...+|+++++.++||||++++++|...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35788899999999999999985 589999999865432    234699999999999999999988532      2367


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-CcEEEeeccCcc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAK  305 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl~~  305 (457)
                      +||||+++ +|.+.+.........+++..++.++.|++.||.|||+++   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999964 777766543333356999999999999999999999999   9999999999999955 678999999998


Q ss_pred             ccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          306 MVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       306 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .+...   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....... ..+.+
T Consensus       206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p-~~~~~  281 (420)
T 1j1b_A          206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP-TREQI  281 (420)
T ss_dssp             ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC-CHHHH
T ss_pred             hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHHHH
Confidence            76432   123446789999999998764 79999999999999999999999998643211111111110000 00111


Q ss_pred             hhhcCCcC--------CC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSL--------QG-----QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l--------~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .. ..+..        ..     .++.....++.+|+.+||+.||.+|||+.|++++  .++++
T Consensus       282 ~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h--p~f~~  342 (420)
T 1j1b_A          282 RE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDE  342 (420)
T ss_dssp             HH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGG
T ss_pred             Hh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC--Hhhcc
Confidence            11 11111        00     0122334689999999999999999999999987  56654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-42  Score=339.08  Aligned_cols=269  Identities=19%  Similarity=0.262  Sum_probs=207.3

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHH-----------------HHHHHHHHHHHHhcCCCCeeeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQR-----------------ERAFRMEVDLLSRLHSPQLVEL  215 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~hpniv~l  215 (457)
                      .++|.+.+.||+|+||.||+|.. +++.||+|++.......                 .+.+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46789999999999999999999 99999999986432111                 1678899999999999999999


Q ss_pred             EEEEEcCCeEEEEEEeCCCCcHHHH------HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCce
Q 012739          216 LGYCADQNHRLLISEYMPNGTLQQH------LHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNV  288 (457)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NI  288 (457)
                      ++++.+.+..++||||+++++|.++      +...  ....+++..++.++.|++.||.|||+ .+   ++||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence            9999999999999999999999998      4432  13469999999999999999999999 88   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCC-CCCc-ccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTT-KSDVYSYGVVLLELLTGRVPVDPNRPPG  366 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~SlG~il~elltg~~p~~~~~~~~  366 (457)
                      |++.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999999999999876432    23456789999999999877 6766 9999999999999999999998543311


Q ss_pred             cchhhhhhccc---cCc-hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          367 EHVLVSWALPR---LTS-REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       367 ~~~~~~~~~~~---~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .  ........   ... .........+..........+..+.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       260 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h--p~f~~  328 (348)
T 2pml_X          260 E--LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH--EWLAD  328 (348)
T ss_dssp             H--HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS--GGGTT
T ss_pred             H--HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC--ccccC
Confidence            1  11110000   000 000000000000000112345589999999999999999999999986  55554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-41  Score=336.57  Aligned_cols=281  Identities=23%  Similarity=0.269  Sum_probs=200.0

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH-  224 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-  224 (457)
                      .......++|++.+.||+|+||.||+|... ++..||+|++...... .....+|++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345667789999999999999999999975 5899999988654322 2345668888899999999999999865433 


Q ss_pred             ------EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeccCccCceEeCC-CCc
Q 012739          225 ------RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH--EHATPPVIHRDFKCSNVLLDQ-NFR  295 (457)
Q Consensus       225 ------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~  295 (457)
                            .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  7899999965 666655543334456899999999999999999999  888   999999999999996 899


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      +||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...
T Consensus       171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            9999999998765432   23345789999999998654 4899999999999999999999999864322111111000


Q ss_pred             ccccCchhHHhhhcCCcC----------------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          375 LPRLTSREEAVEMVDPSL----------------QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l----------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      .... . ......+++..                ....+......+.+|+.+||+.||.+|||+.|++++  .++++...
T Consensus       248 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~~~~  323 (360)
T 3e3p_A          248 LGCP-S-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH--PYFDELHD  323 (360)
T ss_dssp             HCCC-C-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS--GGGGGGGC
T ss_pred             cCCC-C-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC--ccccccCC
Confidence            0000 0 01111111100                011222356789999999999999999999999998  88887554


Q ss_pred             C
Q 012739          439 G  439 (457)
Q Consensus       439 ~  439 (457)
                      +
T Consensus       324 ~  324 (360)
T 3e3p_A          324 P  324 (360)
T ss_dssp             T
T ss_pred             c
Confidence            3

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-41  Score=327.17  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=198.0

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc---------
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD---------  221 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~---------  221 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3467889999999999999999974 6899999998653 3445678899999999999999999998865         


Q ss_pred             ----CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEE
Q 012739          222 ----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAK  297 (457)
Q Consensus       222 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  297 (457)
                          .+..++||||+++++|.+++....   ..+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                356799999999999999998643   34788999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccccccC------------CccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 012739          298 VTDFGLAKMVSDKIN------------GQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRP  364 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~  364 (457)
                      |+|||++........            ........||+.|+|||.+.+. .++.++||||||+++|||++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            999999986643210            1122345689999999999764 78999999999999999998   5542100


Q ss_pred             CCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          365 PGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                           ....        ..........+...++...+..+.+++.+||+.||.+|||+.+++++  .+++
T Consensus       234 -----~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h--~~~~  288 (303)
T 1zy4_A          234 -----RVNI--------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS--GWLP  288 (303)
T ss_dssp             -----HHHH--------HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS--SCSC
T ss_pred             -----HHHH--------HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC--CCcC
Confidence                 0000        00011112222233444555678999999999999999999999986  4443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.7e-41  Score=325.09  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=206.4

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999975 68899999986542  2334568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC---CcEEEeeccCc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN---FRAKVTDFGLA  304 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgl~  304 (457)
                      ||||+++++|.+++....    .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999987654    4899999999999999999999999   9999999999999754   47999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......   ......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......   ....          .+
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----------~~  234 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----------RV  234 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----------HH
T ss_pred             eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----------HH
Confidence            8664321   1233458899999999865 4899999999999999999999999753211   0000          00


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ... ............+..+.+++.+||+.+|++|||+.+++++  +++++.
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--p~~~~~  283 (287)
T 2wei_A          235 ETG-KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH--PWIQKY  283 (287)
T ss_dssp             HHC-CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS--HHHHHH
T ss_pred             HcC-CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC--HHHhcc
Confidence            000 0000000011234579999999999999999999999987  666653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=341.04  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH  224 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~  224 (457)
                      +++....++|++.+.||+|+||.||+|...+  .+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3444456789999999999999999998754  48999886542  2223457789999999999999999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .++||||+++++|.+++....   ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++ ++.+||+|||++
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             eEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence            999999999999999997643   35899999999999999999999999   99999999999998 679999999998


Q ss_pred             ccccccc---CCccccccccCCCccccccccC---------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhh
Q 012739          305 KMVSDKI---NGQISTRVLGTTGYLAPEYAST---------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS  372 (457)
Q Consensus       305 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~  372 (457)
                      .......   .........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||......   ... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~-  252 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII-  252 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH-
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-
Confidence            7653211   1122334568999999999864         45789999999999999999999999753221   000 


Q ss_pred             hhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       373 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      +         .......+...   +...+..+.+++.+||+.||++|||+.++++.|+++.++...
T Consensus       253 ~---------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          253 W---------QMGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             H---------HHHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             H---------HhccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            0         01111111111   112234689999999999999999999999999999887544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.5e-42  Score=340.26  Aligned_cols=269  Identities=20%  Similarity=0.298  Sum_probs=189.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ------N  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~  223 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999864 6889999998654  334456688999999999999999999998654      5


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++|+|++ +++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 7899998865     24999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc------
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP------  376 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------  376 (457)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....      
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865432     344678999999999876 6899999999999999999999999976432111111111000      


Q ss_pred             --ccCch--hHHhhhcCCcCCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          377 --RLTSR--EEAVEMVDPSLQGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       377 --~~~~~--~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                        .+...  ......+.......+   .......+.+|+.+||+.||.+|||+.|++++  .++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h--p~~~~~~  319 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYH  319 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTC
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--hhhhhcc
Confidence              00000  000000000000000   01224578999999999999999999999998  7776543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-41  Score=335.58  Aligned_cols=274  Identities=22%  Similarity=0.296  Sum_probs=205.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~  225 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999975 58899999996543 33445678999999999999999999988654     678


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ++||||+. ++|.+++...     .+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999996 6999998762     4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCc--------cccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          306 MVSDKINGQ--------ISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       306 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      .........        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            765322111        1223578999999998754 7789999999999999999999999986432111100000000


Q ss_pred             ---------ccCchhHHhhhcCC--cCC-C---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          377 ---------RLTSREEAVEMVDP--SLQ-G---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       377 ---------~~~~~~~~~~~~d~--~l~-~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                               .... ....+.+..  ... .   ......+.++.+|+.+||+.||.+|||+.|++++  .++++...
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~~~  314 (353)
T 2b9h_A          241 TPHSDNDLRCIES-PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH--PYLQTYHD  314 (353)
T ss_dssp             CCCSTTTTTTCCC-HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTCC
T ss_pred             CCchhcccccccc-chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC--ccccccCC
Confidence                     0000 000000000  000 0   0011234578999999999999999999999997  78876443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.5e-41  Score=334.76  Aligned_cols=270  Identities=21%  Similarity=0.313  Sum_probs=205.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----------SPQLVELLGYCA  220 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------hpniv~l~~~~~  220 (457)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|++... ......+.+|+.+++.++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35788999999999999999996 46889999999754 334456788999999886           899999999987


Q ss_pred             cCC----eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeC----
Q 012739          221 DQN----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLD----  291 (457)
Q Consensus       221 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~----  291 (457)
                      ..+    ..++||||+ +++|.+++.....  ..+++..++.++.|++.||.|||++ +   |+||||||+|||++    
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            654    789999999 8999999987443  3589999999999999999999998 8   99999999999994    


Q ss_pred             --CCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCc--
Q 012739          292 --QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE--  367 (457)
Q Consensus       292 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~--  367 (457)
                        ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||+||+.||........  
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              4558999999999876432     3345789999999999999999999999999999999999999985432110  


Q ss_pred             -chhhhhh---ccccCch-----hHHhhhcCC-------------------cCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 012739          368 -HVLVSWA---LPRLTSR-----EEAVEMVDP-------------------SLQGQYPKKDLIQIAAIAAVCVQPEAAYR  419 (457)
Q Consensus       368 -~~~~~~~---~~~~~~~-----~~~~~~~d~-------------------~l~~~~~~~~~~~l~~li~~cl~~~p~~R  419 (457)
                       .......   .......     ......++.                   .-...++.....++.+|+.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence             0000000   0000000     000000000                   00113556778899999999999999999


Q ss_pred             CCHHHHHHHHHHhhhhc
Q 012739          420 PLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       420 Ps~~evl~~L~~~~~~~  436 (457)
                      ||+.|++++  .++++.
T Consensus       326 pt~~ell~h--p~f~~~  340 (373)
T 1q8y_A          326 ADAGGLVNH--PWLKDT  340 (373)
T ss_dssp             BCHHHHHTC--GGGTTC
T ss_pred             CCHHHHhhC--hhhhcc
Confidence            999999997  777763

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.1e-42  Score=339.70  Aligned_cols=268  Identities=19%  Similarity=0.297  Sum_probs=202.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE----
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR----  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~----  225 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 5889999999764  233346688999999999999999999999877654    


Q ss_pred             --EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          226 --LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       226 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                        ++||||+. ++|.+++..      .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999996 688887732      3899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhc-------
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL-------  375 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------  375 (457)
                      ++.....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||................       
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            9865432     344578999999999877 789999999999999999999999997643211111000000       


Q ss_pred             -cccCch--hHHhhhcCCcCCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          376 -PRLTSR--EEAVEMVDPSLQGQ---YPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       376 -~~~~~~--~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                       ..+...  ......+.......   ........+.+|+.+||+.||++|||+.|++++  .++++..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~~  331 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEPFR  331 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTTC
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--cccccCC
Confidence             000000  00001111111110   112235689999999999999999999999998  7777543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-41  Score=332.74  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=182.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHH-HHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVD-LLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467888999999999999999975 68899999997653 333344555555 778889999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          230 EYMPNGTLQQHLHRHN-NRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||++ ++|.+++.... .....+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9997 58888776421 1124689999999999999999999998 8   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccc----cCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYA----STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ....   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||..........      ....    
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~----  243 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVV----  243 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC----
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHh----
Confidence            4321   22334689999999998    46678999999999999999999999997532210000      0000    


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                        ....+.+...........+.+|+.+||+.||.+|||+.+++++  .++.
T Consensus       244 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h--p~~~  290 (327)
T 3aln_A          244 --KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH--PFIL  290 (327)
T ss_dssp             --CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS--HHHH
T ss_pred             --cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC--hHHH
Confidence              0001111111122334589999999999999999999999986  4444

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-41  Score=330.96  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=179.6

Q ss_pred             hcCCCCC-ceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEE
Q 012739          153 TENFSEG-NVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHRL  226 (457)
Q Consensus       153 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~  226 (457)
                      .++|.+. ++||+|+||.||+|... +++.||+|++.....    ...+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4677774 46999999999999976 689999999865422    12223345677899999999999865    45589


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccC
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGL  303 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  303 (457)
                      +||||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999986532  46999999999999999999999999   999999999999976   45599999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ++.....    ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...........       ...   
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~---  243 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-------MKR---  243 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-------HHH---
Confidence            9865432    23445789999999999989999999999999999999999999975432111000       000   


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ........+........+..+.+|+.+||+.||.+|||+.|++++  .++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~~  295 (336)
T 3fhr_A          244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH--PWINQSM  295 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS--HHHHTGG
T ss_pred             hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC--ccccccc
Confidence            000000001111112344579999999999999999999999997  7777643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-42  Score=334.79  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH------HHHHHHHHHHHHHhcC--CCCeeeEEEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ------RERAFRMEVDLLSRLH--SPQLVELLGYC  219 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--hpniv~l~~~~  219 (457)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|++......      ..+.+.+|+.+++.++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999986 46889999998654211      1234667999999996  59999999999


Q ss_pred             EcCCeEEEEEEeCCC-CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEE
Q 012739          220 ADQNHRLLISEYMPN-GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAK  297 (457)
Q Consensus       220 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  297 (457)
                      ...+..++|+|++.+ ++|.+++....    .+++..++.++.|++.||.|||+.+   |+||||||+|||++ +++.+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            999999999999976 89999998754    4899999999999999999999999   99999999999998 789999


Q ss_pred             EeeccCccccccccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          298 VTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      |+|||+++.....    ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....             
T Consensus       191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------  253 (320)
T 3a99_A          191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------  253 (320)
T ss_dssp             ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------
Confidence            9999999876532    2334568999999999877665 688999999999999999999996321             


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                            .... ....+...+    +.++.+|+.+||+.||++|||+.+++++  .++++...
T Consensus       254 ------~~~~-~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h--p~~~~~~~  302 (320)
T 3a99_A          254 ------EIIR-GQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH--PWMQDVLL  302 (320)
T ss_dssp             ------HHHH-CCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSSCCC
T ss_pred             ------hhhc-ccccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC--HhhcCccC
Confidence                  0000 001111223    3478999999999999999999999987  66666443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-41  Score=333.44  Aligned_cols=271  Identities=21%  Similarity=0.221  Sum_probs=205.4

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEcCCe
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SP-----QLVELLGYCADQNH  224 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hp-----niv~l~~~~~~~~~  224 (457)
                      ..++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999999975 5788999999754 333456778888888885 44     49999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEeccCccCceEeC--CCCcEEEee
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE--HATPPVIHRDFKCSNVLLD--QNFRAKVTD  300 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~~~~ivH~Dlkp~NIll~--~~~~~kl~D  300 (457)
                      .++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||.  .+   |+||||||+|||++  .++.+||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             eEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999995 699999987542  358999999999999999999994  56   99999999999994  578899999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc--
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL--  378 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  378 (457)
                      ||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.......  
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999876432     334678999999999999999999999999999999999999998643211111000000000  


Q ss_pred             ------CchhHHh-----------------------------hhcCCc---------CCCCCCHHHHHHHHHHHHhhcCC
Q 012739          379 ------TSREEAV-----------------------------EMVDPS---------LQGQYPKKDLIQIAAIAAVCVQP  414 (457)
Q Consensus       379 ------~~~~~~~-----------------------------~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~  414 (457)
                            .......                             ..+...         -...........+.+|+.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                  0000000                             000000         00012234456899999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhhhhc
Q 012739          415 EAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       415 ~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ||++|||+.|++++  +++++.
T Consensus       360 dP~~Rpta~e~L~h--p~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQH--SFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTS--GGGCC-
T ss_pred             ChhhCCCHHHHhcC--cccccC
Confidence            99999999999987  666653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.7e-41  Score=329.99  Aligned_cols=271  Identities=22%  Similarity=0.303  Sum_probs=207.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CC-cEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC------eeeEEEEEEcCCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DG-TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ------LVELLGYCADQNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn------iv~l~~~~~~~~~  224 (457)
                      .++|++.+.||+|+||.||+|... ++ ..||+|++.... ...+.+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468899999999999999999974 34 689999996543 34456788999999997655      9999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe--------------
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL--------------  290 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--------------  290 (457)
                      .++||||+ +++|.+++.....  ..+++.+++.++.|++.||.|||+++   |+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            99999999 6777777766432  35899999999999999999999999   9999999999999              


Q ss_pred             -----CCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC
Q 012739          291 -----DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPP  365 (457)
Q Consensus       291 -----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~  365 (457)
                           +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999764332     34467999999999999999999999999999999999999999854321


Q ss_pred             CcchhhhhhccccCc------------------------h-hHHhhhcCCcC-CCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 012739          366 GEHVLVSWALPRLTS------------------------R-EEAVEMVDPSL-QGQYPKKDLIQIAAIAAVCVQPEAAYR  419 (457)
Q Consensus       366 ~~~~~~~~~~~~~~~------------------------~-~~~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~R  419 (457)
                      ...............                        . ....+...+.. ...........+.+|+.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            111111110000000                        0 00000000000 011223456689999999999999999


Q ss_pred             CCHHHHHHHHHHhhhhcC
Q 012739          420 PLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       420 Ps~~evl~~L~~~~~~~~  437 (457)
                      ||+.|++++  +++++..
T Consensus       326 pt~~e~l~h--p~f~~~~  341 (355)
T 2eu9_A          326 ITLAEALLH--PFFAGLT  341 (355)
T ss_dssp             CCHHHHTTS--GGGGGCC
T ss_pred             cCHHHHhcC--hhhcCCC
Confidence            999999987  7777643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=325.19  Aligned_cols=252  Identities=27%  Similarity=0.470  Sum_probs=196.9

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH------HHHHHHHHHHHHHhc----CCCCeeeEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ------RERAFRMEVDLLSRL----HSPQLVELLG  217 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~hpniv~l~~  217 (457)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.+++.+    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345568899999999999999999986 46889999999655321      222356799999999    8999999999


Q ss_pred             EEEcCCeEEEEEEe-CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCc
Q 012739          218 YCADQNHRLLISEY-MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFR  295 (457)
Q Consensus       218 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~  295 (457)
                      ++...+..++|+|+ +.+++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++ .++.
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            99999999999999 78999999998754    4899999999999999999999999   99999999999998 8999


Q ss_pred             EEEeeccCccccccccCCccccccccCCCccccccccCCCCC-cccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh
Q 012739          296 AKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLT-TKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA  374 (457)
Q Consensus       296 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~  374 (457)
                      +||+|||++......    ......|+..|+|||.+.+..+. .++||||||+++|||++|+.||....           
T Consensus       179 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------  243 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------  243 (312)
T ss_dssp             EEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred             EEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence            999999999876542    23445689999999998776664 58999999999999999999996310           


Q ss_pred             ccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       375 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                              .... ...    ..+......+.+++.+||+.+|++|||+.|++++  .++++..
T Consensus       244 --------~~~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~--~~~~~~~  291 (312)
T 2iwi_A          244 --------EILE-AEL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD--PWMQTPA  291 (312)
T ss_dssp             --------HHHH-TCC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS--TTTCC--
T ss_pred             --------HHhh-hcc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC--hhhcCch
Confidence                    0000 011    1222334578999999999999999999999987  6666533

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-41  Score=339.22  Aligned_cols=253  Identities=20%  Similarity=0.281  Sum_probs=188.8

Q ss_pred             CCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      .|...++||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++.+ +||||+++++++.+.+..++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            345568899999999987777789999999986542   34567899999886 89999999999999999999999995


Q ss_pred             CCcHHHHHhhhCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCC-------------CcEE
Q 012739          234 NGTLQQHLHRHNNRYRP---LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN-------------FRAK  297 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k  297 (457)
                       |+|.+++.........   ..+..++.++.|++.||.|||+++   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865432111   133456789999999999999999   9999999999999654             4899


Q ss_pred             EeeccCccccccccCC--ccccccccCCCccccccccC-------CCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 012739          298 VTDFGLAKMVSDKING--QISTRVLGTTGYLAPEYAST-------GKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGE  367 (457)
Q Consensus       298 l~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~  367 (457)
                      |+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999999877543211  12234679999999999865       678999999999999999999 999996432210 


Q ss_pred             chhhhhhccccCchhHHhhhcC-CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          368 HVLVSWALPRLTSREEAVEMVD-PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .             ........ +......+...+.++.+|+.+||+.||.+|||+.+|+++
T Consensus       248 ~-------------~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 S-------------NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             H-------------HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H-------------HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            0             00001111 111112345667899999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=328.38  Aligned_cols=267  Identities=20%  Similarity=0.303  Sum_probs=201.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-----
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH-----  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-----  224 (457)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467888999999999999999975 5889999998654  23334568899999999999999999999987654     


Q ss_pred             -EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          225 -RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       225 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                       .++||||+. ++|.+++..      .+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999996 688877632      3899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhh--------
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA--------  374 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~--------  374 (457)
                      ++.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...        
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865432     234578999999999876 68899999999999999999999999754321110000000        


Q ss_pred             ccccCch--hHHhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          375 LPRLTSR--EEAVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       375 ~~~~~~~--~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+...  ......+.....   ..........+.+|+.+||+.||++|||+.+++++  .++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h--p~f~~~  312 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEPF  312 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC--cchhhc
Confidence            0000000  000011111111   11223445689999999999999999999999987  777653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=321.67  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=182.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HH-HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QR-ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888899999999999999975 689999999876532 22 233555666788899999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      ||+ ++.+..+.....   ..+++..++.++.|++.||.|||++ +   ++|+||||+|||++.++.+||+|||++....
T Consensus       104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 556666554433   3589999999999999999999995 8   9999999999999999999999999997654


Q ss_pred             cccCCccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          309 DKINGQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ..   .......+|+.|+|||.+.     ...++.++||||||+++|||++|+.||.......  ...          ..
T Consensus       177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----------~~  241 (318)
T 2dyl_A          177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVL----------TK  241 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH----------HH
T ss_pred             CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHH----------HH
Confidence            32   1233456899999999984     5678899999999999999999999997532210  000          00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ......+.+.  .....+..+.+++.+||+.||.+||++.+++++
T Consensus       242 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          242 VLQEEPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHSCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HhccCCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111111111  111234579999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=335.22  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=188.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ..+|...++||+|+||+||.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3467888999999999976655668999999998654322   246799999999 799999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-----CCcEEEeeccCccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-----NFRAKVTDFGLAKM  306 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgl~~~  306 (457)
                      +. |+|.+++.....   .+.+.+++.++.|++.||.|||+.+   |+||||||+|||++.     ...+||+|||+++.
T Consensus       100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            95 699999986543   2444556789999999999999999   999999999999943     34688999999987


Q ss_pred             cccccCC-ccccccccCCCcccccccc---CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCch
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYAS---TGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      ....... .......||+.|+|||++.   ...++.++|||||||++|||+| |..||......                
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----------------  236 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----------------  236 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----------------
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----------------
Confidence            6533211 2234567999999999997   4667889999999999999999 89998632211                


Q ss_pred             hHHhhhcC-CcCC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          382 EEAVEMVD-PSLQ-GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       382 ~~~~~~~d-~~l~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                       ....... .... ...+......+.+|+.+||+.||.+|||+.+|+++
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          237 -QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence             0000000 0011 11223455678899999999999999999999954

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-39  Score=341.84  Aligned_cols=273  Identities=25%  Similarity=0.376  Sum_probs=208.6

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CCe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD------QNH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~  224 (457)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999974 5889999998765 34445668899999999999999999998755      677


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCc---EEEeec
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFR---AKVTDF  301 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  301 (457)
                      .++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999986442 235888999999999999999999999   999999999999987664   999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++......   .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ..|........
T Consensus       169 G~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred             ccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence            999876543   2234567999999999999999999999999999999999999999753211     11110000000


Q ss_pred             hHHh---h------hcCCc--CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH-----HHHHHHHhhhhcC
Q 012739          382 EEAV---E------MVDPS--LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD-----VVQSLIPVVKNNA  437 (457)
Q Consensus       382 ~~~~---~------~~d~~--l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-----vl~~L~~~~~~~~  437 (457)
                      ....   +      .+...  .........+..+.+++..||+.||++|||+.+     +.+.+++++...-
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki  312 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL  312 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence            0000   0      00000  112344567789999999999999999999998     6677777777643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-39  Score=347.56  Aligned_cols=242  Identities=21%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc--CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-----
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS--DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNH-----  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-----  224 (457)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++.... ......+.+|+.+++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  58899999986543 3444568899999999999999999999987655     


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .||||||+++++|.+++..      .+++.+++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence            7999999999999887643      4899999999999999999999999   9999999999999886 8999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      +.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......           +.     
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-----  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-----  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-----
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc-----
Confidence            876432      4457999999999987654 899999999999999999998876421100           00     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHhhhh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-LMTDVVQSLIPVVKN  435 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~  435 (457)
                              ...........+.+|+.+||+.||.+|| +++++.+.|..++++
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                    0000112345789999999999999999 577777788777764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.3e-39  Score=307.38  Aligned_cols=235  Identities=15%  Similarity=0.100  Sum_probs=185.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC-CcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      .++|++.+.||+|+||.||+|.... ++.||+|++....   ....+.+.+|+..++.++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3678889999999999999999754 8999999997653   33346688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++...      ....++..++.|++.||.|||+++   |+||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999998531      355678899999999999999999   9999999999999999999998544      


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                                      |++       .++.++|||||||++|||+||+.||...........   ........      .
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~------~  222 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQ------P  222 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTSC------B
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhccC------C
Confidence                            333       368999999999999999999999986543221100   00000000      0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      .  .........+..+.+++.+||+.||.+| |+.|+++.|+++.....
T Consensus       223 ~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          223 I--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             C--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             C--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            0  0000111234579999999999999999 99999999999876544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.8e-38  Score=303.78  Aligned_cols=234  Identities=23%  Similarity=0.332  Sum_probs=183.2

Q ss_pred             cCCCCC-ceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHH-HhcCCCCeeeEEEEEEc----CCeEE
Q 012739          154 ENFSEG-NVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLL-SRLHSPQLVELLGYCAD----QNHRL  226 (457)
Q Consensus       154 ~~~~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~----~~~~~  226 (457)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 7799999999999997 46889999998643     2456788887 66699999999999876    67789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccC
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGL  303 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  303 (457)
                      +||||+++|+|.+++.....  ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999987542  35899999999999999999999999   999999999999998   78999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      +....                        +..++.++|||||||++|||+||+.||..........       ...    
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~----  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK----  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSC----
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHH----
Confidence            86432                        2457889999999999999999999997543211000       000    


Q ss_pred             HhhhcCCcCCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          384 AVEMVDPSLQGQYP----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       384 ~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                        ..+... ....+    ...+.++.+++.+||+.||.+|||+.|++++  .++++..
T Consensus       212 --~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h--p~~~~~~  264 (299)
T 3m2w_A          212 --TRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH--PWIMQST  264 (299)
T ss_dssp             --CSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHTGG
T ss_pred             --HHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC--hhhcccc
Confidence              000000 00111    1234589999999999999999999999997  6776543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-39  Score=323.67  Aligned_cols=243  Identities=16%  Similarity=0.189  Sum_probs=181.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchH---HHHHHHHHHHHHHhcCC-CCe----------------
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQ---RERAFRMEVDLLSRLHS-PQL----------------  212 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~h-pni----------------  212 (457)
                      ..|...++||+|+||.||+|.+ .+++.||||++......   ..+.+++|+.+++.+.| +|.                
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4466778999999999999995 46899999998744322   24668899999999987 221                


Q ss_pred             -----eeEEEEEEc-----CCeEEEEEEeCCCCcHHHHHhhh---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012739          213 -----VELLGYCAD-----QNHRLLISEYMPNGTLQQHLHRH---NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVI  279 (457)
Q Consensus       213 -----v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  279 (457)
                           ..++.++..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.||.|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                 111111111     22456777766 78999888532   223345888999999999999999999999   99


Q ss_pred             eccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccc----------cCCCCCcccchHHHHHHH
Q 012739          280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA----------STGKLTTKSDVYSYGVVL  349 (457)
Q Consensus       280 H~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~SlG~il  349 (457)
                      ||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998865432     344567 999999999          566789999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          350 LELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       350 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      |||+||+.||..........                ..+..  ...++    ..+.+|+.+||+.||++||++.+++++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE----------------WIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG----------------GGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHCCCCCCCcchhhhHH----------------HHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999997543211100                00110  01233    479999999999999999998777543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-37  Score=305.87  Aligned_cols=242  Identities=18%  Similarity=0.209  Sum_probs=186.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc--------hHHHHHHHHHHHHHHhcC---------CCCeeeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--------KQRERAFRMEVDLLSRLH---------SPQLVEL  215 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------hpniv~l  215 (457)
                      .++|++.+.||+|+||.||+|+. +++.||+|++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46688899999999999999998 78999999987542        122356788999988885         8888888


Q ss_pred             EEEEE------------------------------cCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHH
Q 012739          216 LGYCA------------------------------DQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM  265 (457)
Q Consensus       216 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  265 (457)
                      .+.+.                              +.+..++||||+++|++.+.+..     ..+++.+++.++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            88753                              26789999999999977666643     24899999999999999


Q ss_pred             HHHHHH-hcCCCCeEeccCccCceEeCCCC--------------------cEEEeeccCccccccccCCccccccccCCC
Q 012739          266 ALEFLH-EHATPPVIHRDFKCSNVLLDQNF--------------------RAKVTDFGLAKMVSDKINGQISTRVLGTTG  324 (457)
Q Consensus       266 ~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  324 (457)
                      ||.||| +.+   |+||||||+|||++.++                    .+||+|||+++.....       ...||+.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 899   99999999999999887                    9999999999876432       3479999


Q ss_pred             ccccccccCCCCCcccchHHHHHH-HHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh--cCCcCCCCCCHHHH
Q 012739          325 YLAPEYASTGKLTTKSDVYSYGVV-LLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM--VDPSLQGQYPKKDL  401 (457)
Q Consensus       325 y~aPE~~~~~~~s~~sDV~SlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~~  401 (457)
                      |+|||++.+.. +.++||||||++ .+++++|..||...         .|... .  .......  .............+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~s  309 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHY-L--TDKMLKQMTFKTKCNTPAMKQIK  309 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHH-H--HHHHHHTCCCSSCCCSHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhH-H--HHhhhhhhccCcccchhhhhhcC
Confidence            99999998766 899999998777 77889999988520         01000 0  0011110  11111112234577


Q ss_pred             HHHHHHHHhhcCCCCCCCCCHHHHH-HH
Q 012739          402 IQIAAIAAVCVQPEAAYRPLMTDVV-QS  428 (457)
Q Consensus       402 ~~l~~li~~cl~~~p~~RPs~~evl-~~  428 (457)
                      .++.+|+.+||+.|     |+.|++ ++
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHHhccC-----CHHHHHhcC
Confidence            89999999999976     999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.4e-32  Score=284.04  Aligned_cols=185  Identities=16%  Similarity=0.087  Sum_probs=131.1

Q ss_pred             eccCCcEEEEEEE-EcCCcEEEEEEcccCc----------hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 012739          162 IGNGGFGVVYKGV-LSDGTVAAIKKLHRDG----------KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       162 LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      .+.|++|.+..++ ..-|+.+++|.+....          ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666666554 3358889999886541          12235689999999999 7999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||++|++|.++|....    +++..   .|+.||+.||+|||++|   ||||||||+|||++.+|.+||+|||+++....
T Consensus       322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999997643    46654   47889999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPV  359 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~  359 (457)
                      ..  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            32  23455789999999999865 4677899999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.2e-28  Score=253.87  Aligned_cols=186  Identities=19%  Similarity=0.210  Sum_probs=145.4

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG--------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ...++||+|+||.||+|.. .+..+++|+.....        ....+.+.+|+++++.++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999955 56778888753321        11124578999999999999999666666677778999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++++|.+++..            ++.++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999865            4578999999999999999   999999999999998  99999999999875


Q ss_pred             cccCCc-----cccccccCCCccccccccC--CCCCcccchHHHHHHHHHHHcCCCCCC
Q 012739          309 DKINGQ-----ISTRVLGTTGYLAPEYAST--GKLTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       309 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                      ......     ......||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            432111     1245789999999999976  678889999999999999888877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.1e-24  Score=207.58  Aligned_cols=163  Identities=15%  Similarity=0.087  Sum_probs=125.7

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCch------------------HHHHHHHHHHHHHHhcCCC
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK------------------QRERAFRMEVDLLSRLHSP  210 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~hp  210 (457)
                      +......|.+.+.||+|+||.||+|...+++.||+|.+.....                  .....+.+|+.+++.++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3344456777899999999999999997799999999864321                  124568899999999984 


Q ss_pred             CeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEe
Q 012739          211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLL  290 (457)
Q Consensus       211 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  290 (457)
                        +++.+++.. +..++||||+++++|.+ +..          .+...++.|++.||.|||+.+   |+||||||+|||+
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence              455554433 45699999999999988 421          124469999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccccccCCccccccccCCCccccccccC----------CCCCcccchHHH
Q 012739          291 DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST----------GKLTTKSDVYSY  345 (457)
Q Consensus       291 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~~sDV~Sl  345 (457)
                      + ++.+||+|||+++.               +..++|||.+..          ..|...+|+|.+
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            9 99999999999863               334789998743          344555666543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.3e-20  Score=175.53  Aligned_cols=136  Identities=21%  Similarity=0.170  Sum_probs=106.0

Q ss_pred             CCCCceeccCCcEEEEEEEE-cCCcE--EEEEEcccCch------------------------HHHHHHHHHHHHHHhcC
Q 012739          156 FSEGNVIGNGGFGVVYKGVL-SDGTV--AAIKKLHRDGK------------------------QRERAFRMEVDLLSRLH  208 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~------------------------~~~~~~~~Ei~~l~~l~  208 (457)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999997 67888  99998654311                        11135788999999998


Q ss_pred             CCC--eeeEEEEEEcCCeEEEEEEeCCC-C----cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 012739          209 SPQ--LVELLGYCADQNHRLLISEYMPN-G----TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH-EHATPPVIH  280 (457)
Q Consensus       209 hpn--iv~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH  280 (457)
                      |++  ++.++++    +..+|||||+.+ |    +|.++...       .++.++..++.|++.||.||| +.+   |+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            875  3444443    246899999942 4    67665432       224456789999999999999 888   999


Q ss_pred             ccCccCceEeCCCCcEEEeeccCcccc
Q 012739          281 RDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       281 ~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=6.1e-17  Score=158.85  Aligned_cols=135  Identities=16%  Similarity=0.147  Sum_probs=100.0

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCch-----------------HH---H--HHHHHHHHHHHhcCCCCe-
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK-----------------QR---E--RAFRMEVDLLSRLHSPQL-  212 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------------~~---~--~~~~~Ei~~l~~l~hpni-  212 (457)
                      |.+.+.||.|+||.||+|...+|+.||||+++....                 ..   .  .....|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            889999999999999999998999999998643210                 00   0  012457777777755443 


Q ss_pred             -eeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC
Q 012739          213 -VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD  291 (457)
Q Consensus       213 -v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  291 (457)
                       ...+++  ..  .+|||||++|++|.++..        .  .+...++.|++.+|.|||..|   ||||||||.|||++
T Consensus       177 vp~p~~~--~~--~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          177 VPEPIAQ--SR--HTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             CCCEEEE--ET--TEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCeeeec--cC--ceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence             233332  22  379999999888865432        1  233567889999999999999   99999999999998


Q ss_pred             CCC----------cEEEeeccCcccc
Q 012739          292 QNF----------RAKVTDFGLAKMV  307 (457)
Q Consensus       292 ~~~----------~~kl~Dfgl~~~~  307 (457)
                      +++          .+.|+||+-+...
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCcccccccccceEEEEeCCcccC
Confidence            776          3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=8.2e-13  Score=123.85  Aligned_cols=146  Identities=14%  Similarity=0.073  Sum_probs=112.5

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv  228 (457)
                      ......|.+...++.|+.+.||++.. +++.+++|............+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34446788888889999999999975 46889999886421112234788999999984 67788999999988999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA----------------------------------  274 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------  274 (457)
                      |||++|.+|.+.+..         ..+...++.+++++|..||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999998875321         1123467789999999999811                                  


Q ss_pred             ----------------------CCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          275 ----------------------TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       275 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                                            .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1339999999999999876667899999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.5e-11  Score=114.57  Aligned_cols=129  Identities=17%  Similarity=0.086  Sum_probs=95.9

Q ss_pred             ccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC--eeeEEEEEEcCCeEEEEEEeCCCCcHHHH
Q 012739          163 GNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ--LVELLGYCADQNHRLLISEYMPNGTLQQH  240 (457)
Q Consensus       163 G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  240 (457)
                      +.|..+.||++...+|..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998777888999987553   1234678999999885444  566888888888899999999998884  


Q ss_pred             HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 012739          241 LHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA----------------------------------------------  274 (457)
Q Consensus       241 l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------------  274 (457)
                      ...       .+.   ..++.+++..|..||+..                                              
T Consensus       104 ~~~-------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cCc-------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            111       121   245667777777777643                                              


Q ss_pred             ---------CCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          275 ---------TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       275 ---------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                               ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11299999999999998876678999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=1.6e-10  Score=113.35  Aligned_cols=142  Identities=15%  Similarity=0.256  Sum_probs=106.0

Q ss_pred             CCceeccCCcEEEEEEEEcCCcEEEEEEcc--cCc-hHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEcC---CeEEEEE
Q 012739          158 EGNVIGNGGFGVVYKGVLSDGTVAAIKKLH--RDG-KQRERAFRMEVDLLSRLH--SPQLVELLGYCADQ---NHRLLIS  229 (457)
Q Consensus       158 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~---~~~~lv~  229 (457)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998875 4678888775  322 122345788999999997  45688899988776   4589999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-----------------------------------  274 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------  274 (457)
                      ||++|..+.+..      ...++..++..++.++++.|..||...                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999987774311      123678888889999999999999831                                   


Q ss_pred             --------------------CCCeEeccCccCceEeCCCCc--EEEeeccCccc
Q 012739          275 --------------------TPPVIHRDFKCSNVLLDQNFR--AKVTDFGLAKM  306 (457)
Q Consensus       275 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgl~~~  306 (457)
                                          ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                245999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.07  E-value=3.1e-10  Score=108.73  Aligned_cols=184  Identities=20%  Similarity=0.184  Sum_probs=121.7

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCC--eeeEEEEEEcCC---eEEEEEEeC
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQ--LVELLGYCADQN---HRLLISEYM  232 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~  232 (457)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+++.+. +..  +.+++......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888875432  33456888999998883 322  445555543333   358999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA--------------------------------------  274 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------  274 (457)
                      +|.+|.+....      .++..++..++.+++..|..||+..                                      
T Consensus        99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99888653321      2677777888888888888888621                                      


Q ss_pred             -----------------CCCeEeccCccCceEeCC--CCcEEEeeccCccccccccCCccccccccCCCc---ccccccc
Q 012739          275 -----------------TPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKMVSDKINGQISTRVLGTTGY---LAPEYAS  332 (457)
Q Consensus       275 -----------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~  332 (457)
                                       .+.++|+|++|.||++++  +..+.|+||+.+..-....  ...    ....+   ..|+...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~----~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI----SLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH----TTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH----HHHhhccccCHHHHH
Confidence                             134899999999999988  5668999999986532210  000    00111   2222211


Q ss_pred             C-----CC---------CCcccchHHHHHHHHHHHcCCCCCC
Q 012739          333 T-----GK---------LTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       333 ~-----~~---------~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                      .     +.         .....+.|++|.++|.+.+|..+|.
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0     00         1123689999999999999997763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=8.3e-07  Score=84.81  Aligned_cols=136  Identities=17%  Similarity=0.124  Sum_probs=92.6

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCC---CeeeEEEEEE-cCCeEEEEEEeCCC
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSP---QLVELLGYCA-DQNHRLLISEYMPN  234 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~  234 (457)
                      .+.++.|....||+.    +..+++|+-..  ......+..|.++|+.+.+.   .+.+.+.++. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999997    56678887422  23345688999999999652   3566777764 45667899999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-----------------------------------------  273 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  273 (457)
                      .+|.+....      .++..+...++.++++.|..||+.                                         
T Consensus        98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            887653211      133344444444444444444432                                         


Q ss_pred             ----------------CCCCeEeccCccCceEeCC---CCc-EEEeeccCccc
Q 012739          274 ----------------ATPPVIHRDFKCSNVLLDQ---NFR-AKVTDFGLAKM  306 (457)
Q Consensus       274 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgl~~~  306 (457)
                                      ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            2234799999999999987   355 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=8.2e-07  Score=82.98  Aligned_cols=135  Identities=19%  Similarity=0.164  Sum_probs=95.7

Q ss_pred             eeccCCcE-EEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEEeCCCCcH
Q 012739          161 VIGNGGFG-VVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHRLLISEYMPNGTL  237 (457)
Q Consensus       161 ~LG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L  237 (457)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445554 68987754 4567888875432   3445788999998884 23377888999989999999999999888


Q ss_pred             HHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 012739          238 QQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-------------------------------------------  274 (457)
Q Consensus       238 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------------  274 (457)
                      .+......        .....+..+++..|..||...                                           
T Consensus       108 ~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            77554311        122345556666667776521                                           


Q ss_pred             ------------CCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          275 ------------TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       275 ------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                                  .+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        11389999999999999887788999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.3e-06  Score=85.17  Aligned_cols=79  Identities=3%  Similarity=-0.077  Sum_probs=54.0

Q ss_pred             cee-ccCCcEEEEEEEEc-------CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCC---CCeeeEEEEEEcC---
Q 012739          160 NVI-GNGGFGVVYKGVLS-------DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHS---PQLVELLGYCADQ---  222 (457)
Q Consensus       160 ~~L-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h---pniv~l~~~~~~~---  222 (457)
                      +.| +.|....+|+....       ++..+++|......   ......+..|+.+++.+..   -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998764       26678888764322   0011346778888888742   3577788887665   


Q ss_pred             CeEEEEEEeCCCCcHH
Q 012739          223 NHRLLISEYMPNGTLQ  238 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~  238 (457)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999886653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=2.1e-05  Score=75.78  Aligned_cols=141  Identities=18%  Similarity=0.315  Sum_probs=78.4

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----CCCeeeEE-E--EEEcCCeEEEEEEe
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----SPQLVELL-G--YCADQNHRLLISEY  231 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----hpniv~l~-~--~~~~~~~~~lv~e~  231 (457)
                      +.|+.|..+.||+....++ .+++|+.....    ..+..|..+++.|.     .|.++... |  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999987554 58889886532    22333444444442     34444310 0  12346678999999


Q ss_pred             CCCCcHH--------------HHHhhhCCCC----------CCCCHHHH-------------------------------
Q 012739          232 MPNGTLQ--------------QHLHRHNNRY----------RPLDWRTR-------------------------------  256 (457)
Q Consensus       232 ~~~g~L~--------------~~l~~~~~~~----------~~l~~~~~-------------------------------  256 (457)
                      ++|..+.              ..++......          ..-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986432              1122211100          01123211                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          257 LIIALDCAMALEFLHE----------HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       257 ~~i~~qi~~~l~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      ..+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223445666653          123459999999999999888899999999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.04  E-value=2.2e-05  Score=74.01  Aligned_cols=77  Identities=23%  Similarity=0.255  Sum_probs=56.1

Q ss_pred             CCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC---CCeeeEEEEEEcCCeEEEEEEeC
Q 012739          156 FSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS---PQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       156 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---pniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ....+.+|.|..+.||+....||+.+++|+...........+..|...|+.|.-   --+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            344577999999999999999999999998755433333457889999998842   2345555542    237899999


Q ss_pred             CCCc
Q 012739          233 PNGT  236 (457)
Q Consensus       233 ~~g~  236 (457)
                      +++.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=1.6e-05  Score=78.67  Aligned_cols=75  Identities=19%  Similarity=0.171  Sum_probs=48.0

Q ss_pred             CceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-------HHHHHHHHHHHHHHhcCC--C-CeeeEEEEEEcCCeEEE
Q 012739          159 GNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-------QRERAFRMEVDLLSRLHS--P-QLVELLGYCADQNHRLL  227 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~h--p-niv~l~~~~~~~~~~~l  227 (457)
                      .+.||.|.++.||++... ++..+++|.......       .....+..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 467899997543211       112345678888887732  3 34456544  3345689


Q ss_pred             EEEeCCCC
Q 012739          228 ISEYMPNG  235 (457)
Q Consensus       228 v~e~~~~g  235 (457)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.97  E-value=6.3e-05  Score=71.79  Aligned_cols=139  Identities=18%  Similarity=0.237  Sum_probs=91.1

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEEEEeCCCC
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH---SPQLVELLGYCADQNHRLLISEYMPNG  235 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g  235 (457)
                      .+.|+.|....+|+... ++..+++|.....   ....+..|...|+.|.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999876 5677888876533   2456788998888883   356888898888888899999999987


Q ss_pred             cHH--------H---HHhhhCC--CC----------------CCCCHHHHH---HHHH----------------HHHHH-
Q 012739          236 TLQ--------Q---HLHRHNN--RY----------------RPLDWRTRL---IIAL----------------DCAMA-  266 (457)
Q Consensus       236 ~L~--------~---~l~~~~~--~~----------------~~l~~~~~~---~i~~----------------qi~~~-  266 (457)
                      .+.        .   .|+....  ..                -.-+|.+..   ++..                .++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            542        1   2232211  00                011354321   1111                11111 


Q ss_pred             HHHHHh-cCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          267 LEFLHE-HATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       267 l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123322 2245699999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.74  E-value=0.0002  Score=71.26  Aligned_cols=77  Identities=16%  Similarity=0.127  Sum_probs=47.3

Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCccccccccCCcccccc-ccCCCccccccccCC---CCCcccchHHHHHHHHH
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRV-LGTTGYLAPEYASTG---KLTTKSDVYSYGVVLLE  351 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~~sDV~SlG~il~e  351 (457)
                      +.++|+|++|.|||++.++ ++|+||+.+..-....  ...... .-...|.+|+.....   .-....++......+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            4499999999999998876 9999999886532210  000000 001235666554311   11234566688888888


Q ss_pred             HHcC
Q 012739          352 LLTG  355 (457)
Q Consensus       352 lltg  355 (457)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.67  E-value=0.00037  Score=61.95  Aligned_cols=103  Identities=14%  Similarity=0.183  Sum_probs=68.8

Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      -+|.+.|...+.   +++++++|.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+.+.+ +.+.         
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence            379999988764   799999999999999998877322111  1233457999999999998764 2111         


Q ss_pred             cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCC
Q 012739          315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP  358 (457)
Q Consensus       315 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p  358 (457)
                           .....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 0122367888763 3456788999999999999875544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.53  E-value=0.00046  Score=66.24  Aligned_cols=142  Identities=18%  Similarity=0.145  Sum_probs=72.7

Q ss_pred             ceeccCCcEE-EEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          160 NVIGNGGFGV-VYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       160 ~~LG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      +.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554444 6677654466777776533210   223456666666632  23556776644433  78999997766


Q ss_pred             HHHHHhhhC---------------------C-CCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 012739          237 LQQHLHRHN---------------------N-RYRPLDWRTRL-------I-------------IALDCAMALEFLHE--  272 (457)
Q Consensus       237 L~~~l~~~~---------------------~-~~~~l~~~~~~-------~-------------i~~qi~~~l~~LH~--  272 (457)
                      +.+++....                     . ....++.....       .             ....+...+..+-.  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            655443210                     0 01112221100       0             00011122222311  


Q ss_pred             -cCCCCeEeccCccCceEeCCC----CcEEEeeccCccc
Q 012739          273 -HATPPVIHRDFKCSNVLLDQN----FRAKVTDFGLAKM  306 (457)
Q Consensus       273 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl~~~  306 (457)
                       .....++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             123459999999999999875    6899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.35  E-value=0.00049  Score=65.12  Aligned_cols=71  Identities=10%  Similarity=0.046  Sum_probs=43.0

Q ss_pred             CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEEEeC-CCCc
Q 012739          159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLISEYM-PNGT  236 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~-~~g~  236 (457)
                      .+.|+.|....+|+.     ..+++|+....... ......|...++.+...++ .++++++  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678999999999998     56788876543111 1112457777776632222 4555543  33347899999 6544


Q ss_pred             H
Q 012739          237 L  237 (457)
Q Consensus       237 L  237 (457)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.35  E-value=0.0012  Score=62.79  Aligned_cols=158  Identities=15%  Similarity=0.189  Sum_probs=85.2

Q ss_pred             chHHHHHHhcCCCC-----CceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----CCCeee
Q 012739          145 TYKELETATENFSE-----GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----SPQLVE  214 (457)
Q Consensus       145 ~~~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----hpniv~  214 (457)
                      +.+++.....+|.+     .+.|+.|....+|+....++ .+++|......  ....+..|+.+++.+.     -|.++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34555555555654     24567788899999987655 67888776521  1123455777776663     233332


Q ss_pred             EE-E--EEEcCCeEEEEEEeCCCCcHHH--------------HHhhhCCCCC-----CC---CHHHHHH-----------
Q 012739          215 LL-G--YCADQNHRLLISEYMPNGTLQQ--------------HLHRHNNRYR-----PL---DWRTRLI-----------  258 (457)
Q Consensus       215 l~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~~-----~l---~~~~~~~-----------  258 (457)
                      .. |  +....+..+++++|++|..+..              .++.......     ..   .|...+.           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            10 0  1122456789999998754311              1222111100     01   1222110           


Q ss_pred             -HHHHHHHHHHHHHhc----CCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          259 -IALDCAMALEFLHEH----ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       259 -i~~qi~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                       +...+...+..+...    ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             001234455555532    12349999999999999887666899999775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.22  E-value=0.0004  Score=69.35  Aligned_cols=72  Identities=18%  Similarity=0.233  Sum_probs=48.0

Q ss_pred             CceeccCCcEEEEEEEEcC--------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLIS  229 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~  229 (457)
                      .+.|+.|....+|++...+        +..+++|+......  ...+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753        47888888743211  1234468888888743333 567766543    3899


Q ss_pred             EeCCCCc
Q 012739          230 EYMPNGT  236 (457)
Q Consensus       230 e~~~~g~  236 (457)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998644

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.21  E-value=0.0024  Score=60.95  Aligned_cols=143  Identities=11%  Similarity=0.084  Sum_probs=79.6

Q ss_pred             ceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CCeeeEEEE-----EEcCCeEEEEEEeC
Q 012739          160 NVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQLVELLGY-----CADQNHRLLISEYM  232 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~-----~~~~~~~~lv~e~~  232 (457)
                      ..++ |....||+....+|+.+++|...... .....+..|..+++.+..  -.+++++..     ....+..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 77889999887677789999885321 122345667777777632  123333332     12245668899999


Q ss_pred             CCCcHH-----------HH---HhhhCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 012739          233 PNGTLQ-----------QH---LHRHNN-----RYRPLDWRTR----LII---------------ALDCAMALEFLHEH-  273 (457)
Q Consensus       233 ~~g~L~-----------~~---l~~~~~-----~~~~l~~~~~----~~i---------------~~qi~~~l~~LH~~-  273 (457)
                      +|..+.           ..   ++....     ....+++...    ..+               ...+...+..+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432           11   111110     0112222211    000               00111222333221 


Q ss_pred             ---CCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          274 ---ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       274 ---~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                         ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               223489999999999999 4 899999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.07  E-value=0.0015  Score=65.69  Aligned_cols=74  Identities=15%  Similarity=0.068  Sum_probs=46.3

Q ss_pred             CceeccCCcEEEEEEEEcC-CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEcCCeEEEEEEeCCCCc
Q 012739          159 GNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL-VELLGYCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~  236 (457)
                      .+.|+.|-...+|+....+ +..+++|+....... .-.-..|..+++.|...++ .++++++.  +  .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3567888889999998765 477888876432111 0011468888888865444 56777663  2  25999998754


Q ss_pred             H
Q 012739          237 L  237 (457)
Q Consensus       237 L  237 (457)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0027  Score=62.11  Aligned_cols=142  Identities=14%  Similarity=0.159  Sum_probs=80.5

Q ss_pred             ceeccCCcEEEEEEEEc--------CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEE
Q 012739          160 NVIGNGGFGVVYKGVLS--------DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  230 (457)
                      +.|..|-...+|+....        ++..+++|+.... ........+|..+++.+.- .-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666777889998864        2468888886332 1123345678888888742 223566666543    28999


Q ss_pred             eCCCCcHHH--------------H---HhhhCCC-CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 012739          231 YMPNGTLQQ--------------H---LHRHNNR-YRPLD--WRTRLIIALDCAM-------------------ALEFLH  271 (457)
Q Consensus       231 ~~~~g~L~~--------------~---l~~~~~~-~~~l~--~~~~~~i~~qi~~-------------------~l~~LH  271 (457)
                      |++|..|..              .   |+..... .++..  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998755431              1   1111110 11222  4455555443321                   233332


Q ss_pred             ----hc-CCCCeEeccCccCceEeCCC----CcEEEeeccCccc
Q 012739          272 ----EH-ATPPVIHRDFKCSNVLLDQN----FRAKVTDFGLAKM  306 (457)
Q Consensus       272 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl~~~  306 (457)
                          .. ....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                22 12349999999999999876    7899999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.0014  Score=63.97  Aligned_cols=73  Identities=14%  Similarity=0.092  Sum_probs=42.8

Q ss_pred             ceeccCCcEEEEEEEEcC---------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEE
Q 012739          160 NVIGNGGFGVVYKGVLSD---------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLIS  229 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lv~  229 (457)
                      +.|+.|....+|+....+         +..+++|+....... ......|..+++.+...+ +.++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467788888999988654         267888876543211 112356777777774333 34666554  2  26899


Q ss_pred             EeCCCCcH
Q 012739          230 EYMPNGTL  237 (457)
Q Consensus       230 e~~~~g~L  237 (457)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.84  E-value=0.0025  Score=61.42  Aligned_cols=31  Identities=19%  Similarity=0.284  Sum_probs=27.4

Q ss_pred             CCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          276 PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3499999999999999888899999988764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.13  E-value=0.0037  Score=40.01  Aligned_cols=13  Identities=31%  Similarity=0.322  Sum_probs=5.8

Q ss_pred             HHHHHHHhhccCC
Q 012739           63 LLLVLMLRRLKSS   75 (457)
Q Consensus        63 ~~~~~~~rr~~~~   75 (457)
                      +++++++|||+.+
T Consensus        29 ~~~~~~~RRr~~~   41 (44)
T 2ks1_B           29 LGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHTTTCC
T ss_pred             HHHHHHhhhhHhh
Confidence            3344444554443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.65  E-value=0.026  Score=35.92  Aligned_cols=15  Identities=7%  Similarity=0.270  Sum_probs=6.5

Q ss_pred             HHHHHHHHHhhccCC
Q 012739           61 ALLLLVLMLRRLKSS   75 (457)
Q Consensus        61 ~~~~~~~~~rr~~~~   75 (457)
                      +.++++++.|||+.+
T Consensus        27 ~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           27 LGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHCSC
T ss_pred             HHHHHHhheehhhhh
Confidence            334444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.53  E-value=0.03  Score=35.70  Aligned_cols=14  Identities=21%  Similarity=0.335  Sum_probs=6.3

Q ss_pred             HHHHHHHhhccCCc
Q 012739           63 LLLVLMLRRLKSSS   76 (457)
Q Consensus        63 ~~~~~~~rr~~~~~   76 (457)
                      +++++++|||+.++
T Consensus        28 ~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           28 LTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHTTCSSC
T ss_pred             HHHHHHhhhhhhhh
Confidence            33444455544443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.38  E-value=0.054  Score=53.61  Aligned_cols=73  Identities=11%  Similarity=0.102  Sum_probs=45.6

Q ss_pred             ceeccCCcEEEEEEEEcC--------CcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEE
Q 012739          160 NVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  230 (457)
                      +.+..|-...+|+....+        +..+++|+..... ...-.-.+|..+++.+.. .-..++++.+.  +  ++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEE
Confidence            567778888999988753        5788888864432 111112457777777742 22345555432  2  68999


Q ss_pred             eCCCCcH
Q 012739          231 YMPNGTL  237 (457)
Q Consensus       231 ~~~~g~L  237 (457)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.99  E-value=0.034  Score=34.38  Aligned_cols=28  Identities=18%  Similarity=0.180  Sum_probs=18.2

Q ss_pred             ccccchhhHHHHHHHHHHHHHHHHHHHH
Q 012739           38 HAILSFHSIIIIIVSVISVIVLVALLLL   65 (457)
Q Consensus        38 ~~~~~~~~~~~ii~~~~~~~~li~~~~~   65 (457)
                      .+.+|.+.+..|++++++.+++++.+++
T Consensus         5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~   32 (38)
T 2k1k_A            5 SRGLTGGEIVAVIFGLLLGAALLLGILV   32 (38)
T ss_dssp             STTCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCceeeeehHHHHHHHHHHHHHH
Confidence            4567778887777776666665554443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.34  E-value=0.28  Score=48.09  Aligned_cols=29  Identities=24%  Similarity=0.422  Sum_probs=25.0

Q ss_pred             eEeccCccCceEe------CCCCcEEEeeccCccc
Q 012739          278 VIHRDFKCSNVLL------DQNFRAKVTDFGLAKM  306 (457)
Q Consensus       278 ivH~Dlkp~NIll------~~~~~~kl~Dfgl~~~  306 (457)
                      ++|+|+.+.|||+      +++..+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.71  E-value=0.38  Score=42.52  Aligned_cols=115  Identities=11%  Similarity=0.138  Sum_probs=79.7

Q ss_pred             CCCCeeeEEEEEEcCCeEEEEEEeCCCC-cHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccC
Q 012739          208 HSPQLVELLGYCADQNHRLLISEYMPNG-TLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCS  286 (457)
Q Consensus       208 ~hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~  286 (457)
                      .||+++.. .+-.+.+.+.+.++.-+.+ ++.. +.       .++..++++++.+|+....+++.     -+|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            57888877 4556666666655554322 2222 32       37889999999999988755543     478899999


Q ss_pred             ceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCC
Q 012739          287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       287 NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                      |++++.++.+++.-.|+-..+.                   |.     .++...=.-.+=|++..+++++..|+
T Consensus       109 NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998887644332                   21     11222334567789999999998886

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=90.71  E-value=0.14  Score=32.28  Aligned_cols=25  Identities=20%  Similarity=0.301  Sum_probs=10.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhc
Q 012739           48 IIIVSVISVIVLVALLLLVLMLRRL   72 (457)
Q Consensus        48 ~ii~~~~~~~~li~~~~~~~~~rr~   72 (457)
                      ++++++.++++++++++++++++||
T Consensus        15 I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           15 VIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEeehhHHHHHHHHHHHHheeEeee
Confidence            3333344444433244444444443

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=89.64  E-value=0.17  Score=30.38  Aligned_cols=10  Identities=10%  Similarity=0.524  Sum_probs=4.9

Q ss_pred             HHHHHHHhhc
Q 012739           63 LLLVLMLRRL   72 (457)
Q Consensus        63 ~~~~~~~rr~   72 (457)
                      +.+++++|||
T Consensus        25 l~~~~~iRRr   34 (35)
T 1iij_A           25 VVVGILIKRR   34 (35)
T ss_dssp             TTTTHHHHHC
T ss_pred             HHhheEEeec
Confidence            4444555554

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.25  E-value=1.3  Score=39.17  Aligned_cols=115  Identities=9%  Similarity=0.083  Sum_probs=78.2

Q ss_pred             CCCCeeeEEEEEEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeccCccC
Q 012739          208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE-FLHEHATPPVIHRDFKCS  286 (457)
Q Consensus       208 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~Dlkp~  286 (457)
                      .||++  -..+-.+++.+.+.++.-+++.=...+..       ++..++++++.+++.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57887  33344666777777776544433333432       788999999999887766 5543     578889999


Q ss_pred             ceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCC
Q 012739          287 NVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD  360 (457)
Q Consensus       287 NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~  360 (457)
                      ||+++.++.++|.-.|+-..+                   +|.-+     +..-=.-.+=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL-------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB-------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC-------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999888865432                   22211     222223467788899999988775

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.00  E-value=0.77  Score=29.24  Aligned_cols=23  Identities=9%  Similarity=0.183  Sum_probs=11.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhhccC
Q 012739           52 SVISVIVLVALLLLVLMLRRLKS   74 (457)
Q Consensus        52 ~~~~~~~li~~~~~~~~~rr~~~   74 (457)
                      +++.+++++++.+++=..+++++
T Consensus        21 v~~~~ii~~~~~~~~RRr~~~~k   43 (44)
T 2ks1_B           21 LLLLLVVALGIGLFMRRRHIVRK   43 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSC
T ss_pred             HHHHHHHHHHHHHHhhhhHhhcc
Confidence            33334444555555555544443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.27  E-value=0.85  Score=28.99  Aligned_cols=13  Identities=8%  Similarity=-0.056  Sum_probs=5.2

Q ss_pred             HHHHHHHHHHhhc
Q 012739           60 VALLLLVLMLRRL   72 (457)
Q Consensus        60 i~~~~~~~~~rr~   72 (457)
                      +++.+++=..+++
T Consensus        28 ~~~~~~~RRRr~~   40 (44)
T 2l2t_A           28 LTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHTTCSS
T ss_pred             HHHHHHhhhhhhh
Confidence            3444444433333

>1zza_A Stannin, AG8_1; helix, membrane protein; NMR {Homo sapiens}

Probab=84.75  E-value=2.5  Score=29.51  Aligned_cols=29  Identities=34%  Similarity=0.386  Sum_probs=14.6

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhccCCc
Q 012739           48 IIIVSVISVIVLVALLLLVLMLRRLKSSS   76 (457)
Q Consensus        48 ~ii~~~~~~~~li~~~~~~~~~rr~~~~~   76 (457)
                      .++++++++.++-++++.+|++-|.++-.
T Consensus        16 tv~viliavaalg~li~gcwcylrlqri~   44 (90)
T 1zza_A           16 TVIVILIAIAALGALILGCWCYLRLQRIS   44 (90)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTTSSCSSC
T ss_pred             EehhHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence            33344444444455555566665655543

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=84.07  E-value=2  Score=28.54  Aligned_cols=21  Identities=19%  Similarity=0.523  Sum_probs=9.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHHH
Q 012739           46 IIIIIVSVISVIVLVALLLLV   66 (457)
Q Consensus        46 ~~~ii~~~~~~~~li~~~~~~   66 (457)
                      +++++.++++.+++++++++.
T Consensus        10 WiIi~svl~GLLLL~Lii~~L   30 (54)
T 2l8s_A           10 WVILLSAFAGLLLLMLLILAL   30 (54)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHH
Confidence            344444444444444443333

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=83.27  E-value=2.2  Score=29.40  Aligned_cols=18  Identities=17%  Similarity=0.490  Sum_probs=8.1

Q ss_pred             HHHHHHHHHHHHHHHHHH
Q 012739           48 IIIVSVISVIVLVALLLL   65 (457)
Q Consensus        48 ~ii~~~~~~~~li~~~~~   65 (457)
                      +++++++++++++.++++
T Consensus        12 ivlGg~~~lll~~glcI~   29 (70)
T 2klu_A           12 IVLGGVAGLLLFIGLGIF   29 (70)
T ss_dssp             HHHHHHHHHHHHHHHHHH
T ss_pred             HHHhHHHHHHHHHHHHHH
Confidence            344444444444444444

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=83.25  E-value=3  Score=27.72  Aligned_cols=21  Identities=14%  Similarity=0.243  Sum_probs=8.9

Q ss_pred             hHHHHHHHHHHHHHHHHHHHH
Q 012739           45 SIIIIIVSVISVIVLVALLLL   65 (457)
Q Consensus        45 ~~~~ii~~~~~~~~li~~~~~   65 (457)
                      ++++++.++++++++++++++
T Consensus        12 ~wiIi~svl~GLllL~li~~~   32 (54)
T 2knc_A           12 IWWVLVGVLGGLLLLTILVLA   32 (54)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHH
Confidence            344444444444444443333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	457
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-67
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 8e-74
 Identities = 64/285 (22%), Positives = 122/285 (42%), Gaps = 22/285 (7%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL 207
           + E      + G  IG+G FG VYKG         +  +     Q+ +AF+ EV +L + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
               ++  +GY        +++++    +L  HLH    +    +    + IA   A  +
Sbjct: 62  RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGM 117

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
           ++LH      +IHRD K +N+ L ++   K+ DFGLA + S         ++ G+  ++A
Sbjct: 118 DYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 328 PEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
           PE          + +SDVY++G+VL EL+TG++P        + + +           + 
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                 ++              + A C++ +   RPL   ++ S+
Sbjct: 235 RSNCPKAM------------KRLMAECLKKKRDERPLFPQILASI 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 1e-67
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 12/216 (5%)

Query: 149 LETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSR 206
           +E   ++F + + +G G  GVV+K      G V A K +H + K   R     E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
            +SP +V   G         +  E+M  G+L Q L +       +  +    +++     
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           L +L E     ++HRD K SN+L++     K+ DFG++  + D +    +   +GT  Y+
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM 170

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
           +PE       + +SD++S G+ L+E+  GR P+ P 
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (547), Expect = 2e-67
 Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 24/292 (8%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLHRDGKQRERAFRMEVDLL 204
           Y + E    + +  + +G G +G VY+GV        A+K L  D  + E  F  E  ++
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 67

Query: 205 SRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
             +  P LV+LLG C  +    +I+E+M  G L  +L   N   + +     L +A   +
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 125

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
            A+E+L +      IHRD    N L+ +N   KV DFGL+++++                
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIK 181

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEA 384
           + APE  +  K + KSDV+++GV+L E+ T  +   P                     + 
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQV 225

Query: 385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            E+++   + + P+    ++  +   C Q   + RP   ++ Q+   + + +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  215 bits (547), Expect = 3e-67
 Identities = 71/315 (22%), Positives = 134/315 (42%), Gaps = 39/315 (12%)

Query: 138 KGVVQVFTYKELETATENFSE---------GNVIGNGGFGVVYKGVL----SDGTVAAIK 184
           K  +  FT+++   A   F++           VIG G FG V  G L          AIK
Sbjct: 1   KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60

Query: 185 KLHRDGKQRERA-FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHR 243
            L     +++R  F  E  ++ +   P ++ L G        ++I+E+M NG+L   L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 244 HNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL 303
           ++ ++        + +    A  +++L +      +HRD    N+L++ N   KV+DFGL
Sbjct: 121 NDGQF---TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 304 AKMVSDKINGQISTRVLG---TTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVD 360
           ++ + D  +    T  LG      + APE     K T+ SDV+SYG+V+ E+++      
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---- 230

Query: 361 PNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
               P              + ++ +  ++   +   P      +  +   C Q +  +RP
Sbjct: 231 --ERPYWD----------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRP 278

Query: 421 LMTDVVQSLIPVVKN 435
               +V +L  +++N
Sbjct: 279 KFGQIVNTLDKMIRN 293

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 6e-67
 Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 24/276 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           E       +G G FG V+ G  +  T  A+K L +     +  F  E +L+ +L   +LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLV 71

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            L      Q    +I+EYM NG+L   L   +     L     L +A   A  + F+ E 
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEER 128

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
                IHRD + +N+L+      K+ DFGLA+++ D               + APE  + 
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ 393
           G  T KSDV+S+G++L E++T      P                     E ++ ++   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVIQNLERGYR 228

Query: 394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              P     ++  +  +C +     RP    +   L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-66
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 24/276 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
              +    IG+G FG+V+ G   +    AIK +       E  F  E +++ +L  P+LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           +L G C +Q    L+ E+M +G L  +L      +      T L + LD    + +L E 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEEA 120

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               VIHRD    N L+ +N   KV+DFG+ + V D      ST       + +PE  S 
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSF 176

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ 393
            + ++KSDV+S+GV++ E+ +       NR                   E VE +    +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDISTGFR 220

Query: 394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              P+     +  I   C +     RP  + +++ L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 24/277 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           ++ +    +G G FGVV  G        AIK +       E  F  E  ++  L   +LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
           +L G C  Q    +I+EYM NG L  +L    +R      +  L +  D   A+E+L   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK 119

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
                +HRD    N L++     KV+DFGL++ V D      S        +  PE    
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMY 175

Query: 334 GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ 393
            K ++KSD++++GV++ E+ +        + P E            +  E  E +   L+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLG------KMPYERF----------TNSETAEHIAQGLR 219

Query: 394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI 430
              P     ++  I   C   +A  RP    ++ +++
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  209 bits (532), Expect = 7e-65
 Identities = 72/311 (23%), Positives = 116/311 (37%), Gaps = 46/311 (14%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRERA-FR 198
              LE    N      IG G FG V++            T+ A+K L  +     +A F+
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 199 MEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY---------- 248
            E  L++   +P +V+LLG CA      L+ EYM  G L + L   +             
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 249 ----------RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV 298
                      PL    +L IA   A  + +L E      +HRD    N L+ +N   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
            DFGL++ +      +          ++ PE     + TT+SDV++YGVVL E+ +  + 
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 359 VDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAY 418
                                  EE +  V        P+   +++  +  +C     A 
Sbjct: 242 PYYGMAH----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285

Query: 419 RPLMTDVVQSL 429
           RP    + + L
Sbjct: 286 RPSFCSIHRIL 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 1e-64
 Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 24/293 (8%)

Query: 144 FTYKELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDL 203
                 E   E+      +G G FG V+ G  +  T  AIK L         AF  E  +
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQV 65

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           + +L   +LV+L      +    +++EYM  G+L   L     +Y        + +A   
Sbjct: 66  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQI 122

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           A  + ++        +HRD + +N+L+ +N   KV DFGLA+++ D              
Sbjct: 123 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPI 178

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE 383
            + APE A  G+ T KSDV+S+G++L EL T      P                     E
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------RE 222

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN 436
            ++ V+   +   P +    +  +   C + E   RP    +   L     + 
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-63
 Identities = 72/277 (25%), Positives = 114/277 (41%), Gaps = 30/277 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           +       IG G FG V  G    G   A+K +  D   +   F  E  ++++L    LV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLV 63

Query: 214 ELLGYCADQNHRL-LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           +LLG   ++   L +++EYM  G+L  +L         L     L  +LD   A+E+L  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAS 332
           +     +HRD    NVL+ ++  AKV+DFGL K  S                + APE   
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALR 173

Query: 333 TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL 392
             K +TKSDV+S+G++L E+ +      P  P                 ++ V  V+   
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------------KDVVPRVEKGY 217

Query: 393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           +   P      +  +   C   +AA RP    + + L
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 26/284 (9%)

Query: 151 TATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRL 207
           +  E++     IG G +G   K    SDG +   K+L      +  ++    EV+LL  L
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 208 HSPQLVELLGYCADQNHRLL--ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
             P +V       D+ +  L  + EY   G L   + +     + LD    L +     +
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 266 ALEFLHEH--ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           AL+  H        V+HRD K +NV LD     K+ DFGLA++++   +   +   +GT 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE 383
            Y++PE  +      KSD++S G +L EL     P                     S++E
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----------------SQKE 221

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
               +      + P +   ++  I    +  +  +RP + ++++
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 29/293 (9%)

Query: 150 ETATENFSEGNVIGNGGFGVVYKGVLSDGT-----VAAIKKLHRDGKQRERA-FRMEVDL 203
           E      +   VIG G FG VYKG+L   +       AIK L     +++R  F  E  +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           + +     ++ L G  +     ++I+EYM NG           +         + +    
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGI 119

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGT 322
           A  +++L        +HRD    N+L++ N   KV+DFGL++++  D      ++     
Sbjct: 120 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
             + APE  S  K T+ SDV+S+G+V+ E++T                            
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------H 220

Query: 383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN 435
           E ++ ++   +   P      I  +   C Q E A RP   D+V  L  +++ 
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 4e-62
 Identities = 74/305 (24%), Positives = 109/305 (35%), Gaps = 40/305 (13%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRER-AFRM 199
            + E      S G  +G G FG V +               A+K L       ER A   
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 200 EVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY---------- 248
           E+ +LS L +   +V LLG C      L+I+EY   G L   L R  + +          
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 249 ----RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
                 LD    L  +   A  + FL        IHRD    N+LL      K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
           + + +  N  +         ++APE       T +SDV+SYG+ L EL +      P  P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 365 PGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD 424
                                +M+    +   P+    ++  I   C   +   RP    
Sbjct: 253 VDSKFY---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

Query: 425 VVQSL 429
           +VQ +
Sbjct: 298 IVQLI 302

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 7e-62
 Identities = 72/303 (23%), Positives = 109/303 (35%), Gaps = 45/303 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDGKQRER-AFRMEVDLLSR 206
           EN   G V+G+G FG V                 A+K L       ER A   E+ ++++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 207 L-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRY----------------- 248
           L     +V LLG C       LI EY   G L  +L     ++                 
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 249 --RPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM 306
               L +   L  A   A  +EFL        +HRD    NVL+      K+ DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPG 366
           +    N  +         ++APE    G  T KSDV+SYG++L E+ +          P 
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG------VNP- 266

Query: 367 EHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVV 426
                    P +       +++    +   P     +I  I   C   ++  RP   ++ 
Sbjct: 267 --------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 427 QSL 429
             L
Sbjct: 319 SFL 321

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 5e-61
 Identities = 76/289 (26%), Positives = 116/289 (40%), Gaps = 35/289 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHR---DGKQRERAFRMEVDLLSRLHS 209
           E+F  G  +G G FG VY         + A+K L +   +    E   R EV++ S L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P ++ L GY  D     LI EY P GT+ + L +        D +       + A AL +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSY 121

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
            H      VIHRD K  N+LL      K+ DFG +            T + GT  YL PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPE 174

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
                    K D++S GV+  E L G+ P + N     +  +S             + V 
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------DFVT 228

Query: 390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA 438
                    +DLI         ++   + RP++ +V++   P +  N++
Sbjct: 229 EGA------RDLIS------RLLKHNPSQRPMLREVLEH--PWITANSS 263

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-60
 Identities = 60/293 (20%), Positives = 112/293 (38%), Gaps = 30/293 (10%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGY 218
              IG G FG V++G    G   A+K      ++R      E+     L    ++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 219 CADQN----HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA 274
               N       L+S+Y  +G+L  +L+R+      +     + +AL  A  L  LH   
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEI 120

Query: 275 -----TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN--GQISTRVLGTTGYLA 327
                 P + HRD K  N+L+ +N    + D GLA       +         +GT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 328 PEYAST------GKLTTKSDVYSYGVVLLELLTGRVP----VDPNRPPGEHVLVSWALPR 377
           PE           +   ++D+Y+ G+V  E+           D   P  + V    ++  
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 378 LTSREEAVEMVDPSLQGQYPKKDLIQ-IAAIAAVCVQPEAAYRPLMTDVVQSL 429
           +  +    + + P++  ++   + ++ +A I   C     A R     + ++L
Sbjct: 241 MR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-60
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 29/289 (10%)

Query: 147 KELETATENFSEGNV-IGNGGFGVVYKGVL---SDGTVAAIKKLHRDGKQRERA-FRMEV 201
           K+L    +N    ++ +G G FG V +GV          AIK L +  ++ +      E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 202 DLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIAL 261
            ++ +L +P +V L+G C      +L+ E    G L + L         +       +  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116

Query: 262 DCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVL 320
             +M +++L E      +HRD    NVLL     AK++DFGL+K + +D       +   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 321 GTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS 380
               + APE  +  K +++SDV+SYGV + E L+        + P +             
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG------QKPYKK----------MK 217

Query: 381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
             E +  ++   + + P +   ++ A+ + C   +   RP    V Q +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-60
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 33/277 (11%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVA-AIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVEL 215
              IG G F  VYKG+ ++ TV  A  +L      K   + F+ E ++L  L  P +V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 216 LGYCAD----QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
                     +   +L++E M +GTL+ +L R     + +  +            L+FLH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH 129

Query: 272 EHATPPVIHRDFKCSNVLL-DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
              TPP+IHRD KC N+ +       K+ D GLA +         +  V+GT  ++APE 
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM 184

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
               K     DVY++G+ +LE+ T   P    +   +                   +   
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------VTSG 228

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
                + K  + ++  I   C++     R  + D++ 
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (498), Expect = 1e-59
 Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 39/298 (13%)

Query: 137 DKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE- 194
           D  V ++F   + E   + FS+   IG+G FG VY    + +  V AIKK+   GKQ   
Sbjct: 1   DPDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57

Query: 195 --RAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLD 252
             +    EV  L +L  P  ++  G    ++   L+ EY                 +PL 
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQ 113

Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
                 +       L +LH H    +IHRD K  N+LL +    K+ DFG A +++    
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167

Query: 313 GQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV 369
              +   +GT  ++APE       G+   K DV+S G+  +EL   + P+          
Sbjct: 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224

Query: 370 LVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
            +              +   P+LQ  +  +           C+Q     RP    +++
Sbjct: 225 HI-------------AQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-59
 Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 29/310 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVA----AIKKLHRDG-KQRERAFRMEVDLLSRL 207
             F +  V+G+G FG VYKG+ + +G       AIK+L      +  +    E  +++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 208 HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            +P +  LLG C     +L+  + MP G L  ++  H +       +  L   +  A  +
Sbjct: 69  DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGM 124

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLA 327
            +L +     ++HRD    NVL+      K+TDFGLAK++  +     +        ++A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 328 PEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM 387
            E       T +SDV+SYGV + EL+T         P                  E   +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISSI 225

Query: 388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAAGAISFGSSR 447
           ++   +   P    I +  I   C   +A  RP   +++     + ++     +  G  R
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285

Query: 448 FQHQTPSPSH 457
               +P+ S+
Sbjct: 286 MHLPSPTDSN 295

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-59
 Identities = 74/293 (25%), Positives = 122/293 (41%), Gaps = 39/293 (13%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDG---TVAAIKKLHRDG-KQRERAFRMEVDLLSRL-H 208
            +    +VIG G FG V K  +        AAIK++     K   R F  E+++L +L H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------NNRYRPLDWRTR 256
            P ++ LLG C  + +  L  EY P+G L   L +             N+    L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
           L  A D A  +++L +      IHRD    N+L+ +N+ AK+ DFGL++     +     
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
           T       ++A E  +    TT SDV+SYGV+L E+++          P           
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG------GTPYCG-------- 229

Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              +  E  E +    + + P     ++  +   C + +   RP    ++ SL
Sbjct: 230 --MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-58
 Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 33/283 (11%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            + +     +G+G FG VYK        +AA K +    ++    + +E+D+L+    P 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+LL     +N+  ++ E+   G +   +       RPL      ++      AL +LH
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH 127

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
           ++    +IHRD K  N+L   +   K+ DFG++   +     Q     +GT  ++APE  
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVV 182

Query: 332 ST-----GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE 386
                       K+DV+S G+ L+E+     P     P          +    ++ E   
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPT 234

Query: 387 MVDPSLQGQYPK--KDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           +  PS   ++    KD ++       C++     R   + ++Q
Sbjct: 235 LAQPS---RWSSNFKDFLK------KCLEKNVDARWTTSQLLQ 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-58
 Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 32/295 (10%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGVL------SDGTVAAIKKLHRDGKQRERA-FRME 200
           E E A E  +    +G G FG+VY+GV          T  AIK ++     RER  F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 201 VDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------NNRYRPLDWR 254
             ++   +   +V LLG  +     L+I E M  G L+ +L         N    P    
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 255 TRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ 314
             + +A + A  + +L+ +     +HRD    N ++ ++F  K+ DFG+ + + +    +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 315 ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWA 374
              + L    +++PE    G  TT SDV+S+GVVL E+ T                    
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------- 241

Query: 375 LPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                  E+ +  V        P      +  +  +C Q     RP   +++ S+
Sbjct: 242 -------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-58
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 32/283 (11%)

Query: 155 NFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHS 209
           +F+E  VIG G FG VY G L D        A+K L+R     E + F  E  ++     
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 210 PQLVELLGYCAD-QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
           P ++ LLG C   +   L++  YM +G L+  +            +  +   L  A  ++
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMK 144

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQI--STRVLGTTGYL 326
           FL        +HRD    N +LD+ F  KV DFGLA+ + DK    +   T       ++
Sbjct: 145 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE 386
           A E   T K TTKSDV+S+GV+L EL+T   P  P+    +  +      RL        
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 254

Query: 387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
                     P+     +  +   C  P+A  RP  +++V  +
Sbjct: 255 ---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 30/278 (10%)

Query: 158 EGNVIGNGGFGVVYKGVLSD---GTVAAIKKLHRDGKQRE--RAFRMEVDLLSRLHSPQL 212
           E   +G+G FG V KG           A+K L  +            E +++ +L +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V ++G C +    +L+ E    G L ++L ++    R +  +  + +    +M +++L E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE 125

Query: 273 HATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPEYA 331
                 +HRD    NVLL     AK++DFGL+K + +D+   +  T       + APE  
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS 391
           +  K ++KSDV+S+GV++ E  +                            E   M++  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAMLEKG 226

Query: 392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
            +   P     ++  +  +C   +   RP    V   L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 54/277 (19%), Positives = 100/277 (36%), Gaps = 25/277 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQ 211
           E++     +G G +G V   V        A+K +            + E+ +   L+   
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+  G+  + N + L  EY   G L   +         +               + +LH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
                 + HRD K  N+LLD+    K++DFGLA +       ++  ++ GT  Y+APE  
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 332 STGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
              +      DV+S G+VL  +L G +P D      +            +     + +D 
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWKKIDS 234

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           +         L+         +    + R  + D+ +
Sbjct: 235 AP------LALLHK------ILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 59/277 (21%), Positives = 119/277 (42%), Gaps = 28/277 (10%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ 211
            + ++    IG G  G VY  + ++ G   AI++++   + ++     E+ ++    +P 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V  L      +   ++ EY+  G+L   +         +D      +  +C  ALEFLH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH 133

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
            +    VIHRD K  N+LL  +   K+TDFG    ++        + ++GT  ++APE  
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVV 188

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGE-HVLVSWALPRLTSREEAVEMVDP 390
           +      K D++S G++ +E++ G  P     P    +++ +   P L + E+    +  
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK----LSA 244

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
                   +D +        C+  +   R    +++Q
Sbjct: 245 IF------RDFLNR------CLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 6e-55
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 11/209 (5%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE---RAFRMEVDLLSRLHS 209
           E+F  G ++G G F  V     L+     AIK L +    +E        E D++SRL  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P  V+L     D         Y  NG L +++ +        D         +   ALE+
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEY 123

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH      +IHRD K  N+LL+++   ++TDFG AK++S +     +   +GT  Y++PE
Sbjct: 124 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             +       SD+++ G ++ +L+ G  P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-54
 Identities = 57/285 (20%), Positives = 98/285 (34%), Gaps = 30/285 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSR 206
           ++      +G+G FGVV +G            A+K L  D     +    F  EV+ +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
           L    L+ L G       ++ ++E  P G+L   L R           T    A+  A  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK-MVSDKINGQISTRVLGTTGY 325
           + +L        IHRD    N+LL      K+ DFGL + +  +  +  +         +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 326 LAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV 385
            APE   T   +  SD + +GV L E+ T            +   +   + +   R    
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRP 237

Query: 386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI 430
           E     +       +++        C   +   RP    +   L+
Sbjct: 238 EDCPQDI------YNVMVQ------CWAHKPEDRPTFVALRDFLL 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 41/305 (13%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGVL--------SDGTVAAIKKLHRDGKQRERA-F 197
              E   +    G  +G G FG V             +  T  A+K L  D  +++ +  
Sbjct: 6   PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65

Query: 198 RMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRH------------ 244
             E++++  +     ++ LLG C       +I EY   G L+++L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 245 NNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA 304
           +N    L  +  +  A   A  +E+L        IHRD    NVL+ ++   K+ DFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRP 364
           + +      + +T       ++APE       T +SDV+S+GV+L E+ T      P  P
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 365 PGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTD 424
                            EE  +++    +   P     ++  +   C     + RP    
Sbjct: 243 V----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286

Query: 425 VVQSL 429
           +V+ L
Sbjct: 287 LVEDL 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 5e-54
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 29/287 (10%)

Query: 148 ELETATENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDGKQRERA-FRMEVD 202
           + E   E    G  IG G FG V++G+           AIK          R  F  E  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 203 LLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
            + +   P +V+L+G   + N   +I E    G L+        R   LD  + ++ A  
Sbjct: 61  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQ 116

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
            + AL +L        +HRD    NVL+  N   K+ DFGL++ + D      +++    
Sbjct: 117 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLP 172

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
             ++APE  +  + T+ SDV+ +GV + E+L           P +               
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHG------VKPFQG----------VKNN 216

Query: 383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
           + +  ++   +   P      + ++   C   + + RP  T++   L
Sbjct: 217 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 68/305 (22%), Positives = 111/305 (36%), Gaps = 39/305 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV------LSDGTVAAIKKLHRDGKQRE-RAFRMEVDLLSR 206
           +    G  +G G FG V +         +     A+K L       E RA   E+ +L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 207 -LHSPQLVELLGYCADQNHRLLI-SEYMPNGTLQQHLHRHNNRYRP------------LD 252
             H   +V LLG C      L++  E+   G L  +L    N + P            L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 253 WRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN 312
               +  +   A  +EFL        IHRD    N+LL +    K+ DFGLA+ +    +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVS 372
                       ++APE       T +SDV+S+GV+L E+ +      P     E     
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247

Query: 373 WALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV 432
                          +    + + P     ++      C   E + RP  +++V+ L  +
Sbjct: 248 -------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

Query: 433 VKNNA 437
           ++ NA
Sbjct: 295 LQANA 299

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  180 bits (458), Expect = 2e-53
 Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 27/299 (9%)

Query: 132 YNYVRDKGVVQVFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG 190
           Y  +  K V Q    K+  +  + +     +G+G FGVV++ V  + G V   K ++   
Sbjct: 8   YEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 66

Query: 191 KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRP 250
              +   + E+ ++++LH P+L+ L     D+   +LI E++  G L   +   +     
Sbjct: 67  PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YK 123

Query: 251 LDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNFRAKVTDFGLAKMVS 308
           +     +         L+ +HEH    ++H D K  N++ +  +    K+ DFGLA  ++
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH 368
                +I      T  + APE      +   +D+++ GV+   LL+G  P          
Sbjct: 181 P---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LE 235

Query: 369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
            L +         E+A   V P        KD I+        +Q E   R  + D ++
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEA------KDFIK------NLLQKEPRKRLTVHDALE 282

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  179 bits (456), Expect = 4e-53
 Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 26/277 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
           +++     +G G FGVV++    + G   A K +    +  +   R E+  +S L  P L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           V L     D N  ++I E+M  G L + +   +N+   +     +         L  +HE
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 142

Query: 273 HATPPVIHRDFKCSNVLL--DQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           +     +H D K  N++    ++   K+ DFGL   +  K   Q      GT  + APE 
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEV 196

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
           A    +   +D++S GV+   LL+G  P        +  L +         + A   +  
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWNMDDSAFSGISE 254

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
                   KD I+        +  +   R  +   ++
Sbjct: 255 DG------KDFIR------KLLLADPNTRMTIHQALE 279

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-51
 Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 30/284 (10%)

Query: 147 KELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLS 205
           KEL    E +     +G G FG+V++ V  S       K +   G  +    + E+ +L+
Sbjct: 1   KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILN 56

Query: 206 RLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAM 265
                 ++ L          ++I E++    + + ++        L+ R  +        
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCE 113

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
           AL+FLH H    + H D +  N++     +   K+ +FG A+ +     G     +    
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAP 167

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE 383
            Y APE      ++T +D++S G ++  LL+G  P        + ++ +      T  EE
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEE 225

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           A + +           D +         +  E   R   ++ +Q
Sbjct: 226 AFKEISIEA------MDFVD------RLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 23/284 (8%)

Query: 146 YKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQ-RERAFRMEVDL 203
           +K+ E   + +   +V+G G F  V          + AIK + +   + +E +   E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 204 LSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDC 263
           L ++  P +V L        H  LI + +  G L   +            R    +    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQV 116

Query: 264 AMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTT 323
             A+++LH+        +        LD++ +  ++DFGL+KM      G + +   GT 
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTP 173

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE 383
           GY+APE  +    +   D +S GV+   LL G  P            +  A     S   
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--P 231

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
             + +  S       KD I+        ++ +   R      +Q
Sbjct: 232 YWDDISDSA------KDFIRH------LMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  171 bits (435), Expect = 7e-50
 Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 34/275 (12%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSD-GTVAAIKKLH------RDGKQRERAFRMEVDLLSR 206
            +FS   +IG GGFG VY    +D G + A+K L       + G+      R+ + L+S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 207 LHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMA 266
              P +V +       +    I + M  G L  HL +H               A +  + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILG 119

Query: 267 LEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
           LE +H      V++RD K +N+LLD++   +++D GLA   S     +     +GT GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYM 172

Query: 327 APEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV 385
           APE    G    + +D +S G +L +LL G  P   ++   +H +       LT   E  
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELP 229

Query: 386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
           +   P L      + L++        +Q +   R 
Sbjct: 230 DSFSPEL------RSLLE------GLLQRDVNRRL 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 61/291 (20%), Positives = 107/291 (36%), Gaps = 41/291 (14%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG---------KQRERAFRMEVDL 203
           EN+    ++G G   VV + +        A+K +   G         ++   A   EVD+
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 204 LSRLHS-PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
           L ++   P +++L           L+ + M  G L  +L         L  +    I   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRA 118

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
               +  LH+     ++HRD K  N+LLD +   K+TDFG +  +     G+    V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGT 172

Query: 323 TGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP 376
             YLAPE               + D++S GV++  LL G  P    +      ++     
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232

Query: 377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           +  S E   +    ++      KDL+         +  +   R    + + 
Sbjct: 233 QFGSPEW--DDYSDTV------KDLVS------RFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (423), Expect = 4e-49
 Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 30/277 (10%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLH 208
           ++ +  G ++G GG   V+    L      A+K L  D          FR E    + L+
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 209 SPQLVELLGYCADQNHRL----LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            P +V +      +        ++ EY+   TL+  +H       P+  +  + +  D  
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 121

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIST-RVLGTT 323
            AL F H++    +IHRD K +N+++      KV DFG+A+ ++D  N    T  V+GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 324 GYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE 383
            YL+PE A    +  +SDVYS G VL E+LTG  P   + P           P   S   
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP 420
             E +   L        ++         +      R 
Sbjct: 239 --EGLSADL------DAVVL------KALAKNPENRY 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 5e-49
 Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 14/210 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLH 208
           E+F    ++G G FG V+           AIK L +D        E     +  L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
            P L  +      + +   + EY+  G L  H+          D       A +  + L+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQ 117

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
           FLH      +++RD K  N+LLD++   K+ DFG+ K          +    GT  Y+AP
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAP 172

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           E     K     D +S+GV+L E+L G+ P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  164 bits (415), Expect = 2e-47
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA---FRMEVDLLSRLHS 209
           ++F     +G G FG V+      +G   A+K L ++   R +       E  +LS +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P ++ + G   D     +I +Y+        L     + +          A +  +ALE+
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH      +I+RD K  N+LLD+N   K+TDFG AK V D         + GT  Y+APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE 171

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
             ST       D +S+G+++ E+L G  P
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 62/250 (24%), Positives = 97/250 (38%), Gaps = 12/250 (4%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSP 210
           ENF +   IG G +GVVYK      G V A+KK+  D   +        E+ LL  L+ P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            +V+LL     +N   L+ E++     +       +    +               L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE- 329
           H H    V+HRD K  N+L++     K+ DFGLA+        +  T  + T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEI 173

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
                  +T  D++S G +  E++T R     +    +   +   L              
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 390 PSLQGQYPKK 399
           P  +  +PK 
Sbjct: 234 PDYKPSFPKW 243

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 48/287 (16%), Positives = 101/287 (35%), Gaps = 21/287 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLH--RDGKQRERAFRMEVDLLSRLHSPQ 211
           E +     IG G +GVVYK   + G   A+KK+   ++ +        E+ +L  L    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 212 LVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLH 271
           +V+L      +   +L+ E++     +            L+  T     L     + + H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH 117

Query: 272 EHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYA 331
           +     V+HRD K  N+L+++    K+ DFGLA+        + +  ++           
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLM 173

Query: 332 STGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS 391
            + K +T  D++S G +  E++ G           + + +   L    S+        P 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 392 LQGQYPKKDLIQIAAIAAV-----------CVQPEAAYRPLMTDVVQ 427
               +   + +   +                ++ +   R      ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 62/296 (20%), Positives = 107/296 (36%), Gaps = 38/296 (12%)

Query: 143 VFTYKELETATENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRER------ 195
           VF  + ++   + +  G  +G+G F VV K    S G   A K + +   +  R      
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 196 AFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRT 255
               EV +L  +  P ++ L     ++   +LI E +  G     L         L    
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEE 114

Query: 256 RLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQN----FRAKVTDFGLAKMVSDKI 311
                      + +LH      + H D K  N++L        R K+ DFGLA  +    
Sbjct: 115 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-- 169

Query: 312 NGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV 371
            G     + GT  ++APE  +   L  ++D++S GV+   LL+G  P   +    +  L 
Sbjct: 170 -GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA 226

Query: 372 SWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           + +       +E               KD I+        +  +   R  + D +Q
Sbjct: 227 NVSAVNYEFEDEYFSNTSALA------KDFIR------RLLVKDPKKRMTIQDSLQ 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (388), Expect = 7e-44
 Identities = 48/287 (16%), Positives = 90/287 (31%), Gaps = 29/287 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQL 212
            ++  G  IG G FGV+++G  L +    AIK   R     +   R E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 62

Query: 213 VELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
           +  + Y   +    ++   +   +L+  L       R    +T  + A      ++ +HE
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE 119

Query: 273 HATPPVIHRDFKCSNVLLDQNFR-----AKVTDFGLAKMVSDKINGQI-----STRVLGT 322
                +++RD K  N L+ +          V DFG+ K   D +  Q         + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
             Y++       + + + D+ + G V +  L G +P    +                  E
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------E 226

Query: 383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              E    +   +       +                P    +    
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 29/281 (10%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
           G  IG+G FG +Y G  ++ G   AIK      K  +    +E  +   +     +  + 
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIR 69

Query: 218 YC-ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATP 276
           +C A+ ++ +++ E +                R    +T L++A      +E++H     
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN-- 123

Query: 277 PVIHRDFKCSNVL---LDQNFRAKVTDFGLAKMVSDKINGQI-----STRVLGTTGYLAP 328
             IHRD K  N L     +     + DFGLAK   D    Q      +  + GT  Y + 
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 329 EYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV 388
                 + + + D+ S G VL+    G +P    +   +              E+ +   
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEKKMSTP 236

Query: 389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSL 429
              L   YP     + A     C       +P  + + Q  
Sbjct: 237 IEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 4e-43
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 8/210 (3%)

Query: 153 TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-FRMEVDLLSRLHSP 210
              ++  + IG G +G+V       +    AIKK+     Q        E+ +L R    
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            ++ +           +   Y+    +   L++   + + L               L+++
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYI 125

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV-SDKINGQISTRVLGTTGYLAPE 329
           H      V+HRD K SN+LL+     K+ DFGLA++   D  +    T  + T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 330 YASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
                K  TKS D++S G +L E+L+ R  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-43
 Identities = 58/209 (27%), Positives = 83/209 (39%), Gaps = 13/209 (6%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD---GKQRERAFRMEVDLLSRLHS 209
            +F    ++G G FG V      + G   A+K L ++    K        E  +L     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P L  L       +    + EY   G L  HL R                  +   ALE+
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH      V++RD K  N++LD++   K+TDFGL K      +G       GT  YLAPE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPE 175

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
                      D +  GVV+ E++ GR+P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-42
 Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 19/270 (7%)

Query: 155 NFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLV 213
           ++++  VIGNG FGVVY+  L   G + AIKK+ +D + + R    E+ ++ +L    +V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76

Query: 214 ELLGYC------ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMAL 267
            L  +        D+ +  L+ +Y+P    +   H ++   + L      +       +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 268 EFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYL 326
            ++H      + HRD K  N+LLD +    K+ DFG AK +         + +       
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRA 190

Query: 327 APEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE 386
                     T+  DV+S G VL ELL G+    P     + ++    +    +RE+  E
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEA 416
           M     + ++P+        +      PEA
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 24/294 (8%)

Query: 152 ATENFSEGNVIGNGGFGVVYKG--VLSDGTVAAIKKLHRDGKQR--ERAFRMEVDLLSRL 207
           A + +     IG G +G V+K   + + G   A+K++     +     +   EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 208 ---HSPQLVELLGYCADQNHRLLISEYMPNGTLQQ--HLHRHNNRYRPLDWRTRLIIALD 262
                P +V L   C            +    + Q    +        +   T   +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGT 322
               L+FLH H    V+HRD K  N+L+  + + K+ DFGLA++ S +      T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVT 178

Query: 323 TGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE 382
             Y APE        T  D++S G +  E+   +     +    +   +   +      +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 383 EAVEMVDP----SLQGQYPKKDLIQIAAIAAV-----CVQPEAAYRPLMTDVVQ 427
              ++  P      +   P +  +             C+    A R      + 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 21/211 (9%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG------KQRERAFRMEVDLLSRLHS-- 209
           G ++G+GGFG VY G+ +SD    AIK + +D               MEV LL ++ S  
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
             ++ LL +    +  +LI E                    L              A+  
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRH 125

Query: 270 LHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            H      V+HRD K  N+L+D N    K+ DFG   ++ D     + T   GT  Y  P
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPP 178

Query: 329 EYASTGKLTTKS-DVYSYGVVLLELLTGRVP 358
           E+    +   +S  V+S G++L +++ G +P
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 16/206 (7%)

Query: 160 NVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR-----ERAFRMEVDLLSRLHSPQLV 213
           + +G G F  VYK    +   + AIKK+    +        R    E+ LL  L  P ++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 214 ELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH 273
            LL     +++  L+ ++M             +    L         L     LE+LH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 274 ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYAST 333
               ++HRD K +N+LLD+N   K+ DFGLAK        +  T  + T  Y APE    
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFG 174

Query: 334 GKL-TTKSDVYSYGVVLLELLTGRVP 358
            ++     D+++ G +L ELL     
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-42
 Identities = 66/279 (23%), Positives = 101/279 (36%), Gaps = 34/279 (12%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQLVELL 216
             V+G G  G V +          A+K L    K      R EV+L  R    P +V ++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 217 GYC----ADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE 272
                  A +   L++ E +  G L   +    ++      R    I      A+++LH 
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHS 129

Query: 273 HATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
                + HRD K  N+L      N   K+TDFG AK  +        T    T  Y+APE
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPE 183

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD 389
                K     D++S GV++  LL G  P         H L      +   R    E  +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 390 PSLQGQYPK-KDLIQIAAIAAVCVQPEAAYRPLMTDVVQ 427
           P       + K LI+        ++ E   R  +T+ + 
Sbjct: 239 PEWSEVSEEVKMLIRN------LLKTEPTQRMTITEFMN 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (365), Expect = 6e-40
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 16/209 (7%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA---FRMEVDLLSRLHS 209
           + F     +G G FG V        G   A+K L +    + +       E  +L  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 210 PQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           P LV+L     D ++  ++ EY+  G +  HL R                A    +  E+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEY 156

Query: 270 LHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPE 329
           LH      +I+RD K  N+L+DQ    +VTDFG AK V  +        + GT   LAPE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPE 208

Query: 330 YASTGKLTTKSDVYSYGVVLLELLTGRVP 358
              +       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-39
 Identities = 52/274 (18%), Positives = 100/274 (36%), Gaps = 21/274 (7%)

Query: 144 FTYKELETAT----ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRE--RA 196
           F  +E+          + +   +G+G +G V   V    G   AIKKL+R  +     + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
              E+ LL  +    ++ LL            +++               ++  L     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
             +       L ++H      +IHRD K  N+ ++++   K+ DFGLA+    ++ G + 
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV- 179

Query: 317 TRVLGTTGYLAPE-YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWAL 375
                T  Y APE   +  + T   D++S G ++ E++TG+     +    +   +    
Sbjct: 180 ----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 376 PRLTSREEAVEMVDPSLQ-----GQYPKKDLIQI 404
               +        D +        +  KKD   I
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 6e-39
 Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 21/242 (8%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQR--ERAFRMEVDLLSRLHSP 210
             + +   IG G FG V+K      G   A+KK+  + ++         E+ +L  L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 211 QLVELLGYCADQ--------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALD 262
            +V L+  C  +            L+ ++  +       +                +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQM 125

Query: 263 CAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS--TRVL 320
               L ++H +    ++HRD K +NVL+ ++   K+ DFGLA+  S   N Q +  T  +
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 321 GTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT 379
            T  Y  PE     +      D++  G ++ E+ T    +  N    +  L+S     +T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 380 SR 381
             
Sbjct: 243 PE 244

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 5e-38
 Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 11/266 (4%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSP 210
           + + +   IG G +G V+K        + A+K++  D   +    +   E+ LL  L   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 211 QLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFL 270
            +V L           L+ E+      Q      ++    LD              L F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 271 HEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEY 330
           H      V+HRD K  N+L+++N   K+ +FGLA+     +    S  V+          
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVL 173

Query: 331 ASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP 390
                 +T  D++S G +  EL     P+ P     + +   + L    + E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 391 SLQGQYPKKDLIQIAAIAAVCVQPEA 416
                YP              +    
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATG 259

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  133 bits (335), Expect = 6e-36
 Identities = 42/221 (19%), Positives = 90/221 (40%), Gaps = 22/221 (9%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRL-HSPQ 211
           +++     +G G +  V++ + +++     +K L    K++    + E+ +L  L   P 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPN 91

Query: 212 LVELLGYCADQNHRL--LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEF 269
           ++ L     D   R   L+ E++ N   +Q        Y+ L          +   AL++
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDY 144

Query: 270 LHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAP 328
            H      ++HRD K  NV++D ++ + ++ D+GLA+       GQ     + +  +  P
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGP 198

Query: 329 E-YASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH 368
           E            D++S G +L  ++  + P        + 
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 71/239 (29%), Positives = 100/239 (41%), Gaps = 30/239 (12%)

Query: 142 QVFTYK-ELETAT----------ENFSEGNVIGNGGFGVVYKGVL----SDGTVAAIKKL 186
           Q+ T K EL TA           ENF    V+G G +G V+          G + A+K L
Sbjct: 1   QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60

Query: 187 HR----DGKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLISEYMPNGTLQQHL 241
            +       +     R E  +L  +  SP LV L      +    LI +Y+  G L  HL
Sbjct: 61  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 242 HRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDF 301
            +              I   +  +ALE LH+     +I+RD K  N+LLD N    +TDF
Sbjct: 121 SQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 173

Query: 302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGK--LTTKSDVYSYGVVLLELLTGRVP 358
           GL+K        + +    GT  Y+AP+    G        D +S GV++ ELLTG  P
Sbjct: 174 GLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 2e-34
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 14/222 (6%)

Query: 144 FTYKELETA----TENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERA-- 196
           F  +EL        E +   + +G+G +G V        G   A+KKL R  +    A  
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 197 FRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTR 256
              E+ LL  +    ++ LL            ++      L      +  + + L     
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123

Query: 257 LIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQIS 316
             +       L+++H      +IHRD K SN+ ++++   K+ DFGLA+   D++ G ++
Sbjct: 124 QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180

Query: 317 TRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           TR             +        D++S G ++ ELLTGR  
Sbjct: 181 TRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-33
 Identities = 46/214 (21%), Positives = 79/214 (36%), Gaps = 22/214 (10%)

Query: 154 ENFSEGNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSP 210
           + +     IG+G  G+V            AIKKL R    +   +    E+ L+  ++  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 211 QLVELLGYCADQ------NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCA 264
            ++ LL     Q          L+ E M     Q             D      +     
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129

Query: 265 MALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
             ++ LH      +IHRD K SN+++  +   K+ DFGLA+         + T  + T  
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRY 183

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVP 358
           Y APE           D++S G ++ E++  ++ 
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 17/218 (7%)

Query: 159 GNVIGNGGFGVVYKGV-LSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLG 217
              +G G F  V+    + + T  A+K +  D    E A   E+ LL R++     +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDS 76

Query: 218 YCADQNHRLL--ISEYMPNGTL----------QQHLHRHNNRYRPLDWRTRLIIALDCAM 265
             A+   +LL   +   PNG                      +R +       I+    +
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 266 ALEFLHEHATPPVIHRDFKCSNVLLDQN-FRAKVTDFGLAKMVSDKINGQISTRVLGTTG 324
            L+++H      +IH D K  NVL++       +    +A + +     +  T  + T  
Sbjct: 137 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 325 YLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPN 362
           Y +PE          +D++S   ++ EL+TG    +P+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.2 bits (197), Expect = 3e-18
 Identities = 29/204 (14%), Positives = 60/204 (29%), Gaps = 28/204 (13%)

Query: 159 GNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDG----------KQRERAFRMEVDLLSRLH 208
           G ++G G    V+           +K                   +  F +     +R  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 209 SPQLVELLGYCADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALE 268
              L +L G    + +      +  N  L + +         ++      +       + 
Sbjct: 65  FRALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117

Query: 269 FLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTR-VLGTTGYLA 327
             +      ++H D    NVL+       + DF  +  V ++   +I  R V     Y +
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 328 PEYASTGKLTTKSDVYSYGVVLLE 351
             Y       T+ D+ S    +L+
Sbjct: 174 RTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	457
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.69
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.62
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.71
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.32

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.7e-56  Score=424.39  Aligned_cols=260  Identities=25%  Similarity=0.440  Sum_probs=204.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-C---cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-G---TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.++||+|+||+||+|.+.. +   ..||||++... .....+.|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456667899999999999999743 2   36899988665 344456799999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....   .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999998876443   5999999999999999999999999   9999999999999999999999999998775


Q ss_pred             cccCCcc---ccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          309 DKINGQI---STRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       309 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      .......   .....||+.|||||.+.+..++.++|||||||+||||+| |+.||.....                 .++
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------------~~~  242 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------------QDV  242 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHH
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence            4322211   223457899999999999999999999999999999998 8999975322                 111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ...+........+.+++..+.+|+.+||+.||++|||+.||++.|++++++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         243 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            1222222223344556678999999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=422.29  Aligned_cols=263  Identities=26%  Similarity=0.480  Sum_probs=207.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..++|++.+.||+|+||+||+|++++  .||||+++..  .....+.|.+|+++|++++|||||++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            35789999999999999999998643  5999998654  34455679999999999999999999998765 5689999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....   .+++.+++.++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999976443   5999999999999999999999999   99999999999999999999999999987765


Q ss_pred             ccCCccccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ...........||+.|||||++.+   ..|+.++|||||||+||||+||+.||...........  ..         ...
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~--~~---------~~~  225 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF--MV---------GRG  225 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HH---------HHT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH--HH---------hcC
Confidence            444444566789999999999864   4589999999999999999999999975432111000  00         001


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ...+.+ ...+.+++.++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus       226 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            111111 123334456899999999999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=415.23  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=203.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.+.||+|+||+||+|.+.+++.||||++..... ..+.|.+|+++++.++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46788899999999999999998889999999976543 34568999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++....   ..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++....... 
T Consensus        84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            999999987644   35899999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcCC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQ  393 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  393 (457)
                      .......||+.|+|||++.+..|+.++|||||||++|||+|+..|+......                ......+.....
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----------------~~~~~~i~~~~~  220 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDISTGFR  220 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----------------HHHHHHHHHTCC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHhcCC
Confidence            2233457899999999999999999999999999999999965554432111                111111111122


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          394 GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       394 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      ...+..++.++.+|+.+||+.||++|||++||+++|+++.+
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            23334445689999999999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-56  Score=422.44  Aligned_cols=265  Identities=25%  Similarity=0.425  Sum_probs=221.5

Q ss_pred             HHHHhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          149 LETATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       149 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      ++...++|++.+.||+|+||+||+|.+. +++.||||++..+.. ..+.|.+|+++|+.++|||||+++++|.+.+..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3444567888999999999999999975 588999999976543 34568999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 v~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999976433  46899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                      .... ........|++.|+|||++.+..|+.++|||||||++|||++|..||......                ....+.
T Consensus       166 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~~~~~  228 (287)
T d1opja_         166 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYEL  228 (287)
T ss_dssp             CSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHHHH
T ss_pred             CCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HHHHHH
Confidence            5432 22334456889999999999999999999999999999999988776543221                122222


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      +........+..++.++.+|+.+||+.||++|||+.||++.|+.++++.
T Consensus       229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            3333333445556668999999999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=415.69  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=210.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|+++|+.++||||+++++++.+++..||||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46888999999999999999974 689999999865532 2334588999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999986543    5999999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          312 NGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      ........+||+.|||||++.+..+ +.++|||||||++|||+||+.||...........               .....
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---------------~~~~~  222 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------DWKEK  222 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---------------HHHTT
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---------------HHhcC
Confidence            3344566789999999999988776 5789999999999999999999975432211110               01111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..........+.++.+|+.+||+.||++|||+.|++++  +++++
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h--pwf~~  265 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD--RWYNK  265 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--TTTTC
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCc
Confidence            11111122334578899999999999999999999887  66654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=417.11  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=214.2

Q ss_pred             HHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          150 ETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       150 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +...++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            33456788899999999999999999888999999997653 234568999999999999999999998865 5679999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....  ..+++.+++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence            99999999998765432  35899999999999999999999999   99999999999999999999999999987754


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .. ........||+.|+|||++.+..++.++|||||||++|||+||..|+......                .+....+.
T Consensus       162 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------~~~~~~i~  224 (272)
T d1qpca_         162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVIQNLE  224 (272)
T ss_dssp             SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHH
T ss_pred             Cc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHH
Confidence            32 12334567899999999999999999999999999999999976665432211                11111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .......+..++.++.+|+.+||+.||++||||++|++.|++++..
T Consensus       225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            2222233444556899999999999999999999999999998753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=411.80  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=214.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++++.++|||||++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999996 468999999987655445567899999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++...     .+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            999999987653     4999999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||........   ..          .......+. 
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~----------~~~~~~~~~-  235 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LY----------LIATNGTPE-  235 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----------HHHHHCSCC-
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---HH----------HHHhCCCCC-
Confidence             234556899999999999999999999999999999999999999975322100   00          000111111 


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       ...+...+..+.+|+.+||+.||++|||+.|++++  ++++.
T Consensus       236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H--p~~~~  275 (293)
T d1yhwa1         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLKI  275 (293)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC--GGGGG
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhCC
Confidence             12334455689999999999999999999999987  77764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=408.19  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=211.7

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999975 58899999986432   223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999998754    4999999999999999999999999   99999999999999999999999999986643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .    ......||+.|||||++.+..++.++|||||||++|||+||+.||.......   .             ...+..
T Consensus       159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~-------------~~~i~~  218 (263)
T d2j4za1         159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---T-------------YKRISR  218 (263)
T ss_dssp             C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H-------------HHHHHT
T ss_pred             C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---H-------------HHHHHc
Confidence            2    2345679999999999999999999999999999999999999997532210   0             001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..  ..++...+.++.+|+.+||+.||++|||+.|++++  +++..+
T Consensus       219 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h--p~~~~~  261 (263)
T d2j4za1         219 VE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITAN  261 (263)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC--HHHHHH
T ss_pred             CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC--cCcCCc
Confidence            11  12333445689999999999999999999999987  676654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=413.39  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=197.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD--QNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lv  228 (457)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++...  .....+.+.+|+++++.++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888999999999999999974 6899999998655  33444568899999999999999999999865  4568999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHAT--PPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      |||+++|+|.+++.........+++.+++.++.|++.||.|||+++.  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999997654444569999999999999999999998652  3499999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      +....  .......||+.|||||++.+..|+.++|||||||++|||+||+.||......   ...          ..+..
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~----------~~i~~  228 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----------GKIRE  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----------HHHHH
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH----------HHHHc
Confidence            75422  2344578999999999999999999999999999999999999999753221   000          00111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .   .. ...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       229 ~---~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 G---KF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             T---CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C---CC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1   11 12233445589999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=404.21  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=214.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMP  233 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  233 (457)
                      ++|++.++||+|+||+||+|+++++..||||+++.... ..+.|.+|+.+++.++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999998888999999976543 34568999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCC
Q 012739          234 NGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKING  313 (457)
Q Consensus       234 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~  313 (457)
                      +|+|.+++.....   .+++..+++++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            9999999766543   5899999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          314 QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       314 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                      .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......                 ++...+....
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------~~~~~i~~~~  218 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQGL  218 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHHHHHHTTC
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence            23344678999999999999999999999999999999998 89999754321                 1111111122


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ....|...+..+.+|+.+||+.||++|||+++|+++|.++
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            2234444556899999999999999999999999998653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=408.37  Aligned_cols=261  Identities=26%  Similarity=0.409  Sum_probs=208.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCC-----cEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDG-----TVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      +.|+..++||+|+||.||+|.+.+.     ..||||++.... ......|.+|+++++.++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999997542     369999986653 3344568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+.++++.+++.....   .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999998876543   5999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||+||..|+......                .++..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~~~  224 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVMK  224 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHHHH
Confidence            543222 2233456899999999999999999999999999999999977776533221                12222


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+....+...+.+++..+.+|+.+||+.||++|||+.||++.|+++++..
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            23333334455556678999999999999999999999999999998853

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-54  Score=407.14  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=212.0

Q ss_pred             cCCCCCc-eeccCCcEEEEEEEEc---CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGN-VIGNGGFGVVYKGVLS---DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|.+.+ +||+|+||.||+|.+.   ++..||||++.... ....+.|.+|+++|++++|||||+++|++.+ +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455556 4999999999999864   35579999997653 4445679999999999999999999999875 467999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++....   ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999986543   35999999999999999999999999   9999999999999999999999999998775


Q ss_pred             cccCC-ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          309 DKING-QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       309 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......                 ++..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----------------~~~~  223 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMA  223 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence            43222 22334568999999999999999999999999999999998 89999754321                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+....+...+..++.++.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus       224 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11122223445556678999999999999999999999999999887654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-54  Score=416.56  Aligned_cols=260  Identities=27%  Similarity=0.398  Sum_probs=212.9

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcCC------cEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSDG------TVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQN  223 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~------~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~  223 (457)
                      ..++|++.++||+|+||+||+|++...      ..||+|++.... ......+.+|+.++.++ +|||||+++++|.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            446788999999999999999996432      368999886543 33345688999999998 8999999999999999


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCc
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNR-------------------YRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFK  284 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  284 (457)
                      ..++||||+++|+|.++|......                   ...+++.+++.++.|++.||.|||+++   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            999999999999999999765421                   235899999999999999999999999   9999999


Q ss_pred             cCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 012739          285 CSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNR  363 (457)
Q Consensus       285 p~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~  363 (457)
                      |+|||++.++.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987765544444556778999999999999999999999999999999998 899997543


Q ss_pred             CCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 012739          364 PPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLI  430 (457)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  430 (457)
                      ..                .....++........+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       272 ~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21                1111222222333444555668999999999999999999999999995

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=405.34  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=204.6

Q ss_pred             ceeccCCcEEEEEEEEcC---CcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeCCC
Q 012739          160 NVIGNGGFGVVYKGVLSD---GTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYMPN  234 (457)
Q Consensus       160 ~~LG~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  234 (457)
                      ++||+|+||+||+|.+.+   ++.||||+++...  ....+.|.+|+++|++++|||||+++++|.++ ..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998643   4679999986542  23345689999999999999999999999654 57899999999


Q ss_pred             CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccCCc
Q 012739          235 GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQ  314 (457)
Q Consensus       235 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  314 (457)
                      |+|.+++....    .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.......
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999998654    4999999999999999999999999   9999999999999999999999999998765432222


Q ss_pred             -cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          315 -ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       315 -~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....                 .++...+....
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i~~~~  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGE  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence             2334678999999999999999999999999999999998 8999975322                 11112222222


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ....+..++.++.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            3344455667899999999999999999999999999887654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-54  Score=407.77  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +.|++.+.||+|+||+||+|++. ++..||+|++........+.+.+|+++|+.++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888899999999999999975 68899999997765555667889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++....   .++++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999987654   35999999999999999999999999   9999999999999999999999999997654321 


Q ss_pred             CccccccccCCCcccccccc-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhh
Q 012739          313 GQISTRVLGTTGYLAPEYAS-----TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEM  387 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (457)
                       .......||+.|+|||++.     +..|+.++|||||||++|||+||+.||........  +.           .+...
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~-----------~i~~~  230 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LL-----------KIAKS  230 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH-----------HHHHS
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HH-----------HHHcC
Confidence             2234568999999999984     45689999999999999999999999975432111  00           00010


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          388 VDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       388 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+.  ...+...+.++.+|+.+||+.||++|||+.|++++  ++++.
T Consensus       231 ~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h--p~~~~  274 (288)
T d2jfla1         231 EPPT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH--PFVTV  274 (288)
T ss_dssp             CCCC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGCC
T ss_pred             CCCC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccCC
Confidence            0111  12233455689999999999999999999999987  56653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=414.49  Aligned_cols=271  Identities=22%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|+.+|+.++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467899999999999999999974 68999999987653 3334568899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999998764    399999999999999999999974 8   99999999999999999999999999987644


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhh-hhhcccc----------
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLV-SWALPRL----------  378 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~----------  378 (457)
                      .    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||............ .......          
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    234568999999999999999999999999999999999999999764322110000 0000000          


Q ss_pred             ---------------CchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          379 ---------------TSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       379 ---------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                                     ......................+.++.+|+.+||+.||++|||+.|++++  +++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H--pf~~~~  304 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH--AFIKRS  304 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC--HhhCcC
Confidence                           00000000000000000011234578999999999999999999999998  777653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=407.71  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=205.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56889999999999999999974 68999999986532   223356889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++....    .+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999988765    4999999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      ..........+||+.|+|||++.+..|+.++|||||||++|||+||+.||......   ...             ..+..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~-------------~~i~~  224 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF-------------QKIIK  224 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHHHT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH-------------HHHHc
Confidence            44444455678999999999999999999999999999999999999999753221   000             01111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ..  ..++...+.++.+|+.+||+.||++|||++|++++
T Consensus       225 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         225 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            11  12333445579999999999999999999998654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-53  Score=408.38  Aligned_cols=268  Identities=27%  Similarity=0.402  Sum_probs=218.7

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYC  219 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~  219 (457)
                      .+++...++|++.+.||+|+||+||+|++.      +++.||||++..... ...+.|.+|+++++.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            445556788999999999999999999964      357899999976543 3346699999999999999999999999


Q ss_pred             EcCCeEEEEEEeCCCCcHHHHHhhhCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012739          220 ADQNHRLLISEYMPNGTLQQHLHRHNN--------------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVI  279 (457)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  279 (457)
                      .+.+..+++|||+++|+|.+++.....                    ....+++.+++.++.|++.||+|||+++   +|
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            999999999999999999999975331                    1235889999999999999999999999   99


Q ss_pred             eccCccCceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCC-CC
Q 012739          280 HRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR-VP  358 (457)
Q Consensus       280 H~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~-~p  358 (457)
                      ||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|. .|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998776554444455678999999999999999999999999999999999996 45


Q ss_pred             CCCCCCCCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          359 VDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      |.....                 .+....+........+..++.++.+|+.+||+.+|++||||.||++.|+++.+
T Consensus       243 ~~~~~~-----------------~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         243 YYGMAH-----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            654321                 11111111111223444556689999999999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=410.13  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=207.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCc----EEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGT----VAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .+|++.++||+|+||+||+|.+. +|+    .||+|++.... ....+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            45888999999999999999964 333    58999886542 33456789999999999999999999999875 5678


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ++||+.+|+|.+++....   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence            899999999999887754   35999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .............||+.|+|||.+.++.|+.++|||||||++|||+| |..||......                 ++..
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~~~~  224 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISS  224 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------GHHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----------------HHHH
Confidence            65444334455678999999999999999999999999999999999 78888753221                 1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .+....+...+..++..+.+|+.+||+.||++|||+.||+++|+++.++.
T Consensus       225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            11112222344455668999999999999999999999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=396.28  Aligned_cols=246  Identities=26%  Similarity=0.474  Sum_probs=198.0

Q ss_pred             CCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD----QNHRLLIS  229 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lv~  229 (457)
                      ++.++||+|+||+||+|.+. ++..||+|++...  .....+.+.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 5789999998654  34445668999999999999999999999864    45679999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC-CCCcEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD-QNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgl~~~~~  308 (457)
                      ||+++|+|.+++....    .+++.+++.++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999998754    4999999999999999999999875 4599999999999996 58899999999998643


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.......                .....+
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~----------------~~~~~i  225 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYRRV  225 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHHHH
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH----------------HHHHHH
Confidence            32    2345689999999999865 69999999999999999999999997432211                111111


Q ss_pred             CCcC-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          389 DPSL-QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       389 d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      .... ....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            1000 011222234478999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=406.09  Aligned_cols=272  Identities=25%  Similarity=0.362  Sum_probs=209.3

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcC------CcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSD------GTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGY  218 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~  218 (457)
                      .+++...++|++.++||+|+||.||+|.+..      ++.||||++.... ....+.+..|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            4455556789999999999999999998642      4689999997553 34445677788877777 68999999999


Q ss_pred             EEcC-CeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCcc
Q 012739          219 CADQ-NHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKC  285 (457)
Q Consensus       219 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp  285 (457)
                      +.+. +..++||||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+++   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            8654 568999999999999999976432            1235899999999999999999999999   99999999


Q ss_pred             CceEeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCC-CCCCCCCC
Q 012739          286 SNVLLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR-VPVDPNRP  364 (457)
Q Consensus       286 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~-~p~~~~~~  364 (457)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. .||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998776544444455678999999999999999999999999999999999975 56654322


Q ss_pred             CCcchhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          365 PGEHVLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ..                .....+........+...+.++.+|+.+||+.||++|||+.||+++|+++++.++
T Consensus       243 ~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n~  299 (299)
T d1ywna1         243 DE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  299 (299)
T ss_dssp             SH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred             HH----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCCC
Confidence            11                1111111111223344455689999999999999999999999999999998654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=405.05  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=209.0

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      .++|++.+.||+|+||.||+|+++++..||||++..... ..+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            467899999999999999999998888999999976543 34568999999999999999999999855 5679999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|..++.....  ..++|.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999998876432  34999999999999999999999999   99999999999999999999999999987654322


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCcC
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPSL  392 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  392 (457)
                       .......||+.|+|||.+....++.++|||||||++|||+||..|+......                .+....+....
T Consensus       169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------~~~~~~i~~~~  231 (285)
T d1fmka3         169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQVERGY  231 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTTC
T ss_pred             -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcC
Confidence             2334467899999999999999999999999999999999987776543221                11111111222


Q ss_pred             CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          393 QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       393 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ....+..++.++.+++.+||+.||++||++++|++.|++++...
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            22344455668999999999999999999999999999888653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-53  Score=405.00  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      +.|+..+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|+++|+.++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999964 68899999986543   233456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      |||.+|+|..++....    ++++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999987766543    5999999999999999999999999   99999999999999999999999999986543


Q ss_pred             ccCCccccccccCCCccccccccC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          310 KINGQISTRVLGTTGYLAPEYAST---GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                            .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||........   .          .....
T Consensus       168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~----------~~i~~  228 (309)
T d1u5ra_         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L----------YHIAQ  228 (309)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----------HHHHH
T ss_pred             ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---H----------HHHHh
Confidence                  234679999999999854   4689999999999999999999999975322100   0          01111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...+.+   .+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       229 ~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         229 NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             SCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            111111   122234589999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-53  Score=406.70  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=196.2

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK-QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ..+.|++.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+|+.++|||||++++++.+++..||||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999975 588999999875532 23345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeeccCccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKM  306 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl~~~  306 (457)
                      ||+++|+|.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||+.   +++.+||+|||+++.
T Consensus        87 E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999997643    4999999999999999999999999   99999999999994   578999999999986


Q ss_pred             cccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      ....   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......   .....           .
T Consensus       160 ~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i-----------~  222 (307)
T d1a06a_         160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI-----------L  222 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH-----------H
T ss_pred             ccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH-----------h
Confidence            6432   22345679999999999999999999999999999999999999997532210   00000           0


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+..+........+.++.+|+.+||+.||++|||+.|++++  +++++
T Consensus       223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~~  269 (307)
T d1a06a_         223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH--PWIAG  269 (307)
T ss_dssp             TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS--TTTTS
T ss_pred             ccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC--HhhCC
Confidence            011111112223445689999999999999999999999987  66654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=399.44  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=201.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEcC----CcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLSD----GTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLL  227 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l  227 (457)
                      .++|++.+.||+|+||.||+|.+..    +..||||++.... ....+.+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4678889999999999999998643    3568999986553 333456899999999999999999999996 467899


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMV  307 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~  307 (457)
                      ||||+++|+|.+++....   .++++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            999999999999887644   35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhh
Q 012739          308 SDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVE  386 (457)
Q Consensus       308 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (457)
                      .... ........||+.|+|||.+.+..++.++|||||||++|||+| |..||.......                 +..
T Consensus       159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----------------~~~  220 (273)
T d1mp8a_         159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----------------VIG  220 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHH
T ss_pred             cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----------------HHH
Confidence            5432 223345678999999999999999999999999999999998 888887543211                 111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      .+........+..++..+.+|+.+||+.||++|||+.||+++|++++++
T Consensus       221 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            1111111233444556899999999999999999999999999999876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-52  Score=407.05  Aligned_cols=258  Identities=21%  Similarity=0.291  Sum_probs=213.2

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999974 6899999999877666667789999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC--CCCcEEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl~~~~~~  309 (457)
                      |++|+|.+++....   ..+++.++..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.+..
T Consensus       105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999996543   25999999999999999999999999   99999999999995  468899999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   .......||+.|||||++.+..++.++|||||||++|||+||+.||.......   ....          + ...+
T Consensus       179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~----------i-~~~~  241 (350)
T d1koaa2         179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRN----------V-KSCD  241 (350)
T ss_dssp             T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----------H-HHTC
T ss_pred             c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHH----------H-HhCC
Confidence            3   22445689999999999999999999999999999999999999997542210   0000          0 0001


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+........+.++.+|+.+||+.||++|||+.|++++  .++++
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h--p~~~~  285 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLTP  285 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS--TTTSC
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccCC
Confidence            111111112334578999999999999999999999987  66654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=392.04  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=201.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  232 (457)
                      ++|++.+.||+|+||.||+|.+ .|+.||||+++.+.  ..+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4677789999999999999998 57889999997653  33568899999999999999999999865 45689999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.++|.....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          84 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            99999999976432  25899999999999999999999998   999999999999999999999999999865432  


Q ss_pred             CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCCc
Q 012739          313 GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDPS  391 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  391 (457)
                         .....+|..|+|||.+.+..++.++|||||||++|||+| |+.||......                 ++...+...
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------~~~~~i~~~  216 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKG  216 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTTT
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcC
Confidence               234567899999999999999999999999999999998 67777643221                 111222222


Q ss_pred             CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          392 LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       392 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .+.+.+...+.++.+|+.+||+.||++|||+.+++++|+++..
T Consensus       217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            3334455556689999999999999999999999999988743

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-51  Score=404.19  Aligned_cols=256  Identities=22%  Similarity=0.334  Sum_probs=212.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      ++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56899999999999999999974 69999999997766556667889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC--CCCcEEEeeccCccccccc
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD--QNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ++|+|.+++....   .++++.+++.++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998876543   35999999999999999999999999   99999999999997  6789999999999877543


Q ss_pred             cCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                         .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.......   ...          . ....+.
T Consensus       183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~----------~-i~~~~~  245 (352)
T d1koba_         183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ----------N-VKRCDW  245 (352)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----------H-HHHCCC
T ss_pred             ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------H-HHhCCC
Confidence               23455679999999999999999999999999999999999999997532210   000          0 011111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                      .+........+.++.+|+.+||+.||++|||+.|++++  ++++
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H--p~~~  287 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH--PWLK  287 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS--TTTS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhC
Confidence            12222223345589999999999999999999999986  4444

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=396.94  Aligned_cols=257  Identities=22%  Similarity=0.326  Sum_probs=210.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG------KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHR  225 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~  225 (457)
                      .++|++.+.||+|+||+||+|... +|+.||||++....      ....+.+.+|+.+|+.++|||||+++++|.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999974 68999999986432      12246688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC----cEEEeec
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF----RAKVTDF  301 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  301 (457)
                      |||||||++|+|.+++....    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            99999999999999998764    4999999999999999999999999   99999999999998776    4999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR  381 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  381 (457)
                      |++......   .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......   ....        
T Consensus       162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~--------  227 (293)
T d1jksa_         162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLAN--------  227 (293)
T ss_dssp             TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH--------
T ss_pred             hhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHH--------
Confidence            999876532   22345678999999999999999999999999999999999999997532210   0000        


Q ss_pred             hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        . ......+....+...+..+.+|+.+||+.||++|||+.|++++  +++++
T Consensus       228 --i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~~  276 (293)
T d1jksa_         228 --V-SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH--PWIKP  276 (293)
T ss_dssp             --H-HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTCC
T ss_pred             --H-HhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccCC
Confidence              0 0000111101112234578999999999999999999999987  77775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=396.05  Aligned_cols=262  Identities=28%  Similarity=0.436  Sum_probs=211.1

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC-Cc--EEEEEEcccC-chHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD-GT--VAAIKKLHRD-GKQRERAFRMEVDLLSRL-HSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|++.++||+|+||.||+|.+.+ +.  .||||++... .....+.+.+|+++|+.+ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567888999999999999999754 33  4788887544 333445689999999999 799999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcE
Q 012739          229 SEYMPNGTLQQHLHRHN------------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRA  296 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  296 (457)
                      |||+++|+|.++|+...            .....+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999997642            23457999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCC-CCCCCCCCCcchhhhhhc
Q 012739          297 KVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRV-PVDPNRPPGEHVLVSWAL  375 (457)
Q Consensus       297 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~-p~~~~~~~~~~~~~~~~~  375 (457)
                      ||+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.....           
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----------  232 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------  232 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----------
Confidence            9999999986543321   234568999999999999999999999999999999999765 5653221           


Q ss_pred             cccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          376 PRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       376 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                            .++...+........+...+.++.+|+.+||+.||++||||.||+++|++++++...
T Consensus       233 ------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         233 ------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             ------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence                  111122222222344455667899999999999999999999999999999987543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=397.28  Aligned_cols=269  Identities=26%  Similarity=0.400  Sum_probs=220.4

Q ss_pred             HHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 012739          151 TATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRL-HSPQLVELLGYCADQ  222 (457)
Q Consensus       151 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~  222 (457)
                      ...++|++.++||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++.+ +|||||+++++|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34567888999999999999999852      45689999997653 33445688999999999 699999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCce
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNN--------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNV  288 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  288 (457)
                      +..++||||+++|+|.+++.....              ....+++.+++.++.||+.||.|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            999999999999999999987542              2235899999999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 012739          289 LLDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEH  368 (457)
Q Consensus       289 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~  368 (457)
                      |++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+........ 
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999999999987655444445567899999999999999999999999999999999995555443222111 


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                                    ....++........+...+..+.+|+.+||+.||++|||+.+|++.|++++.+++
T Consensus       256 --------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         256 --------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             --------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             --------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence                          1112222222333344455689999999999999999999999999999998854

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=394.60  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=213.5

Q ss_pred             HhcCCCCCceeccCCcEEEEEEEEcC--------CcEEEEEEcccCch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 012739          152 ATENFSEGNVIGNGGFGVVYKGVLSD--------GTVAAIKKLHRDGK-QRERAFRMEVDLLSRL-HSPQLVELLGYCAD  221 (457)
Q Consensus       152 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~  221 (457)
                      ..++|.+.+.||+|+||.||+|+...        +..||||++..+.. .....+.+|...+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34678888999999999999998532        34799999977643 3346688898888888 89999999999999


Q ss_pred             CCeEEEEEEeCCCCcHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceE
Q 012739          222 QNHRLLISEYMPNGTLQQHLHRHNN------------RYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVL  289 (457)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  289 (457)
                      ++..++||||+++|+|.++|.....            ....+++.+++.++.|++.||.|||+.+   ||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            9999999999999999999976532            2246899999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 012739          290 LDQNFRAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEH  368 (457)
Q Consensus       290 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~  368 (457)
                      ++.++.+||+|||+++...............+|+.|+|||.+.++.|+.++||||||+++|||+| |..||.....    
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----  243 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  243 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence            99999999999999998766554445566789999999999999999999999999999999998 6888764322    


Q ss_pred             hhhhhhccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          369 VLVSWALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                                   ..+...+........+...+.++.+|+.+||+.||.+|||+.||++.|++++.
T Consensus       244 -------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                         11112222222334444556689999999999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-51  Score=394.94  Aligned_cols=245  Identities=26%  Similarity=0.394  Sum_probs=206.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46888999999999999999974 68999999986542   223456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||++||+|..++.....    +++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999999887553    888999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.......                ....+..
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~  215 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILN  215 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHH
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----------------HHHHHHc
Confidence            3     345789999999999999999999999999999999999999997532210                0001111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ..  ..++...+.++.+++.+||+.||.+|+     |+++++++
T Consensus       216 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         216 AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11  122333445799999999999999996     89999886

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=396.19  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=208.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++++.||+|+||.||+|+. .+++.||+|++.+..   ....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5688999999999999999997 468999999986542   223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+++|+|.+++.....    +++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+++....
T Consensus        85 ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999988654    899999999999999999999999   99999999999999999999999999986543


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .  .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......   .+..           ......
T Consensus       158 ~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~-----------~i~~~~  221 (337)
T d1o6la_         158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE-----------LILMEE  221 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH-----------HHHHCC
T ss_pred             C--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH-----------HHhcCC
Confidence            2  22345678999999999999999999999999999999999999999854321   0000           000011


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  428 (457)
                      .    .+|...+.++.+|+.+||+.||.+||+     +.|++++
T Consensus       222 ~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1    233445567899999999999999995     8888875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=396.72  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=219.9

Q ss_pred             HHHHHhcCCCCCceeccCCcEEEEEEEEc------CCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012739          148 ELETATENFSEGNVIGNGGFGVVYKGVLS------DGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCA  220 (457)
Q Consensus       148 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~  220 (457)
                      +++...++|.+.+.||+|+||+||+|.+.      +++.||||++.... ......|.+|++++++++||||++++++|.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34444578888999999999999999863      35789999997653 344456899999999999999999999999


Q ss_pred             cCCeEEEEEEeCCCCcHHHHHhhhC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC
Q 012739          221 DQNHRLLISEYMPNGTLQQHLHRHN------NRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF  294 (457)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  294 (457)
                      ..+..++||||+++|+|.+++....      .....+++..+..++.|+++||.|||+++   |+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            9999999999999999999987542      22245799999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCC-CCCCCCCCCCcchhhhh
Q 012739          295 RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGR-VPVDPNRPPGEHVLVSW  373 (457)
Q Consensus       295 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~-~p~~~~~~~~~~~~~~~  373 (457)
                      .+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||.....         
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---------  241 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------  241 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---------
Confidence            99999999999876654444455667999999999999999999999999999999999985 66653211         


Q ss_pred             hccccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          374 ALPRLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       374 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                              .+....+........+..++..+.+|+.+||+.+|++|||+.+|+++|++.++..
T Consensus       242 --------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         242 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             --------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --------HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                    1111111111122334445568999999999999999999999999998877654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=387.14  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcC--C--cEEEEEEcccC---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSD--G--TVAAIKKLHRD---GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ++|++.+.||+|+||.||+|++..  +  ..||||++...   .....+.|.+|+++|+.++||||++++|+|.+. ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            568889999999999999998643  2  36899988654   233446789999999999999999999999764 678


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999998877543   5999999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCc-cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCCcchhhhhhccccCchhHH
Q 012739          307 VSDKINGQ-ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLT-GRVPVDPNRPPGEHVLVSWALPRLTSREEA  384 (457)
Q Consensus       307 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (457)
                      ........ ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......                +..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~~~  224 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QIL  224 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHH
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------HHH
Confidence            75543322 2334567889999999999999999999999999999998 89999743221                111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHh
Q 012739          385 VEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPV  432 (457)
Q Consensus       385 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  432 (457)
                      ..+.......+.+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            112222222333444556899999999999999999999999988764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-50  Score=384.69  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=202.7

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----e
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----H  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~  224 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46789999999999999999996 468999999996542   334456899999999999999999999987643    4


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .||||||+++++|.+++....    ++++.+++.++.|++.||+|||+++   |+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            789999999999999987765    4999999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccC-CccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          305 KMVSDKIN-GQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       305 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||........  ...          .
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~----------~  226 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ----------H  226 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH----------H
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHH----------H
Confidence            76543322 2234456899999999999999999999999999999999999999975322100  000          0


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHhh
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-LMTDVVQSLIPVV  433 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~  433 (457)
                      ...  ++........+.+.++.+|+.+||+.||.+|| |++++++.|.++.
T Consensus       227 ~~~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         227 VRE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHC--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Hhc--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            000  11111111223345899999999999999999 8999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=387.52  Aligned_cols=255  Identities=29%  Similarity=0.450  Sum_probs=206.0

Q ss_pred             CceeccCCcEEEEEEEEcCC----cEEEEEEcccC-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEEEeC
Q 012739          159 GNVIGNGGFGVVYKGVLSDG----TVAAIKKLHRD-GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD-QNHRLLISEYM  232 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  232 (457)
                      .++||+|+||+||+|.+.++    ..||||++... .....+.|.+|+++|++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997442    35899998754 44455779999999999999999999999865 56899999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      ++|+|.+++.....   .+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999876443   5788999999999999999999999   99999999999999999999999999987654322


Q ss_pred             C--ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcCC
Q 012739          313 G--QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVDP  390 (457)
Q Consensus       313 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  390 (457)
                      .  .......||+.|+|||.+....++.++||||||+++|||+||+.||.......+.  ..          .+..-   
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~----------~i~~g---  250 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV----------YLLQG---  250 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HH----------HHHTT---
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HH----------HHHcC---
Confidence            2  2234467899999999999999999999999999999999988888643321110  10          11111   


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          391 SLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       391 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                       .....+..++..+.+|+.+||+.||++||+|.||+++|+++++.
T Consensus       251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             11122333456899999999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=385.46  Aligned_cols=275  Identities=21%  Similarity=0.297  Sum_probs=205.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----HRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~lv~  229 (457)
                      .+|.+.+.||+|+||.||+|++ +|+.||||++..... .....+.|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4566778999999999999997 688999999865432 2222344666667889999999999997654    679999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-----TPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      ||+++|+|.++|...     .++|.+++.++.|++.||.|||+..     .++|+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999763     4899999999999999999999741     123999999999999999999999999999


Q ss_pred             cccccccCC--ccccccccCCCccccccccCC------CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          305 KMVSDKING--QISTRVLGTTGYLAPEYASTG------KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       305 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      +........  .......||+.|+|||++.+.      .++.++|||||||+||||+||..||........ ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~~~~  234 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVPS  234 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSCS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhcccc
Confidence            877543222  123457899999999998764      367899999999999999999988864332111 11111000


Q ss_pred             ccCchhHHhhhcCCcCCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          377 RLTSREEAVEMVDPSLQGQY-----PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ............+..++...     +.+.+..+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            11111111122333333333     2345677999999999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.1e-50  Score=379.59  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=207.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch---------HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcC
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK---------QRERAFRMEVDLLSRLH-SPQLVELLGYCADQ  222 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~  222 (457)
                      ++|++.+.||+|+||+||+|+. .+++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6788999999999999999997 4689999999865421         11235778999999997 99999999999999


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      +..||||||+++|+|.++|....    ++++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999998755    4999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCCccccccccCCCccccccccC------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcc
Q 012739          303 LAKMVSDKINGQISTRVLGTTGYLAPEYAST------GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALP  376 (457)
Q Consensus       303 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  376 (457)
                      +++.....   .......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.......   ...    
T Consensus       156 ~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~----  225 (277)
T d1phka_         156 FSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR----  225 (277)
T ss_dssp             TCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----
T ss_pred             heeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHH----
Confidence            99877543   22345679999999998853      457889999999999999999999998543210   000    


Q ss_pred             ccCchhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          377 RLTSREEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       377 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                            .... -............+.++.+|+.+||+.||++|||+.||+++  ++++
T Consensus       226 ------~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h--~~~~  274 (277)
T d1phka_         226 ------MIMS-GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH--PFFQ  274 (277)
T ss_dssp             ------HHHH-TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS--GGGC
T ss_pred             ------HHHh-CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC--HHHH
Confidence                  0000 01111112223455689999999999999999999999887  4444

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-50  Score=394.22  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=206.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~  229 (457)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46899999999999999999974 69999999986432   222356789999999999999999999999999999999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~  309 (457)
                      ||+.+|+|..++....    .+++.+++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++.+..
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999998765    3999999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .     .....||+.|||||++.+..++.++|||||||++|||+||+.||......   ...             ..+..
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~-------------~~i~~  252 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIY-------------EKIVS  252 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHHHH
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHH-------------HHHhc
Confidence            2     34567999999999999999999999999999999999999999753211   000             00101


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 012739          390 PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  428 (457)
                      ..  ...+...+.++.+|+.+||+.||.+|+     |+.+++++
T Consensus       253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            11  112233455799999999999999994     89999885

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-49  Score=391.34  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=203.5

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHH---HHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFR---MEVDLLSRLHSPQLVELLGYCADQNHRL  226 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~---~Ei~~l~~l~hpniv~l~~~~~~~~~~~  226 (457)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.   .|+.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999975 58999999985432   11122233   3567778889999999999999999999


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      +||||+++|+|.++|....    .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999998764    3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      +...    ......||+.|+|||++.. ..|+.++|||||||+||||+||+.||.............             
T Consensus       157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-------------  219 (364)
T d1omwa3         157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------  219 (364)
T ss_dssp             CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------------
T ss_pred             cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence            6542    2345679999999999864 568999999999999999999999998644322111100             


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHHHhhh
Q 012739          386 EMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPL-----MTDVVQSLIPVVK  434 (457)
Q Consensus       386 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~~~~  434 (457)
                      ....  .....+...+.++.+|+.+||+.||.+|||     ++|++++  ++++
T Consensus       220 ~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H--p~f~  269 (364)
T d1omwa3         220 MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES--PFFR  269 (364)
T ss_dssp             HSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS--GGGT
T ss_pred             hccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC--cccc
Confidence            0111  111223334557999999999999999999     6888876  4444

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=388.51  Aligned_cols=248  Identities=18%  Similarity=0.284  Sum_probs=206.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++..... ....+.+|+++|+.++|||||++++++.+.+..||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999975 588999999976643 345578999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC--CCcEEEeeccCcccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ--NFRAKVTDFGLAKMVSD  309 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgl~~~~~~  309 (457)
                      |++|+|.+++....   ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.  ...+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999997643   25999999999999999999999999   999999999999985  45899999999987643


Q ss_pred             ccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhcC
Q 012739          310 KINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMVD  389 (457)
Q Consensus       310 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  389 (457)
                      .   .......+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||.......                ....+..
T Consensus       157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------------~~~~i~~  217 (321)
T d1tkia_         157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------IIENIMN  217 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHH
T ss_pred             C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh
Confidence            2   22445678999999999999999999999999999999999999997543210                0011111


Q ss_pred             CcCCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 012739          390 PSLQGQYPK----KDLIQIAAIAAVCVQPEAAYRPLMTDVVQS  428 (457)
Q Consensus       390 ~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~  428 (457)
                      ...  .++.    ..+.++.+|+.+||+.||++|||+.|++++
T Consensus       218 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         218 AEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  1111    234578999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=387.30  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=201.6

Q ss_pred             cCCCCCc-eeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEc----CCeEE
Q 012739          154 ENFSEGN-VIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSR-LHSPQLVELLGYCAD----QNHRL  226 (457)
Q Consensus       154 ~~~~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~----~~~~~  226 (457)
                      ++|.+.+ +||+|+||+||+|.+ .+++.||||++...     ..+.+|++++.+ .+|||||+++++|.+    ++..|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787764 699999999999996 46899999998643     346679988655 589999999999865    46789


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC---CCcEEEeeccC
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ---NFRAKVTDFGL  303 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  303 (457)
                      ||||||+||+|.++|.....  ..+++.++..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999976432  46999999999999999999999999   999999999999975   56799999999


Q ss_pred             ccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      ++.....   .......||+.|+|||++.+..|+.++|||||||+||+|+||+.||............   ..       
T Consensus       161 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~-------  227 (335)
T d2ozaa1         161 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT-------  227 (335)
T ss_dssp             CEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH-------
Confidence            9876543   2245568999999999999999999999999999999999999999754322110000   00       


Q ss_pred             HhhhcCCcC--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          384 AVEMVDPSL--QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       384 ~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                        .+.....  ........+.++.+|+.+||+.||++|||+.|++++  +++++
T Consensus       228 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~~  277 (335)
T d2ozaa1         228 --RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH--PWIMQ  277 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--HHHHT
T ss_pred             --HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC--HHhhC
Confidence              0000001  001112345689999999999999999999999987  55544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=387.04  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=203.2

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc---hHHHHHHHHHHHHH-HhcCCCCeeeEEEEEEcCCeEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG---KQRERAFRMEVDLL-SRLHSPQLVELLGYCADQNHRLLI  228 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~~~~~~lv  228 (457)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++....   ....+.+..|..++ +.++||||+++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888999999999999999975 68999999996532   12233455566655 478999999999999999999999


Q ss_pred             EEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccc
Q 012739          229 SEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~  308 (457)
                      |||+++|+|.+++.....    +++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999987653    899999999999999999999999   9999999999999999999999999998654


Q ss_pred             cccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHhhhc
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAVEMV  388 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (457)
                      ..  ....+...||+.|+|||++.+..|+.++|||||||++|||+||+.||.......   ...           ....-
T Consensus       155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~-----------~i~~~  218 (320)
T d1xjda_         155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH-----------SIRMD  218 (320)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-----------HHHHC
T ss_pred             cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH-----------HHHcC
Confidence            32  223455689999999999999999999999999999999999999997543210   000           00111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 012739          389 DPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMT-DVVQS  428 (457)
Q Consensus       389 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~~  428 (457)
                      .+    .++...+.++.+|+.+||+.||.+||++. +++++
T Consensus       219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            11    22333455799999999999999999995 78654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=381.74  Aligned_cols=269  Identities=23%  Similarity=0.247  Sum_probs=200.3

Q ss_pred             CceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHH-----HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEeC
Q 012739          159 GNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQR-----ERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEYM  232 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  232 (457)
                      +++||+|+||+||+|++. +|+.||||++.......     .+.+.+|+.+++.++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 58999999986543221     235789999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccccC
Q 012739          233 PNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKIN  312 (457)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~  312 (457)
                      .++++..++...    ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            887766554332    35888999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             CccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch--hHHhhhcC
Q 012739          313 GQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR--EEAVEMVD  389 (457)
Q Consensus       313 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d  389 (457)
                       ......+||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+....+..........  ........
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             22345679999999999865 467999999999999999999999997543211111110000000000  00000000


Q ss_pred             Cc---CCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          390 PS---LQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       390 ~~---l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..   .....+     .....++.+|+.+||+.||++|||+.|++++  +++++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~p~  288 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPG  288 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSC
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCCCC
Confidence            00   000111     1234579999999999999999999999988  88887554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=378.93  Aligned_cols=274  Identities=24%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++.....  ...+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788999999999999999997 4689999999965532  223568899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      |+.+ ++.+++.....  ..+++.++..++.|++.||.|||+++   ||||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            9964 55555544322  35999999999999999999999999   999999999999999999999999999876442


Q ss_pred             cCCccccccccCCCccccccccCCC-CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc--hhHHhhh
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS--REEAVEM  387 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  387 (457)
                        ........||+.|+|||.+.... ++.++|||||||++|+|++|+.||......+..............  .......
T Consensus       156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence              23344567999999999877655 578999999999999999999999754321110000000000000  0000000


Q ss_pred             --cCCcC----CCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          388 --VDPSL----QGQY---PKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       388 --~d~~l----~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                        .....    ....   ......++.+|+.+||+.||++|||+.|++++  +++++-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~  290 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVT  290 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCC
Confidence              00000    0000   01223578999999999999999999999997  7776543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=374.17  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCch------HHHHHHHHHHHHHHhcC--CCCeeeEEEEEEcCC
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGK------QRERAFRMEVDLLSRLH--SPQLVELLGYCADQN  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~  223 (457)
                      .++|++.++||+|+||+||+|+.. +++.||||++.....      .....+.+|+.+++.++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357899999999999999999974 689999999864321      11123567999999996  899999999999999


Q ss_pred             eEEEEEEeCCC-CcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-CCcEEEeec
Q 012739          224 HRLLISEYMPN-GTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-NFRAKVTDF  301 (457)
Q Consensus       224 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  301 (457)
                      ..++||||+.+ +++.+++....    .+++.++..++.|++.||.|||+++   |+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            99999999975 58888887654    4999999999999999999999999   999999999999985 579999999


Q ss_pred             cCccccccccCCccccccccCCCccccccccCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          302 GLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKL-TTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       302 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      |+++.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||....                 
T Consensus       156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------------  214 (273)
T d1xwsa_         156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------------  214 (273)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------------
T ss_pred             ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------------
Confidence            999865432    2345679999999999987765 577899999999999999999997421                 


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                        .... ....+...    .+.++.+|+.+||+.||++|||++|++++  +++++.
T Consensus       215 --~i~~-~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h--p~~~~~  261 (273)
T d1xwsa_         215 --EIIR-GQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH--PWMQDV  261 (273)
T ss_dssp             --HHHH-CCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSSC
T ss_pred             --HHhh-cccCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC--HhhCCC
Confidence              0000 01112222    34578999999999999999999999987  677653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.2e-49  Score=375.94  Aligned_cols=271  Identities=21%  Similarity=0.266  Sum_probs=204.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK--QRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.++||+|+||+||+|++.+++.||||++.....  ...+.+.+|+.+|+.++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999999999999999966532  2245688999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCcccccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDKI  311 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~  311 (457)
                      +.++.+..+....    ..+++.++..++.|++.||+|||+.+   ||||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9776666665433    35999999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhcccc--CchhHHhh--
Q 012739          312 NGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRL--TSREEAVE--  386 (457)
Q Consensus       312 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  386 (457)
                        .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+............  ........  
T Consensus       155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence              22344568999999999865 457999999999999999999999997543211111100000000  00000000  


Q ss_pred             hcCCcCC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVDPSLQ-------GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d~~l~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+....       ..........+.+|+.+||+.||++|||++|++++  +++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H--p~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH--AYFKE  286 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGGC
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccCc
Confidence            0010000       11122334578999999999999999999999987  66553

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=375.77  Aligned_cols=273  Identities=21%  Similarity=0.240  Sum_probs=201.5

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-C-CcEEEEEEcccCch--HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEc----
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-D-GTVAAIKKLHRDGK--QRERAFRMEVDLLSRL---HSPQLVELLGYCAD----  221 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~----  221 (457)
                      .++|++.+.||+|+||+||+|++. + ++.||||++.....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999973 3 56799999865321  1122355677776665   89999999999853    


Q ss_pred             -CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEee
Q 012739          222 -QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTD  300 (457)
Q Consensus       222 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  300 (457)
                       ....+++|||+.++++........   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence             357899999998877654443322   35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          301 FGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       301 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      ||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||+||+.||...........+.........
T Consensus       160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            9998765432   2345678999999999999999999999999999999999999999864322111111110000000


Q ss_pred             h---------hHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          381 R---------EEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       381 ~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      .         ..............+.......+.+|+.+||+.||++|||+.|++++  +++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H--pff~~i  299 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQDL  299 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTTC
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--hhhcCc
Confidence            0         00000000000011222334578899999999999999999999987  677653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=366.22  Aligned_cols=276  Identities=19%  Similarity=0.211  Sum_probs=201.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc--------C
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCAD--------Q  222 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~  222 (457)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|+++|+.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67899999999999999999974 79999999986542  2233567889999999999999999998855        3


Q ss_pred             CeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeecc
Q 012739          223 NHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFG  302 (457)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  302 (457)
                      +..++||||+.++.+..+....    ..+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            4689999999877665444332    35889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccccCC--ccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC
Q 012739          303 LAKMVSDKING--QISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT  379 (457)
Q Consensus       303 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  379 (457)
                      +++........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99866543221  223345799999999998754 689999999999999999999999975432111111111110000


Q ss_pred             ch-------hHHhhhcCCcCCCCCCH-------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          380 SR-------EEAVEMVDPSLQGQYPK-------KDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       380 ~~-------~~~~~~~d~~l~~~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                      ..       ...............+.       .....+.+|+.+||+.||++|||++|++++  +++++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H--pff~~~p~  313 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDPM  313 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGSSSSC
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC--hhhccCCC
Confidence            00       00000000000001111       113467889999999999999999999998  88876544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=369.94  Aligned_cols=268  Identities=24%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             CCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CCeEEE
Q 012739          155 NFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQLVELLGYCAD------QNHRLL  227 (457)
Q Consensus       155 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~~~l  227 (457)
                      +|+..++||+|+||+||+|++. +++.||||++......    ..+|+++|++++||||++++++|..      ..+.+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4667789999999999999975 5899999999765322    3469999999999999999999854      335789


Q ss_pred             EEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccc
Q 012739          228 ISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKM  306 (457)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~  306 (457)
                      ||||++++ +...+.........+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999765 44444332223346999999999999999999999999   99999999999999775 899999999987


Q ss_pred             cccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhHHh
Q 012739          307 VSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREEAV  385 (457)
Q Consensus       307 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (457)
                      ....   .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+......... ....
T Consensus       173 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~-~~~~  248 (350)
T d1q5ka_         173 LVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR-EQIR  248 (350)
T ss_dssp             CCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH-HHHH
T ss_pred             ccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH-Hhhh
Confidence            6443   22345679999999998765 57899999999999999999999999754322111111110000000 0000


Q ss_pred             hh----cCCcC--------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          386 EM----VDPSL--------QGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       386 ~~----~d~~l--------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..    .+..+        ..........++.+|+.+||+.||++|||+.|++++  .++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--Hhhccc
Confidence            00    00000        001122345578999999999999999999999987  666653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=367.62  Aligned_cols=267  Identities=20%  Similarity=0.288  Sum_probs=199.4

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQN------  223 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------  223 (457)
                      .++|++.++||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999974 5999999999754  3334456889999999999999999999997654      


Q ss_pred             eEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccC
Q 012739          224 HRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGL  303 (457)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  303 (457)
                      ..++||||+ +.+|..++...     .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence            579999999 66787776542     4999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCccccccccCCCccccccccC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccc-----
Q 012739          304 AKMVSDKINGQISTRVLGTTGYLAPEYAST-GKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPR-----  377 (457)
Q Consensus       304 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  377 (457)
                      ++.....     .+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..................     
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            9876443     345679999999999876 45789999999999999999999999764321111110000000     


Q ss_pred             ---cCc--hhHHhhhcCCcCC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          378 ---LTS--REEAVEMVDPSLQ---GQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       378 ---~~~--~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                         ...  .......+.....   ..........+.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H--p~f~~  306 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFES  306 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTT
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--hhhCc
Confidence               000  0000111111000   01122334578899999999999999999999998  66665

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-46  Score=355.09  Aligned_cols=264  Identities=20%  Similarity=0.279  Sum_probs=202.3

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEEEe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLISEY  231 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~  231 (457)
                      ++|++.+.||+|+||.||+|++ .+++.||||++.....  ...+..|+++++.++|+| |+.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5789999999999999999996 4588999998765432  234778999999998766 55555666788899999999


Q ss_pred             CCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeC---CCCcEEEeeccCccccc
Q 012739          232 MPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLD---QNFRAKVTDFGLAKMVS  308 (457)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl~~~~~  308 (457)
                      + +++|...+....   ..+++..++.++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+.
T Consensus        85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 667777665543   35999999999999999999999999   99999999999985   35579999999999875


Q ss_pred             cccCC-----ccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchhH
Q 012739          309 DKING-----QISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSREE  383 (457)
Q Consensus       309 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  383 (457)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||................      ..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~------~~  231 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------EK  231 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH------HH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh------cc
Confidence            43322     22345689999999999999999999999999999999999999998654322211110000      00


Q ss_pred             HhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          384 AVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       384 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ......+.+...+    +.++.+++..||+.+|++||++.++.+.|++++.+.
T Consensus       232 ~~~~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 KMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHSCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            0000001111223    347999999999999999999999999999887653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=361.93  Aligned_cols=273  Identities=18%  Similarity=0.243  Sum_probs=201.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDG-KQRERAFRMEVDLLSRLHSPQLVELLGYCADQN----HRL  226 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~  226 (457)
                      ..+|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45789999999999999999986 479999999996543 344567889999999999999999999986543    234


Q ss_pred             EEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          227 LISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                      ++++|+.+|+|.+++...     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            555667799999999753     4899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCC-ccccccccCCCcccccccc-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCch---
Q 012739          307 VSDKING-QISTRVLGTTGYLAPEYAS-TGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSR---  381 (457)
Q Consensus       307 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  381 (457)
                      ....... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||......+...............   
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            6543222 2345567999999999984 4567899999999999999999999997643321111111110000000   


Q ss_pred             -----hHHhhhcCCcCCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          382 -----EEAVEMVDPSLQGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       382 -----~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                           ...............+     .....++.+|+.+||+.||.+|||+.|++++  +++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h--pf~~~  300 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLEQ  300 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--Hhhcc
Confidence                 0000000000001111     1223478999999999999999999999997  56664

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-45  Score=353.00  Aligned_cols=266  Identities=18%  Similarity=0.255  Sum_probs=211.9

Q ss_pred             hcCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEE
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  230 (457)
                      .++|++.++||+|+||+||+|++. +++.||||++.....  ...+++|++.++.+.| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367899999999999999999965 688999998755422  2346789999999976 899999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCC-----CCcEEEeeccCcc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQ-----NFRAKVTDFGLAK  305 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgl~~  305 (457)
                      |+ +++|.+++.....   .+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 7899999876543   5899999999999999999999999   999999999999964     5789999999998


Q ss_pred             ccccccCCc-----cccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCc
Q 012739          306 MVSDKINGQ-----ISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTS  380 (457)
Q Consensus       306 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  380 (457)
                      .+.......     ......||+.|||||.+.+..++.++||||||+++|||+||+.||...............    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i----~~  230 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GE  230 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----HH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH----Hh
Confidence            775432221     234567999999999999999999999999999999999999999865443222111110    00


Q ss_pred             hhHHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcC
Q 012739          381 REEAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNA  437 (457)
Q Consensus       381 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  437 (457)
                      ...  ...-+.+...+|    .++.+++..|++.+|++||+++.+.+.|++++++..
T Consensus       231 ~~~--~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         231 KKQ--STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHH--HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccC--CCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            000  000011112333    479999999999999999999999999999988654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=362.78  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=206.0

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc----CCcEEEEEEcccCc----hHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS----DGTVAAIKKLHRDG----KQRERAFRMEVDLLSRLHS-PQLVELLGYCADQNH  224 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~  224 (457)
                      ++|++.+.||+|+||+||+|+..    +|+.||+|.+....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999852    47899999986431    1223457789999999976 899999999999999


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .+++|||+.+|+|.+++.....    +.+..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999987654    788999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCccccccccCCCccccccccCC--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccCchh
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTG--KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLTSRE  382 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  382 (457)
                      +.+..... .......|++.|+|||.+.+.  .++.++|||||||+||||+||+.||...........+..        .
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--------~  247 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------R  247 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--------H
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--------h
Confidence            87654322 223456799999999998654  478899999999999999999999986544322111100        0


Q ss_pred             HHhhhcCCcCCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHHHhhhh
Q 012739          383 EAVEMVDPSLQGQYPKKDLIQIAAIAAVCVQPEAAYRP-----LMTDVVQSLIPVVKN  435 (457)
Q Consensus       383 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~~~~~~  435 (457)
                      .  ....+    .++...+.++.+|+.+||+.||.+||     |++|++++  +++++
T Consensus       248 ~--~~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H--pff~~  297 (322)
T d1vzoa_         248 I--LKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH--LFFQK  297 (322)
T ss_dssp             H--HHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS--GGGTT
T ss_pred             c--ccCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC--HhhcC
Confidence            0  01111    23334556899999999999999999     47888875  55543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=354.78  Aligned_cols=271  Identities=20%  Similarity=0.248  Sum_probs=207.4

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccCc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRDG--KQRERAFRMEVDLLSRLHSPQLVELLGYCADQNHRLLISE  230 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lv~e  230 (457)
                      ++|+++++||+|+||+||+|++. +++.||||+++...  ....+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47899999999999999999974 68899999986542  3345678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCccccccc
Q 012739          231 YMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKMVSDK  310 (457)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~~~~~  310 (457)
                      ++.+++|..++....    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999888776543    4889999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCCccccccccCCCccccccccCCC-CCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhccccCc--hhHHhh
Q 012739          311 INGQISTRVLGTTGYLAPEYASTGK-LTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALPRLTS--REEAVE  386 (457)
Q Consensus       311 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~  386 (457)
                      .  .......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......... ...........  ......
T Consensus       155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            2  2233445778899999987654 6899999999999999999999986433211111 00000000000  000000


Q ss_pred             hcC---------CcCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhh
Q 012739          387 MVD---------PSLQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKN  435 (457)
Q Consensus       387 ~~d---------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  435 (457)
                      ..+         ..............+.+|+.+||+.||.+|||++|++++  +++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H--p~f~~  288 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSD  288 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGSS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--hhhcC
Confidence            000         000111223345578999999999999999999999987  55543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-45  Score=357.73  Aligned_cols=263  Identities=16%  Similarity=0.260  Sum_probs=199.9

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEc--CCeEEEEE
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCAD--QNHRLLIS  229 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~--~~~~~lv~  229 (457)
                      ++|++.++||+|+||+||+|+. .+++.||||+++...   .+.+.+|+++|+.++ ||||++++++|..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999997 468999999987543   345788999999995 9999999999974  45689999


Q ss_pred             EeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCC-cEEEeeccCccccc
Q 012739          230 EYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNF-RAKVTDFGLAKMVS  308 (457)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl~~~~~  308 (457)
                      ||+.+++|..+.       +.+++.++..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            999999997653       24899999999999999999999999   99999999999998654 69999999998765


Q ss_pred             cccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch-hhhhhcc----------
Q 012739          309 DKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV-LVSWALP----------  376 (457)
Q Consensus       309 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~----------  376 (457)
                      ..   .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .......          
T Consensus       182 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            43   224556789999999998765 57999999999999999999999997543321110 0000000          


Q ss_pred             -ccCchhHHhhhcCCc--------CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhh
Q 012739          377 -RLTSREEAVEMVDPS--------LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVK  434 (457)
Q Consensus       377 -~~~~~~~~~~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  434 (457)
                       ...............        ...........++.+|+.+||+.||.+|||++|++++  ++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H--p~F~  323 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH--PYFY  323 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccC
Confidence             000000000000000        0011112334578999999999999999999999986  5544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=361.05  Aligned_cols=268  Identities=22%  Similarity=0.261  Sum_probs=195.8

Q ss_pred             cCCCCCceeccCCcEEEEEEEEc-CCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CCe
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVLS-DGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCAD------QNH  224 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~  224 (457)
                      ++|++.++||+|+||+||+|.+. +|+.||||++...  .......+.+|+.+++.++||||++++++|..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999975 5999999999754  33444568899999999999999999999953      468


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .|+||||+.++ +.+.+.      ..+++.+++.++.|++.||.|||++|   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            89999999655 444442      23899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhh--------hcc
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSW--------ALP  376 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~  376 (457)
                      +.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||..............        ...
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            866442   234556799999999999999999999999999999999999999975432111000000        000


Q ss_pred             ccCch-h------------HHhhhcCCcCCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhc
Q 012739          377 RLTSR-E------------EAVEMVDPSLQG---QYPKKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNN  436 (457)
Q Consensus       377 ~~~~~-~------------~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  436 (457)
                      ..... .            .....+......   ........++.+|+.+||+.||++|||++|++++  ++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H--pw~~~~  317 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH--PYINVW  317 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS--TTTGGG
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCCC
Confidence            00000 0            000011111111   1123456789999999999999999999999999  888764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=357.40  Aligned_cols=271  Identities=20%  Similarity=0.263  Sum_probs=201.8

Q ss_pred             hcCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccC--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 012739          153 TENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRD--GKQRERAFRMEVDLLSRLHSPQLVELLGYCADQ-----NH  224 (457)
Q Consensus       153 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~  224 (457)
                      .++|++.++||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|+.++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999996 46999999999754  234445688999999999999999999998633     34


Q ss_pred             EEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEEeeccCc
Q 012739          225 RLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKVTDFGLA  304 (457)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~  304 (457)
                      .+++++|+.+|+|.+++...     .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            46677888899999998542     4999999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccCCccccccccCCCccccccccCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcchhhhhhccccC----
Q 012739          305 KMVSDKINGQISTRVLGTTGYLAPEYASTG-KLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHVLVSWALPRLT----  379 (457)
Q Consensus       305 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  379 (457)
                      ......     .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+........    
T Consensus       169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            765432     3456789999999987665 568999999999999999999999975432111111100000000    


Q ss_pred             ---chhHHhhhcCCcC-CCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 012739          380 ---SREEAVEMVDPSL-QGQYP-----KKDLIQIAAIAAVCVQPEAAYRPLMTDVVQSLIPVVKNNAA  438 (457)
Q Consensus       380 ---~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  438 (457)
                         ............. ....+     .....++.+|+.+||+.||.+|||+.|++++  +++++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~~~~  309 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHD  309 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTCC
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCCCCC
Confidence               0000000000000 00000     1234578899999999999999999999998  88876543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-39  Score=318.99  Aligned_cols=270  Identities=20%  Similarity=0.262  Sum_probs=195.6

Q ss_pred             cCCCCCceeccCCcEEEEEEEE-cCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEc
Q 012739          154 ENFSEGNVIGNGGFGVVYKGVL-SDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-----------SPQLVELLGYCAD  221 (457)
Q Consensus       154 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------hpniv~l~~~~~~  221 (457)
                      .+|+++++||+|+||+||+|+. .+|+.||||+++.+.. ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4589999999999999999997 4699999999976532 3346778898888875           5789999988754


Q ss_pred             --CCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCccCceEeCCCC----
Q 012739          222 --QNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHE-HATPPVIHRDFKCSNVLLDQNF----  294 (457)
Q Consensus       222 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~----  294 (457)
                        ....+++++++..+......... .....+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence              45667777776655433332222 223468899999999999999999998 77   99999999999997654    


Q ss_pred             --cEEEeeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCCcch---
Q 012739          295 --RAKVTDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLLELLTGRVPVDPNRPPGEHV---  369 (457)
Q Consensus       295 --~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~elltg~~p~~~~~~~~~~~---  369 (457)
                        .++++|||.+......     .....||+.|+|||++.+..++.++||||+||++++|++|+.||..........   
T Consensus       168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence              4999999998765432     345679999999999999999999999999999999999999997543221110   


Q ss_pred             -h--hhhhccccCchh-----HHhhhcCC-----c--------------CCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 012739          370 -L--VSWALPRLTSRE-----EAVEMVDP-----S--------------LQGQYPKKDLIQIAAIAAVCVQPEAAYRPLM  422 (457)
Q Consensus       370 -~--~~~~~~~~~~~~-----~~~~~~d~-----~--------------l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  422 (457)
                       +  ..+.........     .....++.     .              ...........++.+|+.+||+.||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence             0  000100000000     00001110     0              0113345677899999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 012739          423 TDVVQSLIPVVKN  435 (457)
Q Consensus       423 ~evl~~L~~~~~~  435 (457)
                      +|++++  +++++
T Consensus       323 ~e~L~H--p~f~~  333 (362)
T d1q8ya_         323 GGLVNH--PWLKD  333 (362)
T ss_dssp             HHHHTC--GGGTT
T ss_pred             HHHhcC--cccCC
Confidence            999987  67764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=5.3e-25  Score=195.51  Aligned_cols=170  Identities=16%  Similarity=0.147  Sum_probs=121.0

Q ss_pred             CCCceeccCCcEEEEEEEEcCCcEEEEEEcccCch------------------HHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012739          157 SEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGK------------------QRERAFRMEVDLLSRLHSPQLVELLGY  218 (457)
Q Consensus       157 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~hpniv~l~~~  218 (457)
                      .+.++||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999998999999998653210                  011234568899999999999998866


Q ss_pred             EEcCCeEEEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCccCceEeCCCCcEEE
Q 012739          219 CADQNHRLLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHATPPVIHRDFKCSNVLLDQNFRAKV  298 (457)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  298 (457)
                      ..    .+++|||+++..+.+           ++......++.|++.+|.|||+++   |+||||||+|||++++ .++|
T Consensus        83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            32    379999998765533           333445678999999999999999   9999999999999865 5899


Q ss_pred             eeccCccccccccCCccccccccCCCccccccccCCCCCcccchHHHHHHHH
Q 012739          299 TDFGLAKMVSDKINGQISTRVLGTTGYLAPEYASTGKLTTKSDVYSYGVVLL  350 (457)
Q Consensus       299 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~SlG~il~  350 (457)
                      +|||++.............+.+..    -.+. -...|+.++|+||+.--+.
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHHHh
Confidence            999998765432111100000000    0011 1356889999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.69  E-value=4.1e-08  Score=89.26  Aligned_cols=150  Identities=15%  Similarity=0.085  Sum_probs=101.2

Q ss_pred             HHHHHHhcCCCCCceeccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeE
Q 012739          147 KELETATENFSEGNVIGNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLH-SPQLVELLGYCADQNHR  225 (457)
Q Consensus       147 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~  225 (457)
                      .++......|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35666667777666555555678999865 56667788775543333334677888888774 33367788888888899


Q ss_pred             EEEEEeCCCCcHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 012739          226 LLISEYMPNGTLQQHLHRHNNRYRPLDWRTRLIIALDCAMALEFLHEHA-------------------------------  274 (457)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------  274 (457)
                      ++||++++|.++.+.....      ..   ...++.++++.+..||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999988876543211      11   1223445555555666421                               


Q ss_pred             -------------------------CCCeEeccCccCceEeCCCCcEEEeeccCccc
Q 012739          275 -------------------------TPPVIHRDFKCSNVLLDQNFRAKVTDFGLAKM  306 (457)
Q Consensus       275 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~~  306 (457)
                                               ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     11289999999999999877778999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=6e-06  Score=74.00  Aligned_cols=74  Identities=16%  Similarity=0.125  Sum_probs=52.9

Q ss_pred             eccCCc-EEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCeEEEEEEeCCCCcHH
Q 012739          162 IGNGGF-GVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS--PQLVELLGYCADQNHRLLISEYMPNGTLQ  238 (457)
Q Consensus       162 LG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~  238 (457)
                      +..|.. +.||+....++..+++|.......   ..+..|...++.+..  -.+.+++++..+.+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 679999887888888887654422   235667777777733  33677888888888999999999876653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.62  E-value=0.00012  Score=69.97  Aligned_cols=76  Identities=17%  Similarity=0.149  Sum_probs=45.7

Q ss_pred             CceeccCCcEEEEEEEEcC-CcEEEEEEccc----Cc---hHHHHHHHHHHHHHHhcC-C--CCeeeEEEEEEcCCeEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSD-GTVAAIKKLHR----DG---KQRERAFRMEVDLLSRLH-S--PQLVELLGYCADQNHRLL  227 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~----~~---~~~~~~~~~Ei~~l~~l~-h--pniv~l~~~~~~~~~~~l  227 (457)
                      .+.||.|....||+....+ ++.+++|.-..    ..   .........|.+.|+.+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 66788885321    11   011123445777777662 2  345566654  3445679


Q ss_pred             EEEeCCCCc
Q 012739          228 ISEYMPNGT  236 (457)
Q Consensus       228 v~e~~~~g~  236 (457)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.96  E-value=0.001  Score=61.33  Aligned_cols=68  Identities=10%  Similarity=0.041  Sum_probs=45.1

Q ss_pred             EEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC--eeeEEE-----EEEcCCeEEEEEEeCCCCc
Q 012739          168 GVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ--LVELLG-----YCADQNHRLLISEYMPNGT  236 (457)
Q Consensus       168 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~-----~~~~~~~~~lv~e~~~~g~  236 (457)
                      -.||++..++|..+++|+.... ....+++..|...+..|...+  ++..+.     .+...+..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            5899999999999999987543 223455777888888774211  111111     2344667889999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.71  E-value=0.0022  Score=60.84  Aligned_cols=73  Identities=18%  Similarity=0.202  Sum_probs=47.5

Q ss_pred             CceeccCCcEEEEEEEEcCC--------cEEEEEEcccCchHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEE
Q 012739          159 GNVIGNGGFGVVYKGVLSDG--------TVAAIKKLHRDGKQRERAFRMEVDLLSRLHSPQ-LVELLGYCADQNHRLLIS  229 (457)
Q Consensus       159 ~~~LG~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lv~  229 (457)
                      .+.|+.|-.-.+|++...++        ..|+++...... . .....+|..+++.+.-.+ ..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35788888899999986543        456666654222 2 223456888888884333 3467777653    5899


Q ss_pred             EeCCCCcH
Q 012739          230 EYMPNGTL  237 (457)
Q Consensus       230 e~~~~g~L  237 (457)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.32  E-value=0.016  Score=52.59  Aligned_cols=158  Identities=13%  Similarity=0.088  Sum_probs=82.0

Q ss_pred             chHHHHHHhcCCCCCcee-----ccCCcEEEEEEEEcCCcEEEEEEcccCchHHHHHHHHHHHHHHhcCC-----CCeee
Q 012739          145 TYKELETATENFSEGNVI-----GNGGFGVVYKGVLSDGTVAAIKKLHRDGKQRERAFRMEVDLLSRLHS-----PQLVE  214 (457)
Q Consensus       145 ~~~~~~~~~~~~~~~~~L-----G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-----pniv~  214 (457)
                      +.+++.....+|.+++..     ..|---+.|+...++| .+++|+.....  ....+..|++++..|..     |..+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            456778888888875543     4566678899887655 58888875431  22334556667766632     22221


Q ss_pred             EEE---EEEcCCeEEEEEEeCCCCcHHH--------------HHhhhCCCC-----CCCC------------------HH
Q 012739          215 LLG---YCADQNHRLLISEYMPNGTLQQ--------------HLHRHNNRY-----RPLD------------------WR  254 (457)
Q Consensus       215 l~~---~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~-----~~l~------------------~~  254 (457)
                      ..+   +.........++.+..+.....              .++......     ....                  ..
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            110   1223455667777766543210              111100000     0000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHhc-CCCCeEeccCccCceEeCCCCcEEEeeccCcc
Q 012739          255 TRLIIALDCAMALEFLHEH-ATPPVIHRDFKCSNVLLDQNFRAKVTDFGLAK  305 (457)
Q Consensus       255 ~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl~~  305 (457)
                      .....+......+...... -...+||+|+.++||+++++...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1111122222222222211 12249999999999999998878999999875